-DOCSTART- -X- N

rofecoxib NN Pharmocological
, , None
celecoxib NN Pharmocological
acetaminophen NN Pharmocological
acetaminophen NN Pharmocological
celecoxib $ Pharmocological
rofecoxib VBZ Pharmocological
rofecoxib VB Pharmocological
[ NNP None
Vioxx NNP Pharmocological
, , None
Acetaminophen NNP Pharmocological
, , None
Celecoxib NNP Pharmocological
acetaminophen NN Pharmocological
, , None
celecoxib NN Pharmocological
, , None
rofecoxib VBZ Pharmocological
rofecoxib VBZ Pharmocological
acetaminophen NN Pharmocological
rofecoxib CC Pharmocological
celecoxib NN Pharmocological
rofecoxib NN Pharmocological
rofecoxib NN Pharmocological
celecoxib NN Pharmocological
Rofecoxib $ Pharmocological
celecoxib NN Pharmocological
rofecoxib NN Pharmocological
celecoxib NN Pharmocological
acetaminophen VB Pharmocological
. . None
celecoxib NN Pharmocological
rofecoxib VB Pharmocological
acetaminophen NN Pharmocological
Rofecoxib NNP Pharmocological
celecoxib NN Pharmocological
acetaminophen VB Pharmocological
. . None
celecoxib $ Pharmocological
Rofecoxib NNP Pharmocological
celecoxib $ Pharmocological
-DOCSTART- -X- N

Gamma-hydroxybutyric JJ Pharmocological
acid NN Pharmocological
clomethiazole NN Pharmocological
Clomethiazole NNP Pharmocological
( ( Pharmocological
CLO NNP Pharmocological
) ) Pharmocological
Gamma-Hydroxybutyric JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
GHB NNP Pharmocological
) ) Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
GHB NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
GHB NNP Pharmocological
CLO NNP Pharmocological
-DOCSTART- -X- N

simvastatin VB Pharmocological
simvastatin NN None
on IN None
mg NNS None
of IN None
simvastatin NN None
or CC None
placebo NN None
the DT None
simvastatin NN None
and CC None
placebo NN None
of IN None
simvastatin NN None
. . None
The DT None
joint JJ None
-DOCSTART- -X- N

active-learning JJ Psychological
strategies NNS Psychological
motivational JJ Educational
interviewing NN Educational
lecture NN Educational
practice NN Psychological
activities NNS Psychological
( ( Psychological
written VBN Psychological
dialogue NN Psychological
, , Psychological
peer VB Psychological
role-play NN Psychological
, , Psychological
or CC Psychological
mock-patient JJ Psychological
counseling NN Psychological
activities NNS Psychological
) ) Psychological
mock-patient JJ Educational
counseling NN Educational
-DOCSTART- -X- N

Triple JJ Pharmocological
antiretroviral JJ Pharmocological
zidovudine NN Pharmocological
nevirapine JJ Pharmocological
prophylaxis NN Pharmocological
mg NNS None
zidovudine NN None
, , None
mg NN None
lamivudine NN None
, , None
mg NN None
lopinavir NN None
plus CC None
mg NN None
ritonavir NN None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
( ( None
zidovudine NN None
twice RB None
zidovudine JJ None
plus CC None
nevirapine NN None
at IN None
post-partum JJ None
zidovudine NN None
300 CD None
nevirapine NN None
at IN None
3?3-7?7 CD None
% NN None
) ) None
in IN None
the DT None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
group NN None
, , None
and CC None
in IN None
the DT None
zidovudine NN None
nevirapine NN None
group NN None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
group NN None
( ( None
p=0?017 NN None
the DT None
zidovudine NN None
and CC None
single-dose JJ None
nevirapine NN None
group NN None
-DOCSTART- -X- N

estrogens NNS Pharmocological
. . None
GH NNP Pharmocological
treatment NN Pharmocological
combining VBG Pharmocological
GH NNP Pharmocological
treatment NN Pharmocological
with IN Pharmocological
low JJ Pharmocological
dose NN Pharmocological
estrogens NNS Pharmocological
GH NNP Pharmocological
treatment NN Pharmocological
micronized VBN Pharmocological
17beta-estradiol CD Pharmocological
estrogen NN Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

Prizidilol NNP Pharmocological
hydrochloride NN Pharmocological
Isoprenaline JJ Pharmocological
prizidilol NN Pharmocological
prizidilol NN Pharmocological
propranolol NN Pharmocological
prizidilol NN Pharmocological
-DOCSTART- -X- N

Spatial JJ Other
orientation NN Other
adjustments NNS Other
wore VBD Physical
ambient JJ Other
prism NN Other
lenses NNS Other
alterations NNS Other
to TO Other
the DT Other
sensory JJ Other
systems NNS Other
-DOCSTART- -X- N

doxepin NN Pharmocological
bupropion NN Pharmocological
bupropion NN Pharmocological
doxepin VB Pharmocological
placebo NN Control
Doxepin NNP Pharmocological
bupropion NN Pharmocological
doxepin NN Pharmocological
bupropion NN Pharmocological
Doxepin NNP Pharmocological
bupropion NN Pharmocological
doxepin NN Pharmocological
bupropion NN Pharmocological
-DOCSTART- -X- N

play NN Educational
and CC Educational
joint JJ Educational
attention NN Educational
intervention NN Educational
symbolic NN Educational
play NN Educational
then RB Educational
joint JJ Educational
attention NN Educational
intervention NN Educational
joint NN Educational
attention NN Educational
then RB Educational
symbolic JJ Educational
intervention NN Educational
wait-list NN Control
control NN Control
period NN Control
then RB Control
further RB Control
randomized VBN Control
to TO Control
either DT Control
group NN Control
1 CD Control
or CC Control
group NN Control
2 CD Control
. . Control
-DOCSTART- -X- N

oral JJ Pharmocological
zinc NN Pharmocological
sulfate NN Pharmocological
placebo-controlled JJ Control
with IN None
fluoxetine JJ None
plus CC None
zinc NN None
with IN None
fluoxetine JJ None
plus CC None
placebo NN None
. . None
that IN None
zinc NN None
, , None
-DOCSTART- -X- N

Low-fluence JJ Physical
photodynamic JJ Physical
therapy NN Physical
ranibizumab NN Pharmocological
low-fluence NN Physical
PDT NNP Physical
or CC None
3 CD Pharmocological
consecutive JJ Pharmocological
monthly JJ Pharmocological
injections NNS Pharmocological
of IN Pharmocological
ranibizumab NN Pharmocological
. . None
Rescue NNP Control
treatment NN Control
-DOCSTART- -X- N

methotrexate NN Pharmocological
placebo NN Control
methotrexate NN Pharmocological
methotrexate NN Pharmocological
placebo NN None
methotrexate NN Pharmocological
methotrexate NN Pharmocological
-DOCSTART- -X- N

interferon NN Pharmocological
IFN-alpha JJ Pharmocological
2b CD Pharmocological
IFN-alpha JJ Pharmocological
2b CD Pharmocological
( ( Pharmocological
HDI NNP Pharmocological
) ) Pharmocological
Obs NNP Pharmocological
HDI NNP Pharmocological
Obs NNP Pharmocological
HDI NNP Pharmocological
Obs NNP Pharmocological
-DOCSTART- -X- N

loop NN Surgical
vs. FW None
holder NN Surgical
techniques NNS Surgical
. . None
holder NN Surgical
versus IN Surgical
the DT Surgical
paper NN Surgical
loop NN Surgical
technique NN Surgical
. . None
bitewing NN None
holder NN Surgical
and CC Surgical
paper NN Surgical
loop NN Surgical
techniques NNS Surgical
. . None
bitewing NN Surgical
technique NN Surgical
loop NN Surgical
technique NN Surgical
holder NN Surgical
technique NN Surgical
. . Surgical
loop NN Surgical
technique NN Surgical
holder NN Surgical
technique NN Surgical
. . Surgical
loop NN Surgical
and CC Surgical
holder NN Surgical
techniques NNS Surgical
-DOCSTART- -X- N

enflurane NN Pharmocological
versus NN None
propofol NN Pharmocological
. . None
Group NNP None
1 CD None
( ( None
control NN None
) ) None
received VBD None
thiopental JJ Pharmocological
sodium NN Pharmocological
4 CD Pharmocological
mg/kg NN Pharmocological
intravenously RB Pharmocological
( ( None
i.v JJ None
. . None
) ) None
, , None
followed VBN None
by IN None
0.5 CD Pharmocological
% NN Pharmocological
to TO Pharmocological
1.5 CD Pharmocological
% NN Pharmocological
enflurane NN Pharmocological
and CC None
67 CD Pharmocological
% NN Pharmocological
N2O NNP Pharmocological
in IN Pharmocological
oxygen NN Pharmocological
( ( Pharmocological
O2 NNP Pharmocological
) ) None
. . None
Group NNP Pharmocological
2 CD Pharmocological
received VBD Pharmocological
propofol JJ Pharmocological
2 CD Pharmocological
mg/kg NN Pharmocological
i.v. NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
to TO Pharmocological
1.5 CD Pharmocological
% NN Pharmocological
enflurane NN Pharmocological
and CC Pharmocological
67 CD Pharmocological
% NN Pharmocological
N2O NNP Pharmocological
in IN Pharmocological
O2 NNP Pharmocological
. . Pharmocological
Group NNP Pharmocological
3 CD Pharmocological
received VBD Pharmocological
propofol JJ Pharmocological
2 CD Pharmocological
mg/kg NN Pharmocological
i.v. NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
50 CD Pharmocological
to TO Pharmocological
160 CD Pharmocological
micrograms/kg/min NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
and CC Pharmocological
67 CD Pharmocological
% NN Pharmocological
N2O NNP Pharmocological
in IN Pharmocological
O2 NNP Pharmocological
. . Pharmocological
succinylcholine JJ Pharmocological
atracurium NN Pharmocological
thiopental-enflurane-N2O JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
1 CD Pharmocological
) ) Pharmocological
propofol-propofol-N2O JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
3 CD Pharmocological
) ) Pharmocological
propofol NN Pharmocological
thiopental JJ Pharmocological
enflurane NN Pharmocological
propofol NN Pharmocological
enflurane NN Pharmocological
propofol NN Pharmocological
thiopental JJ Pharmocological
. . None
enflurane NN Pharmocological
propofol NN Pharmocological
enflurane NN Pharmocological
-DOCSTART- -X- N

budesonide JJ Pharmocological
Turbuhaler NNP Pharmocological
budesonide JJ Pharmocological
aqua NN Pharmocological
budesonide NN Pharmocological
Turbuhaler NNP Pharmocological
budesonide JJ Pharmocological
aqua NN Pharmocological
budesonide NN Pharmocological
Turbuhaler NNP Pharmocological
Turbuhaler NNP Pharmocological
aqua NN Pharmocological
spray NN Pharmocological
budesonide NN Pharmocological
aqua NN Pharmocological
budesonide NN Pharmocological
Turbuhaler NNP Pharmocological
budesonide NN Pharmocological
powder NN Pharmocological
Turbuhaler NNP Pharmocological
aqua JJ Pharmocological
-DOCSTART- -X- N

750 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
stored JJ Pharmocological
plasma NN Pharmocological
, , None
750 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
fresh JJ Pharmocological
frozen JJ Pharmocological
plasma NN Pharmocological
, , None
and CC None
then RB None
an DT None
infusion NN Pharmocological
of IN Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
Infusion NN Pharmocological
of IN Pharmocological
fresh JJ Pharmocological
frozen JJ Pharmocological
plasma NN Pharmocological
Angiotensin NNP Pharmocological
II NNP Pharmocological
infusion NN Pharmocological
1,000 CD Pharmocological
ml NNS Pharmocological
of IN Pharmocological
fresh JJ Pharmocological
frozen JJ Pharmocological
plasma NN Pharmocological
-DOCSTART- -X- N

FK506 NNP Pharmocological
( ( Pharmocological
tacrolimus NN Pharmocological
) ) Pharmocological
and CC None
cyclosporin NN Pharmocological
cyclosporin NN Pharmocological
. . None
cyclosporin NN Pharmocological
tacrolimus NN Pharmocological
. . None
nifedipine NN Pharmocological
tacrolimus NN Pharmocological
Tacrolimus NNP Pharmocological
cyclosporin NN Pharmocological
-DOCSTART- -X- N

natriuretic JJ Pharmocological
peptide NN Pharmocological
oxidative JJ Educational
natriuretic JJ Pharmocological
peptide NN Pharmocological
oxidative JJ None
stress NN None
-DOCSTART- -X- N

Non-pharmacological JJ Educational
treatment NN Educational
( ( Educational
NPT NNP Educational
) ) Educational
NPT NNP Educational
six CD Educational
self-management JJ Educational
group NN Educational
sessions NNS Educational
provided VBN Educational
by IN Educational
a DT Educational
multi-disciplinary JJ Educational
team NN Educational
two CD Control
group NN Control
sessions NNS Control
and CC Control
four CD Control
sessions NNS Control
by IN Control
telephone NN Control
non-pharmacological JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

evaluating VBG None
-DOCSTART- -X- N

sedation NN Pharmocological
techniques NNS Pharmocological
midazolam NN Pharmocological
and CC None
pethidine NN Pharmocological
combination NN Pharmocological
midazolam NN Pharmocological
and CC None
tramadol JJ Pharmocological
combination NN Pharmocological
. . None
midazolam JJ Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
pethidine NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
intravenously RB Pharmocological
midazolam JJ Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
tramadol NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
pethidine NN Pharmocological
tramadol NN Pharmocological
Midazolam-tramadol NNP Pharmocological
combination NN Pharmocological
midazolam-pethidine JJ Pharmocological
combination NN Pharmocological
-DOCSTART- -X- N

RRR-alpha-tocopheryl NNP Pharmocological
acetate NN Pharmocological
and CC None
fish JJ Pharmocological
oil NN Pharmocological
RRR-alpha-tocpheryl NNP Pharmocological
acetate NN Pharmocological
( ( Pharmocological
alpha-tocopheryl JJ Pharmocological
acetate NN Pharmocological
) ) Pharmocological
and CC None
hormone-replacement JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
) ) None
alpha-tocopheryl JJ Pharmocological
acetate JJ Pharmocological
placebo NN Control
alpha-tocopheryl JJ Pharmocological
-DOCSTART- -X- N

reporting VBG Physical
the DT Physical
presence NN Physical
of IN Physical
MBD NNP Physical
in IN Physical
the DT Physical
screening NN Physical
mammography NN Physical
results NNS Physical
letter NN Physical
that WDT Physical
was VBD Physical
sent VBN Physical
along IN Physical
with IN Physical
an DT Physical
information NN Physical
pamphlet NN Physical
. . None
controls NNS Control
annual JJ Physical
clinical JJ Physical
breast NN Physical
examination NN Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
valproate NN Pharmocological
valproate JJ Pharmocological
placebo-controlled JJ Control
valproate NN Pharmocological
( ( Pharmocological
VPA NNP Pharmocological
) ) Pharmocological
placebo NN Control
( ( Pharmocological
PBO NNP Pharmocological
) ) Pharmocological
VPA NNP Pharmocological
PBO NNP Pharmocological
VPA NNP Pharmocological
VPA NNP Pharmocological
PBO NNP Pharmocological
VPA NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

atropine NN Pharmocological
and CC None
scopolamine NN Pharmocological
unilateral JJ Physical
or CC Physical
bilateral JJ Physical
otoplasty NN Physical
scopolamine NN Pharmocological
scopolamine NN None
( ( None
TTS-scopolamine NNP None
) ) None
placebo NN Control
atropine JJ Pharmocological
10 CD None
microg NN None
x NN None
kg NN None
( ( None
-1 NNP None
) ) None
intravenously RB None
scopolamine-treated JJ Pharmocological
atropine-treated JJ Pharmocological
TTS-scopolamine NNP Pharmocological
TTS-scopolamine-treated JJ Pharmocological
atropine-treated JJ None
atropine-treated JJ Pharmocological
scopolamine-treated JJ Pharmocological
TTS-scopolamine NNP Pharmocological
TTS-scopolamine JJ Pharmocological
TTS-scopolamine NNP Pharmocological
-DOCSTART- -X- N

Low-frequency NNP Physical
repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
rTMS NN Physical
) ) Physical
low-frequency NN Physical
, , Physical
repetitive JJ Physical
Transcranial NNP Physical
Magnetic NNP Physical
Stimulation NNP Physical
( ( Physical
rTMS NN Physical
) ) Physical
low-frequency NN Physical
rTMS NN Physical
-DOCSTART- -X- N

local JJ Physical
anaesthetics NNS Physical
EMLA NNP Pharmocological
cream NN Pharmocological
Ametop NNP Pharmocological
gel NN Pharmocological
Ametop NNP Pharmocological
gel NN Pharmocological
-DOCSTART- -X- N

intramammary JJ Pharmocological
tilmicosin NN Pharmocological
intramammary JJ Pharmocological
infusion NN Pharmocological
, , Pharmocological
containing VBG Pharmocological
tilmicosin NN Pharmocological
phosphate NN Pharmocological
infusion NN Control
of IN Control
a DT Control
negative JJ Control
control NN Control
intramammary JJ Control
placebo NN Control
intramammary JJ Pharmocological
tilmicosin NNS Pharmocological
intramammary JJ Pharmocological
placebo NN Pharmocological
intramammary JJ Pharmocological
tilmicosin NN Pharmocological
-DOCSTART- -X- N

simulators NNS Other
simulator-based JJ Other
OSCE NNP Other
. . None
simulator-based JJ Other
OSCE NNP Other
-DOCSTART- -X- N

Lightwand NNP Surgical
or CC Physical
GlideScope NNP Surgical
to TO Physical
Macintosh NNP Surgical
laryngoscopy NN Surgical
, , Physical
with IN Physical
in-line JJ Surgical
stabilization NN Surgical
. . None
manual JJ Physical
ventilation NN Physical
via IN Physical
bag-mask NN Physical
, , Physical
laryngoscopy NN Surgical
, , Physical
and CC Physical
intubation NN Surgical
. . None
-DOCSTART- -X- N

Minimal NNP None
clinically RB None
important JJ None
change NN None
MCIC NNP None
MCIC NNP None
MCIC NNP None
MCIC NNP None
MCIC NNP None
-DOCSTART- -X- N

estrogens NNS Pharmocological
systemic JJ Physical
hormone NN Physical
therapy NN Physical
( ( Physical
HT NNP Physical
) ) Physical
placebo NN Control
HT NNP Pharmocological
plus CC Pharmocological
vaginal JJ Pharmocological
estriol NN Pharmocological
0.5 CD Pharmocological
mg/day NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

sunitinib NN Pharmocological
37.5 CD Pharmocological
mg/d NN Pharmocological
continuously RB None
or CC None
placebo VB Control
. . None
oral JJ Pharmocological
prednisone NN Pharmocological
5 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
. . None
-DOCSTART- -X- N

5 CD Pharmocological
alpha-reductase JJ Pharmocological
inhibitor NN Pharmocological
finasteride NN Pharmocological
. . None
Finasteride NNP Pharmocological
-DOCSTART- -X- N

improvisational JJ Educational
music NN Educational
therapy NN Educational
. . None
musical JJ Educational
interaction NN Educational
improvisational JJ Other
music NN Other
therapy NN Other
improvisational JJ Educational
music NN Educational
therapy NN Educational
and CC Educational
toy NN Educational
play NN Educational
sessions NNS Educational
, , Educational
and CC Educational
DVD NNP Educational
analysis NN Educational
of IN Educational
sessions NNS Educational
. . None
Improvisational JJ Other
music NN Other
therapy NN Other
toy NN Educational
play NN Educational
sessions NNS Educational
. . None
music NN Other
therapy NN Other
. . None
music NN Educational
therapy NN Educational
-DOCSTART- -X- N

Three NNP Psychological
Component NNP Psychological
Model NNP Psychological
( ( Psychological
3CM CD Psychological
) ) Psychological
usual JJ Control
care NN Control
usual JJ Control
care NN Control
usual JJ Educational
care NN Educational
plus CC Educational
3CM CD Educational
3CM CD Psychological
telephone NN Educational
care NN Educational
management NN Educational
3CM CD Educational
3CM CD Educational
-DOCSTART- -X- N

angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
imidapril NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
imidapril NN Pharmocological
imidapril NN Pharmocological
placebo NN Control
imidapril NN Pharmocological
placebo NN Control
placebo NN Control
imidapril NN Pharmocological
-DOCSTART- -X- N

low-dose JJ None
monoethylglycinexylidide JJ None
test NN None
: : None
lidocaine NN Pharmocological
monoethylglycinexylidide NN Pharmocological
( ( Pharmocological
MEG-X NNP Pharmocological
) ) Pharmocological
MEG-X NNP Pharmocological
lidocaine-induced JJ Pharmocological
MEG-X NNP Pharmocological
lidocaine JJ None
( ( None
MEG-X NNP Pharmocological
lidocaine NN Pharmocological
[ JJ None
MEG-X30min NNP Pharmocological
] NNP None
MEG-X NNP Pharmocological
MEG-X NNP None
MEG-X JJ None
MEG-X JJ None
MEG-X NNP None
-DOCSTART- -X- N

Acute NNP None
prolactin NN Pharmocological
and CC None
oxytocin JJ Pharmocological
-DOCSTART- -X- N

preoperative JJ Pharmocological
to TO Pharmocological
perioperative JJ Pharmocological
chemotherapy NN Pharmocological
preoperative JJ Pharmocological
( ( Pharmocological
PRE NNP Pharmocological
) ) Pharmocological
as IN Pharmocological
opposed VBN Pharmocological
to TO Pharmocological
perioperative VB Pharmocological
( ( Pharmocological
PERI NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
two CD None
chemotherapy NN None
regimens NNS None
( ( None
gemcitabine-cisplatin JJ None
[ NNP None
GP NNP None
] NNP None
versus IN None
paclitaxel-carboplatin JJ None
[ NNP None
TC NNP None
] NNP None
) ) None
. . None
The DT None
PRE NNP None
the DT None
PERI NNP None
receiving VBG None
preoperative JJ None
and CC None
perioperative JJ None
chemotherapy NN None
-DOCSTART- -X- N

Supplemental JJ Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
Supplemental NNP Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
supplemental JJ Pharmocological
oxygen NN Pharmocological
30 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
80 CD Pharmocological
% NN Pharmocological
fraction NN Pharmocological
of IN Pharmocological
inspired JJ Pharmocological
oxygen NN Pharmocological
30 CD Pharmocological
% NN Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
80 CD Pharmocological
% NN Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
. . None
80 CD Pharmocological
% NN Pharmocological
FIO2 NNP Pharmocological
30 CD Pharmocological
% NN Pharmocological
FIO2 NNP Pharmocological
supplemental JJ Pharmocological
inspired JJ Pharmocological
oxygen NN Pharmocological
Supplemental JJ Pharmocological
oxygen NN Pharmocological
-DOCSTART- -X- N

coronary JJ Surgical
angioplasty NN Surgical
and CC None
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
and CC None
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
surgery NN Surgical
. . None
coronary JJ Surgical
angioplasty NN Surgical
or CC None
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

field NN Physical
, , Physical
total JJ Physical
lymphoid NN Physical
, , Physical
or CC Physical
whole JJ Physical
body NN Physical
irradiation NN Physical
, , None
single JJ Pharmocological
alkylating VBG Pharmocological
agent NN Pharmocological
chemotherapy NN Pharmocological
, , None
combination NN Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
CVP NNP Pharmocological
) ) Pharmocological
or CC None
with IN None
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
procarbazine NN Pharmocological
, , Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
C-MOPP NNP Pharmocological
) ) Pharmocological
, , None
or CC None
various JJ None
combinations NNS None
of IN None
chemotherapy NN Pharmocological
and CC None
irradiation NN Physical
. . None
-DOCSTART- -X- N

Moderate-intensity NNP Physical
exercise NN Physical
training NN Physical
moderate-intensity JJ Physical
step NN Physical
aerobics NNS Physical
training NN Physical
moderate-intensity NN Physical
( ( Physical
50 CD Physical
% NN Physical
of IN Physical
peak NN Physical
oxygen NN Physical
uptake NN Physical
) ) Physical
12-week JJ Physical
training NN Physical
program NN Physical
, , None
progressing VBG Physical
to TO Physical
100 CD Physical
minutes NNS Physical
per IN Physical
week NN Physical
of IN Physical
step NN Physical
aerobics NNS Physical
and CC Physical
50 CD Physical
minutes NNS Physical
per IN Physical
week NN Physical
of IN Physical
cycling NN Physical
. . None
perform VB Physical
a DT Physical
training NN Physical
program NN Physical
. . None
-DOCSTART- -X- N

Dopamine NNP Pharmocological
transporter NN Pharmocological
gene NN Pharmocological
dopamine NN Pharmocological
transporter NN Pharmocological
gene NN Pharmocological
( ( Pharmocological
SCL6A3/DAT1 NNP Pharmocological
) ) Pharmocological
behavioral JJ Educational
parent NN Educational
training NN Educational
( ( Educational
BPT NNP Educational
) ) Educational
. . Educational
the DT None
dopamine NN None
system NN None
in IN None
BPT NNP None
. . None
-DOCSTART- -X- N

chelation NN Pharmocological
therapy NN Pharmocological
EDTA NNP Pharmocological
chelation NN Pharmocological
therapy NN Pharmocological
treatment NN None
and CC None
control NN None
groups NNS None
. . None
INTERVENTION NNP None
weekly JJ None
chelation NN None
therapy NN None
for IN None
received VBD None
placebo NN None
for IN None
-DOCSTART- -X- N

iron NN Pharmocological
Paracetamol NNP Pharmocological
iron NN Pharmocological
. . None
Paracetamol NNP Pharmocological
alone RB None
or CC None
( ( None
300 CD None
mg NN None
) ) None
ferrous JJ Pharmocological
sulphate NN Pharmocological
ferrous JJ Pharmocological
sulphate NN Pharmocological
and CC None
paracetamol NN Pharmocological
iron NN Pharmocological
and CC None
paracetamol JJ Pharmocological
-DOCSTART- -X- N

saccadic JJ Educational
eye NN Educational
movements NNS Educational
3 CD Educational
saccadic JJ Educational
eye NN Educational
movement NN Educational
tasks NNS Educational
of IN None
increasing VBG None
difficulty NN None
. . None
-DOCSTART- -X- N

antiangiogenesis NN Pharmocological
therapy NN Pharmocological
anti-neoplastic JJ None
treatment NN None
antiangiogenic JJ Physical
therapy NN Physical
. . None
chemotherapy NN Physical
chemotherapy NN Physical
plus CC Physical
Endostar NNP Physical
) ) None
chemotherapy NN Physical
chemotherapy NN Physical
with IN Physical
Endotatar NNP Physical
) ) None
chemotherapy NN Physical
chemotherapy NN Physical
with IN Physical
Endostar NNP Physical
antiangiogenic JJ Physical
therapy NN Physical
-DOCSTART- -X- N

ketorolac NN Pharmocological
pethidine NN Pharmocological
. . None
thiopentone NN Pharmocological
and CC Pharmocological
suxamethonium NN Pharmocological
and CC Pharmocological
maintained VBD Pharmocological
with IN Pharmocological
atracurium NN Pharmocological
, , Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
and CC Pharmocological
isoflurane NN Pharmocological
. . None
Intravenous JJ Pharmocological
fentanyl JJ Pharmocological
100 CD None
micrograms NN None
was VBD None
given VBN None
after IN None
delivery NN None
of IN None
the DT None
neonate NN None
. . None
-DOCSTART- -X- N

surveillance NN Physical
surveillance NN Physical
surveillance VB Physical
2 CD Physical
years NNS Physical
( ( Physical
group NN Physical
A NNP Physical
) ) Physical
4 CD Physical
years NNS Physical
-DOCSTART- -X- N

control VB Control
( ( Control
standard JJ Control
care NN Control
plus CC Control
telephone NN Control
follow-up NN Control
or CC None
intervention NN Educational
post-PCI JJ Educational
-DOCSTART- -X- N

radiotherapy NN Physical
radiotherapy NN Physical
-DOCSTART- -X- N

mebendazole NN Pharmocological
mebendazole NN Pharmocological
( ( Pharmocological
Phardazone NNP Pharmocological
) ) Pharmocological
mebendazole NN Pharmocological
placebo-controlled JJ Control
mebendazole NN Pharmocological
placebo NN Control
placebo VB Control
mebendazole NN Pharmocological
albendazole NN Pharmocological
albendazole NN Pharmocological
placebo NN Control
placebo VB Control
mebendazole NN Pharmocological
albendazole NN Pharmocological
albendazole NN Pharmocological
. . None
albendazole NN Pharmocological
. . None
anti-helminth JJ Pharmocological
therapies NNS Pharmocological
-DOCSTART- -X- N

bedside-precepted JJ Educational
visit NN Educational
with IN Educational
an DT Educational
specialist NN Educational
with IN Educational
pain NN Educational
specialization NN Educational
and CC Educational
a DT Educational
focus NN Educational
group NN Educational
to TO Educational
discuss VB Educational
attitudinal JJ Educational
issues NNS Educational
. . None
-DOCSTART- -X- N

patient JJ Educational
education NN Educational
and CC None
supervised VBD Physical
exercise NN Physical
patient JJ Educational
education NN Educational
alone RB Educational
patient JJ Educational
education NN Educational
and CC None
supervised VBD Other
exercise NN Other
patient JJ Educational
education NN Educational
alone RB Educational
Patient NNP Educational
education NN Educational
( ( Educational
PE NNP Educational
) ) Educational
. . None
Patient JJ Educational
education NN Educational
and CC None
supervised VBN Physical
exercise NN Physical
( ( None
PE+SE NNP None
) ) None
. . None
PE+SE NNP Physical
PE NNP Educational
PE NNP Educational
and CC None
SE NNP Physical
. . None
PE NNP Educational
program NN Educational
12-week JJ None
SE NNP None
program NN None
between IN None
PE+SE NNP None
vs NNP None
PE NNP None
alone RB None
. . None
Adding VBG None
SE NNP None
to TO None
PE NNP None
may MD None
-DOCSTART- -X- N

2-Chloroprocaine JJ Pharmocological
2-Chloroprocaine JJ Pharmocological
( ( Pharmocological
2-CP JJ Pharmocological
) ) Pharmocological
morphine NN Pharmocological
( ( Pharmocological
EM NNP Pharmocological
) ) Pharmocological
EM NNP Pharmocological
2-CP JJ Pharmocological
. . None
2-CP JJ Pharmocological
, , None
2-CP JJ Pharmocological
+ NN Pharmocological
epinephrine NN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
( ( Pharmocological
Lido NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
Epi NNP Pharmocological
EM NNP Pharmocological
PCA NNP Pharmocological
morphine NN Pharmocological
2-CP JJ Pharmocological
, , None
2-CP+Epi JJ Pharmocological
Lido+Epi NNP None
2-CP JJ Pharmocological
2-CP JJ Pharmocological
EM NNP Pharmocological
2-CP JJ Pharmocological
Lido NNP Pharmocological
+ NNP Pharmocological
Epi NNP Pharmocological
-DOCSTART- -X- N

magnesium NN Pharmocological
sulphate NN Pharmocological
infusion NN Pharmocological
Magnesium NNP Pharmocological
sulphate NN Pharmocological
magnesium NN Pharmocological
Spinal NNP Surgical
anaesthesia NN Surgical
was VBD Surgical
performed VBN Surgical
at IN Surgical
L3-4 NNP Surgical
or CC Surgical
L4-5 NNP Surgical
interspace NN Surgical
with IN Surgical
12.5 CD Surgical
mg NNS Surgical
0.5 CD Surgical
% NN Surgical
heavy JJ Surgical
bupivacaine NN Surgical
, , Surgical
using VBG Surgical
a DT Surgical
25 CD Surgical
G NNP Surgical
Quincke NNP Surgical
needle NN Surgical
. . None
Patients NNS None
received VBD None
a DT None
5 CD Pharmocological
mg NN Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
bolus NN Pharmocological
of IN Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
a DT Pharmocological
500 CD Pharmocological
mg NN Pharmocological
h NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
infusion NN Pharmocological
or CC Pharmocological
saline NN Pharmocological
Magnesium NNP Pharmocological
sulphate JJ Pharmocological
-DOCSTART- -X- N

human JJ Pharmocological
brain NN Pharmocological
natriuretic JJ Pharmocological
peptide NN Pharmocological
Human NNP Pharmocological
brain NN Pharmocological
natriuretic JJ Pharmocological
peptide NN Pharmocological
( ( Pharmocological
hBNP NN Pharmocological
) ) Pharmocological
hBNP NNS Pharmocological
hBNP NN Pharmocological
placebo-controlled JJ Control
placebo JJ Control
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
placebo VB Control
hBNP VB Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP JJ Pharmocological
hBNP NN Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
chemoradiotherapy NN Pharmocological
Preoperative NNP Physical
chemoradiotherapy NN Physical
radiotherapy VB Physical
-DOCSTART- -X- N

Questionnaire NNP Other
. . None
Siriraj NNP Other
Asthma NNP Other
Control NNP Other
Questionnaire NNP Other
Kruskal-Wallis NNP Other
test NN Other
Siriraj NNP Other
Asthma NNP Other
Control NNP Other
Questionnaire NNP Other
-DOCSTART- -X- N

DNAemia NNP Physical
cut-off NN Physical
qualitative JJ Pharmocological
pp65 NN Pharmocological
antigenemia NN Pharmocological
. . None
quantitative JJ Pharmocological
DNAemia NNP Pharmocological
versus NN None
positive JJ Pharmocological
antigenemia NN Pharmocological
DNAemia NNP Pharmocological
antiviral JJ Pharmocological
therapy NN Pharmocological
DNAemia NNP Physical
cut-off NN Physical
positive JJ Pharmocological
antigenemia NN Pharmocological
. . None
DNAemia NNP Physical
DNAemia NNP Pharmocological
cut-off NN Pharmocological
antiviral JJ Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

prajmalium NN Pharmocological
bitartrate NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
tablet NN Pharmocological
( ( None
Neo-Gilurytmal JJ Pharmocological
, , Pharmocological
CAS NNP Pharmocological
2589-47-1 CD Pharmocological
) ) None
compared VBN None
to TO None
an DT None
oral JJ Pharmocological
solution NN Pharmocological
-DOCSTART- -X- N

factor NN Pharmocological
Xa NNP Pharmocological
inhibitor NN Pharmocological
fondaparinux NN Pharmocological
fondaparinux NN Pharmocological
fondaparinux NN Pharmocological
Fondaparinux NNP Pharmocological
-DOCSTART- -X- N

PRL-8-53 NN Pharmocological
: : None
psychotropic NN Pharmocological
3- JJ Pharmocological
( ( Pharmocological
2-benzylmethylaminoethyl JJ Pharmocological
) ) Pharmocological
benzoic NN Pharmocological
acid JJ Pharmocological
methyl NN Pharmocological
ester NN Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
PRL-8-53 NNP Pharmocological
) ) Pharmocological
PRL-8-53 NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

leisure NN Educational
programme NN Educational
1-year JJ Educational
group NN Educational
leisure NN Educational
programme NN Educational
interaction NN Educational
with IN Educational
media NNS Educational
, , None
engagement NN Educational
in IN Educational
exercise NN Educational
, , None
playing VBG Educational
games NNS Educational
and CC Educational
doing VBG Educational
crafts NNS Educational
, , None
attending VBG Educational
events NNS Educational
, , None
and CC None
participating VBG Educational
in IN Educational
other JJ Educational
recreation NN Educational
activities NNS Educational
-DOCSTART- -X- N

PRO NNP Physical
discharge NN Physical
screens NNS Physical
Multivariate NNP Other
logistic JJ Other
regression NN Other
analysis NN Other
Generic NNP Other
discharge NN Other
screens NNS Other
-DOCSTART- -X- N

training NN Educational
intervention NN Educational
with IN Educational
emphases NNS Educational
on IN Educational
the DT Educational
control NN Educational
of IN Educational
lumbar JJ Educational
neutral JJ Educational
zone NN Educational
behavior JJ Educational
modeling NN Educational
cognitive JJ Educational
behavior NN Educational
interventions NNS Educational
control VB Control
group NN Control
exercise NN Other
and CC Other
daily JJ Other
self-care NN Other
-DOCSTART- -X- N

temporal JJ Physical
repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
rTMS NN Physical
) ) Physical
temporal JJ Physical
low-frequency NN Physical
rTMS NN Physical
rTMS JJ Physical
1 CD None
Hz NNP None
rTMS NN None
over IN None
the DT None
left JJ None
temporal JJ None
cortex NN None
. . None
rTMS JJ Physical
rTMS NN Physical
rTMS VB Physical
-DOCSTART- -X- N

hospital JJ Educational
report NN Educational
cards NNS Educational
constructed VBN Educational
using VBG Educational
linked VBN Educational
hospital NN Educational
and CC Educational
prescription NN Educational
administrative JJ Educational
databases NNS Educational
Administrative NNP Educational
Data NNP Educational
Feedback NNP Educational
for IN Educational
Effective NNP Educational
Cardiac NNP Educational
Treatment NNP Educational
confidential JJ Educational
feedback NN Educational
on IN Educational
quality NN Educational
indicators NNS Educational
constructed VBD Educational
using VBG Educational
administrative JJ Educational
data NNS Educational
. . Other
report NN Educational
card NN Educational
interventions NNS Educational
. . Other
-DOCSTART- -X- N

cytokine-induced JJ Pharmocological
killer NN Pharmocological
cells NNS Pharmocological
therapy VBP Pharmocological
Adoptive JJ Pharmocological
immunotherapy NN Pharmocological
Autologous JJ Pharmocological
cytokine-induced JJ Pharmocological
killer NN Pharmocological
( ( Pharmocological
CIK NNP Pharmocological
) ) Pharmocological
cells NNS Pharmocological
were VBD None
transfused VBN None
CIK NNP Pharmocological
cell NN Pharmocological
CIK NNP Pharmocological
cell NN Pharmocological
transfusion NN Pharmocological
-DOCSTART- -X- N

Butorphanol NNP Pharmocological
and CC None
meperidine NN Pharmocological
butorphanol NN Pharmocological
meperidine NN Pharmocological
butorphanol NN Pharmocological
meperidine NN Pharmocological
butorphanol NN Pharmocological
. . None
butorphanol NN Pharmocological
butorphanol NN Pharmocological
. . None
-DOCSTART- -X- N

random JJ Physical
modulation NN Physical
of IN Physical
functional JJ Physical
electrical JJ Physical
stimulation NN Physical
parameters NNS Physical
functional JJ Physical
electrical JJ Physical
stimulation NN Physical
-DOCSTART- -X- N

nizatidine-controlled JJ Pharmocological
release NN Pharmocological
nizatidine NN Pharmocological
nizatidine NN Pharmocological
controlled VBN Pharmocological
release NN Pharmocological
( ( Pharmocological
CR NNP Pharmocological
) ) Pharmocological
nizatidine JJ Pharmocological
CR NNP Pharmocological
. . Pharmocological
single-blind JJ Pharmocological
placebo NN Pharmocological
baseline NN Pharmocological
was VBD Pharmocological
followed VBN Pharmocological
by IN Pharmocological
double-blind JJ Pharmocological
nizatidine JJ Pharmocological
CR NNP Pharmocological
( ( Pharmocological
150 CD Pharmocological
and CC Pharmocological
300 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
in IN Pharmocological
randomized VBN Pharmocological
sequence NN Pharmocological
, , Pharmocological
2 CD Pharmocological
to TO Pharmocological
5 CD Pharmocological
days NNS Pharmocological
apart RB Pharmocological
. . Pharmocological
Each DT Physical
dose NN Physical
was VBD Physical
followed VBN Physical
1 CD Physical
hour NN Physical
later RB Physical
by IN Physical
an DT Physical
egg-beater JJ Physical
meal NN Physical
, , Physical
labeled VBN Physical
with IN Physical
Tc99m NNP Physical
. . Physical
were VBD Physical
obtained VBN Physical
at IN Physical
meal JJ Physical
completion NN Physical
, , Physical
1- JJ Physical
, , Physical
2- JJ Physical
, , Physical
3- JJ Physical
and CC Physical
4-hour JJ Physical
postmeal NN Physical
. . Physical
placebo NN Control
nizatidine JJ Pharmocological
CR NNP Pharmocological
Nizatidine NNP Pharmocological
CR NNP Pharmocological
-DOCSTART- -X- N

Gabapentin NNP Pharmocological
Gabapentin NNP Pharmocological
Gabapentin NNP Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
oxazepam NN Pharmocological
( ( Pharmocological
active JJ Control
placebo NN Control
) ) Pharmocological
Gabapentin NNP Pharmocological
placebo NN Control
gabapentin-treated JJ Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
oxazepam NN Pharmocological
gabapentin NN Pharmocological
. . None
-DOCSTART- -X- N

donepezil NN Pharmocological
placebo-controlled JJ Control
donepezil NN Pharmocological
placebo NN Pharmocological
or CC None
donepezil NN None
donepezil JJ Pharmocological
donepezil RB Pharmocological
-DOCSTART- -X- N

Moist NN Pharmocological
Exposed VBD Pharmocological
Burn NNP Pharmocological
Ointment NNP Pharmocological
( ( Pharmocological
MEBO NNP Pharmocological
) ) Pharmocological
dermaheal NN Pharmocological
( ( Pharmocological
MEBO NNP Pharmocological
) ) Pharmocological
( ( None
MEBO NNP Pharmocological
) ) None
MEBO NNP Pharmocological
Flammazine NNP Pharmocological
MEBO NNP Pharmocological
. . None
MEBO NNP Pharmocological
ointment NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
estrogen NN Pharmocological
transdermal JJ Pharmocological
estrogen NN Pharmocological
oral JJ Pharmocological
or CC Pharmocological
transdermal JJ Pharmocological
estrogen NN Pharmocological
estrogen NN Pharmocological
treatment NN None
transdermal JJ Pharmocological
treatment NN Pharmocological
. . None
estrogen NN Pharmocological
GH NNP Pharmocological
Oral JJ Pharmocological
estrogen NN Pharmocological
Estrogen NNP Pharmocological
replacement NN Pharmocological
-DOCSTART- -X- N

tetanus CC Pharmocological
immune VB Pharmocological
globulin NN Pharmocological
tetanus-diphtheria JJ Pharmocological
vaccine NN Pharmocological
tetanus-diphtheria NN Pharmocological
( ( Pharmocological
Td NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
tetanus JJ Pharmocological
immune JJ Pharmocological
globulin NN Pharmocological
( ( Pharmocological
TIG NNP Pharmocological
) ) Pharmocological
. . None
was VBD None
assessed VBN None
after IN None
4 CD None
weeks NNS None
and CC None
4 CD None
months NNS None
. . None
-DOCSTART- -X- N

fixed VBN None
dose JJ None
combination NN None
lamivudine NN Pharmocological
+ NNP Pharmocological
stavudine NN Pharmocological
lamivudine JJ Pharmocological
stavudine NN Pharmocological
lamivudine NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
134678-17-4 CD Pharmocological
) ) Pharmocological
and CC None
stavudine NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
3056-17-5 CD Pharmocological
) ) Pharmocological
lamivudine JJ Pharmocological
tablet NN Pharmocological
and CC None
stavudine NN Pharmocological
capsule NN Pharmocological
lamivudine VBP Pharmocological
stavudine VBP Pharmocological
-DOCSTART- -X- N

intensive JJ Physical
therapy NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
Intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ None
treatment NN None
Intensive JJ Physical
treatment NN Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
L-carnosine NNP Pharmocological
supplementation NN Pharmocological
L-Carnosine NNP Pharmocological
, , None
a DT None
dipeptide NN Pharmocological
L-carnosine JJ Pharmocological
placebo NN Control
. . None
placebo NN Control
L-carnosine NNP Pharmocological
L-carnosine NNP Pharmocological
-DOCSTART- -X- N

tubular VB Physical
airway RP Physical
resistance NN Physical
endotracheal JJ Surgical
tube NN Surgical
a DT None
mouthpiece NN Physical
fitted VBN Physical
in IN Physical
random JJ Physical
order NN Physical
with IN Physical
a DT Physical
5 CD Physical
, , Physical
6 CD Physical
, , Physical
7 CD Physical
, , Physical
8 CD Physical
, , Physical
or CC Physical
15 CD Physical
mm NNS Physical
diameter NN Physical
( ( Physical
17 CD Physical
mm RB Physical
long RB Physical
) ) Physical
resistor NN Physical
. . Physical
-DOCSTART- -X- N

Bevacizumab NNP Pharmocological
macular JJ Physical
laser NN Physical
grid JJ Physical
photocoagulation NN Physical
intravitreal JJ Pharmocological
injections NNS Pharmocological
of IN Pharmocological
bevacizumab NN Pharmocological
and CC None
macular JJ Physical
grid NN Physical
laser NN Physical
photocoagulation NN Physical
( ( Physical
GLP NNP Physical
) ) Physical
GLP NNP Physical
group NN None
intravitreal VB Pharmocological
bevacizumab NN Pharmocological
( ( Pharmocological
IB NNP Pharmocological
) ) Pharmocological
GLP NNP Physical
IB NNP Pharmocological
GLP NNP Physical
IB NNP Pharmocological
GLP NNP Physical
IB NNP Pharmocological
bevacizumab NN Pharmocological
bevacizumab NN Pharmocological
bevacizumab JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
porcine NN Pharmocological
secretin NN Pharmocological
secretin JJ Pharmocological
secretin NN Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
placebo-controlled JJ Control
secretin JJ Pharmocological
-DOCSTART- -X- N

early JJ Educational
intensification NN Educational
: : None
different JJ Physical
central JJ Physical
nervous JJ Physical
system NN Physical
( ( Physical
CNS NNP Physical
) ) Physical
directed VBD Physical
therapies NNS Physical
. . None
-DOCSTART- -X- N

trimetazidine NN Pharmocological
trimetazidine NN Pharmocological
-DOCSTART- -X- N

monoamine NN Pharmocological
oxidase NN Pharmocological
B NNP Pharmocological
inhibitor NN Pharmocological
mofegiline NN Pharmocological
pharmacokinetics NNS None
, , None
and CC None
pharmacodynamics NNS None
of IN None
single JJ None
oral JJ None
doses NNS None
of IN None
up IN None
to TO None
48 CD None
mg NNS None
and CC None
daily JJ None
( ( None
for IN None
28 CD None
days NNS None
) ) None
doses NNS None
of IN None
up IN None
24 CD None
mg NNS None
mofegiline NN Pharmocological
-DOCSTART- -X- N

Elastic JJ Surgical
stable JJ Surgical
intramedullary JJ Surgical
nailing VBG Surgical
nonoperative JJ Physical
treatment NN Physical
elastic JJ Surgical
stable JJ Surgical
intramedullary JJ Surgical
nailing NN Surgical
( ( Surgical
ESIN NNP Surgical
) ) Surgical
nonoperative JJ Control
treatment NN Control
simple JJ Physical
shoulder NN Physical
sling NN Physical
ESIN NNP Surgical
-DOCSTART- -X- N

hypertonic JJ Pharmocological
saline NN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
and CC Pharmocological
with IN Pharmocological
isotonic JJ Pharmocological
lactated VBN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
prehydrated VBN Pharmocological
with IN Pharmocological
isotonic JJ Pharmocological
lactated VBN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
at IN Pharmocological
7 CD Pharmocological
mg/kg NN Pharmocological
prehydration NN Pharmocological
with IN Pharmocological
3 CD Pharmocological
% NN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
at IN Pharmocological
7 CD Pharmocological
ml/kg NN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
-DOCSTART- -X- N

upright/inverted JJ Psychological
faces VBZ Psychological
with IN Psychological
direct/averted VBN Psychological
gaze NN Psychological
-DOCSTART- -X- N

Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
-DOCSTART- -X- N

levobupivacaine JJ Pharmocological
ropivacaine VB Pharmocological
bupivacaine VB Pharmocological
racemic JJ Pharmocological
bupivacaine NN Pharmocological
s-enantiomers NNS Pharmocological
levobupivacaine NN Pharmocological
ropivacaine NN Pharmocological
levobupivacaine JJ Pharmocological
ropivacaine VB Pharmocological
bupivacaine JJ Pharmocological
bupivacaine JJ Pharmocological
ropivacaine VB Pharmocological
levobupivacaine VB Pharmocological
-DOCSTART- -X- N

Heparan NNP Pharmocological
sulfate NN Pharmocological
randomly RB None
assigned VBN None
to TO None
heparan VB Pharmocological
sulfate NN Pharmocological
( ( Pharmocological
40 CD Pharmocological
mg NN Pharmocological
orally RB Pharmocological
twice RB Pharmocological
a DT Pharmocological
day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
for IN None
6 CD None
months NNS None
. . None
heparan NN Pharmocological
sulfate NN Pharmocological
-DOCSTART- -X- N

albumin JJ Pharmocological
Autologous JJ Pharmocological
technetium-99m NN Pharmocological
( ( Pharmocological
99mTc CD Pharmocological
) ) Pharmocological
-labeled VBD Pharmocological
red JJ Pharmocological
blood NN Pharmocological
cells NNS Pharmocological
and CC None
indium-oxine NN Pharmocological
( ( Pharmocological
( ( Pharmocological
111 CD Pharmocological
) ) Pharmocological
In IN Pharmocological
) ) Pharmocological
-labeled VBD Pharmocological
human JJ Pharmocological
serum NN Pharmocological
albumin NN Pharmocological
were VBD Pharmocological
injected VBN Pharmocological
intravenously RB Pharmocological
-DOCSTART- -X- N

Galactomannan NNP Pharmocological
and CC None
PCR NNP Pharmocological
standard JJ Psychological
diagnostic JJ Psychological
strategy NN Psychological
biomarker-based JJ Pharmocological
diagnostic JJ Pharmocological
strategy NN Pharmocological
( ( Pharmocological
aspergillus JJ Pharmocological
galactomannan NN Pharmocological
and CC Pharmocological
PCR NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

3M CD Surgical
Steri-Strip JJ Surgical
S NNP Surgical
Surgical NNP Surgical
Skin NNP Surgical
Closure NNP Surgical
versus IN Surgical
subcuticular JJ Surgical
closure NN Surgical
. . None
new JJ Surgical
coaptive JJ Surgical
film NN Surgical
device NN Surgical
, , None
3M CD Surgical
Steri-Strip JJ Surgical
S NNP Surgical
Surgical NNP Surgical
Skin NNP Surgical
Closure NNP Surgical
, , Surgical
on IN Surgical
linear JJ Surgical
incisions NNS Surgical
. . None
Steri-Strip NNP Physical
S NNP Physical
or CC Physical
suture JJ Physical
closure NN Physical
. . None
new JJ Physical
scar NN Physical
evaluation NN Physical
tool NN Physical
Steri-Strip NNP Physical
S NNP Physical
suture NN Physical
closure NN Physical
Steri-Strip NNP Pharmocological
S NNP Pharmocological
suture NN Physical
. . None
-DOCSTART- -X- N

group NN Educational
vs. FW None
individual JJ Physical
care NN Physical
Training NN Educational
of IN Educational
physicians NNS Educational
, , Educational
nurses NNS Educational
and CC Educational
dietitians NNS Educational
included VBD Educational
preparation NN Educational
of IN Educational
operating VBG Educational
manual JJ Educational
and CC Educational
videos NNS Educational
, , Educational
interactive JJ Educational
sessions NNS Educational
, , Educational
and CC Educational
evaluation NN Educational
of IN Educational
local JJ Educational
facilities NNS Educational
and CC Educational
resources NNS Educational
. . None
-DOCSTART- -X- N

Docosahexaenoic NNP Pharmocological
acid-rich JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
placebo-controlled JJ Control
docosahexaenoic JJ Pharmocological
acid-rich JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
or CC Control
placebo NN Control
( ( Control
olive JJ Control
oil NN Control
) ) Control
. . Control
-DOCSTART- -X- N

natural JJ Pharmocological
beta-carotene JJ Pharmocological
beta-carotene JJ Pharmocological
preparation NN Pharmocological
beta-carotene-rich JJ Pharmocological
algae NN Pharmocological
60 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
the DT Pharmocological
beta-carotene JJ Pharmocological
preparation NN Pharmocological
-DOCSTART- -X- N

primary JJ Educational
care NN Educational
primary JJ Educational
care NN Educational
intervention NN Educational
provided VBD Educational
assistance NN Educational
to TO Educational
practices NNS Educational
in IN Educational
establishing VBG Educational
an DT Educational
office NN Educational
system NN Educational
that WDT Educational
promoted VBD Educational
sun JJ Educational
protection NN Educational
advice NN Educational
to TO Educational
children NNS Educational
and CC Educational
their PRP$ Educational
parents NNS Educational
during IN Educational
office NN Educational
visits NNS Educational
. . Educational
-DOCSTART- -X- N

Intensive JJ Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
intensive JJ Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
high-dose JJ None
or CC None
standard-dose JJ None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
and CC None
semustine NN Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
, , Pharmocological
nitroglycerin NN Pharmocological
, , Pharmocological
or CC Pharmocological
sodium NN Pharmocological
nitroprusside RB Pharmocological
. . None
Diltiazem NNP Pharmocological
Nitroglycerin NNP Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

ViviScal NNP Pharmocological
, , Pharmocological
with IN Pharmocological
fish JJ Pharmocological
extract NN Pharmocological
ViviScal NNP Pharmocological
( ( Pharmocological
a DT Pharmocological
new JJ Pharmocological
food NN Pharmocological
supplement NN Pharmocological
incorporating VBG Pharmocological
special JJ Pharmocological
marine JJ Pharmocological
extracts NNS Pharmocological
and CC Pharmocological
a DT Pharmocological
silica JJ Pharmocological
compound NN Pharmocological
) ) Pharmocological
with IN None
those DT None
of IN None
a DT None
fish JJ Surgical
extract NN Surgical
fish JJ Pharmocological
extract NN Pharmocological
ViviScal NNP Pharmocological
fish JJ Pharmocological
extract NN Pharmocological
ViviScal NNP Pharmocological
ViviScal JJ Pharmocological
-DOCSTART- -X- N

fenfluramine VB Pharmocological
treatment NN Pharmocological
fenfluramine VB Pharmocological
: : None
fenfluramine NN Pharmocological
-DOCSTART- -X- N

docosahexaenoic JJ Pharmocological
acid NN Pharmocological
docosahexaenoic JJ Pharmocological
acid NNS Pharmocological
docosahexaenoic NN Pharmocological
acid NN Pharmocological
plus CC Pharmocological
15 CD Pharmocological
000 CD Pharmocological
IU/d NNP Pharmocological
of IN Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
given VBN Pharmocological
as IN Pharmocological
retinyl NN Pharmocological
palmitate NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
+ VBZ Pharmocological
A NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
or CC None
control VB Control
fatty JJ Control
acid JJ Control
plus CC Control
15 CD Control
000 CD Control
IU/d NNP Control
of IN Control
vitamin NN Control
A NNP Control
( ( Control
control NN Control
+ VBZ Control
A NNP Control
group NN Control
) ) Control
DHA NNP Pharmocological
+ VBZ Pharmocological
A NNP Pharmocological
control NN Pharmocological
+ VBZ Pharmocological
A DT Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
not RB Educational
taking VBG Educational
vitamin RP Educational
A DT Educational
DHA NNP Pharmocological
+ NNP Pharmocological
A NNP Pharmocological
control NN Pharmocological
+ VBZ Pharmocological
A NNP Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
docosahexaenoic NN Pharmocological
acid IN Pharmocological
not RB Pharmocological
on IN Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
control NN None
+ VBZ None
A NNP None
dietary JJ Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acid NNS Pharmocological
vitamin IN Physical
A NNP Physical
therapy NN Physical
docosahexaenoic NN Pharmocological
acid NN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

dietary JJ None
intervention NN None
gluten NN None
and CC None
casein-free JJ None
diet NN None
controls NNS Control
. . Control
-DOCSTART- -X- N

valsartan/hydrochlorothiazide NN Pharmocological
valsartan/hydrochlorothiazide NN Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
valsartan VB Pharmocological
80 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
V-low NNP Pharmocological
) ) Pharmocological
, , None
valsartan $ Pharmocological
160 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
V-high NNP Pharmocological
) ) Pharmocological
or CC None
valsartan/HCTZ $ Pharmocological
160/12.5 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
V/HCTZ NNP Pharmocological
) ) Pharmocological
, , None
and CC None
electively RB None
titrated VBN None
after IN None
weeks NNS None
2 CD None
and CC None
4 CD None
to TO None
the DT None
next JJ None
dosage NN None
level NN None
( ( None
maximum JJ Pharmocological
dose NN Pharmocological
valsartan/HCTZ NN Pharmocological
160/25 CD Pharmocological
mg NN Pharmocological
) ) None
if IN None
BP NNP Pharmocological
remained VBD Pharmocological
> JJ Pharmocological
140/90 CD Pharmocological
mm NN Pharmocological
Hg NNP Pharmocological
. . None
V/HCTZ NNP Pharmocological
V/HCTZ NNP Pharmocological
valsartan NN Pharmocological
HCTZ NNP Pharmocological
valsartan NN Pharmocological
-DOCSTART- -X- N

amiloride NN Pharmocological
carbenoxolone NN Pharmocological
carbenoxolone NN Pharmocological
sodium NN Pharmocological
as IN Pharmocological
Biogastrone NNP Pharmocological
tablets VBZ Pharmocological
100 CD Pharmocological
mg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
a DT Pharmocological
day NN Pharmocological
dummy NN Control
tablets NNS Control
amiloride NN Pharmocological
amiloride NN Pharmocological
amiloride NN Pharmocological
spironolactone NN Pharmocological
-DOCSTART- -X- N

ofloxacin JJ Pharmocological
otic JJ Pharmocological
drops NNS Pharmocological
neomycin-polymyxin JJ Pharmocological
B-hydrocortisone NNP Pharmocological
otic JJ Pharmocological
drops NNS Pharmocological
antibiotics NNS Pharmocological
ofloxacin JJ Pharmocological
and CC None
neomycin-polymyxin JJ Pharmocological
B NNP Pharmocological
ofloxacin NN Pharmocological
eardrops NNS Pharmocological
ofloxacin JJ Pharmocological
eardrops NNS Pharmocological
-DOCSTART- -X- N

6 CD Physical
minute NN Physical
walk NN Physical
test NN Physical
( ( Physical
6MWT CD Physical
) ) Physical
6MWT CD Physical
-DOCSTART- -X- N

question-asking NN Educational
robot NN Educational
intervention NN Educational
human-trainer JJ Educational
intervention NN Educational
. . None
applied JJ Educational
behaviour NN Educational
analysis NN Educational
( ( Educational
ABA NNP Educational
) ) Educational
-based VBD Educational
intervention NN Educational
conducted VBN Educational
by IN Educational
a DT Educational
robot NN Educational
compared VBN Educational
to TO Educational
an DT Educational
ABA-based JJ Educational
intervention NN Educational
conducted VBN Educational
by IN Educational
a DT Educational
human JJ Educational
trainer NN Educational
in IN None
interventions NNS Educational
conducted VBN Educational
by IN Educational
a DT Educational
robot NN Educational
and CC Educational
a DT Educational
human JJ Educational
trainer NN Educational
-DOCSTART- -X- N

Rosiglitazone NN Pharmocological
Peroxisome VB None
proliferator-activated JJ None
receptor-? NN None
( ( None
PPAR-? NNP None
) ) None
agonists VBZ None
receive VB None
rosiglitazone NN None
( ( None
4mg/day CD None
) ) None
or CC None
placebo NN None
. . None
A DT None
study NN None
, , None
rosiglitazone NN None
had VBD None
rosiglitazone NN None
in IN None
-DOCSTART- -X- N

Cisplatin NNP Pharmocological
, , Pharmocological
epirubicin NN Pharmocological
, , Pharmocological
leucovorin NN Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
PELF NNP Pharmocological
) ) Pharmocological
5-fluorouracil JJ Pharmocological
, , Pharmocological
doxorubicin JJ Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
FAMTX NNP Pharmocological
) ) Pharmocological
5-Fluorouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
FAMTX NNP Pharmocological
) ) Pharmocological
and CC None
cisplatin NN Pharmocological
, , Pharmocological
epirubicin NN Pharmocological
, , Pharmocological
leucovorin NN Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
( ( Pharmocological
PELF NNP Pharmocological
) ) Pharmocological
FAMTX NNP Pharmocological
. . None
PELF NNP Pharmocological
or CC None
FAMTX NNP Pharmocological
FAMTX NNP Pharmocological
PELF NNP Pharmocological
FAMTX NNP Pharmocological
-DOCSTART- -X- N

ranitidine NN Pharmocological
amoxicillin NN Pharmocological
clarithromycin NN Pharmocological
placebo NN None
placebo-treated JJ None
-DOCSTART- -X- N

intense JJ Educational
quality NN Educational
assurance NN Educational
program NN Educational
dummy JJ Physical
run NN Physical
( ( Physical
DR NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

preadmission NN Educational
telephone NN Educational
intervention NN Educational
telephone NN Educational
intervention NN Educational
-DOCSTART- -X- N

prasugrel NN Pharmocological
prasugrel NN Pharmocological
prasugrel NN Pharmocological
. . None
of IN None
prasugrel NN Pharmocological
-DOCSTART- -X- N

repeat NN Surgical
sextant JJ Surgical
prostate NN Surgical
biopsy NN Surgical
radical JJ Surgical
prostatectomy NN Surgical
with IN None
or CC None
without IN None
neoadjuvant JJ Physical
hormonal JJ Physical
therapy NN Physical
. . None
-DOCSTART- -X- N

methylphenidate NN Pharmocological
methylphenidate JJ Pharmocological
placebo NN Control
doses NNS Pharmocological
of IN Pharmocological
methylphenidate NN Pharmocological
methylphenidate NN Pharmocological
hydrochloride NN Pharmocological
placebo NN Control
methylphenidate NN Pharmocological
Methylphenidate NNP Pharmocological
placebo VB Control
methylphenidate NN Pharmocological
Methylphenidate NNP Pharmocological
-DOCSTART- -X- N

home-based JJ Physical
exercise NN Physical
program NN Physical
home-based JJ Physical
exercise NN Physical
intervention NN Physical
usual JJ Physical
care NN Physical
or CC Physical
incremental JJ Physical
walking NN Physical
and CC Physical
home-based JJ Physical
strength NN Physical
training NN Physical
. . Physical
physiotherapy NN Physical
CONCLUSION VB None
A DT None
home-based JJ None
exercise NN None
program NN None
-DOCSTART- -X- N

individual JJ Psychological
peer NN Psychological
support NN Psychological
Peer NNP Pharmocological
support NN Pharmocological
-DOCSTART- -X- N

cefotaxime NN Pharmocological
and CC None
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
or CC None
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole JJ Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
. . None
cefotaxime JJ Pharmocological
-DOCSTART- -X- N

Modified VBN Physical
constraint-induced JJ Physical
movement NN Physical
therapy NN Physical
Constraint-induced JJ Physical
movement NN Physical
therapy NN Physical
( ( Physical
CIMT NNP Physical
) ) Physical
CIMT NNP Physical
modified JJ Physical
CIMT NNP Physical
or CC None
control VB Physical
group NN None
CIMT NNP Physical
physical JJ Physical
rehabilitation NN Physical
restrictive NN Physical
mitten VBZ Physical
modified JJ Physical
CIMT NNP Physical
CIMT NNP Physical
-DOCSTART- -X- N

Growth NNP Physical
hormone NN Physical
( ( Physical
GH NNP Physical
) ) Physical
treatment NN Physical
to TO None
GH NNP None
or CC None
no DT None
treatment NN None
for IN None
-DOCSTART- -X- N

propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
propofol NN Pharmocological
placebo NN Control
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
propofol JJ Pharmocological
droperidol VBZ Pharmocological
metoclopramide RB Pharmocological
placebo NN Control
( ( Control
isotonic JJ Control
saline NN Control
) ) Control
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
placebo NN None
propofol NN Pharmocological
droperidol NN Pharmocological
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
propofol NN Pharmocological
droperidol NN Pharmocological
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide JJ Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

3D CD Other
finite JJ Other
element NN Other
2D CD Physical
radiographs NN Physical
. . None
Finite NNP Other
element NN Other
( ( Other
FE NNP Other
) ) Other
modelling NN Other
patient-specific JJ Other
FE NNP Other
models NNS Other
computed JJ Other
tomography NN Other
create VB Other
personalised VBD Other
3D CD Other
models NNS Other
from IN Other
standard JJ Other
2D CD Other
hip NN Other
radiographs NN Other
. . None
3D CD Physical
femoral JJ Physical
shape NN Physical
obtained VBN Physical
from IN Physical
CT NNP Physical
FE NNP Other
models NNS Other
from IN None
standard JJ None
2D CD None
radiographs NN None
-DOCSTART- -X- N

acupressure NN None
Premedication NNP None
with IN None
sedatives NNS None
acupressure NN Physical
acupressure NN Physical
at IN Physical
the DT Physical
extra JJ Physical
1 CD Physical
point NN Physical
sham NN None
group NN None
acupressure NN Control
at IN Control
a DT Control
sham JJ Control
point NN Control
. . None
electrocardiogram NN None
Acupressure NN Physical
acupressure NN Physical
Acupressure NN Physical
Acupressure NN Physical
acupressure NN Physical
acupressure NN Physical
-DOCSTART- -X- N

Supportive-expressive JJ Psychological
group NN Psychological
therapy NN Psychological
manualized JJ Psychological
12-week JJ Psychological
supportive-expressive JJ Psychological
group NN Psychological
therapy NN Psychological
program NN None
brief JJ Educational
supportive-expressive JJ Educational
intervention NN Educational
-DOCSTART- -X- N

fluke NNS Pharmocological
and CC Pharmocological
worm VB Pharmocological
combination NN Pharmocological
products NNS Pharmocological
ivermectin NN Pharmocological
+ NNP None
clorsulon NN Pharmocological
injection NN Pharmocological
, , None
ivermectin JJ Pharmocological
+ JJ None
closantel NN Pharmocological
injection NN Pharmocological
, , None
or CC None
levamisole JJ Pharmocological
+ JJ None
triclabendazole JJ Pharmocological
oral JJ None
drench NN None
. . None
ivermectin JJ Pharmocological
+ NN None
clorsulon NN Pharmocological
( ( None
single JJ None
injection NN None
) ) None
ivermectin JJ Pharmocological
+ JJ None
closantel NN Pharmocological
levamisole JJ Pharmocological
+ JJ None
triclabendazole NN Pharmocological
-DOCSTART- -X- N

tyrosine JJ Pharmocological
kinase NN Pharmocological
inhibitors NNS Pharmocological
everolimus NN Pharmocological
tyrosine JJ Pharmocological
kinase NN Pharmocological
inhibitors NNS Pharmocological
( ( Pharmocological
TKI NNP Pharmocological
) ) Pharmocological
sunitinib NN Pharmocological
or CC None
sorafenib NN Pharmocological
. . None
TKI NNP Pharmocological
TKI NNP Pharmocological
everolimus NN Pharmocological
: : None
sunitinib NN Pharmocological
sorafenib NN Pharmocological
dovitinib NN Pharmocological
TKI NNP Pharmocological
TKI-everolimus-TKI NNP Pharmocological
everolimus NN Pharmocological
TKI NNP Pharmocological
TKI-everolimus-TKI JJ Pharmocological
sequence NN Pharmocological
-DOCSTART- -X- N

dexamethasone NN Pharmocological
( ( None
DEX NNP None
) ) None
DEX NNP Pharmocological
DEX NNP Pharmocological
DEX NNP Pharmocological
glucocorticoids NNS Pharmocological
. . None
-DOCSTART- -X- N

Methotrexate NNP Pharmocological
placebo-controlled JJ Control
placebo NN Control
methotrexate NN Pharmocological
placebo NN Control
therapy NN Control
. . Control
MTX NNP Pharmocological
placebo NN Control
. . Control
placebo-treatment JJ Control
MTX NNP Pharmocological
. . None
MTX NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
-DOCSTART- -X- N

whole-body JJ Physical
mild-cold JJ Physical
exposure NN Physical
whole-body JJ Educational
mild-cold JJ Educational
12 CD None
?C NNS None
( ( None
mild-cold JJ None
) ) None
and CC None
21 CD None
?C NNP None
( ( None
control NN None
) ) None
on IN None
mild-cold JJ None
and CC None
mild-cold JJ None
exposure NN None
-DOCSTART- -X- N

tamsulone-FS JJ Pharmocological
Tamsulone-FS NNP Pharmocological
-- : Pharmocological
a DT None
novel JJ None
Russian JJ None
alpha1A/D-adrenoblocker NN None
( ( None
Farm-Syntez NNP None
) ) None
-- : None
was VBD None
tamsulone-FS JJ Pharmocological
-DOCSTART- -X- N

prophylactic JJ Pharmocological
amiodarone NN Pharmocological
amiodarone NN Pharmocological
amiodarone NN Pharmocological
group NN Pharmocological
amiodarone NN Pharmocological
control NN None
normal JJ Pharmocological
saline NN Pharmocological
. . None
amiodarone NN Pharmocological
amiodarone NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
lower JJR Educational
fat JJ Educational
challenge NN Educational
vehicle NN Educational
. . None
lower JJR Other
fat NN Other
recipe NN Other
peanut NN Other
-DOCSTART- -X- N

simplified JJ Educational
simplified JJ Educational
neonatal JJ Educational
resuscitation NN Educational
protocol NN Educational
CCD NNP Physical
cameras NNS Physical
and CC Educational
pulse JJ Physical
oximeters NNS Physical
-DOCSTART- -X- N

anesthetics NNS Pharmocological
halothane NN Pharmocological
, , None
enflurane NN Pharmocological
, , None
isoflurane NN Pharmocological
, , None
or CC None
balanced VBD Pharmocological
anesthesia NNS Pharmocological
with IN Pharmocological
enflurane/alfentanil NN Pharmocological
. . None
enflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
. . None
halothane NN Pharmocological
isoflurane NN Pharmocological
. . None
enflurane VB Pharmocological
alfentanil NN Pharmocological
isoflurane NN Pharmocological
Balanced NNP Pharmocological
anesthesia NN Pharmocological
with IN Pharmocological
enflurane/alfentanil NN Pharmocological
-DOCSTART- -X- N

Moclobemide NNP None
, , None
imipramine NN None
and CC None
placebo NN None
Moclobemide NNP Pharmocological
imipramine NN Pharmocological
placebo NN Control
was VBD Pharmocological
300 CD Pharmocological
mg JJ Pharmocological
daily RB Pharmocological
for IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
5 CD Pharmocological
days NNS Pharmocological
, , Pharmocological
after IN Pharmocological
which WDT Pharmocological
it PRP Pharmocological
could MD Pharmocological
be VB Pharmocological
increased VBN Pharmocological
to TO Pharmocological
600 CD Pharmocological
mg. NNS Pharmocological
was VBD Pharmocological
given VBN Pharmocological
in IN Pharmocological
a DT Pharmocological
dosage NN Pharmocological
starting VBG Pharmocological
with IN Pharmocological
33 CD Pharmocological
mg NNS Pharmocological
and CC Pharmocological
gradually RB Pharmocological
increased VBD Pharmocological
to TO Pharmocological
100 CD Pharmocological
mg/day NN Pharmocological
in IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
5 CD Pharmocological
days NNS Pharmocological
placebo NN Control
. . Control
Moclobemide NNP Pharmocological
imipramine NN Pharmocological
-DOCSTART- -X- N

fenoterol NN Pharmocological
and CC Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
Fenoterol NNP None
( ( None
FNT NNP None
) ) None
, , None
ipratropium JJ Pharmocological
bromide NN Pharmocological
( ( Pharmocological
IB NNP Pharmocological
) ) Pharmocological
, , None
and CC None
placebo NN Control
FNT NNP None
or CC None
IB NNP None
, , None
receiving VBG None
FNT NNP None
and CC None
IB NNP None
which WDT None
placebo NN None
FNT NNP None
than IN None
IB NNP None
of IN None
FNT NNP None
or CC None
IB NNP None
with IN None
FNT NNP None
. . None
-DOCSTART- -X- N

face-to-face NN Educational
interviews NNS Educational
Medical JJ Educational
chart NN Educational
data NNS Educational
were VBD Educational
abstracted VBN Educational
Univariate NNP Physical
and CC Physical
multivariate VB Physical
logistic JJ Physical
regression NN Physical
analyses NNS Physical
-DOCSTART- -X- N

Naltrexone NN Pharmocological
naltrexone NN Pharmocological
Naltrexone NNP Pharmocological
, , None
1.0 CD None
mg/kg NN None
, , None
or CC None
placebo NN Control
was VBD None
administered VBN None
daily RB None
for IN None
2 CD None
weeks NNS None
. . None
videotaped JJ Educational
samples NNS Educational
of IN Educational
seminaturalistic JJ Educational
parent-child JJ Educational
interaction NN Educational
. . None
naltrexone NN Pharmocological
placebo NN Control
naltrexone NN Pharmocological
-DOCSTART- -X- N

aliskiren NN Pharmocological
placebo VB Control
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( None
perindopril NN Pharmocological
) ) None
receive VB None
aliskiren NNS None
( ( None
150 CD None
, , None
aliskiren RB None
( ( None
300 CD None
, , None
perindopril NN None
( ( None
5 CD None
, , None
perindopril NN None
( ( None
10 CD None
placebo NN None
. . None
RESULTS NNP None
Aliskiren NNP None
and CC None
perindopril NN None
aliskiren NNS None
( ( None
150 CD None
) ) None
with IN None
aliskiren NN None
( ( None
300 CD None
mg NN None
with IN None
perindopril NN None
( ( None
5 CD None
mg NN None
) ) None
and CC None
with IN None
perindopril NN None
( ( None
10 CD None
mg NN None
) ) None
, , None
compared VBN None
placebo VB None
aliskiren NNS None
and CC None
perindopril NN None
. . None
CONCLUSIONS NNP None
Aliskiren NNP None
perindopril NN None
, , None
for IN None
equivalent JJ None
The DT None
renin JJ None
inhibitor NN None
-DOCSTART- -X- N

amifostine NN Pharmocological
to TO None
carboplatin VB Pharmocological
and CC None
paclitaxel VB Pharmocological
based VBN None
chemoradiation NN Physical
amifostine NN Pharmocological
paclitaxel NN Pharmocological
carboplatin JJ Pharmocological
paclitaxel NN Pharmocological
carboplatin NN Pharmocological
hyperfractionated VBN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
amifostine VB Pharmocological
regimen NNS None
of IN None
carboplatin NN None
and CC None
paclitaxel NN None
produced VBN None
regimens NNS None
. . None
Amifostine NNP None
did VBD None
not RB None
-DOCSTART- -X- N

pneumatic JJ Physical
otoscopy NN Physical
, , None
supplemented VBN Physical
by IN Physical
tympanometry NN Physical
we PRP None
treated VBD None
children NNS None
for IN None
otitis NN Physical
media NNS Physical
according VBG None
to TO None
specified VBN None
guidelines NNS None
. . None
tympanostomy JJ Surgical
tube NN Surgical
placement NN Surgical
-DOCSTART- -X- N

cytarabine NN Pharmocological
versus NN None
amsacrine NN Pharmocological
cytarabine NN Pharmocological
amsacrine NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
poliomyelitis NN Pharmocological
attenuated VBD Pharmocological
live JJ Pharmocological
vaccine NN Pharmocological
Poliomyelitis NNP Pharmocological
vaccine NN Pharmocological
OPV NNP Pharmocological
( ( Pharmocological
HDC NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
OPV NNP Pharmocological
( ( Pharmocological
HDC NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
OPV NNP Pharmocological
( ( Pharmocological
HDC NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

clinician JJ Other
feedback NN Other
patient JJ Educational
feedback NN Educational
a DT Other
letter NN Other
bimonthly JJ Other
telephone NN Other
call NN Other
to TO Educational
collect VB Educational
clinical JJ Educational
information NN Educational
about IN Educational
the DT Educational
child NN Educational
's POS Educational
asthma NN Educational
. . None
bimonthly RB Other
computer-generated JJ Other
letters NNS Other
Asthma NNP Pharmocological
medications NNS Pharmocological
control NN Control
Patient-specific JJ Other
feedback NN Other
-DOCSTART- -X- N

demand-control JJ None
model NN None
of IN None
job NN None
strain NN None
The DT Other
demand-control NN Other
( ( Other
D-C NNP Other
) ) Other
model NN Other
of IN Other
job NN Other
strain NN Other
D-C NNP Physical
model NN Physical
of IN Physical
job NN Physical
strain NN Physical
D-C NNP Physical
model NN Physical
D-C JJ Physical
model NN Physical
D-C NNP Physical
model NN Physical
demand-control JJ Physical
model NN Physical
of IN Physical
job NN Physical
strain NN Physical
-DOCSTART- -X- N

misoprostol NN Pharmocological
oral JJ Pharmocological
misoprostol NN Pharmocological
400 CD Pharmocological
mug NN Pharmocological
or CC Pharmocological
intramuscular JJ Pharmocological
syntometrine NN Pharmocological
misoprostol NN Pharmocological
syntometrine NN Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

active JJ Other
placebo NN Control
-DOCSTART- -X- N

pentoxifylline NN Pharmocological
phosphodiesterase NN Pharmocological
( ( Pharmocological
PDE NNP Pharmocological
) ) Pharmocological
inhibitor NN Pharmocological
pentoxifylline NN Pharmocological
PDE NNP Pharmocological
inhibitor NN Pharmocological
PDE NNP Pharmocological
inhibitor NN Pharmocological
pentoxifylline NN Pharmocological
randomly RB None
assigned VBN None
to TO None
either DT None
pentoxifylline NN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
or CC None
placebo NN Pharmocological
3 CD None
times NNS None
daily RB None
for IN None
14 CD None
days NNS None
. . None
placebo NN Control
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
-DOCSTART- -X- N

Sodium-potassium JJ Pharmocological
pump NN Pharmocological
activity NN Pharmocological
sodium-potassium JJ Pharmocological
pump NN Pharmocological
pump NN Physical
activity NN Physical
-DOCSTART- -X- N

Large JJ Physical
volume NN Physical
, , Physical
low JJ Physical
pressure NN Physical
endotracheal NN Physical
tube NN Physical
cuffs NNS Physical
large JJ Physical
volume NN Physical
cuffed VBD Physical
endotracheal JJ Physical
tubes NNS Physical
Portex NNP Physical
Profile NNP Physical
, , None
Searle NNP Physical
Sensiv NNP Physical
, , None
Mallinkrodt NNP Physical
Hi-Lo NNP Physical
Lanz NNP Physical
. . None
endoscopic JJ None
photographic JJ None
technique NN None
while IN None
varying VBG None
the DT None
cuff NN Physical
inflation NN Physical
pressure NN Physical
. . None
-DOCSTART- -X- N

Ciprofloxacin NNP Pharmocological
, , None
lomefloxacin NN Pharmocological
, , None
or CC None
levofloxacin CC Pharmocological
oral JJ Pharmocological
fluoroquinolones NNS Pharmocological
( ( None
lomefloxacin NN Pharmocological
, , None
levofloxacin NN Pharmocological
, , None
and CC None
ciprofloxacin NN Pharmocological
) ) None
either DT None
lomefloxacin NN Pharmocological
, , None
levofloxacin NN Pharmocological
, , None
or CC None
ciprofloxacin NN Pharmocological
. . None
-DOCSTART- -X- N

inhibitor NN Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blocker NN Pharmocological
valsartan NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
and CC Pharmocological
the DT Pharmocological
same JJ Pharmocological
diet NN Pharmocological
supplemented VBN Pharmocological
by IN Pharmocological
100 CD Pharmocological
mEq NNS Pharmocological
Na+ NNP Pharmocological
for IN Pharmocological
4 CD Pharmocological
weeks NNS Pharmocological
. . None
randomized VBN Pharmocological
to TO Pharmocological
valsartan VB Pharmocological
320 CD Pharmocological
mg/day NN Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
28 CD Pharmocological
) ) Pharmocological
, , None
or CC None
the DT None
addition NN Pharmocological
of IN Pharmocological
hydrochlorothiazide NN Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
12.5 CD Pharmocological
mg/day NN Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
30 CD Pharmocological
) ) Pharmocological
, , None
or CC None
benazepril VB Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
to TO Pharmocological
the DT Pharmocological
valsartan NN Pharmocological
160 CD Pharmocological
mg/day NN Pharmocological
for IN Pharmocological
an DT Pharmocological
additional JJ Pharmocological
6 CD Pharmocological
weeks NNS Pharmocological
. . None
-DOCSTART- -X- N

fuzheng NN Pharmocological
yiliu NN Pharmocological
granule NN Pharmocological
Fuzheng NNP Pharmocological
Yiliu NNP Pharmocological
Granule NNP Pharmocological
( ( Pharmocological
FZYLG NNP Pharmocological
) ) Pharmocological
FZYLG NNP Pharmocological
FZYLG NNP Pharmocological
-DOCSTART- -X- N

Dynamic NNP Other
Hip NNP Other
Screw NNP Other
and CC None
the DT Physical
Gamma NNP Other
locking VBG Other
nail NN Other
Gamma NNP Other
nail NN Other
. . None
Gamma NNP Physical
nail NN Physical
-DOCSTART- -X- N

Synemol NNP Pharmocological
cream NN Pharmocological
Diprosone NNP Pharmocological
cream NN Pharmocological
Aristocort-A NNP Pharmocological
cream NN Pharmocological
Valisone NNP Pharmocological
cream NN Pharmocological
-DOCSTART- -X- N

Enalapril NNP Pharmocological
enalapril NN Pharmocological
placebo NNS Control
enalapril NNS Pharmocological
. . None
Enalapril NNP Pharmocological
-DOCSTART- -X- N

higher JJR None
imatinib NN Pharmocological
doses NNS None
imatinib NN Pharmocological
dose NN None
imatinib JJ Pharmocological
400 CD Pharmocological
-DOCSTART- -X- N

ferrule NN Pharmocological
crown-lengthening JJ Pharmocological
ferrule NN Pharmocological
cast VBN Pharmocological
Ni-Cr JJ Pharmocological
alloy NN Pharmocological
dowel-core NN Pharmocological
with IN Pharmocological
no DT Pharmocological
ferrule NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
A1 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
cast VBD Pharmocological
Ni-Cr JJ Pharmocological
alloy NN Pharmocological
dowel-core NN Pharmocological
with IN Pharmocological
2.0 CD Pharmocological
mm NNS Pharmocological
ferrule NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
A2 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
prefabricated VBN Pharmocological
carbon NN Pharmocological
fiber-reinforced JJ Pharmocological
dowel-resin NN Pharmocological
core NN Pharmocological
with IN Pharmocological
no DT Pharmocological
ferrule NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
B1 NNP Pharmocological
) ) Pharmocological
carbon JJ Pharmocological
fiber-reinforced JJ Pharmocological
dowel-resin NN Pharmocological
core NN Pharmocological
with IN Pharmocological
2.0 CD Pharmocological
mm NNS Pharmocological
ferrule NN Pharmocological
cast JJ Pharmocological
Ni-Cr JJ Pharmocological
dowel-cores NNS Pharmocological
and CC Pharmocological
2.0 CD Pharmocological
mm NN Pharmocological
ferrules NNS Pharmocological
carbon NN Pharmocological
fiber-reinforced JJ Pharmocological
dowel-resin NN Pharmocological
core NN Pharmocological
system NN Pharmocological
Crown NNP None
lengthening VBG None
2.0 CD Pharmocological
mm NN Pharmocological
apical JJ Pharmocological
extended VBD Pharmocological
ferrule NN Pharmocological
-DOCSTART- -X- N

versus NN Pharmocological
intravenous JJ Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
. . None
Fluconazole NNP Pharmocological
( ( Pharmocological
FLU NNP Pharmocological
) ) Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
AMB NNP Pharmocological
) ) Pharmocological
receive VB None
antifungal JJ Pharmocological
prophylaxis NN Pharmocological
with IN Pharmocological
AMB NNP Pharmocological
( ( Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
weekly JJ Pharmocological
) ) None
or CC None
FLU NNP Pharmocological
( ( None
400 CD None
mg NNS None
daily RB None
) ) None
. . None
Trimethoprim-sulfamethoxazole NN Pharmocological
was VBD None
administered VBN None
as IN None
an DT None
antibacterial JJ None
prophylaxis NN None
. . None
Prophylaxis NNP None
was VBD None
continued VBN None
until IN None
the DT None
patient NN None
achieved VBD None
complete JJ None
remission NN None
or CC None
was VBD None
treated VBN None
for IN None
8 CD None
weeks NNS None
without IN None
antileukemic JJ None
response NN None
. . None
AMB NNP Pharmocological
FLU NNP Pharmocological
AMB NNP Pharmocological
FLU NNP Pharmocological
-DOCSTART- -X- N

Granulocyte-macrophage JJ Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
influenza JJ Pharmocological
vaccination NN Pharmocological
granulocyte-macrophage JJ Physical
colony-stimulating JJ Physical
factor NN Physical
( ( Physical
GM-CSF NNP Physical
) ) Physical
influenza JJ Pharmocological
vaccination NN Pharmocological
GM-CSF NNP Physical
GM-CSF JJ Pharmocological
-DOCSTART- -X- N

CRF NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
receptor NN Pharmocological
antagonist JJ Pharmocological
R317573 NNP Pharmocological
Corticotropin-releasing NNP Pharmocological
factor NN Pharmocological
receptor NN Pharmocological
type NN Pharmocological
1 CD Pharmocological
( ( Pharmocological
CRF NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
CRF NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
antagonist NN Pharmocological
R317573 NNP Pharmocological
[ NNP None
( ( None
18 CD None
) ) None
F NNP None
] JJ None
fluoro-2-deoxy-D NN Physical
: : Physical
-glucose NN Physical
( ( Physical
FDG NNP Physical
) ) Physical
positron NN Physical
emission NN Physical
tomography NN Physical
( ( Physical
PET NNP Physical
) ) Physical
R317573 NNP Pharmocological
R317573 NNP Pharmocological
rCMglu NN Pharmocological
FDG-PET NNP Physical
-DOCSTART- -X- N

Mode NNP Physical
of IN Physical
ventilation NN Physical
during IN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
modes NNS Physical
of IN Physical
ventilation NN Physical
during IN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
( ( Surgical
CPB NNP Surgical
) ) Surgical
one CD Physical
of IN Physical
5 CD Physical
modes NNS Physical
of IN Physical
ventilation NN Physical
during IN Physical
bypass NN Surgical
. . None
high-frequency/low-volume JJ Surgical
ventilation NN Surgical
with IN Surgical
100 CD Surgical
% NN Surgical
21 CD Other
% NN Other
oxygen NN Other
continuous JJ Surgical
positive JJ Surgical
airway NN Surgical
pressure NN Surgical
of IN Surgical
5 CD Surgical
cm NN Surgical
H NNP Surgical
( ( Surgical
2 CD Surgical
) ) Surgical
O NN Surgical
with IN Surgical
100 CD Surgical
% NN Surgical
21 CD Other
% NN Other
oxygen NN Other
each DT Surgical
patient NN Surgical
's POS Surgical
airway NN Surgical
was VBD Surgical
disconnected VBN Surgical
from IN Surgical
the DT Surgical
ventilator NN Surgical
( ( Surgical
passive JJ Surgical
deflation NN Surgical
) ) Surgical
Mode NNP Physical
of IN Physical
ventilation NN Surgical
-DOCSTART- -X- N

trivalent NN Pharmocological
poliovirus NN Pharmocological
vaccines NNS Pharmocological
. . None
oral JJ Pharmocological
trivalent NN Pharmocological
poliovirus NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
OPV NNP Pharmocological
) ) Pharmocological
injectable JJ Pharmocological
( ( Pharmocological
inactivated VBN Pharmocological
) ) Pharmocological
trivalent NN Pharmocological
poliovirus NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
IPV NNP Pharmocological
) ) Pharmocological
IPV NNP Pharmocological
-DOCSTART- -X- N

rehabilitation VB Physical
training NN Physical
. . None
physical JJ Physical
training NN Physical
, , None
discharged VBD Control
home NN Control
exercises NNS Physical
every DT Physical
day NN Physical
: : Physical
on IN Physical
bicycle NN Physical
ergometer NN Physical
during IN Physical
30 CD Physical
minutes NNS Physical
( ( Physical
5 CD Physical
times NNS Physical
a DT Physical
week NN Physical
) ) Physical
, , Physical
overall-conditioning JJ Physical
exercises NNS Physical
for IN Physical
30 CD Physical
minutes NNS Physical
daily RB Physical
and CC Physical
30 CD Physical
to TO Physical
60 CD Physical
minutes NNS Physical
of IN Physical
walking VBG Physical
each DT Physical
day NN Physical
. . None
Before IN Physical
administering VBG Physical
of IN Physical
the DT Physical
therapy NN Physical
and CC Physical
3 CD Physical
weeks NNS Physical
later RB Physical
all DT Physical
performed VBD Physical
the DT Physical
bicycle NN Physical
ergometer NN Physical
exercise NN Physical
test NN Physical
until IN Physical
the DT Physical
was VBD Physical
reached VBN Physical
. . None
Before IN None
that DT None
test NN None
and CC None
3 CD None
minutes NNS None
after IN None
its PRP$ None
termination NN None
capillary NN None
and CC None
venous JJ None
blood NN None
samples NNS None
were VBD None
drawn VBN None
. . None
In IN None
the DT None
capillary JJ None
blood NN None
samples NNS None
were VBD None
determined VBN None
. . None
-DOCSTART- -X- N

oxytocin MD Pharmocological
24 CD None
or CC None
12 CD None
international JJ None
units NNS None
( ( None
depending VBG None
on IN None
weight NN None
) ) None
intranasal NN Control
placebo NN Control
or CC None
oxytocin JJ Pharmocological
-DOCSTART- -X- N

immunohistochemical JJ Physical
analysis NN Physical
of IN Physical
bone NN Physical
marrow NN Physical
biopsies NNS Physical
induction NN Pharmocological
chemotherapy VBD Pharmocological
antiangiogenic JJ Other
antileukemic JJ None
treatment NN None
-DOCSTART- -X- N

leukocyte NN Physical
reduction NN Physical
filters NNS Physical
leukocyte JJ Physical
reduction NN Physical
filters NNS Physical
blood VBD None
cardioplegia NN None
was VBD None
administered VBN None
using VBG None
leukocyte JJ None
reduction NN None
filters NNS None
leukocyte JJ Physical
reduction NN Physical
filters NNS Physical
were VBD Physical
not RB Physical
used VBN Physical
for IN Physical
blood NN Physical
cardioplegia NN Physical
. . None
leukocyte JJ None
reduction NN None
filters NNS None
, , None
we PRP None
-DOCSTART- -X- N

Gefitinib NNP Pharmocological
plus CC None
best JJS Other
supportive JJ Other
care NN Other
placebo-controlled JJ Control
gefitinib NN Pharmocological
gefitinib NN Pharmocological
( ( Pharmocological
250 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
, , None
plus CC Other
best JJS Other
supportive JJ Other
care NN Other
. . None
gefitinib NN Pharmocological
-DOCSTART- -X- N

colour-coded JJ Other
QC NNP Other
Result NNP Other
Sheet NNP Other
and CC None
QC NNP Other
Action NNP Other
Sheet NNP Other
for IN Physical
on-site JJ Physical
recording NN Physical
and CC Physical
interpreting NN Physical
of IN Physical
their PRP$ Physical
results NNS Physical
. . None
-DOCSTART- -X- N

Iron NNP Pharmocological
intake NN Pharmocological
and CC Pharmocological
iron NN Pharmocological
nutritional JJ Pharmocological
status NN Pharmocological
Fe-fortified JJ Pharmocological
formula NN Pharmocological
and CC Other
the DT Other
other JJ Other
a DT Other
nonfortified JJ Control
formula NN Control
. . None
Fe NNP Pharmocological
intake NN Pharmocological
Fe NNP Pharmocological
mainly RB Pharmocological
from IN Pharmocological
fortification NN Pharmocological
Fe NNP Pharmocological
with IN Pharmocological
beikost NN Pharmocological
Fe-fortified NNP Pharmocological
formula NN Pharmocological
commercially RB Pharmocological
prepared JJ Pharmocological
Fe-fortified JJ Pharmocological
beikost NN Pharmocological
with IN Pharmocological
meat NN Pharmocological
-DOCSTART- -X- N

indomethacin JJ Pharmocological
phonophoresis NN Pharmocological
indomethacin JJ Pharmocological
phonophoresis NN Pharmocological
placebo-controlled JJ Control
indomethacin JJ Pharmocological
placebo NN Control
indomethacin JJ Pharmocological
phonophoresis NN Pharmocological
-DOCSTART- -X- N

therapy NN Pharmocological
: : None
frontotemporal JJ Pharmocological
nitroglycerin JJ Pharmocological
test NN Pharmocological
. . None
nitroglycerin JJ Pharmocological
ointment NN Pharmocological
-DOCSTART- -X- N

original JJ Other
Qigong NNP Other
massage NN Other
methodology NN Other
. . None
Cignolini NNP Other
methodology NN Other
, , Physical
an DT Physical
original JJ Other
Qigong NNP Other
massage NN Other
methodology NN Other
-DOCSTART- -X- N

cisplatin NN Pharmocological
with IN Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
cisplatin NN Pharmocological
75 CD Pharmocological
mg/m2 NN Pharmocological
or CC Pharmocological
cisplatin NN Pharmocological
50 CD Pharmocological
mg/m2 NN Pharmocological
and CC Pharmocological
cyclophosphamide VB Pharmocological
500 CD Pharmocological
mg/m2 NN Pharmocological
CP NNP Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
CP NNP Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
CP NNP Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
carboplatin NN Pharmocological
or CC Pharmocological
cisplatin NN Pharmocological
platinum-containing JJ Pharmocological
chemotherapy NN Pharmocological
platinum-containing JJ Pharmocological
platinum-free JJ Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
CP NNP Pharmocological
. . Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
CP NNP None
. . None
CP NNP Pharmocological
cisplatin NN Pharmocological
. . Pharmocological
platinum-containing JJ Physical
therapy NN Physical
. . None
-DOCSTART- -X- N

TEN NNP Physical
TPN NNP Physical
enteral JJ Physical
feeding NN Physical
( ( Physical
TEN NNP Physical
) ) Physical
parenteral JJ Physical
nutrition NN Physical
( ( Physical
TPN NNP Physical
) ) Physical
TEN NNP Physical
TPN NNP Physical
TEN NN Physical
( ( None
TEN NNP Physical
TPN NNP Physical
TEN NNP Physical
TEN NNP Pharmocological
TPN NNP Pharmocological
TEN NNP Pharmocological
TEN NNP Pharmocological
TPN NNP Pharmocological
TEN NNP Pharmocological
TPN NNP Pharmocological
. . None
TEN NNP Pharmocological
-DOCSTART- -X- N

enoximone NN Pharmocological
Gallopamil NNP Pharmocological
Enoximone NNP Pharmocological
Gallopamil NNP Pharmocological
Enoximone NNP Pharmocological
. . None
-DOCSTART- -X- N

choline NN Pharmocological
choline NN Pharmocological
with IN Pharmocological
0 CD Pharmocological
( ( Pharmocological
control NN Pharmocological
) ) Pharmocological
, , Pharmocological
425 CD Pharmocological
, , Pharmocological
850 CD Pharmocological
, , Pharmocological
1,700 CD Pharmocological
, , Pharmocological
3,400 CD Pharmocological
6,800 CD Pharmocological
mg/kg NN Pharmocological
of IN Pharmocological
corn-soybean JJ Pharmocological
meal-based JJ Pharmocological
diets NNS Pharmocological
corn-soybean JJ Pharmocological
meal-based JJ Pharmocological
diet NN Pharmocological
-DOCSTART- -X- N

holmium NN Surgical
laser NN Surgical
enucleation NN Surgical
transurethral JJ Surgical
resection NN Surgical
holmium NN Surgical
laser JJR Surgical
enucleation NN Surgical
of IN Surgical
the DT Surgical
prostate NN Surgical
( ( Surgical
HoLEP NNP Surgical
) ) Surgical
transurethral JJ Surgical
resection NN Surgical
of IN Surgical
the DT Surgical
prostate NN Surgical
( ( Surgical
TURP NNP Surgical
) ) Surgical
HoLEP NNP Surgical
TURP NNP Surgical
. . Surgical
TURP NNP Physical
HoLEP NNP Physical
HoLEP NNP Physical
HoLEP NNP Physical
TURP NNP Physical
HoLEP NNP Physical
TURP NNP Physical
HoLEP NNP Physical
TURP NNP Physical
. . None
-DOCSTART- -X- N

yoga NNP Physical
versus NN Physical
stretching VBG Physical
complementary JJ Physical
and CC Physical
alternative JJ Physical
medicine NN Physical
( ( Physical
CAM NNP Physical
) ) Physical
therapies NNS Physical
. . None
Yoga NNP Physical
yoga NN Physical
self PRP Educational
care NN Educational
and CC None
exercise NN Physical
12 CD Physical
weekly JJ Physical
yoga NN Physical
classes NNS Physical
, , Physical
12 CD Physical
weekly JJ Physical
conventional JJ Physical
therapeutic JJ Physical
exercise NN Physical
classes NNS Physical
of IN Physical
comparable JJ Physical
physical JJ Physical
exertion NN Physical
, , Physical
or CC Physical
a DT Physical
self-care JJ Other
book NN Other
. . None
yoga NN Physical
yoga NN Physical
yoga NN Physical
yoga NN Physical
-DOCSTART- -X- N

isosorbide NN Pharmocological
dinitrate NN Pharmocological
placebo NNS Control
or CC None
isosorbide VB Pharmocological
dinitrate NN Pharmocological
( ( Pharmocological
ISDN NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

peridural JJ Pharmocological
morphine NN Pharmocological
sublingual JJ Pharmocological
buprenorphine NN Pharmocological
. . Pharmocological
peridural JJ Pharmocological
morphine NN Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
) ) Pharmocological
sublingual JJ Pharmocological
buprenorphine NN Pharmocological
( ( Pharmocological
0.4 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
buprenorphine NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
fluoxetine NN Pharmocological
selective JJ Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
placebo-controlled JJ Control
fluoxetine NN Pharmocological
fluoxetine VB Pharmocological
( ( None
n JJ None
= NNP None
16 CD None
) ) None
or CC None
a DT None
placebo NN Control
( ( None
n JJ None
= NNP None
19 CD None
) ) None
fluoxetine NN Pharmocological
placebo NN Control
fluoxetine NN Pharmocological
fluoxetine NN Pharmocological
-DOCSTART- -X- N

game NN Educational
play NN Educational
skills NNS Educational
social JJ Educational
story NN Educational
targeting VBG Educational
the DT Educational
during IN Educational
game NN Educational
play NN Educational
-DOCSTART- -X- N

aggressive JJ Pharmocological
cystostatic JJ Pharmocological
aggressiveness NN Pharmocological
of IN Pharmocological
effective JJ Pharmocological
induction NN Pharmocological
treatment NN Pharmocological
maintenance NN None
chemotherapy NN None
. . None
followed VBN Physical
without IN Physical
cytostatics NNS Physical
receiving VBG None
six CD None
courses NNS None
of IN None
melphalan NN None
and CC None
prednisone NN None
( ( None
MP-P NNP None
) ) None
MPH-P NNP None
MPH-P NNP None
and CC None
four CD None
courses NNS None
of IN None
combination NN None
chemotherapy NN None
with IN None
Peptichemio NNP None
, , None
vincristine NN None
and CC None
prednisone NN None
( ( None
PTC-VCR-P NNP None
) ) None
. . None
MPH-P NNP None
MPH-P NNP None
combination NN None
chemotherapy NN None
Combination NNP None
chemotherapy NN None
MPH-P NNP None
MPH-P NNP None
MPH-P NNP None
combination NN None
chemotherapy NN None
. . None
chemotherapy NN None
MPH-P NNP None
PTC NNP None
, , None
VCR NNP None
and CC None
P NNP None
PTC-VCR-P NNP None
MPH-P NNP None
-DOCSTART- -X- N

tobramycin NN Pharmocological
] NN None
-DOCSTART- -X- N

ultrasound-guided JJ Surgical
celiac NN Surgical
plexus NN Surgical
neurolysis NN Surgical
bilateral JJ Surgical
paramedian JJ Surgical
unilateral JJ Surgical
paramedian JJ Surgical
needle-insertion NN Surgical
technique NN Surgical
. . None
Percutaneous NNP Surgical
anterior JJ Surgical
abdominal JJ Surgical
ultrasound NN Surgical
guidance NN Surgical
ultrasound-guided JJ Surgical
celiac NN Surgical
plexus NN Surgical
neurolysis NN Surgical
( ( Surgical
USCPN NNP Surgical
) ) Surgical
USCPN NNP Surgical
bilateral JJ Surgical
paramedian NN Surgical
( ( Surgical
double JJ Surgical
needle NN Surgical
) ) Surgical
technique NN Surgical
unilateral JJ Surgical
paramedian NN Surgical
( ( Surgical
single JJ Surgical
needle NN Surgical
) ) Surgical
technique NN Surgical
. . None
ethanol NN Pharmocological
bupivacaine NN Pharmocological
unilaterally RB Physical
or CC None
bilaterally RB None
CONCLUSION NNP None
Ultrasound-guided JJ None
celiac NN None
plexus NN None
neurolysis NN None
using VBG None
unilateral JJ None
paramedian NN None
( ( None
single JJ None
needle NN None
) ) None
needle-insertion NN None
technique NN None
is VBZ None
with IN None
bilateral JJ None
paramedian NN None
( ( None
double JJ None
needle NN None
) ) None
needle-insertion NN None
technique NN None
with IN None
-DOCSTART- -X- N

soy JJ Pharmocological
soy JJ Pharmocological
soy NN Pharmocological
soy NN Pharmocological
soy JJ Pharmocological
beverage NN Pharmocological
soy JJ Pharmocological
soy JJ Pharmocological
-DOCSTART- -X- N

5-aminosalicylic JJ Pharmocological
acid NN Pharmocological
prednisolone JJ Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
5-aminosalicylic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
5-ASA JJ Pharmocological
) ) Pharmocological
prednisolone NN Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
( ( Pharmocological
PP NNP Pharmocological
) ) Pharmocological
5-ASA JJ Pharmocological
PP NNP Pharmocological
-DOCSTART- -X- N

sublingual JJ Pharmocological
fentanyl NN Pharmocological
orally RB Pharmocological
disintegrating VBG Pharmocological
tablet NN Pharmocological
fast-acting JJ Pharmocological
opioid NN Pharmocological
fentanyl NN Pharmocological
sublingual JJ Pharmocological
fentanyl NN Pharmocological
citrate NN Pharmocological
orally RB Pharmocological
disintegrating VBG Pharmocological
tablet NN Pharmocological
( ( Pharmocological
sublingual JJ Pharmocological
fentanyl NN Pharmocological
ODT NNP Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
fentanyl NN Pharmocological
ODT NNP Pharmocological
-DOCSTART- -X- N

acupuncture NN Physical
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
granules NNS Pharmocological
acupuncture NN Physical
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
Granules NNP Pharmocological
acupuncture NN Physical
acupuncture NN Physical
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
Granules NNP Pharmocological
; : None
Yizhi NNP Pharmocological
Jiannao NNP Pharmocological
Granules NNP Pharmocological
western JJ Pharmocological
medicine NN Pharmocological
group NN Pharmocological
Aricept NNP Pharmocological
. . None
combined JJ Physical
acupuncture NN Physical
and CC Physical
medication NN Physical
Chinese JJ Pharmocological
herb NN Pharmocological
western JJ Pharmocological
medicine NN Pharmocological
acupuncture NN Physical
and CC Physical
medication NN Physical
combined JJ Physical
acupuncture NN Physical
and CC Physical
medication NN Physical
Acupuncture NNP None
combined VBN None
with IN None
Yizhi NNP None
Jiannao NNP None
Granules NNP None
Yizhi NNP None
Jiannao NNP None
Granules NNP None
Aricept NNP None
. . None
-DOCSTART- -X- N

Oxaprozin NNP Pharmocological
diclofenac NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
receive VB None
either RB None
oxaprozin JJ Pharmocological
1200 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
( ( None
n JJ None
= NNP None
49 CD None
) ) None
or CC None
diclofenac $ Pharmocological
50 CD Pharmocological
mg NN Pharmocological
three CD None
times NNS None
daily RB None
( ( None
n JJ None
= NNP None
47 CD None
) ) None
. . None
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
. . None
oxaprozin NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
diclofenac NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
Oxaprozin NNP Pharmocological
diclofenac VB Pharmocological
diclofenac NN Pharmocological
. . None
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
. . None
oxaprozin JJ Pharmocological
diclofenac NN Pharmocological
-DOCSTART- -X- N

amlodipine NN Pharmocological
amlodipine NN Pharmocological
current JJ None
antianginal JJ Control
therapy NN Control
amlodipine/day NN Pharmocological
amlodipine NN Pharmocological
Amlodipine NNP Pharmocological
-DOCSTART- -X- N

language NN Educational
and CC Educational
speech-language JJ Educational
intervention NN Educational
. . None
direct JJ Educational
and CC Educational
indirect JJ Educational
intervention NN Educational
receiving VBG None
both DT None
direct JJ None
and CC None
indirect JJ None
intervention NN None
( ( None
TG NNP None
) ) None
, , None
receiving VBG None
indirect JJ None
intervention NN None
exclusively RB None
the DT None
OG NNP None
-DOCSTART- -X- N

tetracycline NN Pharmocological
. . None
placebo-controlled JJ Control
bronchodilators NNS Pharmocological
, , None
corticosteroids NNS Pharmocological
tetracycline NN Pharmocological
or CC None
placebo NN Control
placebo NN Control
. . None
-DOCSTART- -X- N

explicit JJ Educational
instruction NN Educational
on IN Educational
Japanese JJ Educational
Verbal NNP Educational
Learning NNP Educational
Test NNP Educational
explicit NN Educational
or CC Educational
normal JJ Educational
instruction NN Educational
Japanese JJ Educational
Verbal NNP Educational
Learning NNP Educational
Test NNP Educational
-DOCSTART- -X- N

bilastine NN Pharmocological
bilastine NN Pharmocological
bilastine NN Pharmocological
bilastine NN Pharmocological
bilastine NN Pharmocological
-DOCSTART- -X- N

intravenous JJ Pharmocological
fructose-1,6-diphosphate NN Pharmocological
fructose-1,6-diphosphate NN Pharmocological
intravenous JJ Pharmocological
fructose-1,6-diphosphate JJ Pharmocological
125 CD Pharmocological
mg/kg NN Pharmocological
or CC None
normal JJ Pharmocological
saline JJ Pharmocological
radionuclide NN Physical
ventriculography NN Physical
Fructose-1,6-diphosphate NNP Pharmocological
fructose-1,6-diphosphate JJ Pharmocological
placebo NN Control
. . None
Fructose-1,6-diphosphate NNP Pharmocological
-DOCSTART- -X- N

topical JJ Pharmocological
anesthesia NN Pharmocological
topical JJ Pharmocological
anesthesia NN Pharmocological
proparacaine NN Pharmocological
eye NN Pharmocological
drops NNS Pharmocological
receiving VBG None
saline JJ None
vs NN None
proparacaine NN None
eye NN None
drops NNS None
( ( None
respectively RB None
. . None
Proparacaine NNP None
use VBP None
Proparacaine NNP None
eye NN None
drops NNS None
proparacaine NN None
eye NN None
drops NNS None
-DOCSTART- -X- N

control NN Control
in IN Physical
addition NN Physical
to TO Physical
, , Control
including VBG Control
, , Control
and CC Control
-DOCSTART- -X- N

in-hospital JJ Educational
data NNS Educational
post-hospital JJ Educational
data NNS Educational
post-hospital JJ Educational
data NNS Educational
in-hospital JJ Educational
data NNS Educational
in-hospital JJ Educational
data NNS Educational
post-hospital JJ Educational
data NN Educational
. . None
post-hospital JJ Educational
data NNS Educational
. . None
-DOCSTART- -X- N

MSL-109 NNP Pharmocological
adjuvant JJ Pharmocological
therapy NN Pharmocological
MSL-109 NNP Pharmocological
MSL-109 NNP Pharmocological
placebo NN Control
. . None
Primary JJ Pharmocological
drug NN Pharmocological
therapy NN Pharmocological
MSL-109-treated NNP Pharmocological
placebo-treated JJ Control
MSL-109-treated NNP Pharmocological
MSL-109-treated NNP Pharmocological
placebo-treated JJ Control
MSL-109-treated NNP Pharmocological
( ( None
MSL-109 NNP Pharmocological
placebo NN Control
placebo-treated JJ Control
MSL-109 NNP Pharmocological
MSL-109-treated NNP Pharmocological
-DOCSTART- -X- N

bepotastine NN Pharmocological
besilate NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
placebo-controlled JJ Control
Bepotastine NNP Pharmocological
besilate NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
( ( Pharmocological
BBOS NNP Pharmocological
) ) Pharmocological
dual-acting JJ Pharmocological
histamine NN Pharmocological
placebo-controlled JJ Control
BBOS NNP Pharmocological
or CC None
placebo NN Control
eyedrops NNS Control
-DOCSTART- -X- N

-DOCSTART- -X- N

metoclopramide NN Pharmocological
high-dose JJ Pharmocological
metoclopramide NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
mg/kg NN Pharmocological
, , None
4 CD None
times NNS None
every DT None
2 CD None
hours NNS None
) ) None
metoclopramide NN Pharmocological
metoclopramide JJ Pharmocological
-DOCSTART- -X- N

epigallocatechin-3-gallate NN Pharmocological
Epigallocatechin-3-gallate NNP Pharmocological
( ( Pharmocological
EGCG NNP Pharmocological
) ) Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
w/w NN Pharmocological
of IN Pharmocological
EGCG NNP Pharmocological
. . Pharmocological
EGCG NNP Pharmocological
cream NN Pharmocological
vehicle NN Pharmocological
control NN Pharmocological
cream NN Pharmocological
EGCG NNP Pharmocological
vehicle NN Other
treated VBN Other
EGCG NNP None
treated VBD None
EGCG NNP None
treated VBD None
EGCG NNP None
vs. FW None
vehicle-treated JJ None
skin NN None
< NNP None
0.005 CD None
) ) None
. . None
EGCG NNP None
topical JJ None
-DOCSTART- -X- N

problem-solving JJ Educational
education NN Educational
( ( Educational
PSE NNP Educational
) ) Educational
PSE NNP Educational
usual JJ Control
care NN Control
. . None
Problem-solving JJ Educational
education NN Educational
30-minute JJ Educational
individualized VBN Educational
sessions NNS Educational
by IN Educational
existing VBG Educational
staff NN Educational
research NN None
staff NN None
without IN None
formal JJ None
mental JJ None
health NN None
training NN None
PSE NNP None
usual JJ Control
care NN Control
. . None
PSE NNP None
PSE NNP None
PSE NNP None
-DOCSTART- -X- N

placebo NN Control
omeprazole JJ Pharmocological
2 CD Pharmocological
X NN Pharmocological
20mg CD Pharmocological
, , None
clarithromycin VBD Pharmocological
2 CD Pharmocological
X NNP Pharmocological
500mg CD Pharmocological
, , None
and CC None
amoxicillin RB Pharmocological
2 CD Pharmocological
X NNS Pharmocological
1g CD Pharmocological
for IN None
7 CD None
days NNS None
, , None
or CC None
omeprazole JJ Control
2 CD Control
X NN Control
20mg CD Control
plus CC None
placebo NN Control
. . None
-DOCSTART- -X- N

naltrexone NN Pharmocological
opiate JJ Pharmocological
antagonist NN Pharmocological
naltrexone NN Pharmocological
placebo NN Control
naltrexone NN Pharmocological
-DOCSTART- -X- N

nebivolol NN None
in IN None
with IN None
metoprolol NN None
in IN None
receive VB None
5 CD None
mg NN None
of IN None
nebivolol NN None
( ( None
N=65 NNP None
95 CD None
mg NN None
of IN None
metoprolol NN None
( ( None
N=63 NNP None
-DOCSTART- -X- N

CGM NNP Other
control NN Control
standard JJ Control
home NN Control
blood NN Control
glucose JJ Control
monitoring NN Control
CGM NNP Other
-DOCSTART- -X- N

and/or JJ Pharmocological
antioxidants NNS Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Clonidine NNP Pharmocological
placebo-controlled JJ Control
clonidine NN Pharmocological
. . Pharmocological
clonidine NN Pharmocological
placebo NN Control
. . None
clonidine JJ Pharmocological
clonidine NN Pharmocological
placebo NN Control
. . None
Clonidine NNP Pharmocological
-DOCSTART- -X- N

Dronabinol NNP Pharmocological
versus NN None
megestrol NN Pharmocological
acetate VBP Pharmocological
versus NN Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
dronabinol NN Pharmocological
megestrol JJ Pharmocological
acetate NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
dronabinol NN Pharmocological
-DOCSTART- -X- N

entacapone NN Pharmocological
Entacapone NNP Pharmocological
( ( Pharmocological
OR-611 NNP Pharmocological
) ) Pharmocological
, , None
a DT None
novel JJ Pharmocological
COMT NNP Pharmocological
inhibitor NN Pharmocological
levodopa/50 JJ Pharmocological
carbidopa NN Pharmocological
placebo NN Control
entacapone NN Pharmocological
. . None
-DOCSTART- -X- N

Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
. . None
Ringer NNP Pharmocological
's POS Pharmocological
acetate JJ Pharmocological
solution NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
infusion NN Pharmocological
of IN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
-DOCSTART- -X- N

cognitive-behavioral JJ Educational
intervention NN Educational
cognitive-behavioral JJ Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
-DOCSTART- -X- N

early JJ Physical
rehabilitation NN Physical
protocol NN Physical
-DOCSTART- -X- N

midazolam NN Pharmocological
midazolam NN Pharmocological
or CC None
placebo NN Control
etomidate NN Pharmocological
. . None
midazolam NN Pharmocological
etomidate NN Pharmocological
placebo NN Control
midazolam VBD Pharmocological
-DOCSTART- -X- N

Benzodiazepine NNP Pharmocological
opioid JJ Pharmocological
sedation NN Pharmocological
beta-adrenergic JJ Pharmocological
anatagonist NN Pharmocological
labetalol $ Pharmocological
10mg CD Pharmocological
iv NN Pharmocological
given VBN Pharmocological
with IN Pharmocological
midazolam-alfentanil JJ Pharmocological
sedation NN Pharmocological
. . None
labetalol NN Pharmocological
midazolam-alfentanil JJ Pharmocological
sedation NN Pharmocological
labetalol NN Pharmocological
-DOCSTART- -X- N

autologous JJ Pharmocological
fibroblasts NNS Pharmocological
: : None
autologous JJ Pharmocological
fibroblasts NNS Pharmocological
( ( Pharmocological
human JJ Pharmocological
dermal NN Pharmocological
) ) Pharmocological
injections NNS Pharmocological
placebo JJ Control
autologous JJ Pharmocological
fibroblast JJ Pharmocological
placebo-controlled JJ Control
2 CD Pharmocological
mL NNS Pharmocological
of IN Pharmocological
autologous JJ Pharmocological
fibroblast JJ Pharmocological
suspension NN Pharmocological
vehicle NN Control
control NN Control
Autologous JJ Pharmocological
fibroblast JJ Pharmocological
treatment NN Pharmocological
Autologous JJ Pharmocological
fibroblast JJ Pharmocological
injections NNS Pharmocological
Autologous NNP Pharmocological
fibroblast VBD Pharmocological
injections NNS Pharmocological
-DOCSTART- -X- N

Magnesium NN Pharmocological
sulphate NN Pharmocological
Hypothermia NNP Physical
Magnesium NNP Pharmocological
magnesium NN Pharmocological
control NN Control
magnesium NN Pharmocological
Lactated VBN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
Magnesium NNP Pharmocological
magnesium NN Pharmocological
Magnesium NNP Pharmocological
-DOCSTART- -X- N

antiarrhythmic-drug JJ Pharmocological
therapy NN Pharmocological
with IN None
implantable JJ Physical
defibrillators NNS Physical
Antiarrhythmics NNPS Pharmocological
Implantable JJ Physical
Defibrillators NNS Physical
implantable JJ Physical
cardioverter-defibrillator NN Physical
antiarrhythmic JJ Pharmocological
drugs NNS Pharmocological
implantation NN Physical
of IN Physical
a DT Physical
cardioverter-defibrillator NN Physical
; : Physical
class NN Pharmocological
III NNP Pharmocological
antiarrhythmic JJ Pharmocological
drugs NNS Pharmocological
, , None
primarily RB None
amiodarone NN Pharmocological
implantable JJ Physical
defibrillator NN Physical
antiarrhythmic-drug JJ Pharmocological
implantable JJ Physical
defibrillator NN Physical
implantable JJ Physical
cardioverter-defibrillator NN Physical
antiarrhythmic VB Pharmocological
drugs NNS Pharmocological
-DOCSTART- -X- N

maternal JJ Pharmocological
glucose JJ Pharmocological
infusion NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
dextrose NN Pharmocological
glucose NN Pharmocological
) ) None
or CC None
Ringer NNP Pharmocological
's POS Pharmocological
lactate NN Pharmocological
or CC None
isotonic JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
epidural JJ Physical
anesthesia NN Physical
. . None
-DOCSTART- -X- N

Synthetic JJ Pharmocological
serum NN Pharmocological
substitute NN Pharmocological
( ( Pharmocological
SSS NNP Pharmocological
) ) Pharmocological
: : None
Plasmatein NNP Pharmocological
Plasmanate NNP Pharmocological
divided VBN None
and CC None
cultured VBN None
in IN None
human JJ Pharmocological
tubal JJ Pharmocological
fluid NN Pharmocological
medium NN Pharmocological
( ( Pharmocological
HTF NNP Pharmocological
) ) Pharmocological
supplemented VBD None
with IN None
either DT None
HSA NNP Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg/mL NN Pharmocological
) ) Pharmocological
or CC None
Plasmatein NNP Other
( ( Pharmocological
10 CD Pharmocological
% NN Pharmocological
, , Pharmocological
v/v NN Pharmocological
; : Pharmocological
5 CD Pharmocological
mg/ml NN Pharmocological
) ) Pharmocological
as IN None
a DT None
means NN None
of IN None
indirectly RB None
assessing VBG None
the DT None
effect NN None
alpha- JJ None
and CC None
beta-globulins NNS None
have VBP None
on IN None
embryonic JJ None
development NN None
. . None
Plasmatein NNP Pharmocological
Plasmatein NNP Pharmocological
HSA NNP Pharmocological
Plasmatein NNP Pharmocological
SSS NNP Pharmocological
SSS NNP Pharmocological
Plasmatein NNP Pharmocological
Plasmatein NNP Pharmocological
SSS NNP Pharmocological
Synthetic NNP Pharmocological
serum NN Pharmocological
substitute NN Pharmocological
-DOCSTART- -X- N

error NN Educational
prevention NN Educational
error NN Educational
correction NN Educational
teaching NN Educational
procedures NNS Educational
. . Educational
teaching VBG Educational
procedures NNS Educational
teaching NN Educational
procedures NNS Educational
, , Educational
an DT Educational
error NN Educational
prevention NN Educational
procedure NN Educational
and CC Educational
an DT Educational
error NN Educational
correction NN Educational
procedure NN Educational
, , Educational
for IN Educational
teaching VBG Educational
relations NNS Educational
between IN Educational
objects NNS Educational
and CC Educational
pictures NNS Educational
. . Educational
an DT Educational
error NN Educational
correction NN Educational
method NN Educational
an DT Educational
error NN Educational
prevention NN Educational
method NN Educational
. . Educational
prevention-based JJ Educational
teaching NN Educational
prevention NN Educational
teaching NN Educational
procedure NN Educational
-DOCSTART- -X- N

insulin NN Pharmocological
continuous JJ Pharmocological
subcutaneous JJ Pharmocological
insulin NN Pharmocological
infusion NN Pharmocological
followed VBN None
by IN None
16 CD None
weeks NNS None
intensive JJ Pharmocological
injection NN Pharmocological
therapy NN Pharmocological
or CC None
the DT None
reverse JJ Pharmocological
order NN Pharmocological
. . None
insulin NN Pharmocological
insulin NN Pharmocological
-DOCSTART- -X- N

imaging VBG Physical
intraperitoneal JJ Physical
distribution NN Physical
imaging NN Physical
( ( Physical
IDI NNP Physical
) ) Physical
. . None
IDI NNP Physical
normal JJ Pharmocological
saline NN Pharmocological
and CC None
1 CD Pharmocological
mCi NN Pharmocological
of IN Pharmocological
Tc-99m NNP Pharmocological
SC NNP Pharmocological
IDI NNP Physical
. . None
normal JJ Pharmocological
saline NN Pharmocological
Tc-99m NNP Pharmocological
SC NNP Pharmocological
. . None
-DOCSTART- -X- N

torcetrapib NN Pharmocological
cholesteryl NN Pharmocological
ester NN Pharmocological
transfer NN Pharmocological
protein NN Pharmocological
( ( Pharmocological
CETP NNP Pharmocological
) ) Pharmocological
inhibitor NN Pharmocological
torcetrapib NN Pharmocological
placebo VB Control
torcetrapib NN Pharmocological
Torcetrapib NN Pharmocological
-DOCSTART- -X- N

syndrome NN Educational
: : Educational
differential JJ Educational
attributions NNS Educational
. . None
Nurses NNS None
and CC None
physician JJ None
assistants NNS None
( ( None
PAs NNP None
) ) None
were VBD None
presented VBN None
a DT None
case NN Psychological
study NN Psychological
of IN Psychological
a DT Psychological
( ( Educational
CNDS NNP Educational
) ) Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

prophylactic JJ Pharmocological
fentanyl NN Pharmocological
fentanyl NN Pharmocological
fentanyl NN Pharmocological
-DOCSTART- -X- N

Ganitumab NNP Pharmocological
exemestane NN Pharmocological
fulvestrant NN Pharmocological
Ganitumab NNP Pharmocological
intravenous JJ Pharmocological
ganitumab NNS Pharmocological
12 CD None
mg NNS None
per IN None
kg NN None
bodyweight NN None
or CC None
placebo NN Control
in IN None
combination NN None
with IN None
open-label JJ Physical
intramuscular JJ Physical
fulvestrant NN Pharmocological
( ( None
500 CD None
mg NN None
on IN None
day NN None
1 CD None
, , None
then RB None
250 CD None
mg NNS None
on IN None
days NNS None
15 CD None
, , None
29 CD None
, , None
and CC None
every DT None
28 CD None
days NNS None
) ) None
or CC None
oral JJ None
exemestane NN Pharmocological
( ( None
25 CD None
mg NN None
once RB None
daily RB None
) ) None
on IN None
a DT None
28-day JJ None
cycle NN None
. . None
Response NNP None
was VBD None
assessed VBN None
every DT None
8 CD None
weeks NNS None
. . None
ganitumab NN Pharmocological
ganitumab NN None
the DT None
ganitumab NN None
Addition NNP None
of IN None
ganitumab NN None
-DOCSTART- -X- N

subconjunctival JJ Pharmocological
5-FU JJ Pharmocological
no DT Control
antimetabolite JJ Control
treatment NN Control
-DOCSTART- -X- N

calcium NN Pharmocological
hydroxide NN Pharmocological
and CC None
zinc NN Pharmocological
oxide RB Pharmocological
eugenol RB Pharmocological
Calcium NNP Pharmocological
hydroxide NN Pharmocological
calcium NN Pharmocological
hydroxide NN Pharmocological
and CC None
zinc NN Pharmocological
oxide NN Pharmocological
eugenol NN Pharmocological
used VBN None
as IN None
-DOCSTART- -X- N

toothbrushes NNS Physical
and CC Physical
dentifrice NN Physical
regular JJ Physical
brushing NN Physical
with IN Physical
dentifrices NNS Physical
toothbrush NN Physical
and CC Physical
dentifrice NN Physical
) ) None
introduction NN Physical
of IN Physical
toothbrushes NNS Physical
and CC Physical
dentifrices NNS Physical
-DOCSTART- -X- N

intervention NN Educational
community NN Educational
caregiver RB Educational
training NN Educational
interventions NNS Educational
CMM NNP Educational
CMM NNP Educational
-DOCSTART- -X- N

Single NNP Pharmocological
nucleotide JJ Pharmocological
polymorphism NN Pharmocological
single JJ Pharmocological
nucleotide NN Pharmocological
polymorphism NN Pharmocological
( ( Pharmocological
SNP NNP Pharmocological
) ) Pharmocological
C1772T NNP Pharmocological
polymorphism NN Pharmocological
HIF-1alpha NNP Pharmocological
activation NN Pharmocological
control NN Control
-DOCSTART- -X- N

traditional JJ Physical
bone NN Physical
setting NN Physical
and CC Physical
conventional JJ Physical
physical JJ Physical
therapy NN Physical
. . None
traditional JJ Physical
bone NN Physical
setting NN Physical
and CC Physical
physical JJ Physical
therapy NN Physical
. . None
traditional JJ Physical
bone NN Physical
setting NN Physical
and CC Physical
physical JJ Physical
therapy NN Physical
. . None
Active NNP Physical
back RB Physical
exercise NN Physical
at IN Physical
home NN Physical
treatments NNS Control
-DOCSTART- -X- N

[ JJ None
Intra-arterial JJ Pharmocological
( ( Pharmocological
5-FU/FA JJ Pharmocological
and CC Physical
FUDR NNP Pharmocological
) ) Physical
versus VBP None
systemic JJ Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
5-FU/FA JJ Pharmocological
) ) Pharmocological
HAI NNP Pharmocological
FUDR NNP Pharmocological
, , Physical
HAI NNP Pharmocological
5-FU/FA CD Pharmocological
, , Physical
and CC Physical
i.v NN Physical
. . Physical
5-FU/FA JJ None
chemotherapy NN None
HAI NNP Pharmocological
HAI NNP Pharmocological
FUDR NNP Pharmocological
HAI NNP Pharmocological
5-FU/FA JJ Pharmocological
. . Pharmocological
5-FU/FA-therapy NN Pharmocological
-DOCSTART- -X- N

postoperative JJ Physical
radiation NN Physical
therapy NN Physical
versus NN None
adjuvant JJ Physical
chemotherapy NN Physical
adjuvant JJ Physical
chemotherapy NN Physical
postoperative JJ Physical
radiation NN Physical
( ( None
RT NNP None
) ) None
with IN None
adjuvant JJ Physical
CMF-type JJ Physical
chemotherapy NN Physical
( ( None
CT NNP None
) ) None
. . None
RT NNP Pharmocological
CT NNP Pharmocological
-DOCSTART- -X- N

mesalamine NN Pharmocological
mesalamine NN Pharmocological
( ( None
mesalazine NN Pharmocological
) ) None
granules NNS None
( ( None
MG NNP None
) ) None
. . None
MG NNP None
placebo NN None
( ( None
78.9 CD None
favouring VBG None
MG NNP None
were VBD None
Once-daily JJ None
mesalamine NN None
( ( None
mesalazine NN None
) ) None
was VBD None
effective JJ None
-DOCSTART- -X- N

monodisperse JJ Pharmocological
10 CD Pharmocological
microM NN Pharmocological
MMAD NNP Pharmocological
aerosol NN Pharmocological
of IN Pharmocological
H2SO4 NNP Pharmocological
nominal JJ None
concentration NN None
acid VB Control
or CC Control
control VB Control
equiosmolar JJ Control
NaCl NNP Control
aerosol NN Control
-DOCSTART- -X- N

peer NN Educational
, , Educational
nurse JJ Educational
case-managed JJ Educational
, , Educational
and CC Educational
standard JJ Other
HIV NNP Other
risk-reduction NN Other
programs NNS Other
cognitive-behavioral JJ Educational
HIV NNP Educational
risk-reduction NN Educational
programs NNS Educational
program NN Control
. . None
peer-mentored JJ Educational
and CC Educational
nurse JJ Educational
case-managed JJ Educational
standard JJ Control
group NN Control
-DOCSTART- -X- N

dihydropyridine JJ Pharmocological
calcium NN Pharmocological
antagonists NNS Pharmocological
niguldipine NN Pharmocological
nifedipine JJ Pharmocological
placebo-controlled JJ Control
nifedipine NN Pharmocological
dihydropyridines NNS Pharmocological
nifedipine NN Pharmocological
) ) None
niguldipine NN Pharmocological
) ) None
-DOCSTART- -X- N

bileaflet NN Surgical
prostheses NNS Surgical
bileaflet NN Surgical
prostheses NNS Surgical
prostheses NNS None
Prosthesis NNP Surgical
-DOCSTART- -X- N

Hemolytic JJ Pharmocological
streptococcus NN Pharmocological
preparation NN Pharmocological
OK-432 NNP Pharmocological
; : None
hemolytic JJ Pharmocological
streptococcus NN Pharmocological
preparation NN Pharmocological
3 CD None
groups NNS None
: : None
-DOCSTART- -X- N

warfarin NN Pharmocological
warfarin NN Pharmocological
warfarin NN Pharmocological
control NN Control
Warfarin NNP Pharmocological
verapamil NNS Pharmocological
other JJ Pharmocological
antianginal JJ Pharmocological
drugs NNS Pharmocological
Low JJ Pharmocological
molecular JJ Pharmocological
weight NN Pharmocological
dextran NN Pharmocological
and CC Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
warfarin NN Pharmocological
control NN None
warfarin NN Pharmocological
verapamil NN Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

Screening VBG Physical
, , Physical
brief JJ Physical
intervention NN Physical
, , Physical
and CC Physical
referral JJ Physical
to TO Physical
treatment NN Physical
( ( Physical
SBIRT NNP Physical
) ) Physical
screening NN Physical
, , Physical
brief JJ Physical
intervention NN Physical
, , Physical
and CC Physical
referral JJ Physical
to TO Physical
treatment NN Physical
( ( Physical
SBIRT NNP Physical
) ) Physical
screened VBN Physical
only RB Physical
assessed VBN Educational
received VBN Physical
intervention NN Physical
assessment NN None
intervention NN Physical
intervention NN Other
assessment JJ Educational
intervention NN Physical
-DOCSTART- -X- N

fomivirsen NN Pharmocological
fomivirsen NN Pharmocological
-DOCSTART- -X- N

ofloxacin NN Pharmocological
cefixime NN Pharmocological
fluoroquinolone NN Pharmocological
antibiotics NNS Pharmocological
Cefixime NNP Pharmocological
cephalosporin NN Pharmocological
ofloxacin NN Pharmocological
ofloxacin NN Pharmocological
cefixime NN Pharmocological
ofloxacin JJ Pharmocological
cefixime NN Pharmocological
ofloxacin NN Pharmocological
cefixime NN Pharmocological
ofloxacin NN Pharmocological
. . None
-DOCSTART- -X- N

chestnut NN Pharmocological
tannins NNS Pharmocological
raised VBN None
at IN None
20?C CD None
and CC None
fed VBN None
with IN None
basal NN None
diet NN None
( ( None
N NNP None
) ) None
and CC None
other JJ None
three CD None
groups NNS None
( ( None
33?C CD None
) ) None
were VBD None
fed VBN None
basal JJ None
diet JJ None
with IN None
0 CD None
( ( None
C NNP None
) ) None
, , None
5 CD None
( ( None
CT5 NNP None
) ) None
, , None
and CC None
10 CD None
g NN None
( ( None
CT10 NNP None
) ) None
of IN None
CT/kg NNP None
of IN None
diet NN None
. . None
-DOCSTART- -X- N

percutaneous JJ Surgical
transluminal JJ Surgical
angioplasty NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
angioplasty NN Surgical
( ( Surgical
PTA NNP Surgical
) ) Surgical
vasodilator NN None
, , None
glyceryl JJ Pharmocological
trinitrate NN Pharmocological
( ( Pharmocological
GTN NNP Pharmocological
) ) Pharmocological
balloon NN Physical
dilatation NN Physical
an DT Physical
intra-arterial JJ Physical
bolus NN Physical
of IN None
either CC None
150 CD Pharmocological
micrograms NNS Pharmocological
GTN NNP Pharmocological
, , None
with IN None
or CC None
without IN None
a DT None
10 CD None
mg NN None
GTN NNP Pharmocological
patch NN Pharmocological
for IN None
24 CD None
h NN None
, , None
or CC None
a DT None
saline JJ Control
placebo NN Control
saline JJ Control
GTN NNP Pharmocological
GTN NNP Pharmocological
GTN NNP Pharmocological
-DOCSTART- -X- N

electroacununcture NN Physical
of IN None
electroacupuncture NN None
( ( None
EA NNP None
) ) None
EA NNP None
and CC None
into IN None
medication NN None
group NN None
and CC None
acupuncture NN None
group NN None
acupuncture NN None
group NN None
were VBD None
treated VBN None
with IN None
EA NNP None
( ( None
80 CD None
Hz NNP None
, , None
2.5 CD None
mA NN None
) ) None
of IN None
Shenshu NNP None
( ( None
BL NNP None
23 CD None
) ) None
, , None
Taixi NNP None
( ( None
KI NNP None
3 CD None
) ) None
, , None
Hegu NNP None
( ( None
LI NNP None
4 CD None
) ) None
, , None
etc FW None
. . None
for IN None
30 CD None
min NN None
, , None
once RB None
every DT None
other JJ None
day NN None
, , None
and CC None
those DT None
of IN None
medication NN None
group NN None
were VBD None
treated VBN None
with IN None
oral JJ None
administration NN None
of IN None
hydroxyl-chloroquine JJ None
( ( None
6 CD None
mg/kg NNS None
per IN None
day NN None
) ) None
, , None
oral JJ None
transfer NN None
agent NN None
liquid NN None
, , None
Vit NNP None
B1 NNP None
, , None
Vit NNP None
B2 NNP None
, , None
Vit NNP None
C NNP None
, , None
fish-liver JJ None
oil NN None
, , None
one CD None
tablet/time NN None
, , None
t.i.d. NN None
, , None
and CC None
pilocarpine NN None
( ( None
20 CD None
mg/d NN None
) ) None
, , None
continuously RB None
for IN None
2 CD None
months NNS None
. . None
using VBG None
electro-chemiluminescent JJ None
immunoassay NN None
( ( None
CLIA NNP None
) ) None
. . None
CONCLUSION NNP None
EA NNP None
can MD None
EA NNP None
medication NN None
. . None
-DOCSTART- -X- N

marine NN Pharmocological
lipid JJ Pharmocological
suppositories NNS Pharmocological
suppositories NNS Pharmocological
and CC Pharmocological
ointment NN Pharmocological
with IN Pharmocological
30 CD Pharmocological
% NN Pharmocological
free JJ Pharmocological
fatty JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
FFA NNP Pharmocological
) ) Pharmocological
extract NN Pharmocological
from IN Pharmocological
omega-3 JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
. . None
FFA NNP Pharmocological
suppositories NNS Pharmocological
FFA NNP Pharmocological
ointment NN Pharmocological
placebo NN Control
suppositories NNS Control
-DOCSTART- -X- N

total JJ None
knee NN Surgical
arthroplasty NN Surgical
custom-fit JJ Physical
magnetic JJ Physical
resonance NN Physical
imaging NN Physical
( ( Physical
MRI NNP Physical
) ) Physical
-based VBD Physical
pin NN Physical
guides NNS Physical
intramedullary JJ Physical
alignment NN Physical
jigs NNS Physical
custom-fit JJ Physical
MRI-based JJ Physical
pin NN Physical
guides NNS Physical
cemented VBD Surgical
posterior-stabilized JJ Surgical
implant NN Surgical
custom-fit JJ Physical
custom-fit JJ None
custom-fit JJ None
pin NN None
guides NNS None
-DOCSTART- -X- N

placebo-controlled JJ Control
olanzapine NN Pharmocological
placebo-controlled JJ Control
olanzapine NN Pharmocological
placebo-controlled JJ Control
olanzapine NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

sibutramine NN Pharmocological
sibutramine-induced JJ Pharmocological
sibutramine JJ Pharmocological
placebo NN Control
sibutramine JJ Pharmocological
sibutramine NN Pharmocological
sibutramine JJ Pharmocological
sibutramine NN Pharmocological
sibutramine NN Pharmocological
-DOCSTART- -X- N

docosahexaenoic NN Pharmocological
acid NN Pharmocological
placebo NN Control
30 CD None
mg/kg/d NNS None
DHA NNP None
or CC None
placebo VB None
plus CC None
-DOCSTART- -X- N

Poylmerized VBN Pharmocological
whole JJ Pharmocological
ragweed NN Pharmocological
: : None
glutaraldehyde-treated JJ Pharmocological
polymerized NNS Pharmocological
ragweed VBP Pharmocological
nonpolymerized JJ Pharmocological
monomeric JJ Pharmocological
ragweed NN Pharmocological
. . Pharmocological
ragweed NN Pharmocological
serum-specific JJ None
IgE NNP None
polymerized JJ Pharmocological
ragweed NN Pharmocological
. . None
-DOCSTART- -X- N

acebutolol NN Pharmocological
acebutolol NN Pharmocological
acebutolol NN Pharmocological
placebo-controlled JJ Control
acebutolol NN Pharmocological
Acebutolol NNP Pharmocological
acebutolol NN Pharmocological
acebutolol NN Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
cisplatin NN Pharmocological
paclitaxel NN Pharmocological
cisplatin NN Pharmocological
paclitaxel NN Pharmocological
standard JJ Physical
radiotherapy NN Physical
40 CD None
mg/m? NN None
Cisplatin NNP None
( ( None
group NN None
I PRP None
; : None
16 CD None
patients NNS None
) ) None
or CC None
50 CD None
mg/m? NNS None
paclitaxel NN None
( ( None
group NN None
II NNP None
; : None
15 CD None
patients NNS None
) ) None
concurrently RB None
with IN None
radiotherapy NN None
. . None
weekly VBP None
paclitaxel NN None
does VBZ None
weekly JJ None
cisplatin NN None
for IN None
concurrent JJ None
chemoradiation NN None
-DOCSTART- -X- N

Memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
-DOCSTART- -X- N

niacin JJ Pharmocological
alone NN Pharmocological
or CC None
with IN None
atorvastatin NN Pharmocological
extended-release JJ Pharmocological
niacin NN Pharmocological
( ( Pharmocological
niacin JJ Pharmocological
ER NNP Pharmocological
) ) Pharmocological
either CC None
alone RB None
or CC None
in IN None
combination NN None
with IN None
atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
niacin NN Pharmocological
ER NNP Pharmocological
niacin NNS Pharmocological
ER NNP Pharmocological
combination NN Control
treatment NN Control
treated VBN None
with IN None
atorvastatin NN Pharmocological
( ( Pharmocological
10 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
plus CC None
niacin JJ Pharmocological
ER NNP Pharmocological
-DOCSTART- -X- N

vitamin NN Pharmocological
B6 NNP Pharmocological
supplementation NN Pharmocological
2.5 CD None
, , None
4 CD None
, , None
and CC None
10 CD None
mg NN None
of IN None
pyridoxine JJ Pharmocological
supplementation NN Pharmocological
4 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
pyridoxine JJ Pharmocological
supplementation NN Pharmocological
daily RB Pharmocological
pyridoxine NN Pharmocological
vitamin JJ Pharmocological
B6 NNP Pharmocological
vitamin NN Pharmocological
B6 NNP Pharmocological
-DOCSTART- -X- N

formoterol NN Pharmocological
salbutamol JJ Pharmocological
formoterol NN Pharmocological
salbutamol NN Pharmocological
formoterol NN Pharmocological
formoterol NN Pharmocological
9 CD Pharmocological
microg NN Pharmocological
or CC None
salbutamol VB Pharmocological
100 CD Pharmocological
microg NN Pharmocological
( ( Pharmocological
group NN Pharmocological
A NNP Pharmocological
) ) Pharmocological
or CC None
formoterol $ Pharmocological
18 CD Pharmocological
microg NN Pharmocological
or CC None
salbutamol VB Pharmocological
200 CD Pharmocological
microg NN Pharmocological
( ( None
group NN None
B NNP None
) ) None
. . None
Formoterol NNP Pharmocological
salbutamol NN Pharmocological
-DOCSTART- -X- N

Aerobic NNP Physical
exercise NN Physical
moderate JJ Physical
aerobic JJ Physical
physical JJ Physical
activity NN Physical
comparing VBG None
16 CD None
weeks NNS None
of IN None
aerobic JJ None
physical JJ None
activity NN None
plus CC None
sleep JJ None
hygiene NN None
to TO None
non-physical JJ None
activity NN None
plus CC None
sleep JJ None
hygiene NN None
. . None
-DOCSTART- -X- N

micronutrient NN Pharmocological
supplement NN Pharmocological
supplementation NN None
with IN None
a DT None
micronutrient-fortified JJ Pharmocological
beverage NN Pharmocological
micronutrient-enriched JJ Pharmocological
beverage NN Pharmocological
or CC None
a DT None
placebo NN Control
without IN Control
added JJ Control
micronutrients NNS Control
. . None
micronutrient-enriched JJ Pharmocological
beverage NN Pharmocological
. . None
micronutrients NNS Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Active NNP Pharmocological
specific JJ Pharmocological
immunotherapy NN Pharmocological
active JJ Pharmocological
specific JJ Pharmocological
immunotherapy NN Pharmocological
autologous JJ Physical
tumour NN Physical
cells NNS Physical
. . None
ASI NNP Pharmocological
-DOCSTART- -X- N

three CD Pharmocological
dosage-prediction NN Pharmocological
Three CD Pharmocological
dosage-prediction NN Pharmocological
methods NNS Pharmocological
warfarin JJ Pharmocological
therapy NN Pharmocological
warfarin NN Pharmocological
warfarin NNS Pharmocological
analog NN Physical
computer NN Physical
linear JJ Physical
regression NN Physical
empiric JJ Physical
dosing NN Physical
by IN Physical
the DT Physical
physician NN Physical
-DOCSTART- -X- N

progestogen-only JJ Pharmocological
progestogen-only JJ Pharmocological
continuous JJ Pharmocological
progestogens NNS Pharmocological
for IN None
contraception NN None
depot-medroxyprogesterone JJ Pharmocological
acetate NN Pharmocological
( ( Pharmocological
DMPA NNP Pharmocological
) ) Pharmocological
continuous JJ Control
levonorgestrel NN Control
treatment NN Control
with IN Control
subdermal JJ Control
implants NNS Control
depot-medroxy-progesterone JJ Pharmocological
acetate NN Pharmocological
; : None
DMPA NNP Pharmocological
levonorgestrel NN Pharmocological
DMPA NNP Pharmocological
-DOCSTART- -X- N

biofeedback NN Psychological
treatment NN Psychological
biofeedback NN Psychological
treatment NN Psychological
( ( Psychological
BF NNP Psychological
) ) Psychological
BF NNP Psychological
group NN None
B NNP None
visited VBD Other
the DT Other
clinic NN Other
only RB None
BF NNP Other
. . None
BF NNP Other
. . None
BF NNP None
BF NNP Other
-DOCSTART- -X- N

fennel NN Pharmocological
extract NN Pharmocological
mefenamic JJ Pharmocological
acid NN Pharmocological
fennel NN Pharmocological
mefenamic JJ Pharmocological
acid NN Pharmocological
fennel NN Pharmocological
mefenamic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

desipramine NN Pharmocological
150 CD Pharmocological
mg/day NN Pharmocological
, , None
or CC None
a DT Pharmocological
metapramine JJ Pharmocological
450 CD Pharmocological
mg/day JJ Pharmocological
antidepressant JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

behavioral JJ Psychological
training NN Psychological
therapy NN Psychological
behavioral JJ Educational
program NN Educational
. . None
-DOCSTART- -X- N

indomethacin NN None
indomethacin NN None
placebo NN Control
, , None
indomethacin NN None
indomethacin NN None
placebo NN Control
indomethacin JJ Pharmocological
indomethacin JJ None
placebo NN None
. . None
indomethacin NN None
. . None
-DOCSTART- -X- N

oral JJ Surgical
surgery NN Surgical
local JJ Pharmocological
anesthesia NN Pharmocological
midazolam NNS Pharmocological
: : None
local JJ Pharmocological
anesthetics NNS Pharmocological
. . None
epinephrine-free JJ Pharmocological
and CC Pharmocological
epinephrine-containing JJ Pharmocological
local JJ Pharmocological
anesthetic JJ Pharmocological
4.4 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
with IN Pharmocological
1:80,000 CD Pharmocological
epinephrine NN Pharmocological
as IN Pharmocological
a DT Pharmocological
local JJ Pharmocological
anesthetic NN Pharmocological
and CC None
10 CD None
were VBD None
given VBN None
4.4 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
3 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
with IN Pharmocological
0.03 CD Pharmocological
IU/mL NNP Pharmocological
felypressin NN Pharmocological
. . None
epinephrine-free JJ Pharmocological
solution NN Pharmocological
. . None
epinephrine-free JJ Pharmocological
epinephrine-containing JJ Pharmocological
local JJ Pharmocological
anesthetics NNS Pharmocological
midazolam JJ Pharmocological
sedation NN Pharmocological
. . None
-DOCSTART- -X- N

Gonadotropin-releasing VBG Pharmocological
hormone NN Pharmocological
Gonadotropin-releasing VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GnRH NNP Pharmocological
) ) Pharmocological
agonists NNS Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
3.75 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
depot NN Pharmocological
leuprolide NN Pharmocological
or CC None
a DT None
placebo NN Control
leuprolide JJ Pharmocological
leuprolide NN Pharmocological
leuprolide JJ Pharmocological
leuprolide JJ Pharmocological
Leuprolide NNP Pharmocological
Leuprolide NNP Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

melatonin NN Pharmocological
, , None
singly RB Psychological
and CC Psychological
combined VBN Psychological
with IN Psychological
cognitive JJ Psychological
behavioural JJ Psychological
therapy NN Psychological
melatonin NN Pharmocological
and CC None
cognitive-behavioural JJ Psychological
therapy NN Psychological
combination NN None
of IN None
controlled-release JJ Pharmocological
melatonin NN Pharmocological
and CC None
cognitive-behavioural JJ Educational
therapy NN Educational
; : None
( ( None
2 CD None
) ) None
controlled-release NN Pharmocological
melatonin NN Pharmocological
; : None
( ( None
3 CD None
) ) None
four CD Educational
sessions NNS Educational
of IN Educational
cognitive-behavioural JJ Educational
therapy NN Educational
; : None
or CC None
( ( None
4 CD None
) ) None
placebo FW Control
drug NN None
treatment NN None
condition NN None
Melatonin NNP Pharmocological
cognitive-behavioural JJ Psychological
therapy NN Psychological
behavioural JJ Educational
intervention NN Educational
melatonin VB Pharmocological
-DOCSTART- -X- N

structural JJ Educational
equation NN Educational
modeling NN Educational
( ( Educational
SEM NNP Educational
) ) Educational
( ( None
BL NNP Physical
) ) None
-DOCSTART- -X- N

essential JJ Pharmocological
oils NNS Pharmocological
of IN Pharmocological
garlic NN Pharmocological
and CC Pharmocological
onion NN Pharmocological
garlic NN Pharmocological
and CC Pharmocological
onion NN Pharmocological
garlic NN Pharmocological
or CC Pharmocological
onion NN Pharmocological
essential JJ Pharmocological
oils NNS Pharmocological
Garlic NNP Pharmocological
and CC Pharmocological
onion NN Pharmocological
garlic NN Pharmocological
onion NN Pharmocological
garlic JJ Pharmocological
and CC Pharmocological
onion NN Pharmocological
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
regimen NNS Pharmocological
of IN Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
no DT Pharmocological
adjuvant JJ Pharmocological
treatment NN Pharmocological
or CC None
intravenous JJ Pharmocological
adriamycin NNS Pharmocological
vincristine VBP Pharmocological
cyclophosphamide RB Pharmocological
methotrexate VB Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
AVCMF NNP Pharmocological
) ) Pharmocological
AVCMF NNP Pharmocological
-DOCSTART- -X- N

Reichert NNP Pharmocological
AT550 NNP Pharmocological
Reichert NNP Pharmocological
AT550 NNP Pharmocological
Reichert NNP Physical
Xpert NNP Physical
Plus NNP Physical
Goldmann NNP Other
applanation NN Other
tonometer NN Other
Perkins NNP Other
tonometer NN Other
AT550 NNP Physical
NCT NNP Physical
Goldmann NNP Pharmocological
tonometer NN Pharmocological
AT550 NNP Physical
NCT NNP Physical
Goldmann NNP Pharmocological
tonometry NN Pharmocological
-DOCSTART- -X- N

Diclofenac NNP Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
( ( Pharmocological
NSAIDs NNP Pharmocological
) ) Pharmocological
diclofenac NN Pharmocological
or CC Pharmocological
placebo NN Control
diclofenac NN Pharmocological
placebo NN Control
placebo NN Control
diclofenac NN Pharmocological
Diclofenac NNP Pharmocological
-DOCSTART- -X- N

Hydrogen NNP Pharmocological
peroxide NN Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
: : None
hydrogen NN Pharmocological
peroxide NN Pharmocological
( ( Pharmocological
H2O2 NNP Pharmocological
) ) Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
control NN Control
H2O2 NNP Pharmocological
or CC None
the DT None
group NN Control
. . None
H2O2 NNP Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
-DOCSTART- -X- N

occupation NN Educational
based VBN Educational
physical JJ Educational
activity NN Educational
intervention NN Educational
program NN Educational
: : Educational
occupation NN Educational
based VBN Educational
health NN Educational
and CC Educational
fitness NN Educational
program NN Educational
. . Educational
( ( Educational
implemented VBN Educational
the DT Educational
intervention NN Educational
) ) Educational
( ( Control
continued VBN Control
usual JJ Control
training NN Control
) ) Control
occupational JJ Educational
approach NN Educational
-DOCSTART- -X- N

Bisphosphonate JJ Pharmocological
infusions NNS Pharmocological
: : None
pamidronate NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
or CC None
zoledronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
Z NNP Pharmocological
) ) Pharmocological
P NNP Pharmocological
and CC Pharmocological
Z NNP Pharmocological
infusions NNS Pharmocological
. . None
infusions NNS Pharmocological
of IN Pharmocological
Z NNP Pharmocological
Z NNP Pharmocological
then RB Pharmocological
P NNP Pharmocological
or CC None
P NNP None
then RB None
Z NNP None
Z NNP Pharmocological
infusions NNS Pharmocological
Z NNP Pharmocological
and CC Pharmocological
P NNP Pharmocological
infusions NNS Pharmocological
Z NNP Pharmocological
to TO Pharmocological
P VB Pharmocological
Z NNP Pharmocological
4 CD Pharmocological
mg NN Pharmocological
infusions NNS Pharmocological
Z NNP Pharmocological
rather RB Pharmocological
than IN Pharmocological
P NNP Pharmocological
-DOCSTART- -X- N

tobramycin JJ Pharmocological
aerosols NNS Pharmocological
tobramycin NN Pharmocological
intravenous JJ Pharmocological
betalactam NNS Pharmocological
and CC None
tobramycin NNS Pharmocological
were VBD None
randomly RB None
allocated VBN None
to TO None
receive VB None
aerosolized VBN Pharmocological
tobramycin NN Pharmocological
( ( None
6 CD None
mg/kg/day NN None
, , None
n JJ None
= NNP None
21 CD None
) ) None
or CC None
placebo NN None
( ( None
n JJ None
= NNP None
17 CD None
) ) None
. . None
The DT None
aerosol NN Pharmocological
was VBD None
administered VBN None
via IN None
a DT None
pneumatic JJ None
nebulizer NN None
once RB None
a DT None
day NN None
for IN None
5 CD None
days NNS None
. . None
-DOCSTART- -X- N

MMX NNP None
( ( None
? . None
) ) None
mesalamine NN None
with IN None
mesalamine NN None
MMX NNP None
( ( None
? . None
) ) None
mesalamine NN Pharmocological
( ( None
Lialda NNP None
; : None
Shire NNP None
Pharmaceuticals NNP None
LLC NNP None
, , None
Wayne NNP None
, , None
PA NNP None
) ) None
, , None
once-daily JJ None
MMX NNP None
mesalamine NN None
compared VBN None
twice-daily JJ None
delayed-release JJ None
mesalamine NN None
( ( None
Asacol NNP Pharmocological
; : None
Warner NNP None
Chilcott NNP None
, , None
Dublin NNP None
, , None
Ireland NNP None
) ) None
for IN None
once-daily JJ None
MMX NNP None
mesalamine NN None
2.4 CD None
with IN None
twice-daily JJ None
delayed-release JJ None
mesalamine NN None
at IN None
a DT None
total JJ None
daily JJ None
dose NN None
of IN None
1.6 CD None
g/day NN None
in IN None
-DOCSTART- -X- N

MEC NNP Pharmocological
( ( None
methotrexate NN Pharmocological
, , None
epirubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
) ) None
MEC NNP Pharmocological
M-VAC NNP Pharmocological
( ( None
methotrexate NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
doxorubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
) ) None
methotrexate NN Pharmocological
, , None
epirubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
chemotherapy NN None
group NN None
( ( None
arm JJ None
1 CD None
: : None
S-MEC JJ None
therapy NN None
; : None
n CC None
= VB None
29 CD None
) ) None
, , None
a DT None
dose-intensified JJ None
MEC NNP Pharmocological
therapy NN Pharmocological
combined VBN None
with IN None
G-CSF NNP Pharmocological
group NN None
( ( None
arm JJ None
2 CD None
: : None
I-MEC JJ None
therapy NN None
; : None
n CC None
= VB None
30 CD None
) ) None
or CC None
a DT None
methotrexate NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
doxorubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
chemotherapy NN None
( ( None
arm JJ None
3 CD None
: : None
M-VAC JJ Pharmocological
therapy NN Pharmocological
; : None
n CC None
= VB None
30 CD None
) ) None
. . None
S-MEC NNP Pharmocological
therapy NN Pharmocological
I-MEC NNP Pharmocological
S-MEC NNP Pharmocological
therapy NN Pharmocological
I-MEC NNP Pharmocological
M-VAC NNP Pharmocological
M-VAC NNP Pharmocological
MEC NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Low-dose JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
low-dose JJ Pharmocological
aspirin NN Pharmocological
placebo-controlled JJ Control
aspirin NN Pharmocological
and CC None
beta NN Pharmocological
carotene NN Pharmocological
. . None
aspirin NN Pharmocological
and CC None
placebo NN Control
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

( ( None
control NN Physical
, , None
desensitizer NN Physical
, , None
disinfectant NN Physical
, , None
saliva NN Physical
, , None
blood NN Physical
, , None
and CC None
hydrogen VB Pharmocological
peroxide NN Pharmocological
) ) None
( ( None
scanning VBG Physical
electron RB Physical
microscopy NN Physical
) ) None
-DOCSTART- -X- N

Contingency NNP Educational
management NN Educational
Contingency NNP Educational
management NN Educational
( ( Educational
CM NNP Educational
) ) Educational
CM NNP Educational
The DT None
combination NN None
of IN None
a DT None
standardized JJ None
lifestyle NN None
modification NN None
( ( None
LM NNP None
) ) None
program NN None
payment NN None
for IN None
group NN None
attendance NN None
( ( None
CM NNP None
( ( None
attendance NN None
) ) None
) ) None
, , None
ii NN None
) ) None
The DT None
combination NN None
of IN None
LM NNP None
and CC None
payment NN None
for IN None
weight JJ None
loss NN None
( ( None
CM NNP None
( ( None
weight NN None
) ) None
) ) None
, , None
and CC None
iii NN None
) ) None
waitlist NN None
control NN None
( ( None
CON NNP None
) ) None
. . None
LM NNP None
group NN None
and CC None
received VBD None
payment NN None
for IN None
behavioral JJ None
change NN None
( ( None
CM NNP None
( ( None
behavior NN None
) ) None
) ) None
. . None
CONCLUSION NNP None
LM NNP None
supplemented VBD None
with IN None
CM NNP None
may MD None
-DOCSTART- -X- N

early JJ Pharmocological
enteral JJ Pharmocological
nutrition NN Pharmocological
with IN Pharmocological
addition NN Pharmocological
of IN Pharmocological
probiotics NNS Pharmocological
early JJ Pharmocological
enteral JJ Pharmocological
nutrition NN Pharmocological
( ( Pharmocological
EN NNP Pharmocological
) ) Pharmocological
supplemented VBD Pharmocological
with IN Pharmocological
probiotics NNS Pharmocological
( ( Pharmocological
bifidobacterium NN Pharmocological
) ) Pharmocological
P+EN NNP Pharmocological
EN NNP Pharmocological
probiotics NNS Pharmocological
( ( Pharmocological
bifidobacterium NN Pharmocological
anti-infection NN Pharmocological
and CC Pharmocological
anti-acid JJ Pharmocological
agents NNS Pharmocological
P+EN NNP None
group NN None
PN NNP None
EN NNP None
than IN None
that DT None
in IN None
PN NNP None
between IN None
P+EN NNP None
group NN None
and CC None
PN NNP None
P+EN NNP None
, , None
EN NNP None
, , None
PN NNP None
groups NNS None
PN NNP None
and CC None
EN NNP None
groups NNS None
that IN None
early JJ None
EN NNP None
with IN None
addition NN None
of IN None
probiotics NNS None
( ( None
bifidobacterium NN None
) ) None
resulted VBD None
-DOCSTART- -X- N

flurbiprofen JJ Pharmocological
sodium NN Pharmocological
0.03 CD Pharmocological
% NN Pharmocological
flurbiprofen NN Pharmocological
flurbiprofen NN Pharmocological
Flurbiprofen NNP Pharmocological
flurbiprofen NN Pharmocological
flurbiprofen NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
anticoagulant JJ Pharmocological
therapy NN Pharmocological
oral JJ Physical
anticoagulant JJ Physical
therapy NN Physical
warfarin NN Pharmocological
plus CC Pharmocological
aspirin JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
WASA NNP Pharmocological
) ) Pharmocological
versus NN None
aspirin JJ Pharmocological
therapy NN Pharmocological
alone RB Pharmocological
( ( Pharmocological
ASA NNP Pharmocological
) ) Pharmocological
ASA NNP Physical
WASA NNP Physical
ASA NNP Physical
WASA NNP Physical
ASA NNP Physical
WASA NNP Pharmocological
ASA NNP Pharmocological
WASA NNP Pharmocological
warfarin JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

ApoA-I JJ Pharmocological
apolipoprotein RB Pharmocological
A-I NNP Pharmocological
Apolipoprotein NNP Pharmocological
A-I NNP Pharmocological
Stimulation NNP Pharmocological
apoA-I JJ Pharmocological
inducer NN Pharmocological
( ( Pharmocological
RVX-208 NNP Pharmocological
) ) Pharmocological
Intravascular NNP None
Ultrasound NNP None
RVX-208 NNP Pharmocological
placebo NN Control
RVX-208 NNP Pharmocological
placebo NN Control
RVX-208 NNP Pharmocological
ApoA-I NNP Pharmocological
RVX-208 NNP Pharmocological
-DOCSTART- -X- N

placebo NN Control
of IN Pharmocological
metronidazole NN Pharmocological
and CC Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

synthetic JJ Physical
human JJ Physical
secretin NN Physical
Secretin NNP Physical
secretin NN Physical
secretin JJ Physical
injections NNS Physical
. . None
placebo-controlled JJ Control
synthetic JJ Physical
human JJ Physical
secretin NN Physical
synthetic JJ None
human JJ None
secretin NN None
saline JJ Control
placebo NN Control
. . Control
secretin NN Physical
placebo NN Control
, , None
secretin FW Physical
secretin NN Physical
placebo NN Control
secretin NN Physical
placebo NN None
secretin NN Physical
human JJ Physical
secretin NN Physical
-DOCSTART- -X- N

Desmopressin NNP Pharmocological
desmopressin NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
desmopressin NN Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
desmopressin NN Pharmocological
desmopressin NN Pharmocological
and CC None
placebo NN Control
groups NNS None
-DOCSTART- -X- N

Hydergine NNP Pharmocological
placebo NN Control
placebo NN Control
Hydergine NNP Pharmocological
Hydergine NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

spinal JJ Physical
versus NN Physical
general JJ Physical
anesthesia NN Physical
spinal JJ Physical
versus NN Physical
general JJ Physical
anesthesia NN Physical
hyperbaric JJ Pharmocological
tetracaine NN Pharmocological
General NNP Physical
Anesthesia NNP Physical
( ( Physical
GA NNP Physical
) ) Physical
fentanyl RB Pharmocological
intravenous JJ Pharmocological
anesthesia NN Physical
. . None
anesthesia NN Pharmocological
isoflurane NN Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
N2O NNP Pharmocological
) ) Pharmocological
in IN Pharmocological
oxygen NN Pharmocological
. . None
anesthesia NN Physical
spinal JJ Physical
and CC Physical
general JJ Physical
anesthesia NN Physical
spinal JJ Physical
anesthesia NN Physical
-DOCSTART- -X- N

esmolol NN Pharmocological
isoflurane NN Pharmocological
and CC None
sodium NN Pharmocological
nitroprusside RB Pharmocological
. . None
isoflurane NN Pharmocological
and CC Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
isoflurane NN Pharmocological
sodium JJ Pharmocological
nitroprusside NN Pharmocological
esmolol NN Pharmocological
Esmolol NNP Pharmocological
sodium JJ Pharmocological
nitroprusside NN Pharmocological
isoflurane NN Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
isoflurane NN Pharmocological
. . None
sodium NN Pharmocological
nitroprusside NN Pharmocological
esmolol NN Pharmocological
. . None
esmolol NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

angiotensin NN Pharmocological
II NNP Pharmocological
antagonism NN Pharmocological
antagonistic JJ Pharmocological
agonistic JJ Pharmocological
saralasin NN Pharmocological
renin-angiotensin JJ Pharmocological
axis NN Pharmocological
-DOCSTART- -X- N

Non-contrast-enhanced JJ Physical
4D CD Physical
MR NNP Physical
angiography NN Physical
and/or VBD None
contrast-enhanced JJ None
magnetic JJ None
resonance NN None
angiography NN None
NCE NNP Physical
4D CD Physical
on IN None
NCE NNP None
4D CD None
MRA NNP None
. . None
of IN None
NCE NNP None
4D CD None
MRA NNP None
-DOCSTART- -X- N

enhanced VBD Educational
milieu NNS Educational
teaching VBG Educational
enhanced JJ Educational
milieu NN Educational
teaching NN Educational
( ( Educational
EMT NNP Educational
) ) Educational
parent NN Educational
+ NNP Educational
therapist NN Educational
EMT NNP Educational
therapist-only RB Educational
EMT NNP Educational
-DOCSTART- -X- N

Carbon NNP Pharmocological
dioxide NN Pharmocological
laser NN Pharmocological
treatment NN Pharmocological
carbon NN Pharmocological
dioxide NN Pharmocological
laser NN Pharmocological
did VBD Control
not RB Control
receive VB Control
any DT Control
specific JJ Control
treatment NN Control
carbon NN Pharmocological
dioxide NN Pharmocological
laser NN Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
timolol NN Pharmocological
hydrochlorothiazide JJ Pharmocological
plus CC Pharmocological
amiloride JJ Pharmocological
hydrochlorothiazide JJ Pharmocological
amiloride NN Pharmocological
enalapril NN Pharmocological
timolol JJ Pharmocological
-DOCSTART- -X- N

larger JJR Physical
and CC Physical
small JJ Physical
forceps NNS Physical
bronchoscopy NN Surgical
, , None
placing VBG Surgical
a DT Surgical
non NN Surgical
inflated VBN Surgical
Fogarty NNP Surgical
balloon NN Surgical
and CC None
a DT None
rigid JJ Surgical
aspirator NN Surgical
( ( None
diameter JJ None
4 CD None
mm NN None
) ) None
in IN None
lobar NN None
bronchus NN None
near IN None
the DT None
biopsy NN None
segment NN None
. . None
The DT Surgical
Fogarty NNP Surgical
balloon NN Surgical
has VBZ Surgical
been VBN Surgical
inflated VBN Surgical
in IN Surgical
case NN Surgical
of IN Surgical
bleeding NN Surgical
. . None
-DOCSTART- -X- N

shengxuening VBG Pharmocological
] NNP None
shengxuening VBG Pharmocological
( ( Pharmocological
SXN NNP Pharmocological
) ) Pharmocological
SXN NNP Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
g NN Pharmocological
, , Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
) ) Pharmocological
and CC None
ferrous JJ Pharmocological
gluconate NN Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
g NN Pharmocological
, , Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
) ) Pharmocological
respectively RB None
, , None
for IN None
30 CD None
days NNS None
. . None
SXN NNP Pharmocological
-DOCSTART- -X- N

once-daily JJ Pharmocological
monotherapy NN Pharmocological
new JJ Pharmocological
sustained-release NN Pharmocological
( ( Pharmocological
SR NNP Pharmocological
) ) Pharmocological
formulation NN Pharmocological
of IN Pharmocological
nifedipine JJ Pharmocological
placebo NN Control
placebo NN Pharmocological
or CC Pharmocological
nifedipine JJ Pharmocological
nifedipine JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

progestogen NN Pharmocological
plus CC Pharmocological
oestradiol JJ Pharmocological
micronized JJ Pharmocological
oestradiol-17 JJ Pharmocological
beta NN Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
either DT Pharmocological
norethisterone NN Pharmocological
acetate NN Pharmocological
1 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
megestrol VB Pharmocological
acetate JJ Pharmocological
5 CD Pharmocological
mg NN Pharmocological
norethisterone NN Pharmocological
acetate NN Pharmocological
. . None
oestradiol-progestogen JJ Pharmocological
combination NN Pharmocological
progestogen NN Pharmocological
-DOCSTART- -X- N

group NN Physical
exercise NN Physical
class NN Physical
, , None
individual JJ Physical
physiotherapy NN Physical
, , None
and CC None
home NN Physical
exercises NNS Physical
alone RB Physical
. . None
hospital-based JJ Physical
exercise NN Physical
class NN Physical
-DOCSTART- -X- N

verapamil NN Pharmocological
. . None
verapamil NN Pharmocological
calcium-antagonist JJ Pharmocological
drug NN Pharmocological
oral JJ Pharmocological
verapamil NN Pharmocological
480 CD Pharmocological
mg/day NN Pharmocological
and CC None
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

root NN Physical
planing VBG Physical
Ultrasonic JJ Physical
and CC Physical
power-driven JJ Physical
instrumentation NN Physical
Various JJ Educational
ultrasonic JJ Physical
scalers NNS Physical
, , Educational
hand NN Physical
instruments NNS Physical
and CC Educational
two CD Physical
power-driven JJ Physical
systems NNS Physical
ultrasonic JJ Physical
scaler NN Physical
and CC Physical
Periopolisher NNP Physical
diamond-coated JJ Physical
inserts NNS Physical
( ( Physical
US-POL NNP Physical
) ) Physical
, , Educational
hand NN Physical
instruments NNS Physical
( ( Physical
MANUAL NNP Physical
) ) Physical
, , Educational
Perioplaner-Periopolisher NNP Physical
system NN Physical
( ( Physical
PPL-POL NNP Physical
) ) Physical
and CC Educational
Periokit NNP Physical
ultrasonic-designed JJ Physical
scalers NNS Physical
( ( Physical
PERIOKIT NNP Physical
) ) Physical
. . Educational
ultrasonic JJ Physical
scaler NN Physical
alone RB Other
and CC Other
hand NN Physical
instruments NNS Physical
-DOCSTART- -X- N

psychotherapy NN Physical
with IN Physical
biofeedback NN Physical
( ( None
hypotensive JJ Psychological
drugs NNS Psychological
+ VBP Psychological
psychotherapy NN Psychological
with IN Psychological
biofeedback NN Psychological
or CC Psychological
hypotensive JJ Psychological
drugs NNS Psychological
only RB Psychological
-- : Pharmocological
45 CD Pharmocological
controls NNS Control
-DOCSTART- -X- N

short-term JJ Other
sprint NN Other
and CC Educational
power NN Other
training NN Other
programs NNS Other
short-term JJ Other
sprint NN Other
and CC Educational
power NN Other
training NN Other
protocols NNS Other
The DT Educational
training NN Educational
intervention NN Educational
6 CD Educational
supervised JJ Educational
training NN Educational
sessions NNS Educational
SPRINT NNP Other
training NN Other
protocol NN Other
CONTRAST NNP Educational
training NN Educational
-DOCSTART- -X- N

multifaceted JJ Educational
guideline NN Educational
implementation NN Educational
intervention NN Educational
guideline JJ Educational
education NN Educational
and CC Educational
individual JJ Educational
feedback NN Educational
, , Educational
supporting VBG Educational
patient JJ Educational
education NN Educational
materials NNS Educational
, , Educational
both DT Educational
neither RB Control
. . None
Guideline NNP Educational
implementation NN Educational
patient JJ Educational
education NN Educational
component NN Educational
included VBD Educational
written VBN Educational
and CC Educational
videotaped VBN Educational
materials NNS Educational
on IN Educational
the DT Educational
care NN Educational
of IN Educational
low JJ Educational
back RB Educational
pain NN Educational
. . None
intervention NN Educational
-DOCSTART- -X- N

( ( Psychological
CYBOCS NNP Psychological
) ) Psychological
modified VBD Psychological
for IN Psychological
pervasive JJ Psychological
developmental NN Psychological
disorders NNS Psychological
( ( Psychological
PDDs NNP Psychological
) ) Psychological
. . None
( ( Psychological
CYBOCS-PDD NNP Psychological
) ) Psychological
five CD Educational
Compulsion NNP Educational
severity NN Educational
items NNS Educational
-DOCSTART- -X- N

operative JJ Physical
skills NNS Physical
( ( Physical
SATOS NNP Physical
) ) Physical
: : None
porcine JJ Educational
training NN Educational
model NN Educational
stepwise NN Physical
assessment JJ Physical
tool NN Physical
of IN Physical
operative JJ Physical
skills NNS Physical
( ( Physical
SATOS NNP Physical
) ) Physical
-DOCSTART- -X- N

Befriending NNP Educational
Volunteer NNP Educational
befriending NN Educational
befriending VBG Educational
-DOCSTART- -X- N

randomized VBN None
and CC None
dosed VBN None
with IN None
either DT None
lopinavir/ritonavir JJ None
monotherapy NN None
( ( None
n JJ None
= NNP None
83 CD None
) ) None
or CC None
lopinavir/ritonavir JJ Pharmocological
+ JJ None
zidovudine/lamivudine NN None
( ( None
n JJ None
= NNP None
53 CD None
) ) None
lopinavir/ritonavir VB None
monotherapy NN None
( ( None
n JJ None
First-line JJ None
lopinavir/ritonavir JJ None
monotherapy NN None
can MD None
-DOCSTART- -X- N

Ventilator-delivered JJ Physical
mask NN Physical
ventilation NN Physical
compared VBN None
with IN None
three CD None
standard JJ None
methods NNS None
of IN None
mask NN None
ventilation NN None
bag NN Other
and CC Other
mask NN Other
resuscitation NN Other
ventilator-delivered JJ Physical
mask NN Physical
ventilation NN Physical
( ( Physical
VDMV NNP Physical
) ) Physical
. . None
VDMV NNP Physical
hand-delivered JJ None
methods NNS None
of IN None
bag NN None
and CC None
mask NN None
ventilation NN None
: : None
Laerdal JJ Other
self-inflating JJ Other
bag NN Other
( ( Other
SIB NNP Other
) ) Other
; : None
anaesthetic JJ Other
bag NN Other
and CC None
T-piece NNP Other
Neopuff NNP Other
. . None
mask NN Other
ventilation NN Other
. . None
mask NN Other
ventilation NN Other
mask NN None
ventilation NN None
VDMV NNP Physical
VDMV NNP Physical
Neopuff NNP Other
. . None
VDMV NNP Physical
-DOCSTART- -X- N

Interferon NNP None
treatment NN None
IFN NNP Pharmocological
IFN NNP Pharmocological
IFN NNP Pharmocological
pentostatin NN Pharmocological
) ) Pharmocological
interferon VB Pharmocological
interferon NN Pharmocological
. . None
interferon NN Pharmocological
IFN NNP Pharmocological
pentostatin NN Pharmocological
2-chlorodeoxyadenosine JJ Pharmocological
( ( Pharmocological
2-CdA JJ Pharmocological
) ) Pharmocological
. . Pharmocological
interferon NN Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

imiquimod NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
vehicle NN Control
cream NN Control
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
topically RB Pharmocological
imiquimod-treated JJ Pharmocological
vehicle-treated JJ Control
imiquimod-treated JJ Pharmocological
imiquimod NN Pharmocological
vehicle NN Control
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
vehicle NN Control
cream NN None
-DOCSTART- -X- N

Carbon NNP Pharmocological
dioxide RB Pharmocological
normal JJ Control
saline NN Control
carbon NN Pharmocological
dioxide NN Pharmocological
( ( Pharmocological
CO NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
CO NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
( ( Pharmocological
group NN Pharmocological
A NNP Pharmocological
) ) Pharmocological
or CC None
normal JJ Pharmocological
saline NN Pharmocological
( ( Pharmocological
group NN Pharmocological
B NNP Pharmocological
) ) Pharmocological
endometrial JJ Surgical
biopsy NN Surgical
CO NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

peroxide JJ Pharmocological
gel NN Pharmocological
scaling NN Surgical
and CC Physical
root NN Surgical
planing NN Surgical
Scaling NNP Surgical
and CC Surgical
root NN Surgical
planing NN Surgical
( ( Surgical
SRP NNP Surgical
) ) Surgical
SRP NNP Surgical
hydrogen NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
SRP VB Surgical
SRP NNP Surgical
combined VBN Physical
1.7 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
( ( Pharmocological
Perio NNP Pharmocological
Gel NNP Pharmocological
) ) Pharmocological
brushed VBN Physical
twice RB Physical
daily RB Physical
with IN Physical
a DT Physical
regular JJ Physical
dentifrice NN Physical
and CC Physical
toothbrush NN Physical
SRP NNP Surgical
peroxide JJ Pharmocological
gel NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
SRP NNP Surgical
SRP NNP Surgical
SRP NNP Surgical
peroxide NN Pharmocological
gel NN Pharmocological
SRP NNP Surgical
SRP NNP Surgical
SRP NNP Surgical
SRP NNP Surgical
hydrogen NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
-DOCSTART- -X- N

Intervention NN Educational
comprehensive JJ Educational
intervention NN Educational
Interpersonal NNP Educational
Synchrony NNP Educational
Non-Interpersonal JJ Educational
Synchrony NNP Educational
. . Educational
-DOCSTART- -X- N

Methylphenidate NNP Pharmocological
nursing NN Educational
telephone NN Educational
intervention NN Educational
placebo-controlled JJ Control
methylphenidate NN Pharmocological
( ( Pharmocological
MP NNP Pharmocological
) ) Pharmocological
placebo NN Control
nursing NN Educational
telephone NN Educational
intervention NN Educational
( ( Educational
NTI NNP Educational
) ) Educational
control NN None
telephone NN None
intervention NN None
( ( None
PL+CTI NNP None
. . None
Methylphenidate NNP None
dose NN None
superior JJ None
to TO None
placebo VB None
in IN None
-DOCSTART- -X- N

placebo NN Control
empiric JJ Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
placebo NN Control
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

home-visiting JJ Educational
program NN Educational
The DT Educational
intervention NN Educational
consisted VBD Educational
of IN Educational
44 CD Educational
home NN Educational
visits NNS Educational
from IN Educational
the DT Educational
third JJ Educational
trimester NN Educational
of IN Educational
pregnancy NN Educational
through IN Educational
to TO Educational
the DT Educational
child NN Educational
's POS Educational
second JJ Educational
birthday NN Educational
. . None
use NN Educational
of IN Educational
video NN Educational
during IN Educational
home-visits NNS Educational
. . None
-DOCSTART- -X- N

Sodium NN Pharmocological
bicarbonate NN Pharmocological
, , None
N-acetylcysteine NNP Pharmocological
, , None
and CC None
saline NN Control
sodium NN Pharmocological
bicarbonate NN Pharmocological
combination NN None
of IN None
N-acetylcysteine NNP Surgical
( ( Surgical
NAC NNP Surgical
) ) Surgical
plus CC None
sodium JJ Pharmocological
chloride NN Pharmocological
and CC None
sodium NN Pharmocological
chloride NN Pharmocological
alone RB None
infusion NN None
of IN None
sodium NN Pharmocological
bicarbonate NN Pharmocological
, , None
sodium NN Pharmocological
chloride NN Pharmocological
, , None
sodium NN Pharmocological
chloride NN Pharmocological
plus CC None
oral JJ None
NAC NNP Pharmocological
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
alone RB None
combination NN None
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
sodium JJ Pharmocological
bicarbonate NN Pharmocological
sodium NN Pharmocological
chloride JJ Pharmocological
infusion NN Pharmocological
Combination NNP None
therapy NN None
of IN None
NAC NNP Pharmocological
plus CC Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
alone RB None
. . None
-DOCSTART- -X- N

Maillard NNP Pharmocological
reaction NN Pharmocological
products NNS Pharmocological
Maillard NNP Physical
reaction NN Physical
products NNS Physical
( ( None
MRP NNP None
) ) None
white JJ Pharmocological
diet NN Pharmocological
( ( Pharmocological
WD NNP Pharmocological
) ) Pharmocological
brown JJ Pharmocological
diet NN Pharmocological
( ( Pharmocological
BD NNP Pharmocological
) ) Pharmocological
MRP NNP Pharmocological
MRP NNP Pharmocological
-DOCSTART- -X- N

immunotherapy NN Pharmocological
interleukin-2 JJ Pharmocological
and CC None
interferon-alpha JJ Pharmocological
subcutaneous JJ Pharmocological
low JJ Pharmocological
doses NNS Pharmocological
IL-2 NNP Pharmocological
+ NNP Pharmocological
IFN NNP Pharmocological
chemotherapy NN Pharmocological
Chronic JJ Pharmocological
maintenance NN Pharmocological
immunotherapy NN Pharmocological
-DOCSTART- -X- N

cellulose JJ Pharmocological
sulfate NN Pharmocological
cellulose JJ Pharmocological
sulfate NN Pharmocological
( ( Pharmocological
CS NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
CS NNP Pharmocological
to TO None
placebo VB Control
gel NNS Control
placebo VB Control
CS NNP Pharmocological
vaginal JJ Pharmocological
gel NN Pharmocological
-DOCSTART- -X- N

nonexercising JJ Control
control NN Control
group NN Control
, , Control
a DT Physical
cycle NN Physical
training NN Physical
group NN Physical
( ( Physical
cycle NN Physical
) ) Physical
, , Control
or CC Physical
one CD Physical
of IN Physical
the DT Physical
two CD Physical
HCT NNP Physical
groups NNS Physical
. . None
Training VBG Educational
groups NNS Educational
participated VBN Educational
in IN Educational
a DT Educational
9 CD Educational
wk NN Educational
program NN Educational
, , Educational
3 CD Educational
d.wk-1 NN Educational
. . None
Subjects NNS Physical
assigned VBD Physical
to TO Physical
HCT NNP Physical
exercised VBN Physical
on IN Physical
a DT Physical
9 CD Physical
station NN Physical
circuit NN Physical
, , Physical
completing VBG Physical
3 CD Physical
circuits.d-1 JJ Physical
. . None
-DOCSTART- -X- N

tetracycline- JJ Pharmocological
clarithromycin-containing JJ Pharmocological
omeprazole NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , Pharmocological
bismuth NN Pharmocological
, , Pharmocological
120 CD Pharmocological
mg NN Pharmocological
four CD Pharmocological
times NNS Pharmocological
daily RB Pharmocological
, , Pharmocological
metronidazole NN Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , None
and CC None
either DT None
tetracycline NN Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
four CD None
times NNS None
daily RB None
, , None
or CC None
clarithromycin NN Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
twice RB None
daily RB None
-DOCSTART- -X- N

veno-venous JJ Physical
continuous JJ Physical
renal JJ Physical
replacement NN Physical
therapy NN Physical
veno-venous JJ Physical
continuous JJ Physical
renal JJ Physical
replacement NN Physical
therapy NN Physical
( ( Physical
CRRT NNP Physical
) ) Physical
CRRT NNP Physical
Control NNP Control
conventional JJ Physical
therapy NN Physical
Veno-venous JJ Physical
CRRT NNP Physical
CRRT NNP None
-DOCSTART- -X- N

exercise NN Physical
Androgen NNP Pharmocological
deprivation NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
ADT NNP Pharmocological
) ) Pharmocological
exercise NN Physical
exercise NN Physical
program NN Physical
resistance/impact NN Physical
loading VBG Physical
exercise NN Physical
, , Physical
( ( Physical
2 CD Physical
) ) Physical
resistance/cardiovascular NN Physical
exercise NN Physical
groups NNS Physical
and CC Physical
( ( Physical
3 CD Physical
) ) Physical
usual JJ Physical
care/delayed VBN Physical
exercise NN Physical
. . Physical
progressive JJ Physical
training NN Physical
exercise NN Physical
-DOCSTART- -X- N

Regional JJ Physical
ischemic JJ Physical
preconditioning NN Physical
occluding VBG Physical
the DT Physical
LAD NNP Physical
twice NN Physical
for IN Physical
a DT Physical
2-min JJ Physical
period NN Physical
followed VBN Physical
by IN Physical
3-min JJ Physical
LAD NNP Physical
reperfusion NN Physical
before IN Physical
bypass NN Physical
grafting NN Physical
of IN Physical
the DT Physical
first JJ Physical
coronary JJ Physical
vessel NN Physical
. . Physical
-DOCSTART- -X- N

brain NN Physical
MRI NNP Physical
-DOCSTART- -X- N

adrenocorticotrophic JJ Pharmocological
hormone NN Pharmocological
( ( Pharmocological
4-9 JJ Pharmocological
) ) Pharmocological
analog NN Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
neuropeptide NN Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
ORG JJ Pharmocological
2766 CD Pharmocological
treatment NN Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
-DOCSTART- -X- N

ranitidine NN Pharmocological
or CC None
omeprazole NN Pharmocological
ranitidine NN Pharmocological
omeprazole JJ Pharmocological
-DOCSTART- -X- N

Clomipramine NNP Pharmocological
versus NN Pharmocological
haloperidol NN Pharmocological
placebo-controlled JJ Control
Clomipramine NNP Pharmocological
, , Pharmocological
haloperidol NN Pharmocological
, , None
and CC None
placebo NN Control
clomipramine NN Pharmocological
haloperidol NN Pharmocological
haloperidol NN Pharmocological
. . Pharmocological
clomipramine NN Pharmocological
haloperidol VB Pharmocological
clomipramine NN Pharmocological
haloperidol NN Pharmocological
haloperidol VBZ Pharmocological
Clomipramine NNP Pharmocological
-DOCSTART- -X- N

umbilical JJ Pharmocological
cord NN Pharmocological
serum NN Pharmocological
therapy NN Pharmocological
umbilical JJ Pharmocological
cord NN Pharmocological
serum NN Pharmocological
therapy NN Pharmocological
Umbilical NNP Pharmocological
cord NN Pharmocological
serum NN Pharmocological
or CC Pharmocological
autologous JJ Pharmocological
serum NN Pharmocological
drops NNS Pharmocological
cord NN Pharmocological
serum NN Pharmocological
autologous JJ Control
serum NN Control
control NN Control
group NN Educational
. . Educational
cord NN Pharmocological
serum NN Pharmocological
cord NN Pharmocological
serum NN Pharmocological
Umbilical NNP Pharmocological
cord NN Pharmocological
serum NN Pharmocological
autologous JJ Pharmocological
serum NN Pharmocological
. . None
-DOCSTART- -X- N

Photodynamic NNP Physical
therapy NN Physical
with IN None
5-aminolaevulinic JJ Pharmocological
acid NN Pharmocological
or CC None
placebo NN Control
Photodynamic NNP Pharmocological
therapy NN Pharmocological
( ( Pharmocological
PDT NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
topical JJ Pharmocological
5-aminolaevulinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ALA NNP Pharmocological
) ) Pharmocological
followed VBN Pharmocological
by IN Pharmocological
irradiation NN Pharmocological
with IN Pharmocological
incoherent JJ Pharmocological
light NN Pharmocological
( ( Pharmocological
ALA-PDT NNP Pharmocological
) ) Pharmocological
ALA-PDT NNP Pharmocological
or CC None
placebo-PDT JJ Control
interventions NNS None
combined VBN None
with IN None
standard JJ None
treatment NN None
encompassing VBG None
paring VBG None
followed VBN None
by IN None
a DT None
keratolytic JJ None
( ( None
Verucid NNP None
) ) None
. . None
ALA-PDT NNP Pharmocological
placebo-PDT NN Control
. . None
ALA-PDT NNP Pharmocological
ALA-PDT NNP Pharmocological
placebo-PDT JJ Control
ALA-PDT JJ Pharmocological
placebo-PDT JJ Control
placebo-PDT NN Control
-DOCSTART- -X- N

Digestive JJ Pharmocological
enzyme NN Pharmocological
supplementation NN Pharmocological
digestive JJ Pharmocological
enzyme NN Pharmocological
supplement NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
enzyme NN Pharmocological
-DOCSTART- -X- N

oestradiol JJ Pharmocological
-DOCSTART- -X- N

[ JJ Pharmocological
Bupivacaine-CO2 NNP Pharmocological
and CC Pharmocological
bupivacaine-HCl NN Pharmocological
peridural JJ Pharmocological
anesthesia NN Pharmocological
carbonated JJ Pharmocological
anesthetics NNS Pharmocological
epidural JJ Pharmocological
anesthesia NN Pharmocological
bupivacaine-CO2 JJ Pharmocological
bupivacaine-HCl NN Pharmocological
bupivacaine-CO2 NN Pharmocological
bupivacaine-HCl NN Pharmocological
Epidural JJ Pharmocological
anesthesia NN Pharmocological
18-gauge JJ Physical
Tuohy NNP Physical
bupivacaine NN Pharmocological
with IN Pharmocological
adrenaline JJ Pharmocological
bupivacaine-CO2 JJ Pharmocological
-HCl NN Pharmocological
-DOCSTART- -X- N

Oxytocin NNP Pharmocological
Oxytocin NNP Pharmocological
oxytocin JJ Pharmocological
Oxytocin NNP Pharmocological
and CC None
placebo NN Control
placebo NN Control
oxytocin NN Pharmocological
oxytocin NN Pharmocological
-DOCSTART- -X- N

stable JJ Pharmocological
prostacyclin NN Pharmocological
analogue NN Pharmocological
( ( Pharmocological
iloprost NN Pharmocological
) ) Pharmocological
prostacyclin NN Pharmocological
analogue NN Pharmocological
iloprost NN Pharmocological
iloprost NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

chloroquine VB Pharmocological
sulfadoxine-pyrimethamine VB Pharmocological
chloroquine NN Pharmocological
sulfadoxine-pyrimethamine JJ Pharmocological
CQ-treated JJ Pharmocological
CQ NNP Pharmocological
CQ NNP Pharmocological
-DOCSTART- -X- N

beta-adrenoceptor NN Physical
blocker NN Physical
and CC None
diuretic JJ Physical
combination NN Physical
products NNS Physical
pindolol NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
5 CD Pharmocological
mg NNS Pharmocological
clopamide NN Pharmocological
metoprolol NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
12.5 CD Pharmocological
mg NNS Pharmocological
hydrochlorothiazide RB Pharmocological
pindolol/clopamide JJ Pharmocological
combination NN None
products NNS None
-DOCSTART- -X- N

Ambulation NN Physical
an DT None
ambulant JJ Physical
group NN None
and CC None
half NN None
to TO None
a DT None
recumbent NN Control
group NN None
. . None
Ambulation NNP Physical
-DOCSTART- -X- N

acupuncture NN Physical
acupuncture NN Physical
acupuncture NN Pharmocological
at IN Pharmocological
Dicang NNP Pharmocological
( ( Pharmocological
ST NNP Pharmocological
4 CD Pharmocological
) ) Pharmocological
, , None
Jiache NNP Pharmocological
( ( Pharmocological
ST NNP Pharmocological
6 CD Pharmocological
) ) Pharmocological
, , None
Yangbai NNP Pharmocological
( ( Pharmocological
GB NNP Pharmocological
14 CD Pharmocological
) ) Pharmocological
, , None
etc. FW None
with IN Control
less JJR Control
than IN Control
4 CD Control
points NNS Control
selected VBN Control
on IN Control
the DT Control
face NN Control
and CC Control
with IN Control
shallow JJ Control
puncture NN Control
, , Control
and CC Control
10 CD Control
days NNS Control
later RB Control
electroacupuncture VBP Control
were VBD Control
added VBN Control
at IN Control
acupoints NNS Control
selected VBN Control
routinely RB Control
; : Control
the DT Control
control NN Control
group NN Control
were VBD Control
treated VBN Control
with IN Control
the DT Control
same JJ Control
methods NNS Control
as IN Control
the DT Control
treatment NN Control
group NN Control
but CC Control
acupuncture NN Control
was VBD Control
not RB Control
given VBN Control
at IN Control
the DT Control
acute JJ Control
stage NN Control
. . None
acupuncture NN Physical
-DOCSTART- -X- N

xenogenic JJ Pharmocological
( ( Pharmocological
porcine NN Pharmocological
) ) Pharmocological
acellular NN Pharmocological
dermal JJ Pharmocological
matrix NN Pharmocological
xenogenic NNP Pharmocological
( ( Pharmocological
porcine NN Pharmocological
) ) Pharmocological
acellular NN Pharmocological
dermal JJ Pharmocological
matrix NN Pharmocological
xenogenic NNP Pharmocological
( ( Pharmocological
porcine NN Pharmocological
) ) Pharmocological
acellular NN Pharmocological
dermal JJ Pharmocological
matrix NN Pharmocological
-DOCSTART- -X- N

dopexamine NN Pharmocological
dopexamine JJ Pharmocological
did VBD Control
not RB Control
receive VB Control
a DT Control
dopexamine JJ Control
infusion NN Control
. . None
dopexamine NN Pharmocological
-DOCSTART- -X- N

Multimodal NNP Educational
Anxiety NNP Educational
and CC Educational
Social NNP Psychological
Skill NNP Psychological
Intervention NNP Psychological
Multimodal NNP Educational
Anxiety NNP Educational
and CC Educational
Social NNP Psychological
Skills NNP Psychological
Intervention NNP Psychological
( ( Psychological
MASSI NNP Psychological
) ) Psychological
program NN Psychological
MASSI NNP Psychological
-DOCSTART- -X- N

placebo-controlled JJ Control
digoxin NN Pharmocological
given VBN Educational
postcards NNS Educational
at IN Educational
their PRP$ Educational
final JJ Educational
study NN Educational
visit NN Educational
to TO Educational
be VB Educational
completed VBN Educational
and CC Educational
mailed VBN Educational
on IN Educational
or CC Educational
after IN Educational
January NNP Educational
1 CD Educational
, , Educational
1996 CD Educational
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
oral JJ Pharmocological
human JJ Pharmocological
immunoglobulin NN Pharmocological
placebo-controlled JJ Control
oral JJ Physical
, , Physical
human JJ Pharmocological
immunoglobulin NN Pharmocological
( ( None
IGOH NNP None
IGOH NNP Pharmocological
-DOCSTART- -X- N

Lansoprazole NNP Pharmocological
, , None
omeprazole JJ Pharmocological
MUPS NNP Pharmocological
and CC None
esomeprazole NN Pharmocological
lansoprazole JJ Pharmocological
mgomeprazole JJ Pharmocological
esomeprazole JJ Pharmocological
. . None
omeprazole NN Pharmocological
lansoprazole JJ Pharmocological
omeprazole NN Pharmocological
. . None
esomeprazole NN Pharmocological
lansoprazole NN Pharmocological
esomeprazole NN Pharmocological
lansoprazole NN Pharmocological
-DOCSTART- -X- N

verbascoside NN Pharmocological
verbascoside NN Pharmocological
verbascoside NN Pharmocological
with IN None
verbascoside NN None
and CC None
aspirin NN None
( ( None
verbascoside NN None
( ( None
1 CD None
Verbascoside $ None
2 CD None
mg/dL NN None
aspirin-treated JJ None
0.01 CD None
) ) None
. . None
Verbascoside NNP None
in IN None
vitro JJ None
verbascoside NN None
orally RB None
-DOCSTART- -X- N

Naltrexone NN Pharmocological
naltrexone JJ Pharmocological
Naltrexone NNP Pharmocological
naltrexone NN Pharmocological
naltrexone RB Pharmocological
placebo NN Control
naltrexone NN Pharmocological
placebo NN Control
. . None
Naltrexone NNP Pharmocological
-DOCSTART- -X- N

marine NN Physical
food NN Physical
products NNS Physical
EPA NNP Pharmocological
DHA NNP Pharmocological
marine NN Pharmocological
food NN Pharmocological
products NNS Pharmocological
and CC None
marine VB None
food NN None
products NNS None
( ( None
minimum JJ None
EPA NNP None
+ NNP None
DHA NNP None
intake NN None
-DOCSTART- -X- N

Survey NNP Educational
thank NN Other
you PRP Other
or CC None
reminder VB Other
postcard NN Other
-DOCSTART- -X- N

atomoxetine JJ Pharmocological
placebo NN Control
atomoxetine NN Pharmocological
atomoxetine NN Pharmocological
or CC None
placebo NN Control
atomoxetine JJ Pharmocological
placebo NN Control
atomoxetine NN Pharmocological
placebo NN Control
atomoxetine NN Pharmocological
placebo NN Control
atomoxetine JJ Pharmocological
placebo NN None
Atomoxetine NNP Pharmocological
Atomoxetine NNP Pharmocological
Placebo NNP None
-DOCSTART- -X- N

Nucleotides NNP Pharmocological
nucleotides NNS Pharmocological
soy-based JJ Pharmocological
formula NN Pharmocological
assigned VBN None
randomly RB None
to TO None
soy VB Pharmocological
formula NN Pharmocological
groups NNS None
with IN None
and CC None
without IN None
added VBN None
nucleotides NNS Pharmocological
, , None
was VBD None
Blood NN None
samples NNS None
were VBD None
collected VBN None
at IN None
6 CD None
, , None
7 CD None
, , None
and CC None
12 CD None
months NNS None
. . None
nucleotide-supplemented JJ Pharmocological
nucleotides NNS Pharmocological
. . None
nucleotides NNS Pharmocological
-DOCSTART- -X- N

Hysteroscopic NNP Surgical
transcervical JJ Surgical
endometrial JJ Surgical
resection NN Surgical
thermal JJ Surgical
destruction NN Surgical
transcervical JJ Surgical
hysteroscopic NN Surgical
endometrial JJ Surgical
resection NN Surgical
thermal JJ Surgical
destruction NN Surgical
transcervical JJ Surgical
hysteroscopic NN Surgical
endometrial JJ Surgical
resection NN Surgical
or CC None
to TO None
thermal JJ Surgical
destruction NN Surgical
of IN Surgical
the DT Surgical
endometrium NN Surgical
. . None
thermal JJ Surgical
destruction NN Surgical
transcervical JJ Surgical
hysteroscopic NN Surgical
endometrial JJ Surgical
resection NN Surgical
Thermal NNP Surgical
destruction NN Surgical
of IN Surgical
the DT Surgical
endometrium NN Surgical
-DOCSTART- -X- N

cognitive-behavioral JJ Psychological
group NN Psychological
therapy NN Psychological
cognitive-behavioral JJ Psychological
group NN Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
client-centered JJ Psychological
, , Psychological
supportive-experiential JJ Psychological
group NN Psychological
therapy NN Psychological
( ( Psychological
SET NNP Psychological
) ) Psychological
CBT NNP Psychological
. . None
CBT NNP Educational
SET NNP Educational
cognitive-behavioral JJ Educational
intervention NN Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

manual JJ Physical
physical JJ Physical
therapy NN Physical
and CC Physical
exercise NN Physical
physical JJ Physical
therapy NN Physical
manual JJ Physical
therapy NN Physical
standardized JJ Physical
knee NN Physical
exercise NN Physical
program NN Physical
subtherapeutic JJ Control
ultrasound NN Control
treatment NN Physical
placebo NN Control
treatment NN Physical
treatment NN Physical
placebo NN Control
treatment NN Physical
placebo NN Control
treatment NN Physical
manual JJ Physical
physical JJ Physical
therapy NN Physical
and CC Physical
supervised VBD Physical
exercise NN Physical
-DOCSTART- -X- N

tamoxifen NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
epirubicin NN Pharmocological
tamoxifen NN Pharmocological
to TO Pharmocological
epirubicin VB Pharmocological
versus NN Pharmocological
epirubicin FW Pharmocological
alone RB Pharmocological
tamoxifen NN Pharmocological
to TO Pharmocological
epirubicin VB Pharmocological
epirubicin JJ Pharmocological
plus CC Pharmocological
tamoxifen JJ Pharmocological
tamoxifen JJ Pharmocological
plus CC Pharmocological
epirubicin JJ Pharmocological
. . None
addition NN Pharmocological
of IN Pharmocological
tamoxifen NN Pharmocological
to TO Pharmocological
epirubicin VB Pharmocological
-DOCSTART- -X- N

groups NNS None
; : None
one CD None
was VBD None
cultured VBN None
at IN None
37?C CD None
and CC None
the DT None
other JJ None
at IN None
36?C CD None
from IN None
of IN None
ICSI NNP None
to TO None
time NN None
of IN None
embryo NN None
transfer NN None
or CC None
vitrification NN None
. . None
Paired NNP None
group NN None
. . None
DNA NN None
fingerprinting NN None
was VBD None
-DOCSTART- -X- N

Immunoenhanced NNP Pharmocological
enteral JJ Pharmocological
nutrition NN Pharmocological
formulas NNS Pharmocological
immunoenhanced VBD Pharmocological
enteral JJ Pharmocological
nutritions NNS Pharmocological
arginine-enhanced JJ Pharmocological
formula NN Pharmocological
standard JJ None
polymeric NN None
formula NN None
arginine NN Pharmocological
, , Pharmocological
RNA NNP Pharmocological
and CC Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
enhanced VBD Pharmocological
formula NN Pharmocological
Immunoenhanced NNP None
enteral JJ None
nutrition NN None
formulas NNS None
-DOCSTART- -X- N

isosorbide JJ Pharmocological
dinitrate NN Pharmocological
and CC None
nitroglycerin NN Pharmocological
. . None
Nitroglycerin NNP Pharmocological
( ( Pharmocological
NTG NNP Pharmocological
) ) Pharmocological
nitrate NN Pharmocological
, , None
isosorbide JJ Pharmocological
dinitrate NN Pharmocological
( ( Pharmocological
ISDN NNP Pharmocological
) ) Pharmocological
ISDN NNP Pharmocological
NTG NNP Pharmocological
ISDN NNP Pharmocological
ISDN NNP Pharmocological
NTG NNP Pharmocological
ISDN NNP Pharmocological
NTG NNP Pharmocological
ISDN NNP Pharmocological
-DOCSTART- -X- N

fish-oil JJ Pharmocological
and CC Pharmocological
vegetable-oil JJ Pharmocological
formula NN Pharmocological
liquid JJ Pharmocological
formula NN Pharmocological
containing VBG Pharmocological
either CC Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
enriched VBN Pharmocological
in IN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
or CC None
vegetable JJ Pharmocological
oil NN Pharmocological
enriched VBN Pharmocological
in IN Pharmocological
oleic JJ Pharmocological
acid NN Pharmocological
two CD None
groups NNS None
over IN None
a DT None
42-d JJ None
period NN None
. . None
fish-oil JJ Pharmocological
consumption NN Pharmocological
. . None
vegetable JJ Pharmocological
oil NN Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

PCI NNP Surgical
. . None
PCI NNP Surgical
. . None
-DOCSTART- -X- N

Speech NN Educational
following VBG Educational
sign JJ Educational
language NN Educational
training NN Educational
language NN Educational
training NN Educational
Sign NNP Educational
Alone NNP Educational
-DOCSTART- -X- N

text JJ Educational
processing NN Educational
strategies NNS Educational
-DOCSTART- -X- N

norgestimate NN Pharmocological
ethinyl NN Pharmocological
estradiol NN Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
triphasic JJ Pharmocological
, , Pharmocological
combination NN Pharmocological
OC NNP Pharmocological
( ( Pharmocological
ORTHO NNP Pharmocological
TRI-CYCLEN NNP Pharmocological
[ NNP Pharmocological
Ortho-McNeil NNP Pharmocological
Pharmaceutical NNP Pharmocological
, , Pharmocological
Raritan NNP Pharmocological
, , Pharmocological
N.J. NNP Pharmocological
] NNP Pharmocological
, , Pharmocological
norgestimate/ethinyl RB Pharmocological
estradiol NN Pharmocological
) ) Pharmocological
placebo NN Control
OC NNP Pharmocological
ethinyl JJ Pharmocological
estradiol NN Pharmocological
[ VBD None
0.035 CD None
mg NN None
] NN None
and CC None
increasing VBG None
doses NNS None
of IN None
norgestimate JJ Pharmocological
inactive JJ Pharmocological
drug NN Pharmocological
or CC None
placebo NN Control
ethinyl JJ Pharmocological
estradiol NN Pharmocological
-DOCSTART- -X- N

pentavalent NN Pharmocological
diphtheria NN Pharmocological
, , None
tetanus NN Pharmocological
, , None
acellular JJ Pharmocological
pertussis NN Pharmocological
, , None
inactivated VBN Pharmocological
poliovirus NN Pharmocological
and CC Pharmocological
Haemophilus NNP Pharmocological
influenzae VBP Pharmocological
type JJ Pharmocological
b-tetanus JJ Pharmocological
conjugate NN Pharmocological
vaccine NN Pharmocological
whole JJ Pharmocological
cell NN Pharmocological
pertussis NN Pharmocological
pentavalent NN Pharmocological
vaccine NN Pharmocological
. . None
combined JJ Pharmocological
diphtheria-tetanus-pertussis-inactivated JJ Pharmocological
poliovirus NN Pharmocological
vaccines NNS Pharmocological
containing VBG Pharmocological
either CC Pharmocological
acellular JJ Pharmocological
( ( None
Pa NNP Pharmocological
, , Pharmocological
SmithKline NNP Pharmocological
Beecham NNP Pharmocological
Biologicals NNP Pharmocological
) ) None
or CC None
whole JJ Pharmocological
cell NN Pharmocological
( ( Pharmocological
Pw NNP Pharmocological
, , Pharmocological
Pasteur NNP Pharmocological
Merieux NNP Pharmocological
Connaught NNP Pharmocological
) ) Pharmocological
pertussis NN Pharmocological
components NNS Pharmocological
, , None
mixed JJ Pharmocological
with IN Pharmocological
a DT Pharmocological
Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
b NN Pharmocological
polysaccharide NN Pharmocological
polyribosylribitol IN Pharmocological
phosphate-tetanus JJ Pharmocological
conjugate NN Pharmocological
vaccine NN Pharmocological
tetanus VB Pharmocological
toxoid JJ Pharmocological
combination NN Pharmocological
diphtheria NN None
, , None
tetanus NN None
, , None
whole JJ None
cell NN None
pertussis-H. JJ None
influenzae NN None
b NN None
vaccine NN None
conjugated VBN None
to TO None
tetanus VB None
toxoid JJ None
combination NN None
-DOCSTART- -X- N

intravesical JJ Pharmocological
BCG NNP Pharmocological
mitomycin JJ Pharmocological
C NNP Pharmocological
plus CC Pharmocological
doxorubicin JJ Pharmocological
sequential JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Immunotherapy NNP Pharmocological
CROP NNP Pharmocological
( ( Pharmocological
cytosine JJ Pharmocological
arabinoside NN Pharmocological
, , Pharmocological
daunorubicin NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
prednisolone NN Pharmocological
) ) Pharmocological
( ( Pharmocological
cytosine NN Pharmocological
arabinoside RB Pharmocological
, , Pharmocological
daunorubicin NN Pharmocological
) ) Pharmocological
plus CC Pharmocological
hydroxyurea NN Pharmocological
maintenance NN Pharmocological
therapy NN Pharmocological
chemo-immunotherapy NN Pharmocological
( ( None
BCG NNP Pharmocological
plus CC None
intradermal JJ Pharmocological
leukaemic JJ Pharmocological
blast NN Pharmocological
cells NNS Pharmocological
) ) None
or CC None
chemotherapy VB Pharmocological
alone RB None
. . None
chemotherapy NN Pharmocological
chemo-immunotherapy JJ Pharmocological
immunotherapy NN Pharmocological
. . None
-DOCSTART- -X- N

short-term JJ Physical
training NN Physical
programs NNS Physical
off-season JJ Physical
, , Physical
short-term JJ Physical
basketball NN Physical
training NN Physical
programs NNS Physical
specialized JJ Physical
basketball NN Physical
training NN Physical
group NN Physical
a DT Physical
mixed JJ Physical
basketball NN Physical
plus CC Physical
conditioning VBG Physical
training NN Physical
group NN Physical
and CC None
a DT None
control NN Control
group NN Control
Training VBG Physical
-DOCSTART- -X- N

Sodium NN Pharmocological
bicarbonate NN Pharmocological
( ( None
Bicarb NNP None
, , None
1 CD None
M NNP None
; : None
350-500 CD None
ml NN None
) ) None
or CC None
an DT None
equal JJ None
volume NN None
of IN None
normal JJ Pharmocological
saline NN Pharmocological
( ( None
Sal NNP None
) ) None
was VBD None
infused VBN None
intravenously RB None
at IN None
a DT None
constant JJ None
rate NN None
during IN None
a DT None
'2000 CD None
m NN None
' '' None
maximal JJ None
ergometer NN Pharmocological
row NN Pharmocological
infusion NN None
of IN None
Bicarb NNP None
-DOCSTART- -X- N

Financial JJ None
and CC None
quality-of-life JJ None
burden NN None
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
burden NN Educational
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
burden NN Educational
; : None
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
burden NN Educational
. . None
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
effects NNS Educational
-DOCSTART- -X- N

sugar-free JJ Pharmocological
gum NN Pharmocological
CPP-ACP NNP Pharmocological
sugar-free JJ Control
gum NN Control
not RB Control
containing VBG Control
CPP-ACP NNP Control
gum NN Pharmocological
containing VBG Pharmocological
CPP-ACP NNP Pharmocological
control NN Control
gum NN Control
sugar-free JJ Pharmocological
gum NN Pharmocological
containing VBG Pharmocological
CPP-ACP NNP Pharmocological
gum NN Control
-DOCSTART- -X- N

biopsychosocial JJ Psychological
therapy NN Psychological
( ( Psychological
BT NNP Psychological
) ) Psychological
with IN None
a DT None
conventional JJ Pharmocological
biomedical JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
MT NNP Pharmocological
) ) Pharmocological
biopsychosocial JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
a DT Pharmocological
solely JJ Pharmocological
conventional JJ Pharmocological
biomedical JJ Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
biomedical JJ Pharmocological
therapy NN Pharmocological
biopsychosocial JJ Psychological
therapy NN Psychological
-DOCSTART- -X- N

Palliative JJ Physical
brachytherapy NN Physical
with IN Surgical
or CC Surgical
without IN Surgical
primary JJ Surgical
stent JJ Surgical
placement NN Surgical
combination NN Physical
of IN Physical
self-expanding JJ Surgical
metal NN Surgical
stent NN Surgical
( ( Surgical
SEMS NNP Surgical
) ) Surgical
and CC Physical
brachytherapy NN Physical
SEMS NNP None
followed VBN None
by IN None
brachytherapy NN None
, , None
8 CD None
Gy?3 NNP None
( ( None
n=21 NN None
) ) None
or CC None
brachytherapy VB None
alone RB None
, , None
8 CD None
Gy?3 NNP None
( ( None
receiving VBG None
SEMS NNP None
followed VBN None
by IN None
brachytherapy NN None
had VBD None
receiving VBG None
brachytherapy NN None
alone RB None
( ( None
dysphagia NN None
, , None
SEMS NNP None
followed VBN None
brachytherapy NN None
is VBZ None
while IN None
brachytherapy NN None
with IN None
or CC None
without IN None
preceding VBG None
SEMS NNP None
provides VBZ None
-DOCSTART- -X- N

Nitroglycerin NNP Pharmocological
, , None
nitroprusside RB Pharmocological
vasodilating NN Pharmocological
cocktails NNS Pharmocological
heparin NN Pharmocological
, , None
lidocaine NN Pharmocological
diltiazem NN Pharmocological
. . None
nitroglycerin JJ Pharmocological
; : None
nitroprusside JJ Pharmocological
nitroglycerin NN Pharmocological
; : None
nitroglycerin NNS Pharmocological
and CC None
nitroprusside RB Pharmocological
. . None
direct JJ None
nitric JJ Pharmocological
oxide NN Pharmocological
donor NN None
nitroglycerin VB Pharmocological
nitroglycerin NN Pharmocological
nitroprusside NN Pharmocological
. . None
-DOCSTART- -X- N

Piperacillin/tazobactam NNP Pharmocological
plus CC None
tobramycin JJ Pharmocological
versus NN None
ceftazidime NN Pharmocological
plus CC Pharmocological
tobramycin NN Pharmocological
piperacillin NN Pharmocological
and CC Pharmocological
tazobactam NN Pharmocological
ceftazidime RB Pharmocological
tobramycin $ Pharmocological
piperacillin VB Pharmocological
tazobactam JJ Pharmocological
tobramycin $ Pharmocological
Vancomycin NNP Pharmocological
ceftazidime NN Pharmocological
piperacillin/tazobactam NN Pharmocological
antibacterial JJ Pharmocological
therapy NN Pharmocological
piperacillin/tazobactam NN Pharmocological
ceftazidime NN Pharmocological
piperacillin/ JJ Pharmocological
tazobactam JJ Pharmocological
ceftazidime NN Pharmocological
piperacillin/tazobactam NN Pharmocological
piperacillin/tazobactam NN Pharmocological
-DOCSTART- -X- N

Percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
underwent VBP None
percutaneous JJ None
coronary JJ None
intervention NN None
only RB None
for IN None
-DOCSTART- -X- N

levamisole VB Pharmocological
placebo VB Control
levamisole JJR Pharmocological
placebo-treated JJ Control
levamisole NN Pharmocological
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo JJ Pharmocological
( ( Pharmocological
b NN Pharmocological
, , Pharmocological
f NN Pharmocological
) ) Pharmocological
pyrazino- NN Pharmocological
( ( Pharmocological
1,2 CD Pharmocological
-- : Pharmocological
d NN Pharmocological
) ) Pharmocological
- : Pharmocological
( ( Pharmocological
1,4 CD Pharmocological
) ) Pharmocological
-oxazepine NN Pharmocological
hydrogen NN Pharmocological
maleate NN Pharmocological
( ( Pharmocological
Org NNP Pharmocological
GC NNP Pharmocological
94 CD Pharmocological
) ) Pharmocological
. . Pharmocological
1,3,4,14b-Tetrahydro-2,7-dimethyl-2H-dibenzo JJ Pharmocological
( ( Pharmocological
b NN Pharmocological
, , Pharmocological
f NN Pharmocological
) ) Pharmocological
pyrazino- NN Pharmocological
( ( Pharmocological
1,2-d CD Pharmocological
) ) Pharmocological
- : Pharmocological
( ( Pharmocological
1,4 CD Pharmocological
) ) Pharmocological
-oxazepine NN Pharmocological
hydrogen NN Pharmocological
maleate NN Pharmocological
( ( Pharmocological
Org NNP Pharmocological
GC NNP Pharmocological
94 CD Pharmocological
) ) Pharmocological
Org NNP Pharmocological
GC NNP Pharmocological
94 CD Pharmocological
-DOCSTART- -X- N

off-pump JJ Surgical
versus NN None
on-pump JJ Surgical
bypass NN Surgical
surgery NN Surgical
: : None
off-pump JJ Surgical
or CC None
on-pump JJ Surgical
techniques NNS None
off-pump JJ Surgical
on-pump JJ Surgical
off-pump JJ Surgical
on-pump JJ Surgical
off-pump NN Surgical
off-pump NN Surgical
on-pump JJ Surgical
off-pump JJ Surgical
on-pump JJ Surgical
-DOCSTART- -X- N

Similac NNP Pharmocological
With IN Pharmocological
Iron NNP Pharmocological
. . None
-DOCSTART- -X- N

methadone NN Pharmocological
methadone NN Pharmocological
Methadone NNP Pharmocological
hydrochloride NN Pharmocological
Liquid NNP Physical
Chromatography-Electrospray NNP Physical
Ionization-Tandem NNP Physical
Mass NNP Physical
Spectrometry NNP Physical
and CC None
radioimmunoassay VB Physical
methadone NN Pharmocological
. . None
methadone NN Pharmocological
methadone NN Pharmocological
methadone NN Pharmocological
methadone NN Pharmocological
-DOCSTART- -X- N

hyperfractionated VBN Physical
radiation NN Physical
therapy NN Physical
concurrent JJ Physical
chemotherapy NN Physical
Gy NNP Pharmocological
hyperfractionated JJ Physical
radiation NN Physical
therapy NN Physical
( ( None
HFX NNP None
RT NNP None
) ) None
Gy NNP Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
CDDP NNP Pharmocological
) ) Pharmocological
50.6 CD Pharmocological
Gy NNP Pharmocological
to TO Pharmocological
HFX NNP Physical
RT NNP Physical
CDDP NNP Pharmocological
. . None
radio-chemotherapy NN Physical
-DOCSTART- -X- N

intensive JJ None
moderate JJ Pharmocological
blood NN Pharmocological
pressure NN Pharmocological
control NN Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
( ( Pharmocological
nisoldipine JJ Pharmocological
) ) Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
enalapril NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Green JJ Pharmocological
banana-supplemented JJ Pharmocological
diet NN Pharmocological
green JJ Pharmocological
banana NN Pharmocological
standard JJ None
care NN None
group NN None
or CC None
a DT None
standard JJ None
care NN None
plus CC None
green JJ None
banana NN None
group NN None
where WRB None
add VB None
cooked JJ None
green JJ None
banana NN None
to TO None
receiving VBG None
green JJ None
banana NN None
had VBD None
green JJ None
banana-supplemented JJ None
-DOCSTART- -X- N

face NN Educational
expertise NN Educational
training NN Educational
expertise NN Educational
training NN Educational
with IN Educational
faces VBZ Educational
computerized JJ Educational
training NN Educational
program NN Educational
involving VBG Educational
either CC Educational
faces VBZ Educational
or CC Educational
houses NNS Educational
. . None
training NN Educational
. . None
-DOCSTART- -X- N

sclerotherapy NN Surgical
staple JJ Surgical
transection NN Surgical
of IN Surgical
the DT Surgical
esophagus NN Surgical
undergo VB Surgical
either DT Surgical
emergency NN Surgical
sclerotherapy NN Surgical
( ( None
n JJ None
= NNP None
50 CD None
) ) None
or CC None
staple JJ Surgical
transection NN Surgical
of IN Surgical
the DT Surgical
esophagus NN Surgical
( ( None
n JJ None
= NNP None
51 CD None
) ) None
sclerotherapy VB Surgical
sclerotherapy VB Surgical
sclerotherapy VB Surgical
sclerotherapy NN Surgical
sclerotherapy NN Surgical
-DOCSTART- -X- N

Breast NNP Surgical
reduction NN Surgical
reduction NN Surgical
mammaplasty NN Surgical
reduction NN Surgical
mammaplasty RB Surgical
mammaplasty NN Surgical
-DOCSTART- -X- N

Desmopressin NNP Pharmocological
desmopressin NN Pharmocological
desmopressin JJ Pharmocological
desmopressin NN Pharmocological
placebo NN Control
. . None
desmopressin NN Pharmocological
placebo NN Pharmocological
desmopressin-treated JJ Control
placebo-treated JJ Control
desmopressin NN Pharmocological
desmopressin NN Pharmocological
placebo NN Pharmocological
; : None
desmopressin NN Pharmocological
placebo NN Pharmocological
; : None
desmopressin NN Pharmocological
placebo NN Pharmocological
desmopressin NN Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

Abdominoperineal NNP Physical
resection NN Physical
anterior JJ Physical
resection NN Physical
adjuvant VB Physical
preoperative JJ Physical
radiotherapy NN Physical
. . None
radiotherapy NN Physical
Sphincter-saving JJ Educational
procedures NNS Educational
-DOCSTART- -X- N

spinal JJ Physical
manipulation NN Physical
therapy NN Physical
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
fixed-point JJ Physical
spin NN Physical
reduction NN Physical
of IN Physical
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
and CC None
dialectical JJ Pharmocological
prescription NN Pharmocological
. . None
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
-DOCSTART- -X- N

cutting VBG Surgical
balloon NN Surgical
angioplasty JJ Surgical
high-pressure NN Surgical
balloon NN Surgical
angioplasty NN Surgical
cutting VBG Surgical
balloon NN Surgical
angioplasty NN Surgical
( ( Surgical
CBA NNP Surgical
) ) Surgical
versus IN Surgical
high-pressure NN Surgical
balloon NN Surgical
angioplasty NN Surgical
( ( Surgical
HPBA NNP Surgical
) ) Surgical
CBA NNP Surgical
HPBA NNP Surgical
CBA NNP Physical
CBA NNP Physical
HPBA NNP Physical
CBA NNP Physical
HPBA NNP Physical
CBA NNP Physical
. . None
HPBA NNP Physical
CBA NNP Physical
HPBA NNP Physical
CBA NNP Physical
-DOCSTART- -X- N

conventional JJ Physical
and CC Physical
accelerated JJ Physical
radiotherapy NN Physical
. . None
assessed VBN Physical
by IN Physical
Ki-67 NNP Physical
staining NN Physical
accelerated VBN Physical
radiotherapy NN Physical
. . None
-DOCSTART- -X- N

rituximab NN Pharmocological
( ( Pharmocological
R NNP Pharmocological
) ) Pharmocological
to TO Pharmocological
fludarabine VB Pharmocological
and CC Pharmocological
cyclophosphamide VB Pharmocological
from IN None
R-FC NNP None
from IN None
R-FC NNP None
, , None
with IN None
R-FC NNP None
vs NN None
FC NNP None
. . None
-DOCSTART- -X- N

Videotaped NNP Educational
training NN Educational
in IN Educational
alcohol NN Educational
counseling NN Educational
videotaped JJ Educational
training NN Educational
for IN Educational
in IN Educational
motivational JJ Educational
interviewing NN Educational
skills NNS Educational
20-minute JJ Educational
videotape NN Educational
motivational JJ Educational
interviewing NN Educational
videotape NN Educational
. . None
Control NNP Pharmocological
20-minute JJ Pharmocological
docudrama NN Pharmocological
training NN Educational
video NN Educational
videotaped JJ Educational
instruction NN Educational
in IN Educational
motivational JJ Educational
interviewing NN Educational
. . Educational
motivational JJ Educational
interviewing NN Educational
-DOCSTART- -X- N

randomly RB None
allocated VBN None
to TO None
the DT None
intervention NN None
condition NN None
and CC None
all DT None
remaining VBG None
students NNS None
were VBD None
either RB None
allocated VBN None
to TO None
the DT None
no-intervention JJ None
peer NN None
or CC None
no-intervention JJ None
non-peer JJ None
condition NN None
. . None
-DOCSTART- -X- N

tetracycline-immobilized JJ Pharmocological
collagen NN Pharmocological
film NN Pharmocological
and CC Pharmocological
root NN Pharmocological
planing NN Pharmocological
tetracycline-immobilized JJ Pharmocological
cross-linked JJ Pharmocological
collagen NN Pharmocological
film NN Pharmocological
( ( Pharmocological
TC NNP Pharmocological
film NN Pharmocological
) ) Pharmocological
root NN Control
planing VBG Control
treatment NN Control
( ( Control
RP NNP Control
TC NNP Control
+ NNP Control
RP NNP Control
RP NNP Control
TC NNP Control
+ NNP Control
RP NNP Control
TC NNP Control
+ NNP Control
RP NNP Control
TC NNP Control
-DOCSTART- -X- N

-DOCSTART- -X- N

cytarabine NN Pharmocological
cisplatin JJ Pharmocological
cytarabine NN Pharmocological
cisplatin NN Pharmocological
cytarabine NN Pharmocological
cisplatin-5-fluorouracil NN Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
1000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
cytarabine NN Pharmocological
cisplatin NN Pharmocological
infusion NN Pharmocological
cisplatin NN Pharmocological
cisplatin NNS Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
irradiation+/-surgery NN Surgical
cytarabine NN Pharmocological
cisplatin NN Pharmocological
. . None
-DOCSTART- -X- N

high-protein JJ Pharmocological
, , Pharmocological
energy-restricted JJ Pharmocological
diet NN Pharmocological
energy NN Other
restriction NN Other
energy NN Other
balance NN Other
high-protein NN Pharmocological
( ( Pharmocological
HP NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
lower-protein JJ Pharmocological
( ( Pharmocological
LP NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
HP NNP Other
LP NNP Other
HP NNP Physical
LP NNP Physical
-DOCSTART- -X- N

culture-specific JJ Educational
education NN Educational
program NN Educational
to TO Educational
promote VB Educational
language NN Educational
and CC Educational
culture NN Educational
specific JJ Educational
education NN Educational
-DOCSTART- -X- N

Injection NNP Pharmocological
sclerotherapy NN Pharmocological
versus NN Physical
electrocoagulation NN Physical
injection NN Pharmocological
sclerotherapy NN Pharmocological
( ( Pharmocological
IS NNP Pharmocological
) ) Pharmocological
with IN None
electrocoagulation NN Physical
( ( Physical
EC NNP Physical
) ) Physical
phenol NN Pharmocological
in IN Pharmocological
almond NN Pharmocological
oil NN Pharmocological
sclerotherapy NN None
( ( None
IS NNP None
) ) None
-DOCSTART- -X- N

gluten- JJ Other
and CC Other
casein-free JJ Other
dietary JJ Other
intervention NN Other
gluten- JJ Other
and CC Other
casein-free JJ Other
diets NNS Other
dietary JJ Other
intervention NN Other
placebo NN Control
-DOCSTART- -X- N

High-intensity NNP Physical
physical JJ Physical
training NN Physical
training VBG Physical
on IN Physical
land NN Physical
and CC Physical
in IN Physical
water NN Physical
. . None
high-intensity JJ Physical
physical JJ Physical
training NN Physical
on IN Physical
land NN Physical
as IN Physical
in IN Physical
water NN Physical
10-week JJ Physical
supervised JJ Physical
rehabilitation NN Physical
program NN Physical
with IN Physical
emphasis NN Physical
on IN Physical
physical JJ Physical
training NN Physical
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

meropenem NN Pharmocological
imipenem NN Pharmocological
. . None
meropenem NN Pharmocological
new JJ Pharmocological
carbapenem NN Pharmocological
antibiotic JJ Pharmocological
imipenem NN Pharmocological
prophylactic JJ Control
treatment NN Control
prophylactic JJ Control
treatment NN Control
0.5 CD Pharmocological
g NNS Pharmocological
meropenem JJ Pharmocological
t.i.d NN Pharmocological
. . None
intravenously RB None
or CC None
0.5 CD None
g NNS None
imipenem JJ Pharmocological
q.i.d NN None
. . None
intravenously RB None
. . None
Meropenem NNP Pharmocological
imipenem NN Pharmocological
-DOCSTART- -X- N

5 CD Pharmocological
mg NNS Pharmocological
finasteride RB Pharmocological
( ( None
n JJ None
= NNP None
81 CD None
) ) None
or CC None
placebo NN Control
( ( None
n JJ None
= NNP None
40 CD None
) ) None
for IN None
12 CD None
months NNS None
; : None
all DT None
patients NNS None
continuing VBG None
into IN None
an DT None
open JJ None
extension NN None
received VBD None
finasteride RB Pharmocological
during IN None
the DT None
second JJ None
12 CD None
months NNS None
of IN None
therapy NN None
. . None
-DOCSTART- -X- N

Ketoconazole NNP Pharmocological
tretinoin CC Pharmocological
cream NN Pharmocological
Adapalene NNP Pharmocological
gel NN Pharmocological
adapalene NN Pharmocological
gel NN Pharmocological
adapalene NN Pharmocological
gel NN Pharmocological
adapalene JJ Pharmocological
gel NNS Pharmocological
and CC None
2 CD Pharmocological
% NN Pharmocological
ketoconazole JJ Pharmocological
cream NN Pharmocological
2 CD Pharmocological
% NN Pharmocological
ketoconazole JJ Pharmocological
cream NN Pharmocological
adapalene JJ Pharmocological
gel NN Pharmocological
Adapalene NNP Pharmocological
adapalene NN Pharmocological
-DOCSTART- -X- N

lithium NN Pharmocological
induction NN Physical
therapy NN Physical
oral JJ Pharmocological
lithium NN Pharmocological
carbonate NN Pharmocological
1200 CD Pharmocological
mg JJ Pharmocological
daily JJ Pharmocological
or CC None
no DT Pharmocological
lithium NN Pharmocological
. . None
lithium NN Pharmocological
lithium NN Pharmocological
lithium NN Pharmocological
-DOCSTART- -X- N

Physiological JJ Other
pacing VBG Other
physiological JJ Other
pacing NN Other
atrioventricular JJ Physical
synchronous JJ Physical
and CC Physical
ventricular JJ Physical
pacing NN Physical
. . Physical
atrioventricular JJ Physical
synchronous JJ Physical
ventricular JJ Physical
pacing NN Physical
-DOCSTART- -X- N

gaviscon JJ Pharmocological
preparation NN Pharmocological
Geviskon NNP Pharmocological
aluminum-magnesium JJ Pharmocological
antacids NNS Pharmocological
alginate JJ Pharmocological
product NN Pharmocological
-- : Pharmocological
Geviskon NNP Pharmocological
forte VBP Pharmocological
dose NN Pharmocological
of IN Pharmocological
10 CD Pharmocological
ml NNS Pharmocological
and CC Pharmocological
aluminum-magnesium JJ Pharmocological
antacid JJ Pharmocological
drug NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
1 CD Pharmocological
sachet NN Pharmocological
. . Pharmocological
antacids NNS Pharmocological
Geviskon NNP Pharmocological
-DOCSTART- -X- N

B-vitamins NNS Pharmocological
B NNP Pharmocological
vitamins NNS Pharmocological
2mg CD Pharmocological
of IN Pharmocological
folate NN Pharmocological
, , None
plus CC Pharmocological
25mg CD Pharmocological
of IN Pharmocological
B6 NNP Pharmocological
and CC None
400 CD Pharmocological
microg NN Pharmocological
of IN Pharmocological
B12 NNP Pharmocological
, , None
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
to TO Pharmocological
bradykinin VB Pharmocological
( ( Pharmocological
BK NNP Pharmocological
) ) Pharmocological
, , None
substance NN Pharmocological
P NNP Pharmocological
( ( Pharmocological
SP NNP Pharmocological
) ) Pharmocological
and CC None
citric JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Shouldice NNP None
, , None
Lichtenstein NNP None
transabdominal JJ Surgical
preperitoneal NN Surgical
( ( Surgical
TAPP NNP Surgical
) ) Surgical
hernia NN Surgical
repair NN Surgical
Shouldice NNP None
, , None
tension-free JJ None
Lichtenstein NNP None
or CC None
laparoscopic JJ Surgical
TAPP NNP Surgical
repair NN Surgical
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

diuresis NN Physical
extracorporeal JJ Physical
shockwave JJ Physical
lithotripsy NN Physical
( ( Physical
ESWL NNP Physical
) ) Physical
ESWL NNP Surgical
Siemens NNP None
Lithostar NNP None
2 CD None
machine NN None
. . None
standard JJ Surgical
ESWL NNP Surgical
ESWL NNP Surgical
with IN Surgical
diuresis NN Surgical
during IN Surgical
the DT Surgical
ESWL NNP Surgical
session NN Surgical
. . None
-DOCSTART- -X- N

Ropinirole NNP Pharmocological
levodopa NN Pharmocological
sustained VBD Pharmocological
release NN Pharmocological
. . None
ropinirole NN Pharmocological
vs. FW None
levodopa NN Pharmocological
sustained VBN Pharmocological
release NN Pharmocological
( ( Pharmocological
SR NNP Pharmocological
) ) Pharmocological
levodopa JJ Pharmocological
SR NNP Pharmocological
or CC None
ropinirole VB Pharmocological
then RB None
the DT None
alternate NN Pharmocological
treatment NN Pharmocological
Ropinirole NNP Pharmocological
levodopa VB Pharmocological
SR NNP Pharmocological
-DOCSTART- -X- N

and CC Surgical
blood NN Physical
collected VBN Physical
before IN Physical
anesthesia NN Physical
CPB NNP Surgical
ELISA NNP None
. . None
CPB NNP Surgical
-DOCSTART- -X- N

zoledronic JJ Pharmocological
acid NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
Zoledronic JJ Pharmocological
acid NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
placebo NN Control
zoledronic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

isoprenaline NN Pharmocological
and CC None
glyceryl NN Pharmocological
trinitrate NN Pharmocological
glyceryl JJ Pharmocological
trinitrate JJ Pharmocological
isoprenaline JJ Pharmocological
glyceryl JJ Pharmocological
trinitrate NN Pharmocological
head-up NN Pharmocological
tilt NN Pharmocological
and CC None
isoprenaline JJ Pharmocological
head-up NN Pharmocological
tilt NN Pharmocological
Glyceryl NNP Pharmocological
trinitrate VB Pharmocological
head-up JJ Pharmocological
tilt NN Pharmocological
isoprenaline JJ Pharmocological
head-up JJ Pharmocological
tilt NN Pharmocological
-DOCSTART- -X- N

adriamycin NN Pharmocological
adriamycin JJ Pharmocological
Adriamycin NNP Pharmocological
adriamycin JJ Pharmocological
-DOCSTART- -X- N

formoterol NN Pharmocological
formoterol NN Pharmocological
placebo NN Control
formoterol NN Pharmocological
12 CD Pharmocological
microg NN Pharmocological
dry JJ Pharmocological
powder NN Pharmocological
inhalation NN Pharmocological
or CC None
matching VBG None
placebo JJ Control
twice RB None
daily RB None
for IN None
8 CD None
weeks NNS None
. . None
Twenty CD Physical
four-hour JJ Physical
continuous JJ Physical
electrocardiography NN Physical
( ( Physical
Holter NNP Physical
monitoring NN Physical
) ) Physical
formoterol NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

nutritional JJ None
counselling NN None
hypocaloric NN Pharmocological
diet NN Pharmocological
Optisource NNP Pharmocological
diet JJ Pharmocological
I PRP Pharmocological
with IN Pharmocological
lunch NN Pharmocological
and CC Pharmocological
dinner NN Pharmocological
substituted VBN Pharmocological
by IN Pharmocological
two CD Pharmocological
Optisource NNP Pharmocological
II NNP None
with IN None
nutritional JJ None
counselling VBG None
with IN None
a DT None
decrease NN None
of IN None
500 CD None
cal/day NN None
from IN None
the DT None
previous JJ None
dietary JJ None
intake NN None
. . None
commercial JJ Other
hypocaloric NN Other
formula NN Other
dietary JJ Pharmocological
counselling NN Pharmocological
-DOCSTART- -X- N

everolimus-eluting JJ Surgical
and CC Surgical
paclitaxel-eluting JJ Surgical
stents NNS Surgical
: : None
everolimus-eluting JJ Surgical
stent NN Surgical
( ( Surgical
EES NNP Surgical
) ) Surgical
paclitaxel-eluting JJ Surgical
stent NN Surgical
( ( Surgical
PES NNP Surgical
) ) Surgical
EES NNP Surgical
PES NNP Surgical
. . None
-DOCSTART- -X- N

Succinate NNP Pharmocological
sumatriptan JJ Pharmocological
sumatriptan JJ Pharmocological
sumatriptan NN Control
( ( Control
group NN Control
A NNP Control
) ) Control
or CC None
placebo NN Control
( ( Control
group NN Control
B NNP Control
) ) Control
. . None
After IN None
a DT None
2-week JJ None
complete JJ None
pharmacological NN None
washout NN None
, , None
clinical JJ None
examination NN None
, , None
electrocardiogram NN None
, , None
and CC None
Doppler NNP None
echocardiography NN None
were VBD None
performed VBN None
at IN None
baseline NN None
, , None
15 CD None
, , None
30 CD None
, , None
45 CD None
, , None
and CC None
60 CD None
min NN None
after IN None
sumatriptan NN None
or CC None
placebo JJ None
administration NN None
. . None
succinate JJ Pharmocological
sumatriptan NNS Pharmocological
-DOCSTART- -X- N

penicillin NN Pharmocological
placebo NN Control
penicillin NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

Teacher-implemented JJ Educational
joint JJ Educational
attention NN Educational
intervention NN Educational
: : None
( ( Educational
the DT Educational
Joint NNP Educational
Attention NNP Educational
and CC Educational
Symbolic NNP Educational
Play/Engagement NNP Educational
and CC Educational
Regulation NNP Educational
intervention NN Educational
; : Educational
JASP/ER NNP Educational
) ) Educational
JASP/ER NNP Educational
intervention NN Educational
control NN Control
group NN Control
. . Control
JASP/ER NNP Educational
JASP/ER NNP Educational
JASP/ER NNP Educational
JASP/ER NNP Educational
taped VBN Educational
play NN Educational
interaction NN Educational
. . None
-DOCSTART- -X- N

calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
supplements NNS Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
and CC None
vitamin NN Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
total JJ Pharmocological
thyroidectomy NN Pharmocological
plus CC Pharmocological
CND NNP Pharmocological
. . None
oral JJ Pharmocological
calcium NN Pharmocological
vitamin JJ Pharmocological
D NNP Pharmocological
calcium NN Pharmocological
alone RB Pharmocological
no DT Pharmocological
supplements NNS Pharmocological
-DOCSTART- -X- N

adult NN None
confederate NN None
and CC None
an DT None
interaction NN None
partner NN None
, , None
) ) None
another DT None
adult NN None
human NN None
, , None
( ( None
2 CD None
) ) None
a DT None
touchscreen JJ None
computer NN None
game NN None
, , None
and CC None
( ( None
3 CD None
) ) None
a DT None
social JJ None
dinosaur NN None
robot NN None
. . None
-DOCSTART- -X- N

concurrent JJ Pharmocological
gemcitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
sequential JJ Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
gemcitabine/cisplatin JJ Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
concurrent JJ Pharmocological
5-fluorouracil JJ Pharmocological
radiotherapy NN Pharmocological
5-fluorouracil NNP Pharmocological
radiotherapy NN Pharmocological
concurrent JJ Pharmocological
gemcitabine NN Pharmocological
cisplatin NN Pharmocological
same JJ Pharmocological
concurrent NN Pharmocological
treatment NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
sequential JJ Pharmocological
full-dose JJ Pharmocological
gemcitabine NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

ranolazine NN Pharmocological
concurrent JJ Pharmocological
antidiabetic JJ Pharmocological
therapy NN Pharmocological
Ranolazine NNP Pharmocological
glycemic NN None
and CC None
antidiabetes VBZ Pharmocological
drug NN Pharmocological
usage NN None
data NNS None
ranolazine NN Pharmocological
ranolazine NN Pharmocological
placebo NN Control
ranolazine NN Pharmocological
Ranolazine NNP Pharmocological
-DOCSTART- -X- N

Intravenous JJ Pharmocological
fibrinolysis NN Pharmocological
( ( Pharmocological
IVF NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
rt-PA NN Pharmocological
( ( Pharmocological
alteplase NN Pharmocological
) ) Pharmocological
Intra-arterial JJ Pharmocological
fibrinolysis NN Pharmocological
( ( Pharmocological
IAF NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
pro-urokinase NN Pharmocological
IVF NNP Pharmocological
IAF NNP Pharmocological
IVF NNP Pharmocological
IAF NNP Pharmocological
urokinase JJ Pharmocological
IVF NNP Pharmocological
-DOCSTART- -X- N

gluten-free JJ Physical
, , Physical
casein-free JJ Physical
diet NN Physical
gluten-free JJ Other
and CC Other
casein-free JJ Other
( ( Other
GFCF NNP Other
) ) Other
diet NN Other
GFCF NNP Physical
diet NN Physical
-DOCSTART- -X- N

placebo JJ Psychological
placebo-informed JJ Psychological
instructions NNS Psychological
individuals NNS Psychological
informed VBD Psychological
of IN Psychological
the DT Psychological
placebo NN Psychological
) ) None
placebo-uninformed JJ Psychological
instructions NNS Psychological
individuals NNS Educational
informed VBD Educational
they PRP Educational
are VBP Educational
taking VBG Educational
an DT Educational
active JJ Educational
stimulant NN Educational
) ) Educational
caffeine NN Pharmocological
caffeine NN Pharmocological
-DOCSTART- -X- N

cholinomimetic JJ Pharmocological
SDZ NNP Pharmocological
ENS-163 NNP Pharmocological
new JJ Pharmocological
cholinomimetic JJ Pharmocological
SDZ NNP Pharmocological
ENS-163 NNP Pharmocological
. . None
oral JJ Control
placebo/intravenous JJ Control
saline NN Control
, , None
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
SDZ NNP Pharmocological
ENS-163/intravenous JJ Pharmocological
saline NN Pharmocological
, , None
oral JJ Control
placebo/0.4 NN Control
mg NN Control
of IN Control
intravenous JJ Control
scopolamine NN Control
, , None
and CC None
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
SDZ NNP Pharmocological
ENS-163/0.4 NNP Pharmocological
mg NN Pharmocological
of IN Pharmocological
intravenous JJ Pharmocological
scopolamine NN Pharmocological
. . None
-DOCSTART- -X- N

new JJ Other
softcyte NN Other
a DT None
conventional JJ Other
endocyte NN Other
. . None
endocyte NN Other
softcyte NN Other
endocyte NN Other
. . Other
softcyte NN Other
endocyte NN Other
-DOCSTART- -X- N

Hyperbaric NNP Physical
oxygen NN Physical
hyperbaric JJ Physical
therapy NN Physical
one-hour JJ Physical
sessions NNS Physical
of IN Physical
either DT Physical
HBOT NNP Physical
at IN Physical
153 CD Physical
kPa NN Physical
sham JJ Physical
air NN Physical
at IN Physical
116 CD Physical
kPa NN Physical
HBOT NNP Physical
-DOCSTART- -X- N

Clonidine NNP Pharmocological
clonidine NN None
low-dose JJ Pharmocological
clonidine NN Pharmocological
versus NN Pharmocological
placebo NN Control
and CC Pharmocological
low-dose JJ Pharmocological
aspirin NN Pharmocological
versus NN Pharmocological
placebo NN Pharmocological
clonidine NN Pharmocological
with IN Pharmocological
placebo NN Pharmocological
clonidine NN None
or CC None
placebo VB None
-DOCSTART- -X- N

preoperative JJ Pharmocological
xeloda NN Pharmocological
and CC None
radiotherapy NN Pharmocological
combined JJ Pharmocological
preoperative JJ Pharmocological
xeloda NN Pharmocological
and CC Pharmocological
pelvic JJ Pharmocological
radiotherapy NN Pharmocological
operation NN Surgical
alone RB Surgical
xeloda NNP Pharmocological
and CC Pharmocological
radiotherapy NN Pharmocological
before IN Pharmocological
operation NN Pharmocological
. . None
Combined VBD Pharmocological
preoperative JJ Pharmocological
xeloda NN Pharmocological
and CC Pharmocological
radiotherapy NN Pharmocological
-DOCSTART- -X- N

isotonic JJ Educational
& CC Educational
isometric JJ Educational
training NN Educational
short-term JJ Physical
exercises NNS Physical
isotonic JJ Physical
training NN Physical
( ( Physical
5BX CD Physical
programme NN Physical
) ) Physical
and CC Educational
isometric JJ Physical
training NN Physical
( ( Educational
a DT Educational
programme NN Educational
of IN Educational
isometric JJ Educational
exercises NNS Educational
working VBG Educational
all DT Educational
major JJ Educational
groups NNS Educational
of IN Educational
muscles NNS Educational
) ) Educational
with IN None
a DT None
control NN Control
group NN None
isotonic JJ Educational
and CC Educational
isometric JJ Physical
training NN Physical
Isotonic JJ Physical
training NN Physical
isotonic JJ Educational
or CC Educational
isometric JJ Educational
training NN Educational
-DOCSTART- -X- N

TOM NNP Other
test NN Other
: : None
TOM NNP Other
test NN Other
TOM NNP Other
test NN Other
. . None
TOM NNP Other
test NN Other
-DOCSTART- -X- N

griseofulvin NN Pharmocological
griseofulvin NN Pharmocological
antimycotic JJ Physical
therapy NN Physical
. . Pharmocological
griseofulvin NN Educational
Griseofulvin NNP Pharmocological
placebo NN Control
griseofulvin NN Pharmocological
placebo-treated JJ Control
griseofulvin-treated JJ Pharmocological
-DOCSTART- -X- N

paclitaxel NN Control
or CC None
cyclophosphamide JJ Control
combination NN Control
treatment NN None
chemotherapy NN Pharmocological
paclitaxel NN Pharmocological
therapy NN None
. . None
paclitaxel NN Pharmocological
and CC None
cisplatin NN None
or CC None
cyclophosphamide NN Pharmocological
and CC None
cisplatin NN Pharmocological
. . None
paclitaxel/cisplatin NN Pharmocological
therapy NN None
cyclophosphamide/cisplatin JJ Pharmocological
paclitaxel/cisplatin NN Pharmocological
chemotherapy NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
cyclophosphamide NN Pharmocological
cisplatin NN Pharmocological
therapy NN None
paclitaxel/cisplatin JJ Pharmocological
-DOCSTART- -X- N

sublingual JJ Pharmocological
immunotherapy NN Pharmocological
Sublingual NNP Pharmocological
administration NN Pharmocological
of IN Pharmocological
allergens NNS Pharmocological
sublingual JJ Pharmocological
immunotherapy NN Pharmocological
. . None
symptomatic JJ Control
treatments NNS Control
. . None
sublingual JJ Pharmocological
immunotherapy NN Pharmocological
, , None
with IN None
three CD None
different JJ None
induction NN None
protocols NNS None
( ( None
8- CD None
, , None
15- CD None
and CC None
20-day JJ None
, , None
respectively RB None
) ) None
sublingual JJ Pharmocological
immunotherapy NN Pharmocological
-DOCSTART- -X- N

Dexamethasone NN Pharmocological
dexamethasone NN Pharmocological
placebo NN Control
or CC None
4 CD None
mg/day NN None
of IN None
oral JJ Pharmocological
dexamethasone NN Pharmocological
for IN None
4 CD None
days NNS None
. . None
dexamethasone NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

GS-9620 NNP Pharmocological
GS-9620 NNP Pharmocological
placebo-controlled JJ Control
GS-9620 NNP Pharmocological
single JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
GS-9620 NNP Pharmocological
( ( Pharmocological
0.3 CD Pharmocological
, , Pharmocological
1 CD Pharmocological
, , Pharmocological
2 CD Pharmocological
, , Pharmocological
4 CD Pharmocological
, , Pharmocological
6 CD Pharmocological
, , Pharmocological
8 CD Pharmocological
or CC Pharmocological
12 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
GS-9620 NNP Pharmocological
GS-9620 NNP None
doses NNS None
CONCLUSIONS NNP None
GS-9620 NNP None
-DOCSTART- -X- N

JASPER NNP Educational
intervention NN Educational
( ( Educational
JASPER NNP Educational
, , Educational
Joint NNP Educational
Attention NNP Educational
Symbolic NNP Educational
Play NNP Educational
Engagement NNP Educational
and CC Educational
Regulation NNP Educational
) ) Educational
were VBD None
randomized VBN None
to TO None
a DT None
control NN None
group NN None
( ( None
treatment NN None
as IN None
usual JJ None
, , None
30 CD None
h NN None
of IN None
ABA-based JJ None
therapy NN None
per IN None
week NN None
) ) None
or CC None
a DT None
treatment NN None
group NN None
( ( None
substitution NN None
of IN None
30 CD None
min NN None
of IN None
JASPER NNP None
treatment NN None
, , None
twice RB None
weekly RB None
during IN None
their PRP$ None
regular JJ None
program NN None
) ) None
. . None
A DT None
JASPER NNP None
treatment NN None
-DOCSTART- -X- N

hydrocodone/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
oral JJ Pharmocological
hydrocodone/acetaminophen NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg/500 RB Pharmocological
mg NN Pharmocological
) ) Pharmocological
to TO Pharmocological
oral JJ Pharmocological
codeine/acetaminophen NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg/300 RB Pharmocological
mg NN Pharmocological
) ) Pharmocological
. . None
hydrocodone/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
-DOCSTART- -X- N

5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
2 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
and CC None
2 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
two CD Pharmocological
groups NNS Pharmocological
to TO Pharmocological
receive VB Pharmocological
5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
n JJ Pharmocological
= NNP Pharmocological
27 CD Pharmocological
) ) Pharmocological
or CC None
2 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
( ( Pharmocological
0.8 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
n JJ Pharmocological
= NNP Pharmocological
30 CD Pharmocological
) ) Pharmocological
We PRP Surgical
collected VBD Surgical
data NNS Surgical
on IN Surgical
after IN Surgical
surgery NN Surgical
. . None
prilocaine NN Pharmocological
mepivacaine NN Pharmocological
) ) None
-DOCSTART- -X- N

tested VBN None
with IN None
TRH NNP Pharmocological
( ( None
200 CD None
micrograms NNS None
IV NNP None
bolus NN None
) ) None
in IN None
the DT None
presence NN None
( ( None
experimental JJ None
test NN None
) ) None
and CC None
absence NN None
( ( None
control VB None
test NN None
) ) None
of IN None
the DT None
serotonergic JJ Pharmocological
agonist NN Pharmocological
fenfluramine NN Pharmocological
( ( None
60 CD None
mg NN None
PO NNP None
90 CD None
min NN None
before IN None
TRH NNP None
) ) None
. . None
-DOCSTART- -X- N

two CD Physical
consecutive JJ Physical
overnight JJ Physical
polysomnographies NNS Physical
, , None
one CD None
with IN None
a DT None
chinstrap NN Physical
, , None
in IN None
random JJ None
order NN None
. . None
with IN Physical
and CC Physical
without IN Physical
a DT Physical
chinstrap NN Physical
-DOCSTART- -X- N

atenolol NN Pharmocological
, , None
labetalol NN Pharmocological
, , None
metoprolol NN Pharmocological
and CC None
pindolol NN Pharmocological
. . None
( ( None
atenolol JJ Pharmocological
labetalol VBZ Pharmocological
metoprolol PRP Pharmocological
pindolol VB Pharmocological
. . None
. . None
-DOCSTART- -X- N

radiotherapy NN Physical
combined VBN Control
therapy NN Control
. . None
radiotherapy NN Physical
alone RB Physical
radiotherapy NN Physical
( ( None
the DT None
same JJ None
schedule NN None
) ) None
plus CC Control
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
) ) Pharmocological
. . None
radiotherapy VB Physical
combined JJ Physical
therapy NN Physical
adjuvant JJ Physical
chemotherapy NN Physical
radiotherapy NN Physical
-DOCSTART- -X- N

coumarin NN Pharmocological
coumarin NN Pharmocological
( ( Pharmocological
1,2-benzopyrone CD Pharmocological
) ) Pharmocological
and CC None
warfarin $ Pharmocological
( ( Pharmocological
4-hydroxycoumarin JJ Pharmocological
) ) Pharmocological
coumarin NN Pharmocological
-DOCSTART- -X- N

mifepristone NN Pharmocological
mifepristone NN Pharmocological
receive VB Pharmocological
either RB Pharmocological
5 CD Pharmocological
or CC Pharmocological
10 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
mifepristone JJ Pharmocological
daily JJ Pharmocological
for IN Pharmocological
6 CD Pharmocological
months NNS Pharmocological
in IN Pharmocological
an DT Pharmocological
open-label JJ Pharmocological
study NN Pharmocological
. . Pharmocological
Mifepristone NNP Pharmocological
mifepristone NN Pharmocological
. . None
-DOCSTART- -X- N

trans NNS Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
Consumption NN None
of IN None
industrial JJ Pharmocological
trans NNS Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
iTFA NN Pharmocological
) ) Pharmocological
iTFA NN Pharmocological
conjugated VBD Pharmocological
linoleic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
CLA NNP Pharmocological
) ) Pharmocological
oleic JJ Control
acid NN Control
( ( Control
control VB Control
diet NN Control
) ) Control
, , None
iTFA JJ Pharmocological
, , None
or CC None
CLA NNP Pharmocological
. . None
of IN None
iTFA NN None
iTFA NN None
and CC None
CLA NNP None
did VBD None
which WDT None
iTFA JJ None
increase NN None
-DOCSTART- -X- N

heparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
UFH NNP Pharmocological
administration NN None
of IN None
two CD None
LMWHs NNP Pharmocological
. . None
UFH NNP Pharmocological
dalteparin NN Pharmocological
, , None
200 CD None
U/kg NNP None
once RB None
daily RB None
, , None
and CC None
enoxaparin RB Pharmocological
UFH NNP Pharmocological
UFH NNP Pharmocological
UFH NNP Pharmocological
LMWHs NNP Pharmocological
UFH NNP Pharmocological
-DOCSTART- -X- N

hip NN Surgical
fracture NN Surgical
surgery NN Surgical
hip NN Surgical
fracture NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

cangrelor NN Pharmocological
cangrelor NN Pharmocological
cangrelor NN Pharmocological
cangrelor NN Pharmocological
placebo NN Control
cangrelor NN Pharmocological
cangrelor NN Pharmocological
ADP NNP Pharmocological
blockade NN Pharmocological
with IN Pharmocological
cangrelor NN Pharmocological
-DOCSTART- -X- N

pyridoxine JJ Pharmocological
administration NN Pharmocological
-DOCSTART- -X- N

Famotidine NNP Pharmocological
famotidine NN Pharmocological
oral JJ Pharmocological
famotidine NN Pharmocological
was VBD Pharmocological
2 CD Pharmocological
mg/kg/day NN Pharmocological
( ( Pharmocological
given VBN Pharmocological
in IN Pharmocological
two CD Pharmocological
divided JJ Pharmocological
doses NNS Pharmocological
) ) Pharmocological
; : Pharmocological
the DT Pharmocological
maximum JJ Pharmocological
total JJ Pharmocological
daily JJ Pharmocological
dose NN Pharmocological
was VBD Pharmocological
100 CD Pharmocological
mg NN Pharmocological
. . Pharmocological
famotidine NN Pharmocological
-DOCSTART- -X- N

reducing VBG None
dietary JJ None
[ NN None
( ( None
Na+ NNP None
+ NNP None
K+ NNP None
) ) None
- : None
( ( None
Cl- JJ None
+ NNP None
SO4= NNP None
) ) None
] NN None
[ NNP None
( ( None
Na+ NNP None
+ NNP None
K+ NNP None
) ) None
- : None
( ( None
Cl- JJ None
+ NNP None
SO4= NNP None
) ) None
] VBP None
-4 JJ None
meq NN None
( ( None
anion NN None
diet NN None
) ) None
or CC None
+572.5 JJ None
meq NN None
( ( None
cation NN None
diet NN None
) ) None
of IN None
[ NN None
( ( None
Na+ NNP None
+ NNP None
K+ NNP None
) ) None
- : None
( ( None
Cl- JJ None
+ NNP None
SO4= NNP None
) ) None
] VBD None
kg-1 JJ None
dietary JJ None
dry JJ None
matter NN None
( ( None
DM NNP None
) ) None
. . None
grass NN None
hay NN None
and CC None
concentrates NNS None
. . None
KCl NNP None
, , None
K2SO4 NNP None
and CC None
( ( None
NH4 NNP None
) ) None
2SO4 CD None
( ( None
anion NN None
diet NN None
) ) None
or CC None
K2CO3 NNP None
( ( None
cation NN None
diet NN None
) ) None
-DOCSTART- -X- N

allocated VBN None
to TO None
12 CD None
consecutive JJ None
cycles NNS None
of IN None
treatment NN None
with IN None
monophasic JJ Pharmocological
combinations NNS Pharmocological
of IN Pharmocological
: : Pharmocological
20 CD Pharmocological
micrograms NNS Pharmocological
ethinyl VBP Pharmocological
estradiol NN Pharmocological
and CC None
150 CD Pharmocological
micrograms NNS Pharmocological
desogestrel NN Pharmocological
( ( None
n JJ None
= NNP None
15 CD None
) ) None
or CC None
30 CD Pharmocological
micrograms NNS Pharmocological
ethinyl VBP Pharmocological
estradiol NN Pharmocological
and CC None
75 CD Pharmocological
micrograms NNS Pharmocological
gestodene NN Pharmocological
( ( None
n JJ None
= NNP None
19 CD None
) ) None
-DOCSTART- -X- N

electrothermal JJ Surgical
bipolar JJ Surgical
vessel NN Surgical
system NN Surgical
( ( Surgical
EBVS NNP Surgical
) ) Surgical
electrothermal JJ Surgical
bipolar JJ Surgical
vessel NN Surgical
sealing NN Surgical
( ( Surgical
EBVS NNP Surgical
) ) Surgical
EBVS NNP Surgical
( ( Physical
25 CD Physical
pts NNS Physical
, , Physical
group NN Physical
A NNP Physical
) ) Physical
versus IN Physical
the DT Physical
UltraSonic NNP Physical
Shears NNP Physical
( ( Physical
USS NNP Physical
) ) Physical
device NN Physical
-DOCSTART- -X- N

heparin NN Pharmocological
. . None
Heparin NNP Pharmocological
placebo-controlled JJ Control
trial NN Control
intravenous JJ Pharmocological
heparin NN Pharmocological
, , None
aspirin NN Pharmocological
, , None
both DT Educational
treatments NNS Educational
, , None
and CC None
neither RB None
heparin NN Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

Risperidone NN Pharmocological
Risperidone NN Pharmocological
risperidone NN Pharmocological
haloperidol NN Pharmocological
, , None
perphenazine NN Pharmocological
or CC None
zuclopenthixol NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
haloperidol NN Pharmocological
, , None
perphenazine NN Pharmocological
or CC None
zuclopenthixol NN Pharmocological
. . None
-DOCSTART- -X- N

seven CD Pharmocological
plant NN Pharmocological
extracts NNS Pharmocological
placebo-controlled JJ Control
seven CD Pharmocological
medical JJ Pharmocological
plant NN Pharmocological
extracts NNS Pharmocological
placebo-controlled JJ Control
1.5 CD Pharmocological
fold JJ Pharmocological
UV-B NNP Pharmocological
minimal NN Pharmocological
erythema NN Pharmocological
dose NN Pharmocological
Aloe NNP Pharmocological
vera NN Pharmocological
, , None
Chamomilla NNP Pharmocological
recutita NN Pharmocological
, , None
Hamamelis NNP Pharmocological
virginiana NN Pharmocological
, , None
Melissa NNP Pharmocological
officinalis NN Pharmocological
, , None
Mentha NNP Pharmocological
arvensis NN Pharmocological
, , None
Melaleuca NNP Pharmocological
alternifolia NN Pharmocological
, , None
Coriandrum NNP Pharmocological
sativum NN Pharmocological
as RB None
well RB None
as IN None
1 CD Pharmocological
% NN Pharmocological
hydrocortisone NN Pharmocological
acetate NN Pharmocological
and CC None
0.1 CD Pharmocological
% NN Pharmocological
betamethasone NN Pharmocological
valerate NN Pharmocological
unguentum JJ Pharmocological
leniens NNS Pharmocological
RESULTS NNP None
Aloe NNP None
vera NN None
, , None
Chamomilla NNP None
recutita NN None
, , None
Melissa NNP None
officinalis NN None
, , None
Melaleuca NNP None
alternifolia NN None
and CC None
Coriandrum NNP None
sativum NN None
showed VBD None
CONCLUSION NNP None
Aloe NNP None
vera NN None
possesses VBZ None
-DOCSTART- -X- N

computerised JJ Physical
posturography NN Physical
propofol/alfentanil/N2O NN Pharmocological
anaesthesia NN Pharmocological
with IN Pharmocological
thiopentone/halothane/N2O JJ Pharmocological
anaesthesia NN Pharmocological
. . None
propofol/alfentanil/N2O NNS Pharmocological
thiopentone/halothane/N2O RB Pharmocological
. . None
propofol/alfentanil/N2O NN Pharmocological
anaesthesia NN Pharmocological
thiopentone/halothane/N2O VB Pharmocological
anaesthesia NN Pharmocological
otolaryngological JJ Surgical
surgery NN Surgical
. . Surgical
-DOCSTART- -X- N

observing VBG Educational
-DOCSTART- -X- N

ketorolac NN Pharmocological
, , Pharmocological
topical JJ Pharmocological
bupivacaine NN Pharmocological
placebo NN Control
intramuscular JJ Pharmocological
ketorolac NN Pharmocological
and CC Pharmocological
topical JJ Control
placebo NN Control
intramuscular JJ Control
placebo NN Control
and CC Control
topical JJ Pharmocological
bupivacaine NN Pharmocological
intramuscular JJ Control
placebo NN Control
and CC Control
topical JJ Control
placebo NN Control
. . None
placebo NN Control
ketorolac NNS Pharmocological
placebo NN Control
. . None
bupivacaine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

pegvisomant NN Pharmocological
pegvisomant NN Pharmocological
pegvisomant NN Pharmocological
placebo NN Control
pegvisomant JJ Pharmocological
pegvisomant NN Pharmocological
-DOCSTART- -X- N

diethylcarbamazine NN Pharmocological
ivermectin NN Pharmocological
chemotherapy NN Pharmocological
annual JJ Pharmocological
community-wide JJ Pharmocological
single-dose JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
diethylcarbamazine JJ Pharmocological
alone NN Pharmocological
or CC Pharmocological
with IN Pharmocological
ivermectin JJ Pharmocological
diethylcarbamazine JJ Pharmocological
ivermectin JJ Pharmocological
diethylcarbamazine VBP Pharmocological
diethylcarbamazine JJ Pharmocological
Annual JJ None
single-dose JJ None
community-wide JJ None
treatment NN None
with IN None
diethylcarbamazine JJ None
alone NN None
or CC None
with IN None
ivermectin NN None
-DOCSTART- -X- N

Acipimox NNP Pharmocological
acipimox JJ Pharmocological
placebo NN Control
. . Control
acipimox NNS Pharmocological
placebo VB Control
acipimox NN Pharmocological
placebo VB None
Acipimox NNP Pharmocological
-DOCSTART- -X- N

atorvastatin NN Pharmocological
Atorvastatin NNP Pharmocological
atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
-DOCSTART- -X- N

auscultation NN Physical
oesophageal JJ Surgical
intubation NN Surgical
intubation NN Surgical
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
pravastatin NN Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
supplementation NN Pharmocological
calcium NN Pharmocological
supplementation NN Pharmocological
calcium NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
receiving VBG Pharmocological
a DT Pharmocological
1200-mg JJ Pharmocological
calcium NN Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
Caltrate NNP Pharmocological
) ) Pharmocological
supplement NN Pharmocological
. . Pharmocological
Calcium NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

nitric JJ Pharmocological
oxide NN Pharmocological
nitric JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
NO NNP Pharmocological
) ) Pharmocological
NO NNP Pharmocological
. . None
for IN None
conventional JJ Control
therapy NN Control
( ( Control
control NN Control
) ) Control
or CC None
continuous JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
10 CD Pharmocological
parts NNS Pharmocological
per IN Pharmocological
million CD Pharmocological
( ( Pharmocological
ppm NN Pharmocological
) ) Pharmocological
inhaled VBD Pharmocological
NO NNP Pharmocological
until IN None
weaning VBG None
was VBD None
initiated VBN None
. . None
NO-treated JJ Pharmocological
-DOCSTART- -X- N

Beta-carotene NNP Pharmocological
beta-Carotene NN Pharmocological
beta-carotene JJ Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
beta-carotene NN Pharmocological
beta-carotene NN Pharmocological
, , Pharmocological
180 CD Pharmocological
mg/day NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

granulocyte/colony-stimulating JJ Physical
factor NN Physical
granulocyte/colony-stimulating JJ Physical
factor NN Physical
( ( Physical
G-CSF NNP Physical
) ) Physical
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
-DOCSTART- -X- N

cefixime NN Pharmocological
ceftriaxone NN Pharmocological
ceftriaxone NN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
800 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
cefixime NN Pharmocological
, , None
administered VBN Educational
orally RB Educational
, , None
and CC None
250 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
ceftriaxone NN Pharmocological
cefixime NN Pharmocological
cefixime NN Pharmocological
ceftriaxone NN Pharmocological
cefixime NN Pharmocological
ceftriaxone NN Pharmocological
-DOCSTART- -X- N

Neoton NNP Pharmocological
thrombolytic JJ Pharmocological
therapy NN Pharmocological
neoton JJ Pharmocological
TLT NNP Control
neoton NN Control
TLT NNP Pharmocological
streptokinase JJ Pharmocological
streptokinase JJ Pharmocological
preparations NNS Pharmocological
neoton NN Pharmocological
neoton NNS Pharmocological
neoton NN Pharmocological
Neoton NNP Pharmocological
-DOCSTART- -X- N

tocainide NN Pharmocological
and CC None
prajmalium NN Pharmocological
bitartrate NN Pharmocological
tocainide NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
tocainide NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
-DOCSTART- -X- N

arrow NN Physical
localization NN Physical
of IN Physical
a DT Physical
target NN Physical
that WDT None
appeared VBD None
to TO None
the DT None
left NN None
or CC None
right NN None
of IN None
the DT None
fixation NN None
point NN None
. . None
the DT None
participant NN None
's POS None
attention NN None
was VBD None
cued VBN None
to TO None
the DT None
left NN None
or CC None
right NN None
by IN None
either DT None
an DT None
arrow NN Physical
or CC None
the DT None
direction NN Physical
of IN Physical
eye NN Physical
gaze NN Physical
on IN Physical
a DT Physical
computerized JJ Physical
face NN Physical
. . None
-DOCSTART- -X- N

alkalinized JJ Pharmocological
lidocaine JJ Pharmocological
2 CD Pharmocological
% NN Pharmocological
standard JJ None
general JJ None
anesthesia NN None
by IN None
means NNS None
of IN None
low-flow JJ Physical
rebreathing NN Physical
system NN Physical
low-flow JJ Physical
anesthesia NN Physical
only RB Physical
low-flow JJ Physical
anesthesia NN Physical
with IN Physical
additional JJ Physical
reflective JJ Physical
blankets NNS Physical
low-flow JJ Physical
anesthesia NN Physical
with IN Physical
active JJ Physical
forced-air JJ Physical
warming NN Physical
low-flow JJ Physical
anesthesia NN Physical
alone RB Physical
and CC Physical
in IN Physical
combination NN Physical
with IN Physical
reflective JJ Physical
blankets NNS Physical
-DOCSTART- -X- N

Nasotracheal JJ None
intubation NN None
under IN None
curve-tipped JJ None
suction NN None
catheter NN None
Nasotracheal NNP None
intubation NN None
( ( None
NTI NNP None
) ) None
curve-tipped JJ Physical
suction NN Physical
catheter NN Physical
( ( Physical
CTSC NNP Physical
) ) Physical
to TO None
NTI NN None
without IN None
CTSC NNP None
guidance NN None
Nasotracheal NNP None
intubation NN None
under IN None
CTSC NNP None
guidance NN None
-DOCSTART- -X- N

placebo-controlled JJ Control
oral JJ Control
dosing VBG Control
with IN Control
placebo NN Control
or CC None
fluoxetine NN Pharmocological
, , Pharmocological
40 CD Pharmocological
mg NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
. . None
[ NNP None
( ( Physical
11 CD Physical
) ) Physical
C NNP Physical
] NNP Physical
SB207145 NNP Physical
-DOCSTART- -X- N

fluoxetine NN Pharmocological
alone RB Pharmocological
vs. FW None
fluoxetine JJ Pharmocological
plus CC None
local JJ Pharmocological
lidocaine NN Pharmocological
ointment NN Pharmocological
fluoxetine NN Pharmocological
alone RB Pharmocological
vs. FW None
fluoxetine JJ Pharmocological
plus CC None
local JJ Pharmocological
lidocaine NN Pharmocological
ointment NN Pharmocological
fluoxetine JJ Pharmocological
fluoxetine JJ Pharmocological
lidocaine JJ Pharmocological
ointment NN Pharmocological
. . None
fluoxetine JJ Pharmocological
lidocaine JJ Pharmocological
fluoxetine VB Pharmocological
-DOCSTART- -X- N

Anesthesia NNP Pharmocological
was VBD None
induced VBN None
with IN None
thiopental JJ None
and CC None
remifentanil NN Pharmocological
( ( Pharmocological
1.0 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
bolus NN Pharmocological
and CC None
a DT None
1 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
infusion NN Pharmocological
) ) Pharmocological
or CC None
fentanyl NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
bolus NN Pharmocological
and CC None
a DT None
1.0 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
infusion NN Pharmocological
) ) None
. . None
The DT None
opioid JJ Pharmocological
infusion NN Pharmocological
continued VBD None
until IN None
the DT None
level NN None
of IN None
anesthesia NN Pharmocological
was VBD None
deemed VBN None
appropriate JJ None
for IN None
intubation NN None
. . None
Anesthesia NNP Pharmocological
was VBD None
maintained VBN None
with IN None
N NNP None
( ( None
2 CD None
) ) None
O/O NNP None
( ( None
2 CD None
) ) None
, , None
isoflurane $ Pharmocological
0.5 CD Pharmocological
MAC NNP Pharmocological
and CC None
remifentanil VB Pharmocological
0.2 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 JJ Pharmocological
) ) Pharmocological
or CC None
fentanyl $ Pharmocological
0.04 CD Pharmocological
micro NN Pharmocological
g NN Pharmocological
x NNP Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
x VBP Pharmocological
min NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
. . None
At IN Physical
bone NN Physical
flap NN Physical
replacement NN Physical
, , None
either DT Pharmocological
morphine NN Pharmocological
0.08 CD Pharmocological
mg NN Pharmocological
x NN None
kg NN None
( ( None
-1 NN None
) ) None
( ( None
remifentanil JJ Pharmocological
group NN Pharmocological
) ) Pharmocological
or CC None
saline NN Pharmocological
( ( None
fentanyl JJ None
group NN None
) ) None
was VBD None
given VBN None
. . None
-DOCSTART- -X- N

Heparin NNP Pharmocological
plus CC Pharmocological
dipyridamole NN Pharmocological
heparin NN Pharmocological
and CC Pharmocological
dipyridamole NN Pharmocological
or CC Pharmocological
with IN Pharmocological
supportive JJ Pharmocological
management NN Pharmocological
only RB Pharmocological
. . Pharmocological
treatment NN None
with IN None
-DOCSTART- -X- N

beta-endorphin NN Pharmocological
beta-endorphin NN Pharmocological
1-h JJ Pharmocological
iv JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
beta-endorphin JJ Pharmocological
( ( Pharmocological
250 CD Pharmocological
mug/h NN Pharmocological
) ) Pharmocological
and CC None
, , None
on IN None
another DT None
occasion NN None
, , None
the DT None
same JJ None
infusion NN None
protocol NN None
preceded VBN None
by IN None
the DT None
opioid JJ Pharmocological
antagonist NN Pharmocological
naloxone NN Pharmocological
( ( Pharmocological
8 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
. . None
beta-endorphin JJ Pharmocological
beta-endorphin JJ Pharmocological
-DOCSTART- -X- N

'Senokot NNP Pharmocological
' POS None
Senokot NNP Pharmocological
behavioural JJ None
approach NN None
and CC Pharmocological
either DT Pharmocological
Senokot NNP Pharmocological
, , None
placebo NN Control
or CC Pharmocological
no DT Pharmocological
medication NN Pharmocological
. . None
-DOCSTART- -X- N

triamcinolone NN Pharmocological
acetonide RB Pharmocological
aqueous JJ Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
of IN Pharmocological
triamcinolone NN Pharmocological
acetonide NN Pharmocological
triamcinolone NN Pharmocological
acetonide RB Pharmocological
aqueous JJ Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
placebo NN Control
triamcinolone NN Pharmocological
acetonide RB Pharmocological
aqueous JJ Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

Antioxidant JJ Pharmocological
supplementation NN None
antipyrine NN None
antioxidant JJ Pharmocological
supplementation NN Pharmocological
dl-alpha-tocopheryl JJ Pharmocological
acetate NN Pharmocological
ascorbic JJ Pharmocological
acid NN Pharmocological
beta-carotene NN Pharmocological
placebo NN Control
Antipyrine NNP Pharmocological
antioxidant JJ Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

dan NN Pharmocological
shao NN Pharmocological
tang NN Pharmocological
Dan NNP Pharmocological
Shao NNP Pharmocological
Tang NNP Pharmocological
( ( Pharmocological
DST NNP Pharmocological
) ) Pharmocological
DST NNP Pharmocological
and CC None
western JJ Pharmocological
medicine NN Pharmocological
only RB None
with IN Pharmocological
western JJ Pharmocological
medicine NN Pharmocological
. . None
DST NNP Pharmocological
-DOCSTART- -X- N

pulsed JJ Physical
Doppler NNP Physical
echocardiography NN Physical
] NNP None
Doppler NNP Physical
echocardiography NN Physical
pulsed JJ Physical
Doppler NNP Physical
-DOCSTART- -X- N

Epirubicin-based JJ Pharmocological
chemotherapy NN Pharmocological
epirubicin JJ Pharmocological
fluorouracil NN Pharmocological
epirubicin $ Pharmocological
cyclophosphamide RB Pharmocological
( ( None
FEC NNP Pharmocological
FEC NNP Pharmocological
100 CD Pharmocological
epirubicin JJ Pharmocological
FEC NNP Pharmocological
50 CD Pharmocological
( ( Pharmocological
epirubicin JJ Pharmocological
FEC NNP Pharmocological
100 CD Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
-DOCSTART- -X- N

to TO Pharmocological
receive VB Pharmocological
( ( Pharmocological
group NN Pharmocological
S NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
not RB Pharmocological
( ( Pharmocological
group NN Pharmocological
C NNP Pharmocological
) ) Pharmocological
sevoflurane NN Pharmocological
Transoesophageal NNP Physical
Tissue NNP Physical
Doppler NNP Physical
echocardiographic JJ Physical
examination NN Physical
of IN Physical
myocardial JJ Physical
systolic NN Physical
and CC None
early JJ Surgical
diastolic NN Surgical
velocities NNS Surgical
in IN Surgical
both DT Surgical
groups NNS Surgical
basally RB Surgical
and CC Surgical
60 CD Surgical
s NN Surgical
after IN Surgical
coronary JJ Surgical
occlusion NN Surgical
by IN Surgical
the DT Surgical
surgeon NN Surgical
. . None
-DOCSTART- -X- N

bumetanide NN Pharmocological
benzodiazepines NNS Pharmocological
bumetanide IN Pharmocological
placebo NN Control
bumetanide NN Pharmocological
Bumetanide NNP Pharmocological
placebo NN Control
) ) None
placebo NN Control
) ) None
Therefore RB None
, , None
bumetanide NN None
is VBZ None
-DOCSTART- -X- N

, , Educational
newly RB Educational
familiar JJ Educational
faces VBZ Educational
novel JJ Educational
faces VBZ Educational
-DOCSTART- -X- N

clozapine NN None
conventional JJ None
antipsychotic JJ None
medication NN None
clozapine NN Pharmocological
Clozapine NNP Pharmocological
clozapine NN Pharmocological
Clozapine NNP Pharmocological
-DOCSTART- -X- N

somatostatin NN Pharmocological
( ( Pharmocological
octreotide JJ Pharmocological
) ) Pharmocological
Somatostatin NNP Pharmocological
somatostatin NN Pharmocological
saline NN Pharmocological
octreotide NN Pharmocological
( ( Pharmocological
Sandostatin NNP Pharmocological
octreotide RB Pharmocological
saline NN Pharmocological
octreotide RB Pharmocological
octreotide JJ Pharmocological
saline NN Pharmocological
octreotide NN Pharmocological
saline NN Pharmocological
octreotide NN Pharmocological
octreotide JJ Pharmocological
saline NN Control
octreotide NN Pharmocological
somatostatin NN Pharmocological
somatostatin NN Pharmocological
octreotide NN Pharmocological
somatostatin NN Pharmocological
-DOCSTART- -X- N

manual JJ Physical
external JJ Physical
defibrillation NN Physical
external JJ Physical
defibrillation NN Physical
. . None
defibrillator NN Physical
paddles NNS Physical
Transverse NNP Physical
paddle JJ Physical
orientation NN Physical
-DOCSTART- -X- N

creatine JJ Pharmocological
supplementation NN Pharmocological
creatine NN Pharmocological
monohydrate NN Pharmocological
( ( Pharmocological
Cr NNP Pharmocological
) ) Pharmocological
maltodextrin JJ Pharmocological
placebo NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
Cr NNP Pharmocological
-DOCSTART- -X- N

Chinese JJ Pharmocological
herbal JJ Pharmocological
medicine NN Pharmocological
Chinese NNP Pharmocological
herbal JJ Pharmocological
medicine NN Pharmocological
( ( Pharmocological
CHM NNP Pharmocological
) ) Pharmocological
Participants NNS None
were VBD None
initially RB None
randomized VBN None
to TO None
either DT None
wait-list JJ Control
control NN Control
( ( Control
WLC NNP Control
) ) Control
or CC None
treatment NN None
groups NNS None
to TO None
receive VB None
either DT None
individualized JJ Pharmocological
CHM NNP Pharmocological
decoctions NNS Pharmocological
or CC None
a DT None
therapeutically RB Control
inert JJ Control
placebo NN Control
decoction NN Control
. . None
-DOCSTART- -X- N

docosahexaenoic NN Pharmocological
acid NN Pharmocological
docosahexaenoic NN Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
DHA NNP Pharmocological
DHA NNP Pharmocological
placebo NN Control
. . None
placebo NN Control
DHA NNP Pharmocological
DHA NNP Pharmocological
-DOCSTART- -X- N

parent-mediated JJ Psychological
communication-focused JJ Psychological
treatment NN Psychological
-DOCSTART- -X- N

ozone NN Physical
application NN Physical
ozone NN Physical
and CC None
sodium NN Physical
ascorbate NN Physical
not RB None
treated VBN None
with IN None
ozone NN None
; : None
ozone NN None
application NN None
followed VBN None
by IN None
acid NN None
etching NN None
; : None
acid NN None
etching VBG None
followed VBN None
by IN None
ozone NN None
application NN None
; : None
ozone NN None
and CC None
application NN None
of IN None
sodium NN None
ascorbate NN None
. . None
-DOCSTART- -X- N

social JJ Educational
phobia NN Educational
social JJ Psychological
phobics NNS Psychological
. . None
participants NNS Psychological
heard VBP Psychological
their PRP$ Psychological
heart NN Psychological
sounds VBZ Psychological
first JJ Psychological
via IN Psychological
headphones NNS Psychological
and CC None
then RB None
via IN None
loudspeakers NNS None
which WDT None
were VBD None
also RB None
audible JJ None
to TO None
observers NNS None
. . None
controls NNS Control
-DOCSTART- -X- N

Cimetidine NNP Pharmocological
H2-histamine NNP Pharmocological
receptor NN Pharmocological
antagonists NNS Pharmocological
cimetidine NN Pharmocological
Cimetidine NNP Pharmocological
cimetidine NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

treatment NN Pharmocological
as IN Pharmocological
usual JJ Pharmocological
control NN Control
treatment NN Control
Computer NNP Other
generated VBD Other
block NN Other
randomization NN Other
Stratified NNP None
block NN None
randomization NN None
-DOCSTART- -X- N

pretense NN Educational
pretend JJ Educational
play NN Educational
pretense NN Educational
scenarios NNS Educational
lacking VBG Educational
pretend JJ Educational
speech NN Educational
or CC Educational
sound JJ Educational
effects NNS Educational
-DOCSTART- -X- N

Bupropion NNP Pharmocological
SR NNP Pharmocological
and CC None
counseling VBG Educational
for IN Educational
standard JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
bupropion NN Pharmocological
SR NNP Pharmocological
bupropion NN Pharmocological
SR NNP Pharmocological
bupropion NN Pharmocological
SR NNP Pharmocological
behavioral JJ Educational
counseling NN Educational
( ( Educational
tailored JJ Educational
mailings NNS Educational
or CC Educational
proactive JJ Educational
telephone NN Educational
counseling NN Educational
) ) Educational
bupropion NN Pharmocological
SR NNP Pharmocological
-DOCSTART- -X- N

Yinxing VBG Pharmocological
Damo NNP Pharmocological
combined VBN Pharmocological
with IN Pharmocological
betahistine JJ Pharmocological
hydrochloride NN Pharmocological
Yinxing VBG Pharmocological
Damo NNP Pharmocological
( ( Pharmocological
YXDM NNP Pharmocological
) ) Pharmocological
combined VBD Pharmocological
with IN Pharmocological
Betahistine NNP Pharmocological
Hydrochloride NNP Pharmocological
Injection NNP Pharmocological
YXDM NNP Pharmocological
BHI NNP Pharmocological
-DOCSTART- -X- N

Cemented VBN Physical
CeraOne NNP Physical
and CC Physical
porcelain NN Physical
fused VBD Physical
to TO Physical
TiAdapt NNP Physical
abutment JJ Physical
restorations NNS Physical
: : None
cemented VBN Physical
noncemented VBN Physical
single-implant JJ Physical
restorations NNS Physical
baked VBN Physical
porcelain NN Physical
to TO Physical
custom-made JJ Physical
TiAdapt NNP Physical
titanium NN Physical
abutments NNS Physical
or CC None
cement JJ None
crowns NNS None
onto IN None
CeraOne NNP None
( ( None
Nobel NNP None
Biocare NNP None
AB NNP None
) ) None
abutments NNS None
( ( None
control NN None
) ) None
the DT None
implants NNS None
the DT None
test NN None
and CC None
control NN None
groups NNS None
the DT None
implants NNS None
was VBD None
) ) None
. . None
Implants NNS None
with IN None
with IN None
implants NNS None
with IN None
the DT None
test NN None
and CC None
control VB None
single-implant JJ None
restorations NNS None
during IN None
some DT None
restorations NNS None
presented VBD None
one-piece JJ None
single-implant JJ None
protocol NN None
( ( None
test NN None
) ) None
allows VBZ None
installed JJ None
single JJ None
implant NN None
crowns NNS None
in IN None
-DOCSTART- -X- N

Fluvoxamine NNP Pharmocological
clomipramine NN Pharmocological
fluvoxamine NN Pharmocological
clomipramine NN Pharmocological
. . Pharmocological
placebo JJ Control
fluvoxamine NN Pharmocological
or CC Pharmocological
clomipramine NN Pharmocological
-DOCSTART- -X- N

montelukast NN Pharmocological
montelukast NN Pharmocological
, , Pharmocological
a DT Pharmocological
cysteinyl JJ Pharmocological
leukotriene NN Pharmocological
receptor NN Pharmocological
antagonist NN Pharmocological
placebo- JJ Control
placebo JJ Control
montelukast JJ Pharmocological
loratadine JJ Pharmocological
or CC None
placebo NN Control
Montelukast NNP Pharmocological
placebo NN Control
montelukast NN Pharmocological
Loratadine NNP Pharmocological
montelukast NN Pharmocological
loratadine NN Pharmocological
montelukast NN Pharmocological
-DOCSTART- -X- N

Simvastatin JJ Pharmocological
statins NNS Pharmocological
placebo-controlled JJ Control
simvastatin NN Pharmocological
or CC None
placebo NN Control
Statin NNP Pharmocological
simvastatin NN Pharmocological
Simvastatin NNP Pharmocological
-DOCSTART- -X- N

Peritoneovenous JJ Physical
shunting VBG Physical
medical JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

physical JJ Physical
activity NN Physical
intervention NN Physical
physical JJ Physical
activity NN Physical
intervention NN Physical
wait JJ Control
list NN Control
control NN Control
physical JJ Physical
activity NN Physical
intervention NN Physical
will MD Physical
consist VB Physical
of IN Physical
a DT Physical
number NN Physical
of IN Physical
strategies NNS Physical
including VBG Physical
: : None
delivering NN Physical
structured VBD Physical
fundamental JJ Physical
movement NN Physical
skill NN Physical
activities NNS Physical
, , Physical
increasing VBG Physical
physical JJ Physical
activity NN Physical
opportunities NNS Physical
, , Physical
increasing VBG Physical
staff NN Physical
role NN Physical
modelling NN Physical
, , Physical
providing VBG Physical
children NNS Physical
with IN Physical
a DT Physical
physical JJ Physical
activity NN Physical
promoting VBG Physical
indoor NN Physical
and CC Physical
outdoor JJ Physical
environment NN Physical
and CC Physical
limiting VBG Physical
children NNS Physical
's POS Physical
small JJ Physical
screen JJ Physical
recreation NN Physical
and CC Physical
sedentary JJ Physical
behaviours NNS Physical
. . None
-DOCSTART- -X- N

Dalteparin NNP Pharmocological
heparin NN Pharmocological
dalteparin NN Pharmocological
standard JJ Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
CT NNP Pharmocological
) ) Pharmocological
dalteparin NN Pharmocological
CONCLUSION NNP None
Dalteparin NNP None
is VBZ None
dalteparin NN None
. . None
-DOCSTART- -X- N

HIV NNP None
risk NN None
reduction NN None
intervention NN None
community-based JJ None
, , None
small JJ None
group NN None
HIV NNP None
risk NN None
reduction NN None
intervention NN None
theoretically-guided JJ Educational
intervention NN Educational
HIV-related JJ None
intervention NN None
control NN Control
( ( Control
health NN Control
promotion NN Control
) ) Control
intervention NN Control
. . None
HIV NNP None
intervention NN None
-DOCSTART- -X- N

neuraminidase NN Pharmocological
inhibitor NN Pharmocological
oseltamivir NN Pharmocological
placebo-controlled JJ Control
inoculated VBN Other
intranasally RB Other
with IN Other
influenza JJ Other
A/Texas/36/91 NNP Other
( ( Other
H1N1 NNP Other
) ) Other
virus NN Other
. . None
oral JJ Pharmocological
oseltamivir NN Pharmocological
matching VBG None
placebo JJ Control
placebo JJ Control
-DOCSTART- -X- N

chiropractic JJ Pharmocological
and CC None
medical JJ Educational
care NN Educational
medical JJ Educational
and CC Educational
chiropractic JJ Educational
care NN Educational
for IN Educational
physical JJ Physical
therapy NN Physical
chiropractic VB Physical
with IN Physical
or CC Physical
without IN Physical
physical JJ Physical
modalities NNS Physical
, , None
or CC None
medical JJ Physical
care NN Physical
with IN Physical
or CC Physical
without IN Physical
physical JJ Physical
therapy NN Physical
physical JJ Physical
therapy NN Physical
chiropractic JJ Educational
care NN Educational
chiropractic JJ Educational
medical JJ Educational
and CC Educational
chiropractic JJ Educational
care NN Educational
Physical JJ Physical
therapy NN Physical
-DOCSTART- -X- N

prostamol NN Pharmocological
uno JJ Pharmocological
Prostamol NNP Pharmocological
Uno NNP Pharmocological
( ( Pharmocological
PU NNP Pharmocological
) ) Pharmocological
PU NNP Pharmocological
PU NNP Pharmocological
-DOCSTART- -X- N

cyclosporine JJ Pharmocological
reduction NN None
sirolimus NN Pharmocological
, , Pharmocological
corticosteroid NN Pharmocological
, , Pharmocological
and CC Pharmocological
cyclosporine VB Pharmocological
reduction NN None
standard-dose JJ Pharmocological
cyclosporine NN Pharmocological
( ( None
sCsA NN None
reduced-dose JJ Pharmocological
cyclosporine NN Pharmocological
( ( None
rCsA NN None
sirolimus JJ Pharmocological
and CC None
corticosteroids NNS Pharmocological
. . None
-DOCSTART- -X- N

gammaglobulin NN Pharmocological
intravenous JJ Pharmocological
gammaglobulins NNS Pharmocological
gammaglobulins NNS Pharmocological
305 CD Pharmocological
infusions NNS Pharmocological
of IN Pharmocological
IVIG NNP Pharmocological
200 CD Pharmocological
mg/kg NN Pharmocological
; : Pharmocological
170 CD Pharmocological
infusions NNS Pharmocological
of IN Pharmocological
400 CD Pharmocological
mg/kg NNS Pharmocological
247 CD Pharmocological
infusions NNS Pharmocological
of IN Pharmocological
600 CD Pharmocological
mg/kg NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

tryptophan NN Pharmocological
depletion NN Pharmocological
low-tryptophan JJ Pharmocological
diet NN Pharmocological
amino NN Pharmocological
acid NN Pharmocological
drink NN Pharmocological
amino NN Pharmocological
acid NN Pharmocological
drink NN Pharmocological
-DOCSTART- -X- N

liquid JJ None
fluoxetine NN None
serotonin-receptive JJ Pharmocological
inhibitor NN Pharmocological
fluvoxamine NN Pharmocological
placebo NN Control
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
liquid JJ Pharmocological
fluoxetine NN Pharmocological
fluoxetine NN Pharmocological
placebo NN None
liquid JJ Pharmocological
fluoxetine NN Pharmocological
placebo VB Control
Liquid NNP Pharmocological
fluoxetine NN Pharmocological
fluoxetine NN Pharmocological
placebo VB None
placebo NN None
Liquid NNP Pharmocological
fluoxetine NN Pharmocological
placebo NN None
-DOCSTART- -X- N

sponsor JJ Educational
kit NN Educational
of IN Educational
promotional JJ Educational
materials NNS Educational
sponsorship NN Educational
kits NNS Educational
-DOCSTART- -X- N

latanoprost NN Pharmocological
combination NN Pharmocological
with IN Pharmocological
timolol NN Pharmocological
. . None
latanoprost NN Pharmocological
0.5 CD None
% NN None
timolol JJ Pharmocological
maleate NN Pharmocological
. . None
timolol NN Pharmocological
treatment NN None
3 CD None
weeks NNS None
before IN None
the DT None
beginning NN None
of IN None
the DT None
study NN None
. . None
latanoprost NN Pharmocological
) ) None
( ( None
placebo NN Control
) ) None
latanoprost NN Pharmocological
timolol NN Pharmocological
. . None
-DOCSTART- -X- N

pioglitazone NN Pharmocological
and CC None
glimepiride NN Pharmocological
Pioglitazone NNP Pharmocological
glimepiride VB Pharmocological
Pioglitazone NN Pharmocological
glimepiride NN Pharmocological
glimepiride NN Pharmocological
or CC None
pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
glimepiride RB Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
pioglitazone NN Pharmocological
glimepirede NN Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
Pioglitazone NN Pharmocological
glimepiride NN Pharmocological
Pioglitazone NNP Pharmocological
glimepiride NN Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
glimepiride VB Pharmocological
pioglitazone NN Pharmocological
-DOCSTART- -X- N

sensory JJ Physical
stimulation NN Physical
( ( Physical
acupuncture NN Physical
) ) Physical
sensory JJ Physical
stimulation NN Physical
( ( Physical
acupuncture NN Physical
) ) Physical
needle JJ Physical
sensation NN Physical
short JJ Physical
acupuncture NN Physical
needle NN Physical
acupuncture NN Physical
needle NN Physical
acupuncture NN Physical
needle NN Physical
sensory JJ Physical
stimulation NN Physical
( ( Physical
acupunctura NN Physical
) ) Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

noninvasive JJ Physical
and CC Educational
invasive JJ Surgical
approaches NNS Educational
. . Educational
noninvasive JJ Physical
( ( None
suppression NN None
of IN None
ventricular JJ None
arrhythmias NNS None
detected VBN None
by IN None
ambulatory JJ None
monitoring NN None
) ) None
invasive JJ Surgical
( ( None
suppression NN None
of IN None
arrhythmias NNS None
induced VBN None
by IN None
programmed JJ None
stimulation NN None
) ) None
invasive JJ Surgical
approach NN Surgical
noninvasive JJ Physical
approach NN Physical
noninvasive JJ Physical
invasive JJ Surgical
invasive JJ Surgical
approach NN Surgical
-DOCSTART- -X- N

denopamine NN Pharmocological
denopamine NN Pharmocological
ergometer NN Physical
20 CD Pharmocological
mg NN Pharmocological
denopamine NN Pharmocological
or CC None
placebo NN Control
. . None
placebo NN Control
denopamine NN Pharmocological
Denopamine NNP Pharmocological
denopamine NN Pharmocological
-DOCSTART- -X- N

Noninfiltrative JJ Pharmocological
anesthesia NN Pharmocological
lidocaine-prilocaine JJ Pharmocological
cream NN Pharmocological
lidocaine-ketorolac JJ Pharmocological
gel NN Pharmocological
. . None
anesthesia NN Pharmocological
Noninfiltrative NNP Pharmocological
anesthesia NN Pharmocological
perianal-intrarectal JJ Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
lidocaine NN Pharmocological
gel NN Pharmocological
, , None
lidocaine-ketorolac JJ Pharmocological
gel NN Pharmocological
lidocaine-prilocaine JJ Pharmocological
cream NN Pharmocological
PI NNP None
lidocaine JJ Pharmocological
gel NN Pharmocological
5 CD Pharmocological
g JJ Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
lidocaine JJ Pharmocological
gel NN Pharmocological
and CC Pharmocological
0.3 CD Pharmocological
% NN Pharmocological
ketorolac NN Pharmocological
tromethamine JJ Pharmocological
solution NN Pharmocological
1 CD None
hour NN None
before IN None
TPB NNP None
5 CD Pharmocological
g JJ Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
and CC Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
cream NN Pharmocological
20 CD None
minutes NNS None
before IN None
TPB NNP None
ketorolac NN Pharmocological
prilocaine NN Pharmocological
to TO None
lidocaine VB Pharmocological
lidocaine-prilocaine JJ Pharmocological
, , None
lidocaine-ketorolac JJ Pharmocological
CONCLUSIONS NNP None
Lidocaine-prilocaine JJ None
cream NN None
whereas IN None
lidocaine-ketorolac JJ None
gel NN None
was VBD None
-DOCSTART- -X- N

Lithium NN Pharmocological
lithium NN Pharmocological
carbonate NN Pharmocological
, , Pharmocological
300 CD Pharmocological
mg NN Pharmocological
t.i.d. NN Pharmocological
or CC None
no DT Pharmocological
lithium NN Pharmocological
. . None
lithium NN Pharmocological
no-lithium JJ Pharmocological
lithium NN Pharmocological
lithium NN Pharmocological
lithium VB Pharmocological
-DOCSTART- -X- N

clomipramine NN Pharmocological
, , None
desipramine NN Pharmocological
, , None
and CC None
placebo NN Control
clomipramine NN Pharmocological
hydrochloride NN Pharmocological
placebo NN Control
noradrenergic JJ Pharmocological
tricyclic JJ Pharmocological
antidepressant NN Pharmocological
agent NN Pharmocological
, , None
desipramine JJ Pharmocological
hydrochloride NN Pharmocological
. . None
placebo NN Control
clomipramine NN Pharmocological
and CC None
placebo NN Control
clomipramine NN Pharmocological
desipramine NN Pharmocological
. . None
Clomipramine NNP Pharmocological
desipramine NN Pharmocological
placebo NN Control
. . None
Clomipramine NNP Pharmocological
desipramine VB Pharmocological
-DOCSTART- -X- N

sildenafil NN Pharmocological
sildenafil NN Pharmocological
placebo-controlled JJ Control
sildenafil VB Pharmocological
placebo NN Control
Sildenafil NNP Pharmocological
sildenafil-treated JJ Pharmocological
sildenafil-treated JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
risperidone NN Pharmocological
plus CC Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
to TO Pharmocological
risperidone VB Pharmocological
risperidone JJ Pharmocological
plus CC Pharmocological
amantadine JJ Pharmocological
, , None
and CC None
the DT None
other JJ None
group NN None
received VBD None
risperidone JJ Pharmocological
plus CC Pharmocological
placebo NN Control
. . None
amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
-DOCSTART- -X- N

vascularized JJ Surgical
bone NN Surgical
grafts NNS Surgical
one-third NN Surgical
of IN Surgical
the DT Surgical
total JJ Surgical
length NN Surgical
of IN Surgical
the DT Surgical
bone NN Surgical
was VBD Surgical
removed VBN Surgical
-DOCSTART- -X- N

Symptomatic JJ Physical
treatment NN Physical
combination NN Pharmocological
chemotherapy NN Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
cisplatin NN Pharmocological
etoposide VB Pharmocological
symptomatic JJ Physical
treatment NN Physical
. . None
-DOCSTART- -X- N

Recombinant NNP Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
administered VBN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NN Pharmocological
Radioiodine NNP Pharmocological
WBS NNP Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
administration NN Pharmocological
thyroid JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
thyroid JJ Pharmocological
hormone NN Pharmocological
withdrawal NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
administration NN Pharmocological
-DOCSTART- -X- N

olanzapine NN Pharmocological
haloperidol NN Pharmocological
olanzapine NN Pharmocological
haloperidol NN Pharmocological
-DOCSTART- -X- N

two CD Physical
different JJ Physical
testosterone NN Physical
undecanoate JJ Physical
formulations NNS Physical
two CD Physical
different JJ Physical
preparations NNS Physical
of IN Physical
testosterone NN Physical
undecanoate NN Physical
( ( Physical
TU NNP Physical
) ) Physical
transdermal JJ Control
placebo NN Control
gel NN Control
TU NNP Pharmocological
] NNP None
oral JJ Pharmocological
TU NNP Pharmocological
P NNP Control
im JJ Pharmocological
TU NNP Pharmocological
TU NNP Pharmocological
im JJ Pharmocological
TU NNP Pharmocological
TU NNP Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

diclofenac NN Pharmocological
versus NN None
paracetamol NN Pharmocological
and CC None
placebo NN Control
diclofenac-K NN Pharmocological
paracetamol NN Pharmocological
placebo VB Control
placebo-controlled JJ Control
diclofenac-K NN Pharmocological
( ( Pharmocological
12.5 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
tablets VBZ Pharmocological
vs JJ Pharmocological
paracetamol NN Pharmocological
placebo NN Control
diclofenac-K NN Pharmocological
paracetamol NN Pharmocological
placebo JJ Control
diclofenac-K NN Pharmocological
placebo VB Control
paracetamol VB Pharmocological
placebo NN Control
. . None
placebo NN Control
. . None
diclofenac-K NN Pharmocological
paracetamol NN Pharmocological
-DOCSTART- -X- N

nicotine JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
NRT NNP Pharmocological
) ) Pharmocological
NRT NNP Pharmocological
NRT NNP Pharmocological
. . None
NRT NNP Pharmocological
. . None
NRT NNP Pharmocological
NRT NNP Pharmocological
. . None
NRT NNP Pharmocological
-DOCSTART- -X- N

individual VBP Psychological
diet JJ Psychological
and CC Psychological
anti-smoking JJ Psychological
counselling NN Psychological
-DOCSTART- -X- N

spinal JJ Pharmocological
anesthesia NN Pharmocological
light NN Other
deep JJ Other
sedation NN Pharmocological
light NN Pharmocological
deep JJ Pharmocological
sedation NN Pharmocological
spinal JJ Pharmocological
anesthesia NN Pharmocological
. . None
-DOCSTART- -X- N

aripiprazole NN Pharmocological
aripiprazole JJ Pharmocological
placebo NN Control
placebo-controlled JJ Control
aripiprazole NN Pharmocological
continue VB None
aripiprazole NN None
or CC None
switch VB None
to TO None
placebo VB None
. . None
aripiprazole NN None
and CC None
placebo NN None
was VBD None
for IN None
placebo NN None
( ( None
between IN None
aripiprazole NN None
and CC None
placebo NN None
in IN None
-DOCSTART- -X- N

interferon VB Pharmocological
. . None
alpha-interferon NN Pharmocological
-DOCSTART- -X- N

zidovudine NN Pharmocological
and CC Pharmocological
zalcitabine NN Pharmocological
placebo NN Control
zidovudine NN Pharmocological
zalcitabine NN Pharmocological
ZDV NNP Pharmocological
ddC VB Pharmocological
SH NNP Pharmocological
a DT Pharmocological
combination NN Pharmocological
of IN Pharmocological
ZDV NNP Pharmocological
200 CD Pharmocological
mg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
, , Pharmocological
ddC VB Pharmocological
0.75 CD Pharmocological
mg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
, , Pharmocological
and CC Pharmocological
placebo VBZ Control
SH NNP Pharmocological
SH NNP Pharmocological
-DOCSTART- -X- N

Herpes NNP Pharmocological
simplex JJ Pharmocological
virus NN Pharmocological
vaccine NN Pharmocological
antiherpetic JJ Pharmocological
vaccine NN Pharmocological
specific JJ Pharmocological
vaccination NN Pharmocological
with IN Pharmocological
heat NN Pharmocological
shock-inactivated JJ Pharmocological
herpes NNS Pharmocological
simplex JJ Pharmocological
virus NN Pharmocological
type NN Pharmocological
1 CD Pharmocological
observed VBN None
as IN None
controls NNS Control
vaccination NN Pharmocological
-DOCSTART- -X- N

arteriovenous JJ Physical
extracorporeal NN Physical
lung NN Physical
assist NN Physical
and CC None
high-frequency NN Physical
oscillatory NN Physical
ventilation NN Physical
arteriovenous JJ Physical
extracorporeal NN Physical
lung NN Physical
assist NN Physical
( ( Physical
AV-ECLA NNP Physical
) ) Physical
and CC None
high-frequency JJ Physical
oscillatory NN Physical
ventilation NN Physical
( ( Physical
HFOV NNP Physical
) ) Physical
Saline NNP Physical
lung NN Physical
lavage NN Physical
pressure-controlled JJ Physical
ventilation NN Physical
( ( Physical
PCV NNP Physical
) ) Physical
PCV NNP Physical
AV-ECLA NNP Physical
; : Surgical
HFOV NNP Physical
; : None
HFOV NNP Physical
and CC Physical
AV-ECLA NNP Physical
. . None
AV-ECLA NNP Physical
AV-ECLA-treated JJ Physical
AV-ECLA NNP Physical
AV-ECLA NNP Physical
and CC None
HFOV NNP Physical
-DOCSTART- -X- N

lipoproteins NNS Pharmocological
lipoprotein JJ Pharmocological
subfractions NNS Pharmocological
high-density NN Pharmocological
lipoprotein NN Pharmocological
low-density NN Pharmocological
lipoprotein NN Pharmocological
lipoprotein JJ Pharmocological
subfractions NNS Pharmocological
lipoprotein JJ Physical
subfractions NNS Physical
. . None
subfractions NNS Physical
( ( None
L1 NNP Pharmocological
) ) None
L1 NNP Physical
lipoprotein JJ Physical
subfractions NNS Physical
-DOCSTART- -X- N

spiritually RB Educational
based VBN Educational
and CC Educational
non-spiritually RB Educational
based VBN Educational
educational JJ Educational
intervention NN Educational
Health NNP Educational
communication NN Educational
interventions NNS Educational
spiritually RB Educational
based VBN Educational
or CC Educational
the DT Educational
non-spiritual JJ Educational
intervention NN Educational
. . None
educational JJ Educational
session NN Educational
distributed VBD Educational
educational JJ Educational
print NN Educational
materials NNS Educational
. . Educational
-DOCSTART- -X- N

Oat NNP Other
ingestion NN Other
soluble JJ Other
fiber-rich JJ Other
whole JJ Other
oat NN Other
cereals NNS Other
oat NN Pharmocological
cereal NN Pharmocological
group NN Pharmocological
( ( Pharmocological
standardized VBN Pharmocological
to TO Pharmocological
5.52 CD Pharmocological
g/day JJ Pharmocological
beta-glucan JJ Pharmocological
) ) Pharmocological
to TO None
a DT Pharmocological
low-fiber JJ Pharmocological
cereal NN Pharmocological
control NN Pharmocological
group NN Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
1.0 CD Pharmocological
g/day JJ Pharmocological
total JJ Pharmocological
fiber NN Pharmocological
) ) Pharmocological
over IN None
6 CD None
weeks NNS None
. . None
oat NN Pharmocological
cereals NNS Pharmocological
Soluble JJ Pharmocological
fiber-rich JJ Pharmocological
whole JJ Pharmocological
oats NNS Pharmocological
-DOCSTART- -X- N

Accumulated VBN Physical
brisk JJ Physical
walking NN Physical
days/week NN None
) ) None
brisk NN None
walking NN None
current JJ None
physical JJ None
activity NN None
-DOCSTART- -X- N

Stapled JJ None
mucosectomy NN None
conventional JJ None
haemorrhoidectomy NN None
. . None
Stapled NNP Surgical
mucosectomy NN Surgical
conventional JJ Physical
haemorrhoidectomy NN Physical
conventional JJ Surgical
procedure NN Surgical
conventional JJ Physical
Milligan-Morgan JJ Physical
haemorrhoidectomy NN Physical
and CC Physical
stapled VBD Physical
mucosectomy NN Physical
stapled VBN Educational
group NN Educational
conventional JJ Educational
group NN Educational
stapled VBN None
group NN None
Stapled VBD None
mucosectomy NN None
conventional JJ None
procedure NN None
. . None
-DOCSTART- -X- N

CBT NNP Pharmocological
CBT NNP None
CBT-group NNP Pharmocological
participated VBN Educational
in IN Educational
psychoeducation NN Educational
. . None
Children NNP Control
were VBD Control
randomly RB Control
assigned VBN Control
to TO Control
an DT Control
experimental JJ Control
or CC Control
delayed-treatment JJ Control
control NN Control
group NN Control
. . None
CBT NNP Pharmocological
-DOCSTART- -X- N

palatal JJ Surgical
operations NNS Surgical
2 CD Surgical
palatal JJ Surgical
surgical JJ Surgical
procedures NNS Surgical
radiofrequency NN Surgical
ablation NN Surgical
of IN Surgical
the DT Surgical
palate NN Surgical
( ( Surgical
RFAP NNP Surgical
) ) Surgical
for IN Surgical
a DT Surgical
planned JJ Surgical
3-stage JJ Surgical
treatment NN Surgical
or CC None
laser-assisted JJ Surgical
uvulopalatoplasty JJ Surgical
( ( Surgical
LAUP NNP Surgical
) ) Surgical
, , Surgical
also RB Surgical
for IN Surgical
3 CD Surgical
stages NNS Surgical
of IN Surgical
treatment NN Surgical
, , Surgical
using VBG Surgical
a DT Surgical
CO NNP Surgical
( ( Surgical
2 CD Surgical
) ) Surgical
laser NN Surgical
. . Physical
alternative JJ Surgical
surgical JJ Surgical
therapy NN Surgical
for IN Surgical
attempted JJ Surgical
salvage NN Surgical
. . None
RFAP NNP Physical
LAUP NNP Surgical
RFAP NNP Surgical
LAUP NNP Surgical
. . None
LAUP NNP Surgical
nasal JJ Surgical
surgery NN Surgical
. . None
RFA NNP Surgical
. . None
LAUP NNP Surgical
RFAP NNP Surgical
-DOCSTART- -X- N

two-filter JJ Other
model NN Other
two-filter JJ Other
model NN Other
six CD Other
frequencies NNS Other
( ( Other
from IN Other
0.25 CD Other
to TO Other
8 CD Other
kHz NN Other
) ) Other
-DOCSTART- -X- N

standard NN Educational
wound NN Educational
care NN Educational
adjunctive JJ Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
( ( Physical
HBOT NNP Physical
) ) Physical
adjunctive JJ Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
plus CC Physical
standard NN Physical
wound NN Physical
care NN Physical
standard NN Physical
wound NN Physical
care NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
ongoing VBG Educational
wound NN Educational
care NN Educational
hyperbaric JJ None
oxygen NN None
therapy NN None
hyperbaric JJ None
oxygen NN None
therapy NN None
-DOCSTART- -X- N

antimicrobial JJ Pharmocological
additive NN Pharmocological
an DT Pharmocological
antimicrobial JJ Pharmocological
additive NN Pharmocological
( ( None
Microban NNP Pharmocological
) ) None
antimicrobial JJ Pharmocological
additive NN Pharmocological
-DOCSTART- -X- N

prepackaged VBN Pharmocological
, , Pharmocological
low JJ Pharmocological
residual JJ Pharmocological
test NN Pharmocological
meals NNS Pharmocological
with IN Pharmocological
4L CD Pharmocological
polyethylene NN Pharmocological
glycol NN Pharmocological
versus IN None
a DT None
clear JJ Pharmocological
liquid NN Pharmocological
diet NN Pharmocological
with IN Pharmocological
4L CD Pharmocological
polyethylene NN Pharmocological
glycol NN Pharmocological
bowel NN Pharmocological
preparation NN Pharmocological
: : None
low JJ Pharmocological
residue JJ Pharmocological
diet NN Pharmocological
4L CD Pharmocological
polyethylene NN Pharmocological
glycol NN Pharmocological
( ( Pharmocological
PEG NNP Pharmocological
) ) Pharmocological
solution NN Pharmocological
traditional JJ Pharmocological
liquid NN Pharmocological
diet NN Pharmocological
and CC Pharmocological
the DT Pharmocological
PEG NNP Pharmocological
4L CD Pharmocological
lavage NN Pharmocological
. . None
clear JJ Pharmocological
liquid NN Pharmocological
diet NN Pharmocological
and CC Pharmocological
the DT Pharmocological
PEG NNP Pharmocological
4L CD Pharmocological
regimen NNS Pharmocological
low JJ Pharmocological
residue JJ Pharmocological
test NN Pharmocological
meals NNS Pharmocological
and CC Pharmocological
the DT Pharmocological
PEG NNP Pharmocological
4L CD Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
TM-PEG JJ Pharmocological
-DOCSTART- -X- N

80-kilovoltage NN Physical
( ( Physical
kV NN Physical
) ) Physical
tube NN Physical
voltage NN Physical
coronary JJ Physical
computed VBD Physical
tomographic JJ Physical
angiography NN Physical
( ( Physical
CCTA NNP Physical
) ) Physical
[ VBD Educational
standard-tube JJ Educational
voltage NN Educational
( ( Educational
120-kV JJ Educational
) ) Educational
vs. FW None
low-tube JJ Physical
voltage NN Physical
( ( Physical
80-kV JJ Physical
) ) Physical
] NN Physical
80-kV JJ None
The DT None
80-kV JJ None
protocol NN None
-DOCSTART- -X- N

erythromycin NN Pharmocological
erythromycin JJ Pharmocological
erythromycin JJ Pharmocological
250 CD None
mg RB None
four CD None
times NNS None
daily RB None
for IN None
10 CD None
days NNS None
or CC None
an DT None
identical-appearing JJ None
placebo NN None
. . None
erythromycin NN Pharmocological
placebo-treated JJ Control
erythromycin NN Pharmocological
placebo NN Control
erythromycin VB Pharmocological
Erythromycin NNP Pharmocological
-DOCSTART- -X- N

granulocyte JJ None
colony-stimulating JJ None
factor NN None
G-CSF NNP Pharmocological
PBSCT NNP Pharmocological
) ) None
control NN Control
group NN Control
high-dose JJ Pharmocological
regimens NNS Pharmocological
without IN Pharmocological
total JJ Pharmocological
body NN Pharmocological
irradiation NN Pharmocological
consisted VBD Pharmocological
of IN Pharmocological
the DT Pharmocological
MCVAC NNP Pharmocological
regimen NNS Pharmocological
using VBG Pharmocological
ranimustine NN Pharmocological
( ( Pharmocological
MCNU NNP Pharmocological
, , Pharmocological
450 CD Pharmocological
mg/m2 NN Pharmocological
) ) Pharmocological
, , Pharmocological
cytosine JJ Pharmocological
arabinoside NN Pharmocological
( ( Pharmocological
16 CD Pharmocological
g/m2 NN Pharmocological
) ) Pharmocological
, , Pharmocological
etoposide RB Pharmocological
( ( Pharmocological
1.6 CD Pharmocological
g/m2 NN Pharmocological
) ) Pharmocological
, , Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
Hi-MEC NNP Pharmocological
regimen NNS Pharmocological
using VBG Pharmocological
melphalan NN Pharmocological
etoposide RB Pharmocological
carboplatinum NN Pharmocological
-DOCSTART- -X- N

radiation NN Physical
breast NN Control
conserving NN Control
treatment NN Control
: : None
boost NN Physical
radiation NN Physical
breast NN Physical
conservative JJ Physical
therapy NN Physical
( ( Physical
BCT NNP Physical
) ) Physical
boost NN Physical
boost NN Physical
boost NN Physical
boost NN Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
lornoxicam NN Pharmocological
and CC None
aspirin NN Pharmocological
lornoxicam NN Pharmocological
lornoxicam NN Pharmocological
aspirin JJ Pharmocological
650 CD Pharmocological
placebo NN Control
. . None
Lornoxicam NNP Pharmocological
lornoxicam NN Pharmocological
aspirin VB Pharmocological
-DOCSTART- -X- N

one-time JJ Educational
e-mail JJ Educational
reminder NN Educational
highlighting VBG Educational
six CD Educational
HF-specific JJ Educational
clinical JJ Educational
recommendations NNS Educational
. . None
initial JJ Educational
e-mail JJ Educational
reminder NN Educational
supplemented VBN Educational
by IN Educational
provider NN Educational
prompts NNS Educational
, , Educational
patient JJ Educational
education NN Educational
material NN Educational
, , Educational
and CC Educational
clinical JJ Educational
nurse NN Educational
specialist NN Educational
outreach NN Educational
. . None
-DOCSTART- -X- N

neurohormones NNS None
-DOCSTART- -X- N

panitumumab NN Pharmocological
( ( Pharmocological
Vectibix NNP Pharmocological
) ) Pharmocological
panitumumab VB Pharmocological
( ( Pharmocological
Vectibix NNP Pharmocological
; : Pharmocological
panitumumab JJ Pharmocological
chemotherapy NN Pharmocological
and CC None
bevacizumab NN Pharmocological
with IN Pharmocological
and CC Pharmocological
without IN Pharmocological
panitumumab NN Pharmocological
bevacizumab NN Pharmocological
and CC Pharmocological
chemotherapy NN Pharmocological
panitumumab NN Pharmocological
panitumumab-treated JJ Pharmocological
panitumumab NN Pharmocological
to TO Pharmocological
bevacizumab VB Pharmocological
and CC Pharmocological
chemotherapy VB Pharmocological
bevacizumab NN Pharmocological
and CC Pharmocological
chemotherapy NN Pharmocological
alone RB Pharmocological
. . None
panitumumab NN Pharmocological
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
morphine JJ Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

estrogens NNS Pharmocological
at IN None
different JJ None
times NNS None
of IN None
the DT None
day NN None
conjugated VBN Pharmocological
equine JJ Pharmocological
estrogens NNS Pharmocological
conjugated JJ Pharmocological
equine NN Pharmocological
estrogens NNS Pharmocological
-DOCSTART- -X- N

DMSA NNP Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
dimercapto NN Pharmocological
succinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DMSA NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
DMSA NNP Pharmocological
DMSA NNP Pharmocological
-DOCSTART- -X- N

racemic JJ Pharmocological
epinephrine NN Pharmocological
Racemic NNP Pharmocological
epinephrine NN Pharmocological
saline NN Pharmocological
or CC Pharmocological
racemic JJ Pharmocological
epinephrine NN Pharmocological
racemic JJ Pharmocological
epinephrine NN Pharmocological
Racemic NNP Pharmocological
epinephrine NN Pharmocological
racemic JJ Pharmocological
epinephrine NN Pharmocological
-DOCSTART- -X- N

Profile NNP Educational
of IN Educational
Mood NNP Educational
States NNPS Educational
( ( Educational
POMS NNP Educational
) ) Educational
questionnaire NN Educational
. . None
-DOCSTART- -X- N

capecitabine JJ Pharmocological
plus CC None
docetaxel JJ Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
Docetaxel NNP Pharmocological
and CC None
capecitabine NN Pharmocological
capecitabine/docetaxel JJ Pharmocological
therapy NN Pharmocological
single-agent JJ Pharmocological
docetaxel NN Pharmocological
capecitabine NN Pharmocological
docetaxel JJ Pharmocological
docetaxel VB Pharmocological
Capecitabine/docetaxel NNP Pharmocological
docetaxel NN Pharmocological
. . None
combination NN Pharmocological
therapy NN Pharmocological
single-agent JJ Pharmocological
docetaxel NN Pharmocological
. . None
combination NN None
therapy NN None
docetaxel NN Pharmocological
addition NN Pharmocological
of IN Pharmocological
capecitabine NN Pharmocological
to TO Pharmocological
docetaxel VB Pharmocological
combination NN None
single-agent JJ Pharmocological
docetaxel NN Pharmocological
Docetaxel/capecitabine NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Fondaparinux NNP Pharmocological
combined VBD Pharmocological
with IN Pharmocological
intermittent JJ Pharmocological
pneumatic JJ Pharmocological
compression NN Pharmocological
intermittent JJ Physical
pneumatic JJ Physical
compression NN Physical
alone RB Physical
fondaparinux NN Pharmocological
in IN Pharmocological
conjunction NN Pharmocological
with IN Pharmocological
intermittent JJ Pharmocological
pneumatic JJ Pharmocological
compression NN Pharmocological
intermittent JJ Physical
pneumatic JJ Physical
compression NN Physical
alone RB Physical
placebo-controlled JJ Control
fondaparinux JJ Pharmocological
placebo NN Control
intermittent JJ Physical
pneumatic JJ Physical
compression NN Physical
. . Physical
Fondaparinux NNP Pharmocological
fondaparinux-treated JJ Pharmocological
placebo-treated JJ Control
fondaparinux NN Pharmocological
placebo NN Control
, , Pharmocological
fondaparinux VBP Pharmocological
pneumatic JJ Physical
compression NN Physical
alone RB Physical
placebo VB Control
. . None
-DOCSTART- -X- N

reperfusion NN None
primary VB Physical
percutaneous JJ Physical
coronary JJ Physical
intervention NN Physical
streptokinase NN Pharmocological
. . None
Primary NNP Physical
percutaneous JJ Physical
coronary JJ Physical
intervention NN Physical
( ( Physical
PCI NNP Physical
) ) Physical
thrombolytic JJ Pharmocological
therapy NN Pharmocological
PCI NNP Physical
thrombolytic JJ Pharmocological
therapy NN Pharmocological
PCI NNP Physical
SK NNP Pharmocological
-DOCSTART- -X- N

azithromycin NN Pharmocological
Azithromycin NNP Pharmocological
azithromycin JJ Pharmocological
azithromycin VB Pharmocological
-DOCSTART- -X- N

Dietary NNP Pharmocological
lignan NN Pharmocological
and CC Pharmocological
proanthocyanidin NN Pharmocological
consumption NN Pharmocological
polyphenols NNS Pharmocological
lignan NN Pharmocological
and CC Pharmocological
proanthocyanidin JJ Pharmocological
intake NN Pharmocological
-DOCSTART- -X- N

haloperidol NN Pharmocological
placebo-controlled JJ Control
haloperidol NN Pharmocological
with IN None
placebo NN Control
-DOCSTART- -X- N

flecainide NN Pharmocological
placebo-controlled JJ Control
flecainide NN Pharmocological
or CC None
placebo VB Control
placebo NN Control
flecainide NN Pharmocological
. . None
flecainide NN Pharmocological
) ) None
flecainide NN Pharmocological
flecainide NN Pharmocological
-DOCSTART- -X- N

quinapril NN Pharmocological
and CC None
captopril NN Pharmocological
diuretic JJ Physical
therapy NN Physical
quinapril NN Pharmocological
captopril NN Pharmocological
diuretic JJ Pharmocological
therapy NN Pharmocological
quinapril NN Pharmocological
captopril NN Pharmocological
quinapril VB Pharmocological
captopril VB Pharmocological
. . None
quinapril NN Pharmocological
captopril NN Pharmocological
) ) None
quinapril NN Pharmocological
. . None
quinapril NN Pharmocological
captopril NN Pharmocological
-DOCSTART- -X- N

interleukin-2 NN Pharmocological
( ( Pharmocological
IS-IL-2 NNP Pharmocological
) ) Pharmocological
continuous JJ None
infusion NN None
with IN None
low JJ Pharmocological
dose JJ Pharmocological
recombinant NN Pharmocological
of IN Pharmocological
IL-2 NNP Pharmocological
-DOCSTART- -X- N

Endoscopic NNP Pharmocological
injection NN Pharmocological
sclerotherapy NN Pharmocological
( ( Pharmocological
EIS NNP Pharmocological
) ) Pharmocological
and CC None
endoscopic $ Surgical
variceal JJ Surgical
ligation NN Surgical
( ( Surgical
EVL NNP Surgical
) ) Surgical
EIS NNP Pharmocological
EVL NNP Surgical
. . None
EIS NNP Pharmocological
-DOCSTART- -X- N

systemic JJ Pharmocological
penicillin NN Pharmocological
penicillin NN Pharmocological
received VBD None
a DT None
7-day JJ None
oral JJ None
dose NN None
( ( None
28 CD None
capsules NNS None
, , None
500 CD None
mg NN None
each DT None
, , None
to TO None
be VB None
taken VBN None
every DT None
6 CD None
hours NNS None
) ) None
of IN None
either DT None
penicillin NN Pharmocological
or CC None
a DT None
placebo NN Control
control NN None
in IN None
a DT None
double-blind JJ None
manner NN None
. . None
ibuprofen NNS Pharmocological
; : None
acetaminophen VBZ Pharmocological
with IN Pharmocological
codeine NN Pharmocological
( ( None
30 CD None
mg NN None
) ) None
; : None
and CC None
a DT None
penicillin NN Pharmocological
-DOCSTART- -X- N

Routine NNP Pharmocological
antibiotic JJ Pharmocological
use NN Pharmocological
routine JJ Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
routine JJ Pharmocological
antibiotics NNS Pharmocological
control NN Control
group NN Control
( ( None
no DT Pharmocological
antibiotics NNS Pharmocological
unless IN None
clinically RB None
indicated VBN None
) ) None
. . None
antibiotic JJ Pharmocological
-DOCSTART- -X- N

high JJ Pharmocological
protein NN Pharmocological
, , Pharmocological
low JJ Pharmocological
carbohydrate NN Pharmocological
diet NN Pharmocological
carbohydrate NN Pharmocological
restricted VBN Pharmocological
versus IN Pharmocological
a DT Pharmocological
low JJ Pharmocological
fat NN Pharmocological
diet NN Pharmocological
diets NNS None
: : None
a DT None
high JJ Other
protein NN Other
, , Other
low JJ Other
carbohydrate NN Other
( ( Other
20 CD Other
g/d NN Other
) ) Other
diet NN Other
( ( Other
high JJ Other
protein NN Other
, , Other
low JJ Other
carbohydrate NN Other
, , Other
HPLC NNP Other
) ) Other
or CC None
low JJ Physical
fat NN Physical
( ( Physical
30 CD Physical
% NN Physical
of IN Physical
calories NNS Physical
) ) Physical
regimen VBP Physical
for IN None
13 CD None
weeks NNS None
; : None
HPLC NNP Pharmocological
-DOCSTART- -X- N

Alpha NNP Pharmocological
interferon NN Pharmocological
placebo-controlled JJ Control
alpha-2 JJ Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
Human NNP Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
receptor NN Pharmocological
2 CD Pharmocological
chemotherapy NN Pharmocological
anti-HER2 JJ Pharmocological
therapy NN Pharmocological
local JJ None
and CC None
central JJ None
evaluation NN None
using VBG None
immunohistochemistry NN Physical
combined VBN None
with IN None
in IN Physical
situ-hybridization NN Physical
evaluation NN None
of IN None
using VBG None
kinetic JJ Physical
RT-PCR JJ Physical
from IN None
formalin-fixed JJ None
, , None
paraffin-embedded JJ None
( ( None
FFPE NNP None
) ) None
tissue NN None
samples NNS None
-DOCSTART- -X- N

with IN Physical
technetium-99m JJ Physical
methoxyisobutylisonitrile NN Physical
single JJ Physical
photon NN Physical
emission NN Physical
computed VBD Physical
tomography NN Physical
and CC None
computed VBD Physical
tomography NN Physical
: : None
18-fluoro-2-deoxyglucose JJ Physical
positron NN Physical
emission NN Physical
tomography NN Physical
. . Physical
technetium-99m JJ Physical
methoxyisobutylisonitrile NN Physical
( ( Physical
Tc-MIBI NNP Physical
) ) Physical
single JJ Physical
photon NN Physical
emission NN Physical
computed VBN Physical
tomography NN Physical
( ( Physical
SPECT NNP Physical
) ) Physical
and CC None
computed VBN Physical
tomography NN Physical
( ( Physical
CT NNP Physical
) ) Physical
radiotherapy NN Physical
positron NN Physical
emission NN Physical
tomography NN Physical
( ( Physical
PET NNP Physical
) ) Physical
with IN Physical
18-fluoro-2-deoxyglucose JJ Physical
( ( Physical
FDG NNP Physical
) ) Physical
. . None
FDG-PET NNP Physical
FDG-PET NNP Physical
CT NNP Physical
and CC None
Tc-MIBI NNP Physical
SPECT NNP Physical
FDG-PET NNP Physical
. . None
-DOCSTART- -X- N

exogenous JJ Physical
subclinical JJ Physical
hyperthyroidism NN Physical
two-dimensional JJ Physical
speckle NN Physical
tracking VBG Physical
echocardiography NN Physical
imaging NN Physical
( ( Physical
2D-STE JJ Physical
) ) Physical
TSH-suppressive JJ Pharmocological
l-T NN Pharmocological
( ( Pharmocological
4 CD Pharmocological
) ) Pharmocological
substitution NN Pharmocological
restoration NN Pharmocological
of IN Pharmocological
euthyroidism NN Pharmocological
. . None
Prolonged NNP Physical
subclinical JJ Physical
hyperthyroidism NN Physical
-DOCSTART- -X- N

saliva VB Physical
salivary JJ Physical
erosive JJ Physical
challenges NNS Physical
salivary JJ Physical
-DOCSTART- -X- N

Placebo-controlled JJ Control
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide IN Pharmocological
whitening VBG Pharmocological
strips NNS Pharmocological
. . None
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide IN Pharmocological
whitening VBG Pharmocological
strips NNS Pharmocological
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide JJ Pharmocological
strips NNS Pharmocological
or CC Pharmocological
placebo VB Pharmocological
strips NNS Pharmocological
. . Pharmocological
6 CD Pharmocological
% NN Pharmocological
strip NN Pharmocological
placebo NN Control
6 CD Pharmocological
% NN Pharmocological
strip NN Pharmocological
placebo NN Control
strip NN Control
6 CD Pharmocological
% NN Pharmocological
strip NN Pharmocological
placebo NN Control
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide IN Pharmocological
whitening VBG Pharmocological
strips NNS Pharmocological
placebo JJ Control
strips NNS Control
. . None
-DOCSTART- -X- N

calcineurin NN Pharmocological
inhibitors NNS Pharmocological
and CC None
everolimus JJ Pharmocological
monotherapy NN Pharmocological
early JJ None
withdrawal NN None
of IN None
cyclosporine NN Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
followed VBN None
by IN None
the DT None
initiation NN None
of IN None
everolimus NN Pharmocological
( ( Pharmocological
Evr NNP Pharmocological
) ) Pharmocological
monotherapy NN Pharmocological
CsA NNP Pharmocological
Evr NNP Pharmocological
in IN None
combination NN None
with IN Pharmocological
CsA NNP Pharmocological
Evr NNP Control
monotherapy NN Control
( ( Control
Evr NNP Control
group NN Control
) ) Control
CsA NNP Pharmocological
with/without NN None
mycophenolate NN Pharmocological
mofetil NN Pharmocological
( ( None
CsA NNP None
group NN None
) ) None
( ( None
Evr NNP Pharmocological
CsA NNP Pharmocological
Evr NNP Pharmocological
CsA NNP Pharmocological
Evr NNP Pharmocological
CsA NNP None
withdrawal NN None
of IN None
CsA NNP None
followed VBN None
by IN None
Evr NNP None
-DOCSTART- -X- N

heparinized VBN Pharmocological
and CC Pharmocological
nonheparinized JJ Pharmocological
solutions NNS Pharmocological
heparinized VBN Pharmocological
and CC Pharmocological
nonheparinized VBN Pharmocological
infusions NNS Pharmocological
2 CD None
groups NNS None
to TO None
receive VB None
heparinized VBN Pharmocological
( ( None
group NN None
H NNP None
, , None
n JJ None
= NNP None
100 CD None
) ) None
or CC None
nonheparinized VBN Pharmocological
( ( None
group NN None
S NNP None
, , None
n JJ None
= NNP None
100 CD None
) ) None
flush NN Pharmocological
solutions NNS Pharmocological
. . None
were VBD Physical
assessed VBN Physical
using VBG Physical
before IN Physical
, , Physical
just RB Physical
after IN Physical
, , Physical
and CC Physical
24 CD Physical
h NN Physical
after IN Physical
by IN Physical
the DT Physical
same JJ Physical
investigator NN Physical
. . Physical
heparinized VBN Pharmocological
and CC Pharmocological
nonheparinized VBN Pharmocological
flush JJ Pharmocological
solutions NNS Pharmocological
-DOCSTART- -X- N

Concurrent NNP Pharmocological
doxorubicin NN Pharmocological
plus CC Pharmocological
docetaxel NN Pharmocological
concurrent NN Pharmocological
doxorubicin NN Pharmocological
plus CC Pharmocological
cyclophosphamide NN Pharmocological
doxorubicin NN Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
AC NNP Pharmocological
) ) Pharmocological
Doxorubicin NNP Pharmocological
and CC Pharmocological
docetaxel NN Pharmocological
( ( Pharmocological
AT NNP Pharmocological
) ) Pharmocological
doxorubicin NN Pharmocological
plus CC Pharmocological
either DT Pharmocological
cyclophosphamide NN Pharmocological
or CC Pharmocological
docetaxel NN Pharmocological
AC NNP Pharmocological
AT NNP Pharmocological
-DOCSTART- -X- N

hemi-body JJ Physical
irradiation NN Physical
recombinant NN Pharmocological
alpha VBD Pharmocological
2b CD Pharmocological
interferon NN Pharmocological
alpha-2b JJ Pharmocological
interferon NN Pharmocological
maintenance NN Pharmocological
. . None
single JJ Physical
hemi-body JJ Physical
irradiation NN Physical
alone RB Physical
persistent JJ None
cytopoenias NN None
interferon NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

losartan NN Pharmocological
and CC Pharmocological
enalapril NN Pharmocological
enalapril NN Pharmocological
( ( Pharmocological
E NNP Pharmocological
) ) Pharmocological
and/or NN Pharmocological
losartan NN Pharmocological
E NNP Pharmocological
L NNP Pharmocological
E NNP Pharmocological
+ NNP Pharmocological
L NNP Pharmocological
E NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
L NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
, , Pharmocological
L NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
E NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
glucose NN Pharmocological
control NN Pharmocological
protocol NN Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
. . None
intensive JJ Pharmocological
glucose NNS Pharmocological
control NN Pharmocological
group NN Pharmocological
continuous JJ Pharmocological
insulin NN Pharmocological
infusion NN Pharmocological
conventional JJ Pharmocological
treatment NN Pharmocological
group NN Pharmocological
insulin NN Pharmocological
insulin JJ Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
control NN None
group NN None
conventional JJ Pharmocological
therapy NN Pharmocological
group NN None
conventional JJ Pharmocological
and CC None
intensive JJ Pharmocological
therapy NN Pharmocological
groups NNS None
conventional JJ Pharmocological
and CC None
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ None
insulin NN None
therapy NN None
conventional JJ Pharmocological
therapy NN Pharmocological
Intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

endocervical JJ Physical
sampling VBG Physical
endocervical JJ Physical
sampling NN Physical
endocervical JJ Physical
sampling NN Physical
. . None
endocervical JJ Physical
sampling VBG Physical
with IN Physical
the DT Physical
Kevorkian NNP Physical
curette NN Physical
sampling VBG Physical
with IN Physical
the DT Physical
Medscand NNP Physical
endocervical JJ Physical
brush NN Physical
. . None
Endocervical NNP Physical
sampling VBG Physical
-DOCSTART- -X- N

Corticosteroids NNP Pharmocological
plus CC Pharmocological
pulse JJ Pharmocological
cyclophosphamide NN Pharmocological
and CC Pharmocological
plasma NN Pharmocological
exchanges NNS Pharmocological
corticosteroids NNS Pharmocological
plus CC Pharmocological
pulse JJ Pharmocological
cyclophosphamide NN Pharmocological
alone RB Pharmocological
prednisone NN Pharmocological
, , Pharmocological
cyclophosphamide NN Pharmocological
plasma NN Pharmocological
exchanges NNS Pharmocological
prednisone NN Pharmocological
cyclophosphamide VB Pharmocological
-DOCSTART- -X- N

laparoscopy NN Physical
open JJ Surgical
appendicectomy NN Surgical
laparoscopy VBN Physical
, , None
followed VBN None
by IN None
open JJ Surgical
appendicectomy NN Surgical
-DOCSTART- -X- N

streptokinase-mediated JJ Pharmocological
fibrinolysis NN Pharmocological
; : None
intravenous JJ Pharmocological
heparin NNS Pharmocological
by IN Pharmocological
infusion NN Pharmocological
. . Pharmocological
heparin NN Pharmocological
Heparin NNP Pharmocological
-DOCSTART- -X- N

Tetrahydrobiopterin NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
tetrahydrobiopterin JJ Pharmocological
placebo NN Control
. . None
tetrahydrobiopterin NN Pharmocological
-DOCSTART- -X- N

Probiotics NNS Pharmocological
probiotic-supplemented JJ Pharmocological
, , None
Bifidobacterium NNP Pharmocological
lactis VBZ Pharmocological
Bb-12 NNP Pharmocological
or CC None
Lactobacillus NNP Pharmocological
strain VBP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
ATCC NNP Pharmocological
53103 CD Pharmocological
) ) Pharmocological
, , Pharmocological
extensively RB Pharmocological
hydrolysed VBD Pharmocological
whey JJ Pharmocological
formulas NNS Pharmocological
or CC None
to TO None
the DT None
same JJ Control
formula NN Control
without IN Control
probiotics NNS Control
. . None
-DOCSTART- -X- N

placebo NN Control
N-Acetylcysteine NNP Pharmocological
added VBD None
to TO None
risperidone VB Pharmocological
N-acetylcysteine NNP Pharmocological
( ( Pharmocological
NAC NNP Pharmocological
) ) Pharmocological
NAC NNP None
( ( None
1200 CD None
mg/day NN None
) ) None
+risperidone NN None
or CC None
placebo+risperidone NN None
. . None
NAC NNP None
and CC None
placebo NN None
were VBD None
the DT None
NAC+risperidone NNP None
and CC None
placebo+risperidone NN Control
groups NNS None
the DT None
NAC+risperidone NNP None
group NN None
CONCLUSIONS NNP None
Risperidone NNP None
plus CC None
NAC NNP None
more JJR None
and CC None
NAC NNP None
was VBD None
-DOCSTART- -X- N

marine NN Pharmocological
oils NNS Pharmocological
supplementation NN Pharmocological
oil NN Pharmocological
from IN Pharmocological
blubber NN Pharmocological
of IN Pharmocological
seal NN Pharmocological
, , Pharmocological
cod NN Pharmocological
liver NN Pharmocological
, , Pharmocological
seal/cod NN Pharmocological
liver NN Pharmocological
, , Physical
blubber NN Pharmocological
of IN Pharmocological
Minke NNP Pharmocological
whale NN Pharmocological
, , None
or CC None
no DT Control
oil NN Control
seal/cod NN Pharmocological
liver NN Pharmocological
oil NN Pharmocological
whale JJ Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

Physician-pharmacist JJ Educational
cooperation NN Educational
program NN Educational
cooperation NN Educational
between IN Educational
physician NN Educational
and CC Educational
pharmacist NN Educational
physician-pharmacist JJ Educational
intervention NN Educational
group NN Educational
control NN Control
group NN Control
-DOCSTART- -X- N

COMPASS NNP Educational
intervention NN Educational
-DOCSTART- -X- N

tegafur NN Pharmocological
uracil NN Pharmocological
tegafur NN Pharmocological
and CC Pharmocological
uracil NN Pharmocological
( ( Pharmocological
UFT NNP Pharmocological
) ) Pharmocological
no DT Control
chemotherapy NN Control
or CC Control
radiotherapy NN Control
. . None
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone VB Pharmocological
or CC None
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
-DOCSTART- -X- N

desflurane NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
ondansetron NNS Pharmocological
compared VBN None
with IN None
propofol NN Pharmocological
prophylactic JJ Pharmocological
ondansetron NN Pharmocological
to TO None
desflurane-based JJ Pharmocological
anesthesia NN Pharmocological
desflurane NN Control
anesthetic NN Control
( ( Control
placebo NN Control
) ) Control
or CC None
a DT None
propofol-infusion-based JJ Pharmocological
( ( Pharmocological
active JJ Pharmocological
control NN Pharmocological
) ) Pharmocological
anesthetic NN Pharmocological
. . None
ondansetron NN Pharmocological
) ) None
ondansetron NN Pharmocological
desflurane NN Pharmocological
desflurane-only JJ Pharmocological
desflurane NN Pharmocological
propofol NN Pharmocological
desflurane-only JJ Pharmocological
desflurane NN Pharmocological
-DOCSTART- -X- N

MRI NNP Physical
. . None
MRI NNP Physical
plain NN Physical
radiography NN Physical
MRI NNP Physical
core-decompression NN Physical
group NN None
or CC None
a DT None
conservatively-treated JJ Physical
group NN None
. . None
plain VBP Physical
radiography NN Physical
MRI NNP Physical
-DOCSTART- -X- N

2-chloroprocaine JJ Pharmocological
: : None
clonidine NN Pharmocological
. . None
2-chloroprocaine JJ Pharmocological
( ( Pharmocological
2-CP JJ Pharmocological
) ) Pharmocological
Clonidine NNP Pharmocological
2-CP JJ Pharmocological
. . None
clonidine NN Pharmocological
clonidine NN Pharmocological
Clonidine NNP Pharmocological
clonidine NN Pharmocological
-DOCSTART- -X- N

beta-blocker NN Pharmocological
usage NN Pharmocological
: : None
preoperative JJ None
?-blockers NNS None
preoperative JJ None
?-blocker NN None
use NN None
-DOCSTART- -X- N

Early RB Pharmocological
versus NN None
late JJ Physical
replacement NN Physical
of IN None
autotransfused JJ Pharmocological
blood NN Pharmocological
autologous JJ Pharmocological
blood NN Pharmocological
autologous JJ Pharmocological
autologous JJ Pharmocological
blood NN Pharmocological
reinfusion NN Pharmocological
in IN None
elective JJ None
spinal JJ Surgical
surgery NN Surgical
. . None
early JJ Pharmocological
versus NN None
delayed VBN Physical
reinfusion NN Physical
groups NNS Physical
early JJ Pharmocological
and CC None
delayed JJ Physical
reinfusion NN Physical
groups NNS None
. . None
early JJ Pharmocological
reinfusion NN Pharmocological
group NN Pharmocological
early JJ Pharmocological
versus NN None
delayed VBN Physical
reinfusion NN Physical
early JJ Pharmocological
reinfusion NN Pharmocological
-DOCSTART- -X- N

cyclosporin NN Pharmocological
A NNP Pharmocological
placebo VB Control
cyclosporin VB Pharmocological
A NNP Pharmocological
. . None
cyclosporin VBP Pharmocological
A DT Pharmocological
cyclosporin JJ Pharmocological
cyclosporin NN Pharmocological
A NNP Pharmocological
cyclosporin NN Pharmocological
A NNP Pharmocological
placebo NN Control
cyclosporin NN Pharmocological
A NNP Pharmocological
-DOCSTART- -X- N

prostaglandin NN Pharmocological
E1 NNP Pharmocological
placebo-controlled JJ Control
early JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
PGE1 NNP Pharmocological
( ( Pharmocological
PGE1 NNP Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
) ) None
-DOCSTART- -X- N

INCB13739 NNP Pharmocological
placebo-controlled JJ Control
INCB13739 NNP Pharmocological
doses NNS Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

insulin NN Pharmocological
1-2 JJ Pharmocological
units NNS Pharmocological
insulin/kg VBP Pharmocological
body NN Pharmocological
weight/24 JJ Pharmocological
h NN Pharmocological
with IN Pharmocological
their PRP$ Pharmocological
feed NN Pharmocological
received VBD Control
the DT Control
feed NN Control
only RB Control
. . None
15N-glycine JJ Pharmocological
insulin NN Pharmocological
insulin NN Pharmocological
insulin NN Pharmocological
insulin NN Pharmocological
. . None
insulin NN Pharmocological
. . None
insulin NN Pharmocological
-DOCSTART- -X- N

Classroom NNP Educational
intervention NN Educational
medical JJ Pharmocological
intervention NN Pharmocological
alone RB Pharmocological
behavioral JJ Educational
plus CC Educational
medical JJ Other
intervention NN Other
medical JJ Other
and CC Educational
behavioral JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

Combined-modality NNP Pharmocological
treatment NN Pharmocological
positron NN Physical
emission NN Physical
tomography NN Physical
( ( Physical
PET NNP Physical
) ) Physical
involved-node JJ Physical
radiotherapy NN Physical
( ( Physical
IN-RT NNP Physical
) ) Physical
( ( Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
bleomycin NN Pharmocological
, , Pharmocological
vinblastine NN Pharmocological
, , Pharmocological
and CC Pharmocological
dacarbazine NN Pharmocological
) ) Pharmocological
combined-modality NN Pharmocological
treatment NN Pharmocological
. . None
PET JJ Physical
scan JJ Physical
PET JJ Physical
scan JJ Physical
PET-negative JJ Physical
-DOCSTART- -X- N

Extra NNP Pharmocological
virgin NN Pharmocological
olive JJ Pharmocological
oil NN Pharmocological
( ( Pharmocological
EVOO NNP Pharmocological
) ) Pharmocological
EVOO NNP Pharmocological
polyphenol-rich JJ Pharmocological
EVOO NNP Pharmocological
with IN None
high JJ Pharmocological
oleuropein NNS Pharmocological
derivative JJ Pharmocological
contents NNS Pharmocological
. . None
control NN Control
group NN Control
( ( None
CG NNP None
) ) None
maintained VBD Educational
their PRP$ Educational
dietary JJ Other
habits NNS Other
olive JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
OG NNP Pharmocological
) ) Pharmocological
who WP None
consumed VBD None
EVOO NNP Pharmocological
EVOO NNP Physical
EVOO NNP Pharmocological
EVOO NNP Pharmocological
EVOO NNP Pharmocological
-DOCSTART- -X- N

allopurinol NN Pharmocological
Allopurinol NNP Pharmocological
Allopurinol NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
g NN Pharmocological
) ) Pharmocological
were VBD None
measured VBN None
before IN None
anesthesia NN None
in IN None
arterial JJ None
blood NN None
, , None
before IN None
cross-clamping JJ None
and CC None
1 CD None
and CC None
10 CD None
min NN None
after IN None
reperfusion NN None
in IN None
arterial JJ None
and CC None
coronary JJ None
sinus NN None
blood NN None
. . None
Levels NNS Educational
were VBD Educational
measured VBN Educational
as IN Educational
relative JJ Educational
concentrations NNS Educational
by IN Educational
the DT Educational
electron NN Educational
spin NN Educational
resonance NN Educational
method NN Educational
. . None
-DOCSTART- -X- N

Virtual NNP Educational
Dolphinarium NNP Educational
virtual JJ Educational
reality NN Educational
( ( Educational
VR NNP Educational
) ) Educational
technology NN Educational
applications NNS Educational
Dolphin-assisted JJ Psychological
therapy NN Psychological
Virtual NNP Educational
Dolphinarium NNP Educational
Immersive JJ Educational
visualization NN Educational
gesture-based JJ Educational
interaction NN Educational
the DT None
virtual JJ None
dolphin NN None
interaction NN None
. . None
-DOCSTART- -X- N

Fibrin NNP Pharmocological
application NN Pharmocological
fibrin JJ Pharmocological
glue NN Pharmocological
treated VBN Pharmocological
with IN Pharmocological
fibrin JJ Pharmocological
glue NN Pharmocological
or CC None
not RB Control
. . None
Serial JJ Physical
computed JJ Physical
tomography NN Physical
( ( Physical
CT NNP Physical
) ) Physical
scans NNS Physical
fibrin JJ Pharmocological
glue NN Pharmocological
-DOCSTART- -X- N

regular JJ Physical
health NN Physical
checks NNS Physical
to TO None
health NN Physical
checks NNS Physical
control NN Control
intervention NN None
health NN Physical
check NN Physical
which WDT Physical
included VBD Physical
being VBG Physical
screened VBN Physical
for IN Physical
cardiovascular JJ Physical
risk NN Physical
factors NNS Physical
, , Physical
lung NN Physical
and CC Physical
liver NN Physical
function NN Physical
, , Physical
fitness NN Physical
, , Physical
sight NN Physical
and CC Physical
hearing NN Physical
and CC Physical
an DT Physical
optional JJ Physical
test NN Physical
for IN Physical
the DT Physical
human JJ Physical
immunodeficiency NN Physical
virus NN Physical
( ( Physical
HIV NNP Physical
) ) Physical
; : Physical
this DT Physical
group NN Physical
received VBD Physical
written VBN Physical
feedback RB Physical
from IN Physical
the DT Physical
general JJ Physical
practitioner NN Physical
. . Physical
health NN Physical
check NN Physical
and CC Physical
written VBN Other
feedback NN Other
; : Physical
in IN Physical
addition NN Physical
, , Physical
they PRP Physical
were VBD Physical
given VBN Physical
the DT Physical
opportunity NN Physical
to TO Physical
attend VB Physical
their PRP$ Physical
general JJ Physical
practitioner NN Physical
to TO Physical
discuss VB Physical
preventive JJ Physical
health NN Physical
. . Physical
health NN Physical
checks NNS Physical
-DOCSTART- -X- N

active JJ Physical
physical JJ Physical
training NN Physical
active JJ Physical
training NN Physical
programme NN Physical
( ( Physical
AT NNP Physical
) ) Physical
with IN None
a DT None
physiotherapy NN Physical
treatment NN Physical
without IN Physical
active JJ Physical
training NN Physical
( ( Physical
PT NNP Physical
) ) Physical
-DOCSTART- -X- N

ropivacaine NN Pharmocological
, , None
bupivacaine NN Pharmocological
etidocaine NN Pharmocological
] NN None
Ropivacaine NNP Pharmocological
( ( None
bupivacaine VB Pharmocological
ropivacaine VB Pharmocological
etidocaine VB Pharmocological
ropivacaine JJ Pharmocological
bupivacaine VB Pharmocological
etidocaine VB Pharmocological
. . None
bupivacaine VBP Pharmocological
ropivacaine VB Pharmocological
etidocaine VBP Pharmocological
Injections NNS Pharmocological
of IN Pharmocological
3 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
the DT Pharmocological
local JJ Pharmocological
anesthetic NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
the DT Pharmocological
remainder NN Pharmocological
of IN Pharmocological
the DT Pharmocological
local JJ Pharmocological
anesthetic NN Pharmocological
at IN Pharmocological
10 CD Pharmocological
ml/min NN Pharmocological
1 CD Pharmocological
min NN Pharmocological
later RB Pharmocological
. . None
bupivacaine NN Pharmocological
ropivacaine JJ Pharmocological
etidocaine JJ Pharmocological
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
) ) None
bupivacaine NN Pharmocological
, , None
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
bupivacaine NN Pharmocological
, , None
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
. . None
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
ropivacaine NN Pharmocological
bupivacaine NN Pharmocological
etidocaine NN Pharmocological
Bupivacaine NNP Pharmocological
ropivacaine NN Pharmocological
etidocaine VB Pharmocological
ropivacaine NN Pharmocological
bupivacaine NN Pharmocological
etidocaine NN Pharmocological
... : None
-DOCSTART- -X- N

Chlorhexidine-based JJ Pharmocological
antiseptic JJ Pharmocological
solution NN Pharmocological
alcohol-based JJ Pharmocological
povidone-iodine NN Pharmocological
chlorhexidine-based JJ Pharmocological
solutions NNS Pharmocological
alcohol-based JJ Pharmocological
povidone-iodine NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
povidone-iodine NN Pharmocological
in IN Pharmocological
70 CD Pharmocological
% NN Pharmocological
ethanol NN Pharmocological
or CC Pharmocological
with IN Pharmocological
a DT Pharmocological
combination NN Pharmocological
of IN Pharmocological
0.25 CD Pharmocological
% NN Pharmocological
chlorhexidine NN Pharmocological
gluconate NN Pharmocological
, , Pharmocological
0.025 CD Pharmocological
% NN Pharmocological
benzalkonium NN Pharmocological
chloride NN Pharmocological
, , Pharmocological
and CC Pharmocological
4 CD Pharmocological
% NN Pharmocological
benzylic JJ Pharmocological
alcohol NN Pharmocological
. . Pharmocological
povidone-iodine NN Pharmocological
chlorhexidine-based JJ Pharmocological
solution NN Pharmocological
povidone-iodine NN Pharmocological
Chlorhexidine-based JJ Pharmocological
solutions NNS Pharmocological
povidone-iodine NN Pharmocological
( ( Pharmocological
including VBG Pharmocological
alcohol-based VBN Pharmocological
) ) Pharmocological
formulations NNS Pharmocological
-DOCSTART- -X- N

( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Prophylactic JJ Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
vs NN None
placebo NN Control
. . None
Lidocaine NNP Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
. . None
lidocaine JJ Pharmocological
-DOCSTART- -X- N

bisphosphonate NN Pharmocological
therapy NN Pharmocological
risedronate NN Pharmocological
placebo-controlled JJ Control
risedronate NN Pharmocological
placebo NN Control
. . None
risedronate NN Pharmocological
Risedronate NNP Pharmocological
Risedronate NNP Pharmocological
-DOCSTART- -X- N

lithium NN Pharmocological
disilicate NN Pharmocological
glass NN Pharmocological
ceramic NN Pharmocological
-DOCSTART- -X- N

Relaxing VBG Physical
retinotomy NN Physical
with IN Physical
silicone JJ Physical
oil NN Physical
or CC Physical
long-acting NN Physical
gas NN Physical
vitrectomy NN Pharmocological
relaxing VBG Physical
retinotomy NN Physical
treatment NN Pharmocological
with IN Pharmocological
long-acting JJ Pharmocological
gas NN Pharmocological
or CC Pharmocological
silicone NN Pharmocological
oil NN Pharmocological
. . None
perflouropropane NN Pharmocological
-DOCSTART- -X- N

ultrasound-guided JJ Surgical
laser NN Surgical
photocoagulation NN Surgical
percutaneous JJ Surgical
ultrasound NN Surgical
( ( Surgical
US NNP Surgical
) ) Surgical
-guided VBD Surgical
laser NN Surgical
photocoagulation NN Surgical
( ( Surgical
PLP NNP Surgical
) ) Surgical
-DOCSTART- -X- N

antibiotic JJ Pharmocological
cefotiam NN Pharmocological
. . Pharmocological
cefotiam NN Pharmocological
cefotiam NN Pharmocological
antibiotic NN Pharmocological
anaesthesia NN Pharmocological
. . Pharmocological
cefotiam NN Pharmocological
-DOCSTART- -X- N

antiepileptic JJ Pharmocological
drug NN Pharmocological
antiepileptic JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
AED NNP Pharmocological
) ) Pharmocological
treatment NN Pharmocological
implementation NN None
intention NN None
intervention NN None
self-administered JJ Educational
questionnaire NN Educational
intention NN None
of IN None
taking VBG None
medication NN None
with IN None
a DT None
particular JJ None
time NN None
, , None
place NN None
, , None
and CC None
other JJ None
activity NN None
AED NNP Pharmocological
Intervention NN None
intention NN Pharmocological
intervention NN Pharmocological
AED NNP Pharmocological
-DOCSTART- -X- N

risperidone VB Pharmocological
risperidone NN Pharmocological
versus NN None
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

pirarubicin NN Pharmocological
( ( Pharmocological
THP NNP Pharmocological
) ) Pharmocological
THP NNP Pharmocological
50 CD Pharmocological
ml NNS Pharmocological
saline NN Pharmocological
no DT Control
instillation NN Control
was VBD None
performed VBN None
before IN None
TUR NNP Surgical
. . None
-DOCSTART- -X- N

endotracheal NN Pharmocological
and CC Pharmocological
peripheral JJ Pharmocological
intravenous JJ Pharmocological
adrenaline NN Pharmocological
adrenaline NN Pharmocological
and CC None
noradrenaline NN Pharmocological
. . None
adrenaline NN Pharmocological
adrenaline JJ Pharmocological
-DOCSTART- -X- N

Rapid-sequence JJ Physical
intubation NN Physical
pancuronium NN Pharmocological
minidose JJ Pharmocological
succinylcholine NN Pharmocological
. . None
succinylcholine JJ Pharmocological
administration NN Pharmocological
. . None
succinylcholine NN Pharmocological
rapid-sequence NN Physical
intubation NN Physical
maneuvers NNS Physical
lidocaine NN Pharmocological
minidose JJ Pharmocological
succinylcholine NN Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
mg/kg NN Pharmocological
) ) Pharmocological
or CC None
pancuronium NN Pharmocological
full JJ Pharmocological
paralytic JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
succinylcholine NN Pharmocological
pancuronium NN Pharmocological
succinylcholine NN Pharmocological
succinylcholine JJ Pharmocological
pancuronium NN Pharmocological
succinylcholine NN Pharmocological
-DOCSTART- -X- N

low-fat JJ Physical
, , Physical
high-fiber JJ Physical
diet NN Physical
an DT None
intervention NN None
group NN None
given VBN None
intensive JJ None
counseling NN None
and CC None
assigned VBD None
to TO None
follow VB None
a DT None
diet NN Educational
that WDT Educational
was VBD Educational
low JJ Educational
in IN Educational
fat NN Educational
( ( None
20 CD None
percent NN None
of IN None
total JJ None
calories NNS None
) ) None
and CC None
high JJ Educational
in IN Educational
fiber NN Educational
( ( Educational
18 CD Educational
g NN Educational
of IN Educational
dietary JJ Educational
fiber NN Educational
per IN Educational
1000 CD Educational
kcal NN Educational
) ) Educational
and CC None
fruits NNS Educational
and CC Educational
vegetables NNS Educational
( ( None
3.5 CD None
servings NNS None
per IN None
1000 CD None
kcal NN None
) ) None
, , None
and CC None
a DT None
control NN None
group NN None
given VBN None
a DT None
standard JJ None
brochure NN None
on IN None
healthy JJ None
eating NN None
and CC None
assigned VBD None
to TO None
follow VB None
their PRP$ None
usual JJ None
diet NN None
. . None
-DOCSTART- -X- N

two CD None
alternative JJ None
therapeutic JJ Pharmocological
regimens NNS Pharmocological
for IN None
MAC NNP None
. . None
-DOCSTART- -X- N

biopsy NN None
sheathed JJ Physical
needle NN Physical
suction NN Physical
biopsy NN Physical
needle NN Physical
( ( Physical
Menghini NNP Physical
) ) Physical
routine JJ Physical
percutaneous JJ Physical
liver NN Physical
biopsy NN Physical
. . None
suction NN Physical
needle NN Physical
sheathed JJ Other
needle NN Other
. . None
Menghini NNP Physical
technique NN Physical
. . Physical
suction NN Other
needle NN Other
sheathed JJ Other
needle NN Other
-DOCSTART- -X- N

irradiated VBN Physical
with IN Physical
7 CD Physical
Gy NNP Physical
single JJ Physical
dose NN Physical
within IN Physical
16-20 JJ Physical
h NN Physical
before IN Physical
operation NN Physical
. . Physical
treated VBN Pharmocological
with IN Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
Voltaren NNP Pharmocological
resinat VBZ Pharmocological
2 CD Pharmocological
x NN Pharmocological
75 CD Pharmocological
mg/day NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
) ) Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Letrozole NNP Pharmocological
Neoadjuvant JJ Pharmocological
chemotherapy NN Pharmocological
Preoperative JJ Pharmocological
endocrine NN Pharmocological
therapy NN Pharmocological
aromatase NN Pharmocological
inhibitors NNS Pharmocological
tamoxifen NN Pharmocological
AI NNP Pharmocological
tamoxifen NN Pharmocological
letrozole NN Pharmocological
tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
letrozole NN Pharmocological
letrozole NN Pharmocological
letrozole NN Pharmocological
letrozole NN Pharmocological
tamoxifen VB Pharmocological
-DOCSTART- -X- N

Parent-based JJ Educational
sleep JJ Educational
education NN Educational
sleep JJ Educational
education NN Educational
to TO Educational
individual NN Educational
group NN Educational
format NN Educational
-DOCSTART- -X- N

prednisolone NN Pharmocological
and CC Pharmocological
cytotoxics NNS Pharmocological
prednisolone NN Pharmocological
and CC Pharmocological
cytotoxic NN Pharmocological
agents NNS Pharmocological
low-dose JJ Pharmocological
cyclophosphamide NN Pharmocological
then RB None
azathioprine VB Pharmocological
, , None
and CC None
to TO None
control VB Control
groups NNS Control
. . Control
prednisolone NN Pharmocological
cytotoxic NN Pharmocological
agents NNS Pharmocological
; : Pharmocological
-DOCSTART- -X- N

( ( None
cryotherapy NN Physical
and CC None
control NN Control
) ) None
-DOCSTART- -X- N

KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
KC NNP Pharmocological
11458 CD Pharmocological
placebo NN Control
. . None
KC NNP Pharmocological
11458 CD Pharmocological
-DOCSTART- -X- N

[ JJ None
Stent NNP Surgical
and CC Surgical
surgery NN Surgical
stent-supported JJ Surgical
angioplasty NN Surgical
( ( Surgical
CAS NNP Surgical
) ) Surgical
vs NN None
carotid NN Surgical
endarterectomy NN Surgical
( ( Surgical
CEA NNP Surgical
) ) Surgical
CAS NNP Surgical
CEA NNP Surgical
CAS NNP Surgical
CEA NNP Surgical
CAS NNP Surgical
Stent-supported JJ Surgical
angioplasty NN Surgical
-DOCSTART- -X- N

homeopathic JJ Pharmocological
preparation NN Pharmocological
Galphimia NNP Pharmocological
potentiation NN Pharmocological
D6 NNP Pharmocological
, , None
Galphimia NNP Pharmocological
dilution NN Pharmocological
10 CD Pharmocological
( ( Pharmocological
-6 NN Pharmocological
) ) Pharmocological
and CC None
placebo NN Control
homeopathic JJ Pharmocological
drugs NNS Pharmocological
ethanol NN Pharmocological
) ) None
D6 NNP Pharmocological
Galphimia NNP Pharmocological
D6 NNP Pharmocological
, , None
a DT None
conventional JJ None
Galphimia NNP Pharmocological
dilution NN Pharmocological
placebo NN Control
placebo NN Control
. . None
homeopathic JJ Pharmocological
drugs NNS Pharmocological
-DOCSTART- -X- N

levetiracetam NN Pharmocological
-DOCSTART- -X- N

Alendronate NNP Pharmocological
Bisphosphonates NNS Pharmocological
alendronate NN Pharmocological
10mg/day CD Pharmocological
: : None
alendronate NN Pharmocological
70 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
a DT Pharmocological
week NN Pharmocological
: : Pharmocological
enteric JJ Pharmocological
alendronate NN Pharmocological
70 CD Pharmocological
mg NN Pharmocological
per IN Pharmocological
week NN Pharmocological
. . None
alendronate NN Pharmocological
Enteric JJ Pharmocological
alendronate NN Pharmocological
-DOCSTART- -X- N

abstinent-contingent JJ Educational
housing NN Educational
and CC Educational
work NN Educational
. . None
-DOCSTART- -X- N

Infliximab NNP Pharmocological
methotrexate NN Pharmocological
Methotrexate NNP Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
infliximab JJ Pharmocological
infliximab NN Pharmocological
MTX NNP Pharmocological
on IN Pharmocological
infliximab NN Pharmocological
infliximab NN Pharmocological
alone RB Pharmocological
or CC Pharmocological
infliximab JJ Pharmocological
combined VBN Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
infliximab NN Pharmocological
+ NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Educational
and CC Educational
infliximab NN Educational
infliximab JJ Educational
-DOCSTART- -X- N

PVB NNP Pharmocological
, , Pharmocological
VAB-6 NNP Pharmocological
, , Pharmocological
BVP NNP Pharmocological
regimen VBP Pharmocological
versus NN Pharmocological
PEB NNP Pharmocological
chemotherapy NN Pharmocological
PVB NNP Pharmocological
, , Pharmocological
VAB-6 NNP Pharmocological
, , Pharmocological
BVP NNP Pharmocological
regimen NNS Pharmocological
without IN None
etoposide JJ Pharmocological
versus NN None
PEB NNP Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
bleomycin NN Pharmocological
, , Pharmocological
etoposide RB Pharmocological
and CC Pharmocological
cisplatinum NN Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
surgery NN Surgical
-DOCSTART- -X- N

Pentaglobin NNP Pharmocological
( ( None
Pentaglobin NNP Pharmocological
) ) None
12.5 CD Pharmocological
g JJ Pharmocological
human JJ Pharmocological
albumin NN Pharmocological
-DOCSTART- -X- N

read VB Educational
the DT Educational
same JJ Educational
question NN Educational
, , Educational
relating VBG Educational
to TO Educational
either DT Educational
physical JJ Educational
or CC Educational
social JJ Educational
world NN Educational
knowledge NN Educational
, , Educational
when WRB Educational
it PRP Educational
was VBD Educational
either CC Educational
relevant JJ Educational
or CC Educational
irrelevant JJ Educational
to TO Educational
the DT Educational
bridging NN Educational
inference NN Educational
evoked VBN Educational
by IN Educational
a DT Educational
preceding VBG Educational
two-sentence NN Educational
vignette NN Educational
. . None
-DOCSTART- -X- N

Paracetamol NNP Pharmocological
by IN Surgical
the DT Surgical
transaxillary JJ Surgical
approach NN Surgical
. . None
intravenous JJ Pharmocological
paracetamol NN Pharmocological
robot-assisted JJ Surgical
endoscopic JJ Surgical
thyroidectomy NN Surgical
transaxillary JJ Surgical
approach NN Surgical
. . None
placebo-controlled JJ Control
placebo NNS Control
paracetamol NN Pharmocological
anesthesia NN Pharmocological
paracetamol NN Pharmocological
placebo NN Control
paracetamol NN Pharmocological
placebo NN Control
placebo NN Control
paracetamol NN Pharmocological
intravenous JJ Pharmocological
paracetamol NN Pharmocological
-DOCSTART- -X- N

duplex JJ Physical
US NNP Physical
scanning VBG Physical
SEPS NNP Physical
saphenous JJ Physical
vein NN Physical
ligation NN Physical
and CC Physical
stripping NN Physical
-DOCSTART- -X- N

Eberconazole JJ Pharmocological
miconazole JJ Pharmocological
Eberconazole NNP Pharmocological
eberconazole JJ Pharmocological
miconazole JJ Pharmocological
eberconazole VB Pharmocological
miconazole VB Pharmocological
-DOCSTART- -X- N

mild JJ Physical
physical JJ Physical
exercise NN Physical
physical JJ Physical
exercise NN Physical
regular JJ Physical
physical JJ Physical
exercise NN Physical
exercise NN Physical
exercise NN Physical
mild JJ Physical
regular JJ Physical
physical JJ Physical
exercise NN Physical
-DOCSTART- -X- N

YM17E NNP Pharmocological
, , Pharmocological
an DT Pharmocological
inhibitor NN Pharmocological
of IN Pharmocological
acyl NN Pharmocological
coenzyme NN Pharmocological
dose NN Pharmocological
study NN Pharmocological
of IN Pharmocological
YM17E NNP Pharmocological
YM17E NNP Pharmocological
was VBD Pharmocological
administered VBN Pharmocological
after IN Pharmocological
a DT Pharmocological
meal NN Pharmocological
to TO Pharmocological
YM17E NNP Pharmocological
YM17E NNP Pharmocological
. . Pharmocological
150 CD Pharmocological
mg NNS Pharmocological
YM17E VBN Pharmocological
test JJ Pharmocological
drug NN Pharmocological
at IN Pharmocological
150 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
300 CD Pharmocological
mg NN Pharmocological
placebo NN Control
( ( Control
n JJ Control
= NNP Control
3 CD Control
) ) Control
twice RB Control
a DT Control
day NN Control
YM17E NNP Pharmocological
once RB Pharmocological
a DT Pharmocological
day NN Pharmocological
-DOCSTART- -X- N

Ho'ouna NNP Educational
Pono NNP Educational
substance NN Educational
use NN Educational
prevention NN Educational
curriculum NN Educational
: : None
called VBN Educational
Ho'ouna NNP Educational
Pono NNP Educational
. . None
Ho'ouna NNP Educational
Pono NNP Educational
-DOCSTART- -X- N

infusion NN Pharmocological
of IN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
1-3 JJ Pharmocological
g/kg/day NN Pharmocological
of IN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
into IN Pharmocological
either CC Pharmocological
the DT Pharmocological
ecmo NN Pharmocological
circuit NN Pharmocological
or CC Pharmocological
separate JJ Pharmocological
intravenous JJ Pharmocological
access NN Pharmocological
. . None
fat JJ Pharmocological
emulsion NN Pharmocological
Fat NNP Pharmocological
emulsion NN Pharmocological
-DOCSTART- -X- N

Topical JJ Physical
anesthesia NN Physical
topical JJ Physical
anesthesia NN Physical
normal JJ Pharmocological
saline NN Pharmocological
or CC Pharmocological
proparacaine NN Pharmocological
HCl NNP Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
eye NN Pharmocological
drops VBZ Pharmocological
anesthetic JJ Pharmocological
-DOCSTART- -X- N

subcutaneous JJ Pharmocological
interleukin-2 NN Pharmocological
( ( Pharmocological
IL-2 NNP Pharmocological
) ) Pharmocological
IL-2 NNP Pharmocological
Interleukin-2 NN Pharmocological
Subcutaneous NNP Pharmocological
IL-2 NNP Pharmocological
IL-2 NNP Pharmocological
-DOCSTART- -X- N

allograft NN Pharmocological
experimental JJ Physical
putty NN Physical
carrier NN Physical
and CC Physical
a DT Physical
bovine-derived JJ Physical
xenograft NN Physical
graft NN Physical
materials NNS Physical
. . None
ridge NN None
preservation NN None
treatment NN None
with IN None
either DT None
an DT None
allograft NN None
in IN None
an DT None
experimental JJ None
putty NN None
carrier NN None
plus CC None
a DT None
calcium NN Pharmocological
sulfate NN Pharmocological
barrier NN Pharmocological
( ( None
PUT NNP None
) ) None
or CC None
a DT None
bovine-derived JJ Pharmocological
xenograft NN Pharmocological
( ( Pharmocological
BDX NNP Pharmocological
) ) Pharmocological
plus CC None
a DT None
collagen NN None
membrane NN None
. . None
BDX NNP Pharmocological
PUT NNP None
BDX NNP Physical
PUT NNP None
xenograft NN Pharmocological
-DOCSTART- -X- N

physical JJ None
activity NN None
monitoring NN None
and CC None
distance NN None
counselling NN None
lifestyle JJ Educational
intervention NN Educational
control NN Control
daily JJ Educational
activity NN Educational
monitoring NN Educational
and CC Educational
distance NN Educational
counselling NN Educational
. . Educational
daily JJ None
physical JJ None
activity NN None
monitoring NN None
and CC None
distance NN None
counselling NN None
-DOCSTART- -X- N

growth NN Pharmocological
hormone NN Pharmocological
releasing VBG Pharmocological
hormone CD Pharmocological
administration NN None
growth NN Pharmocological
hormone NN Pharmocological
GHRH NNP Pharmocological
( ( None
1 CD None
microgram/kg RB None
iv NN None
) ) None
or CC None
TRH NNP Pharmocological
( ( None
400 CD None
microgram RB None
iv NN None
) ) None
GHRH-induced JJ Pharmocological
placebo NN Control
GHRH-stimulated JJ Pharmocological
TRH-stimulated NNP Pharmocological
-DOCSTART- -X- N

antilymphocyte JJ Pharmocological
globulin NN Pharmocological
, , Pharmocological
cyclosporine NN Pharmocological
and CC Pharmocological
two CD Pharmocological
different JJ Pharmocological
granulocyte NNS Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
regimens NNS Pharmocological
: : Pharmocological
5 CD Pharmocological
micro NN Pharmocological
g/kg/day NN Pharmocological
higher JJR None
dose NN None
of IN None
G-CSF NNP Physical
( ( None
10 CD None
micro NNS None
g/kg/day NN None
) ) None
receive VB Pharmocological
G-CSF NNP Pharmocological
5 CD Pharmocological
micro NN Pharmocological
g/kg/day NN Pharmocological
( ( Pharmocological
n=38 JJ Pharmocological
, , Pharmocological
group NN Pharmocological
A NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
10 CD Pharmocological
micro NNS Pharmocological
g/kg/day NN Pharmocological
( ( Pharmocological
n=39 JJ Pharmocological
, , Pharmocological
group NN Pharmocological
B NNP Pharmocological
) ) Pharmocological
from IN Pharmocological
day NN Pharmocological
+1 CD Pharmocological
to TO Pharmocological
day NN Pharmocological
+30 NNP Pharmocological
. . Pharmocological
All DT None
patients NNS None
then RB None
received VBD None
G-CSF NNP Pharmocological
5 CD Pharmocological
micro NN None
g/kg/day NN None
from IN None
day NN None
+31 CD None
to TO None
day NN None
+90 NNP None
. . None
G-CSF NNP Physical
-DOCSTART- -X- N

Hexetidine NNP Pharmocological
( ( Pharmocological
'Oraldene NNP Pharmocological
' POS Pharmocological
) ) Pharmocological
: : None
0.1 CD Pharmocological
% NN Pharmocological
solution NN Pharmocological
of IN Pharmocological
hexetidine NN Pharmocological
with IN None
that DT None
of IN None
placebo NN Control
. . None
hexetidine NN Pharmocological
or CC None
placebo NN Control
Hexetidine NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

methadone NN Pharmocological
interim JJ None
clinic NN None
or CC None
a DT None
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

tracheostomy NN Physical
electrocautery JJ Surgical
division NN Surgical
of IN Surgical
the DT Surgical
isthmus NN Surgical
electrocautery DT Physical
division NN Physical
of IN Physical
the DT Physical
-DOCSTART- -X- N

energy NN Pharmocological
supplementation NN Pharmocological
programs NNS Pharmocological
and CC Pharmocological
amount NN Pharmocological
of IN Pharmocological
starch NN Pharmocological
CP NNP Pharmocological
supplement NN Pharmocological
CP NNP Pharmocological
supplement/d NN Pharmocological
and CC Pharmocological
pasture NN Pharmocological
a DT Pharmocological
high-starch NN Pharmocological
( ( Pharmocological
HS NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
( ( Pharmocological
73 CD Pharmocological
% NN Pharmocological
HS NNP Pharmocological
diet JJ Pharmocological
fed NN Pharmocological
in IN Pharmocological
drylot NN Pharmocological
a DT Pharmocological
low-starch NN Pharmocological
( ( Pharmocological
LS NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
self-fed NN Educational
on IN Educational
pasture NN Educational
HS-60 JJ Pharmocological
HS-30 JJ Pharmocological
LS-30 JJ Pharmocological
High-starch-60 JJ None
42 CD Pharmocological
% NN Pharmocological
CP NNP Pharmocological
supplement/d NN Pharmocological
SBM NNP Pharmocological
supplement/d NN Pharmocological
; : None
distiller NN Pharmocological
's POS Pharmocological
grain NN Pharmocological
and CC Pharmocological
soybean JJ Pharmocological
hull-based JJ Pharmocological
diet NN Pharmocological
limited-fed JJ Pharmocological
a DT Pharmocological
corn-based JJ Pharmocological
diet NN Pharmocological
LS NNP Pharmocological
or CC None
a DT None
HS NNP Pharmocological
diet NN Pharmocological
-DOCSTART- -X- N

gonadotropin-releasing NN Pharmocological
hormone NN Pharmocological
analog NN Pharmocological
( ( Pharmocological
Diphereline NNP Pharmocological
) ) Pharmocological
Cabergoline NNP Pharmocological
( ( Pharmocological
Dostinex NNP Pharmocological
) ) Pharmocological
cabergoline NN Pharmocological
( ( Pharmocological
Dostinex NNP Pharmocological
, , Pharmocological
a DT Pharmocological
dopamine JJ Pharmocological
agonist NN Pharmocological
) ) Pharmocological
Diphereline NNP Pharmocological
( ( Pharmocological
a DT Pharmocological
gonadotropin-releasing NN Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
) ) Pharmocological
. . Pharmocological
Diphereline NNP Pharmocological
Cabergoline NNP Pharmocological
. . Pharmocological
Diphereline NNP Pharmocological
Cabergoline NNP Pharmocological
Cabergoline NNP Pharmocological
gonadotropin NN Pharmocological
releasing VBG Pharmocological
hormone JJ Pharmocological
agonist NN Pharmocological
dopamine NN Pharmocological
agonists NNS Pharmocological
-DOCSTART- -X- N

Eltrombopag NNP Pharmocological
Eltrombopag NNP Pharmocological
eltrombopag NNS Pharmocological
placebo NN Control
eltrombopag NN None
placebo JJ None
eltrombopag VB None
placebo NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
placebo NN None
placebo NN None
eltrombopag-treated JJ None
placebo VB None
placebo NN None
eltrombopag NN None
Eltrombopag NNP None
eltrombopag JJ None
-DOCSTART- -X- N

Divalproex NNP Pharmocological
sodium NN Pharmocological
vs. FW None
placebo NN None
Divalproex NNP Pharmocological
divalproex NN Pharmocological
placebo-controlled JJ Control
divalproex NN Pharmocological
sodium NN Pharmocological
vs. FW None
placebo NN Control
. . None
divalproex NN Pharmocological
-DOCSTART- -X- N

induction NN Physical
chemotherapy NN Physical
followed VBN None
by IN None
either DT None
standard JJ Physical
thoracic NN Physical
radiotherapy NN Physical
or CC None
hyperfractionated VBN Physical
accelerated JJ Physical
radiotherapy NN Physical
once-daily JJ Physical
radiation NN Physical
therapy NN Physical
( ( Physical
qdRT NN Physical
) ) Physical
hyperfractionated VBN Physical
accelerated JJ Physical
radiation NN Physical
therapy NN Physical
( ( Physical
HART NNP Physical
) ) Physical
induction NN Physical
chemotherapy NN Physical
. . None
Induction NNP Physical
chemotherapy NN Physical
carboplatin JJ Pharmocological
paclitaxel JJ Pharmocological
qdRT NN Physical
HART NNP Physical
; : None
qdRT VB Physical
HART NNP Physical
HART NNP Pharmocological
qdRT NN Physical
HART NNP Physical
qdRT NN Pharmocological
HART NNP Pharmocological
qdRT NN Pharmocological
HART NNP Pharmocological
qdRT NN Pharmocological
HART NNP Pharmocological
induction NN Physical
chemotherapy NN Physical
carboplatin-paclitaxel NN Pharmocological
, , Pharmocological
HART NNP Pharmocological
HART NNP Pharmocological
-DOCSTART- -X- N

parent-delivered JJ Educational
Qigong JJ Educational
massage NN Educational
program NN Educational
: : None
dual JJ Educational
parent NN Educational
and CC Educational
trainer-delivered JJ Educational
qigong JJ Educational
massage NN Educational
parent-delivered JJ Educational
program NN Educational
for IN Educational
4 CD Educational
mo NN Educational
. . None
parent NN Educational
training NN Educational
and CC Educational
support NN Educational
. . None
parent-delivered JJ Educational
component NN Educational
-DOCSTART- -X- N

tamoxifen NN Pharmocological
and CC None
to TO None
assess VB None
the DT None
of IN None
sequentially RB None
adding VBG None
low-dose JJ Pharmocological
cyclophosphamide-methotrexate-5-fluorouracil NN Pharmocological
( ( Pharmocological
CMF NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
in IN Pharmocological
tamoxifen JJ Pharmocological
responders NNS Pharmocological
. . None
tamoxifen NN Pharmocological
alone RB Pharmocological
-DOCSTART- -X- N

Folic JJ Pharmocological
acid-based JJ Pharmocological
intervention NN Pharmocological
Folic NNP Pharmocological
acid NN Pharmocological
combined VBN None
with IN None
vitamins NNS Pharmocological
B NNP Pharmocological
( ( Pharmocological
6 CD Pharmocological
) ) Pharmocological
and CC Pharmocological
B NNP Pharmocological
( ( Pharmocological
12 CD Pharmocological
) ) Pharmocological
placebo-controlled JJ Pharmocological
folic JJ Pharmocological
acid-based JJ Pharmocological
supplement NN Pharmocological
folate NN Pharmocological
placebo NN Control
group NN Control
folic JJ Pharmocological
acid RB Pharmocological
vitamin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
12 CD Pharmocological
) ) Pharmocological
vitamin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
6 CD Pharmocological
) ) Pharmocological
Folic JJ Pharmocological
acid-based JJ Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

two CD Other
oscillating/rotating/pulsating VBG Other
toothbrushes NNS Other
( ( None
Oral-B NNP Other
ProfessionalCare NNP Other
7000 CD Other
[ NNP Other
PC NN Other
7000 CD Other
] NN None
and CC None
Oral-B JJ Other
3D CD Other
Excel NNP Other
[ VBD Other
3DE CD Other
] NN None
) ) None
and CC None
a DT None
high-frequency NN None
toothbrush NN None
( ( None
Sonicare NNP None
Advance NNP None
, , None
Philips NNP None
Oral NNP None
Healthcare NNP None
; : None
SA NNP None
) ) None
-DOCSTART- -X- N

Reciprocal NNP Educational
Imitation NNP Educational
Training NNP Educational
Reciprocal JJ Educational
Imitation NNP Educational
Training NNP Educational
( ( Educational
RIT NNP Educational
) ) Educational
-DOCSTART- -X- N

aspirin JJ Pharmocological
aspirin NN Pharmocological
placebo NN Control
. . Control
aspirin JJ Pharmocological
-DOCSTART- -X- N

acyclovir NN Pharmocological
and CC None
vidarabine NN Pharmocological
. . None
intravenous JJ Pharmocological
acyclovir NNS Pharmocological
and CC None
vidarabine NN Pharmocological
acyclovir NN Pharmocological
vidarabine NN Pharmocological
Acyclovir NNP Pharmocological
acyclovir NN Pharmocological
acyclovir NN Pharmocological
vidarabine NN Pharmocological
-DOCSTART- -X- N

second-line JJ Physical
chemotherapy NN Physical
platinum-based JJ Pharmocological
regimen NN Pharmocological
mono NN Pharmocological
chemotherapy NN Pharmocological
docetaxel NN Pharmocological
docetaxel NN Pharmocological
cisplatin NN Pharmocological
doublet NN Pharmocological
. . Pharmocological
docetaxel NN Pharmocological
cisplatin NN Pharmocological
docetaxel NN Pharmocological
alone RB Pharmocological
-DOCSTART- -X- N

new JJ Pharmocological
capsule-type JJ Pharmocological
colon NN Pharmocological
specific JJ Pharmocological
drug NN Pharmocological
delivery NN Pharmocological
system NN Pharmocological
Colonic JJ Physical
drug NN Physical
delivery NN Physical
novel JJ Physical
capsule-type JJ Physical
colonic NN Physical
delivery NN Physical
system NN Physical
( ( Physical
Colon-Targeted JJ Physical
Delivery NNP Physical
Capsule NNP Physical
) ) Physical
-DOCSTART- -X- N

R-salbutamol NNP Pharmocological
R-salbutamol NNP Pharmocological
sulphate NN Pharmocological
R-salbutamol NNP Pharmocological
cream NN Pharmocological
vs. FW None
placebo NN Control
randomized VBN None
- : None
19 CD Pharmocological
to TO Pharmocological
the DT Pharmocological
R-salbutamol NNP Pharmocological
cream NN Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
and CC None
18 CD None
to TO None
placebo VB Control
- : None
and CC None
treated JJ None
twice RB None
daily RB None
for IN None
8 CD None
weeks NNS None
. . None
placebo NN Control
-DOCSTART- -X- N

amifostine NN Pharmocological
amifostine NN Pharmocological
Amifostine NNP Pharmocological
radiochemotherapy NN Physical
. . None
Cytoprotection NN Pharmocological
amifostine NN Pharmocological
Amifostine NNP Pharmocological
amifostine NN Pharmocological
Amifostine NNP Pharmocological
-DOCSTART- -X- N

fosamprenavir NN Pharmocological
( ( Pharmocological
FPV NNP Pharmocological
) ) Pharmocological
and CC None
ritonavir NN Pharmocological
( ( Pharmocological
RTV NNP Pharmocological
) ) Pharmocological
FPV NNP Pharmocological
RTV $ Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
FPV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
-DOCSTART- -X- N

school NN Educational
dental JJ Educational
screening VBG Educational
programme NN Educational
school NN None
dental JJ None
screening NN None
programme NN None
school NN Educational
dental JJ Educational
screening NN Educational
standard JJ Educational
school NN Educational
dental JJ Educational
screening NN Educational
group NN Educational
children NNS Educational
were VBD Educational
not RB Educational
, , Educational
at IN Educational
this DT Educational
stage NN Educational
, , Educational
screened VBD Educational
same JJ None
questionnaire NN None
assessing VBG None
over IN None
the DT None
2-month JJ None
period NN None
. . None
control NN None
-DOCSTART- -X- N

acetaminophen NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
acetaminophen NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
without IN Educational
nurse JJ Educational
coaching NN Educational
; : None
with IN None
coaching NN Educational
. . None
-DOCSTART- -X- N

patient JJ Educational
involvement NN Educational
support VB Educational
self-care NN Educational
mediate VB Educational
doctor/patient JJ Educational
interaction NN Educational
Semi-structured JJ Educational
interviews NNS Educational
-DOCSTART- -X- N

losartan JJ Pharmocological
versus NN None
atenolol NN Pharmocological
losartan NN Pharmocological
and CC None
atenolol NN Pharmocological
losartan JJ Pharmocological
versus NN None
atenolol NN Pharmocological
. . None
losartan-treated JJ Pharmocological
atenolol-treated JJ Pharmocological
losartan JJ Pharmocological
atenolol NN Pharmocological
losartan NN Pharmocological
Losartan NNP Pharmocological
atenolol VB Pharmocological
. . None
-DOCSTART- -X- N

Dexamethasone NNP Pharmocological
therapy NN Pharmocological
Glucocorticoids NNS Pharmocological
radioimmunoassay NN None
. . None
dexamethasone NN Pharmocological
glucocorticoids NNS Pharmocological
cortisol NN Pharmocological
. . None
-DOCSTART- -X- N

[ JJ None
Prophylactic NNP Physical
intraaortic JJ Physical
balloon NN Physical
pumping VBG Physical
prophylactic JJ Physical
IABP NNP Physical
insertion NN Physical
postoperative JJ None
IABP NNP None
support NN None
Prophylactic NNP None
preoperative JJ None
IABP NNP None
insertion NN None
in IN None
-DOCSTART- -X- N

GnRH NNP Pharmocological
analogue NN Pharmocological
GnRH NNP Pharmocological
analogue NN Pharmocological
GnRH NNP Pharmocological
analogue NN Pharmocological
-DOCSTART- -X- N

[ NN None
Statins VBZ Pharmocological
statin NN Pharmocological
treatment NN None
-DOCSTART- -X- N

Disopyramide-pyridostigmine JJ Pharmocological
placebo FW Control
cholinesterase NN Pharmocological
inhibitor NN Pharmocological
-- : Pharmocological
slow-release JJ Pharmocological
pyridostigmine NN Pharmocological
disopyramide NN Pharmocological
. . None
disopyramide JJ Pharmocological
Disopyramide NNP Pharmocological
disopyramide NN Pharmocological
. . None
disopyramide NN Pharmocological
pyridostigmine NN Pharmocological
pyridostigmine NN Pharmocological
: : None
pyridostigmine NN Pharmocological
placebo NN Control
: : None
-DOCSTART- -X- N

plastic NN Other
curettes NNS Other
conventional JJ Other
steel NN Other
curettes NNS Other
conventional JJ Other
steel NN Other
curettes NNS Other
plastic NN Other
curettes NNS Other
non-root JJ Other
substance NN Other
removing VBG Other
curettes NNS Other
-DOCSTART- -X- N

enalapril NN Pharmocological
and CC None
indapamide NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitor NN Pharmocological
enalapril NN Pharmocological
and CC None
diuretic JJ Pharmocological
indapamide NN Pharmocological
placebo JJ Control
enalapril NN Pharmocological
or CC None
indapamide NN Pharmocological
indapamide JJ Pharmocological
enalapril NN Pharmocological
indapamide JJ Pharmocological
enalapril JJ Pharmocological
indapamide JJ Pharmocological
Enalapril NNP Pharmocological
and CC None
indapamide NN Pharmocological
enalapril NN Pharmocological
indapamide NN Pharmocological
. . None
enalapril NN Pharmocological
. . None
-DOCSTART- -X- N

FEC NNP Pharmocological
epirubicin NN Pharmocological
fluorouracil/epirubicin/cyclophosphamide NN Pharmocological
( ( Pharmocological
FEC NNP Pharmocological
) ) Pharmocological
FEC NNP Pharmocological
FEC NNP Physical
FEC NNP Pharmocological
FEC NNP Pharmocological
pegfilgrastim JJ Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
-DOCSTART- -X- N

low-level JJ Physical
laser NN Physical
and CC Physical
plyometric JJ Physical
exercises NNS Physical
laser NN Physical
with IN Physical
plyometric JJ Physical
exercises NNS Physical
placebo NN Control
laser NN Control
with IN Control
the DT Control
same JJ Control
program NN Control
low-level JJ Physical
laser NN Physical
plyometric JJ Physical
exercises NNS Physical
904 CD Physical
Ga-As NNP Physical
laser NN Physical
CW NNP Physical
plus CC Physical
plyometric JJ Physical
exercises NNS Physical
placebo NNS Physical
laser RBR Physical
plus CC Physical
the DT Physical
same JJ Physical
plyometric JJ Physical
exercises NNS Physical
. . Physical
laser NN Physical
or CC Physical
placebo NN Control
combination NN Physical
of IN Physical
laser NN Physical
with IN Physical
plyometric JJ Physical
exercises NNS Physical
placebo FW Control
laser NN Control
with IN Control
the DT Control
same JJ Control
plyometric JJ Control
exercises NNS Control
-DOCSTART- -X- N

psychological JJ Educational
intervention NN Educational
psychological JJ Psychological
intervention NN Psychological
psychological JJ Psychological
intervention NN Psychological
( ( Psychological
weekly JJ Psychological
cognitive VBP Psychological
individual JJ Psychological
psychotherapy NN Psychological
and CC Psychological
bimonthly JJ Psychological
family NN Psychological
counselling VBG Psychological
) ) Psychological
standard JJ Control
follow-up NN Control
. . None
-DOCSTART- -X- N

cefditoren NNS Pharmocological
pivoxil VBP Pharmocological
ceftriaxone NN Pharmocological
cefditoren NNS Pharmocological
pivoxil VBP Pharmocological
IV NNP Pharmocological
ceftriaxone NN Pharmocological
2g CD Pharmocological
IV NNP Pharmocological
ceftriaxone NN Pharmocological
( ( None
IV NNP Pharmocological
ceftriaxone NN Pharmocological
) ) None
( ( None
oral JJ Pharmocological
cefditoren NNS Pharmocological
pivoxil VBP Pharmocological
400mg CD Pharmocological
ceftriaxone NN Pharmocological
cefditoren NNS Pharmocological
pivoxil NN Pharmocological
-DOCSTART- -X- N

oxibendazole JJ Pharmocological
] NN None
for IN None
comparison NN None
and CC None
as IN None
control NN None
under IN None
double-blind JJ None
observations NNS None
. . None
-DOCSTART- -X- N

cisplatin JJ Pharmocological
carboplatin NN Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
carboplatin JJ Pharmocological
standard NN Pharmocological
concurrent NN Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
cisplatin NN Pharmocological
Planned VBD Pharmocological
radiotherapy NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

remaxol NN Pharmocological
remaxol JJ Pharmocological
infusion NN Pharmocological
solution NN Pharmocological
remaxol NNS Pharmocological
placebo NN Control
. . None
remaxol NN Pharmocological
vs NN None
placebo NN Control
remaxol JJ Pharmocological
-DOCSTART- -X- N

ketazolam NN Pharmocological
, , None
diazepam NN Pharmocological
and CC None
placebo NN Control
ketazolam NNP Pharmocological
diazepam NN Pharmocological
and CC None
placebo VB Control
diazepam JJ Pharmocological
ketazolam NN Pharmocological
-DOCSTART- -X- N

guanethidine JJ Pharmocological
3 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
and CC Pharmocological
adrenaline VB Pharmocological
0.5 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
( ( Pharmocological
Ganda NNP Pharmocological
3.0/0.5 CD Pharmocological
) ) Pharmocological
guanethidine $ Pharmocological
1 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
adrenaline VB Pharmocological
0.2 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
( ( None
Ganda NNP Pharmocological
1.0/0.2 CD Pharmocological
) ) None
Timolol NNP Pharmocological
( ( Pharmocological
Timoptol NNP Pharmocological
) ) Pharmocological
0.25 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
. . None
Ganda NNP Pharmocological
3.0/0.5 CD Pharmocological
Timolol NNP Pharmocological
0.25 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
Ganda NNP Pharmocological
1.0/0.2 CD Pharmocological
Timolol $ Pharmocological
0.25 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
-DOCSTART- -X- N

computer-based JJ Educational
intervention NN Educational
. . None
FaceSay NNP Educational
, , Educational
a DT Educational
computer-based JJ Educational
training VBG Educational
program NN Educational
-DOCSTART- -X- N

topotecan JJ Pharmocological
paclitaxel NN Pharmocological
topotecan JJ Pharmocological
paclitaxel NN Pharmocological
topotecan VB Pharmocological
paclitaxel NN Pharmocological
topotecan JJ Pharmocological
paclitaxel NN Pharmocological
topotecan JJ Pharmocological
paclitaxel NN Pharmocological
Topotecan NNP Pharmocological
paclitaxel VB Pharmocological
topotecan JJ Pharmocological
-DOCSTART- -X- N

Diet NNP Physical
data NNS Other
sets NNS Other
of IN Other
the DT Other
DCCT NNP Other
-DOCSTART- -X- N

randomly RB None
assigned VBN None
to TO None
ASC NNP Pharmocological
alone RB None
( ( None
treatment NN None
could MD None
include VB None
steroids NNS Pharmocological
, , Pharmocological
analgesic JJ Pharmocological
drugs NNS Pharmocological
, , Pharmocological
bronchodilators NNS Pharmocological
, , Pharmocological
palliative JJ Pharmocological
radiotherapy NN Pharmocological
[ NNP None
n=136 RB None
] NNP None
) ) None
; : None
to TO None
ASC NNP Pharmocological
plus CC Pharmocological
MVP NNP Pharmocological
( ( None
four CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
mitomycin NN Pharmocological
6 CD Pharmocological
mg/m2 NN Pharmocological
, , Pharmocological
vinblastine VBP Pharmocological
6 CD Pharmocological
mg/m2 NN Pharmocological
, , Pharmocological
and CC Pharmocological
cisplatin VBZ Pharmocological
50 CD None
mg/m2 NN None
every DT None
3 CD None
weeks NNS None
[ JJ None
n=137 RB None
] NNP None
) ) None
; : None
or CC None
to TO None
ASC NNP Pharmocological
plus CC Pharmocological
vinorelbine NN Pharmocological
( ( Pharmocological
one CD Pharmocological
injection NN Pharmocological
of IN Pharmocological
vinorelbine NN Pharmocological
30 CD Pharmocological
mg/m2 NN Pharmocological
every DT Pharmocological
week NN Pharmocological
for IN Pharmocological
12 CD Pharmocological
weeks NNS Pharmocological
[ JJ None
n=136 RB None
] NN None
) ) None
Follow-up NN None
was VBD None
every DT None
3 CD None
weeks NNS None
to TO None
21 CD None
weeks NNS None
after IN None
randomisation NN None
, , None
and CC None
every DT None
8 CD None
weeks NNS None
thereafter RB None
. . None
-DOCSTART- -X- N

reinforcement NN None
or CC None
stimulus NN None
control NN None
family-based JJ Educational
behavioral JJ Educational
treatment NN Educational
that WDT None
included VBD None
either DT None
stimulus NN None
control NN None
or CC None
reinforcement NN None
stimulus JJ None
control NN None
and CC None
reinforcing VBG None
-DOCSTART- -X- N

TENS NNP Physical
placebo-controlled JJ Control
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
and CC None
placebo JJ Control
TENS NNP Physical
-DOCSTART- -X- N

fenbendazole JJ Pharmocological
ivermectin JJ Pharmocological
fenbendazole JJ Pharmocological
oral JJ Pharmocological
drench NN Pharmocological
in IN None
addition NN None
to TO None
an DT None
ivermectin JJ Pharmocological
pour-on NN Pharmocological
( ( Pharmocological
SG+IVPO NNP Pharmocological
) ) None
ivermectin JJ Pharmocological
pour-on NN Pharmocological
( ( Pharmocological
IVPO NNP Pharmocological
) ) Pharmocological
doramectin NN Pharmocological
injectable JJ Pharmocological
( ( Pharmocological
DMX NNP Pharmocological
) ) Pharmocological
alone RB Pharmocological
SG+IVPO-treated JJ Pharmocological
-DOCSTART- -X- N

p16 FW Physical
( ( Physical
INK4a NNP Physical
) ) Physical
immunohistochemical JJ Physical
staining NN Physical
. . None
p16 NN Physical
( ( Physical
INK4a NNP Physical
) ) Physical
-negative NN Physical
and CC None
-positive JJ None
-DOCSTART- -X- N

enalapril NN Pharmocological
and CC None
eprosartan NN Pharmocological
Enalapril NNP Pharmocological
and CC None
eprosartan RB Pharmocological
placebo-controlled JJ Control
placebo NN Control
, , None
enalapril NN Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
, , None
eprosartan FW Pharmocological
( ( Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
, , None
or CC None
combination NN Pharmocological
of IN Pharmocological
both DT Pharmocological
drugs NNS Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
enalapril JJ Pharmocological
eprosartan JJ Pharmocological
eprosartan NN Pharmocological
enalapril NN Pharmocological
eprosartan NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
placebo-controlled JJ Control
MEDI-545 NNP Pharmocological
( ( None
0.3-30.0 JJ None
mg/kg NN None
) ) None
or CC None
placebo NN Control
. . None
MEDI-545 NNP Pharmocological
and CC None
placebo NN Control
. . None
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
-DOCSTART- -X- N

continuous JJ Physical
femoral JJ Physical
nerve NN Physical
block NN Physical
( ( Physical
CFNB NNP Physical
) ) Physical
continuous JJ Physical
epidural JJ Physical
infusion NN Physical
( ( Physical
CEI NNP Physical
) ) Physical
femoral JJ Physical
nerve NN Physical
block NN Physical
( ( Physical
FNB NNP Physical
) ) Physical
continuous JJ Physical
epidural JJ Physical
infusion NN Physical
( ( Physical
CEI NNP Physical
) ) Physical
continuous JJ Physical
femoral JJ Physical
nerve NN Physical
block NN Physical
( ( Physical
CFNB NNP Physical
) ) Physical
CEI NNP Physical
levobupivacaine NN Pharmocological
morphine JJ Pharmocological
CFNB NNP Physical
levobupivacaine NN Pharmocological
CFNB NNP Physical
CEI NNP Physical
CEI NNP Physical
CFNB NNP Physical
CFNB NNP Physical
CFNB NNP Physical
-DOCSTART- -X- N

Oral JJ Pharmocological
ribavirin NN Pharmocological
treatment NN Pharmocological
administration NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
ribavirin NN Pharmocological
ribavirin NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

randomly RB Educational
allocated VBN Educational
to TO Educational
three CD Educational
groups NNS Educational
: : Educational
intraoperative JJ Educational
music NN Educational
, , Educational
postoperative JJ Educational
music NN Educational
and CC Educational
silence NN Control
( ( Educational
control VB Educational
group NN Educational
) ) Educational
. . None
Anaesthesia NNP Physical
and CC Physical
postoperative JJ Physical
analgesia NN Physical
were VBD Physical
standardized VBN Physical
and CC None
the DT None
same JJ None
surgeon NN Surgical
performed VBD Surgical
all PDT Surgical
the DT Surgical
operations NNS Surgical
. . None
was VBD None
assessed VBN None
during IN None
and CC None
after IN None
surgery NN None
by IN None
determining VBG None
the DT None
was VBD None
evaluated VBN None
by IN None
studying VBG None
-DOCSTART- -X- N

auditory JJ Educational
stimuli NNS Educational
Stimuli NNP Educational
were VBD Educational
presented VBN Educational
via IN Educational
headphones NNS Educational
and CC Educational
consisted VBN Educational
of IN Educational
common JJ Educational
facts NNS Educational
or CC None
familiar JJ Educational
or CC Educational
unfamiliar JJ Educational
full JJ Educational
names NNS Educational
of IN Educational
fictitious JJ Educational
people NNS Educational
-DOCSTART- -X- N

levobunolol NN Pharmocological
placebo NN Control
or CC None
levobunolol NN Pharmocological
levobunolol NN Pharmocological
-DOCSTART- -X- N

Limbal NNP Surgical
epithelial NN Surgical
autograft NN Surgical
transplantation NN Surgical
limbal JJ Surgical
epithelial JJ Surgical
autograft NN Surgical
transplantation NN Surgical
pterygium NN Surgical
excision NN Surgical
excision NN Surgical
of IN Surgical
pterygium NN Surgical
limbal JJ Surgical
epithelial JJ Surgical
autograft NN Surgical
transplantation NN Surgical
surgery NN Surgical
simple JJ Surgical
pterygium NN Surgical
excision NN Surgical
limbal JJ Surgical
epithelial JJ Surgical
autograft NN Surgical
transplantation NN Surgical
-DOCSTART- -X- N

dietetic JJ Physical
treatment NN Physical
dietetic JJ Physical
treatment NN Physical
the DT None
intervention NN None
( ( None
referral JJ None
to TO None
and CC None
treatment NN None
by IN None
a DT None
trained JJ None
dietitian NN None
) ) None
or CC None
control VB None
group NN None
( ( None
no DT None
a DT None
dietetic JJ None
treatment NN None
by IN None
trained JJ None
dietitians NNS None
does VBZ None
not RB None
-DOCSTART- -X- N

monoiodoacetate NN Pharmocological
. . None
monoiodoacetate NN Pharmocological
( ( Pharmocological
MIA NNP Pharmocological
) ) Pharmocological
MIA NNP Pharmocological
phenylbutazone NN Pharmocological
, , None
butorphanol NN Pharmocological
, , None
and CC None
abaxial JJ Pharmocological
sesamoidean NN Pharmocological
nerve NN Physical
blocks NNS Physical
non-exercised JJ None
exercised JJ None
Exercise NNP Physical
-DOCSTART- -X- N

Rehabilitation NN Educational
including VBG Educational
Social NNP Educational
and CC Educational
Physical NNP Educational
activity NN Educational
and CC Educational
Education NN Educational
multimodal JJ Educational
intervention NN Educational
program NN Educational
, , Educational
including VBG Educational
ambassador-facilitated JJ Educational
educational JJ Educational
, , Educational
physical JJ Educational
, , Educational
and CC Educational
social JJ Educational
interventions NNS Educational
. . Educational
educational JJ Educational
intervention NN Educational
educational JJ Educational
program NN Educational
visit VBP Pharmocological
the DT Pharmocological
and CC None
participate VB None
in IN None
the DT None
intervention NN None
program NN None
. . None
physical JJ None
and CC None
social JJ None
intervention NN None
educational JJ None
, , None
physical JJ None
, , None
and CC None
social JJ None
intervention NN None
programs NNS None
. . None
classmates NNS Physical
as IN Physical
ambassadors NNS Physical
-DOCSTART- -X- N

intensive JJ Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
LNH-84 NNP Pharmocological
) ) Pharmocological
three CD None
or CC None
four CD None
courses NNS None
of IN None
doxorubicin NN Pharmocological
, , None
75 CD None
mg/m2 NN None
; : None
cyclophosphamide NN Pharmocological
, , None
1,200 CD None
mg/m2 NN None
; : None
vindesine NN Pharmocological
, , None
2 CD None
mg/m2 NN None
x NN None
2 CD None
; : None
bleomycin NN Pharmocological
, , None
10 CD None
mg NN None
x NN None
2 CD None
; : None
and CC None
prednisolone NN Pharmocological
, , None
60 CD None
mg/m2 NN None
x NN None
5 CD None
( ( None
ACVB NNP None
) ) None
, , None
consolidation NN None
with IN None
high-dose JJ None
methotrexate NN Pharmocological
, , None
ifosfamide NN Pharmocological
, , None
etoposide RB Pharmocological
, , None
asparaginase NN Pharmocological
, , None
and CC None
cytarabine NN Pharmocological
, , None
and CC None
a DT None
randomized VBN None
late JJ None
intensification NN None
with IN None
two CD None
courses NNS None
of IN None
cytarabine NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
teniposide NN Pharmocological
, , None
bleomycin NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( None
AraCVmB NNP None
) ) None
. . None
-DOCSTART- -X- N

moxifloxacin NN Pharmocological
Roux-en-Y JJ Surgical
gastric JJ Surgical
bypass NN Surgical
surgery NN Surgical
moxifloxacin NN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
moxifloxacin NN Pharmocological
orally RB Pharmocological
or CC Pharmocological
intravenously RB Pharmocological
moxifloxacin VB None
moxifloxacin NN None
-DOCSTART- -X- N

esmolol JJ Pharmocological
electroconvulsive JJ Physical
therapy NN Physical
( ( Physical
ECT NNP Physical
) ) Physical
esmolol JJ Pharmocological
ECT NNP Surgical
with IN Pharmocological
and CC Pharmocological
without IN Pharmocological
esmolol JJ Pharmocological
pretreatment NN Pharmocological
-DOCSTART- -X- N

surgically RB Surgical
assisted VBN Surgical
rapid JJ Surgical
maxillary JJ Surgical
expansion NN Surgical
; : None
surgically RB Surgical
assisted VBN Surgical
rapid JJ Surgical
maxillary JJ Surgical
expansion NN Surgical
( ( Surgical
SARME NNP Surgical
) ) Surgical
bone-borne JJ Physical
and CC Other
tooth-borne JJ Physical
devices NNS Physical
SARME NNP Surgical
-DOCSTART- -X- N

placebo NN Control
. . None
placebo NN Control
highly RB Educational
aversive JJ Educational
bitter NN Educational
taste NN Educational
. . None
fMRI NN None
design NN None
misleading NN Educational
cue NN Educational
-DOCSTART- -X- N

breast NN Educational
self-examination NN Educational
( ( Educational
BSE NNP Educational
) ) Educational
Program NNP Educational
BSE NNP Educational
BSE NNP Educational
-DOCSTART- -X- N

sheltered VBD Educational
workshops NNS Educational
sheltered VBN Educational
workshops NNS Educational
sheltered JJ Educational
workshops NNS Educational
non-sheltered JJ Educational
workshop NN Educational
-DOCSTART- -X- N

RU NNP Pharmocological
486 CD Pharmocological
RU NNP Pharmocological
486 CD Pharmocological
and CC None
three CD None
of IN None
its PRP$ None
metabolites NNS None
( ( None
RU NNP Pharmocological
42633-monodemethyl CD Pharmocological
, , Pharmocological
RU NNP Pharmocological
42848-didemethyl CD Pharmocological
, , None
and CC None
RU NNP Pharmocological
42698-hydroxymetabolite JJ Pharmocological
) ) None
RU NNP Pharmocological
486 CD Pharmocological
dose NN None
RU NNP Pharmocological
486 CD Pharmocological
-DOCSTART- -X- N

manidipine/delapril NN Pharmocological
losartan/hydrochlorothiazide NN Pharmocological
fixed-dose JJ Pharmocological
manidipine/delapril NN Pharmocological
losartan/hydrochlorothiazide JJ Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
manidipine/delapril NN Pharmocological
losartan/HCTZ NN Pharmocological
manidipine/delapril NN Pharmocological
manidipine/delapril NN Pharmocological
losartan/HCTZ NN Pharmocological
manidipine/delapril NN Pharmocological
-DOCSTART- -X- N

indomethacin NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
oral JJ Pharmocological
cilazapril NN Pharmocological
oral JJ Pharmocological
indomethacin NN Pharmocological
Cilazapril NNP Pharmocological
Indomethacin NNP Pharmocological
cilazapril NN Pharmocological
. . None
indomethacin JJ Control
plus CC Control
placebo NN Control
cilazapril NN Pharmocological
cilazapril JJ Control
plus CC Control
placebo NN Control
indomethacin NN Pharmocological
. . None
indomethacin NN Pharmocological
cilazapril NN Pharmocological
-DOCSTART- -X- N

fluoxetine NN Pharmocological
monotherapy NN Pharmocological
open-label JJ Pharmocological
fluoxetine NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
every DT Educational
day NN Educational
for IN Educational
up IN Educational
to TO Educational
8 CD Educational
weeks NNS Educational
. . None
fluoxetine NN Pharmocological
Fluoxetine NNP Pharmocological
Fluoxetine NNP Pharmocological
fluoxetine JJ Pharmocological
monotherapy NN Pharmocological
-DOCSTART- -X- N

teniposide NN Pharmocological
teniposide NN Pharmocological
with IN Physical
whole-brain JJ Physical
radiotherapy NN Physical
-- : None
a DT None
Whole-brain JJ Physical
radiotherapy NN Physical
( ( Physical
WBRT NNP Physical
) ) Physical
WBRT NNP Physical
teniposide NN Pharmocological
WBRT NNP Physical
. . None
Teniposide NNP Pharmocological
WBRT NNP Physical
chemotherapy NN Pharmocological
. . None
teniposide-alone JJ Pharmocological
teniposide-alone JJ Pharmocological
WBRT NNP Physical
teniposide RB Pharmocological
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
: : None
recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
r-HuEPO JJ Pharmocological
) ) Pharmocological
r-HuEPO NN Pharmocological
intravenous JJ Pharmocological
iron NN Pharmocological
gluconate NN Pharmocological
-DOCSTART- -X- N

desvenlafaxine NN Pharmocological
versus NN None
placebo NN Control
. . None
desvenlafaxine NN Pharmocological
desvenlafaxine JJ Pharmocological
succinate NN Pharmocological
) ) Pharmocological
( ( None
n JJ None
= NNP None
285 CD None
) ) None
and CC None
placebo NN None
( ( None
n JJ None
desvenlafaxine NN None
and CC None
placebo NN None
were VBD None
desvenlafaxine NN None
( ( None
n JJ None
= NNP None
208 CD None
) ) None
and CC None
placebo NN None
Desvenlafaxine NNP None
-DOCSTART- -X- N

Co-administration NN None
of IN None
pethidine NN Pharmocological
and CC None
clonidine NN Pharmocological
: : None
pethidine NN Pharmocological
0.75 CD None
mg NN None
kg-1 NN None
and CC None
clonidine NN Pharmocological
75 CD None
micrograms NNS None
0.5 CD Pharmocological
% NN Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
. . Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
with IN None
morphine JJ Pharmocological
( ( None
pethidine-clonidine JJ Pharmocological
: : None
bupivacaine NN Pharmocological
: : None
bupivacaine JJ Pharmocological
alone NN Pharmocological
bupivacaine NN Pharmocological
and CC None
morphine NN Pharmocological
-DOCSTART- -X- N

vitreous JJ Surgical
needle JJ Surgical
aspiration NN Surgical
mechanized VBN Surgical
vitreous JJ Surgical
biopsy NN Surgical
vitreous JJ Surgical
needle JJ Surgical
tap NN Surgical
vitreous JJ Physical
biopsy NN Physical
20-gauge JJ Physical
vitrectomy NN Physical
-DOCSTART- -X- N

Tolfenamic NNP Pharmocological
acid NN Pharmocological
and CC Pharmocological
caffeine NN Pharmocological
: : None
Tolfenamic NNP Pharmocological
acid NN Pharmocological
caffeine NN Pharmocological
, , None
metoclopramide NN Pharmocological
and CC None
pyridoxine NN Pharmocological
tolfenamic VB Pharmocological
acid NN Pharmocological
tolfenamic JJ Pharmocological
acid NN Pharmocological
either DT None
caffeine NN Pharmocological
metoclopramide RB Pharmocological
or CC None
pyridoxine NN Pharmocological
tolfenamic JJ Pharmocological
acid-caffeine JJ Pharmocological
combination NN Pharmocological
Metoclopramide NNP Pharmocological
pyridoxine NN Pharmocological
-DOCSTART- -X- N

metformin NN Pharmocological
and CC Pharmocological
insulin NN Pharmocological
metformin NN Pharmocological
placebo NN Control
metformin NN Pharmocological
treatment NN None
( ( None
850 CD None
mg RB None
b.i.d NN None
) ) None
vs NN None
placebo NN None
. . None
placebo NN Control
metformin NN Pharmocological
metformin NN Pharmocological
-DOCSTART- -X- N

moderate-intensity NN Physical
exercise NN Physical
therapy NN None
. . None
brisk JJ Physical
walking VBG Physical
program NN Physical
exercise NN Physical
usual JJ Educational
care NN Educational
usual JJ Physical
care NN Physical
plus CC Physical
exercise NN Physical
. . None
exercise NN Physical
standardized JJ None
, , None
self-administered JJ None
, , None
home-based JJ Physical
brisk NN Physical
walking VBG Physical
intervention NN Physical
exercise NN Physical
programs NNS Physical
. . None
structured JJ Physical
exercise NN Physical
program NN Physical
-DOCSTART- -X- N

school-based JJ Educational
physical-activity NN Educational
intervention NN Educational
. . Educational
Lifestyle NNP Educational
Education NNP Educational
for IN Educational
Activity NNP Educational
Program NNP Educational
( ( Educational
LEAP NNP Educational
) ) Educational
intervention NN Educational
LEAP NNP Educational
PE NNP Educational
component NN Educational
with IN Educational
core NN Educational
objectives NNS Educational
LEAP NNP Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

propofol NN Pharmocological
in IN Pharmocological
general JJ Pharmocological
anesthesia NN Pharmocological
( ( None
propofol NN Pharmocological
, , None
halothane NN Pharmocological
and CC None
midazolam/fentanyl NN Pharmocological
) ) None
in IN None
combination NN None
with IN None
catheter JJ None
epidural JJ None
anesthesia NN None
] NN None
. . None
epidural JJ Surgical
anaesthesia NN Surgical
bupivacaine NN Pharmocological
( ( Pharmocological
halothane NN Pharmocological
) ) Pharmocological
, , Pharmocological
light JJ Pharmocological
general JJ Pharmocological
anaesthesia NN Pharmocological
thiopental JJ Pharmocological
3-5 JJ Pharmocological
mg/kg NN Pharmocological
and CC Pharmocological
maintained VBD Pharmocological
with IN Pharmocological
halothane NN Pharmocological
. . None
propofol NN Pharmocological
midazolam FW Pharmocological
and CC Pharmocological
fentanyl NNS Pharmocological
intubated VBN Physical
non-depolarising JJ Pharmocological
muscle NN Pharmocological
relaxants NNS Pharmocological
manually RB Pharmocological
ventilated VBN Pharmocological
with IN Pharmocological
nitrous JJ Pharmocological
oxide-oxygen NN Pharmocological
morphine NN Pharmocological
epidurally RB Pharmocological
midazolam/fentanyl NN Pharmocological
propofol NN Pharmocological
midazolam/fentanyl NN Pharmocological
halothane NN Pharmocological
propofol NN Pharmocological
halothane NN Pharmocological
midazolam/fentanyl NN Pharmocological
Propofol NNP Pharmocological
midazolam/fentanyl NN Pharmocological
halothane NN Pharmocological
-DOCSTART- -X- N

proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
and CC None
roxithromycin NN Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
roxithromycin NN Pharmocological
omeprazole VBP Pharmocological
20 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
lansoprazole JJ Pharmocological
30 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
roxithromycin VBZ Pharmocological
300 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
and CC None
the DT None
combination NN None
of IN None
roxithromycin NN Pharmocological
with IN None
either DT None
omeprazole NN Pharmocological
or CC Pharmocological
lansoprazole NN Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
and CC None
roxithromycin NN Pharmocological
roxithromycin VB Pharmocological
proton NN None
pump NN None
inhibitor NN None
Proton NNP Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
roxithromycin VB Pharmocological
proton VBP Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
-DOCSTART- -X- N

Valsartan NNP Pharmocological
selective JJ Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blocker NN Pharmocological
( ( Pharmocological
ARB NNP Pharmocological
) ) Pharmocological
ARB NNP Pharmocological
valsartan NN Pharmocological
placebo NN Control
ARB NNP None
ARB NNP None
placebo NN None
ARB NNP None
-DOCSTART- -X- N

oral JJ Pharmocological
ganciclovir NN Pharmocological
Ganciclovir NNP Pharmocological
oral JJ Pharmocological
ganciclovir NN Pharmocological
oral JJ Pharmocological
ganciclovir NN Pharmocological
1000 CD Pharmocological
placebo NN Control
ganciclovir NN Pharmocological
placebo NN Control
ganciclovir NN Pharmocological
placebo NN None
ganciclovir NN Pharmocological
( ( None
placebo JJ None
ganciclovir CC Pharmocological
placebo NN Control
ganciclovir NN Pharmocological
-DOCSTART- -X- N

ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
UDCA NNP Pharmocological
) ) Pharmocological
UDCA NNP Pharmocological
UDCA NNP Pharmocological
-DOCSTART- -X- N

ranitidine VB Pharmocological
Ranitidine NNP Pharmocological
ranitidine NN Pharmocological
placebo-controlled JJ Control
placebo NN Pharmocological
ranitidine NN Pharmocological
placebo NN Pharmocological
ranitidine NN Pharmocological
placebo NN Pharmocological
ranitidine NN Pharmocological
ranitidine NN Pharmocological
thoracotomy NN Surgical
. . None
placebo-controlled JJ Control
ranitidine NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

personalized VBN Educational
feedback NN Educational
Web-based JJ Educational
screening NN Educational
and CC None
brief JJ Educational
interventions NNS Educational
laboratory-based JJ Educational
computerized JJ Educational
intervention NN Educational
. . Educational
Intervention NNP None
( ( None
Alcohol NNP None
Feedback NNP None
vs. IN None
Control NNP None
) ) None
?2 FW None
Assessment NNP None
( ( None
Motivational NNP None
Assessment NNP None
vs. IN None
No NNP None
Motivational NNP None
Assessment NNP None
) ) None
between-subjects NNS None
that IN None
a DT None
feedback-based JJ None
computerized JJ None
intervention NN None
that WDT None
-DOCSTART- -X- N

torso NN Physical
weighting VBG Physical
balance-based JJ Physical
torso NN Physical
weighting NN Physical
( ( Physical
BBTW NNP Physical
) ) Physical
BBTW NNP Physical
BBTW NNP Physical
-DOCSTART- -X- N

LV5FU2-irinotecan JJ Pharmocological
and CC None
LV5FU2 NNP Pharmocological
alone RB Pharmocological
or CC None
LV5FU2-cisplatin NNP Pharmocological
LV5FU2-cisplatin JJ Pharmocological
LV5FU2-irinotecan JJ Pharmocological
LV5FU2-irinotecan JJ Pharmocological
-DOCSTART- -X- N

Home NNP Physical
monitoring NN Physical
: : None
Home NNP Physical
blood NN Physical
pressure NN Physical
monitoring NN Physical
home NN Educational
blood NN Educational
pressure NN Educational
monitoring NN Educational
home NN Physical
monitoring NN Physical
Home NNP Physical
blood NN Physical
pressure NN Physical
monitoring NN Physical
non-pharmacologic JJ Physical
means NNS Physical
. . None
-DOCSTART- -X- N

aspirin NN Pharmocological
aspirin NNS Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
vitamin NN Pharmocological
E NN Pharmocological
aspirin VB Pharmocological
aspirin JJ Pharmocological
aspirin JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

bifidobacterium NN Pharmocological
breve VBP Pharmocological
Bifidobacterium NNP Pharmocological
breve NN Pharmocological
( ( Pharmocological
B. NNP Pharmocological
breve VBP Pharmocological
) ) Pharmocological
supplements NNS Pharmocological
three CD None
groups NNS None
: : None
Group NNP None
A NNP None
and CC None
B NNP None
received VBD None
a DT None
dose NN None
of IN None
1.6 CD None
x NNS None
10 CD None
( ( None
8 CD None
) ) None
cells NNS None
of IN None
B. NNP None
breve VBP None
supplement NN None
twice RB None
a DT None
day NN None
, , None
commencing VBG None
either CC None
from IN None
several JJ None
hours NNS None
after IN None
birth NN None
( ( None
group NN None
A NNP None
) ) None
or CC None
24 CD None
h NN None
after IN None
birth NN None
( ( None
group NN None
B NNP None
) ) None
. . None
control NN Control
group NN Control
no DT None
supplement NN None
. . None
-DOCSTART- -X- N

cavitron NN Surgical
ultrasonic JJ Surgical
surgical JJ Surgical
aspirator NN Surgical
with IN Surgical
bipolar JJ Surgical
cautery NN Surgical
cavitron NN Surgical
ultrasonic JJ Surgical
surgical JJ Surgical
aspirator NN Surgical
with IN Surgical
radiofrequency NN Surgical
coagulator-A JJ Surgical
Cavitron NNP Surgical
ultrasonic JJ Surgical
surgical JJ Surgical
aspirator NN Surgical
( ( Surgical
CUSA NNP Surgical
) ) Surgical
with IN Surgical
bipolar JJ Surgical
cautery NN Surgical
( ( Surgical
BP NNP Surgical
) ) Surgical
to TO Surgical
CUSA NNP Surgical
with IN Surgical
a DT Surgical
radiofrequency NN Surgical
coagulator NN Surgical
CUSA NNP Surgical
with IN Surgical
BP NNP Surgical
CUSA NNP Surgical
with IN Surgical
TL NNP Surgical
. . None
-DOCSTART- -X- N

4'-epi-doxorubicin JJ Pharmocological
cyclophosphamide NN Pharmocological
4'-epi-doxorubicin JJ Pharmocological
+ NN None
cisplatin NN Pharmocological
high-dose JJ Pharmocological
epirubicin NN Pharmocological
cyclophosphamide NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

telephone NN Educational
call NN Educational
interventions NNS Educational
telephone NN Educational
call NN Educational
interventions NNS Educational
, , Educational
who WP Educational
received VBD Educational
a DT Educational
weekly JJ Educational
telephone NN Educational
call NN Educational
intervention NN Educational
in IN Educational
addition NN Educational
to TO Educational
the DT Educational
usual JJ Educational
care NN Educational
. . None
-DOCSTART- -X- N

Clonidine NNP Pharmocological
clonidine NN Pharmocological
clonidine NN Pharmocological
or CC None
flunitrazepam NN Pharmocological
insulin NN Pharmocological
clonidine NN Pharmocological
clonidine JJ Pharmocological
-DOCSTART- -X- N

opioids NNS Pharmocological
placebo-controlled JJ Control
1 CD Pharmocological
mg/kg JJ Pharmocological
meperidine NN Pharmocological
or CC None
0.9 CD Control
% NN Control
saline NN Control
tracheal JJ Physical
suction NN Physical
or CC None
routine JJ Physical
nursing NN Physical
care NN Physical
. . None
opioid JJ Pharmocological
analgesia NN Pharmocological
-DOCSTART- -X- N

trandolapril JJ Pharmocological
hydrochlorothiazide VB Pharmocological
single-blind JJ None
placebo NN Control
trandolapril JJ Pharmocological
hydrochlorothiazide RB Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
or CC None
the DT None
combination NN None
-DOCSTART- -X- N

Growth NNP Pharmocological
hormone NN Pharmocological
treatment NN Pharmocological
GH NNP Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
GH NNP Pharmocological
therapy NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

progesterone NN Pharmocological
progesterone NN Pharmocological
were VBD None
assigned VBN None
to TO None
be VB None
untreated JJ None
, , None
control NN None
animals NNS None
( ( None
C NNP None
) ) None
, , None
or CC None
to TO None
receive VB None
PGF NNP None
( ( None
2? CD None
) ) None
on IN None
d0 NN None
( ( None
PG NNP None
) ) None
, , None
or CC None
receive VB None
two CD None
injections NNS None
of IN None
progesterone NN None
( ( None
200mg CD None
, , None
i.m NN None
. . None
each DT None
) ) None
on IN None
D NNP None
-5 NNP None
and CC None
on IN None
D NNP None
-2.5 NNP None
, , None
prior RB None
to TO None
PGF NNP None
( ( None
2? CD None
) ) None
, , None
on IN None
D NNP None
0 CD None
( ( None
2PPG CD None
) ) None
. . None
Treatment NN None
-DOCSTART- -X- N

lag NN Psychological
trials NNS Educational
practice NN Educational
testing VBG Educational
after IN Educational
a DT Educational
delay NN Educational
alphabet JJ Educational
subtraction NN Educational
items NNS Educational
in IN Educational
short JJ Educational
lag NN Educational
and CC Educational
long JJ Educational
lag NN Educational
conditions NNS Educational
. . Educational
immediately RB Educational
tested VBN Educational
tested VBN Educational
after IN Educational
a DT Educational
7-day JJ Educational
delay NN Educational
. . Educational
-DOCSTART- -X- N

Liposome-encapsulated JJ Pharmocological
doxorubicin NNS Pharmocological
conventional JJ Pharmocological
doxorubicin NN Pharmocological
liposome-encapsulated JJ Pharmocological
doxorubicin NN Pharmocological
, , None
TLC NNP Pharmocological
D-99 NNP Pharmocological
( ( Pharmocological
Myocet NNP Pharmocological
, , Pharmocological
Elan NNP Pharmocological
Pharmaceuticals NNP Pharmocological
, , Pharmocological
Princeton NNP Pharmocological
, , Pharmocological
NJ NNP Pharmocological
) ) Pharmocological
conventional JJ Pharmocological
doxorubicin NN Pharmocological
TLC NNP Pharmocological
D-99 NNP Pharmocological
( ( Pharmocological
75 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
or CC None
doxorubicin NN Pharmocological
multiple-gated JJ Pharmocological
radionuclide NN Pharmocological
cardioangiography NN Pharmocological
scan JJ Pharmocological
doxorubicin-treated JJ Pharmocological
doxorubicin NN Pharmocological
TLC NNP Pharmocological
D-99 NNP Pharmocological
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
. . None
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
. . None
TLC NNP Pharmocological
D-99 NNP Pharmocological
doxorubicin NNS Pharmocological
-DOCSTART- -X- N

citalopram NN Pharmocological
citalopram NN Pharmocological
Selective NNP Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitors NNS Pharmocological
citalopram JJ Pharmocological
hydrobromide NN Pharmocological
therapy NN Pharmocological
citalopram NN Pharmocological
placebo NN Control
citalopram NN Pharmocological
hydrobromide NN Pharmocological
( ( Pharmocological
10 CD Pharmocological
mg/5 RB Pharmocological
mL NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
citalopram NN Pharmocological
hydrobromide NN Pharmocological
citalopram-treated JJ Pharmocological
placebo NN Control
citalopram-treated JJ Pharmocological
placebo NN Control
Citalopram NNP Pharmocological
citalopram NN Pharmocological
-DOCSTART- -X- N

risperidone-associated JJ Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
-DOCSTART- -X- N

Zolmitriptan NNP Pharmocological
( ( Pharmocological
311C90 CD Pharmocological
) ) Pharmocological
fluoxetine NN Pharmocological
Zolmitriptan NNP Pharmocological
( ( Pharmocological
Zomig NNP Pharmocological
, , Pharmocological
formerly RB Pharmocological
311C90 CD Pharmocological
) ) Pharmocological
selective JJ Pharmocological
5-hydroxytryptamine JJ Pharmocological
( ( Pharmocological
5-HT JJ Pharmocological
) ) Pharmocological
1B/1D-receptor JJ Pharmocological
agonist NN Pharmocological
placebo-controlled JJ Control
fluoxetine JJ Pharmocological
fluoxetine JJ Pharmocological
fluoxetine JJ Pharmocological
zolmitriptan NN Pharmocological
fluoxetine NN Pharmocological
. . None
Zolmitriptan NNP Pharmocological
fluoxetine NN Pharmocological
. . None
zolmitriptan NN Pharmocological
zolmitriptan NN Pharmocological
-DOCSTART- -X- N

Gefitinib NNP Pharmocological
or CC None
placebo NN Control
tamoxifen JJ Pharmocological
plus CC None
placebo NN Control
gefitinib NN Pharmocological
( ( None
gefitinib NN Pharmocological
: : Pharmocological
placebo NN Pharmocological
) ) None
with IN None
gefitinib NN None
with IN None
placebo NN None
. . None
with IN None
gefitinib NN None
with IN None
placebo NN None
. . None
with IN None
gefitinib JJ None
plus CC None
tamoxifen JJ None
for IN None
gefitinib NN None
; : None
-DOCSTART- -X- N

emotional JJ Educational
distress NN Educational
structured JJ Other
questionnaire NN Other
enhanced JJ Educational
intervention NN Educational
conditions NNS Educational
standard JJ Educational
intervention NN Educational
. . None
motivation NN Educational
intervention NN Educational
-DOCSTART- -X- N

One CD Pharmocological
quadrant JJ Pharmocological
sub-Tenon NN Pharmocological
's POS Pharmocological
capsule NN Pharmocological
anesthesia NN Pharmocological
Sub-Tenon NNP Pharmocological
's POS Pharmocological
capsule NN Pharmocological
anesthesia NN Pharmocological
retrobulbar NN None
sub-Tenon NN Pharmocological
's POS Pharmocological
retrobulbar NN Pharmocological
anesthesia NN Pharmocological
. . Pharmocological
sub-Tenon NN Pharmocological
's POS Pharmocological
or CC Pharmocological
retrobulbar NN Pharmocological
anesthesia NN Pharmocological
; : None
Retrobulbar NNP Pharmocological
anesthesia NN Pharmocological
lidocaine NN Pharmocological
without IN Pharmocological
epinephrine NN Pharmocological
and CC Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
bupivacaine NN Pharmocological
. . None
Sub-Tenon NNP Pharmocological
's POS Pharmocological
anesthesia NN Pharmocological
1-QST CD Pharmocological
retrobulbar VB Pharmocological
anesthesia NN Pharmocological
; : None
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
1-QST JJ Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
JAK NNP Pharmocological
inhibitor NN Pharmocological
tofacitinib NN Pharmocological
( ( Pharmocological
CP-690,550 NNP Pharmocological
) ) Pharmocological
versus NN None
placebo NN Control
background NN Pharmocological
methotrexate NN Pharmocological
oral JJ Pharmocological
tofacitinib NN Pharmocological
( ( Pharmocological
CP-690,550 NNP Pharmocological
) ) Pharmocological
with IN None
placebo NN Control
placebo NN Control
or CC None
tofacitinib NN Pharmocological
MTX NNP Pharmocological
. . None
tofacitinib NN Pharmocological
placebo NN None
( ( None
33.3 CD None
addition NN None
of IN None
tofacitinib NN None
at IN None
-DOCSTART- -X- N

[ JJ Pharmocological
Mitomycin NNP Pharmocological
C NNP Pharmocological
plus CC Pharmocological
HCFU NNP Pharmocological
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
mitomycin JJ Pharmocological
C NNP Pharmocological
( ( Pharmocological
MMC NNP Pharmocological
) ) Pharmocological
and CC None
carmofur NN Pharmocological
( ( Pharmocological
HCFU NNP Pharmocological
) ) Pharmocological
MMC NNP Pharmocological
MMC NNP Pharmocological
+ NNP Pharmocological
HCFU NNP Pharmocological
group NN Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
+ NNP Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
only RB Pharmocological
MMC NNP Pharmocological
+ NNP Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
HCFU NNP Pharmocological
-DOCSTART- -X- N

compare VB None
pretreatment JJ Physical
plasma JJ Physical
EBV-DNA JJ Physical
quantification NN Physical
with IN None
EBV NNP Physical
by IN Physical
-DOCSTART- -X- N

Tegaserod NNP Pharmocological
, , Pharmocological
a DT Pharmocological
5-hydroxytryptamine JJ Pharmocological
type NN Pharmocological
4 CD Pharmocological
receptor NN Pharmocological
partial JJ Pharmocological
agonist NN Pharmocological
GI NNP Pharmocological
prokinetic JJ Pharmocological
agents NNS Pharmocological
selective JJ Pharmocological
5-hydroxytryptamine JJ Pharmocological
type NN Pharmocological
4 CD Pharmocological
receptor NN Pharmocological
partial JJ Pharmocological
agonist NN Pharmocological
tegaserod NN Pharmocological
tegaserod NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Drawtex NNP Physical
with IN Physical
standard JJ Physical
dressings NNS Physical
capillary JJ Physical
dressing NN Physical
( ( None
Drawtex NNP Physical
, , Physical
now RB Physical
rebranded VBN Physical
as IN Physical
Vibriant NNP Physical
RCD NNP Physical
[ NNP None
Vibriant NNP Physical
Technology NNP Physical
Services NNP Physical
] NNP None
) ) None
with IN Physical
routine JJ Physical
practice NN Physical
for IN Physical
-DOCSTART- -X- N

lymphadenectomy NN Physical
lymphadenectomy NN Physical
lymph NN Physical
node NN Physical
sampling VBG Physical
systematic JJ Physical
lymphadenectomy NN Physical
lymphadenectomy NN Physical
lymph NN Physical
node NN Physical
sampling NN Physical
( ( Physical
LS NNP Physical
radical JJ Physical
systematic JJ Physical
lymphadenectomy NN Physical
( ( Physical
LA NNP Physical
lymphadenectomy NN Physical
systematic JJ Physical
lymphadenectomy NN Physical
lymphadenectomy NN Physical
. . None
-DOCSTART- -X- N

auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
( ( Educational
AIT NNP Educational
) ) Educational
-DOCSTART- -X- N

Minocycline NNP Pharmocological
Minocycline NNP Pharmocological
placebo-controlled JJ Control
minocycline NN Pharmocological
minocycline NN Pharmocological
at IN Pharmocological
100 CD Pharmocological
and CC Pharmocological
200 CD Pharmocological
mg/day NN Pharmocological
-DOCSTART- -X- N

153Gd CD Physical
transmission NN Physical
computed VBN Physical
tomography NN Physical
99mTc-ethyl JJ Physical
cysteinate NN Physical
dimer NN Physical
( ( Physical
ECD NNP Physical
) ) Physical
images NNS Physical
ECD NNP Physical
TCT NNP Physical
ECD NNP Physical
ECD-based JJ Physical
TCT-based JJ Physical
ECD/CD NNP Physical
, , None
ECD/NMI NNP Physical
TCT/CD NNP Physical
ECD NNP Physical
CD NN Physical
NMI NNP Physical
TCT NNP Physical
TCT NNP Physical
-DOCSTART- -X- N

Movement-related JJ Physical
potentials NNS Physical
temporal JJ Other
and CC Other
spatial JJ Other
cues NNS Other
. . None
movement-related JJ Physical
potentials NNS Physical
( ( Physical
MRPs NNP Physical
) ) Physical
Movement-related JJ Educational
potentials NNS Educational
associated VBN Educational
with IN Educational
sequential JJ Educational
movements NNS Educational
were VBD Educational
investigated VBN Educational
under IN Educational
various JJ Educational
cueing VBG Educational
conditions NNS Educational
( ( None
non-cued JJ Physical
externally RB Physical
cued VBN Physical
, , None
predictable JJ Physical
not RB Educational
unpredictable JJ Educational
( ( None
non-cued JJ Other
not RB Physical
externally RB Physical
cued VBN Physical
external JJ None
cues NNS None
are VBP None
given VBN None
. . None
external JJ None
cues NNS None
timing VBG Physical
cues NNS Physical
not RB None
spatial JJ None
cues NNS None
non-cued JJ None
-DOCSTART- -X- N

intravenous JJ Control
nitroglycerin JJ Control
plus CC Control
placebo JJ Control
nitroglycerin JJ Pharmocological
plus CC Pharmocological
N-acetylcysteine JJ Pharmocological
N-acetylcysteine NN Pharmocological
nitroglycerin NN Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
microgram/kg NN Pharmocological
per IN Pharmocological
min NN Pharmocological
) ) Pharmocological
combined VBN None
with IN None
N-acetylcysteine NNP Pharmocological
placebo NN Control
N-acetylcysteine NNP Pharmocological
and CC Pharmocological
nitroglycerin RB Pharmocological
( ( None
nitroglycerin JJ Pharmocological
plus CC Pharmocological
N-acetylcysteine JJ Pharmocological
nitroglycerin CC Control
plus CC Control
placebo NN Control
N-acetylcysteine NNP Pharmocological
( ( None
nitroglycerin JJ Pharmocological
plus CC Pharmocological
N-acetylcysteine JJ Pharmocological
: : None
nitroglycerin JJ Pharmocological
plus CC Pharmocological
placebo NN Pharmocological
: : None
nitroglycerin JJ Pharmocological
and CC Pharmocological
N-acetylcysteine JJ Pharmocological
N-acetylcysteine NNP Pharmocological
nitroglycerin NN Pharmocological
-DOCSTART- -X- N

postpartum JJ Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
regimen NNS Pharmocological
Magnesium NN Pharmocological
sulphate NN Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
standard JJ Pharmocological
Pritchard NNP Pharmocological
regimen NN Pharmocological
of IN Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
shortened JJ None
postpartum NN None
course NN None
intramuscular JJ Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

Calcium NN Pharmocological
acetate NN Pharmocological
calcium NN Pharmocological
carbonate NN Pharmocological
CA NNP Pharmocological
CC NNP Pharmocological
-DOCSTART- -X- N

argon-laser NN Surgical
trabeculoplasty NN Surgical
-DOCSTART- -X- N

radiotherapy NN Physical
, , None
chemotherapy NN Pharmocological
( ( Pharmocological
cyclophosphamide NN Pharmocological
) ) Pharmocological
and CC None
placebo JJ Control
treatment NN None
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
placebo NN Control
. . None
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
placebo NN Control
. . None
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
placebo NN Control
. . None
placebo NN Control
radiotherapy NN Physical
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
radiotherapy NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

Vancomycin NNP Pharmocological
ceftazidime NN Pharmocological
plus CC Pharmocological
amikacin NN Pharmocological
( ( Pharmocological
CA NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
vancomycin NN Pharmocological
( ( Pharmocological
V NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

cytoflavin NN Pharmocological
-DOCSTART- -X- N

phonophoresis NN Physical
iontophoresis NN Physical
dexamethasone NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
Dexamethasone NNP Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
DEX-P NNP Pharmocological
) ) Pharmocological
phonophoresis NN Physical
( ( Physical
PH NNP Physical
) ) Physical
0.4 CD Pharmocological
% NN Pharmocological
DEX-P JJ Pharmocological
iontophoresis NN Physical
( ( Physical
ION NNP Physical
) ) Physical
therapy NN Pharmocological
PH NNP Physical
ION NNP Physical
DEX-P JJ Pharmocological
phonophoresis NN Physical
DEX-P JJ Pharmocological
iontophoresis NN Physical
-DOCSTART- -X- N

resources NNS None
used VBN None
for IN None
intensive JJ Physical
and CC Physical
conventional JJ Physical
therapy NN Physical
and CC None
to TO None
deal VB None
with IN None
the DT None
side NN None
effects NNS None
of IN None
therapy NN None
were VBD None
assessed VBN None
at IN None
each DT None
of IN None
the DT None
and CC None
summarized VBN None
. . None
Unit NN None
costs NNS None
were VBD None
derived VBN None
from IN None
the DT None
DCCT NNP None
, , None
manufacturers NNS None
, , None
and CC None
Medicare NNP None
DCCT NNP None
DCCT NNP None
DCCT NNP None
intensive JJ None
therapy NN None
-DOCSTART- -X- N

alcohol NN Pharmocological
morphine NN Pharmocological
sulfate NN Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
opioids NNS Pharmocological
Morphine NNP Pharmocological
sulfate NN Pharmocological
and CC Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
extended VBD Pharmocological
release NN Pharmocological
capsules NNS Pharmocological
( ( Pharmocological
MS-sNT NNP Pharmocological
) ) Pharmocological
MS-sNT NNP Pharmocological
alcohol NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
recombinant JJ Pharmocological
hypoallergenic JJ Pharmocological
Bet NNP Pharmocological
v NN Pharmocological
1 CD Pharmocological
recombinant JJ Pharmocological
Bet NNP Pharmocological
v NN Pharmocological
1 CD Pharmocological
( ( Pharmocological
rBet JJ Pharmocological
v IN Pharmocological
1-FV JJ Pharmocological
) ) Pharmocological
of IN None
rBet JJ None
v JJ None
1-FV JJ None
one CD None
placebo NN None
placebo NN None
( ( None
n JJ None
= NNP None
placebo NN None
( ( None
-18.8 CD None
of IN None
rBet JJ None
v JJ None
1-FV JJ None
appears VBZ None
-DOCSTART- -X- N

CDP571 NNP Pharmocological
placebo-controlled JJ Control
CDP571 NNP Pharmocological
placebo-controlled JJ Control
intravenous JJ None
CDP571 NNP Control
10 CD None
mg/kg NN None
or CC None
placebo NN None
CDP571 NNP Pharmocological
placebo NN Control
CDP571 NNP Pharmocological
CDP571 NNP Pharmocological
-DOCSTART- -X- N

Uvulopalatopharyngoplasty NNP Surgical
laser NN Physical
assisted VBD Physical
uvulopalatoplasty JJ Physical
conventional JJ Physical
uvulopalatopharyngoplasty JJ Physical
( ( Physical
UPPP NNP Physical
) ) Physical
laser $ Physical
assisted VBN Physical
uvulopalatoplasty JJ Physical
( ( Physical
LAUP NNP Physical
) ) Physical
LAUP NNP Physical
UPPP NNP Physical
. . None
LAUP NNP Physical
UPPP NNP Physical
-DOCSTART- -X- N

Arm-cranking JJ Physical
exercise NN Physical
arm-cranking JJ Physical
exercise NN Physical
program NN Physical
12-week JJ Physical
arm-cranking JJ Physical
exercise NN Physical
program NN Physical
consisting VBG Educational
of IN Educational
warming-up JJ Educational
( ( Educational
10-15min JJ Educational
) ) Educational
followed VBN Educational
by IN Educational
a DT Educational
main JJ Educational
part NN Educational
in IN Educational
arm-crank JJ Educational
cooling-down JJ Physical
arm-cranking JJ Physical
exercise NN Physical
program NN Physical
-DOCSTART- -X- N

nootropic JJ Pharmocological
therapy NN Pharmocological
Actovegin NNP Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
with IN Pharmocological
250 CD Pharmocological
ml NNS Pharmocological
20 CD Pharmocological
% NN Pharmocological
Actovegin NNP Pharmocological
and CC None
250 CD Control
ml NNS Control
placebo JJ Control
daily RB None
. . None
Auditory NNP Physical
ERPs NNP Physical
placebo VB None
. . None
placebo VB None
. . None
-DOCSTART- -X- N

calcium NN Pharmocological
and CC None
salmon JJ Pharmocological
calcitonin NN Pharmocological
] NN None
salmon JJ Pharmocological
calcitonin NN Pharmocological
. . None
calcium NN Pharmocological
100 CD None
I.U NNP None
. . None
calcitonin NN Pharmocological
subcutaneously RB None
every DT None
second JJ None
evening NN None
and CC None
group NN None
3 CD None
( ( None
n JJ None
= NNP None
20 CD None
) ) None
received VBD None
the DT None
same JJ None
dose NN None
every DT None
evening NN None
. . None
-DOCSTART- -X- N

dietary JJ Pharmocological
pyridoxine NN Pharmocological
dietary JJ Pharmocological
pyridoxine NN Pharmocological
( ( Pharmocological
PN NNP Pharmocological
) ) Pharmocological
into IN None
six CD None
treatments NNS None
in IN None
triplicates NNS None
( ( None
Five CD None
iso-nitrogenous JJ None
( ( None
356.3 CD None
? . None
2.7 CD None
g/kg JJ None
crude NN None
protein NN None
) ) None
purified VBD None
diets NNS None
were VBD None
PN NNP None
supplementation NN None
increased VBD None
mg JJ None
PN/kg NNP None
diet-fed NN None
group NN None
their PRP$ None
non-PN-fed JJ None
counterpart NN None
dietary JJ None
PN NNP None
supplementation NN None
at IN None
-DOCSTART- -X- N

Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
b NN Pharmocological
vaccines NNS Pharmocological
. . Pharmocological
Hib NNP Pharmocological
vaccines NNS Pharmocological
Hib-specific NNP Pharmocological
capsular JJ Pharmocological
polysaccharide NN Pharmocological
, , Pharmocological
PRP NNP Pharmocological
; : Pharmocological
contained VBN None
PRP NNP Pharmocological
pertussis NN Pharmocological
vaccine NN Pharmocological
, , Pharmocological
PRP-P. NNP Pharmocological
DTP NNP Pharmocological
control NN Control
PRP NNP Pharmocological
PRP-P NNP Pharmocological
PRP-P NNP Pharmocological
-DOCSTART- -X- N

intravenously RB Pharmocological
administered VBN Pharmocological
histamine NN Pharmocological
Placebo NNP Pharmocological
or CC None
histamine NN Pharmocological
histamine NN Pharmocological
administration NN None
of IN None
histamine NN Pharmocological
Intravenous NNP Pharmocological
histamine NN Pharmocological
-DOCSTART- -X- N

Risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Control
placebo-controlled JJ Control
risperidone NN Pharmocological
placebo NN Control
. . None
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
Risperidone NN Pharmocological
Risperidone NN Pharmocological
-DOCSTART- -X- N

ischaemic JJ Physical
preconditioning NN Physical
, , None
cardiopulmonary JJ Surgical
bypass NN Surgical
and CC None
myocardial JJ Surgical
ischaemic/reperfusion NN Surgical
ischaemic JJ Physical
preconditioning NN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
ischaemic JJ Physical
preconditioning NN Physical
. . Surgical
ischaemic JJ Physical
preconditioning NN Physical
control NN None
group NN None
. . None
ischaemic JJ Physical
preconditioning NN Physical
two CD None
cycles NNS None
of IN None
2-min JJ None
ischaemia NN Physical
followed VBN None
by IN None
3-min JJ None
reperfusion NN Physical
. . None
ischaemic JJ Physical
preconditioning NN Physical
ischaemic JJ Physical
preconditioning NN Physical
ischaemic JJ Physical
preconditioning NN Physical
. . Surgical
ischaemic JJ Physical
preconditioning NN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
ischaemic JJ Physical
preconditioning NN Physical
-DOCSTART- -X- N

naltrexone NN Pharmocological
. . None
naltrexone NN Pharmocological
( ( Pharmocological
NAL NNP Pharmocological
) ) Pharmocological
. . None
double-blind JJ None
crossover NN None
study NN None
with IN None
NAL NNP Pharmocological
at IN None
the DT None
doses NNS None
of IN None
0.5 CD None
, , None
1.0 CD None
and CC None
1.5 CD None
mg/kg NN None
every DT None
48 CD None
hours NNS None
. . None
The DT None
behavioural JJ None
evaluation NN None
was VBD None
conducted VBN None
using VBG None
the DT None
specific JJ None
NAL NNP Pharmocological
treatment NN None
produced VBD None
a DT None
significant JJ None
reduction NN None
of IN None
the DT None
in IN None
seven CD None
( ( None
responders NNS None
) ) None
out IN None
of IN None
12 CD None
pharmacological JJ None
therapy NN None
with IN None
opiate JJ Pharmocological
antagonists NNS Pharmocological
. . None
-DOCSTART- -X- N

educational JJ Educational
intervention NN Educational
view VB Educational
a DT Educational
video NN Educational
of IN Educational
the DT Educational
same JJ Educational
boy NN Educational
in IN Educational
one CD Educational
of IN Educational
three CD Educational
conditions NNS Educational
: : Educational
No DT Educational
Autism NNP Educational
, , Educational
Autism NNP Educational
, , Educational
or CC Educational
Autism/Information NNP Educational
. . Educational
-DOCSTART- -X- N

Whole-body JJ Other
CT NNP Other
screening NN Other
: : None
scan JJ None
delay NN None
and CC None
contrast NN Pharmocological
injection NN Pharmocological
contrast-enhanced JJ Other
whole-body NN Other
computed VBN Other
tomography NN Other
( ( Other
CT NNP Other
) ) Other
. . Other
protocol NN None
A-scan JJ None
delay NN None
of IN None
65 CD None
s NNS None
after IN None
starting VBG None
contrast NN Pharmocological
injection NN Pharmocological
over IN None
30 CD None
s NNS None
; : None
protocol CC None
B-105 NNP None
and CC None
70 CD None
s NN None
; : None
and CC None
protocol VB None
C-145 NNP None
and CC None
110 CD None
s NN None
protocol NN None
C NNP None
whole-body JJ Other
CT NNP Other
. . Other
-DOCSTART- -X- N

rituximab NN Pharmocological
etoposide JJ Pharmocological
and CC Pharmocological
G-CSF JJ Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
rituximab NN Pharmocological
etoposide JJ Pharmocological
etoposide NN Pharmocological
, , Pharmocological
G-CSF NNP Pharmocological
and CC Pharmocological
rituximab NN Pharmocological
. . None
-DOCSTART- -X- N

educational JJ Educational
instrument NN Educational
intervention NN None
intervention NN None
reference NN Educational
education NN Educational
instrument NN Educational
education NN Educational
seminar NN Educational
-DOCSTART- -X- N

Teaching VBG Educational
to TO Educational
seek VB Educational
information NN Educational
: : Educational
A DT Educational
time NN Educational
delay NN Educational
procedure NN Educational
was VBD Educational
used VBN Educational
to TO Educational
teach VB Educational
to TO Educational
ask VB Educational
the DT Educational
question NN Educational
What WP Educational
's VBZ Educational
that DT Educational
? . Educational
when WRB Educational
novel JJ Educational
stimuli NNS Educational
were VBD Educational
presented VBN Educational
during IN Educational
an DT Educational
instructional JJ Educational
task NN Educational
. . Educational
-DOCSTART- -X- N

Lumbar NNP Physical
puncture NN Physical
-DOCSTART- -X- N

clinical JJ Educational
pharmacy NN Educational
services NNS Educational
clinical JJ Educational
pharmacist NN Educational
received VBD Educational
clinical JJ Educational
pharmacy NN Educational
services NNS Educational
that WDT Educational
included VBD Educational
a DT Educational
clinical JJ Educational
pharmacist NN Educational
performing VBG Educational
patient JJ Educational
medication NN Educational
reviews NNS Educational
, , Educational
with IN Educational
emphasis NN Educational
on IN Educational
preventing VBG Educational
or CC Educational
resolving VBG Educational
medication-related JJ Educational
problems NNS Educational
and CC Educational
providing VBG Educational
medication NN Educational
recommendations NNS Educational
. . Educational
received VBD Educational
routine JJ Control
clinic NN Control
services NNS Control
, , Educational
but CC Educational
had VBD Educational
no DT Control
clinical JJ Control
pharmacist NN Control
interaction NN Control
. . Educational
-DOCSTART- -X- N

ketoconazole NN Pharmocological
griseofulvin NN Pharmocological
ketoconazole JJ Pharmocological
200 CD Pharmocological
mg JJ Pharmocological
daily JJ Pharmocological
or CC Pharmocological
griseofulvin JJ Pharmocological
1 CD Pharmocological
g JJ Pharmocological
ketoconazole NN Pharmocological
griseofulvin NN Pharmocological
-DOCSTART- -X- N

telehealth NN Educational
intervention NN Educational
telehealth NN Educational
intervention NN Educational
Health NNP Physical
Buddy NNP Physical
( ( Physical
R NNP Physical
) ) Physical
telehealth NN Educational
intervention NN Educational
-DOCSTART- -X- N

stanol NN Pharmocological
ester NN Pharmocological
stanol NN Pharmocological
esters NNS Pharmocological
stanol JJ Pharmocological
ester NN Pharmocological
or CC None
placebo NN Physical
stanol NN Pharmocological
( ( Pharmocological
ester JJ Pharmocological
form NN Pharmocological
) ) Pharmocological
stanol NN Pharmocological
( ( Pharmocological
ester JJ Pharmocological
form NN Pharmocological
) ) Pharmocological
stanol NN Pharmocological
placebo VB Control
stanol JJ Pharmocological
esters NNS Pharmocological
placebo NN Control
. . None
Stanol NNP Pharmocological
esters NNS Pharmocological
-DOCSTART- -X- N

modified VBN None
starch NN None
hydrophilic NN None
matrix NN None
for IN None
the DT None
sustained JJ None
release NN None
of IN None
theophylline NN Pharmocological
theophylline NN Pharmocological
with IN Pharmocological
a DT Pharmocological
hydrophilic JJ Pharmocological
starch NN Pharmocological
matrix NN Pharmocological
Theo-dur NN Pharmocological
Theo-dur NNP Pharmocological
theophylline NN None
with IN None
70 CD None
% NN None
drum-dried JJ None
corn NN None
starch NN None
as IN None
the DT None
sustained-release JJ None
agent NN None
( ( None
DDCS-70 NNP None
) ) None
Theo-dur NNP Pharmocological
-DOCSTART- -X- N

Laser-aided JJ Surgical
external JJ Surgical
subretinal JJ Surgical
fluid NN Surgical
transchoroidally RB Surgical
needle JJ Other
angulated VBN Surgical
endolaser NN Surgical
probe NN Surgical
laser-aided JJ Surgical
drainage NN Surgical
transchoroidal NN Surgical
needle JJ Surgical
drainage NN Surgical
-DOCSTART- -X- N

occupational JJ Educational
physiotherapy JJ Psychological
specialist JJ Psychological
therapy NN Psychological
-DOCSTART- -X- N

ovarian JJ Physical
cancer NN Physical
algorithm NN Physical
( ( Physical
ROCA NNP Physical
) ) Physical
screening NN None
with IN None
CA-125 NNP None
and CC None
transvaginal JJ None
ultrasound NN None
( ( None
TVU NNP None
) ) None
. . None
ovarian JJ Physical
cancer NN Physical
algorithm NN Physical
( ( Physical
ROCA NNP Physical
) ) Physical
ROCA NNP Physical
in IN Physical
PLCO NNP Physical
ROCA NNP Physical
ROCA NNP Physical
ROCA NNP Physical
ROCA NNP Physical
-DOCSTART- -X- N

Family RB Educational
economic JJ Educational
empowerment NN Educational
family NN Educational
economic JJ Educational
empowerment NN Educational
family NN Educational
economic JJ Educational
empowerment NN Educational
intervention NN Educational
matched JJ Educational
children NNS Educational
savings NNS Educational
accounts NNS Educational
, , Educational
financial JJ Educational
management NN Educational
workshops NNS Educational
and CC Educational
mentorship NN Educational
. . Educational
control NN None
-DOCSTART- -X- N

botulinum NN Pharmocological
neurotoxin NN Pharmocological
type IN Pharmocological
a DT Pharmocological
botulinum NN Pharmocological
neurotoxin NN Pharmocological
type NN Pharmocological
A DT Pharmocological
preparation NN Pharmocological
NT NNP Pharmocological
201 CD Pharmocological
single JJ Pharmocological
injections NNS Pharmocological
of IN Pharmocological
NT NNP Pharmocological
201 CD Pharmocological
extensor NN Pharmocological
digitorum NN Pharmocological
brevis NN Pharmocological
same JJ Pharmocological
dose NN Pharmocological
into IN Pharmocological
the DT Pharmocological
contralateral JJ Pharmocological
EDB NNP Pharmocological
. . None
NT NNP Pharmocological
201 CD Pharmocological
and CC Pharmocological
BTXCo NNP Pharmocological
NT CC Pharmocological
201 CD Pharmocological
BTXCo NNP Pharmocological
NT NNP Pharmocological
201 CD Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
MC-1 NNP Pharmocological
MC-1 NN Pharmocological
MC-1 NNP Pharmocological
MC-1 NNP Pharmocological
MC-1 NNP Pharmocological
placebo NNS Control
MC-1 NNP Pharmocological
-DOCSTART- -X- N

Thermal JJ Surgical
welding VBG Surgical
versus NN None
bipolar JJ Surgical
tonsillectomy NN Surgical
: : None
thermal JJ Physical
welding VBG Physical
tonsillectomy NN Physical
( ( Physical
TWT NNP Physical
) ) Physical
with IN None
bipolar JJ Physical
electrocautery NN Physical
tonsillectomy NN Physical
( ( Physical
BET NNP Physical
) ) Physical
procedure NN Surgical
. . None
TWT NNP Physical
BET NNP Physical
TWT NNP Physical
BET NNP Physical
TWT NNP Physical
BET NNP Physical
TWT NNP Physical
BET NNP Physical
Thermal NNP Surgical
welding VBG Surgical
tonsillectomy JJ Surgical
procedure NN Surgical
-DOCSTART- -X- N

snowshoeing VBG Physical
. . None
snowshoe JJ Physical
training NN Physical
program NN Physical
run RP Control
training VBG Control
program NN Control
. . None
-DOCSTART- -X- N

family NN Pharmocological
therapy NN Pharmocological
family NN Pharmocological
therapy NN Pharmocological
family NN Physical
therapy NN Physical
or CC None
the DT None
control NN Control
treatment NN Control
( ( Control
individual JJ Control
supportive JJ Control
therapy NN Control
) ) None
-DOCSTART- -X- N

cyclical JJ Pharmocological
clodronate NN Pharmocological
therapies NNS Pharmocological
clodronate NN Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
, , Pharmocological
1000 CD Pharmocological
mg/day NN Pharmocological
; : Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
plus CC Pharmocological
oral JJ Pharmocological
clodronate NN Pharmocological
, , Pharmocological
400 CD Pharmocological
mg/day NN Pharmocological
; : Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
plus CC Pharmocological
oral JJ Pharmocological
clodronate NN Pharmocological
, , Pharmocological
400 CD Pharmocological
mg/day NN Pharmocological
for IN Pharmocological
30 CD Pharmocological
days NNS Pharmocological
, , Pharmocological
followed VBN Pharmocological
by IN Pharmocological
a DT Pharmocological
60-day JJ Pharmocological
period NN Pharmocological
of IN Pharmocological
calcium JJ Pharmocological
supplement NN Pharmocological
alone RB Pharmocological
. . Pharmocological
clodronate-treated JJ Pharmocological
cyclical JJ Pharmocological
clodronate NN Pharmocological
Continuous JJ Pharmocological
clodronate NN Pharmocological
treatment NN Pharmocological
clodronate NN Pharmocological
-DOCSTART- -X- N

adenosine NN Pharmocological
by IN None
adenosine NN None
intravenous JJ Pharmocological
adenosine NN Pharmocological
, , None
140 CD None
?g?kg NN None
( ( None
-1 NNP None
) ) None
?min NNP None
( ( None
-1 NNP None
) ) None
, , None
during IN None
5 CD None
min NNS None
vs. FW None
placebo NN None
) ) None
. . None
We PRP None
did VBD None
effect NN None
. . None
Adenosine NNP None
Intravenous JJ None
-DOCSTART- -X- N

evidence-based JJ Educational
prescription NN Educational
label NN Educational
enhanced JJ Educational
label NN Educational
label NN Educational
-DOCSTART- -X- N

ambient JJ Physical
transitional JJ Physical
prism NN Physical
lenses NNS Physical
. . Educational
wearing VBG Physical
ambient JJ Physical
lenses NNS Physical
placebo NN Control
ambient JJ Physical
lenses NNS Physical
-DOCSTART- -X- N

object-based JJ Educational
positive JJ Educational
and CC Educational
negative JJ Educational
priming NN Educational
tasks NNS Educational
visual JJ Educational
search NN Educational
procedure NN Educational
. . Educational
visual JJ Educational
search NN Educational
task NN Educational
performance NN Educational
-DOCSTART- -X- N

ibopamine NN Pharmocological
Ibopamine NNP Pharmocological
ibopamine NN Pharmocological
placebo NN Control
Ibopamine NNP Pharmocological
was VBD Pharmocological
employed VBN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
100 CD Pharmocological
mg NN Pharmocological
t.i.d NN Pharmocological
. . Pharmocological
in IN Physical
in IN Pharmocological
basal NN Pharmocological
conditions NNS Pharmocological
and CC Pharmocological
following VBG Pharmocological
7 CD Pharmocological
days NNS Pharmocological
of IN Pharmocological
ibopamine NN Pharmocological
and CC None
placebo NN None
treatment NN None
. . None
-DOCSTART- -X- N

synbiotic JJ Pharmocological
formulation NN Pharmocological
containing VBG Pharmocological
Lactobacillus NNP Pharmocological
paracasei NN Pharmocological
B21060 NNP Pharmocological
plus CC Pharmocological
arabinogalactan JJ Pharmocological
and CC Pharmocological
xilooligosaccharides NNS Pharmocological
synbiotic JJ Pharmocological
formulation NN Pharmocological
containing VBG Pharmocological
Lactobacillus NNP Pharmocological
paracasei NN Pharmocological
B21060 NNP Pharmocological
, , Pharmocological
arabinogalactan NN Pharmocological
and CC Pharmocological
xilooligosaccharides NNS Pharmocological
placebo VB None
or CC None
synbiotic JJ None
group NN None
. . None
placebo VB Control
placebo VB Control
synbiotic JJ Pharmocological
formulation NN Pharmocological
-DOCSTART- -X- N

proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
. . None
lansoprazole NN Pharmocological
. . Pharmocological
placebo-controlled JJ Control
lansoprazole JJ Pharmocological
60 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
or CC None
placebo NN Control
placebo JJ Control
lansoprazole VBZ Pharmocological
placebo JJ Control
lansoprazole JJ Pharmocological
-DOCSTART- -X- N

intravenous JJ Pharmocological
iron NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
low-dose JJ Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
parenteral JJ None
iron NN None
and CC None
recombinant JJ None
human JJ None
erythropoietin-? NN None
( ( None
rHuEPO-? JJ None
) ) None
administered VBN None
( ( None
control NN None
) ) None
or CC None
( ( None
200 CD None
mg NN None
of IN None
iron NN None
sucrose NN None
intravenously RB None
over IN None
1 CD None
hr NNS None
and CC None
3000 CD None
IU NNP None
of IN None
rHuEPO-? JJ None
subcutaneously NN None
parenteral JJ None
iron NN None
and CC None
low-dose JJ None
rHuEPO-? NN None
in IN None
bilateral JJ None
-DOCSTART- -X- N

propranolol NN Pharmocological
Propranolol NNP Pharmocological
propranolol NN Pharmocological
propranolol JJ Pharmocological
propranolol NNS Pharmocological
saline NN Pharmocological
propranolol NN Pharmocological
-DOCSTART- -X- N

insufficient JJ Physical
sleep NN Physical
24-h JJ Physical
monitoring NN Physical
sleep JJ Physical
deprivation NN Physical
full JJ Physical
night NN Physical
's POS Physical
sleep NN Physical
sleep-deprivation JJ Physical
sleep JJ Physical
deprivation NN Physical
sleep-insufficient JJ Physical
-DOCSTART- -X- N

arzoxifene NN Pharmocological
( ( Pharmocological
LY353381 NNP Pharmocological
) ) Pharmocological
selective JJ Pharmocological
estrogen NN Pharmocological
receptor NN Pharmocological
modulator NN Pharmocological
arzoxifene NN Pharmocological
arzoxifene NN Pharmocological
was VBD None
assessed VBN None
using VBG None
World NNP Physical
Health NNP Physical
Organization NNP Physical
criteria NNS Physical
. . None
were VBD None
graded VBN None
according VBG None
to TO None
the DT None
National NNP Physical
Cancer NNP Physical
Institute NNP Physical
Common NNP Physical
Toxicity NNP Physical
Criteria NNP Physical
( ( Physical
NCI-CTC NNP Physical
) ) Physical
system NN Physical
. . None
Arzoxifene NNP Pharmocological
arzoxifene NN Pharmocological
arzoxifene NN Pharmocological
. . None
arzoxifene VBZ Pharmocological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
-DOCSTART- -X- N

three CD None
kinds NNS None
of IN None
resin NN None
core NN None
material NN None
] NNP None
FRC NNP Physical
( ( Physical
Fiber NNP Physical
Reinforced NNP Physical
Composite NNP Physical
) ) Physical
posts NNS Physical
three CD Physical
kinds NNS Physical
of IN Physical
resin NN Physical
core NN Physical
material NN Physical
. . None
prefabricated JJ Physical
glass-fiber JJ Physical
posts NNS Physical
and CC Physical
Artglass NNP Physical
polymer NN Physical
core NN Physical
; : None
prefabricated JJ Physical
glass-fiber JJ Physical
posts NNS Physical
and CC Physical
Charisma NNP Physical
composite JJ Physical
resin NN Physical
core NN Physical
; : None
prefabricated JJ Physical
glass-fiber JJ Physical
posts NNS Physical
and CC Physical
AB NNP Physical
composite JJ Physical
resin NN Physical
core NN Physical
. . None
FRC NNP Physical
posts NNS Physical
combined VBD Physical
with IN Physical
resin NN Physical
core NN Physical
and CC Physical
resin VB Physical
crown NN Physical
hot-press JJ Physical
methods NNS Physical
. . None
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
( ( Pharmocological
low-dose JJ Pharmocological
: : None
0.125 CD None
mg/day NN None
[ VBD None
20 CD None
to TO None
< VB None
45 CD None
kg NN None
] NN None
, , None
0.175 CD None
mg/day NN None
[ NNP None
> VBZ None
45 CD None
kg NN None
] NN None
or CC None
high-dose NN Pharmocological
: : None
1.25 CD None
mg/day NN None
[ VBD None
20 CD None
to TO None
< VB None
45 CD None
kg NN None
] NN None
, , None
1.75 CD None
mg/day NN None
[ NNP None
> VBZ None
45 CD None
kg NN None
] NN None
) ) None
or CC None
placebo NN Control
-DOCSTART- -X- N

post-Resources NNS Other
for IN Other
Enhancing VBG Other
Alzheimer NNP Other
's POS Other
Caregiver NNP Other
Health NNP Other
( ( Other
REACH NNP Other
) ) Other
intervention NN Other
REACH NNP Control
intervention NN Control
or CC None
a DT None
no-treatment JJ Control
control NN Control
group NN Control
. . None
REACH NNP None
intervention NN None
through IN None
in-home JJ None
telephone NN Educational
sessions NNS Educational
check-in JJ Control
telephone NN Control
calls VBZ Control
-DOCSTART- -X- N

receive VB None
raltegravir NN None
400 CD None
mg NN None
daily RB None
or CC None
placebo VB None
for IN None
CONCLUSIONS NNP None
Raltegravir NNP None
intensification NN None
-DOCSTART- -X- N

Decompressive JJ Physical
craniectomy NN Physical
decompressive JJ Physical
craniectomy NN Physical
decompressive JJ Physical
craniectomy NN Physical
-DOCSTART- -X- N

aerobic VB Physical
training VBG Physical
aerobic JJ Physical
training VBG Physical
training NN Physical
aerobic JJ Physical
program NN Physical
above IN Physical
standard JJ Physical
treatment NN Physical
) ) None
control VB Control
group NN None
standard JJ Physical
treatment NN Physical
without IN Physical
special JJ Physical
advice NN Physical
for IN Physical
exercise NN Physical
) ) None
-DOCSTART- -X- N

Oral JJ None
ganciclovir NN None
oral JJ None
formulation NN None
of IN None
ganciclovir NN None
( ( None
GCV NNP None
) ) None
GCV NNP Pharmocological
GCV NNP Pharmocological
was VBD Pharmocological
taken VBN Pharmocological
within IN Pharmocological
30 CD Pharmocological
min NNS Pharmocological
after IN Pharmocological
a DT Pharmocological
meal NN Pharmocological
. . None
oral JJ Pharmocological
GCV NNP Pharmocological
oral JJ Pharmocological
GCV NNP Pharmocological
-DOCSTART- -X- N

relaxation NN Physical
training NN Physical
effects NNS Physical
. . None
45-item JJ Educational
questionnaire NN Educational
relaxation NN Psychological
training NN Psychological
, , None
tension NN Psychological
inducement NN Psychological
, , None
pre-postcontrol NN Psychological
, , Psychological
or CC Psychological
postcontrol NN Psychological
. . None
relaxation NN Psychological
training NN Psychological
. . None
-DOCSTART- -X- N

Bacterial NNP Pharmocological
ribosomal JJ Pharmocological
immunostimulants NNS Pharmocological
D53 NNP Pharmocological
( ( Pharmocological
Ribomunyl NNP Pharmocological
) ) Pharmocological
, , Pharmocological
a DT Pharmocological
composite JJ Pharmocological
bacterial JJ Pharmocological
ribosomal NN Pharmocological
immunostimulant NN Pharmocological
D53 NNP Pharmocological
D53 NNP Pharmocological
placebo NN Control
D53-treated NNP Pharmocological
D53-treated NNP Pharmocological
placebo NN None
D53-treated NNP Pharmocological
D53 NNP Pharmocological
immunostimulant NN Pharmocological
D53 NNP Pharmocological
immunostimulant NN Pharmocological
-DOCSTART- -X- N

zotarolimus-eluting JJ Pharmocological
stents NNS Pharmocological
sirolimus-eluting JJ Pharmocological
stents NNS Pharmocological
drug-eluting JJ Pharmocological
stents NNS Pharmocological
zotarolimus-eluting JJ Physical
stent NN Physical
( ( None
ZES NNP None
; : None
Endeavor NNP None
Sprint? NNP None
, , None
sirolimus-eluting JJ Physical
stent NN Physical
( ( None
SES NNP None
; : None
Cypher? NNP None
, , None
-DOCSTART- -X- N

labetalol NN Pharmocological
labetalol NN Pharmocological
Labetalol NNP Pharmocological
Labetalol NNP Pharmocological
labetalol NN Pharmocological
. . None
labetalol JJ Pharmocological
-DOCSTART- -X- N

Viozan NNP Pharmocological
( ( Pharmocological
sibenadet JJ Pharmocological
HCl NNP Pharmocological
) ) Pharmocological
Viozan NNP Pharmocological
( ( None
sibenadet JJ Pharmocological
HCl NNP Pharmocological
, , None
AR-C68397AA NNP Pharmocological
) ) None
sibenadet NN Pharmocological
500 CD Pharmocological
microg NN Pharmocological
sibenadet NN Pharmocological
or CC None
placebo NN Control
Sibenadet NNP Pharmocological
therapy NN None
placebo NN Control
-DOCSTART- -X- N

low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
placebo NN Control
low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
with IN None
a DT None
placebo NN Control
. . None
placebo NN Control
Low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

Pulsed VBN Pharmocological
azithromycin JJ Pharmocological
treatment NN Pharmocological
2-week-longer JJ Pharmocological
daily JJ Pharmocological
doxycycline NN Pharmocological
treatment NN Pharmocological
azithromycin NN Pharmocological
and CC Pharmocological
doxycycline NN Pharmocological
azithromycin NNS Pharmocological
and CC None
doxycycline NN Pharmocological
treatments NNS None
azithromycin NN Pharmocological
doxycycline NN Pharmocological
azithromycin NN Pharmocological
doxycycline NN Pharmocological
. . None
-DOCSTART- -X- N

Hysteroscopic NNP Surgical
morcellation NN Surgical
electrical JJ Pharmocological
resection NN Pharmocological
hysteroscopic JJ Surgical
morcellation NN Surgical
bipolar JJ Surgical
electrosurgical JJ Surgical
resection NN Surgical
office NN Surgical
hysteroscopic NN Surgical
morcellation NN Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
morcellation VB Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
morcellation NN Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
electrosurgical JJ Pharmocological
resection NN Pharmocological
morcellation NN Surgical
electrosurgical JJ Pharmocological
resection NN Pharmocological
. . None
-DOCSTART- -X- N

live JJ Other
supervision NN Other
via IN Other
teleconferencing VBG Other
Teleconferencing VBG Other
Supervision NNP Other
Teleconferencing VBG Other
Supervision NN Other
-DOCSTART- -X- N

gadodiamide JJ Pharmocological
MR NNP Physical
imaging VBG Physical
gadodiamide JJ Pharmocological
injection NN Pharmocological
0.1 CD Pharmocological
mM/kg NNS Pharmocological
gadopentetate JJ Pharmocological
dimeglumine NN Pharmocological
. . Pharmocological
gadodiamide NN Pharmocological
gadodiamide NN Pharmocological
gadodiamide NN Pharmocological
gadodiamide JJ Pharmocological
gadopentetate NN Pharmocological
dimeglumine NN Pharmocological
-DOCSTART- -X- N

Long-term JJ None
oral JJ Pharmocological
branched-chain NN Pharmocological
amino NN Pharmocological
acid NN Pharmocological
treatment NN None
branched-chain JJ Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
placebo NN Control
( ( Control
casein NN Control
) ) Control
active JJ Pharmocological
treatment NN Pharmocological
casein NN Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
casein NN Pharmocological
alternative JJ Pharmocological
treatment NN Pharmocological
amino JJ Pharmocological
acid-treated JJ Pharmocological
oral JJ Pharmocological
branched-chain NN Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
casein VB Pharmocological
-DOCSTART- -X- N

tegafur/uracil NN Pharmocological
and CC Pharmocological
oral JJ Pharmocological
leucovorin NN Pharmocological
versus IN Pharmocological
parenteral JJ Pharmocological
fluorouracil NN Pharmocological
and CC Pharmocological
leucovorin NN Pharmocological
dihydropyrimidine JJ Pharmocological
dehydrogenase NN Pharmocological
inhibitory NN Pharmocological
fluoropyrimidine NN Pharmocological
tegafur NN Pharmocological
and CC Pharmocological
uracil NN Pharmocological
leucovorin $ Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
IV NNP Pharmocological
) ) Pharmocological
fluorouracil NN Pharmocological
and CC Pharmocological
LV NNP Pharmocological
UFT NNP Pharmocological
LV NNP Pharmocological
5-FU JJ Pharmocological
LV NNP Pharmocological
-DOCSTART- -X- N

gamma-secretase JJ Pharmocological
inhibitor NN Pharmocological
LY450139 NNP Pharmocological
using VBG Pharmocological
doses NNS Pharmocological
from IN Pharmocological
5 CD Pharmocological
to TO Pharmocological
50 CD Pharmocological
mg/day NN Pharmocological
given VBN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
. . Pharmocological
and CC Pharmocological
LY450139 NNP Pharmocological
-DOCSTART- -X- N

Tromethamine NNP Pharmocological
buffer NN Pharmocological
tromethamine NN Pharmocological
( ( Pharmocological
THAM NNP Pharmocological
) ) Pharmocological
THAM NNP Pharmocological
THAM NNP Pharmocological
. . None
-DOCSTART- -X- N

resistance NN Physical
versus NN Physical
endurance NN Physical
training NN Physical
resistance NN Physical
and CC Physical
endurance NN Physical
training NN Physical
endurance NN Physical
training NN Physical
group NN Educational
( ( Educational
n=8 NN Educational
) ) Educational
, , Educational
resistance NN Physical
training NN Physical
group NN Educational
( ( Educational
n=8 CC Educational
) ) Educational
and CC Educational
control NN Control
group NN Educational
( ( Educational
n=8 RB Educational
) ) Educational
. . None
were VBD None
taken VBN None
in IN None
fasting VBG None
state NN None
from IN None
all DT None
subjects NNS None
. . None
The DT None
experimental JJ None
groups NNS None
performed VBD None
either CC None
endurance NN Physical
or CC None
resistance NN Physical
training NN Physical
3 CD None
days NNS None
a DT None
week NN None
for IN None
12 CD None
weeks NNS None
. . None
The DT None
endurance NN Physical
training NN Physical
programme NN Physical
included VBD None
continuous JJ None
running VBG None
at IN None
an DT None
intensity NN None
corresponding VBG None
to TO None
75-85 CD None
% NN None
of IN None
maximal JJ None
heart NN None
rate NN None
, , None
while IN None
resistance NN Physical
training NN Physical
consisted VBD None
of IN None
four CD None
sets NNS None
of IN None
circuit NN None
weight NN None
training NN None
for IN None
11 CD None
stations NNS None
and CC None
at IN None
an DT None
intensity NN None
corresponding VBG None
to TO None
50-60 CD None
% NN None
of IN None
one-repetition JJ None
maximum NN None
. . None
-DOCSTART- -X- N

stereotactic JJ None
radiotherapy NN None
stereotactic JJ None
radiotherapy NN None
stereotactic JJ None
radiotherapy NN None
stereotactic JJ Physical
radiotherapy NN Physical
literature NN None
survey NN None
advanced JJ None
algorithm NN None
stereotactic JJ None
radiotherapy NN None
-DOCSTART- -X- N

minimally-invasive JJ Surgical
surgery NN Surgical
plus CC Surgical
rtPA NN Surgical
minimally-invasive JJ Surgical
surgery NN Surgical
plus CC Surgical
recombinant JJ Surgical
tissue NN Surgical
plasminogen NN Surgical
activator NN Surgical
( ( Surgical
rtPA NN Surgical
) ) Surgical
surgical JJ Surgical
intervention NN Surgical
plus CC Surgical
rtPA NN Surgical
and CC None
standard JJ None
medical JJ None
management NN None
for IN None
stereotactic JJ Surgical
catheter NN Surgical
placement NN Surgical
and CC Surgical
clot NN Surgical
aspiration NN Surgical
. . None
Injections NNS Pharmocological
of IN Pharmocological
rtPA NN Pharmocological
sterile JJ Pharmocological
saline NN Pharmocological
-DOCSTART- -X- N

movement NN Physical
selection NN Physical
and CC Physical
initiation NN Physical
( ( Physical
initiate NN Physical
) ) Physical
, , Physical
synchronisation NN Physical
of IN Physical
finger NN Physical
tapping VBG Physical
with IN Physical
an DT Physical
external JJ Physical
auditory NN Physical
cue NN Physical
( ( Physical
synchronise NN Physical
) ) Physical
continued VBD Physical
tapping VBG Physical
in IN Physical
absence NN Physical
of IN Physical
the DT Physical
auditory JJ Physical
pacer NN Physical
continuation NN Physical
synchronisation NN Physical
-DOCSTART- -X- N

Catheter NNP Physical
ablation NN Physical
of IN Physical
stable JJ Physical
implantable JJ Surgical
cardioverter NN Surgical
defibrillator NN Surgical
( ( Surgical
ICD NNP Surgical
) ) Surgical
catheter NN Physical
ablation NN Physical
receive VB Physical
catheter NN Physical
ablation NN Physical
and CC Physical
an DT Physical
ICD NNP Physical
( ( Physical
ablation NN Physical
group NN Physical
, , Physical
n=54 RB Physical
) ) Physical
or CC None
ICD NNP Control
alone RB Control
( ( Control
control NN Control
group NN Control
, , Control
n=56 RB Control
) ) Control
. . None
ablation NN Physical
group NN Physical
control NN Control
group NN Control
ablation NN Physical
group NN Physical
control NN Control
group NN Control
( ( None
ablation NN Physical
group NN Physical
control NN Control
group NN Control
Prophylactic NNP Physical
VT NNP Physical
ablation NN Physical
defibrillator NN Surgical
implantation NN Surgical
Prophylactic NNP Physical
catheter NN Physical
ablation NN Physical
cardioverter NN Surgical
defibrillator NN Surgical
-DOCSTART- -X- N

single-incision NN Surgical
laparoscopic NN Surgical
vs JJ None
conventional JJ Surgical
3-port JJ Surgical
laparoscopic NN Surgical
appendectomy NN Surgical
single-incision NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
SILS NNP Surgical
) ) Surgical
multiport NN Surgical
laparoscopy NN Surgical
. . None
SILS NNP Surgical
3-port JJ Surgical
laparoscopic NN Surgical
appendectomy NN Surgical
. . None
SILS NNP Surgical
or CC None
3-port JJ Surgical
laparoscopic NN Surgical
appendectomy NN Surgical
. . None
SILS NNP None
averaged VBD None
converted VBN None
to TO None
3-port JJ None
. . None
There EX None
However RB None
, , None
3-port JJ None
patients NNS None
and CC None
SILS NNP None
patients NNS None
Single-incision NNP None
laparoscopic NN None
surgery NN None
appendectomy NN None
resulted VBD None
in IN None
-DOCSTART- -X- N

family NN Educational
practice-based JJ Educational
lifestyle JJ Educational
intervention NN Educational
program NN Educational
multi-component JJ Educational
lifestyle JJ Educational
intervention NN Educational
standard NN Educational
of IN Educational
care NN Educational
lifestyle JJ Educational
intervention NN Educational
behaviourally-based JJ Educational
, , Educational
matched VBD Educational
prescriptive JJ Educational
physical JJ Educational
activity NN Educational
and CC Educational
diet JJ Educational
change NN Educational
program NN Educational
. . None
-DOCSTART- -X- N

rosuvastatin NN Pharmocological
rosuvastatin NN Pharmocological
rosuvastatin NN Pharmocological
placebo NN Control
or CC None
rosuvastatin VB Pharmocological
20 CD None
mg NN None
Rosuvastatin NNP Pharmocological
Rosuvastatin NNPS Pharmocological
rosuvastatin VBP Pharmocological
rosuvastatin NN Pharmocological
-DOCSTART- -X- N

ibuprofen JJ Pharmocological
arginate NN Pharmocological
versus NN None
dexibuprofen NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
ibuprofen NN Pharmocological
S NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
-ibuprofen VBD Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
dexibuprofen NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
dexibuprofen NN Pharmocological
dexibuprofen NN Pharmocological
, , None
ibuprofen JJ Pharmocological
arginate NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
dexibuprofen NN Pharmocological
. . None
-DOCSTART- -X- N

enalapril NN Pharmocological
enalapril NN Pharmocological
Enalapril NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHu-EPO JJ Pharmocological
) ) Pharmocological
treatment NN None
. . None
rHu-EPO JJ Pharmocological
rHu JJ Pharmocological
EPO NNP Pharmocological
-DOCSTART- -X- N

zilpaterol NN Pharmocological
hydrochloride NN Pharmocological
of IN None
leptin JJ None
R25C NNP None
genotypes NNS None
and CC None
zilpaterol $ None
hydrochloride NN None
( ( None
ZH NNP None
) ) None
-DOCSTART- -X- N

Clonidine NN Pharmocological
clonidine NN Pharmocological
saline NN Control
2-micrograms/kg JJ None
bolus NN None
of IN None
clonidine NN Pharmocological
-DOCSTART- -X- N

nasal JJ Pharmocological
IgA NNP Pharmocological
Immunoglobulin NNP Pharmocological
A NNP Pharmocological
( ( Pharmocological
IgA NNP Pharmocological
) ) None
IgA NNP Pharmocological
LAIV NNP None
placebo NN Control
nasal JJ Pharmocological
IgA NNP Pharmocological
LAIV NNP Pharmocological
LAIV NNP None
in IN None
LAIV NNP None
and CC None
that IN None
LAIV-induced NNP None
immunity NN None
-DOCSTART- -X- N

heat NN Physical
and CC Physical
cold NN Physical
episiotomy/laceration NN Physical
heat NN Physical
and CC Physical
cold NN Physical
-DOCSTART- -X- N

glycoPEGylated JJ None
recombinant NN None
activated VBD None
factor NN None
VII NNP None
derivative NN None
: : None
is VBZ None
glycoPEGylation NN None
, , None
rFVIIa NN None
derivative JJ None
( ( None
N7-GP NNP None
) ) None
of IN None
N7-GP NNP None
placebo NN None
( ( None
-DOCSTART- -X- N

Naltrexone NN Pharmocological
opiate JJ Pharmocological
antagonist NN Pharmocological
naltrexone NN Pharmocological
placebo NN Control
Naltrexone CC Pharmocological
placebo NN Control
-DOCSTART- -X- N

Transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
. . None
randomly RB Physical
allocated VBN Physical
to TO Physical
receive VB Physical
either RB Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
with IN Physical
intramuscular JJ Physical
papaveretum NN Physical
( ( Physical
20 CD Physical
patients NNS Physical
) ) Physical
or CC None
intramuscular JJ Physical
papaveretum NN Physical
alone RB Physical
( ( Physical
20 CD Physical
patients NNS Physical
) ) Physical
for IN Physical
postoperative JJ Physical
pain NN Physical
relief NN Physical
. . Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

magnesium NN Pharmocological
supplementation NN Pharmocological
magnesium NN Pharmocological
magnesium NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

gabapentin NN Pharmocological
Gabapentin NNP Pharmocological
placebo-controlled JJ Control
single JJ Educational
and CC Educational
repeated VBD Educational
cutaneous JJ Educational
and CC Educational
intramuscular JJ Physical
electrical JJ Physical
stimulation NN Physical
( ( Educational
temporal JJ Physical
summation NN Physical
to TO Physical
5 CD Physical
stimuli NNS Physical
delivered VBN Educational
at IN Educational
2 CD Educational
Hz NNP Educational
) ) Educational
; : None
stimulus-response NN None
function NN None
relating VBG None
to TO None
increasing VBG None
current JJ None
intensities NNS None
for IN None
electrical JJ None
skin NN None
and CC None
muscle NN None
stimuli NNS None
( ( None
single JJ None
and CC None
repeated VBD None
, , None
determined VBD None
at IN None
baseline NN None
) ) None
; : None
of IN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
. . Pharmocological
gabapentin NN Pharmocological
: : None
placebo NN None
Gabapentin NNP Pharmocological
-DOCSTART- -X- N

diltiazem NNS Pharmocological
Diltiazem NNP Pharmocological
intravenous JJ Pharmocological
diltiazem NNS Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

Ligaclip NNP Surgical
lymphadenectomy NN Surgical
in IN None
1 CD None
side NN None
of IN None
the DT None
pelvis NN None
using VBG None
the DT None
Ligaclip NNP Surgical
bipolar JJ Surgical
coagulation NN Surgical
to TO Surgical
seal VB Surgical
lymphatic JJ Surgical
vessels NNS Surgical
-DOCSTART- -X- N

Dietary NNP Other
Approaches NNP Other
to TO Other
Stop VB Other
Hypertension NNP Other
( ( Other
DASH NNP Other
) ) Other
diet NN Other
reduced JJ Physical
sodium NN Physical
intake NN Physical
DASH NNP Educational
diet NN Educational
or CC None
a DT None
typical JJ Control
American NNP Control
( ( Control
control NN Control
) ) Control
diet NN Control
, , None
consuming VBG None
three CD None
different JJ None
sodium NN None
intakes NNS None
control/lower NN Control
sodium NN Control
diet NN Control
DASH/lower NNP Educational
sodium NN Educational
diet NN Educational
. . None
-DOCSTART- -X- N

action NN Physical
observation NN Physical
treatment NN Physical
( ( Physical
AOT NNP Physical
) ) Physical
or CC None
control NN Control
group NN None
. . None
observe VB Educational
video JJ Educational
clips NNS Educational
showing VBG Educational
daily JJ Educational
actions NNS Educational
and CC Educational
to TO Educational
imitate VB Educational
them PRP Educational
afterward RB Educational
. . Physical
observe VB Educational
video JJ Educational
clips NNS Educational
with IN Educational
no DT Educational
motor NN Educational
content NN Educational
and CC Educational
to TO Educational
execute VB Educational
the DT Educational
same JJ Educational
actions NNS Educational
as IN Educational
patients NNS Educational
in IN Educational
the DT Educational
case NN Educational
group NN Educational
-DOCSTART- -X- N

single-dose JJ Pharmocological
conventional-dose JJ Control
antibiotic JJ Control
treatment NN Control
single-dose JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
7-10 JJ Pharmocological
day NN Pharmocological
courses NNS Pharmocological
of IN Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
. . None
single-dose JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Diet NNP None
and CC None
vitamin NNP None
D NNP None
the DT None
dietary JJ None
intake NN None
of IN None
margarine NN None
, , None
of IN None
vitamin NN None
D NNP None
of IN None
vitamin NN None
D NNP None
, , None
-DOCSTART- -X- N

Exposure NN None
to TO None
the DT None
self-face NN Physical
facilitates VBZ Physical
self-face NN Physical
( ( None
self-face JJ Physical
prime NN Physical
) ) Physical
or CC Physical
faces VBZ Physical
of IN Physical
others NNS Physical
( ( Physical
nonself-face JJ Physical
prime NN Physical
) ) None
-DOCSTART- -X- N

HOXB13 NNP Physical
G84E NNP Physical
mutation NN Physical
G84E NNP Physical
in IN Physical
HOXB13 NNP Physical
G84E NNP Physical
mutation NN Physical
Genotyping VBG Physical
-DOCSTART- -X- N

vitamin JJ Pharmocological
A-fortified NNP Pharmocological
coconut NN Pharmocological
cooking VBG Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified NNP Pharmocological
coconut NN Pharmocological
cooking VBG Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
unfortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
ration NN Pharmocological
; : None
without IN Control
cooking VBG Control
oil NN Control
ration NN Control
. . None
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
vitamin JJ Pharmocological
A-fortified JJ Pharmocological
cooking NN Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

schedules NNS Other
of IN Other
antenatal JJ Other
visits NNS Other
: : None
antenatal JJ Educational
care NN Educational
( ( Educational
traditional JJ Educational
care NN Educational
) ) Educational
( ( Educational
new JJ Educational
style NN Educational
care NN Educational
) ) Educational
antenatal JJ Educational
care NN Educational
antenatal JJ Educational
care NN Educational
visits NNS Other
reduced JJ Other
visit NN Other
schedules NNS Other
-DOCSTART- -X- N

racemic JJ Pharmocological
warfarin NN Pharmocological
25 CD Pharmocological
mg NN Pharmocological
single JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
and CC Pharmocological
chronically RB Pharmocological
administered VBD Pharmocological
ketorolac NN Pharmocological
Ketorolac NNP Pharmocological
Ketorolac NNP Pharmocological
Ketorolac NNP Pharmocological
ketorolac NN Pharmocological
warfarin NN Pharmocological
-DOCSTART- -X- N

gonadotropin NN Pharmocological
recombinant JJ None
follicle NN None
stimulating VBG None
hormone NN None
( ( None
rFSH NN None
) ) None
GnRH-agonist JJ Physical
followed VBN None
by IN None
rFSH JJ Physical
administration NN Physical
. . None
GnRH-a NNP Pharmocological
rFSH NN Physical
rFSH NN None
rFSH NN None
rFSH JJ None
rFSH NN None
rFSH NN None
rFSH NN None
-DOCSTART- -X- N

Propofol NNP Pharmocological
and CC None
isoflurane NN Pharmocological
propofol NN Pharmocological
isoflurane NN Pharmocological
. . None
randomised VBN None
crossover NN None
study NN None
to TO None
monitor VB None
-DOCSTART- -X- N

amantadine NN None
pemoline NN None
Amantadine NNP Pharmocological
hydrochloride NN Pharmocological
pemoline NN None
amantadine NN Pharmocological
and CC Pharmocological
pemoline NN Pharmocological
amantadine NN None
, , None
pemoline NN None
, , None
or CC None
placebo NN Control
amantadine JJ Pharmocological
pemoline JJ Pharmocological
placebo NN Control
. . Control
-DOCSTART- -X- N

Phonophoresis NNP Pharmocological
ketoprofen NN Pharmocological
: : None
phonophoresis NN Pharmocological
of IN Pharmocological
a DT Pharmocological
ketoprofen NN Pharmocological
gel NN Pharmocological
continuous JJ Physical
ultrasound NN Physical
pulsed JJ Physical
ultrasound NN Physical
sham NN Control
ultrasound NN Control
with IN Control
the DT Control
ketoprofen NN Control
gel NN Control
. . None
-DOCSTART- -X- N

diltiazem NN Pharmocological
placebo-controlled JJ Control
diltiazem NN Pharmocological
placebo VB Control
diltiazem NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

minoxidil NN Pharmocological
lignocaine NN Pharmocological
: : Pharmocological
minoxidil NN Pharmocological
lignocaine NN Pharmocological
local JJ Pharmocological
applications NNS Pharmocological
of IN Pharmocological
ointments NNS Pharmocological
containing VBG Pharmocological
5 CD Pharmocological
% NN Pharmocological
lignocaine NN Pharmocological
( ( Pharmocological
n=28 JJ Pharmocological
) ) Pharmocological
, , Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
minoxidil NN Pharmocological
or CC None
both DT Pharmocological
( ( None
lignocaine VB Pharmocological
minoxidil VBD Pharmocological
minoxidil NN Pharmocological
lignocaine JJ Pharmocological
lignocaine JJ Pharmocological
minoxidil NN Pharmocological
lignocaine NN Pharmocological
-DOCSTART- -X- N

diamorphine NN Pharmocological
pethidine NN Pharmocological
pethidine NN Pharmocological
pethidine NN Pharmocological
pethidine NN Pharmocological
diamorphine NN Pharmocological
diamorphine NN Pharmocological
pethidine NN Pharmocological
Diamorphine NNP Pharmocological
Pethidine NNP Pharmocological
diamorphine NN Pharmocological
pethidine NN Pharmocological
diamorphine NN Pharmocological
diamorphine NN Pharmocological
opioid NN Pharmocological
-DOCSTART- -X- N

SQ29,852 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
new JJ Pharmocological
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibitor NN Pharmocological
atenolol NN Pharmocological
. . None
SQ29,852 NNP Pharmocological
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibitor NN Pharmocological
atenolol NN Pharmocological
SQ29,852 NNP Pharmocological
atenolol $ Pharmocological
SQ29,852 NNP Pharmocological
atenolol RB Pharmocological
. . None
SQ29,852 NNP Pharmocological
-DOCSTART- -X- N

aquatics NNS Educational
programme NN Educational
aquatic JJ Educational
exercise NN Educational
programme NN Educational
aquatic JJ Educational
exercise NN Educational
group NN Educational
and CC Educational
eight CD Educational
to TO Educational
a DT Educational
control NN Educational
group NN Educational
. . None
-DOCSTART- -X- N

alone RB Educational
or CC Educational
combined VBN Educational
with IN Educational
the DT Educational
commercial JJ Educational
Weight NNP Educational
Watchers NNP Educational
program NN Educational
. . Educational
control NN Control
group NN Control
Weight NNP Educational
Watchers NNP Educational
group NN Educational
comprehensive JJ Educational
group NN Educational
that WDT Educational
used VBD Educational
both DT Educational
individualized JJ Educational
counseling NN Educational
and CC Educational
Weight NNP Educational
Watchers NNP Educational
. . Educational
-DOCSTART- -X- N

Chloroprocaine NNP Pharmocological
and CC Pharmocological
lidocaine JJ Pharmocological
Lumbar NNP None
epidural JJ None
anesthesia NN None
with IN None
20 CD None
ml NN None
of IN None
either DT None
3 CD Pharmocological
% NN Pharmocological
2-chloroprocaine JJ Pharmocological
( ( Pharmocological
C NNP Pharmocological
) ) Pharmocological
, , None
1.5 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
( ( Pharmocological
L NNP Pharmocological
) ) Pharmocological
, , None
or CC None
1.5 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
( ( Pharmocological
M NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
epinephrine NN Pharmocological
-DOCSTART- -X- N

secretin NN Pharmocological
secretin NN Pharmocological
placebo NN Control
2.0 CD Pharmocological
clinical JJ Pharmocological
units NNS Pharmocological
of IN Pharmocological
secretin NN Pharmocological
per IN Pharmocological
kilogram NN Pharmocological
of IN Pharmocological
body NN Pharmocological
weight NN Pharmocological
placebo NN Control
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
. . None
secretin NN Pharmocological
-DOCSTART- -X- N

Dipyridamole NNP Pharmocological
dipyridamole NN Pharmocological
dipyridamole NN Pharmocological
modified JJ Pharmocological
release NN Pharmocological
dipyridamole NN Pharmocological
corresponding VBG None
placebo NN Control
conventional JJ Pharmocological
antianginal JJ Pharmocological
therapy NN Pharmocological
withdrawal NN Pharmocological
of IN Pharmocological
standard JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
calcium NN Pharmocological
antagonists NNS Pharmocological
and/or VBP Pharmocological
beta-blockers NNS Pharmocological
and/or JJ Pharmocological
long-acting JJ Pharmocological
( ( Pharmocological
prophylactic JJ Pharmocological
) ) Pharmocological
nitrates NNS Pharmocological
. . None
dipyridamole VB Pharmocological
placebo VB Control
dipyridamole NN None
-DOCSTART- -X- N

transfusion NN Physical
of IN Physical
residual JJ Physical
blood NN Physical
centrifugation NN Physical
and CC Physical
multiple-pass NN Physical
hemoconcentration NN Physical
. . Physical
methods NNS None
of IN None
centrifugation NN None
( ( None
CF NNP None
) ) None
and CC None
multiple-pass JJ None
hemoconcentration NN None
( ( None
MPH NNP None
) ) None
centrifugation NN Physical
or CC None
multiple-pass NN Physical
hemoconcentration NN Physical
method NN Physical
centrifugation NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
centrifugation NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
centrifugation NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
centrifugation NN Physical
CF NNP Physical
method NN Physical
heparin NN Pharmocological
MPH NNP Physical
method NN Physical
-DOCSTART- -X- N

Omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ None
1.5 CD Pharmocological
g/d NN Pharmocological
of IN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
.84 JJ Pharmocological
g/d NN Pharmocological
eicosapentaenoic NN Pharmocological
acid NN Pharmocological
, , Pharmocological
.7 NNP Pharmocological
g/d NN Pharmocological
docosahexaenoic NN Pharmocological
acid NN Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
placebo NN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

paroxetine NN Pharmocological
Methamphetamine NNP Pharmocological
methamphetamine VBP Pharmocological
's POS Pharmocological
SSRI NNP Pharmocological
paroxetine NN Pharmocological
versus NN None
placebo NN Control
-DOCSTART- -X- N

cyclosporin NN Pharmocological
cyclosporin NN Pharmocological
-DOCSTART- -X- N

inactivated JJ Pharmocological
whole-virus JJ Pharmocological
H1N1 NNP Pharmocological
A/California/07/2009 NNP Pharmocological
vaccine NN Pharmocological
. . None
3.75 CD None
or CC None
7.5 CD None
?g JJ None
hemagglutinin NN None
antigen NN None
21 CD None
days NNS None
apart RB None
. . None
-DOCSTART- -X- N

Buprenorphine NNP None
naloxone NN None
naloxone NN Pharmocological
buprenorphine NN Pharmocological
buprenorphine NN None
naloxone NN None
placebo NN Control
. . None
Buprenorphine NNP None
naloxone RB None
buprenorphine NN None
. . None
buprenorphine NN None
buprenorphine VB None
-DOCSTART- -X- N

cardiotocography NN Physical
cardiotocography NN Physical
Cardiotocography NNP Physical
-DOCSTART- -X- N

coronary JJ Surgical
bypass NN Surgical
surgery NN Surgical
angioplasty NN Surgical
Coronary-artery JJ Surgical
bypass NN Surgical
grafting NN Surgical
( ( Surgical
CABG NNP Surgical
) ) Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
( ( Surgical
PTCA NNP Surgical
) ) Surgical
CABG NNP Surgical
PTCA NNP Surgical
CABG NNP Surgical
PTCA NNP Surgical
. . None
-DOCSTART- -X- N

focused JJ Educational
imitation NN Educational
intervention NN Educational
focused JJ Educational
imitation NN Educational
intervention NN Educational
imitation NN None
-DOCSTART- -X- N

more RBR None
intensive JJ Pharmocological
( ( Pharmocological
MI NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
less RBR Pharmocological
intensive JJ Pharmocological
( ( Pharmocological
LI NNP Pharmocological
) ) Pharmocological
belatacept IN Pharmocological
immunosuppression NN Pharmocological
regimen NNS Pharmocological
, , None
or CC None
cyclosporine VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

atropine VBP Pharmocological
neostigmine JJ Pharmocological
atropine JJ Pharmocological
plus CC Physical
neostigmine JJ Pharmocological
0.9 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
atropine NN Pharmocological
control NN Control
1.2 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
atropine NN Pharmocological
. . None
2.5 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
neostigmine JJ Pharmocological
simultaneously RB None
. . None
atropine NN Pharmocological
neostigmine JJ Pharmocological
-DOCSTART- -X- N

syncope NN Physical
unit NN Physical
evaluation NN Physical
and CC None
standard NN Control
care NN Control
. . None
-DOCSTART- -X- N

Promoting VBG Other
social JJ Other
skill NN Other
development NN Other
social JJ Educational
skills NNS Educational
intervention NN Educational
group NN Educational
intervention NN Educational
designed VBN Educational
to TO Educational
teach VB Educational
appropriate JJ Educational
social JJ Educational
behavior NN Educational
. . None
social JJ Educational
skills NNS Educational
intervention NN Educational
. . Educational
-DOCSTART- -X- N

Isoniazid NNP None
isoniazid NN Pharmocological
isoniazid NN Pharmocological
isoniazid JJ Pharmocological
placebo NN Control
isoniazid JJ Pharmocological
-DOCSTART- -X- N

Discrete-trial JJ Physical
training NN Physical
DTkid NNP Educational
training NN Educational
or CC None
to TO None
a DT None
control NN Control
task NN Control
. . None
DTkid NNP Physical
training NN Physical
trials NNS None
-DOCSTART- -X- N

glucocorticoids NNS Pharmocological
glucocorticoid JJ Pharmocological
glucocorticoid VB Pharmocological
( ( Pharmocological
methylprednisolone NN Pharmocological
, , Pharmocological
METH NNP Pharmocological
; : Pharmocological
placebo NN Control
( ( Control
PLAC NNP Control
; : Control
-DOCSTART- -X- N

[ JJ Pharmocological
Local NNP Pharmocological
therapy NN Pharmocological
of IN Pharmocological
combination NN Pharmocological
preparation NN Pharmocological
with IN Pharmocological
standardized JJ Pharmocological
blood NN Pharmocological
leech NN Pharmocological
extract NN Pharmocological
] NNP Pharmocological
topical JJ Pharmocological
combination NN Pharmocological
preparation NN Pharmocological
containing VBG Pharmocological
standardized VBN Pharmocological
leech JJ Pharmocological
extract NN Pharmocological
, , Pharmocological
polidocanol NN Pharmocological
and CC Pharmocological
allantoin NN Pharmocological
. . Pharmocological
Placebo-controlled NNP Control
test NN Educational
preparation NN Educational
placebo NN None
. . None
preparation NN None
placebo NN None
topical JJ Pharmocological
therapeutic JJ Pharmocological
preparation NN Pharmocological
-DOCSTART- -X- N

antiplatelet NN Pharmocological
agents NNS Pharmocological
aspirin NN Pharmocological
dipyridamole NN Pharmocological
aspirin JJ Pharmocological
plus CC Pharmocological
dipyridamole JJ Pharmocological
versus NN None
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

disclaimer NN Educational
versus NN None
warning VBG Educational
label NN Educational
. . None
groups NNS None
: : None
( ( None
a DT None
) ) None
disclaimer NN Educational
, , None
( ( None
b NN None
) ) None
warning NN Educational
, , None
( ( None
c NN None
) ) None
model NN Control
control NN Control
, , None
or CC None
( ( None
d NN None
) ) None
car NN Control
control NN Control
. . None
-DOCSTART- -X- N

allergen-specific JJ Physical
immunotherapy NN Physical
Epicutaneous NNP None
allergen NN None
receive VB None
placebo NN None
or CC None
3 CD None
different JJ None
doses NNS None
of IN None
allergen NN None
. . None
Epicutaneous NNP None
immunotherapy NN None
-DOCSTART- -X- N

selamectin NN Pharmocological
, , Pharmocological
imidacloprid JJ Pharmocological
, , Pharmocological
and CC Pharmocological
fipronil- NN Pharmocological
( ( Pharmocological
S NNP Pharmocological
) ) Pharmocological
-methoprene VBD Pharmocological
selamectin NN Pharmocological
, , Pharmocological
imidacloprid JJ Pharmocological
, , Pharmocological
and CC Pharmocological
fipronil- NN Pharmocological
( ( Pharmocological
S NNP Pharmocological
) ) Pharmocological
-methoprene NN Pharmocological
imidacloprid JJ Pharmocological
selamectin NN Pharmocological
, , Pharmocological
fipronil- JJ Pharmocological
( ( Pharmocological
S NNP Pharmocological
) ) Pharmocological
-methoprene NN Pharmocological
, , Pharmocological
and CC Pharmocological
imidacloprid VB Pharmocological
-DOCSTART- -X- N

two-stage JJ Physical
restoration NN Physical
immediate JJ None
restoration NN None
groups NNS None
Restoring VBG Physical
-DOCSTART- -X- N

Sequential JJ Pharmocological
therapy NN Pharmocological
versus IN None
standard JJ Pharmocological
triple-drug JJ Pharmocological
therapy NN Pharmocological
sequential JJ Pharmocological
vs. FW None
standard JJ Pharmocological
triple-drug JJ Pharmocological
therapy NN Pharmocological
10-day JJ Pharmocological
sequential JJ Pharmocological
regimen NNS Pharmocological
( ( None
40 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
, , None
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
amoxicillin NN Pharmocological
, , None
each DT None
administered VBN None
twice RB None
daily RB None
for IN None
the DT None
first JJ None
5 CD None
days NNS None
, , None
followed VBN None
by IN None
40 CD Pharmocological
mg NNS Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
, , None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
clarithromycin NN Pharmocological
, , None
and CC None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
tinidazole NN Pharmocological
, , None
each DT None
administered VBN None
twice RB None
daily RB None
for IN None
the DT None
remaining VBG None
5 CD None
days NNS None
) ) None
or CC None
to TO None
standard VB Pharmocological
14-day JJ Pharmocological
therapy NN Pharmocological
( ( None
40 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
, , None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
clarithromycin NN Pharmocological
, , None
and CC None
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
amoxicillin NN Pharmocological
, , None
each DT None
administered VBN None
twice RB None
daily RB None
) ) None
. . None
sequential JJ Pharmocological
regimen NN Pharmocological
triple JJ Pharmocological
therapy NN Pharmocological
. . None
sequential JJ Pharmocological
therapy NN Pharmocological
standard JJ None
drug NN None
standard JJ None
and CC None
sequential JJ None
therapy NN None
groups NNS None
. . None
Sequential JJ None
therapy NN None
includes VBZ None
tinidazole NN None
standard JJ None
therapy NN None
. . None
CONCLUSIONS NNP None
Sequential NNP None
therapy NN None
was VBD None
standard JJ None
therapy NN None
for IN None
-DOCSTART- -X- N

augmented JJ Physical
sensorimotor NN Physical
input NN Physical
manually RB Physical
guided VBN Physical
-DOCSTART- -X- N

Human NNP Physical
recombinant JJ Physical
GM-CSF NNP Physical
for IN None
14 CD None
days NNS None
after IN None
allogeneic JJ None
matched VBD None
sibling VBG None
bone NN None
marrow NN None
transplantation NN None
. . None
GM NNP Physical
CSF NNP Physical
GM-CSF NNP Pharmocological
placebo NN Control
GM-CSF NNP Pharmocological
GM NNP Pharmocological
CSF NNP Pharmocological
-DOCSTART- -X- N

psychiatric JJ Educational
hospital NN Educational
community NN Educational
treatment NN Educational
standard JJ Educational
hospital NN Educational
care NN Educational
and CC Educational
follow-up NN Educational
back RB Educational
to TO Educational
the DT Educational
community NN Educational
follow-up JJ Educational
treatment NN Educational
-DOCSTART- -X- N

chemoradiation NN Physical
therapy NN Physical
curative JJ Pharmocological
radical JJ Pharmocological
chemoradiation NN Pharmocological
therapy NN Pharmocological
. . None
radiation NN Physical
therapy NN Physical
moderate JJ Pharmocological
dose JJ Pharmocological
chemoradiation NN Pharmocological
therapy NN Pharmocological
Gy/20 NNP Pharmocological
weekly JJ Pharmocological
vinorelbine NN Pharmocological
25 CD Pharmocological
mg/m NN Pharmocological
+ NNP Pharmocological
cisplatin VBZ Pharmocological
Gy/15 NNP Pharmocological
weekly JJ Pharmocological
gemcitabine NN Pharmocological
200 CD Pharmocological
mg. NN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

local JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

topiroxostat NN Pharmocological
new JJ Pharmocological
xanthine JJ Pharmocological
oxidase NN Pharmocological
inhibitor NN Pharmocological
topiroxostat NN Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
topiroxostat NN Pharmocological
180 CD None
mg NN None
) ) None
, , None
moxifloxacin FW None
( ( None
400 CD None
mg NN None
) ) None
or CC None
placebo NN None
in IN None
prolonged VBN None
by IN None
moxifloxacin NN None
, , None
of IN None
which WDT None
Moxifloxacin NNP None
can MD None
be VB None
-DOCSTART- -X- N

omeprazole NN Pharmocological
amoxycillin NN Pharmocological
omeprazole JJ Pharmocological
amoxycillin NN Pharmocological
omeprazole JJ Pharmocological
placebo VB None
omeprazole JJ Pharmocological
plus CC Pharmocological
amoxycillin JJ Pharmocological
omeprazole JJ Pharmocological
plus CC Pharmocological
amoxycillin JJ Pharmocological
omeprazole JJ None
placebo NN None
omeprazole JJ None
amoxycillin NN None
-DOCSTART- -X- N

erythromycin NN Pharmocological
and CC None
gentamicin NN Pharmocological
erythromycin JJ Pharmocological
control NN Control
, , None
2 CD None
mL NN None
of IN None
0.9 CD None
% NN None
NaCl NNP None
; : None
erythromycin NN Pharmocological
, , None
8.8 CD None
mg/kg NN None
; : None
low-dose JJ Pharmocological
gentamicin NN Pharmocological
, , None
4.4 CD None
mg/kg NN None
; : None
high-dose JJ Pharmocological
gentamicin NN Pharmocological
, , None
6.6 CD None
mg/kg NN None
. . None
acetaminophen NN Pharmocological
-DOCSTART- -X- N

statins NNS Pharmocological
statins NNS Pharmocological
statins NNS Pharmocological
simvastatin NN Pharmocological
placebo NN Control
simvastatin $ Pharmocological
placebo NN Control
placebo NN Control
simvastatin JJ Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
dactinomycin NN Pharmocological
( ( Pharmocological
Actinomycin NNP Pharmocological
D NNP Pharmocological
[ NNP Pharmocological
AMD NNP Pharmocological
] NNP Pharmocological
vincristine NN Pharmocological
( ( Pharmocological
VCR NNP Pharmocological
) ) Pharmocological
AMD NNP Pharmocological
+ NNP Pharmocological
VCR NNP Pharmocological
+/- JJ Pharmocological
Adriamycin NNP Pharmocological
( ( Pharmocological
ADR NNP Pharmocological
postoperative JJ Physical
radiation NN Physical
therapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
AMD NNP Pharmocological
+ NNP Pharmocological
VCR NNP Pharmocological
+ NNP Pharmocological
ADR NNP Pharmocological
+/- JJ Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
CPM NNP Pharmocological
) ) Pharmocological
. . None
CPM NNP Pharmocological
-DOCSTART- -X- N

[ RB None
Dexmedetomidine NNP Pharmocological
with IN None
trimeperidine NN Pharmocological
and CC None
dexmedetomidine NN Pharmocological
sedation NN None
hypokinetic JJ None
type NN None
of IN None
haemodynamics NNS None
dexmedetomidine NN Pharmocological
trimeperidine NN Pharmocological
Dexmedetomidine NNP Pharmocological
-DOCSTART- -X- N

Pravastatin NNP Pharmocological
Pravastatin NNP Pharmocological
placebo-controlled JJ Control
pravastatin NN Control
pravastatin NN Pharmocological
pravastatin NNS Pharmocological
placebo-in JJ Control
-DOCSTART- -X- N

growth NN Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GH NNP Pharmocological
) ) Pharmocological
treatment NN Pharmocological
GH NNP Pharmocological
treatment NN Pharmocological
placebo-controlled JJ Control
Recombinant JJ Pharmocological
human JJ Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

Riluzole NNP Pharmocological
risperidone VB Pharmocological
placebo-controlled JJ Control
Riluzole NNP Pharmocological
riluzole NN Pharmocological
received VBD None
riluzole JJ None
( ( None
titrated VBN None
bodyweight NN None
) ) None
or CC None
placebo NN None
in IN None
addition NN None
to TO None
risperidone VB None
( ( None
titrated VBN None
by IN None
the DT None
riluzole-treated JJ None
with IN None
the DT None
placebo NN None
group NN None
the DT None
riluzole NN None
group NN None
the DT None
riluzole NN None
group NN None
placebo NN None
group NN None
the DT None
riluzole NN None
in IN None
the DT None
placebo NN None
Riluzole NNP None
add-on JJ None
add-on JJ None
to TO None
risperidone VB None
also RB None
-DOCSTART- -X- N

PNU-142633 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
selective JJ Pharmocological
5-HT1D JJ Pharmocological
agonist NN Pharmocological
50-mg JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
a DT Pharmocological
5-HT JJ Pharmocological
( ( Pharmocological
1D CD Pharmocological
) ) Pharmocological
agonist NN Pharmocological
, , Pharmocological
PNU-142633 NNP Pharmocological
( ( None
n JJ None
= NNP None
34 CD None
) ) None
, , None
or CC None
matching VBG Control
placebo NN Control
PNU-142633 NNP Pharmocological
placebo NN None
PNU-142633 NNP None
placebo NN None
PNU-142633 NNP None
5-HT JJ None
( ( None
1D CD None
) ) None
5-HT JJ Pharmocological
agonist JJ Pharmocological
-DOCSTART- -X- N

pegylated VBN Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
topotecan JJ Pharmocological
pegylated JJ Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
( ( Pharmocological
PLD NNP Pharmocological
) ) Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan VB Pharmocological
topotecan JJ Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
-DOCSTART- -X- N

transcranial JJ Physical
electrostimulation NN Physical
traditional JJ Pharmocological
treatment NN Pharmocological
transcranial JJ Physical
electrotherapy NN Physical
( ( Pharmocological
traditional JJ Pharmocological
therapy NN Pharmocological
plus CC Pharmocological
electrostimulation NN Physical
-DOCSTART- -X- N

ferric NNS Pharmocological
carboxymaltose VBP Pharmocological
injection NN Pharmocological
large-dose JJ Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
IV NNP Pharmocological
) ) Pharmocological
administration NN Pharmocological
of IN Pharmocological
ferric JJ Pharmocological
carboxymaltose NN Pharmocological
oral JJ Pharmocological
iron NN Pharmocological
IV NNP Pharmocological
ferric NN Pharmocological
carboxymaltose NN Pharmocological
of IN Pharmocological
ferrous JJ Pharmocological
sulfate NN Pharmocological
ferrous JJ Pharmocological
sulfate NN Pharmocological
ferric VB Pharmocological
carboxymaltose NN Pharmocological
ferric JJ Pharmocological
carboxymaltose NN Pharmocological
ferrous JJ Pharmocological
sulfate NN Pharmocological
new JJ Pharmocological
iron NN Pharmocological
agent NN Pharmocological
, , Pharmocological
ferric JJ Pharmocological
carboxymaltose NN Pharmocological
oral JJ Pharmocological
iron NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

were VBD None
also RB None
measured VBN None
. . None
-DOCSTART- -X- N

pulsed JJ Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
Pulsed VBD Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
( ( Physical
300 CD Physical
to TO Physical
600 CD Physical
microA NN Physical
) ) Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
pulsed VBD Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
Pulsed VBD Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
pulsed JJ Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
-DOCSTART- -X- N

Thrombolysis NN Pharmocological
thrombolysis NN Pharmocological
-DOCSTART- -X- N

Modulation NN Physical
of IN Physical
oxidant JJ Physical
stress NN Physical
in IN Physical
vivo NN Physical
8-epi-prostaglandin JJ Pharmocological
( ( Pharmocological
PG NNP Pharmocological
) ) Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
, , Pharmocological
a DT Pharmocological
stable JJ Pharmocological
product NN Pharmocological
of IN Pharmocological
lipid JJ Pharmocological
peroxidation NN Pharmocological
in IN Pharmocological
vivo NN Pharmocological
modulation NN None
by IN None
aspirin NN Pharmocological
and CC None
antioxidant JJ Pharmocological
vitamins NNS Pharmocological
smoking VBG Educational
cessation NN Educational
( ( None
3 CD None
weeks NNS None
) ) None
and CC None
nicotine JJ Pharmocological
patch NN Pharmocological
supplementation NN Pharmocological
aspirin NN Pharmocological
consumption NN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
vitamin FW Pharmocological
C NNP Pharmocological
( ( None
2 CD None
g NN None
) ) None
Aspirin NNP Pharmocological
treatment NN Pharmocological
Vitamin NNP Pharmocological
C NNP Pharmocological
combination NN Pharmocological
of IN Pharmocological
vitamin JJ Pharmocological
C NNP Pharmocological
and CC Pharmocological
E NNP Pharmocological
vitamin JJ Pharmocological
E NNP Pharmocological
quitting VBG Educational
cigarettes NNS Educational
and CC None
switching VBG Pharmocological
to TO Pharmocological
nicotine VB Pharmocological
patches NNS Pharmocological
antioxidant JJ Pharmocological
vitamin NN Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

18F-FDG JJ None
PET/CT NNP None
neoadjuvant JJ Pharmocological
lapatinib NN Pharmocological
, , None
trastuzumab NN Pharmocological
, , None
and CC None
their PRP$ Pharmocological
combination NN Pharmocological
Neo-ALTTO NNP None
( ( None
Neoadjuvant NNP Pharmocological
Lapatinib NNP Pharmocological
and/or VBZ None
Trastuzumab NNP Pharmocological
neoadjuvant JJ Pharmocological
lapatinib NN Pharmocological
, , None
trastuzumab NN Pharmocological
, , None
and CC None
their PRP$ None
combination NN Pharmocological
. . None
anti-HER2 JJ Pharmocological
therapy NN Pharmocological
paclitaxel NN Pharmocological
. . Pharmocological
anti-HER2 JJ Pharmocological
therapies NNS Pharmocological
anti-HER2 JJ Pharmocological
treatment NN Pharmocological
. . Pharmocological
neoadjuvant JJ Pharmocological
trastuzumab NN Pharmocological
, , None
lapatinib NN Pharmocological
, , None
or CC None
their PRP$ None
combination NN Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

tumor-infiltrating JJ Physical
lymphocytes NNS Physical
tumor-infiltrating JJ Physical
lymphocytes NNS Physical
( ( Physical
TIL NNP Physical
) ) Physical
TIL NNP Physical
plus CC Physical
interleukin-2 JJ Physical
( ( Physical
IL-2 NNP Physical
) ) Physical
IL-2 NNP Pharmocological
only RB None
. . None
TIL+IL-2 NNP Pharmocological
IL-2 NNP Pharmocological
TIL NNP Pharmocological
-DOCSTART- -X- N

psychological JJ Educational
training NN Educational
program NN Educational
psychological JJ Educational
training NN Educational
programs NNS Educational
( ( Educational
P.T.P NNP Educational
. . Educational
) ) Educational
24-h JJ Educational
P.T.P NNP Educational
. . Educational
or CC Control
to TO Control
a DT Control
waiting VBG Control
list NN Control
period NN Control
. . None
assessed VBN Educational
by IN Educational
a DT Educational
was VBD Educational
assessed VBN Educational
by IN Educational
and CC Educational
were VBD Educational
assessed VBN Educational
by IN Educational
P.T.P NNP Educational
. . None
-DOCSTART- -X- N

artesunate JJ Pharmocological
plus CC Pharmocological
amodiaquine JJ Pharmocological
Artesunate NNP None
plus CC None
amodiaquine NN None
amodiaquine JJ Pharmocological
-DOCSTART- -X- N

Rivaroxaban NNP Pharmocological
versus NN None
warfarin NN Pharmocological
warfarin NN Pharmocological
Rivaroxaban NNP Pharmocological
warfarin NN Pharmocological
. . None
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
. . None
rivaroxaban NN Pharmocological
warfarin VB Pharmocological
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
rivaroxaban NN Pharmocological
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
rivaroxaban NN Pharmocological
warfarin NN Pharmocological
rivaroxaban NN Pharmocological
rivaroxaban NN Pharmocological
rivaroxaban NN Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
-DOCSTART- -X- N

indomethacin NN Pharmocological
, , None
angiotensin NN Pharmocological
II NNP Pharmocological
and CC None
frusemide VB Pharmocological
indomethacin NN Pharmocological
( ( None
200 CD None
mg NN None
) ) None
, , None
to TO None
infused VBN Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
placebo-controlled JJ Control
placebo NN Control
, , None
angiotensin NN Pharmocological
II NNP Pharmocological
infusion NN Pharmocological
indomethacin JJ Pharmocological
indomethacin JJ Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
infusion NN None
placebo NN Control
) ) None
Frusemide NNP Pharmocological
pre-frusemide JJ Pharmocological
-DOCSTART- -X- N

Steven NNP Educational
's POS Educational
psychophysical JJ Educational
method NN Educational
of IN Educational
magnitude NN Educational
estimation NN Educational
. . Educational
two-way JJ None
analyses NNS None
of IN None
variance NN None
-DOCSTART- -X- N

IMVAMUNE NNP Pharmocological
third JJ Pharmocological
generation NN Pharmocological
smallpox VBD Pharmocological
vaccine JJ Pharmocological
MVA-BN NNP Pharmocological
( ( Pharmocological
IMVAMUNE NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
Lister-Elstree NNP Pharmocological
or CC None
Dryvax NNP Pharmocological
. . None
-DOCSTART- -X- N

Echocardiography NN Physical
natriuretic JJ None
peptide NN None
Carvedilol NN Pharmocological
-DOCSTART- -X- N

testicular JJ Physical
biopsy NN Physical
local JJ Physical
testicular JJ Physical
irradiation NN Physical
systemic JJ Pharmocological
re-treatment NN Pharmocological
; : None
biopsy NN Surgical
testicular JJ Surgical
biopsies NNS Surgical
-DOCSTART- -X- N

Metformin NNP Pharmocological
metformin NN Pharmocological
pretreatment NN Pharmocological
metformin RB Pharmocological
day-1 NN None
) ) None
/placebo NN Control
metformin/placebo VBN Pharmocological
together RB None
with IN None
clomiphene NN Pharmocological
metformin NNS Pharmocological
placebo NN Control
placebo NN Control
metformin NN Pharmocological
placebo NN Control
metformin NNS Pharmocological
placebo NNS Control
Metformin NNP Pharmocological
-DOCSTART- -X- N

external JJ Physical
flow NN Physical
resistive NN Physical
( ( Physical
R NNP Physical
) ) Physical
and CC Physical
elastic JJ Physical
( ( Physical
E NNP Physical
) ) Physical
mechanical JJ Physical
loads NNS Physical
imperceptible JJ Educational
just RB Educational
perceptible JJ Educational
large JJ Educational
-DOCSTART- -X- N

donor NN Educational
recruitment NN Educational
brochure NN Educational
. . None
blood NN Educational
donor NN Educational
recruitment NN Educational
materials NNS Educational
brochures NNS Educational
: : None
a DT Educational
new JJ Educational
brochure NN Educational
addressing VBG Educational
common JJ Educational
donor NN Educational
concerns NNS Educational
and CC Educational
suggesting VBG Educational
specific JJ Educational
coping VBG Educational
strategies NNS Educational
, , None
2 CD None
) ) None
a DT None
standard JJ Educational
blood NN Educational
center NN Educational
brochure NN Educational
a DT Control
control JJ Educational
brochure NN Educational
on IN Educational
healthy JJ Educational
eating NN Educational
and CC Educational
exercise NN Educational
. . None
-DOCSTART- -X- N

5-fluorouracil JJ Pharmocological
plus CC Pharmocological
folinic JJ Pharmocological
acid NN Pharmocological
ifosfamide NN Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
plus CC None
folinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
FA NNP Pharmocological
) ) Pharmocological
with IN None
or CC None
without IN None
ifosfamide JJ Pharmocological
( ( Pharmocological
IFO NNP Pharmocological
) ) Pharmocological
FA NNP Pharmocological
5-FU JJ Pharmocological
FA NNP Pharmocological
5-FU JJ Pharmocological
IFO NNP Pharmocological
-DOCSTART- -X- N

traditional JJ Physical
implant NN Physical
or CC Physical
one CD Physical
which WDT Physical
incorporated VBD Physical
new JJ Physical
design NN Physical
features NNS Physical
. . None
new JJ Physical
design NN Physical
implant JJ Physical
traditional JJ Physical
implant NN Physical
knee NN Physical
implant NN Physical
of IN Physical
a DT Physical
modern JJ Physical
design NN Physical
traditional JJ Physical
implant NN Physical
-DOCSTART- -X- N

Circulating VBG Physical
blood NN Physical
B NNP Physical
cells NNS Physical
flow JJ Physical
cytometry NN Physical
. . None
PCR NNP Physical
-DOCSTART- -X- N

Topical JJ Pharmocological
treatment NN Pharmocological
dinitrochlorobenzene NN Pharmocological
( ( Pharmocological
DNCB NNP Pharmocological
) ) Pharmocological
contact NN Pharmocological
allergens NNS Pharmocological
. . None
croton NN Pharmocological
oil NN Pharmocological
DNCB NNP Pharmocological
. . None
DNCB NNP Pharmocological
-DOCSTART- -X- N

CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
, , None
5-fluorouracil JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
topical JJ Pharmocological
application NN Pharmocological
and CC None
Interferon NNP Pharmocological
alpha-2a NN Pharmocological
( ( Pharmocological
IFA NNP Pharmocological
alpha-2a NN Pharmocological
) ) Pharmocological
5-FU JJ Pharmocological
plus JJ Pharmocological
IFN NNP Pharmocological
alpha-2a NN Pharmocological
CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
plus CC Pharmocological
5-FU JJ Pharmocological
plus JJ Pharmocological
IFN NNP Pharmocological
alpha-2a NN Pharmocological
( ( Pharmocological
high JJ Pharmocological
dose NN Pharmocological
) ) Pharmocological
( ( Pharmocological
93.93 CD Pharmocological
% NN Pharmocological
) ) Pharmocological
combination NN Pharmocological
of IN Pharmocological
CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
plus CC Pharmocological
5-FU JJ Pharmocological
IFN NNP Pharmocological
alpha-2a NN Pharmocological
CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
or/plus IN Pharmocological
5-FU JJ Pharmocological
-DOCSTART- -X- N

Continuous JJ None
low-level JJ None
heatwrap NN None
therapy NN None
continuous JJ Physical
low-level JJ Physical
heatwrap NN Physical
therapy NN Physical
placebo-controlled JJ Control
( ( None
heatwrap NN Physical
, , Physical
n=95 RB Physical
; : Physical
oral JJ Physical
placebo NN Physical
, , Physical
n=96 NN Physical
) ) Physical
and CC None
blinding VBG Control
( ( Control
oral JJ Control
ibuprofen NN Control
, , Control
n=12 RB Control
; : Control
unheated VBN Control
back RB Control
, , Control
wrap NN Control
n=16 NN Control
) ) Control
. . None
Heatwrap NNP Physical
therapy NN Physical
placebo NN Control
heatwrap NN Physical
placebo NN Control
. . None
heatwrap NN Physical
heatwrap NN Physical
therapy NN Physical
-DOCSTART- -X- N

nicotine VB Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
: : None
nicotine JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
NRT NNP Pharmocological
) ) Pharmocological
NRT NNP Pharmocological
-DOCSTART- -X- N

influenza NN Pharmocological
vaccine NN Pharmocological
, , Pharmocological
trivalent NN Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
2 CD Pharmocological
doses NNS Pharmocological
of IN Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
, , None
or CC None
placebo VB Control
influenza JJ Pharmocological
vaccine NN Pharmocological
placebo NN Control
influenza JJ Pharmocological
vaccine NN Pharmocological
placebo NN Control
. . Control
placebo NN Control
influenza NN Pharmocological
vaccine NN Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

Psychosocial JJ Psychological
nursing NN Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
cognitive JJ Psychological
behavioral JJ Psychological
therapy NN Psychological
control NN Control
Psychosocial NNP Psychological
therapy NN Psychological
-DOCSTART- -X- N

stepwise NN None
screening NN None
strategy NN None
for IN None
type NN None
2 CD None
diabetes NNS None
; : None
intensive JJ Educational
multifactorial JJ Educational
treatment NN Educational
for IN None
no DT Control
screening NN Control
( ( Control
control NN Control
) ) Control
, , None
screening VBG Educational
followed VBN Educational
by IN Educational
intensive JJ Educational
treatment NN Educational
( ( Educational
IT NNP Educational
) ) Educational
and CC None
screening VBG None
plus CC None
routine JJ None
care NN None
-DOCSTART- -X- N

lasalocid NN Pharmocological
lasalocid NN Pharmocological
lasalocid NN Pharmocological
lasalocid NN Pharmocological
lasalocid JJ Pharmocological
lasalocid NN Pharmocological
-DOCSTART- -X- N

Lancet NNP Educational
puncture NN Educational
to TO Educational
the DT Educational
side NN Educational
of IN Educational
the DT Educational
thumb NN Educational
lancet JJ Educational
puncture NN Educational
to TO Educational
the DT Educational
finger NN Educational
or CC Educational
venepuncture NN Educational
at IN Educational
the DT Educational
elbow NN Educational
. . Educational
-DOCSTART- -X- N

pre-counselling VBG Educational
. . Educational
-DOCSTART- -X- N

behavioral JJ Psychological
intervention NN Psychological
social-cognitive JJ Psychological
theory-based JJ Psychological
intervention NN Psychological
or CC Physical
control NN Control
comparison NN Control
. . None
-DOCSTART- -X- N

trimethoprim-sulfamethoxazole JJ Pharmocological
or CC None
aerosolized JJ Pharmocological
pentamidine NN Pharmocological
treated VBN None
with IN None
zidovudine NN Pharmocological
receive VB None
either RB None
800 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
sulfamethoxazole NN Pharmocological
and CC Pharmocological
160 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
trimethoprim JJ Pharmocological
once JJ None
daily JJ None
or CC None
300 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
aerosolized JJ Pharmocological
pentamidine NN Pharmocological
administered VBN None
every DT None
four CD None
weeks NNS None
by IN None
jet NN Pharmocological
nebulizer NN Pharmocological
. . None
trimethoprim-sulfamethoxazole JJ Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
pentamidine NN Pharmocological
pentamidine NN Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
pentamidine NN Pharmocological
, , None
trimethoprim-sulfamethoxazole JJ Pharmocological
aerosolized JJ Pharmocological
pentamidine NN Pharmocological
-DOCSTART- -X- N

placebo VB Control
cetirizine NN Pharmocological
pseudoephedrine NN Pharmocological
cetirizine NN Pharmocological
pseudoephedrine NN Pharmocological
placebo VB Control
cetirizine/PSE NN Pharmocological
cetirizine/PSE NN Pharmocological
placebo VB Control
cetirizine/PSE NN Pharmocological
placebo NN Control
placebo VB Control
cetirizine/PSE NN Pharmocological
-DOCSTART- -X- N

anesthesia NN Physical
anesthesia JJ Physical
clove NN None
solution NN None
-DOCSTART- -X- N

Resistance NNP Physical
training NN Physical
strength NN Physical
training NN Physical
program NN Physical
randomly RB None
assigned VBN None
to TO None
either CC None
a DT None
whole JJ Physical
body NN Physical
strength NN Physical
training VBG Physical
who WP None
underwent VBD None
three CD None
supervised VBN None
resistance NN Physical
training NN Physical
sessions NNS None
per IN None
week NN None
for IN None
13 CD None
wk NN None
or CC None
who WP None
participated VBD None
in IN None
a DT None
supervised JJ None
stretching NN None
program NN None
. . None
strength NN Physical
training VBG Physical
group NN Physical
strength NN Physical
training NN Physical
short-term JJ Physical
strength NN Physical
training NN Physical
-DOCSTART- -X- N

Removing VBG Physical
bee JJ Physical
stings NNS Physical
. . None
venom NN Pharmocological
quick JJ Physical
removal NN Physical
-DOCSTART- -X- N

surgery NN Surgical
: : None
glucose RB Pharmocological
parenteral JJ Pharmocological
nutrition NN Pharmocological
glucose NN Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
glucose JJ Pharmocological
isotope NN Pharmocological
infusion NN Pharmocological
fasting VBG Physical
amino NN Pharmocological
acids NNS Pharmocological
, , None
Travasol NNP None
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
glucose JJ Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
amino JJ None
acids NNS None
and CC None
glucose VB None
amino JJ Pharmocological
acids NNS Pharmocological
and CC None
glucose VB Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
glucose JJ Pharmocological
glucose NN Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

intravenous JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
gamma JJ Pharmocological
globulin NN Pharmocological
( ( Pharmocological
IVGG NNP Pharmocological
) ) Pharmocological
plus CC None
aspirin JJ Pharmocological
versus NN None
aspirin NN Pharmocological
alone RB Pharmocological
IVGG NNP Pharmocological
-DOCSTART- -X- N

Direct JJ Physical
microscopy NN Physical
of IN Physical
the DT Physical
bile NN Physical
antibiotic JJ Pharmocological
group NN Pharmocological
control NN Control
group NN Control
. . None
cholecystectomy VB Surgical
-DOCSTART- -X- N

tirofiban VB Pharmocological
or CC None
abciximab VB Pharmocological
. . None
-DOCSTART- -X- N

primary JJ Physical
closure NN Physical
exteriorization NN Physical
-DOCSTART- -X- N

levocetirizine NN Pharmocological
and CC None
diphenhydramine NN Pharmocological
Levocetirizine NNP Pharmocological
levocetirizine NN Pharmocological
diphenhydramine NN Pharmocological
and CC Control
placebo NN Control
placebo-controlled JJ Control
diphenhydramine NN Physical
diphenhydramine NN Pharmocological
levocetirizine NN Pharmocological
levocetirizine NN Pharmocological
diphenhydramine NN Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
enalapril NN Pharmocological
or CC None
matched VBN None
placebo JJ Control
-DOCSTART- -X- N

S-1+paclitaxel JJ Pharmocological
S-1+cisplatin NNP Pharmocological
S-1 NNP Pharmocological
cisplatin NN Pharmocological
S-1+paclitaxel NNP Pharmocological
S-1+cisplatin NNP Pharmocological
S-1+cisplatin NNP Pharmocological
. . None
S-1+cisplatin NNP Pharmocological
. . None
S-1+paclitaxel NNP Pharmocological
non-platinum-based JJ None
regimen NNS None
-DOCSTART- -X- N

Citalopram NNP Pharmocological
9-week JJ Pharmocological
study NN Pharmocological
a DT Pharmocological
median NN Pharmocological
of IN Pharmocological
168 CD Pharmocological
days NNS Pharmocological
( ( Pharmocological
range VB Pharmocological
6-913 NNP Pharmocological
) ) Pharmocological
post NN Pharmocological
stroke NN Pharmocological
and CC Pharmocological
were VBD Pharmocological
treated VBN Pharmocological
with IN Pharmocological
citalopram JJ Pharmocological
10-20 JJ Pharmocological
mg NNS Pharmocological
daily RB Pharmocological
for IN Pharmocological
3 CD Pharmocological
weeks NNS Pharmocological
. . None
citalopram NN Pharmocological
-DOCSTART- -X- N

( ( None
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
methotrexate NN Pharmocological
, , Pharmocological
prednisone NN Pharmocological
[ NNP Pharmocological
COMP NNP Pharmocological
] NNP Pharmocological
) ) Pharmocological
10-drug JJ Pharmocological
( ( Pharmocological
LSA2-L2 NNP Pharmocological
modified VBN Pharmocological
) ) Pharmocological
central JJ Pharmocological
nervous JJ Pharmocological
system NN Pharmocological
prophylaxis NN Pharmocological
with IN Pharmocological
intrathecal JJ Pharmocological
methotrexate NN Pharmocological
local JJ Physical
or CC Physical
regional JJ Physical
radiation NN Physical
treatment NN Physical
. . None
COMP NNP Pharmocological
LSA2-L2 NNP Pharmocological
LSA2-L2 NNP Pharmocological
COMP NNP Pharmocological
-DOCSTART- -X- N

Anticholinergic NNP Pharmocological
drugs NNS Pharmocological
: : None
anticholinergic JJ Pharmocological
drugs NNS Pharmocological
atropine NN Pharmocological
glycopyrrolate NN Pharmocological
scopolamine NN Pharmocological
and CC None
placebo NN Control
Atropine NNP Pharmocological
glycopyrrolate NN Pharmocological
Scopolamine NNP Pharmocological
glycopyrrolate NN Pharmocological
Atropine NNP Pharmocological
atropine NN Pharmocological
, , None
glycopyrrolate NN Pharmocological
scopolamine NN Pharmocological
-DOCSTART- -X- N

Specific JJ Educational
exercises VBZ Educational
exercise NN Educational
program NN Educational
, , Educational
including VBG Educational
specific JJ Educational
stabilizing NN Educational
exercises NNS Educational
specific JJ Educational
exercise NN Educational
program NN Educational
-DOCSTART- -X- N

receive VB Educational
the DT Educational
decision NN Educational
aid NN Educational
or CC Educational
a DT Educational
control JJ Educational
pamphlet NN Educational
at IN Educational
the DT Educational
end NN Educational
of IN Educational
their PRP$ Educational
first JJ Educational
genetic JJ Educational
counseling NN Educational
consultation NN Educational
. . None
decision NN Educational
aid NN Educational
control NN Control
pamphlet NN Control
. . None
decision NN Educational
aid NN Educational
control NN Control
pamphlet NN Control
decision NN Educational
aid NN Educational
-DOCSTART- -X- N

nicotine NN Pharmocological
nicotine NN Pharmocological
chewing VBG Pharmocological
gum NN Pharmocological
nicotine NN Pharmocological
nicotine JJ Pharmocological
gum NN Pharmocological
( ( Pharmocological
4 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
echocardiograms JJ Physical
and CC Physical
signal-averaged JJ Physical
electrocardiograms NNS Physical
nicotine JJ Pharmocological
gum NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

vitamin NN Pharmocological
E NNP Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
twice RB Pharmocological
daily JJ Pharmocological
dosing NN Pharmocological
of IN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
( ( Pharmocological
400 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
/placebo NN Control
. . None
( ( None
34 CD None
% NN None
-vitamin NNP Pharmocological
E NNP Pharmocological
Vitamin NNP None
E NNP None
did VBD None
-DOCSTART- -X- N

intra- JJ Physical
and CC Physical
extracapsular JJ Physical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
implantation NN Physical
ECCE NNP Physical
and CC Physical
PCL NNP Physical
. . Physical
ICCE NNP Physical
and CC Physical
ACL NNP Physical
implantation NN Physical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
. . None
ECCE NNP Physical
with IN Physical
PCL NNP Physical
. . None
ECCE NNP Physical
and CC Physical
PCL NNP Physical
YAG-laser NNP Surgical
capsulotomy NN Surgical
. . None
YAG-laser NNP Surgical
capsulotomy NN Surgical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
ECCE VB Surgical
with IN Surgical
PCL NNP Surgical
ACL-implantation NN Surgical
-DOCSTART- -X- N

somatostatin NN None
infusion NN None
test NN None
bezafibrate JJ Pharmocological
medication NN Pharmocological
] NN None
infusion NN Pharmocological
test NN Pharmocological
of IN Pharmocological
bezafibrate NN Pharmocological
bezafibrate NN Pharmocological
bezafibrate NN Pharmocological
infusion NN Pharmocological
test NN Pharmocological
of IN Pharmocological
somatostatin NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
amantadine JJ Pharmocological
hydrochloride NN Pharmocological
amantadine JJ Pharmocological
single JJ None
daily JJ None
dose NN None
of IN None
amantadine NN Pharmocological
( ( None
2.5 CD None
mg/kg NNS None
per IN None
day NN None
) ) None
or CC None
placebo NN Control
for IN None
the DT None
next JJ None
week NN None
, , None
and CC None
then RB None
bid VB None
dosing VBG None
( ( None
5.0 CD None
mg/kg NNS None
per IN None
day NN None
) ) None
for IN None
the DT None
subsequent JJ None
3 CD None
weeks NNS None
. . None
amantadine-treated JJ Pharmocological
Amantadine NNP Pharmocological
amantadine JJ Pharmocological
-DOCSTART- -X- N

primary JJ Psychological
prevention NN Psychological
program NN Psychological
school-based JJ Psychological
primary JJ Psychological
prevention NN Psychological
psychological JJ Psychological
program NN Psychological
-DOCSTART- -X- N

radiotherapy NN Surgical
conventional JJ Physical
roentgen NN Physical
unit NN Physical
60Co CD Physical
unit NN Physical
60Co CD Physical
radiation NN Physical
60Co CD Physical
radiation NN Physical
-DOCSTART- -X- N

hydroxyzine NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
doxepin NN Pharmocological
at IN Pharmocological
night NN Pharmocological
, , None
pentoxifylline NN Pharmocological
, , None
indomethacin NN Pharmocological
and CC Pharmocological
topical JJ Pharmocological
moisturization NN Pharmocological
with IN Pharmocological
medium-strength JJ Pharmocological
topical JJ Pharmocological
steroids NNS Pharmocological
. . None
-DOCSTART- -X- N

Small-diameter JJ Physical
hysteroscopy NN Physical
with IN Physical
Versapoint NNP Physical
resectoscopy NN Physical
with IN Physical
a DT Physical
unipolar JJ Physical
knife NN Physical
resectoscopy NN Physical
with IN Physical
monopolar JJ Physical
knife NNS Physical
small-diameter JJ Physical
hysteroscopy NN Physical
fitted VBN Physical
with IN Physical
a DT Physical
Versapoint NNP Physical
device NN Physical
. . None
Hysteroscopic NNP Physical
26F CD Physical
resectoscope NN Physical
with IN Physical
unipolar JJ Physical
knife NN Physical
5-mm JJ Physical
diameter NN Physical
hysteroscope NN Physical
with IN Physical
Versapoint NNP Physical
device NN Physical
hysteroscopy NN Physical
resectoscopy NN Physical
-DOCSTART- -X- N

chemotherapy NN Pharmocological
with IN None
chemohormonal JJ Pharmocological
therapy NN Pharmocological
chemotherapy NN Pharmocological
simultaneous JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
chemotherapy NN None
( ( None
cyclophosphamide NN None
, , None
doxorubicin NN None
, , None
and CC None
fluorouracil RB None
?CAF NNP None
) ) None
or CC None
chemohormonal JJ None
therapy NN None
( ( None
CAF NNP None
plus CC None
tamoxifen NN None
and CC None
Halotestin NNP None
?fluoxymesterone NN None
; : None
Pharmacia-Upjohn NNP None
, , None
Kalamazoo NNP None
, , None
MI NNP None
?CAFTH NNP None
) ) None
as IN None
front-line JJ None
therapy NN None
for IN None
cancer NN None
, , None
chemohormonal JJ None
therapy NN None
prolongs NNS None
-DOCSTART- -X- N

calculus NN Pharmocological
scaling VBG Pharmocological
gel NN Pharmocological
. . None
calculus NN Pharmocological
scaling VBG Pharmocological
gel NN Pharmocological
( ( Pharmocological
SofScale NNP Pharmocological
) ) Pharmocological
gel NN Pharmocological
was VBD None
applied VBN None
directly RB None
to TO None
the DT None
calculus NN None
and CC None
subgingivally RB None
to TO None
the DT None
area NN None
to TO None
be VB None
scaled VBN None
. . None
Pre- JJ None
and CC None
post-treatment JJ None
gingival NN None
and CC None
stain NN None
indices NNS None
were VBD None
taken VBN None
. . None
SofScale NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

lidocaine NN Pharmocological
hyaluronic JJ Pharmocological
acid NN Pharmocological
filler NN Pharmocological
alone RB Pharmocological
. . None
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
gel NN Pharmocological
HA NNP Pharmocological
gel NN Pharmocological
with IN Pharmocological
preincorporated JJ Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
-DOCSTART- -X- N

remifentanil NN Pharmocological
and CC None
alfentanil NN Pharmocological
remifentanil NNS Pharmocological
remifentanil NN Pharmocological
placebo-controlled JJ Control
saline NN Pharmocological
, , None
remifentanil NN Pharmocological
, , None
or CC None
alfentanil NN Pharmocological
for IN None
120 CD None
min NN None
. . None
age- JJ None
and CC None
weight-adjusted JJ None
infusions NNS None
( ( None
determined VBN None
with IN None
STANPUMP NNP Pharmocological
, , None
a DT None
computer NN Pharmocological
modeling VBG Pharmocological
software NN Pharmocological
package NN Pharmocological
) ) None
40 CD None
min NNS None
each DT None
of IN None
remifentanil NN Pharmocological
( ( None
0.75 CD None
, , None
1.5 CD None
, , None
and CC None
3 CD None
ng/ml NN None
) ) None
and CC None
alfentanil NN None
( ( None
16 CD None
, , None
32 CD None
, , None
and CC None
64 CD None
ng/ml NN None
) ) None
. . None
Remifentanil NNP Pharmocological
remifentanil NN Pharmocological
-DOCSTART- -X- N

blood NN Physical
conservation NN Physical
device NN Physical
blood NN Physical
conservation NN Physical
device NN Physical
incorporated VBN Physical
into IN Physical
the DT Physical
arterial JJ Physical
pressure NN Physical
monitoring NN Physical
system NN Physical
control NN Control
group NN Control
received VBD Control
a DT Control
conventional JJ Control
arterial JJ Control
pressure NN Control
monitoring NN Control
system NN Control
. . Control
blood NN Physical
conservation NN Physical
system NN Physical
-DOCSTART- -X- N

captopril NN Pharmocological
, , None
atenolol NN Pharmocological
and CC None
pravastatin NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
life NN Pharmocological
style NN Pharmocological
intervention NN Pharmocological
. . None
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
captopril NN Pharmocological
) ) Pharmocological
, , None
and CC None
a DT None
beta-receptor NN Pharmocological
blocking NN Pharmocological
agent NN Pharmocological
( ( Pharmocological
atenolol NN Pharmocological
) ) Pharmocological
, , None
given VBN None
alone RB None
or CC None
in IN None
combination NN None
with IN None
a DT None
cholesterol NN Pharmocological
reducing VBG Pharmocological
drug NN Pharmocological
, , None
the DT None
beta-hydroxy-methylglutaryl-coenzyme NN Pharmocological
A DT Pharmocological
reductase NN Pharmocological
inhibitor NN Pharmocological
pravastatin NN Pharmocological
Lifestyle JJ Educational
intervention NN Educational
alone RB Educational
. . None
Continued JJ Pharmocological
lifestyle JJ Pharmocological
intervention NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
captopril NN Pharmocological
or CC Pharmocological
atenolol NN Pharmocological
. . None
Continued JJ Pharmocological
lifestyle JJ Other
intervention NN Other
combined VBN Other
with IN Other
the DT Other
same JJ Other
drugs NNS Other
as IN Other
in IN Other
phase NN Other
II NNP Other
and CC None
in IN None
addition NN None
pravastatin NN Pharmocological
or CC None
placebo NN Other
. . None
captopril NN Pharmocological
and CC None
atenolol NN Pharmocological
pravastatin NN Pharmocological
. . None
pravastatin NN Pharmocological
captopril NN Pharmocological
or CC None
atenolol NN Pharmocological
. . None
Pravastatin NNP Pharmocological
captopril NN Pharmocological
or CC None
atenolol NN Pharmocological
-DOCSTART- -X- N

recombinant JJ Pharmocological
alpha JJ Pharmocological
2b-interferon JJ Pharmocological
with IN None
or CC None
without IN None
indomethacin NNS Pharmocological
alpha-Interferon NN Pharmocological
indomethacin JJ Pharmocological
indomethacin NN Pharmocological
alpha JJ Pharmocological
2b-interferon CD Pharmocological
indomethacin NN Pharmocological
indomethacin NN Pharmocological
Indomethacin NNP Pharmocological
Indomethacin NNP Pharmocological
indomethacin NN Pharmocological
-DOCSTART- -X- N

recombinant NN Pharmocological
adenoassociated VBN Pharmocological
vector NN Pharmocological
containing VBG Pharmocological
a DT Pharmocological
tumour JJ Pharmocological
necrosis NN Pharmocological
factor NN Pharmocological
alpha IN Pharmocological
antagonist JJ Pharmocological
gene NN Pharmocological
rAAV2-TNFR NN Pharmocological
: : Pharmocological
Fc NNP Pharmocological
, , Pharmocological
an DT Pharmocological
adenoassociated JJ Pharmocological
virus NN Pharmocological
serotype NN Pharmocological
2 CD Pharmocological
vector NN Pharmocological
containing VBG Pharmocological
the DT Pharmocological
cDNA NN Pharmocological
placebo-controlled JJ Control
rAAV2-TNFR NN Pharmocological
: : Pharmocological
Fc NN Pharmocological
or CC Control
placebo NN Control
-DOCSTART- -X- N

home NN Educational
TEACCHing NNP Educational
program NN Educational
training NN Psychological
intervention NN Psychological
waitlist NN Control
-DOCSTART- -X- N

cloxacillin NN Pharmocological
or CC None
carbenicillin NN Pharmocological
plus CC Pharmocological
gentamicin NN Pharmocological
-DOCSTART- -X- N

home-visit JJ Educational
invitation NN Educational
in-home JJ Educational
education NN Educational
and CC Educational
invitation NN Educational
intervention NN Educational
intervention NN Educational
control VB Control
zone NN Control
. . Control
visited VBN Educational
in IN Educational
their PRP$ Educational
homes NNS Educational
by IN Educational
one CD Educational
of IN Educational
the DT Educational
researchers NNS Educational
, , Educational
who WP Educational
provided VBD Educational
culturally-sensitive JJ Educational
health NN Educational
education NN Educational
that WDT Educational
emphasized VBD Educational
the DT Educational
need NN Educational
for IN Educational
screening VBG Educational
. . Educational
screening-coverage JJ Educational
interviews NNS Educational
home NN Educational
visit NN Educational
education NN Educational
and CC Educational
invitation NN Educational
intervention NN Educational
-DOCSTART- -X- N

health NN Educational
promotion NN Educational
Working NNP Educational
Well NNP Educational
with IN Educational
a DT Educational
Disability NNP Educational
health-promotion NN Educational
program NN Educational
Health-promotion NN Educational
interventions NNS Educational
Working NNP Educational
Well NNP Educational
health NN Educational
promotion NN Educational
program NN Educational
. . None
Intervention-group JJ Educational
Working NNP Educational
Well NNP Educational
Control-group NN Control
Working NNP Educational
Well NNP Educational
program NN Educational
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
placebo NN Control
morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
. . None
morphine NN Pharmocological
-DOCSTART- -X- N

medication NN Educational
adherence NN Educational
and CC Educational
AA NNP Educational
meeting NN Educational
attendance NN Educational
lithium NN Pharmocological
carbonate NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

pooled VBN Pharmocological
human JJ Pharmocological
milk NN Pharmocological
( ( Pharmocological
BM NNP Pharmocological
) ) Pharmocological
; : Pharmocological
formula $ Pharmocological
1 CD Pharmocological
( ( Pharmocological
F1 NNP Pharmocological
) ) Pharmocological
= VBD Pharmocological
1.5 CD Pharmocological
gm/dl NN Pharmocological
protein NN Pharmocological
, , Pharmocological
60 CD Pharmocological
parts NNS Pharmocological
bovine NN Pharmocological
whey NN Pharmocological
proteins NNS Pharmocological
: : Pharmocological
40 CD Pharmocological
parts NNS Pharmocological
bovine NN Pharmocological
caseins NNS Pharmocological
; : Pharmocological
F2 NNP Pharmocological
= VBD Pharmocological
3.0 CD Pharmocological
gm/dl NN Pharmocological
, , Pharmocological
60:40 CD Pharmocological
; : Pharmocological
F3 NNP Pharmocological
= VBD Pharmocological
1.5 CD Pharmocological
gm/dl NN Pharmocological
, , Pharmocological
18:82 CD Pharmocological
; : Pharmocological
F4 NNP Pharmocological
= VBD Pharmocological
3.0 CD Pharmocological
gm/dl NN Pharmocological
-DOCSTART- -X- N

device-guided JJ Educational
breathing NN Educational
exercises NNS Educational
device NN Educational
that WDT Educational
helps VBZ Educational
to TO Educational
( ( Educational
Resperate NNP Educational
) ) Educational
listened VBD Educational
to TO Educational
music NN Educational
and CC Educational
used VBN Educational
no DT Educational
other JJ Educational
therapeutic JJ Educational
device NN Educational
. . None
-DOCSTART- -X- N

Insulin NNP Pharmocological
pump NN Pharmocological
insulin JJ None
pump NN None
insulin NN None
MDI NNP None
insulin NN None
therapy NN None
pump JJ None
therapy NN None
pump NN None
therapy NN None
insulin JJ None
insulin NN None
pump NN None
therapy NN None
-DOCSTART- -X- N

Anecortave NNP Pharmocological
acetate NN Pharmocological
treatment NN Pharmocological
anecortave JJ Pharmocological
acetate JJ Pharmocological
treatment NN Pharmocological
anecortave NN Pharmocological
acetate NN Pharmocological
sterile JJ Pharmocological
suspension NN Pharmocological
for IN Pharmocological
juxtascleral JJ Pharmocological
administration NN Pharmocological
. . None
anecortave JJ Pharmocological
acetate NN Pharmocological
anecortave VBP Pharmocological
acetate JJ Pharmocological
-DOCSTART- -X- N

CHOP NNP Pharmocological
of IN None
CHOP NNP Pharmocological
followed VBN None
by IN None
a DT None
BEAM NNP Pharmocological
autograft NN Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
prednisolone NN Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
. . None
CHOP NNP Pharmocological
CHOP NNP Pharmocological
followed VBN None
by IN None
a DT None
BEAM NNP Pharmocological
( ( Pharmocological
carmustine NN Pharmocological
, , Pharmocological
etoposide RB Pharmocological
, , Pharmocological
cytarabine NN Pharmocological
, , Pharmocological
melphalan NN Pharmocological
) ) Pharmocological
autograft NN Pharmocological
. . None
CHOP NNP Pharmocological
CHOP NNP Pharmocological
CHOP NNP Pharmocological
-DOCSTART- -X- N

cognitive-behavioral JJ Psychological
therapy NN Psychological
treatment NN Control
as IN Control
usual JJ Control
cognitive-behavioral JJ Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
treatment NN Control
as IN Control
usual JJ Control
( ( None
TAU NNP None
) ) None
CBT NNP Educational
TAU NNP Control
CBT NNP Control
TAU VB Control
CBT NNP Educational
TAU NNP Control
CBT NNP Control
CBT NNP Educational
CBT NNP Educational
-DOCSTART- -X- N

angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
calcium NN Pharmocological
antagonist NN Pharmocological
. . Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
lisinopril NN Pharmocological
calcium NN Pharmocological
antagonist NN Pharmocological
nifedipine NN Pharmocological
lisinopril JJ Pharmocological
and CC Pharmocological
slow-release JJ Pharmocological
nifedipine NN Pharmocological
lisinopril NN Pharmocological
nifedipine JJ Pharmocological
lisinopril NN Pharmocological
nifedipine NN Pharmocological
lisinopril RB Pharmocological
nifedipine NN Pharmocological
lisinopril FW Pharmocological
nifedipine NN Pharmocological
-DOCSTART- -X- N

smoking-cessation NN Educational
therapy NN Educational
Generalized NNP None
linear JJ None
regression NN None
models NNS None
were VBD None
used VBN None
to TO None
analyze VB None
on IN None
smoking-cessation JJ Educational
therapy NN Educational
-DOCSTART- -X- N

corticosteroid NN Pharmocological
( ( Pharmocological
ICS NNP Pharmocological
) ) Pharmocological
triamcinolone NN Pharmocological
acetonide NN Pharmocological
placebo NN Control
ICS NNP Pharmocological
placebo VB None
ICS NNP Pharmocological
placebo NN None
ICS NNP Pharmocological
ICSs NNP None
-DOCSTART- -X- N

Grenz NNP Physical
rays NNS Physical
topical JJ Physical
corticosteroid NN Physical
combined VBN Physical
with IN Physical
Grenz NNP Physical
rays NNS Physical
. . Physical
Grenz NNP Physical
ray NN Physical
therapy NN Physical
Grenz NNP Pharmocological
rays NNS Pharmocological
combined VBN Pharmocological
with IN Pharmocological
a DT Pharmocological
topical JJ Pharmocological
corticosteroid NN Pharmocological
( ( Pharmocological
betamethasone JJ Pharmocological
dipropionate NN Pharmocological
) ) Physical
4 CD None
Grenz NNP Physical
ray NN Physical
treatment NN Physical
plus CC Physical
topical JJ Physical
corticosteroid NN Physical
. . Physical
Grenz NNP Physical
ray NN Physical
Grenz NNP Physical
ray NN Physical
Grenz NNP Physical
ray NN Physical
therapy NN Physical
corticosteroid NN Physical
-DOCSTART- -X- N

intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
Intensive NNP Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
IIT NNP Pharmocological
) ) Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
CIT NNP Pharmocological
) ) Pharmocological
. . None
IIT NNP Pharmocological
IIT NNP Pharmocological
. . None
IIT NNP Pharmocological
CIT NNP Pharmocological
IIT NNP Pharmocological
IIT NNP Pharmocological
IIT NNP Pharmocological
-DOCSTART- -X- N

Standard NNP Physical
extended VBD Surgical
lymphadenectomy NN Surgical
extended VBD Surgical
lymphadenectomy NN Surgical
standard JJ Surgical
lymphadenectomy NN Surgical
. . Surgical
-DOCSTART- -X- N

Transthoracic NNP Physical
versus NN None
transesophageal NN Surgical
cardioversion NN Surgical
of IN Surgical
atrial JJ Surgical
fibrillation NN Surgical
under IN None
light JJ None
sedation NN None
: : None
intravenous JJ Pharmocological
midazolam NNS Pharmocological
. . None
-DOCSTART- -X- N

nonspecific JJ Pharmocological
inhalation NN Pharmocological
provocation NN Pharmocological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
surgical JJ Surgical
oophorectomy NN Surgical
tamoxifen NN Pharmocological
undergo VB Surgical
a DT Surgical
surgical JJ Surgical
oophorectomy NN Surgical
. . Surgical
. . None
tamoxifen NN Pharmocological
surgical JJ Surgical
oophorectomy NN Surgical
tamoxifen EX Pharmocological
surgical JJ Surgical
oophorectomy NN Surgical
. . None
-DOCSTART- -X- N

snacks NNS Physical
no DT Physical
snacks NNS Physical
vs VBP None
three CD Physical
snacks NNS Physical
3 CD Physical
meals/day NN Physical
( ( Physical
3M CD Physical
) ) Physical
3 CD Physical
meals NNS Physical
and CC Physical
3 CD Physical
snacks/day NN Physical
3M CD Pharmocological
3+3M CD Pharmocological
( ( None
3M CD Pharmocological
3+3M=-4.1+/-6.1 JJ Pharmocological
3M CD Pharmocological
3+3M CD Pharmocological
-DOCSTART- -X- N

non-nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitors NNS Pharmocological
, , Pharmocological
protease NN Pharmocological
inhibitors NNS Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
in IN Pharmocological
the DT Pharmocological
presence NN Pharmocological
of IN Pharmocological
nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitors NNS Pharmocological
protease NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
non-nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
NNRTI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
are VBP Pharmocological
lacking VBG Pharmocological
. . Pharmocological
protease NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
strategy NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
plus CC Pharmocological
nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitor NN Pharmocological
[ NNP Pharmocological
NRTI NNP Pharmocological
] NNP Pharmocological
; : Pharmocological
a DT Pharmocological
non-nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
NNRTI NNP Pharmocological
) ) Pharmocological
strategy NN Pharmocological
( ( Pharmocological
NNRTI NNP Pharmocological
plus CC Pharmocological
NRTI NNP Pharmocological
; : Pharmocological
or CC Pharmocological
a DT Pharmocological
three-class JJ Pharmocological
strategy NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
plus CC Pharmocological
NNRTI NNP Pharmocological
plus CC Pharmocological
NRTI NNP Pharmocological
; : Pharmocological
NNRTI-based JJ Pharmocological
regimen NNS Pharmocological
PI-based JJ Pharmocological
regimen NN Pharmocological
-DOCSTART- -X- N

porcine NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
. . None
secretin VB Pharmocological
or CC None
placebo VB None
placebo NN Control
or CC None
porcine NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
. . None
porcine NN Pharmocological
secretin NN Pharmocological
-DOCSTART- -X- N

continuous JJ Pharmocological
infusion NN Pharmocological
fluorouracil NN Pharmocological
versus NN None
fluorouracil NN Pharmocological
plus CC Pharmocological
cisplatin NN Pharmocological
infusional JJ Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
FU NNP Pharmocological
) ) Pharmocological
versus NN None
cisplatin NN Pharmocological
( ( Pharmocological
CDDP NNP Pharmocological
) ) Pharmocological
and CC None
FU NNP Pharmocological
. . None
CDDP/FU NNP Pharmocological
CDDP NNP Pharmocological
CDDP/FU NNP Pharmocological
FU NNP Pharmocological
CDDP/FU NNP Pharmocological
FU NNP Pharmocological
CDDP/FU NNP Pharmocological
FU NNP Pharmocological
FU NNP Pharmocological
CDDP/FU NNP Pharmocological
CDDP/FU NNP Pharmocological
-DOCSTART- -X- N

( ( None
5-fluorouracil JJ Pharmocological
interferon NN Pharmocological
) ) None
laser NN Surgical
surgery NN Surgical
interferon NN Pharmocological
5-fluorouracil JJ Pharmocological
interferon NN Pharmocological
5-fluorouracil JJ Pharmocological
laser NN Surgical
alone RB Surgical
5-fluorouracil JJ Pharmocological
interferon NN Pharmocological
surgical JJ Surgical
deleulking NN Surgical
-DOCSTART- -X- N

Self-management JJ Educational
improvement NN Educational
program NN Educational
combined VBN Educational
with IN Educational
community NN Educational
involvement NN Educational
program NN Educational
that WDT Educational
utilizes VBZ Educational
community NN Educational
involvement NN Educational
self-management JJ Educational
strategies NNS Educational
experimental JJ Educational
group NN Educational
control NN Control
group NN Control
program NN Educational
to TO Educational
improve VB Educational
self-management JJ Educational
methods NNS Educational
based VBN Educational
on IN Educational
social JJ Educational
cognitive JJ Educational
theory NN Educational
( ( Educational
SCT NNP Educational
) ) Educational
. . None
group NN Educational
meetings NNS Educational
home NN Educational
visit NN Educational
monitoring NN Educational
social JJ Educational
cognitive JJ Educational
theory NN Educational
( ( Educational
SCT NNP Educational
) ) Educational
self-management JJ Educational
techniques NNS Educational
-DOCSTART- -X- N

laparoscopic NN Surgical
open JJ Surgical
surgery NN Surgical
laparoscopic NN Surgical
treatment NN Surgical
laparoscopic NN Surgical
neoadjuvant JJ Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
capecitabine NN Pharmocological
and CC None
50-54 JJ Physical
Gy NNP Physical
external JJ Physical
beam NN Physical
radiotherapy NN Physical
. . None
Sphincter-preserving JJ Surgical
surgery NN Surgical
open JJ Surgical
open JJ Surgical
surgery NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
open JJ Surgical
surgery NN Surgical
. . None
laparoscopic NN Surgical
Laparoscopic NNP Surgical
surgery NN Surgical
open VB Surgical
surgery NN Surgical
-DOCSTART- -X- N

Norasept NNP Pharmocological
II NNP Pharmocological
-DOCSTART- -X- N

limbal JJ None
pars NNS None
plana VBP None
approach NN None
primary JJ Physical
posterior JJ Physical
capsulectomy NN Physical
and CC None
anterior JJ Physical
vitrectomy NN Physical
Primary JJ Physical
posterior JJ Physical
capsulectomy NN Physical
and CC None
anterior JJ Physical
vitrectomy NN Physical
posterior JJ Physical
capsulectomy NN Physical
and CC None
anterior JJ Physical
vitrectomy NN Physical
lensectomy NN Surgical
and CC Surgical
PC NN Surgical
IOL NNP Surgical
implantation NN Surgical
-DOCSTART- -X- N

Endovascular NNP Surgical
aneurysm NN Surgical
repair NN Surgical
( ( Surgical
EVAR NNP Surgical
) ) Surgical
EVAR NNP Surgical
or CC None
no DT Pharmocological
intervention NN Pharmocological
aneurysm JJ Surgical
repair NN Surgical
EVAR NNP Surgical
-DOCSTART- -X- N

Retroinfusion-supported JJ Surgical
stenting NN Surgical
retroinfusion-supported JJ Surgical
stenting NN Surgical
bypass VB Surgical
surgery NN Surgical
. . None
stent JJ Surgical
implantation NN Surgical
conventional JJ Surgical
bypass NN Surgical
surgery NN Surgical
stent JJ Surgical
implantation NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary JJ Surgical
angioplasty/stent NN Surgical
procedure NN Surgical
bypass NN Surgical
surgery NN Surgical
stent VB Surgical
implantation NN Surgical
selective JJ Surgical
pressure-regulated JJ Surgical
retroinfusion NN Surgical
retroinfusion-supported JJ Surgical
stent NN Surgical
implantation NN Surgical
bypass NN Surgical
surgery NN Surgical
. . None
retroinfusion-supported JJ Surgical
stent NN Surgical
implantation NN Surgical
-DOCSTART- -X- N

booster NN Pharmocological
vaccination NN Pharmocological
] NNP None
booster NN Pharmocological
vaccination NN Pharmocological
against IN Pharmocological
diphtheria NN Pharmocological
vaccination NN None
booster NN Pharmocological
booster NN Pharmocological
vaccination NN Pharmocological
-DOCSTART- -X- N

High-calcium JJ Pharmocological
milk NN Pharmocological
high-calcium NN Pharmocological
, , Pharmocological
fortified VBN Pharmocological
, , Pharmocological
low-fat JJ Pharmocological
milk NN Pharmocological
drink NN Pharmocological
added JJ Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
low-calcium JJ Control
placebo NN Control
drink NN Control
high-calcium JJ Pharmocological
milk NN Pharmocological
placebo NN Control
drink NN None
. . None
high-calcium NN Pharmocological
fortified VBD Pharmocological
milk NN Pharmocological
-DOCSTART- -X- N

exclusive JJ Educational
breastfeeding NN Educational
breastfeeding VBG Educational
24-hour JJ Educational
hotline NN Educational
and CC Educational
postpartum NN Educational
support NN Educational
film NN Educational
multiple JJ None
logistic JJ None
regression NN None
analysis NN None
breastfeeding NN Educational
-DOCSTART- -X- N

clopidogrel NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NNS Pharmocological
extended-release JJ Pharmocological
dipyridamole JJ Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
clopidogrel NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ASA NNP Pharmocological
) ) Pharmocological
dipyridamole+ASA NN Pharmocological
. . None
dual JJ Pharmocological
antiplatelet NN Pharmocological
regimens NNS Pharmocological
clopidogrel JJ Pharmocological
75 CD Pharmocological
mg NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
extended-release JJ Pharmocological
dipyridamole NN Pharmocological
200 CD Pharmocological
mg NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
clopidogrel JJ Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
extended-release JJ Pharmocological
dipyridamole JJ Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
Clopidogrel NNP Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
extended-release JJ Pharmocological
dipyridamole JJ Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

N NNP Pharmocological
, , Pharmocological
N-dimethylglycine NNP Pharmocological
receive VB None
either DT None
placebo NN Control
or CC None
dimethylglycine NN Pharmocological
for IN None
4 CD None
weeks NNS None
. . None
two CD Educational
behavioral JJ Educational
measures NNS Educational
, , Educational
the DT Educational
-DOCSTART- -X- N

Midazolam NNP Pharmocological
vs NN None
ondansetron NN Pharmocological
midazolam NN Pharmocological
ondansetron NN Pharmocological
Midazolam NNP Pharmocological
2 CD Pharmocological
mg NN Pharmocological
or CC None
ondansetron $ Pharmocological
4 CD Pharmocological
mg NN Pharmocological
ondansetron NN Pharmocological
midazolam VB Pharmocological
-DOCSTART- -X- N

propofol NN Pharmocological
, , None
isoflurane NN Pharmocological
, , None
and CC None
sevoflurane NN Pharmocological
group NN None
received VBD None
100 CD None
microg NNS None
x JJ None
kg NN None
( ( None
-1 NNP None
) ) None
x VBP None
min NN None
( ( None
-1 NNP None
) ) None
propofol NN Pharmocological
, , None
the DT None
other JJ None
groups NNS None
received VBD None
one CD None
minimum NN None
alveolar JJ None
concentration NN None
of IN None
sevoflurane NN Pharmocological
or CC None
isoflurane NN Pharmocological
for IN None
anesthesia JJ Pharmocological
maintenance NN Pharmocological
. . None
-DOCSTART- -X- N

pill NN Pharmocological
containing VBG Pharmocological
drospirenone NN Pharmocological
with IN None
those DT None
of IN None
a DT None
combined JJ Pharmocological
contraceptive JJ Pharmocological
vaginal JJ Pharmocological
ring NN Pharmocological
on IN None
drospirenone+ethinylestradiol VB Pharmocological
or CC None
combined VBN Pharmocological
contraceptive JJ Pharmocological
vaginal JJ Pharmocological
ring NN Pharmocological
therapy NN Pharmocological
. . None
6 CD None
months NNS None
of IN None
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

strict JJ Physical
treatment NN Physical
to TO Physical
maintain VB Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
mild JJ Physical
treatment NN Physical
to TO Physical
maintain VB Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
strict JJ Physical
treatment NN Physical
( ( None
n=2,212 JJ None
) ) None
or CC None
mild JJ Physical
treatment NN Physical
( ( None
n=2,206 JJ None
) ) None
efonidipine JJ Physical
hydrochloride NN Physical
, , None
a DT None
long-acting JJ None
calcium NN None
antagonist NN None
. . None
-DOCSTART- -X- N

atropine NN Pharmocological
and CC None
metoclopramide NN Pharmocological
atropine NN Pharmocological
and CC Pharmocological
metoclopramide NN Pharmocological
Atropine NNP Pharmocological
Metoclopramide NNP Pharmocological
atropine NN Pharmocological
-DOCSTART- -X- N

pentoxifylline JJ Pharmocological
pentoxifylline NN Pharmocological
( ( Pharmocological
PTF NNP Pharmocological
) ) Pharmocological
PTF NNP Pharmocological
control NN Control
PTF NNP Pharmocological
PTF NNP Pharmocological
-DOCSTART- -X- N

Internet-based JJ Educational
intervention NN Educational
psychotherapeutic JJ Educational
interventions NNS Educational
control VB Control
groups NNS Control
. . None
-DOCSTART- -X- N

randomly RB Pharmocological
allocated VBN Pharmocological
to TO Pharmocological
receive VB Pharmocological
a DT Pharmocological
single JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
either DT Pharmocological
one CD Pharmocological
FDC NNP Pharmocological
tablet NN Pharmocological
or CC None
co-administration NN Pharmocological
of IN Pharmocological
two CD Pharmocological
separate JJ Pharmocological
diflunisal NN Pharmocological
and CC Pharmocological
naproxen RB Pharmocological
marketed VBN Pharmocological
tablets NNS Pharmocological
. . None
Plasma NNP None
samples NNS None
were VBD None
obtained VBN None
over IN None
a DT None
72-h JJ None
interval NN None
and CC None
analyzed VBN None
for IN None
by IN None
reversed JJ None
phase NN None
liquid NN None
chromatography NN None
with IN None
UV NNP None
detection NN None
. . None
-DOCSTART- -X- N

Left NNP Surgical
thoracoabdominal JJ Surgical
approach NN Surgical
abdominal-transhiatal JJ Surgical
approach NN Surgical
left JJ Surgical
thoracoabdominal JJ Surgical
approach NN Surgical
( ( Physical
LTA NNP Physical
) ) Physical
LTA NNP Surgical
with IN Surgical
the DT Surgical
abdominal-transhiatal JJ Surgical
approach NN Surgical
( ( Physical
TH NNP Physical
) ) Physical
in IN Physical
the DT Physical
treatment NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

troxerutin NN Pharmocological
and CC Pharmocological
carbazochrome JJ Pharmocological
combination NN Pharmocological
troxerutin NN Pharmocological
troxerutin $ Pharmocological
carbazochrome VB Pharmocological
troxerutin NN Pharmocological
150 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
carbazochrome VB Pharmocological
1.5 CD Pharmocological
mg NN Pharmocological
placebo NN Control
combination NN Pharmocological
of IN Pharmocological
troxerutin $ Pharmocological
and CC None
carbazochrome VB Pharmocological
placebo VB Control
-DOCSTART- -X- N

enamel JJ Pharmocological
preparation NN Pharmocological
method NN Pharmocological
Er NNP Physical
: : Physical
YAG NNP Physical
laser NN Physical
diamond-bur JJ Physical
conventional JJ Physical
technique NN Physical
. . Educational
high-speed JJ Pharmocological
handpiece NN Pharmocological
+ VBD None
37 CD Pharmocological
% NN Pharmocological
phosphoric JJ Pharmocological
acid NN Pharmocological
; : Pharmocological
Er NN Pharmocological
: : Pharmocological
YAG NNP Pharmocological
laser NN Pharmocological
( ( Pharmocological
350 CD Pharmocological
mJ NN Pharmocological
, , None
4 CD None
Hz NNP None
and CC None
112 CD None
J/cm NNP None
( ( None
2 CD None
) ) None
) ) None
+ $ None
37 CD Pharmocological
% NN Pharmocological
phosphoric JJ Pharmocological
acid NN Pharmocological
; : None
Er NN Pharmocological
: : Pharmocological
YAG NNP Pharmocological
laser NN Pharmocological
( ( Pharmocological
350 CD Pharmocological
mJ NN Pharmocological
, , None
4 CD None
Hz NNP None
and CC None
112 CD None
J/cm NNP None
( ( None
2 CD None
) ) None
) ) None
+ FW None
Er NNP Pharmocological
: : Pharmocological
YAG NNP Pharmocological
laser NN Pharmocological
( ( Pharmocological
80 CD Pharmocological
mJ NN Pharmocological
, , Pharmocological
4 CD Pharmocological
Hz NNP Pharmocological
, , Pharmocological
and CC Pharmocological
25 CD Pharmocological
mJ/cm NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
thermal VB Physical
cycling NN Physical
silver NN Pharmocological
nitrate JJ Pharmocological
solutions NNS Pharmocological
enamel NN Pharmocological
preparation NN Pharmocological
Er NNP Physical
: : Physical
YAG NNP Physical
laser NN Physical
-DOCSTART- -X- N

Azelnidipine NNP Pharmocological
amlodipine VB Pharmocological
azelnidipine NN Pharmocological
amlodipine NN Pharmocological
azelnidipine VB Pharmocological
amlodipine VB Pharmocological
-DOCSTART- -X- N

treatment NN None
with IN None
0.3 CD Pharmocological
% NN Pharmocological
ofloxacin JJ Pharmocological
eyedrops NNS Pharmocological
, , Pharmocological
BID NNP Pharmocological
or CC Pharmocological
QID NNP Pharmocological
, , Pharmocological
for IN Pharmocological
10 CD Pharmocological
days NNS Pharmocological
. . None
-DOCSTART- -X- N

remifentanil NN Pharmocological
fentanyl NN Pharmocological
midazolam NN Pharmocological
, , Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
midazolam JJ Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
fentanyl VBP Pharmocological
1 CD Pharmocological
microg/kg NN Pharmocological
, , Pharmocological
and CC Pharmocological
propofol VB Pharmocological
initially RB Pharmocological
at IN Pharmocological
140 CD Pharmocological
microg/kg/min NN Pharmocological
. . Pharmocological
midazolam RB Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
remifentanil NN Pharmocological
: : Pharmocological
propofol NN Pharmocological
( ( Pharmocological
1:500 CD Pharmocological
) ) Pharmocological
given VBN Pharmocological
at IN Pharmocological
an DT Pharmocological
initial JJ Pharmocological
propofol JJ Pharmocological
infusion NN Pharmocological
rate NN Pharmocological
of IN Pharmocological
40 CD Pharmocological
microg/kg/min NN Pharmocological
. . Pharmocological
propofol NN Pharmocological
propofol JJ Pharmocological
fentanyl JJ Pharmocological
-DOCSTART- -X- N

remifentanil NN Pharmocological
propofol NN Pharmocological
fentanyl NN Pharmocological
midazolam NN Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
propofol NN Pharmocological
midazolam NN Pharmocological
fentanyl NN Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
propofol NN Pharmocological
fentanyl NN Pharmocological
midazolam FW Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
propofol NN Pharmocological
-DOCSTART- -X- N

Continuous JJ Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
. . None
discontinue VB Pharmocological
cytotoxics NNS Pharmocological
after IN Pharmocological
6 CD Pharmocological
months NNS Pharmocological
and CC Pharmocological
move VB Pharmocological
to TO Pharmocological
maintenance VB Pharmocological
hormones NNS Pharmocological
continue VB Pharmocological
chemotherapy NN Pharmocological
Continuous JJ Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

induction NN Pharmocological
chemotherapy NN Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
followed VBN None
by IN None
maintenance NN Pharmocological
chemotherapy NN Pharmocological
etoposide NN Pharmocological
vindesine NN Pharmocological
-DOCSTART- -X- N

Tailored NNP Educational
, , Educational
iterative JJ Educational
, , Educational
printed JJ Educational
dietary JJ Educational
feedback NN Educational
tailored VBN Educational
, , Educational
iterative JJ Educational
, , Educational
printed JJ Educational
dietary JJ Educational
feedback NN Educational
( ( Educational
TF NNP Educational
) ) Educational
nutrition NN Educational
education NN Educational
sessions NNS Educational
dietary JJ Educational
measures NNS Educational
and CC Educational
socio-demographic JJ Educational
questionnaires NNS Educational
TF NNP Educational
-DOCSTART- -X- N

pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
Pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
Pioglitazone-treated JJ Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
pioglitazone-induced JJ Other
pioglitazone NN Pharmocological
-DOCSTART- -X- N

sizofiran NN Pharmocological
Adjuvant NNP Pharmocological
immunochemotherapy NN Pharmocological
using VBG Pharmocological
the DT Pharmocological
antitumour JJ Pharmocological
polysaccharide NN Pharmocological
sizofiran NN Pharmocological
( ( Pharmocological
SPG NNP Pharmocological
) ) Pharmocological
sizofiran NN Pharmocological
-DOCSTART- -X- N

nutrition NN Physical
intervention NN Physical
nutrition NN Physical
intervention NN Physical
nutritious JJ Pharmocological
supplement NN Pharmocological
( ( Pharmocological
atole JJ Pharmocological
) ) Pharmocological
for IN Pharmocological
all DT Pharmocological
children NNS Pharmocological
and CC None
two CD Pharmocological
villages NNS Pharmocological
a DT Pharmocological
less RBR Pharmocological
nutritious JJ Pharmocological
one CD Pharmocological
( ( Pharmocological
fresco NN Pharmocological
) ) Pharmocological
. . None
atole VB Pharmocological
fresco VB Pharmocological
atole VB Pharmocological
atole VB Pharmocological
-DOCSTART- -X- N

[ JJ None
Radiotherapy NNP Physical
low- JJ Physical
versus NN Physical
high-dose JJ Physical
photon NN Physical
bean NN Physical
radiation NN Physical
] NN None
low-dose JJ Physical
radiation NN Physical
therapy NN Physical
10 CD Physical
Gy NNP Physical
10 CD Physical
Gy NNP Physical
36 CD Physical
Gy NNP Physical
. . None
10 CD Physical
or CC Physical
36 CD Physical
Gy NNP Physical
. . None
10 CD Physical
Gy NNP Physical
36 CD Physical
Gy NNP Physical
; : None
-DOCSTART- -X- N

Questionnaire NNP None
responses NNS None
changes NNS Educational
in IN Educational
epilepsy NN Educational
management NN Educational
. . Educational
usual JJ Control
care NN Control
-DOCSTART- -X- N

stenting VBG Physical
. . Surgical
stenting VBG Physical
or CC None
no DT Control
further JJ Control
treatment NN Control
. . None
-DOCSTART- -X- N

Vilazodone NN Pharmocological
Vilazodone NNP Pharmocological
vilazodone NN Pharmocological
placebo- JJ Control
placebo NN Control
; : None
moxifloxacin CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
; : None
or CC None
vilazodone NN Pharmocological
Placebo-corrected JJ Control
vilazodone NN Pharmocological
vilazodone NN Pharmocological
vilazodone NN Pharmocological
Vilazodone NNP Pharmocological
vilazodone NN Pharmocological
vilazodone NN Pharmocological
moxifloxacin NN Pharmocological
placebo NN Control
Vilazodone NNP Pharmocological
-DOCSTART- -X- N

interdental JJ Educational
hygiene NN Educational
structural JJ Educational
equation NN Educational
modeling NN Educational
pre-curved JJ Educational
interdental JJ Educational
brushes NNS Educational
and CC Educational
flossing VBG Educational
-DOCSTART- -X- N

urokinase NN Pharmocological
A NNP None
multicentre JJ None
trial NN None
( ( None
10 CD None
centres NNS None
) ) None
of IN None
urokinase NN Pharmocological
( ( Pharmocological
UK NNP Pharmocological
) ) Pharmocological
two CD Pharmocological
doses NNS Pharmocological
of IN Pharmocological
UK NNP Pharmocological
administered VBD None
via IN None
a DT None
catheter NN None
in IN None
the DT None
pulmonary JJ None
artery NN None
: : None
2000 CD None
IU NNP None
kg-1 JJ None
h-1 NN None
for IN None
24 CD Pharmocological
hours NNS Pharmocological
( ( Pharmocological
UK IN Pharmocological
2000 CD Pharmocological
) ) Pharmocological
in IN Pharmocological
conjunction NN Pharmocological
with IN Pharmocological
heparin NN Pharmocological
versus NN None
4400 CD Pharmocological
IU NNP Pharmocological
kg-1 JJ Pharmocological
h-1 JJ Pharmocological
UK NNP Pharmocological
alone RB Pharmocological
for IN Pharmocological
12 CD Pharmocological
hours NNS Pharmocological
( ( Pharmocological
UK IN Pharmocological
4400 CD Pharmocological
) ) Pharmocological
followed VBN Pharmocological
by IN Pharmocological
heparin NN Pharmocological
. . None
thrombolytic JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

skeletal JJ Physical
myoblast NN Physical
implantation NN Physical
myoblasts NNS Physical
placebo NN Control
myoblasts NNS Pharmocological
placebo NN Control
myoblast-treated JJ Pharmocological
placebo NN Control
myoblast-treated JJ Pharmocological
myoblasts NNS None
myoblast JJ None
myoblast JJ None
-DOCSTART- -X- N

features NNS Educational
and CC Educational
outcomes NNS Educational
of IN Educational
therapy NN Educational
in IN Educational
these DT Educational
children NNS Educational
were VBD Educational
compared VBN Educational
by IN Educational
age NN Educational
. . None
-DOCSTART- -X- N

endurance NN Physical
training NN Physical
interval NN Physical
and CC Physical
continuous JJ Physical
training NN Physical
In IN Physical
the DT Physical
last JJ Physical
week NN Physical
of IN Physical
training VBG Physical
the DT Physical
exercise NN Physical
intensity NN Physical
in IN Physical
the DT Physical
group NN Physical
of IN Physical
patients NNS Physical
who WP Physical
were VBD Physical
trained VBN Physical
by IN Physical
the DT Physical
continuous JJ Physical
method NN Physical
was VBD Physical
at IN Physical
83 CD Physical
watts NN Physical
, , Physical
and CC Physical
at IN Physical
20:121 CD Physical
watts NN Physical
in IN Physical
the DT Physical
group NN Physical
of IN Physical
patients NNS Physical
who WP Physical
were VBD Physical
trained VBN Physical
by IN Physical
interval JJ Physical
method NN Physical
( ( Physical
rest NN Physical
: : Physical
work NN Physical
each DT Physical
1:1 CD Physical
min NN Physical
) ) Physical
. . None
-DOCSTART- -X- N

clonidine NN Pharmocological
and CC None
clonidine NN Pharmocological
plus CC Pharmocological
naltrexone NN Pharmocological
. . None
clonidine NN Pharmocological
clonidine NN Pharmocological
plus CC Pharmocological
naltrexone NN Pharmocological
naltrexone NN Pharmocological
-DOCSTART- -X- N

hexaminolevulinate NN Physical
enabled VBN Physical
fluorescence NN Physical
cystoscopy NN Physical
. . None
hexaminolevulinate NN Physical
fluorescence NN Physical
cystoscopic NN Physical
detection NN Physical
white JJ Physical
light NN Physical
fluorescence NN Physical
white JJ Physical
light NN Physical
fluorescence NN Physical
Cystectomy NNP Physical
white JJ Physical
light NN Physical
fluorescence NN Physical
Hexaminolevulinate NNP Physical
fluorescence NN Physical
cystoscopy NN Physical
-DOCSTART- -X- N

Collagen NNP Pharmocological
cross-linking NN Pharmocological
with IN Pharmocological
photoactivated JJ Pharmocological
riboflavin NN Pharmocological
( ( Pharmocological
PACK-CXL NNP Pharmocological
) ) Pharmocological
corneal JJ Pharmocological
collagen NN Pharmocological
cross-linking NN Pharmocological
( ( Pharmocological
CXL NNP Pharmocological
) ) Pharmocological
photoactivated VBN Pharmocological
riboflavin NN Pharmocological
( ( Pharmocological
photoactivated VBN Pharmocological
chromophore NN Pharmocological
for IN Pharmocological
infectious JJ Pharmocological
keratitis NN Pharmocological
[ NNP Pharmocological
PACK NNP Pharmocological
] NNP Pharmocological
-CXL NNP Pharmocological
) ) Pharmocological
only RB Pharmocological
antimicrobial JJ Pharmocological
therapy NN Pharmocological
. . None
the DT None
PACK-CXL NNP None
PACK-CXL NNP None
group NN None
PACK-CXL NNP None
group NN None
PACK-CXL NNP None
group NN None
CONCLUSIONS NNP None
Corneal NNP None
CXL NNP None
with IN None
photoactivated JJ None
riboflavin NN None
did VBD None
PACK-CXL NNP None
may MD None
-DOCSTART- -X- N

nitric JJ Pharmocological
oxide IN Pharmocological
synthase JJ Pharmocological
( ( None
60 CD None
min NN None
of IN None
seated JJ Physical
upright JJ Physical
rest NN Physical
) ) None
( ( None
60 CD Physical
min NN Physical
of IN Physical
upright JJ Physical
cycling NN Physical
at IN None
60 CD None
% NN None
peak NN None
aerobic JJ None
capacity NN None
) ) None
-DOCSTART- -X- N

Project NNP Physical
SEARCH NNP Physical
plus CC Physical
ASD NNP Physical
Supports NNP Physical
-DOCSTART- -X- N

unexpected JJ Physical
forward NN Physical
perturbations NNS Physical
( ( Physical
FP NNP Physical
) ) Physical
FP NNP Physical
FP NNP Physical
. . Physical
-DOCSTART- -X- N

random JJ Physical
single JJ Physical
donor NN Physical
platelet NN Physical
transfusions NNS Physical
: : None
multiple-donor JJ Pharmocological
platelet NN Pharmocological
concentrates NNS Pharmocological
random JJ Physical
single-donor JJ Physical
platelets NNS Physical
random NN Physical
SD NNP Physical
platelet NN Physical
transfusions NNS Physical
-DOCSTART- -X- N

TGMD-2 NNP Educational
Test NNP Psychological
of IN Psychological
Gross NNP Psychological
Motor NNP Psychological
Development NNP Psychological
( ( Psychological
TGMD-2 NNP Psychological
) ) Psychological
TGMD-2 NNP Educational
( ( None
traditional JJ Other
protocol NN Other
, , None
picture NN Other
task NN Other
card NN Other
protocol NN Other
, , None
and CC None
picture NN Other
activity NN Other
schedule NN Other
protocol NN Other
) ) None
TGMD-2 NNP Educational
-DOCSTART- -X- N

tramadol JJ Pharmocological
] NN None
Tramal NNP Pharmocological
Tramal NNP Pharmocological
Tramal JJ Pharmocological
-DOCSTART- -X- N

delavirdine NN Pharmocological
mesylate NN Pharmocological
and CC None
didanosine NN Pharmocological
Didanosine NNP Pharmocological
delavirdine JJ Pharmocological
mesylate NN Pharmocological
didanosine NN Pharmocological
delavirdine NN Pharmocological
didanosine NN Pharmocological
. . None
delavirdine JJ Pharmocological
didanosine NN Pharmocological
-DOCSTART- -X- N

protein NN Pharmocological
ingestion NN Pharmocological
50 CD Pharmocological
g NN Pharmocological
protein NN Pharmocological
in IN Pharmocological
the DT Pharmocological
form NN Pharmocological
of IN Pharmocological
very RB Pharmocological
lean JJ Pharmocological
beef NN Pharmocological
or CC None
only RB Control
water NN Control
at IN None
0800 CD None
h NN None
and CC None
studied VBN None
over IN None
the DT None
subsequent JJ None
8 CD None
h. NN None
Protein NNP Pharmocological
-DOCSTART- -X- N

recombinant JJ Physical
human JJ Physical
granulocyte NN Physical
colony-stimulating NN Physical
factor NN Physical
chemotherapy JJ Physical
recombinant JJ Physical
human JJ Physical
granulocyte NN Physical
colony-stimulating NN Physical
factor NN Physical
( ( Physical
[ JJ Physical
G-CSF NNP Physical
] NNP Physical
lenogastrim NN Physical
) ) None
consolidation NN Physical
chemotherapy NN Physical
chemotherapy NN Physical
; : None
combination NN None
of IN None
high-dose JJ Pharmocological
cytarabine NN Pharmocological
, , None
etoposide RB Pharmocological
, , None
and CC None
dexamethasone NN Pharmocological
( ( None
R3 NNP None
) ) None
vincristine NN Pharmocological
, , None
prednisone NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
doxorubicin NN Pharmocological
, , None
and CC None
methotrexate NN Pharmocological
( ( None
COPADM NNP None
) ) None
. . None
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
non-G-CSF JJ Pharmocological
G-CSF NNP Pharmocological
post-COPADM JJ Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
administration NN Pharmocological
. . None
-DOCSTART- -X- N

Epidural JJ Pharmocological
morphine NN Pharmocological
epidurally RB Pharmocological
administered VBN Pharmocological
morphine NN Pharmocological
epidural JJ Pharmocological
morphine NN Pharmocological
intramuscular JJ Pharmocological
regime NN Pharmocological
. . None
morphine NN Pharmocological
-DOCSTART- -X- N

Stepping NNP Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
: : None
Stepping VBG Educational
Stones JJ Educational
Triple NNP Educational
P NNP Educational
( ( Educational
SSTP NNP Educational
) ) Educational
Group NNP Educational
Stepping NNP Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
( ( Educational
GSSTP NNP Educational
) ) Educational
GSSTP NNP Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

an DT None
ion NN Physical
exchange NN Physical
membrane NN Physical
with IN Physical
30-microgram JJ Physical
dexamethasone NN Physical
elution NN Physical
in IN Physical
a DT Physical
contoured JJ Physical
activated JJ Physical
carbon NN Physical
tip NN Physical
lead NN Physical
the DT Educational
same JJ Physical
lead NN Physical
design NN Physical
without IN Physical
steroid NN Physical
the DT Educational
same JJ Physical
lead NN Physical
design NN Physical
without IN Physical
steroid NN Physical
or CC Physical
membrane NN Physical
ion NN Physical
exchange NN Physical
membrane NN Physical
-DOCSTART- -X- N

eptifibatide NN Pharmocological
platelet NN Pharmocological
glycoprotein NN Pharmocological
IIb/IIIa NNP Pharmocological
inhibitor NN Pharmocological
therapy NN Pharmocological
eptifibatide JJ Pharmocological
therapy NN Pharmocological
as IN None
an DT None
adjunct NN None
to TO None
stent VB None
implantation NN None
( ( None
1,755 CD None
with IN None
CrCl NNP None
> NNP None
or CC None
=60 NNP None
ml/min NN None
and CC None
289 CD None
with IN None
CrCl NNP None
< NNP None
60 CD None
ml/min NN None
) ) None
eptifibatide NN Pharmocological
eptifibatide NN Pharmocological
-DOCSTART- -X- N

granulocyte-macrophage JJ Physical
colony-stimulating JJ Physical
factor NN Physical
erythropoietin NN Pharmocological
combination NN Pharmocological
of IN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
granulocyte-macrophage NN Pharmocological
colony-stimulating NN Pharmocological
factor NN Pharmocological
( ( Pharmocological
rhGM-CSF NN Pharmocological
) ) Pharmocological
and CC None
recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHuEPO NN Pharmocological
) ) Pharmocological
autologous JJ Physical
BMT NNP Physical
treated VBN None
with IN None
rhGM-CSF JJ Pharmocological
alone NN None
. . None
-DOCSTART- -X- N

Calcium NN Pharmocological
and CC Pharmocological
fibre JJ Pharmocological
supplementation NN Pharmocological
calcium NN Pharmocological
fibre JJ Pharmocological
diet JJ Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
calcium NN Pharmocological
and CC Pharmocological
fibre NN Pharmocological
calcium NN Other
gluconolactate NN Other
and CC Other
carbonate NN Other
( ( Other
2 CD Other
g NN Other
elemental JJ Other
calcium NN Other
daily RB Other
) ) Other
, , None
fibre JJ Other
( ( Other
3.5 CD Other
g NN Other
ispaghula NN Other
husk NN Other
) ) Other
, , None
or CC None
placebo NN Control
. . None
calcium NN None
calcium NN None
fibre JJ None
calcium NN None
fibre NN None
-DOCSTART- -X- N

sevelamer NN Pharmocological
hydrochloride NN Pharmocological
and CC Pharmocological
calcium NN Pharmocological
carbonate NN Pharmocological
sevelamer JJ Pharmocological
hydrochloride NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
calcium JJ Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
CC NNP Pharmocological
) ) Pharmocological
CC NNP Pharmocological
to TO Pharmocological
sevelamer VB Pharmocological
group NN Pharmocological
A NNP Pharmocological
, , Pharmocological
sevelamer NN Pharmocological
6.0 CD Pharmocological
g/day NN Pharmocological
; : Pharmocological
group NN Pharmocological
B NNP Pharmocological
, , Pharmocological
sevelamer VBD Pharmocological
3.0 CD Pharmocological
g/day NN Pharmocological
and CC Pharmocological
CC NNP Pharmocological
3.0 CD Pharmocological
g/day NN Pharmocological
; : Pharmocological
group NN Pharmocological
C NNP Pharmocological
, , Pharmocological
CC NNP Pharmocological
3.0 CD Pharmocological
g/day NN Pharmocological
. . Pharmocological
sevelamer VB Pharmocological
. . None
sevelamer JJ Pharmocological
-DOCSTART- -X- N

error NN Educational
training NN Educational
surgical JJ Surgical
technical JJ Surgical
skill NN Surgical
instruction NN Surgical
and CC Surgical
evaluation NN Surgical
. . Surgical
two CD Educational
types NNS Educational
of IN Educational
rater NN Educational
training NN Educational
videotapes NNS Educational
examples NNS Educational
of IN Educational
common JJ Educational
errors NNS Educational
( ( Educational
error NN Educational
) ) Educational
skill NN Educational
being VBG Educational
performed VBN Educational
correctly RB Educational
( ( Educational
correct NN Educational
) ) Educational
error NN Educational
instruction NN Educational
none NN Educational
, , Educational
error NN Educational
only RB Educational
, , Educational
correct VBP Educational
only RB Educational
, , Educational
and CC Educational
error+correct NN Educational
. . Educational
error NN Educational
training NN Educational
testing NN Educational
videotape NN Educational
and CC Educational
interrater NN Educational
reliability NN Educational
error NN Educational
training NN Educational
no DT Control
training NN Control
. . Control
error+correct JJ Educational
correct NN None
only RB None
error VBZ None
only RB None
common JJ None
errors NNS None
surgical JJ Surgical
technical JJ Surgical
skill NN Surgical
instruction NN Surgical
. . Surgical
error NN None
training NN None
-DOCSTART- -X- N

thyroidectomy NN Physical
local/regional JJ Pharmocological
anesthesia NN Pharmocological
and CC Pharmocological
IV NNP Pharmocological
sedation NN Pharmocological
. . None
mini-incision NN Physical
thyroidectomy NN Physical
local/regional JJ Pharmocological
anesthesia NN Pharmocological
and CC Pharmocological
intravenous JJ Pharmocological
sedation NN Pharmocological
. . None
nerve JJ Physical
monitoring NN Physical
of IN Physical
the DT Physical
EBSLN NNP Physical
or CC Physical
no DT Physical
nerve NN Physical
monitoring NN Physical
mini-incision JJ Surgical
thyroidectomy NN Surgical
local/regional JJ Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

antioxidant JJ Pharmocological
supplementation NN Pharmocological
antioxidants NNS Pharmocological
diet JJ Pharmocological
low JJ Pharmocological
in IN Pharmocological
ascorbate NN Pharmocological
filtered VB Physical
air NN Physical
for IN Physical
2 CD Physical
h NNS Physical
while IN Physical
exercising VBG Physical
( ( Physical
20 CD Physical
L/min/m NNP Physical
( ( Physical
2 CD Physical
) ) Physical
) ) Physical
, , None
and CC None
then RB None
underwent JJ None
bronchoalveolar JJ Physical
lavage NN Physical
( ( Physical
BAL NNP Physical
) ) Physical
and CC None
were VBD None
randomly RB None
assigned VBN None
to TO None
receive VB None
either CC None
a DT None
placebo NN Control
or CC None
250 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
vitamin NN Pharmocological
C NNP Pharmocological
, , None
50 CD Pharmocological
IU NNP Pharmocological
of IN Pharmocological
alpha-tocopherol NN Pharmocological
, , None
and CC None
12 CD None
oz NN None
of IN None
vegetable JJ Pharmocological
cocktail JJ Pharmocological
daily NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
wk NN Pharmocological
. . None
exposed VBN None
to TO None
0.4 CD None
ppm NNS None
O NNP None
( ( None
3 CD None
) ) None
for IN None
2 CD None
h NN None
and CC None
underwent NN None
a DT None
second JJ None
BAL NNP Physical
. . None
placebo NN None
dietary JJ Pharmocological
antioxidants NNS Pharmocological
-DOCSTART- -X- N

aldose JJ Pharmocological
reductase NN Pharmocological
tolrestat NN Pharmocological
tolrestat NN Pharmocological
placebo NN Control
placebo NN Control
tolrestat NN Pharmocological
tolrestat NN Pharmocological
tolrestat NN Pharmocological
-DOCSTART- -X- N

practice NN Physical
, , Physical
no-practice JJ Physical
, , Physical
or CC Physical
control NN Control
groups NNS Control
. . None
-DOCSTART- -X- N

Flow NNP Other
cytometry NN Other
colony-stimulating NN Pharmocological
factor NN Pharmocological
[ IN Pharmocological
G-CSF NNP Pharmocological
] NNP Pharmocological
) ) Pharmocological
and CC None
autologous JJ Pharmocological
stem NN Pharmocological
cell NN Pharmocological
support NN Pharmocological
. . None
chemotherapy NN Pharmocological
-DOCSTART- -X- N

, , None
to TO None
-DOCSTART- -X- N

pronase NN Pharmocological
ultrasonography NN Physical
. . None
proteolytic JJ Pharmocological
enzyme NN Pharmocological
, , None
pronase NN Pharmocological
endoscopic JJ Physical
ultrasonography NN Physical
. . None
pronase NN Pharmocological
C NNP None
) ) None
pronase NN Pharmocological
treatments NNS None
A DT None
and CC None
B NNP None
) ) None
pronase NN Pharmocological
pronase NN Pharmocological
( ( None
treatment NN None
C NNP None
) ) None
treatments NNS None
A NNP None
and CC None
B NNP None
. . None
pronase NN Pharmocological
-DOCSTART- -X- N

tipifarnib JJ Pharmocological
plus CC Pharmocological
etoposide JJ Pharmocological
-DOCSTART- -X- N

Ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
Bile NNP Pharmocological
acid JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
exogenous JJ Pharmocological
bile NN Pharmocological
acid NN Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

non-depolarizing JJ Pharmocological
neuromuscular JJ Pharmocological
blockers NNS Pharmocological
neuromuscular JJ Pharmocological
blockers NNS Pharmocological
fentanyl NN Pharmocological
pancuronium NN Pharmocological
0.12 CD Pharmocological
mg.kg-1 NN Pharmocological
, , Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
vecuronium NN Pharmocological
0.12 CD Pharmocological
mg.kg-1 NN Pharmocological
, , None
( ( Pharmocological
3 CD Pharmocological
) ) Pharmocological
atracurium NN Pharmocological
0.4 CD Pharmocological
mg.kg-1 NN Pharmocological
, , None
or CC None
( ( Pharmocological
4 CD Pharmocological
) ) Pharmocological
pancuronium-metocurine NN Pharmocological
mixture NN Pharmocological
Neuromuscular JJ Pharmocological
blockers NNS Pharmocological
fentanyl NN Pharmocological
; : None
pancuronium NN Pharmocological
vecuronium NN Pharmocological
atracurium NN Pharmocological
; : None
pancuronium-metocurine JJ Pharmocological
mixture NN Pharmocological
vecuronium NN Pharmocological
. . None
pancuronium-metocurine JJ Pharmocological
Vecuronium NNP Pharmocological
vecuronium NN Pharmocological
, , None
pancuronium NN Pharmocological
pancuronium-metocurine JJ Pharmocological
mixture NN Pharmocological
; : None
vecuronium NN Pharmocological
. . None
Atracurium NNP Pharmocological
vecuronium VB Pharmocological
atracurium NN Pharmocological
-DOCSTART- -X- N

Topical NNP Pharmocological
retapamulin NN Pharmocological
ointment NN Pharmocological
cephalexin NN Pharmocological
topical JJ Pharmocological
retapamulin NN Pharmocological
ointment VBD Pharmocological
cephalexin NN Pharmocological
retapamulin VB Pharmocological
ointment JJ Pharmocological
oral JJ Pharmocological
cephalexin NN Pharmocological
Retapamulin NNP Pharmocological
cephalexin NN Pharmocological
retapamulin NN Pharmocological
cephalexin NN Pharmocological
. . None
Retapamulin NNP Pharmocological
oral JJ Pharmocological
drug NN Pharmocological
. . None
retapamulin NN Pharmocological
cephalexin NN Pharmocological
) ) None
retapamulin NN Pharmocological
cephalexin NN Pharmocological
. . None
Retapamulin NNP Pharmocological
ointment VBD Pharmocological
cephalexin NN Pharmocological
-DOCSTART- -X- N

Online NNP Other
conductivity NN Other
monitoring NN Other
: : None
reduced JJ Other
dialysate NN Other
conductivity NN Other
. . None
Relatively RB Other
low JJ Other
dialysate NN Other
conductivity NN Other
( ( Other
Cndi NNP Other
) ) Other
controlled JJ None
reduction NN Other
of IN Other
Cndi NNP Other
. . Other
reduction NN Other
of IN Other
Cndi NNP Other
Reduction NN Other
in IN Other
Cndi NNP Other
-DOCSTART- -X- N

botulinum RB Pharmocological
toxin NN Pharmocological
saline JJ Control
injections NNS Control
. . Control
surgical JJ Pharmocological
deactivation NN Pharmocological
deactivation NN Educational
-DOCSTART- -X- N

adenosine JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging VBG Physical
adenosine JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging NN Physical
Coronary NNP Physical
angiography NN Physical
was VBD None
conducted VBN None
within IN None
6 CD None
weeks NNS None
of IN None
an DT None
adenosine JJ Physical
thallium-201 JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging VBG Physical
study NN None
. . None
adenosine JJ Physical
thallium-201 JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging NN Physical
-DOCSTART- -X- N

Combination NNP Pharmocological
chemotherapy NN Pharmocological
ALVAC-CEA/B7.1 NNP Pharmocological
vaccine NN Pharmocological
vaccines NNS Pharmocological
chemotherapy NN Pharmocological
fluorouracil NN Pharmocological
, , None
leucovorin NN Pharmocological
, , None
and CC None
irinotecan JJ Pharmocological
ALVAC-CEA/B7.1 NNP Pharmocological
vaccine NN Pharmocological
with IN None
or CC None
without IN None
tetanus JJ Pharmocological
toxoid NN Pharmocological
adjuvant NN Pharmocological
. . None
ALVAC NNP Pharmocological
followed VBN None
by IN None
chemotherapy NN Pharmocological
and CC None
booster NN Pharmocological
vaccination NN Pharmocological
( ( None
group NN None
1 CD None
) ) None
, , None
ALVAC NNP Pharmocological
and CC None
tetanus NN Pharmocological
toxoid NN Pharmocological
followed VBN None
by IN None
chemotherapy NN Pharmocological
( ( None
group NN None
2 CD None
) ) None
, , None
or CC None
chemotherapy VB Pharmocological
alone RB None
followed VBN None
by IN None
ALVAC NNP Pharmocological
in IN None
( ( None
group NN None
ELISA NNP Physical
assay NN Physical
IFN-gamma NNP Physical
enzyme-linked JJ Physical
immunospot NN Physical
assay NN Physical
. . None
ALVAC NNP Pharmocological
chemotherapy NN Pharmocological
ALVAC NNP Pharmocological
tetanus NN Pharmocological
adjuvant NN Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
ALVAC NNP Pharmocological
ALVAC-CEA/B7.1 NNP Pharmocological
vaccine NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

alcohol NN Educational
intervention NN Educational
-DOCSTART- -X- N

tropisetron NN Pharmocological
and CC Pharmocological
granisetron NN Pharmocological
Tropisetron NNP Pharmocological
and CC None
granisetron NN Pharmocological
tropisetron RP Pharmocological
granisetron NN Pharmocological
chemotherapy NN Pharmocological
. . Physical
tropisetron NN Pharmocological
granisetron NN Pharmocological
tropisetron NN Pharmocological
granisetron NN Pharmocological
granisetron NN Pharmocological
tropisetron RB Pharmocological
granisetron NN Pharmocological
ganisetron NN Pharmocological
-DOCSTART- -X- N

Sunlight JJ Control
exposure NN Control
or CC None
vitamin NN Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
Vitamin NNP Pharmocological
D NNP Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
advised JJ Physical
sunlight NN Physical
exposure NN Physical
. . None
Vitamin NNP Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
advised JJ Control
sunlight JJ Control
exposure NN Control
vitamin NN None
D NNP None
supplementation NN None
or CC None
sunlight JJ None
exposure NN None
. . None
METHODS NNP None
effect NN None
of IN None
vitamin NN None
D NNP None
( ( None
3 CD None
) ) None
supplementation NN None
( ( None
daily JJ None
800 CD None
IU NNP None
or CC None
100,000 CD None
IU/3 NNP None
months NNS None
) ) None
or CC None
sunlight JJ None
exposure NN None
advice NN None
is VBZ None
supplementation NN None
( ( None
daily JJ None
800 CD None
or CC None
advice NN None
for IN None
sunlight JJ None
exposure NN None
for IN None
advised JJ None
sunlight NN None
exposure NN None
( ( None
supplementation NN None
vs FW None
sunshine NN None
p NN None
< NNP None
supplementation NN None
groups NNS None
than IN None
in IN None
the DT None
advised JJ None
sunlight NN None
CONCLUSION NNP None
Vitamin NNP None
D NNP None
supplementation NN None
is VBZ None
more RBR None
effective JJ None
than IN None
advised JJ None
sunlight JJ None
exposure NN None
for IN None
treating VBG None
-DOCSTART- -X- N

Needle NNP Surgical
versus NN Surgical
loop NN Surgical
diathermy NN Surgical
excision NN Surgical
needle JJ Surgical
excision NN Surgical
of IN Surgical
the DT Surgical
transformation NN Surgical
zone NN Surgical
( ( Surgical
NETZ NNP Surgical
) ) Surgical
than IN None
with IN None
loop JJ Surgical
excision NN Surgical
( ( Surgical
LLETZ NNP Surgical
) ) Surgical
. . None
LLETZ NNP Surgical
or CC None
NETZ NNP Surgical
. . None
LLETZ NNP Surgical
NETZ NNP Surgical
NETZ NNP Surgical
LLETZ NNP Surgical
. . None
-DOCSTART- -X- N

Postal NNP Other
Group NNP Other
, , None
( ( None
2 CD None
) ) None
Telephone CD Other
Group NNP Other
, , None
and CC None
( ( None
3 CD None
) ) None
Face-to-face NN Other
Group NNP Other
. . None
mail NN Other
survey NN Other
-DOCSTART- -X- N

drug NN Physical
infusions NNS Physical
at IN Physical
the DT Physical
bedside NN Physical
pre-filled JJ Pharmocological
syringes NNS Pharmocological
. . None
Vasopressor NNP Pharmocological
infusions NNS Pharmocological
diluting VBG Pharmocological
concentrated VBN Pharmocological
drugs NNS Pharmocological
from IN Pharmocological
ampoules NNS Pharmocological
syringes NNS Pharmocological
pre-filled JJ Pharmocological
pre-filled JJ Pharmocological
syringes NNS Pharmocological
epinephrine NN Pharmocological
; : None
pre-filled JJ Pharmocological
syringes NNS Pharmocological
infusions NNS Pharmocological
norepinephrine NN Pharmocological
epinephrine NN Pharmocological
) ) None
drug NN Pharmocological
infusions NNS Pharmocological
pre-filled VBN Pharmocological
-DOCSTART- -X- N

induction VB Pharmocological
chemotherapy NN Pharmocological
utilized JJ Pharmocological
bleomycin NN Pharmocological
, , None
Cytoxan NNP Pharmocological
, , None
methotrexate NN Pharmocological
and CC None
5-fluorouracil JJ Pharmocological
in IN None
two CD None
cycles NNS None
( ( None
one CD None
cycle NN None
if IN None
no DT None
tumor NN None
response NN None
) ) None
, , None
followed VBN Pharmocological
by IN Pharmocological
standard NN Pharmocological
treatment NN Pharmocological
which WDT Pharmocological
consisted VBD Pharmocological
of IN Pharmocological
combined JJ Pharmocological
irradiation NN Pharmocological
and CC Pharmocological
surgery NN Pharmocological
or CC Pharmocological
, , Pharmocological
in IN Pharmocological
some DT Pharmocological
instances NNS Pharmocological
, , Pharmocological
primary JJ Pharmocological
irradiation NN Pharmocological
alone RB None
. . None
The DT None
second JJ None
study NN None
utilized VBD None
cisplatin NN Pharmocological
and CC Pharmocological
5-fluorouracil NN Pharmocological
in IN Pharmocological
three CD None
cycles NNS None
prior RB Control
to TO Control
standard VB Control
treatment NN Control
. . None
-DOCSTART- -X- N

oxitropium NN Pharmocological
bromide NN Pharmocological
. . None
placebo NN Control
( ( None
drug NN Pharmocological
placebo NN Control
) ) Control
placebo NN Control
oxitropium NN Pharmocological
oxitropium JJ Pharmocological
bromide NN Pharmocological
treatment NN None
placebo NN Control
-DOCSTART- -X- N

7-hexanoyltaxol-eluting JJ Surgical
stent NN Surgical
stent-based JJ Surgical
polymer NN Surgical
sleeve NN Surgical
delivering VBG None
7-hexanoyltaxol JJ Pharmocological
. . None
7-hexanoyltaxol JJ Surgical
( ( Surgical
QP2 NNP Surgical
) ) Surgical
-eluting VBG Surgical
stents NNS Surgical
( ( Surgical
qDES NN Surgical
) ) Surgical
with IN Surgical
bare NN Surgical
metal NN Surgical
stents NNS Surgical
( ( Surgical
BMS NNP Surgical
) ) Surgical
qDES NNS Surgical
BMS NNP Surgical
qDES RB Surgical
qDES NN Surgical
qDES NN Surgical
BMS NNP Surgical
. . None
7-hexanoyltaxol NNP Pharmocological
-DOCSTART- -X- N

multiplane NN Other
probe NN Other
biplane NN Other
probe NN Other
multiplane NN Other
probe NN Other
biplane NN Other
probe NN Other
transesophageal JJ Physical
echocardiography NN Physical
with IN None
either DT None
probe NN None
. . None
multiplane NN Other
and CC Other
biplane NN Other
probes NNS Other
multiplane NN Other
probe NN Other
multiplane NN Other
probe NN Other
. . None
-DOCSTART- -X- N

antiretroviral JJ Physical
therapy NN Physical
( ( Physical
ART NNP Physical
) ) Physical
dual-energy JJ Physical
absorptiometry NN Physical
( ( Physical
DXA NNP Physical
) ) Physical
and CC None
abdominal JJ Physical
computed VBN Physical
tomography NN Physical
for IN Physical
body NN Physical
composition NN Physical
. . None
to TO None
ATV/r NNP Pharmocological
( ( None
vs. FW None
EFV NNP None
) ) None
TDF/FTC NNP None
did VBD None
-DOCSTART- -X- N

dietary JJ Pharmocological
selenium NN Pharmocological
( ( Pharmocological
Se-enriched NNP Pharmocological
yeast NN Pharmocological
) ) Pharmocological
selenium NN Pharmocological
experimental JJ Pharmocological
diet JJ Pharmocological
with IN Pharmocological
different JJ Pharmocological
Se NNP Pharmocological
levels NNS Pharmocological
real-time JJ None
PCR NNP None
and CC None
-DOCSTART- -X- N

intravenous JJ Pharmocological
synthetic JJ Pharmocological
human NN Pharmocological
secretin NN Pharmocological
intravenous JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
2 CD Pharmocological
IU/kg NNP Pharmocological
of IN Pharmocological
intravenous JJ Pharmocological
synthetic JJ Pharmocological
human NN Pharmocological
secretin NN Pharmocological
intravenous JJ Control
saline NN Control
placebo NN Control
-DOCSTART- -X- N

ketorolac NN Pharmocological
tromethamine NN Pharmocological
ketorolac NN Pharmocological
tromethamine NN Pharmocological
placebo VB Control
ketorolac NN Pharmocological
tromethamine NN Pharmocological
placebo JJ Control
ketorolac $ Pharmocological
-DOCSTART- -X- N

Angiotensin-converting NNP Physical
enzyme NN Physical
inhibitor NN Physical
therapy NN Physical
placebo NN Pharmocological
, , None
quinapril RB Pharmocological
losartan JJ Pharmocological
quinapril NN Pharmocological
placebo VB Control
losartan VB Pharmocological
-DOCSTART- -X- N

Oral JJ Pharmocological
magnesium NN Pharmocological
supplementation NN Pharmocological
magnesium NN Pharmocological
30 CD None
mL NN None
of IN None
MgCl2 NNP Pharmocological
5 CD None
% NN None
solution NN None
( ( None
equivalent JJ None
to TO None
382 CD None
mg NN None
of IN None
magnesium NN Pharmocological
) ) None
and CC None
individuals NNS None
in IN None
the DT None
control NN None
group NN None
30 CD Control
mL NN Control
of IN Control
placebo JJ Control
solution NN Control
, , Control
once RB Control
daily JJ Control
during IN Control
4 CD Control
months NNS Control
. . None
received VBD None
MgCl2 NNP None
compared VBN None
individuals NNS None
in IN None
the DT None
control NN None
group NN None
CONCLUSIONS NNP None
Oral NNP None
magnesium NN None
-DOCSTART- -X- N

( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
-cyanidanol-3 NN Pharmocological
12 CD Pharmocological
months NNS Pharmocological
' POS Pharmocological
treatment NN Pharmocological
with IN Pharmocological
( ( Pharmocological
+ NN Pharmocological
) ) Pharmocological
-cyanidanol-3 NN Pharmocological
was VBD Pharmocological
carried VBN Pharmocological
-DOCSTART- -X- N

trained VBN Educational
to TO Educational
match VB Educational
probes NNS Educational
to TO Educational
targets NNS Educational
induction NN Physical
test NN Physical
behavioral JJ Educational
task NN Educational
explicit JJ Educational
questions NNS Educational
. . None
training VBG Educational
modified JJ Educational
training NN Educational
protocol NN Educational
-DOCSTART- -X- N

placebo-controlled JJ None
conducted VBN None
in IN None
a DT None
normobaric JJ None
hypoxic NN None
chamber NN None
, , None
chronic JJ None
high-altitude NN None
exposure NN None
-DOCSTART- -X- N

bupivacaine NN Pharmocological
diamorphine NN Pharmocological
. . None
a DT None
control NN None
group NN None
, , None
a DT None
group NN None
who WP None
received VBD None
a DT None
caudal JJ None
injection NN None
of IN None
20 CD None
ml NNS None
bupivacaine VBP Pharmocological
0.5 CD None
% NN None
plain NN None
and CC None
a DT None
group NN None
who WP None
received VBD None
diamorphine JJ Pharmocological
2.5 CD None
mg NN None
in IN None
10 CD None
ml NNS None
normal JJ None
saline NN None
by IN None
caudal JJ Pharmocological
injection NN Pharmocological
; : None
a DT None
comparison NN None
was VBD None
then RB None
made VBN None
of IN None
postoperative JJ None
analgesia NN None
requirements NNS None
. . None
bupivacaine NN Pharmocological
diamorphine NN Pharmocological
diamorphine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
diamorphine NN Pharmocological
-DOCSTART- -X- N

summary JJ Physical
ST-segment JJ Physical
and CC Physical
T-wave JJ Physical
changes NNS Physical
. . None
ST-segment JJ Physical
and CC Physical
T-wave JJ Physical
changes NNS Physical
on IN None
the DT None
initial JJ Surgical
electrocardiogram NN Surgical
( ( Surgical
ECG NNP Surgical
) ) Surgical
-DOCSTART- -X- N

ketoprofen NN Pharmocological
ketoprofen $ Pharmocological
ketoprofen NN Pharmocological
-DOCSTART- -X- N

Misoprostol NNP Pharmocological
( ( None
400 CD None
mcg NN None
) ) None
or CC None
its PRP$ None
matching JJ None
placebo NN Control
misoprostol NN Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

Stress NNP Educational
reduction NN Educational
stress JJ Educational
reduction NN Educational
program NN Educational
group-based JJ Educational
psychosocial JJ Educational
intervention NN Educational
program NN Educational
or CC Educational
usual JJ Educational
care NN Educational
. . Educational
education NN Educational
about IN Educational
risk NN Educational
factors NNS Educational
, , None
relaxation NN Educational
training NN Educational
techniques NNS Educational
, , None
methods NNS Educational
for IN Educational
self-monitoring NN Educational
and CC Educational
cognitive JJ Educational
restructuring NN Educational
, , None
with IN None
an DT None
emphasis NN None
on IN None
coping VBG Educational
with IN Educational
stress JJ Educational
exposure NN Educational
from IN Educational
family NN Educational
and CC Educational
work NN Educational
, , None
and CC None
self-care NN Educational
and CC Educational
compliance NN Educational
with IN Educational
clinical JJ Educational
advice NN Educational
. . None
into IN None
multivariate NN None
models NNS None
group-based JJ Educational
psychosocial JJ Educational
intervention NN Educational
program NN Educational
-DOCSTART- -X- N

concurrent NN Physical
cisplatin NN Physical
and CC None
preoperative NN Physical
or CC Physical
definitive JJ Physical
radiation NN Physical
. . None
concurrent NN Physical
cisplatin NN Physical
to TO Physical
preoperative VB Physical
or CC None
definitive JJ None
radiation NN None
therapy NN None
radiotherapy NN Physical
or CC None
precystectomy JJ Physical
radiotherapy NN Physical
; : None
intravenous JJ Pharmocological
cisplatin NNS Pharmocological
concurrent VBP Physical
with IN Physical
pelvic JJ Physical
radiation NN Physical
receive VB Physical
radiation NN Physical
without IN Physical
chemotherapy NN Physical
. . None
cisplatin-treated JJ Pharmocological
concurrent NN Pharmocological
cisplatin NN Pharmocological
cisplatin NN Pharmocological
Concurrent NNP Pharmocological
cisplatin NN Pharmocological
preoperative JJ Physical
or CC Physical
definitive JJ Physical
radiation NN Physical
concurrent NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

whole JJ Physical
body NN Physical
vibration NN Physical
whole JJ Physical
body NN Physical
vibration NN Physical
( ( None
control VB None
condition NN None
) ) None
( ( None
treatment NN None
condition NN None
) ) None
-DOCSTART- -X- N

Antibiotic JJ Pharmocological
strategy NN Pharmocological
Empiric JJ Pharmocological
broad-spectrum JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
impact NN None
of IN None
a DT None
set NN None
of IN None
rules NNS None
that WDT None
evolved VBD None
during IN None
the DT None
first JJ None
randomized JJ None
trials NNS None
. . None
Evaluation NN None
of IN None
Treatment NNP None
was VBD None
modified VBN None
antibiotic JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

pentoxifylline NN Pharmocological
added VBN Pharmocological
to TO Pharmocological
risperidone VB Pharmocological
: : None
pentoxifylline NN Pharmocological
plus CC Pharmocological
risperidone NN Pharmocological
pentoxifylline+risperidone VB Pharmocological
or CC None
placebo+risperidone VB Pharmocological
risperidone NN Pharmocological
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
combination NN Pharmocological
of IN Pharmocological
atypical JJ Pharmocological
antipsychotic JJ Pharmocological
medications NNS Pharmocological
and CC Pharmocological
pentoxifylline NN Pharmocological
-DOCSTART- -X- N

COMPASS NNP Other
web-based JJ Other
face-to-face JJ Educational
teacher NN Educational
coaching NN Educational
Collaborative NNP Educational
Model NNP Educational
for IN Educational
Promoting VBG Educational
Competence NNP Educational
and CC Educational
Success NNP Educational
( ( Educational
COMPASS NNP Educational
; : None
1 CD None
of IN None
3 CD None
groups NNS None
: : None
( ( None
1 CD None
) ) None
a DT None
placebo NN Control
control NN None
( ( None
PBO NNP None
) ) None
group NN None
, , None
( ( None
2 CD None
) ) None
COMPASS NN Educational
followed VBN Educational
by IN Educational
face-to-face NN Educational
( ( Educational
FF NNP Educational
) ) Educational
coaching NN Educational
sessions NNS Educational
, , None
and CC None
( ( None
3 CD None
) ) None
COMPASS NN Educational
followed VBN Educational
by IN Educational
web-based JJ Educational
( ( Educational
WEB NNP Educational
) ) Educational
coaching NN Educational
sessions NNS Educational
. . None
Three CD None
individualized JJ None
goals NNS None
( ( None
social JJ Educational
, , Educational
communication NN Educational
, , Educational
and CC Educational
independence NN Educational
skills NNS Educational
) ) None
COMPASS NNP Other
-DOCSTART- -X- N

continuous JJ Physical
passive JJ Physical
movement NN Physical
continuous JJ Physical
passive JJ Physical
movement NN Physical
at IN Physical
home NN Physical
continuous JJ Physical
passive JJ Physical
movement NN Physical
-DOCSTART- -X- N

levocetirizine NN Pharmocological
levocetirizine NN Pharmocological
levocetirizine JJ Pharmocological
placebo NN Control
levocetirizine JJ Pharmocological
placebo NN Control
levocetirizine NN Pharmocological
levocetirizine NN Pharmocological
-DOCSTART- -X- N

brief JJ Psychological
Early JJ Psychological
Start NNP Psychological
Denver NNP Psychological
model NN Psychological
( ( Psychological
ESDM NNP Psychological
) ) Psychological
-based VBD Psychological
intervention NN Psychological
on IN Psychological
low-intensity JJ Psychological
( ( Psychological
1-hour/wk CD Psychological
of IN Psychological
therapist JJ Psychological
contact NN Psychological
) ) Psychological
, , Psychological
parent-delivered JJ Psychological
intervention NN Psychological
for IN Psychological
Early JJ Educational
Start NNP Educational
Denver NNP Educational
model NN Educational
( ( Educational
P-ESDM NNP Educational
) ) Educational
compared VBN Control
to TO Control
community NN Control
treatment NN Control
as IN Control
usual JJ Control
. . Control
Parents NNS None
receiving VBG None
P-ESDM NNP None
P-ESDM NNP None
Parent-implemented JJ None
intervention NN None
studies NNS None
-DOCSTART- -X- N

Na+ NNP Pharmocological
modeling VBG Pharmocological
Na+ NNP Pharmocological
standard JJ Pharmocological
Na+ NNP Pharmocological
dialysate NN Pharmocological
linear NN Physical
Na+ NNP Physical
program NN Physical
Na+ NNP Pharmocological
modeling VBG Pharmocological
Na+ NNP Pharmocological
modeling NN Pharmocological
: : None
Na+ NNP Pharmocological
modeling VBG Pharmocological
. . None
Na+ NNP Pharmocological
modeling VBG Pharmocological
. . None
Na+ NNP Pharmocological
modeling VBG Pharmocological
-DOCSTART- -X- N

interleukin-10 JJ Pharmocological
lentivirus NN None
delivering VBG None
human JJ None
IL-10 NNP None
( ( None
LV/hIL-10 NNP None
) ) None
was VBD None
Group NNP None
CCI?Normal NNP None
Saline NNP None
( ( None
NS NNP None
) ) None
, , None
Group NNP None
CCI?LV/hIL-10 NNP None
( ( None
LV/hIL-10 NNP None
) ) None
, , None
and CC None
Group NNP None
CCI?LV/control NNP None
( ( None
NS NNP None
, , None
LV/control NNP None
, , None
or CC None
recombinant JJ None
vector NN None
LV/hIL-10 NNP None
in IN None
a DT None
that DT None
intrathecal JJ None
LV/hIL-10 NNP None
reverses NNS None
of IN None
IL-10 NNP None
-DOCSTART- -X- N

nebulized JJ Pharmocological
flunisolide NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
salbutamol NN Pharmocological
and CC Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
corticosteroids NNS Pharmocological
nebulized JJ Pharmocological
flunisolide NN Pharmocological
+ VBZ Pharmocological
salbutamol/ipratropium JJ Pharmocological
bromide NN Pharmocological
placebo NN Control
+ NNP None
salbutamol/ipratropium NN Control
bromide NN Control
. . None
flunisolide NN Pharmocological
placebo NN Control
flunisolide NN Pharmocological
placebo NN Control
flunisolide JJ Pharmocological
flunisolide NN Pharmocological
flunisolide RB Pharmocological
placebo NN Control
Nebulized NNP Pharmocological
flunisolide NN Pharmocological
nebulized JJ Pharmocological
salbutamol/ipratropium NN Pharmocological
bromide NN Pharmocological
-DOCSTART- -X- N

DMSA NNP Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
dimercapto NN Pharmocological
succinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DMSA NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
DMSA NNP Pharmocological
or CC None
placebo NN Control
. . None
DMSA NNP Pharmocological
DMSA NNP Pharmocological
-DOCSTART- -X- N

propofol JJ Pharmocological
with IN Pharmocological
and CC Pharmocological
without IN Pharmocological
EDTA NNP Pharmocological
EDTA NNP Pharmocological
to TO Pharmocological
propofol VB Pharmocological
induction NN Pharmocological
of IN Pharmocological
anesthesia NN Pharmocological
with IN Pharmocological
halothane NN Pharmocological
received VBD None
propofol NN Pharmocological
without IN Pharmocological
EDTA NNP Pharmocological
( ( None
n JJ None
= NNP None
33 CD None
) ) None
or CC None
propofol NN Pharmocological
with IN Pharmocological
EDTA NNP Pharmocological
Propofol NNP Pharmocological
with IN Pharmocological
EDTA NNP Pharmocological
Propofol NNP Pharmocological
and CC None
propofol JJ Pharmocological
EDTA NNP Pharmocological
EDTA NNP Pharmocological
EDTA NNP Pharmocological
, , None
propofol NN Pharmocological
-DOCSTART- -X- N

sertraline NN Pharmocological
GnRH NNP Pharmocological
agonist JJ Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ None
sertraline NN Pharmocological
sertraline NN Pharmocological
GnRH NNP Pharmocological
agonist JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

simvastatin NN Pharmocological
simvastatin NN Pharmocological
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

300 CD Pharmocological
microg NNS Pharmocological
( ( Pharmocological
1.2 CD Pharmocological
micromol NN Pharmocological
) ) Pharmocological
biotin/d NN Pharmocological
or CC Pharmocological
placebo NN Control
. . Pharmocological
-DOCSTART- -X- N

home-based JJ Physical
task-specific JJ Physical
reach-to-grasp NN Physical
( ( Physical
RTG NNP Physical
) ) Physical
14 CD Physical
training NN Physical
sessions NNS Physical
arm NN Control
therapy NN Control
-DOCSTART- -X- N

methotrexate NN Pharmocological
or CC None
colchicine NN Pharmocological
Colchicine NNP Pharmocological
or CC None
methotrexate NN Pharmocological
colchicine NN Pharmocological
and CC None
methotrexate NN Pharmocological
. . None
methotrexate NN Pharmocological
colchicine-treated JJ Pharmocological
-DOCSTART- -X- N

new JJ Pharmocological
3.3 CD Pharmocological
g NN Pharmocological
b.i.d NN Pharmocological
. . Pharmocological
tablet NN Pharmocological
formulation NN Pharmocological
balsalazide NN Pharmocological
disodium NN Pharmocological
1.1 CD Pharmocological
g NN Pharmocological
tablet NN Pharmocological
balsalazide NN Pharmocological
or CC None
placebo NN Pharmocological
balsalazide NN Pharmocological
placebo NN Control
placebo NN Control
Balsalazide NNP Pharmocological
disodium NN Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

15-day JJ None
study NN None
periods NNS None
during IN None
which WDT None
250 CD Pharmocological
mg NN Pharmocological
theophylline NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
or CC None
matching VBG Control
placebo NN Control
was VBD None
used VBN None
. . None
On IN None
the DT None
final JJ None
day NN None
of IN None
each DT None
period NN None
, , None
hyperinsulinemic JJ None
( ( None
360 CD None
pmol NN None
x NNP None
m NN None
( ( None
-2 NNP None
) ) None
x VBP None
min NN None
( ( None
-1 NNP None
) ) None
) ) None
hypoglycemic NN None
( ( None
5.0 CD None
, , None
3.5 CD None
, , None
2.5 CD None
mmol NN None
x NN None
L NNP None
( ( None
-1 NNP None
) ) None
) ) None
glucose VBP None
clamps NNS None
were VBD None
used VBN None
to TO None
assess VB None
-DOCSTART- -X- N

penbutolol NN Pharmocological
placebo NN Control
penbutolol NN Pharmocological
placebo VB Control
treated VBN None
with IN None
penbutolol NN Pharmocological
and CC None
placebo NN Control
for IN None
a DT None
period NN None
of IN None
three CD None
days NNS None
, , None
and CC None
then RB None
were VBD None
examined VBN None
with IN None
the DT None
help NN None
of IN None
the DT None
glucose-controlled JJ Physical
insulin NN Physical
infusion NN Physical
system NN Physical
. . None
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
therapy NN Pharmocological
Recombinant NNP Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHuEPO NN Pharmocological
) ) Pharmocological
rHuEPO NN Pharmocological
placebo NN Control
rHuEPO NN Pharmocological
rHuEPO VB Pharmocological
rHuEPO NN Pharmocological
-DOCSTART- -X- N

810-nm JJ Physical
diode NN Physical
laser NN Physical
Laser NNP Physical
therapy NN Physical
810-nm JJ Physical
diode NN Physical
laser RBR Physical
treatment NN Physical
non-invasive JJ Physical
techniques NNS Physical
single-session JJ Physical
diode NN Physical
laser NN Physical
therapy NN Physical
. . None
diode NN Physical
laser NN Physical
can MD Physical
-DOCSTART- -X- N

Seven-star NNP Physical
needle JJ Physical
stimulation NN Physical
Seven-star NNP Physical
Needle NNP Physical
Stimulation NNP Physical
30 CD Physical
sessions NNS Physical
of IN Physical
Seven-star NNP Physical
Needle NNP Physical
Stimulation NNP Physical
Seven-star JJ Physical
Needles NNP Physical
. . None
Seven-star NNP Physical
Needle NNP Physical
Stimulation NNP Physical
-DOCSTART- -X- N

CMF- NNP Pharmocological
( ( Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
methotrexate NN Pharmocological
and CC Pharmocological
5-fluorouracil NN Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
in IN None
addition NN None
to TO None
endocrine VB Pharmocological
therapy NN Pharmocological
. . None
goserelin NN Pharmocological
, , Pharmocological
goserelin NN Pharmocological
plus CC Pharmocological
tamoxifen NN Pharmocological
, , Pharmocological
tamoxifen VB Pharmocological
alone RB Pharmocological
or CC None
no DT Control
endocrine JJ Control
treatment NN Control
. . None
-DOCSTART- -X- N

local JJ Pharmocological
anaesthesia NN Pharmocological
Lidoca?ne NNP None
gel NN None
with IN None
Lidoca?ne NNP None
periprostatic JJ None
infiltration NN None
prior RB None
15 CD None
ml VBD None
2 CD None
% NN None
Lidoca?ne NNP None
gel NN None
was VBD None
administered VBN None
1 CD None
% NN None
Lidoca?ne NNP None
in IN None
two CD None
p?riprostatique JJ None
equivalent JJ None
injections NNS None
, , None
4 CD None
minutes NNS None
administration NN None
of IN None
Lidoca?ne NNP None
gel NN None
and CC None
infiltration NN None
of IN None
Lidoca?ne NNP None
lead NN None
to TO None
, , None
the DT None
Lidoca?ne NNP None
gel NN None
, , None
being VBG None
-DOCSTART- -X- N

pindolol NN Pharmocological
and CC None
clopamide NN Pharmocological
clopamide NN Pharmocological
, , None
pindolol NN Pharmocological
and CC None
its PRP$ None
combination NN Pharmocological
on IN Pharmocological
plasma JJ Pharmocological
lipids NNS Pharmocological
-DOCSTART- -X- N

galacto-oligosaccharides NNS Pharmocological
and CC None
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
LGG NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
galacto-oligosaccharides NNS Pharmocological
( ( Pharmocological
GOS NNP Pharmocological
) ) Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
+ NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
GOS NNP Pharmocological
-DOCSTART- -X- N

epinephrine NN Pharmocological
epinephrine NN Pharmocological
. . None
epinephrine-induced JJ Pharmocological
-DOCSTART- -X- N

recombinant JJ Educational
human JJ Educational
nerve NN Educational
growth NN Educational
factor NN Educational
Recombinant JJ Educational
human JJ Educational
nerve NN Educational
growth NN Educational
factor NN Educational
( ( Educational
rhNGF NN Educational
) ) Educational
placebo-controlled JJ Control
rhNGF NN Pharmocological
placebo NN Control
rhNGF NN Educational
placebo NN Control
. . None
rhNGF NN Pharmocological
rhNGF NN Pharmocological
. . None
rhNGF NN Pharmocological
-DOCSTART- -X- N

continuous JJ Physical
infusion NN Physical
continuous JJ Physical
and CC Physical
intermittent JJ Physical
insulin NN Physical
delivery NN Physical
saline NN Pharmocological
or CC None
continuous JJ Pharmocological
or CC None
pulsatile NN Pharmocological
human JJ None
insulin NN None
saline NN Pharmocological
smaller JJR Physical
amount NN Physical
of IN Physical
insulin NN Physical
delivered VBN Physical
continuously RB Physical
or CC None
in IN Pharmocological
a DT Pharmocological
pulsatile JJ Physical
manner NN Pharmocological
arginine NN Pharmocological
-DOCSTART- -X- N

Orlistat NNP Pharmocological
orlistat-assisted JJ Pharmocological
diet NN Pharmocological
. . None
Orlistat NNP Educational
and CC Educational
diet JJ Educational
counseling NN Educational
were VBD Educational
compared VBN Educational
with IN Educational
diet JJ Educational
counseling VBG Educational
alone RB Educational
. . None
Orlistat CC Pharmocological
Orlistat NNP Pharmocological
-DOCSTART- -X- N

intermittent JJ Physical
mandatory JJ Physical
ventilation NN Physical
synchronized JJ Physical
intermittent NN Physical
mandatory JJ Physical
ventilation NN Physical
pressure NN Physical
support NN Physical
intermittent JJ Physical
mandatory JJ Physical
ventilation NN Physical
( ( Physical
IMV NNP Physical
) ) Physical
synchronized JJ Physical
intermittent JJ Physical
mandatory NN Physical
ventilation NN Physical
plus CC Physical
pressure NN Physical
support NN Physical
( ( Physical
SIMV+PS NNP Physical
) ) Physical
IMV NNP Physical
( ( Physical
IMVG NNP Physical
; : None
SIMV+PS NNP Physical
( ( None
SIMVG NNP Physical
; : None
[ JJ None
IMVG NNP Physical
: : None
SIMVG NNP Physical
: : None
[ JJ None
IMVG NNP Physical
: : None
SIMVG NNP Physical
: : None
IMV NNP Physical
SIMV+PS NNP Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
valacyclovir NN Pharmocological
alone RB Pharmocological
aspirin NN Pharmocological
valacyclovir NN Pharmocological
alone RB Pharmocological
aspirin NN Pharmocological
placebo NN Control
500 CD Pharmocological
mg NNS Pharmocological
valacyclovir JJ Pharmocological
once RB Pharmocological
daily JJ Pharmocological
500 CD Pharmocological
mg NNS Pharmocological
valacyclovir JJ Pharmocological
once RB Pharmocological
daily JJ Pharmocological
and CC None
350 CD Pharmocological
mg NN Pharmocological
aspirin JJ Pharmocological
treatment NN None
valacyclovir NNS Pharmocological
valacyclovir NN Pharmocological
with IN Pharmocological
aspirin JJ Pharmocological
valacyclovir JJ Pharmocological
valacyclovir NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

Psychiatric NNP Psychological
treatment NN Psychological
dermatological JJ Physical
treatment NN Physical
only RB Physical
same JJ Educational
dermatological JJ Psychological
treatment NN Psychological
plus CC Psychological
psychiatric JJ Psychological
treatment NN Psychological
psychiatric JJ Psychological
treatment NN Psychological
-DOCSTART- -X- N

cementless NN Surgical
implant NN Surgical
-DOCSTART- -X- N

Locomoting-to-reach NN Physical
: : None
Locomoting-to-reach NNP Physical
locomotion-to-reach JJ Physical
task NN Physical
. . None
-DOCSTART- -X- N

administration NN Pharmocological
of IN Pharmocological
exogenous JJ Pharmocological
growth NN Pharmocological
hormone NN Pharmocological
placebo-controlled JJ Control
recombinant JJ Pharmocological
human JJ Pharmocological
growth NN Pharmocological
hormone NN Pharmocological
( ( Pharmocological
rhGH NN Pharmocological
) ) Pharmocological
placebo JJ Control
bicycle NN Physical
exercise NN Physical
test NN Physical
-DOCSTART- -X- N

amlodipine NN Pharmocological
and CC None
enalapril NN Pharmocological
amlodipine NN Pharmocological
and CC Pharmocological
enalapril NN Pharmocological
placebo-controlled JJ Control
placebo NNS Control
amlodipine VB Pharmocological
or CC Pharmocological
enalapril JJ Pharmocological
placebo NN None
enalapril NN Pharmocological
and CC None
amlodipine NN Pharmocological
. . None
Enalapril NNP Pharmocological
Amlodipine NNP Pharmocological
amlodipine NN Pharmocological
enalapril JJ Pharmocological
amlodipine NN Pharmocological
enalapril JJ Pharmocological
enalapril NN Pharmocological
amlodipine NN Pharmocological
amlodipine VB Pharmocological
-DOCSTART- -X- N

enoxaparin VBZ Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
-DOCSTART- -X- N

pain-free JJ Physical
treadmill NN Physical
training VBG Physical
pain-free JJ Physical
treadmill NN Physical
training VBG Physical
treadmill NN Physical
training NN Physical
control NN Control
group NN Control
( ( None
no DT Physical
change NN Physical
in IN Physical
physical JJ Physical
activity NN Physical
) ) None
treadmill JJ Physical
pain-free JJ None
treadmill NN None
training NN None
parallels NNS None
-DOCSTART- -X- N

doxycycline NN Pharmocological
doxycycline NN Pharmocological
doxycycline NN Pharmocological
-DOCSTART- -X- N

bacillus NN None
Calmette-Gu?rin NNP None
vaccination NN None
without IN None
bacillus JJ None
Calmette-Gu?rin NNP None
( ( None
BCG NNP None
) ) None
after IN None
BCG NNP None
in IN None
with IN None
BCG NNP None
from IN None
-DOCSTART- -X- N

psychosocial JJ Psychological
interventions NNS Psychological
psychosocial JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

paroxetine NN Pharmocological
352 CD None
paroxetine NN Pharmocological
paroxetine NN Pharmocological
and CC None
imipramine NN Pharmocological
paroxetine NN Pharmocological
or CC None
imipramine VB Pharmocological
versus NN None
placebo NN Control
. . None
-DOCSTART- -X- N

Tiotropium NNP Pharmocological
Tiotropium NNP Pharmocological
bromide NN Pharmocological
tiotropium VBP Pharmocological
Respimat NNP Pharmocological
Soft NNP Pharmocological
Mist NNP Pharmocological
inhaler NN Pharmocological
tiotropium NN Pharmocological
HandiHaler NNP Pharmocological
tiotropium NN Pharmocological
's POS Pharmocological
tiotropium NN None
Respimat NNP None
5 CD None
?g NNP None
with IN None
tiotropium NN None
HandiHaler NNP None
18 CD None
? . None
once RB None
daily JJ None
( ( None
marketed VBN None
that IN None
tiotropium NN None
Respimat NNP None
5 CD None
Respimat NNP None
2.5 CD None
non-inferior JJ None
to TO None
HandiHaler NNP None
in IN None
terms NNS None
tiotropium NN None
Respimat NNP None
5 CD None
?g NNP None
superior JJ None
to TO None
HandiHaler NNP None
in IN None
terms NNS None
Respimat NNP None
and CC None
HandiHaler NNP None
formulations NNS None
of IN None
tiotropium NN None
, , None
assess JJ None
-DOCSTART- -X- N

silicone NN Physical
intraocular NN Physical
lens NNS Physical
( ( Physical
IOL NNP Physical
) ) Physical
( ( None
SI40NB NNP Physical
, , Physical
Allergan NNP Physical
) ) None
or CC None
an DT None
AcrySof NNP Physical
IOL NNP Physical
IOL NNP Physical
optics NNS Physical
acrylic JJ Physical
IOLs NNP Physical
. . None
-DOCSTART- -X- N

Acustimulation NNP Physical
wrist NN Physical
bands NNS Physical
acustimulation NN Physical
wrist NN Physical
band NN Physical
( ( None
active JJ Physical
acustimulation NN Physical
, , None
sham JJ Physical
acustimulation NN Physical
no DT Physical
acustimulation NN Physical
) ) None
acustimulation NN Physical
bands NNS Physical
-DOCSTART- -X- N

conventional JJ None
and CC None
a DT None
new JJ None
sampling NN Physical
device NN Physical
. . None
PapCone? NNP None
versus IN None
the DT None
conventional JJ None
sampling NN None
method NN None
( ( None
Ayre NNP None
's POS None
spatula NN None
plus CC None
cytobrush NN None
) ) None
-DOCSTART- -X- N

Concomitant NNP Pharmocological
radiochemotherapy NN Pharmocological
vs NN None
radiotherapy NN Pharmocological
alone RB Pharmocological
standard JJ Pharmocological
fractionated VBN Pharmocological
radiotherapy NN Pharmocological
( ( Pharmocological
RT NNP Pharmocological
) ) Pharmocological
with IN None
the DT None
same JJ None
RT NNP None
concomitantly RB None
with IN None
cisplatin NN Pharmocological
( ( Pharmocological
DDP NNP Pharmocological
) ) Pharmocological
or CC None
carboplatin NN Pharmocological
( ( Pharmocological
Cb NNP Pharmocological
) ) Pharmocological
. . None
RT NNP Pharmocological
monotherapy NN Pharmocological
RT NNP Pharmocological
concomitantly RB Pharmocological
with IN Pharmocological
DDP NNP Pharmocological
or CC None
Cb NNP Pharmocological
chemoradiotherapy NN Pharmocological
. . None
concomitant JJ Pharmocological
chemoradiotherapy NN Pharmocological
. . None
concomitant JJ Pharmocological
chemoradiotherapy NN Pharmocological
concomitant JJ Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
platinum NN Pharmocological
analogs NNS Pharmocological
-DOCSTART- -X- N

dual-axis JJ Physical
rotational JJ Physical
coronary NN Physical
angiography NN Physical
( ( Physical
XPERSWING NN Physical
) ) Physical
conventional JJ Physical
angiography NN Physical
Rotational JJ Physical
angiography NN Physical
conventional JJ Physical
coronary JJ Physical
angiography NN Physical
( ( Physical
A DT Physical
) ) Physical
vs FW Physical
rotational JJ Physical
angiography NN Physical
rotational JJ Physical
angiography NN Physical
conventional JJ Physical
coronary JJ Physical
angiography NN Physical
. . None
-DOCSTART- -X- N

temporary JJ Surgical
clamping NN Surgical
of IN Surgical
drains NNS Surgical
immediate JJ Surgical
drain NN Surgical
opening NN Surgical
( ( None
n JJ None
= NNP None
45 CD None
) ) None
or CC None
drains NNS Surgical
opened VBN Surgical
at IN Surgical
2 CD Surgical
h NN Surgical
clamping VBG Surgical
drains NNS Surgical
drains NNS Surgical
-DOCSTART- -X- N

tamoxifen NN Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
to TO Pharmocological
receive VB Pharmocological
: : Pharmocological
A DT Pharmocological
) ) Pharmocological
tamoxifen NN Pharmocological
( ( Pharmocological
TAM NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/die NN Pharmocological
) ) Pharmocological
until IN Pharmocological
progression NN Pharmocological
or CC Pharmocological
B NNP Pharmocological
) ) Pharmocological
TAM NNP Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/die NN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
then RB Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
1500 CD Pharmocological
mg/die NN Pharmocological
p.o NN Pharmocological
. . Pharmocological
for IN Control
14 CD Control
days NNS Control
) ) Control
followed VBN Control
by IN Control
7 CD Control
days NNS Control
of IN Control
wash-out NN Control
before IN Control
repeating VBG Control
the DT Control
TAM/MPA NNP Control
treatment NN Control
. . Control
when WRB Educational
possible JJ Educational
a DT Educational
second JJ Educational
was VBD Educational
performed VBN Educational
after IN Educational
the DT Educational
initial JJ Educational
14 CD Educational
day NN Educational
cycle NN Educational
of IN Educational
TAM NNP Educational
. . Educational
-DOCSTART- -X- N

Propofol NNP Pharmocological
submucosal JJ None
Propofol NNP Pharmocological
-DOCSTART- -X- N

Ondansetron NNP Pharmocological
Ondansetron NNP Pharmocological
ondansetron NN Pharmocological
vs NN Pharmocological
placebo NN Control
. . None
ondansetron NN Pharmocological
ondansetron NN Pharmocological
-DOCSTART- -X- N

nitrogen VB Pharmocological
dioxide NN Pharmocological
nitrogen VB Pharmocological
dioxide NN Pharmocological
( ( Pharmocological
NO2 NNP Pharmocological
) ) Pharmocological
air NN Control
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
NO2 NNP Pharmocological
-DOCSTART- -X- N

Melatonin NNP Pharmocological
versus NN None
placebo NN Control
placebo NN Control
melatonin NN Pharmocological
Melatonin NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

descriptive JJ Educational
( ( Educational
AUT-D NNP Educational
) ) Educational
descriptive JJ Educational
and CC Educational
explanatory JJ Educational
information NN Educational
( ( Educational
AUT-D NNP Educational
+ NNP Educational
E NNP Educational
) ) Educational
descriptive JJ Educational
and CC Educational
explanatory JJ Educational
information NN Educational
-DOCSTART- -X- N

three CD Psychological
performed VBD Psychological
supportive-expressive JJ Psychological
psychotherapy NN Psychological
; : Psychological
three CD Psychological
, , Psychological
cognitive-behavioral JJ Psychological
psychotherapy NN Psychological
; : Psychological
and CC Psychological
three CD Psychological
, , Psychological
drug NN Psychological
counseling NN Psychological
. . Psychological
-DOCSTART- -X- N

new JJ None
, , None
highly RB Pharmocological
purified VBN Pharmocological
, , Pharmocological
heat-treated JJ Pharmocological
equine NN Pharmocological
rabies NNS Pharmocological
immunoglobulin VBP Pharmocological
Vero-cell NNP Pharmocological
rabies VBZ Pharmocological
vaccine NN Pharmocological
. . Pharmocological
new JJ None
, , None
purified JJ Pharmocological
, , Pharmocological
heat-treated JJ Pharmocological
equine NN Pharmocological
rabies NNS Pharmocological
immunoglobulin VBP Pharmocological
( ( Pharmocological
PHT-Erig NNP Pharmocological
) ) Pharmocological
, , None
F NNP Pharmocological
( ( Pharmocological
ab IN Pharmocological
' POS Pharmocological
) ) Pharmocological
2 CD Pharmocological
preparation NN Pharmocological
PHT-Erig NNP Pharmocological
a DT None
commercially-available JJ None
, , None
equine JJ Pharmocological
rabies NNS Pharmocological
immune VBP Pharmocological
globulin NN Pharmocological
( ( Pharmocological
Erig NNP Pharmocological
PMC NNP Pharmocological
) ) Pharmocological
. . None
the DT None
purified JJ Pharmocological
Vero-cell NNP Pharmocological
rabies NNS Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
PVRV NNP Pharmocological
) ) Pharmocological
either DT None
Erig NNP Pharmocological
PMC NNP Pharmocological
or CC None
PHT-Erig NNP Pharmocological
. . None
-DOCSTART- -X- N

supplementation NN Pharmocological
. . None
iron NN Pharmocological
and CC Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Dader NNP Educational
Method NNP Educational
pharmacist JJ Educational
intervention NN Educational
community NN Educational
pharmacist NN Educational
interventions NNS Educational
Dader NNP Educational
Method NNP Educational
for IN Educational
pharmaceutical JJ Educational
care NN Educational
intervention NN Educational
group NN Educational
that WDT Educational
received VBD Educational
pharmaceutical JJ Educational
care NN Educational
, , Educational
which WDT Educational
was VBD Educational
provided VBN Educational
by IN Educational
specially RB Educational
trained JJ Educational
pharmacists NNS Educational
working VBG Educational
in IN Educational
collaboration NN Educational
with IN Educational
physicians NNS Educational
control NN Educational
group NN Educational
that WDT Educational
received VBD Educational
usual JJ Educational
care NN Educational
( ( Educational
routine JJ Educational
dispensing VBG Educational
counseling NN Educational
) ) Educational
and CC Educational
verbal JJ Educational
and CC Educational
written VBN Educational
counseling VBG Educational
regarding VBG Educational
CVD NNP Educational
prevention NN Educational
. . None
intervention NN None
control NN None
) ) None
usual JJ None
care NN None
plus CC None
written VBN None
education NN None
, , None
pharmaceutical JJ None
care NN None
focused VBN None
on IN None
patient JJ None
evaluation NN None
and CC None
follow-up NN None
in IN None
collaboration NN None
with IN None
physicians NNS None
-DOCSTART- -X- N

eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
, , Pharmocological
gamma-linolenic JJ Pharmocological
acid NN Pharmocological
, , None
and CC None
antioxidants NNS Pharmocological
enteral JJ None
diet NN None
containing VBG None
eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
and CC None
gamma-linolenic JJ Pharmocological
acid NN Pharmocological
and CC None
elevated JJ None
antioxidants NNS Pharmocological
( ( None
EPA+GLA NNP None
; : None
Oxepa NNP None
) ) None
EPA+GLA NNP None
or CC None
an DT None
isonitrogenous JJ Pharmocological
, , None
isocaloric JJ None
standard NN None
diet NN None
EPA+GLA NNP Pharmocological
-DOCSTART- -X- N

gemcitabine NN Pharmocological
plus CC None
tipifarnib NN Pharmocological
gemcitabine JJ Pharmocological
plus CC None
placebo NN Control
tipifarnib NN Pharmocological
gemcitabine JJ Pharmocological
+ NNP Pharmocological
tipifarnib NN Pharmocological
gemcitabine NN None
+ NNP None
placebo NN None
Tipifarnib NNP Pharmocological
was VBD Pharmocological
given VBN Pharmocological
at IN Pharmocological
200 CD Pharmocological
mg NNS Pharmocological
bid VBD Pharmocological
orally RB Pharmocological
continuously RB Pharmocological
; : Pharmocological
gemcitabine NN Pharmocological
was VBD Pharmocological
given VBN Pharmocological
at IN Pharmocological
1,000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
intravenously RB Pharmocological
weekly JJ Pharmocological
x NN Pharmocological
7 CD Pharmocological
for IN Pharmocological
8 CD Pharmocological
weeks NNS Pharmocological
, , Pharmocological
then RB Pharmocological
weekly JJ Pharmocological
x NN Pharmocological
3 CD Pharmocological
every DT Pharmocological
4 CD Pharmocological
weeks NNS Pharmocological
. . Pharmocological
gemcitabine NN Pharmocological
and CC Pharmocological
tipifarnib NN Pharmocological
-DOCSTART- -X- N

Radiographic NNP Physical
views NNS Physical
of IN None
the DT None
TF NNP None
and CC None
PF NNP None
compartments NNS None
, , None
knee VB Physical
extension NN Physical
strength NN Physical
, , None
and CC None
knee VB Physical
range NN Physical
of IN Physical
motion NN Physical
Treatment NNP None
strategies VBZ None
targeting VBG None
the DT None
PF NNP None
joint NN None
may MD None
-DOCSTART- -X- N

insulin NN Pharmocological
therapy NN Pharmocological
diet JJ Educational
and CC Educational
diabetes VBZ Educational
education NN Educational
insulin JJ Pharmocological
therapy NN Pharmocological
was VBD None
withdrawn VBN None
. . None
-DOCSTART- -X- N

benzodiazepine NN Pharmocological
( ( Pharmocological
temazepam NN Pharmocological
) ) Pharmocological
a DT Pharmocological
non-benzodiazepine JJ Pharmocological
hypnotic NN Pharmocological
( ( Pharmocological
zolpidem NN Pharmocological
) ) Pharmocological
] NN None
oral JJ Pharmocological
temazepam NN Pharmocological
medium NN Pharmocological
half-life JJ Pharmocological
benzodiazepine NN Pharmocological
vs IN None
oral JJ Pharmocological
zolpidem NN Pharmocological
, , None
a DT Pharmocological
short JJ Pharmocological
half-life JJ Pharmocological
non-benzodiazepine JJ Pharmocological
drug NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

12-lead JJ Physical
ECG NNP Physical
, , Physical
and CC Physical
24-h JJ Physical
ambulatory NN Physical
ECG NNP Physical
monitoring NN Physical
. . None
L-thyroxine NNP Pharmocological
L-thyroxine NNP Pharmocological
. . None
L-tiroxine NNP Pharmocological
L-thyroxine JJ Pharmocological
-DOCSTART- -X- N

risedronate NN Pharmocological
received VBD None
risedronate JJ Pharmocological
2.5 CD Pharmocological
or CC Pharmocological
5 CD Pharmocological
mg/day NN Pharmocological
or CC None
placebo NN Control
; : None
all DT None
subjects NNS None
also RB None
received VBD None
elemental JJ Pharmocological
calcium NN Pharmocological
1000 CD Pharmocological
mg/day NN Pharmocological
, , None
and CC None
up RB None
to TO None
500 CD Pharmocological
IU/day NNP Pharmocological
vitamin FW Pharmocological
D NNP Pharmocological
if IN None
baseline NN None
levels NNS None
were VBD None
low JJ None
. . None
the DT None
2.5 CD None
mg NN None
group NN None
was VBD None
discontinued VBN None
by IN None
protocol NN None
amendment NN None
after IN None
2 CD None
years NNS None
. . None
-DOCSTART- -X- N

Computer-delivered JJ Educational
tailored VBN Educational
intervention NN Educational
computer-delivered JJ Educational
tailored JJ Educational
intervention NN Educational
-DOCSTART- -X- N

Multisensory JJ Physical
temporal JJ Physical
integration NN Physical
DSM-5 NNP Pharmocological
multisensory JJ Physical
temporal JJ Physical
tasks NNS Physical
( ( None
with IN None
both DT None
simple JJ None
and CC None
complex JJ None
stimuli NN None
) ) None
multisensory JJ Educational
temporal JJ Educational
tasks NNS Educational
-DOCSTART- -X- N

Albumin-glutaraldehyde JJ Pharmocological
bioadhesive NN Pharmocological
( ( Pharmocological
Bioglue NNP Pharmocological
) ) Pharmocological
biological JJ Pharmocological
albumin-glutaraldehyde JJ Pharmocological
glue NN Pharmocological
Bioglue NNP Pharmocological
Bioglue NNP Pharmocological
in IN Pharmocological
the DT Pharmocological
mucosa NN Pharmocological
anastomosis NN Pharmocological
area NN Pharmocological
. . None
standardized JJ Pharmocological
postoperative JJ Pharmocological
analgesic NN Pharmocological
, , Pharmocological
laxative JJ Pharmocological
and CC Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

drug-containing JJ Pharmocological
porcine-cornea NN Pharmocological
irradiated JJ Pharmocological
drug-containing NN Pharmocological
( ( Pharmocological
ofloxacin UH Pharmocological
, , Pharmocological
acetyl JJ Pharmocological
cysteine NN Pharmocological
and CC Pharmocological
reduced JJ Pharmocological
glutathione NN Pharmocological
) ) Pharmocological
porcine-cornea NN Pharmocological
. . None
porcine-cornea NN Physical
-DOCSTART- -X- N

conventional JJ Physical
physical JJ Physical
therapy NN Physical
alone RB Physical
with IN None
a DT None
specialised JJ Educational
balance NN Educational
retraining VBG Educational
program NN Educational
physical JJ Physical
therapy NN Physical
therapy NN Physical
and CC Physical
retraining NN Physical
conventional JJ Control
therapy NN Control
therapy NN Physical
combined VBN Physical
with IN Physical
standing VBG Physical
balance NN Physical
training NN Physical
by IN Physical
biofeedback NN Physical
( ( Physical
BPM NNP Physical
Monitor NNP Physical
) ) Physical
conventional JJ Physical
therapy NN Physical
-DOCSTART- -X- N

pre- NN Surgical
and CC Surgical
intraoperative JJ Surgical
positioning NN Surgical
of IN Surgical
the DT Surgical
condyle NN Surgical
positioning NN Surgical
of IN Surgical
the DT Surgical
condylar JJ Surgical
process NN Surgical
condyles NNS Surgical
were VBD Surgical
placed VBN Surgical
in IN Surgical
the DT Surgical
centre NN Surgical
of IN Surgical
the DT Surgical
articular JJ Surgical
fossa NN Surgical
before IN Surgical
and CC Surgical
during IN Surgical
the DT Surgical
operation NN Surgical
, , Surgical
and CC Surgical
in IN Surgical
the DT Surgical
other JJ Surgical
group NN Surgical
they PRP Surgical
were VBD Surgical
not RB Surgical
. . None
Fixing VBG Physical
the DT Physical
condylar JJ Physical
process NN Physical
in IN Physical
the DT Physical
centre NN Physical
of IN Physical
the DT Physical
articular JJ Physical
fossa NN Physical
intraoperatively RB Physical
-DOCSTART- -X- N

flunarizine NN Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
. . None
blocker NN Pharmocological
Flunarizine NNP Pharmocological
( ( Pharmocological
Sibelium NNP Pharmocological
) ) Pharmocological
Acetylsalicylic NNP Pharmocological
acid NN Pharmocological
( ( Pharmocological
ASS NNP Pharmocological
) ) Pharmocological
ASS NNP Pharmocological
Flunarizine NNP Pharmocological
. . None
Flunarizine NNP Pharmocological
-DOCSTART- -X- N

Propofol NNP Pharmocological
and CC None
midazolam NNP Pharmocological
i.v NN None
. . None
propofol NN Pharmocological
and CC None
midazolam NN Pharmocological
propofol NN Pharmocological
and CC None
midazolam VB Pharmocological
alone RB None
and CC None
in IN None
combination NN None
. . None
midazolam NN Pharmocological
propofol NN Pharmocological
midazolam NN Pharmocological
-DOCSTART- -X- N

Endoscopic NNP Physical
sphincterotomy NN Physical
pure-cut JJ Physical
electrosurgical JJ Physical
current JJ Physical
sphincterotomy NN Physical
pure-cut JJ Physical
current JJ Physical
sphincterotomy NN Surgical
over IN Physical
a DT Physical
non-conductive JJ Physical
guidewire NN Physical
with IN Physical
30 CD Physical
W/sec NNP Physical
pure-cut JJ Physical
current JJ Physical
or CC Physical
30 CD Physical
W/sec JJ Physical
blend-2 JJ Physical
current JJ Physical
by IN Physical
a DT Physical
blinded JJ Physical
endoscopist NN Physical
. . None
current JJ Physical
endoscopic RB Physical
sphincterotomy NN Physical
electrosurgical JJ Physical
current JJ Physical
endoscopic NN Physical
sphincterotomy NN Physical
-DOCSTART- -X- N

electroacupuncture NN Physical
arthroscopic JJ Physical
debridement NN Physical
] NN None
electroacupuncture NN Physical
arthroscopic JJ Physical
debridement NN Physical
. . None
arthroscopic JJ Physical
debridement NN Physical
combined VBN None
with IN None
electroacupuncture NN Physical
after IN None
operation NN None
. . None
arthroscopic JJ Physical
debridment NN Physical
. . None
isometric JJ Physical
quadriceps NNS Physical
femoris JJ Physical
contraction NN Physical
exercise NN Physical
and CC None
knee NN Physical
flexion NN Physical
and CC None
extension NN Physical
activities NNS Physical
after IN None
operation NN None
. . None
-DOCSTART- -X- N

distinctive JJ Educational
information NN Educational
studying VBG Educational
pictures NNS Educational
retrieval NN Educational
strategy NN Educational
. . Educational
picture NN Educational
encoding VBG Educational
word NN Educational
encoding NN Educational
. . Educational
test NN Educational
-DOCSTART- -X- N

second JJ None
third JJ None
generation NN None
oral JJ Pharmocological
contraceptives NNS Pharmocological
second JJ Educational
third JJ Pharmocological
generation NN Pharmocological
combination NN Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
( ( Pharmocological
OCs NNP Pharmocological
) ) Pharmocological
ethinyl JJ Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/levonorgestrel NN Pharmocological
ethinyl VB Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl VB Pharmocological
estradiol/levonorgestrel NN Pharmocological
. . Pharmocological
desogestrel-containing JJ Pharmocological
contraceptive NN Pharmocological
levonorgestrel-containing JJ Pharmocological
contraceptive NN Pharmocological
. . Pharmocological
levonorgestrel NN Pharmocological
desogestrel NN Pharmocological
ethinyl JJ Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/levonorgestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol/levonorgestrel NN Pharmocological
third JJ Educational
generation NN Educational
OCs NNP Physical
desogestrel NN Pharmocological
second JJ None
and CC None
third JJ None
generation NN None
OCs NNP Physical
-DOCSTART- -X- N

Direct JJ None
renin NN None
inhibition NN None
Direct JJ None
renin NN None
inhibition NN None
direct JJ None
renin NN None
inhibition NN None
placebo-controlled JJ Control
aliskiren NN Pharmocological
or CC None
placebo NN Pharmocological
aliskiren NNS Pharmocological
placebo NN Control
interaction NN None
( ( None
aliskiren VB None
? . None
visit NN None
on IN None
aliskiren NNS None
. . None
MCR NNP None
( ( None
aliskiren NN None
) ) None
and CC None
38.2 CD None
placebo NN None
-DOCSTART- -X- N

PEERS NNPS Educational
intervention NN Educational
: : Educational
Program NNP Educational
for IN Educational
the DT Educational
Education NNP Educational
and CC Educational
Enrichment NNP Educational
of IN Educational
Relational NNP Educational
Skills NNP Educational
( ( Educational
PEERS NNS Educational
: : Educational
PEERS CC Educational
immediate JJ Educational
treatment NN Educational
or CC None
waitlist NN Control
comparison NN Control
group NN Control
. . None
waitlist NN Educational
experimental JJ Educational
treatment NN Educational
PEERS NNP Educational
intervention NN Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

telephone NN None
appointing VBG None
telephone NN Other
appointments NNS Other
telephone NN Other
call NN Other
from IN Other
the DT Other
practice NN Other
receptionist NN Other
intervention NN None
control NN Control
intervention NN None
group NN None
controlgroup NN Control
intervention NN None
-DOCSTART- -X- N

serum NN Pharmocological
methotrexate NN Pharmocological
methotrexate NN Pharmocological
6-mercaptopurine JJ Pharmocological
( ( Pharmocological
6-MP JJ Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

weight NN Physical
training NN Physical
weight JJ Physical
training NN Physical
exercises NNS Physical
risedronate NN Pharmocological
calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
strength/weight JJ Physical
training NN Physical
( ( Physical
ST NNP Physical
) ) Physical
exercises NNS Physical
exercise VB Physical
plus JJ Educational
medication NN Pharmocological
medication NN Pharmocological
calcium NN Pharmocological
vitamin NNP Pharmocological
D NNP Pharmocological
risedronate JJ Pharmocological
exercise NN Physical
ST NNP Physical
exercises NNS Physical
medications NNS Physical
exercising VBG Physical
exercised VBD None
exercise VB None
Strength/weight NNP None
training NN None
exercises NNS None
-DOCSTART- -X- N

local JJ Pharmocological
immunotherapy NN Pharmocological
powder NN Pharmocological
extract NN Pharmocological
of IN Pharmocological
house NN Pharmocological
dust NN Pharmocological
mite NN Pharmocological
( ( Pharmocological
HDM NNP Pharmocological
) ) Pharmocological
parenteral JJ Pharmocological
immunotherapy NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
placebo NN Control
lactose NN Pharmocological
disodium NN Pharmocological
cromoglycate NN Pharmocological
( ( Pharmocological
DSCG NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

nocturnal JJ Physical
continuous JJ Physical
positive JJ Physical
airway NN Physical
pressure NN Physical
. . None
continuous JJ Physical
positive JJ Physical
airway NN Physical
pressure NN Physical
( ( Physical
CPAP NNP Physical
) ) Physical
of IN None
were VBD None
recorded VBN None
on IN None
the DT None
morning NN None
after IN None
overnight JJ None
polysomnography NN None
, , None
and CC None
again RB None
one CD None
month NN None
after IN None
patients NNS None
were VBD None
randomly RB None
allocated VBN None
nocturnal JJ Physical
CPAP NNP Physical
treatment NN Physical
or CC None
no DT None
CPAP NNP None
( ( None
control NN None
) ) None
nocturnal JJ Physical
CPAP NNP Physical
-DOCSTART- -X- N

simvastatin NN Pharmocological
simvastatin NN Pharmocological
( ( Pharmocological
MK NNP Pharmocological
733 CD Pharmocological
) ) None
HMG NNP None
CoA NNP None
reductase NN None
, , None
alone RB None
and CC None
in IN None
combination NN None
with IN None
a DT None
bile JJ Pharmocological
acid NN Pharmocological
sequestrant NN Pharmocological
, , Pharmocological
cholestyramine NN Pharmocological
simvastatin JJ Pharmocological
treatment NN Pharmocological
cholestyramine NN Pharmocological
cholestyramine JJ Pharmocological
treatment NN Pharmocological
simvastatin NN Pharmocological
simvastatin-cholestyramine JJ Pharmocological
regimen NNS Pharmocological
-DOCSTART- -X- N

social JJ Educational
treatment NN Educational
manualized VBN Educational
social JJ Educational
intervention NN Educational
treatment NN Educational
wait-list JJ Control
conditions NNS Control
. . Control
Treatment NNP None
instruction NN Educational
and CC Educational
therapeutic JJ Educational
activities NNS Educational
targeting VBG Educational
social JJ Educational
skills NNS Educational
, , Educational
face-emotion NN Educational
recognition NN Educational
, , Educational
interest NN Educational
expansion NN Educational
, , Educational
and CC Educational
interpretation NN Educational
of IN Educational
non-literal JJ Educational
language NN Educational
. . Educational
-DOCSTART- -X- N

studied VBD Educational
-DOCSTART- -X- N

heparin NN Pharmocological
. . Pharmocological
heparin NNS Pharmocological
Heparin NNP Pharmocological
heparin NN Pharmocological
. . Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

after-school JJ Educational
exercise NN Educational
program NN Educational
. . None
exercise NN Physical
intervention NN Physical
instructor-led JJ None
after-school JJ None
program NN None
every DT None
Tractography NN None
was VBD None
the DT None
exercise NN None
intervention NN None
, , None
the DT None
control NN None
intervention NN None
, , None
exercise NN None
-DOCSTART- -X- N

educational JJ Other
baby NN Other
books NNS Other
an DT None
educational JJ Other
book NN Other
group NN Other
, , None
a DT None
noneducational JJ Other
book NN Other
group NN Other
, , None
or CC None
a DT None
no-book JJ Control
group NN Control
. . None
-DOCSTART- -X- N

Dofequidar NNP Pharmocological
fumarate NN Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
dofequidar NN Pharmocological
plus CC Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
CAF NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
CAF NNP Pharmocological
alone RB Pharmocological
placebo-controlled JJ Control
CAF NNP Pharmocological
therapy NN Pharmocological
: : None
days/cycle NN None
, , None
with IN None
doxorubicin NN Pharmocological
( ( None
25 CD None
mg/m2 NN None
) ) None
and CC None
fluorouracil NN Pharmocological
( ( None
500 CD None
mg/m2 NN None
) ) None
administered VBN None
on IN None
days NNS None
1 CD None
and CC None
8 CD None
and CC None
cyclophosphamide NN Pharmocological
( ( None
100 CD None
mg NN None
orally RB None
[ NNP None
PO NNP None
] NNP None
) ) None
administered VBD None
on IN None
day NN None
1 CD None
through IN None
14 CD None
. . None
dofequidar NN Pharmocological
( ( Pharmocological
900 CD Pharmocological
mg RB Pharmocological
PO NNP Pharmocological
) ) Pharmocological
doxorubicin NN Pharmocological
. . None
CAF NNP Pharmocological
dofequidar NN Pharmocological
+ NNP Pharmocological
CAF NNP Pharmocological
dofequidar NN Pharmocological
Dofequidar NNP Pharmocological
+ NNP Pharmocological
CAF NNP Pharmocological
-DOCSTART- -X- N

methotrexate NN Pharmocological
methotrexate NN Pharmocological
methotrexate NN Pharmocological
double-dose JJ None
( ( None
50mg/m CD None
( ( None
2 CD None
) ) None
intramuscularly RB None
on IN None
days NNS None
0 CD None
and CC None
4 CD None
; : None
group NN None
1 CD None
) ) None
or CC None
single-dose JJ None
( ( None
50mg/m CD None
( ( None
2 CD None
) ) None
intramuscularly RB None
on IN None
day NN None
0 CD None
; : None
group NN None
2 CD None
) ) None
methotrexate NN Pharmocological
. . None
double-dose JJ None
methotrexate NN None
had VBD None
-DOCSTART- -X- N

laryngeal JJ Other
LMA NNP None
Unique? NNP None
in IN None
the DT None
self-pressurised JJ None
air-Q? JJ None
intubating NN None
laryngeal NN None
airway RB None
( ( None
air-Q JJ None
SP NNP None
) ) None
with IN None
the DT None
-DOCSTART- -X- N

nimodipine JJ None
placebo NNS Control
nimodipine JJ Pharmocological
( ( Pharmocological
Nimotop NNP Pharmocological
) ) Pharmocological
10-min JJ Physical
EEG NN Physical
nimodipine VBP None
nimodipine VBP None
nimodipine JJ None
nimodipine VBP Pharmocological
-DOCSTART- -X- N

Anxiolytics NNS Pharmocological
anxiolytic JJ Pharmocological
analgesic JJ Physical
Midazolam NNP Pharmocological
( ( Pharmocological
Mi NNP Pharmocological
) ) Pharmocological
+Morphine NN Pharmocological
( ( Pharmocological
Mo NNP Pharmocological
) ) Pharmocological
and CC None
Mo NNP Control
alone RB Control
. . None
Mi+Mo NNP None
and CC None
Mo NNP None
alone RB None
Mi+Mo NNP None
and CC None
anxiolytics NNS None
and CC None
analgesics NNS None
as IN None
-DOCSTART- -X- N

radiation NN Physical
therapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
with IN None
or CC None
without IN None
short-term JJ Pharmocological
androgen NN Pharmocological
deprivation NN Pharmocological
( ( Pharmocological
STAD NNP Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

generalized JJ Other
estimating NN Other
equations NNS Other
( ( Other
GEE NNP Other
) ) Other
GEE-independent NNP Physical
GEE-independent JJ Physical
-DOCSTART- -X- N

Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
B NNP Pharmocological
conjugate NN Pharmocological
Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
b NN Pharmocological
( ( Pharmocological
Hib NNP Pharmocological
) ) Pharmocological
capsular VBD Pharmocological
polysaccharide-protein JJ Pharmocological
conjugate NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
PRP-OMP NNP Pharmocological
, , Pharmocological
PRP-T NNP Pharmocological
, , Pharmocological
and CC Pharmocological
HbOC NNP Pharmocological
) ) Pharmocological
Hib NNP Pharmocological
vaccines NNS Pharmocological
( ( Pharmocological
Hib NNP Pharmocological
groups NNS Pharmocological
) ) Pharmocological
or CC None
into IN None
a DT None
control NN Control
group NN Control
. . None
Hib NNP Pharmocological
conjugate NN Pharmocological
vaccines NNS Pharmocological
( ( None
PRP-T NNP Pharmocological
, , None
HbOC NNP Pharmocological
PRP-OMP NNP Pharmocological
) ) None
-DOCSTART- -X- N

Alternating VBG Physical
chemotherapy NN Physical
rapid JJ Pharmocological
cyclic JJ Pharmocological
alternating VBG Pharmocological
chemotherapy NN Pharmocological
initial JJ Pharmocological
common JJ Pharmocological
continuous JJ Pharmocological
therapy NN Pharmocological
. . None
continuous JJ Physical
standard NN Physical
therapy NN Physical
based VBN Physical
on IN Physical
the DT Physical
CAV- NNP Pharmocological
or CC Pharmocological
CMC-protocol NNP Pharmocological
with IN Pharmocological
an DT Pharmocological
alternating VBG Pharmocological
schedule NN Pharmocological
often RB Pharmocological
consisting VBG Pharmocological
of IN Pharmocological
the DT Pharmocological
CAV- NNP Pharmocological
or CC Pharmocological
CMC-derived JJ Pharmocological
combinations NNS Pharmocological
and CC None
a DT None
second JJ Pharmocological
regimen NN Pharmocological
including VBG Pharmocological
cisplatinum NN Pharmocological
and/or NN Pharmocological
etoposide NN Pharmocological
. . None
-DOCSTART- -X- N

topical JJ Pharmocological
anti-inflammatory JJ Pharmocological
agents NNS Pharmocological
. . Pharmocological
image NN None
analytic JJ None
method NN None
using VBG None
a DT None
videomicroscope NN None
interfaced VBN None
with IN None
a DT None
computer NN None
. . None
corticosteroids NNS Pharmocological
indomethacin NN Pharmocological
topical JJ Pharmocological
anti-inflammatory JJ Pharmocological
agents NNS Pharmocological
-DOCSTART- -X- N

Lactate NNP Physical
Minimum NNP Physical
Test NNP Physical
( ( Physical
LMT NNP Physical
) ) Physical
-DOCSTART- -X- N

L-arginine NNP Pharmocological
or CC None
L-citrulline JJ Pharmocological
oral JJ Pharmocological
supplementation NN Pharmocological
L-arginine NNP Pharmocological
and CC None
L-citrulline NNP Pharmocological
L-arginine NNP Pharmocological
the DT None
citrulline NN None
( ( None
Administration NNP None
of IN None
L-arginine NNP None
and CC None
-DOCSTART- -X- N

captopril NN Pharmocological
and CC None
propranolol NN Pharmocological
captopril NN Pharmocological
and CC None
of IN None
propranolol NNS Pharmocological
captopril NN Pharmocological
propranolol NN Pharmocological
. . None
captopril VB Pharmocological
Captopril NNP Pharmocological
-DOCSTART- -X- N

Cross-sectional JJ Educational
study NN Educational
1-day JJ None
activity NN None
diary NN None
. . None
questionnaire NN None
. . None
the DT None
Children NNP None
's POS None
Depression NNP None
Inventory NNP None
( ( None
CDI NNP None
) ) None
. . None
the DT None
Childhood NNP None
Health NNP None
Assessment NNP None
Questionnaire NNP None
-DOCSTART- -X- N

exercise NN Physical
, , Physical
training NN Physical
glycogen NN Physical
availability NN Physical
exercise NN Physical
exercise NN Physical
, , Physical
training NN Physical
, , None
and CC None
glycogen NN Physical
availability NN Physical
10 CD Physical
wk NN Physical
of IN Physical
training VBG Physical
with IN Physical
an DT Physical
acute JJ Physical
exercise NN Physical
bout NN Physical
before IN Physical
and CC Physical
after IN Physical
the DT Physical
training NN Physical
period NN Physical
, , None
or CC None
a DT None
low-glycogen JJ Pharmocological
vs. NN None
normal-glycogen JJ Physical
acute NN Physical
exercise NN Physical
trial NN Physical
. . None
-DOCSTART- -X- N

Beverage NNP Physical
vs. FW Educational
solid JJ Physical
fruits NNS Physical
and CC Physical
vegetables NNS Physical
: : Educational
Energy-matched JJ Physical
beverage NN Physical
or CC Educational
solid JJ Physical
forms NNS Physical
of IN Physical
fruits NNS Physical
and CC Physical
vegetables NNS Physical
-DOCSTART- -X- N

xylometazoline NNP Pharmocological
dexpanthenol JJ Pharmocological
Xylometazoline NN Pharmocological
Dexpanthenol NNP Pharmocological
( ( Pharmocological
Nasic NNP Pharmocological
) ) Pharmocological
Xylometazoline NNP Pharmocological
alone RB None
verum NN Pharmocological
placebo NN Control
Xylometazoline-Dexpanthenol JJ Pharmocological
Xylometazoline NNP Pharmocological
Xylometazoline-Dexpanthenol NNP Pharmocological
Xylometazoline NNP Pharmocological
-DOCSTART- -X- N

imidafenacin JJ Pharmocological
versus NN Pharmocological
fesoterodine NN Pharmocological
imidafenacin NN Pharmocological
fesoterodine NN Pharmocological
fesoterodine-controlled JJ Control
twice-daily JJ None
0.1 CD None
mg NN None
imidafenacin NN None
with IN None
placebo NN None
, , None
or CC None
4 CD None
mg NNS None
fesoterodine JJ None
with IN None
placebo NN None
were VBD None
non-inferior JJ None
to TO None
fesoterodine VB None
, , None
and CC None
CONCLUSIONS NNP None
Imidafenacin NNP None
was VBD None
non-inferior JJ None
to TO None
fesoterodine VB None
in IN None
terms NNS None
-DOCSTART- -X- N

LX4211 NNP Pharmocological
LX4211 NNP Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

secretin NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
. . None
Human NNP Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
, , None
mean VBP None
dose JJ None
3.4 CD None
clinical JJ None
units NNS None
, , None
and CC None
placebo NN Control
were VBD None
administered VBN None
intravenously RB None
in IN None
randomized JJ None
order NN None
every DT None
4th CD None
wk NN None
, , None
on IN None
three CD None
occasions NNS None
each DT None
. . None
secretin NN Pharmocological
-DOCSTART- -X- N

Single NNP Physical
negative JJ Physical
colposcopy NN Physical
: : None
-DOCSTART- -X- N

received VBD None
progressive JJ None
exercise NN None
training NN None
. . None
either RB None
4 CD None
mg NNS None
perindopril NN None
or CC None
matching VBG None
placebo JJ None
daily JJ None
-DOCSTART- -X- N

bare-metal JJ Physical
stent JJ Physical
implantation NN Physical
with IN Physical
sirolimus-eluting JJ Physical
stent NN Physical
implantation NN Physical
sirolimus-eluting JJ Surgical
Cypher NNP Surgical
stents NNS Surgical
( ( Surgical
SESs NNP Surgical
) ) Surgical
SESs NNP None
BMSs NNP None
-DOCSTART- -X- N

L-carnitine NNP Pharmocological
L-carnitine NNP Pharmocological
placebo-controlled JJ Control
L-carnitine JJ Pharmocological
L-carnitine NNP Pharmocological
in IN Pharmocological
1500 CD Pharmocological
ml NN Pharmocological
cardioplegia NN Pharmocological
aortic JJ Surgical
cross-clamping NN Surgical
. . None
L-carnitine JJ Pharmocological
therapy NN Pharmocological
L-carnitine NNP Pharmocological
-DOCSTART- -X- N

nicardipine NN Pharmocological
propranolol NN Pharmocological
nicardipine JJ Pharmocological
propranolol JJ Pharmocological
nicardipine NN Pharmocological
propranolol NN Pharmocological
nicardipine NN Pharmocological
propranolol NN Pharmocological
nicardipine NN Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
-DOCSTART- -X- N

Cophenylcaine NNP Pharmocological
placebo NN Control
cophenylcaine NN Pharmocological
placebo NN Control
cophenylcaine NN Pharmocological
cophenylcaine NN Pharmocological
-DOCSTART- -X- N

develop VB Other
the DT Other
formulas NN Educational
validate VB Other
the DT Other
prediction NN Educational
algorithms NN Educational
-DOCSTART- -X- N

Intensive JJ Educational
behavioral JJ Educational
treatment NN Educational
early JJ Educational
intensive JJ Educational
behavioral JJ Educational
treatment NN Educational
developed VBD Educational
at IN Educational
UCLA NNP Educational
, , None
that WDT Educational
received VBD Educational
intensive JJ Educational
hours NNS Educational
but CC Educational
less JJR Educational
supervision NN Educational
by IN Educational
equally RB Educational
well-trained JJ Educational
supervisors NNS Educational
. . None
-DOCSTART- -X- N

placebo NN Control
piracetam NN Pharmocological
risperidone VB Pharmocological
piracetam NN Pharmocological
piracetam VB Pharmocological
+ NNP None
risperidone NN Pharmocological
( ( None
Group NNP None
A NNP None
) ) None
or CC None
placebo JJ Control
+ NN None
risperidone NN Pharmocological
risperidone NN Pharmocological
piracetam NN Pharmocological
-DOCSTART- -X- N

weighted JJ Physical
vests NNS Physical
. . None
weighted JJ Physical
vest NN Physical
intervention NN Physical
control NN Control
with IN Other
and CC Other
without IN Other
a DT Other
vest NN Other
. . None
intervention NN Physical
control NN None
nonweighted JJ Other
vest NN Other
. . None
weighted JJ Physical
vests NNS Physical
-DOCSTART- -X- N

Vector NNP Physical
system NN Physical
. . None
Vector NNP Physical
system NN Physical
Vector NNP Physical
system NN Physical
carbon NN Other
fiber NN Other
curette NN Other
. . None
Vector-treated NNP Physical
sites NNS Physical
Vector NNP Physical
system NN Physical
-DOCSTART- -X- N

cluster NN Educational
randomized VBN Educational
controlled VBN Educational
lifestyle JJ Educational
intervention NN Educational
lifestyle JJ Educational
programme NN Educational
health NN Educational
intervention NN Educational
programme NN Educational
health NN Educational
interventions NNS Educational
-DOCSTART- -X- N

compare VB Educational
dietary JJ Educational
patterns NNS Educational
diet JJ Educational
and CC Educational
exercise JJ Educational
intervention NN Educational
two CD None
45- JJ None
to TO None
60-minute JJ None
telephone NN None
surveys NNS None
, , None
which WDT None
included VBD None
two CD None
24-hour JJ None
dietary JJ None
recalls NNS None
. . None
Principal JJ None
components NNS None
analysis NN None
and CC None
multivariable JJ None
general JJ None
linear JJ None
models NNS None
were VBD None
-DOCSTART- -X- N

treatment NN None
-- : None
cyclophosphamide NN Pharmocological
ifosfamide NN Pharmocological
etoposide NN Pharmocological
cyclophosphamide NN Pharmocological
ifosfamide NN Pharmocological
etoposide JJ Pharmocological
vincristine NN Pharmocological
, , Pharmocological
dactinomycin NN Pharmocological
, , Pharmocological
ifosfamide NN Pharmocological
, , Pharmocological
and CC Pharmocological
doxorubicin NN Pharmocological
( ( Pharmocological
VAIA NNP Pharmocological
) ) Pharmocological
induction NN Pharmocological
therapy NN Pharmocological
VAIA NNP Pharmocological
or CC Pharmocological
vincristine NN Pharmocological
, , Pharmocological
dactinomycin NN Pharmocological
, , Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
and CC Pharmocological
doxorubicin NN Pharmocological
( ( None
VACA NNP None
; : None
cyclophosphamide NN None
replacing VBG None
ifosfamide NN None
) ) None
VAIA NNP Pharmocological
VAIA NNP Pharmocological
plus CC None
etoposide NN Pharmocological
( ( Pharmocological
EVAIA NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

diet-controlled JJ Educational
crossover NN Educational
intervention NN Educational
caffeine NN Pharmocological
placebo NN Control
. . None
caffeine NN Pharmocological
-DOCSTART- -X- N

Preservative-free JJ Pharmocological
ocular JJ Pharmocological
hydrating VBG Pharmocological
agents NNS Pharmocological
saline NN Pharmocological
versus IN None
PVP NNP Pharmocological
solution NN Pharmocological
. . None
preservative-free JJ Pharmocological
hydrating VBG Pharmocological
agents NNS Pharmocological
2 CD Pharmocological
% NN Pharmocological
polyvinylpyrrolidone NN Pharmocological
( ( Pharmocological
PVP NNP Pharmocological
) ) Pharmocological
solution NN Pharmocological
with IN None
a DT None
0.9 CD Pharmocological
% NN Pharmocological
NaCl NNP Pharmocological
solution NN Pharmocological
PVP NNP Pharmocological
NaCl NNP Pharmocological
PVP NNP Pharmocological
NaCl NNP Pharmocological
PVP NNP Pharmocological
NaCl NNP Pharmocological
PVP NNP Pharmocological
-DOCSTART- -X- N

DFT NNP Physical
determined VBD Physical
using VBG Physical
biphasic JJ Physical
shocks NNS Physical
VF NNP Physical
-DOCSTART- -X- N

NO-aspirin NNP Pharmocological
( ( Pharmocological
NCX-4016 NNP Pharmocological
) ) Pharmocological
NCX-4016 NNP Pharmocological
NCX-4016 NNP Pharmocological
NCX-4016 NNP Pharmocological
( ( Pharmocological
400 CD Pharmocological
and CC Pharmocological
800 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
) ) Pharmocological
, , None
equimolar JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
aspirin NN Pharmocological
( ( Pharmocological
200 CD Pharmocological
and CC Pharmocological
420 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
) ) None
, , None
or CC None
placebo NN Control
. . None
aspirin NN Pharmocological
-DOCSTART- -X- N

treated VBN Pharmocological
with IN Pharmocological
either DT Pharmocological
medication NN Pharmocological
or CC Pharmocological
trabeculectomy NN Pharmocological
. . None
treated VBN Physical
aggressively RB Physical
in IN Physical
an DT Physical
effort NN Physical
to TO Physical
to TO Physical
a DT Physical
level NN Physical
at IN Physical
or CC Physical
below IN Physical
a DT Physical
predetermined JJ Physical
, , Physical
eye-specific JJ Physical
target NN Physical
pressure NN Physical
. . Physical
Visual JJ Physical
field NN Physical
progression NN Physical
was VBD Physical
analyzed VBN Physical
using VBG Physical
repeated JJ Physical
measures NNS Physical
models NNS Physical
. . None
Initial JJ Surgical
surgery NN Surgical
initial JJ Pharmocological
medicine NN Pharmocological
-DOCSTART- -X- N

Procalcitonin NNP Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
procalcitonin NN None
antibiotic JJ Pharmocological
therapy NN Pharmocological
Procalcitonin NNP Pharmocological
was VBD None
measured VBN None
daily RB None
by IN None
a DT None
semi-quantitative JJ None
immunoassay NN None
in IN None
the DT None
study NN None
group NN None
. . None
2 CD Educational
groups NNS Educational
including VBG Educational
a DT Educational
PCT-guided JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
study VB Pharmocological
group NN Pharmocological
) ) Pharmocological
and CC None
a DT Educational
prophylactic JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
( ( Educational
control VB Educational
group NN Educational
) ) Educational
Antibiotic JJ Pharmocological
therapy NN Pharmocological
in IN None
the DT None
study NN None
group NN None
was VBD None
not RB None
applied VBN None
until IN None
clinical JJ None
signs NNS None
and CC None
symptoms NNS None
of IN None
infection NN None
appeared VBN None
( ( None
PCT NNP None
value NN None
was VBD None
> JJ None
0.5ng/ml CD None
) ) None
antibiotic JJ Pharmocological
therapy NN Pharmocological
Procalcitonin NNP Pharmocological
-DOCSTART- -X- N

Soluble JJ Pharmocological
intercellular JJ Pharmocological
adhesion NN Pharmocological
molecule-1 NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
immunosuppressive JJ Pharmocological
therapy NN Pharmocological
. . None
Soluble JJ None
intercellular JJ None
adhesion NN None
molecule-1 NN None
( ( None
sICAM-1 JJ None
) ) None
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
alone RB Pharmocological
azathioprine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
prednisone NN Pharmocological
and CC Pharmocological
azathioprine NN Pharmocological
, , None
or CC None
placebo NN Control
in IN None
addition NN None
to TO None
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
. . None
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
azathioprine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
. . None
prednisone NN Pharmocological
and CC Pharmocological
azathioprine NN Pharmocological
. . None
-DOCSTART- -X- N

Theory-driven JJ Educational
intervention NN Educational
osteoporosis JJ Educational
education NN Educational
program NN Educational
( ( None
wait-list JJ Educational
control NN Educational
group NN Educational
) ) None
6 CD Educational
weekly JJ Educational
education NN Educational
program NN Educational
sessions NNS Educational
baseline NN Educational
assessment NN Educational
educational JJ Educational
program NN Educational
-DOCSTART- -X- N

intensive JJ Physical
diabetes NNS Physical
management NN Physical
with IN Physical
implantable JJ Physical
pumps NNS Physical
multiple JJ Pharmocological
subcutaneous JJ Pharmocological
injections NNS Pharmocological
intraperitoneal JJ Physical
( ( Physical
IP NNP Physical
) ) Physical
insulin NN Physical
infusion NN Physical
via IN Physical
programmable JJ Physical
implantable JJ Physical
pumps NNS Physical
subcutaneous JJ Pharmocological
( ( Pharmocological
SC NNP Pharmocological
) ) Pharmocological
insulin NN Pharmocological
via IN Pharmocological
multiple JJ Pharmocological
injections NNS Pharmocological
. . None
pump NN Physical
implantable JJ Physical
pump NN Physical
multiple JJ Pharmocological
injections NNS Pharmocological
-DOCSTART- -X- N

dronedarone NN Pharmocological
dronedarone NN Pharmocological
dronedarone NN Pharmocological
. . None
dronedarone NN Pharmocological
placebo NN Pharmocological
or CC None
dronedarone NN Pharmocological
. . None
Dronedarone NNP Pharmocological
placebo NN Control
) ) None
dronedarone NN Pharmocological
placebo NN Control
) ) None
Dronedarone NNP Pharmocological
dronedarone NN Pharmocological
Dronedarone NNP Pharmocological
-DOCSTART- -X- N

soft JJ Physical
contact NN Physical
lenses NNS Physical
rigid JJ Physical
gas NN Physical
permeable NN Physical
( ( Physical
RGP NNP Physical
) ) Physical
lenses VBZ Physical
regular JJ Physical
replacement NN Physical
extended VBN Physical
wear NN Physical
RGP NNP Physical
contact NN Physical
lenses VBZ Physical
. . None
wore NN Physical
extended VBD Physical
wear JJ Physical
Quantum NNP Physical
2 CD Physical
lenses NNS Physical
replaced VBD Physical
lenses NNS Physical
every DT Physical
3 CD Physical
months NNS Physical
not RB Other
scheduled VBN Other
to TO Other
replace VB Other
their PRP$ Other
lenses NNS Other
. . None
-DOCSTART- -X- N

granisetron NNS Pharmocological
perphenazine NN Pharmocological
granisetron NN Pharmocological
perphenazine NN Pharmocological
granisetron NN Pharmocological
perphenazine VB Pharmocological
granisetron NN Pharmocological
perphenazine NN Pharmocological
granisetron NN Pharmocological
perphenazine NN Pharmocological
-DOCSTART- -X- N

Paromomycin NNP Pharmocological
paromomycin NN Pharmocological
paromomycin VB Pharmocological
or CC None
placebo VB Control
paromomycin NN Pharmocological
placebo NNS Control
drug NN Pharmocological
placebo NN Control
Paromomycin NNP Pharmocological
-DOCSTART- -X- N

Oxytocin NNP Pharmocological
neuropeptide JJ Pharmocological
oxytocin NN Pharmocological
placebo-controlled JJ Control
intranasal JJ Pharmocological
oxytocin NN Pharmocological
functional JJ Physical
magnetic JJ Physical
resonance NN Physical
imaging NN Physical
oxytocin NN Pharmocological
neurotypical JJ Control
control NN Control
neuropeptide JJ Pharmocological
oxytocin NN Pharmocological
oxytocin NN Pharmocological
-DOCSTART- -X- N

detection NN Physical
of IN Physical
in IN Physical
novel NN Other
red JJ Other
lesion NN Other
detection NN Other
method NN Other
red JJ Other
lesion NN Other
candidate NN Other
detection NN Other
system NN Other
-DOCSTART- -X- N

esmolol NN Pharmocological
placebo NN Control
Esmolol NNP Pharmocological
vs NN None
Placebo NNP Pharmocological
esmolol NN Pharmocological
placebo NN Control
esmolol NN Pharmocological
placebo NN Control
esmolol VB Pharmocological
esmolol JJ Pharmocological
esmolol JJ Pharmocological
esmolol JJ Pharmocological
esmolol NN Pharmocological
-DOCSTART- -X- N

bendrofluazide NN Pharmocological
, , None
bumetanide NN Pharmocological
and CC None
xipamide NNP Pharmocological
. . None
daily JJ None
dose NN None
of IN None
5 CD Pharmocological
mg NNS Pharmocological
bendrofluazide RB Pharmocological
, , None
1 CD Pharmocological
mg NN Pharmocological
bumetanide NN Pharmocological
and CC None
40 CD Pharmocological
mg NN Pharmocological
xipamide NN Pharmocological
. . None
bumetanide NN Pharmocological
. . None
-DOCSTART- -X- N

adaptive JJ None
low-pass NN None
filtered VBD None
speech JJ None
test NN None
low-pass NN Physical
filtered VBD Physical
speech JJ Physical
test NN Physical
LPFST NNP Physical
The DT Educational
University NNP Educational
of IN Educational
Canterbury NNP Educational
Adaptive NNP Educational
Speech NNP Educational
Test NNP Educational
( ( Educational
UCAST NNP Educational
) ) Educational
platform NN Educational
was VBD Educational
used VBN Educational
to TO Educational
administer VB Educational
a DT Educational
four-alternative JJ Educational
forced-choice JJ Educational
adaptive JJ Educational
test NN Educational
that WDT Educational
altered VBD Educational
a DT Educational
low-pass JJ Educational
filter NN Educational
( ( Educational
LPF NNP Educational
) ) Educational
to TO Educational
track VB Educational
the DT Educational
corner NN Educational
frequency NN Educational
at IN Educational
which WDT Educational
participants NNS Educational
correctly RB Educational
identified VBN Educational
a DT Educational
certain JJ Educational
percentage NN Educational
of IN Educational
the DT Educational
word NN Educational
stimuli NN Educational
. . Educational
UCAST-FW JJ None
-DOCSTART- -X- N

massage NN Physical
combined VBN Physical
Chinese JJ Physical
materia NNS Physical
medica VBP Physical
footbath JJ Physical
fumigation NN Physical
and CC Physical
washing VBG Physical
] NNP None
massage NN Physical
combined VBN Physical
Chinese JJ Physical
materia NNS Physical
medica NN Physical
( ( Physical
CMM NNP Physical
) ) Physical
footbath NN Physical
fumigation NN Physical
and CC Physical
washing NN Physical
massage NN Physical
combined VBN Physical
CMM NNP Physical
footbath JJ Physical
fumigation NN Physical
and CC Physical
washing NN Physical
oral JJ None
administration NN None
of IN None
meloxicam NNS Pharmocological
. . None
Massage NNP Physical
combined VBD Physical
CMM NNP Physical
footbath NN Physical
fumigation NN Physical
and CC Physical
washing NN Physical
-DOCSTART- -X- N

Face NNP Other
composite JJ Other
composite JJ Educational
paradigm NN Educational
. . None
-DOCSTART- -X- N

beclomethasone NN Pharmocological
dipropionate NN Pharmocological
intranasal NN Pharmocological
beclomethasone NN Pharmocological
dipropionate NN Pharmocological
( ( Pharmocological
Bdp NNP Pharmocological
) ) Pharmocological
Bdp NNP Pharmocological
Bdp NNP Pharmocological
. . None
-DOCSTART- -X- N

naproxen NN Pharmocological
naproxen JJ Pharmocological
250-mg JJ Pharmocological
naproxen JJ Pharmocological
tablets NNS Pharmocological
naproxen NN Pharmocological
-DOCSTART- -X- N

angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blockade NN Pharmocological
DASH NNP Pharmocological
diet NN Pharmocological
angiotensin JJ Pharmocological
receptor NN Pharmocological
blockers NNS Pharmocological
( ( Pharmocological
ARB NNP Pharmocological
) ) Pharmocological
DASH NNP Pharmocological
( ( Pharmocological
Dietary NNP Pharmocological
Approaches NNP Pharmocological
to TO Pharmocological
Stop NNP Pharmocological
Hypertension NNP Pharmocological
) ) Pharmocological
diet VBP Pharmocological
control NN Other
diet NN Other
DASH NNP Pharmocological
diet NN Pharmocological
. . None
losartan NN Pharmocological
placebo NN Control
diet NN Other
-DOCSTART- -X- N

Olanzapine NNP Pharmocological
versus NN None
haloperidol NN Pharmocological
neuroleptics NNS Pharmocological
Atypical JJ Pharmocological
neuroleptics NNS Pharmocological
olanzapine NN Pharmocological
haloperidol NN Pharmocological
open JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
olanzapine NN Pharmocological
or CC None
haloperidol NN Pharmocological
. . None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
. . None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
olanzapine NN Pharmocological
olanzapine NN Pharmocological
-DOCSTART- -X- N

cuffed NN Physical
and CC Physical
uncuffed JJ Physical
endotracheal NN Physical
tubes NNS Physical
Uncuffed NNP Physical
endotracheal NN Physical
tubes NNS Physical
cuffed NN Physical
versus NN Physical
uncuffed JJ Physical
endotracheal NN Physical
tubes NNS Physical
cuffed NN Physical
tube NN Physical
sized VBN Physical
by IN Physical
a DT Physical
new JJ Physical
formula NN Physical
uncuffed JJ Physical
tube NN Physical
sized VBN Physical
by IN Physical
the DT Physical
modified JJ Physical
Cole NNP Physical
's POS Physical
formula NN Physical
Cuffed NNP Physical
tubes RB Physical
Uncuffed NNP Physical
tubes RB Physical
cuffed JJ Physical
endotracheal JJ Physical
tubes NNS Physical
cuffed NN Physical
endotracheal VBP Physical
tubes NNS Physical
-DOCSTART- -X- N

Oral JJ Pharmocological
6-mercaptopurine JJ Pharmocological
oral JJ Pharmocological
6-thioguanine JJ Pharmocological
substitution NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
6-thioguanine JJ Pharmocological
( ( Pharmocological
TG NNP Pharmocological
) ) Pharmocological
for IN Pharmocological
6-mercaptopurine JJ Pharmocological
( ( Pharmocological
MP NNP Pharmocological
) ) Pharmocological
and CC None
triple JJ Pharmocological
intrathecal JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
ITT NNP Pharmocological
) ) Pharmocological
for IN Pharmocological
intrathecal JJ Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
IT-MTX NNP Pharmocological
) ) Pharmocological
MP NNP Pharmocological
or CC None
TG NNP Pharmocological
and CC None
IT-MTX NNP Pharmocological
or CC None
ITT NNP Pharmocological
-DOCSTART- -X- N

immune JJ Pharmocological
globulin NN Pharmocological
immune NNS Pharmocological
globulin NN Pharmocological
intravenous JJ Pharmocological
immune JJ Pharmocological
globulin NN Pharmocological
group NN Pharmocological
control NN Control
group NN Control
immune JJ None
globulin NN None
immune JJ Pharmocological
globulin NN Pharmocological
-DOCSTART- -X- N

guided VBN Physical
tissue NN Physical
regeneration NN Physical
( ( Physical
GTR NNP Physical
) ) Physical
radiographs NN Physical
GTR NNP Physical
-DOCSTART- -X- N

Stepping VBG Educational
Stones JJ Educational
Triple NNP Educational
P NNP Educational
group NN Educational
parenting VBG Educational
training NN Educational
-DOCSTART- -X- N

diltiazem NN Pharmocological
and CC Pharmocological
propranolol NN Pharmocological
diltiazem NN Pharmocological
( ( Pharmocological
D NNP Pharmocological
) ) Pharmocological
propranolol NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
D NNP Pharmocological
P NNP Pharmocological
D NNP Pharmocological
P NNP Pharmocological
D. NNP Pharmocological
P NNP Pharmocological
D NNP Pharmocological
P NNP Pharmocological
P NNP Pharmocological
D. NNP Pharmocological
D NNP Pharmocological
P VB Pharmocological
-DOCSTART- -X- N

Amphotericin NNP Pharmocological
pentamidine NN Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
pentamidine JJ Pharmocological
isethionate NN Pharmocological
pentamidine NN Pharmocological
amphotericin JJ Pharmocological
pentamidine VBP Pharmocological
amphotericin NN Pharmocological
Amphotericin NNP Pharmocological
-DOCSTART- -X- N

hyperbaric JJ Physical
oxygen NN Physical
treatment NN Physical
: : None
hyperbaric JJ Physical
oxygen NN Physical
treatment NN Physical
( ( Physical
HBOT NNP Physical
) ) Physical
HBOT NNP Physical
Doppler NNP Physical
imaging NN Physical
Early JJ None
HBOT NNP None
had VBD None
study NN None
. . None
HBOT NNP None
may MD None
-DOCSTART- -X- N

Pregabalin NNP Pharmocological
naltrexone NN Pharmocological
Pregabalin NNP Pharmocological
( ( Pharmocological
PRE NNP Pharmocological
) ) Pharmocological
naltrexone NN Pharmocological
( ( Pharmocological
NAL NNP Pharmocological
) ) Pharmocological
receiving VBG Pharmocological
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
NAL NNP Pharmocological
or CC Pharmocological
150-450 JJ Pharmocological
mg NN Pharmocological
of IN Pharmocological
PRE NNP Pharmocological
. . Pharmocological
NAL NNP Pharmocological
, , Pharmocological
PRE NNP Pharmocological
PRE NNP None
NAL NNP Pharmocological
. . Pharmocological
PRE NNP Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
serotonin2A-dopamine JJ Pharmocological
D2 NNP Pharmocological
antagonist NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
. . None
risperidone NN Pharmocological
placebo NN Control
Risperidone NN Pharmocological
placebo VB Control
placebo NN Control
Risperidone NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

complementary JJ None
radiotherapy NN Physical
combination NN None
chemotherapy NN Physical
modern JJ Physical
combination NN Physical
cycles NNS None
of IN None
alternating VBG None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
procarbazine NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( Pharmocological
COPP NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
doxorubicin JJ Pharmocological
, , None
bleomycin NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
and CC None
dacarbazine NN Pharmocological
( ( Pharmocological
ABVD NNP Pharmocological
) ) Pharmocological
followed VBN None
by IN None
EF NNP Physical
irradiation NN Physical
radiation NN Physical
. . None
polychemotherapy NN Physical
. . None
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
consisting NN Pharmocological
of IN Pharmocological
doxorubicin NN Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
or CC Pharmocological
equal JJ Pharmocological
to TO Pharmocological
550 CD Pharmocological
mg/m2 NN Pharmocological
) ) Pharmocological
, , None
cyclophosphamide RB Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
or CC Pharmocological
equal JJ Pharmocological
to TO Pharmocological
5500 CD Pharmocological
mg/m2 NN Pharmocological
) ) Pharmocological
, , None
and CC None
methotrexate NN Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
or CC Pharmocological
equal JJ Pharmocological
to TO Pharmocological
1000 CD Pharmocological
mg/kg NN Pharmocological
) ) None
chemotherapy NN Pharmocological
no-chemotherapy JJ Control
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
fenofibrate NN Pharmocological
Omega-3 NNP Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
fenofibrate NN Pharmocological
placebo NNS Control
, , None
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
2 CD None
g NN None
fenofibrate VB Pharmocological
160 CD Pharmocological
mg NN Pharmocological
Omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
therapy NN Pharmocological
Fenofibrate NNP Pharmocological
therapy NN Pharmocological
placebo NN Control
and CC None
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
, , None
fenofibrate JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

dopamine NN Pharmocological
dopamine NN Pharmocological
dopamine NN Pharmocological
bumetanide NN Pharmocological
dopamine NN Pharmocological
dopamine NN Pharmocological
-DOCSTART- -X- N

Bevacizumab NNP Pharmocological
plus CC Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
fluorouracil NN Pharmocological
, , Pharmocological
and CC Pharmocological
leucovorin NN Pharmocological
Bevacizumab NNP Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
bolus JJ Pharmocological
fluorouracil NN Pharmocological
, , Pharmocological
and CC Pharmocological
leucovorin NN Pharmocological
( ( Pharmocological
IFL NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
. . Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
bevacizumab NN Pharmocological
fluorouracil-based JJ Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

naftopidil NN Pharmocological
then RB None
50 CD None
mg NN None
of IN None
naftopidil NN Pharmocological
was VBD None
given VBN None
once RB None
a DT None
day NN None
after IN None
breakfast NN None
or CC None
supper NN None
for IN None
8 CD None
weeks NNS None
. . None
Naftopidil NNP Pharmocological
-DOCSTART- -X- N

psychological JJ Psychological
treatment NN Psychological
manual JJ Psychological
assisted VBN Psychological
cognitive-behaviour JJ Psychological
therapy NN Psychological
( ( Psychological
MACT NNP Psychological
) ) Psychological
and CC None
treatment NN Physical
as IN Physical
usual JJ Physical
( ( Physical
TAU NNP Physical
) ) Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
intravenous JJ Pharmocological
immunoglobulin NN Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
intravenously RB Pharmocological
administered VBN Pharmocological
immunoglobulin NN Pharmocological
G. NNP Pharmocological
placebo JJ Control
solution NN Control
or CC None
immunoglobulin NN Pharmocological
Immunomodulatory NNP Pharmocological
treatment NN Pharmocological
immunoglobulin NN Pharmocological
-DOCSTART- -X- N

LEGO NNP Psychological
therapy NN Psychological
social JJ Educational
use NN Educational
of IN Educational
language NN Educational
programme NN Educational
: : None
LEGO NNP Psychological
therapy NN Psychological
Social NNP Educational
Use NNP Educational
of IN Educational
Language NNP Educational
Programme NNP Educational
( ( Educational
SULP NNP Educational
) ) Educational
social JJ Educational
skills NNS Educational
interventions NNS Educational
LEGO NNP Psychological
SULP NNP Educational
. . None
no-intervention JJ Control
control NN Control
group NN Control
LEGO NNP Psychological
no-intervention JJ Control
-DOCSTART- -X- N

usual JJ Physical
pain NN Physical
management NN Physical
( ( Physical
n JJ Physical
= NNP Physical
132 CD Physical
) ) Physical
was VBD Physical
compared VBN Physical
to TO Physical
a DT Physical
multifactorial JJ Physical
strategy NN Physical
( ( Physical
n JJ Physical
= NNP Physical
107 CD Physical
) ) Physical
associating VBG Physical
preliminary JJ Physical
application NN Physical
of IN Physical
an DT Physical
anesthesic JJ Physical
patch NN Physical
, , Physical
preferential JJ Physical
use NN Physical
of IN Physical
specified JJ Physical
vaccines NNS Physical
, , None
child JJ Educational
education NN Educational
by IN Educational
the DT Educational
parents NNS Educational
and CC Educational
the DT Educational
doctor NN Educational
, , Educational
parental JJ Educational
accompaniment NN Educational
and CC Educational
child JJ Educational
distraction NN Educational
with IN Educational
soap NN Educational
bubbles NNS Educational
during IN Educational
the DT Educational
procedure NN Educational
. . None
-DOCSTART- -X- N

bed NN Physical
rest NN Physical
bed NN Physical
rest NN Physical
-DOCSTART- -X- N

[ JJ None
Plasma NNP Pharmocological
separation NN Pharmocological
CVVHF NNP Pharmocological
plasmapheresis NN Physical
in IN Physical
combination NN Physical
with IN Physical
continuous JJ Physical
venovenous JJ Physical
hemofiltration NN Physical
( ( Physical
CVVHF NNP Physical
) ) Physical
-DOCSTART- -X- N

pioglitazone NN Pharmocological
oral JJ Pharmocological
pioglitazone NN Pharmocological
titrated VBD Pharmocological
from IN Pharmocological
15 CD Pharmocological
mg NNS Pharmocological
to TO Pharmocological
45 CD Pharmocological
mg NN Pharmocological
or CC None
matching VBG None
placebo NN Control
in IN Pharmocological
addition NN Pharmocological
to TO Pharmocological
their PRP$ Pharmocological
glucose-lowering JJ Pharmocological
drugs NNS Pharmocological
and CC Pharmocological
other JJ Pharmocological
medications NNS Pharmocological
. . None
-DOCSTART- -X- N

acetaminophen NN Pharmocological
codeine NN Pharmocological
acetaminophen NN Pharmocological
, , Pharmocological
1000 CD Pharmocological
mg NN Pharmocological
, , None
and CC None
codeine NN Pharmocological
, , Pharmocological
60 CD Pharmocological
mg NN Pharmocological
acetaminophen NN Pharmocological
codeine NN None
acetaminophen NN Pharmocological
plus CC Pharmocological
60 CD Pharmocological
mg NN Pharmocological
codeine NN Pharmocological
placebo NN Control
. . Control
acetaminophen NN Pharmocological
codeine NN Pharmocological
placebo NN None
. . None
-DOCSTART- -X- N

5-fluorouracil JJ Pharmocological
( ( Pharmocological
FU NNP Pharmocological
) ) Pharmocological
-based VBD Pharmocological
5-FU/folinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
FA NNP Pharmocological
, , Pharmocological
FUFA NNP Pharmocological
) ) Pharmocological
alone RB Pharmocological
or CC Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
irinotecan JJ Pharmocological
5-fluorouracil/folinic JJ Pharmocological
acid NN Pharmocological
and CC Pharmocological
irinotecan JJ Pharmocological
( ( Pharmocological
FOLFIRI NNP Pharmocological
) ) Pharmocological
stratified VBN Pharmocological
by IN Pharmocological
TS NNP Pharmocological
( ( Pharmocological
low JJ Pharmocological
versus RB Pharmocological
high JJ Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Intraperitoneal NNP Pharmocological
cisplatin NN Pharmocological
First-line NNP Physical
intravenous JJ Physical
chemotherapy NN Physical
four CD Pharmocological
courses NNS Pharmocological
of IN Pharmocological
intraperitoneal NN Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
90 CD Pharmocological
mg/m2 NN Pharmocological
every DT Pharmocological
3 CD Pharmocological
weeks NNS Pharmocological
) ) Pharmocological
or CC None
observation NN Control
. . None
Intraperitoneal NNP Pharmocological
CT NNP Pharmocological
intraperitoneal NN Pharmocological
cisplatin NN Pharmocological
intraperitoneal JJ Pharmocological
CT NNP Pharmocological
-DOCSTART- -X- N

propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
Clonidine NNP Pharmocological
Clonidine NNP Pharmocological
clonidine NN Pharmocological
propofol NN Pharmocological
propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
. . Pharmocological
propofol NN Pharmocological
Nothing NN Control
was VBD Control
administered VBN Control
to TO Control
the DT Control
Control NNP Control
group NN Control
. . Control
Clonidine NNP Pharmocological
Clonidine NNP Pharmocological
propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
Clonidine NNP Pharmocological
Clonidine NNP Pharmocological
propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
clonidine NN Pharmocological
propofol JJ Pharmocological
-DOCSTART- -X- N

pressure- JJ None
and CC None
volume-limited JJ None
full JJ None
face NN None
mask NN None
and CC None
an DT None
artificial JJ None
leak NN None
in IN None
the DT None
ventilatory NN None
circuit NN None
either RB None
without IN None
leakage NN None
( ( None
setting VBG None
I PRP None
) ) None
, , None
with IN None
leakage NN None
during IN None
inspiration NN None
only RB None
( ( None
setting VBG None
II NNP None
) ) None
, , None
and CC None
with IN None
leakage NN None
during IN None
inspiration NN None
and CC None
expiration NN None
( ( None
setting VBG None
III NNP None
) ) None
. . None
-DOCSTART- -X- N

atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
colestimide NN Pharmocological
atorvastatin NN Pharmocological
colestimide NN Pharmocological
atorvastatin NN Pharmocological
. . None
after IN None
20 CD Pharmocological
mg/day JJ Pharmocological
atorvastatin RB Pharmocological
failed VBD None
to TO None
achieve VB None
their PRP$ None
target NN None
level NN None
. . None
atorvastatin NN Pharmocological
colestimide NN Pharmocological
atorvastatin NN Pharmocological
. . None
-DOCSTART- -X- N

computer-controlled JJ Pharmocological
articaine NN Pharmocological
+ NNP Pharmocological
epinephrine NN Pharmocological
delivery NN Pharmocological
: : Pharmocological
intraseptal JJ Pharmocological
anesthesia NN Pharmocological
( ( Pharmocological
ISA NNP Pharmocological
) ) Pharmocological
periodontal JJ Pharmocological
ligament NN Pharmocological
anesthesia NN Pharmocological
( ( Pharmocological
PLA NNP Pharmocological
) ) Pharmocological
articaine NN Pharmocological
epinephrine NN Pharmocological
( ( Pharmocological
Ar NNP Pharmocological
+ NNP Pharmocological
Ep NNP Pharmocological
) ) Pharmocological
computer-controlled JJ Pharmocological
local JJ Pharmocological
anesthetic JJ Pharmocological
delivery NN Pharmocological
system NN Pharmocological
( ( Pharmocological
CCLADS NNP Pharmocological
) ) Pharmocological
. . None
receive VB None
16 CD None
mg NN None
+ VBD None
4 CD None
?g NNP None
, , None
24 CD None
mg NN None
+ VBD None
6 CD None
?g NN None
, , None
and CC None
32 CD None
mg NN None
+ VBD None
8 CD None
?g NN None
of IN None
Ar NNP None
+ NNP None
Ep NNP None
, , None
obtained VBN None
with IN None
different JJ None
volumes NNS None
( ( None
0.4 CD None
, , None
0.6 CD None
, , None
and CC None
0.8 CD None
ml NN None
, , None
respectively RB None
) ) None
, , None
for IN None
the DT None
ISA NNP None
and CC None
PLA NNP None
evaluated VBN None
by IN None
the DT None
the DT None
recorded VBN None
using VBG None
the DT None
ISA NNP None
Ar NNP None
Ep NNP None
-DOCSTART- -X- N

-DOCSTART- -X- N

weight-bearing JJ Physical
versus NN None
nonweight-bearing JJ Physical
exercise NN Physical
weight-bearing NN Physical
( ( Physical
WB NNP Physical
) ) Physical
exercise NN Physical
nonweight-bearing JJ Physical
( ( Physical
NWB NNP Physical
) ) Physical
exercise NN Physical
WB NNP Physical
exercise NN Physical
, , None
NWB NNP Physical
exercise NN Physical
control NN Control
group NN Control
( ( Control
no DT Control
exercise NN Control
) ) Control
. . None
WB NNP Physical
exercise NN Physical
and CC None
NWB NNP Physical
exercise NN Physical
groups NNS Physical
underwent VBD None
8-week JJ Physical
knee NN Physical
extension-flexion NN Physical
exercise NN Physical
program NN Physical
. . None
WB NNP Physical
exercise NN Physical
( ( Physical
WB NNP Physical
NWB NNP Physical
) ) None
NWB NNP Physical
exercise NN Physical
WB NNP Physical
exercise NN Physical
-DOCSTART- -X- N

Stepwise NNP Physical
hook NN Physical
extension NN Physical
technique NN Physical
stepwise NN Physical
hook NN Physical
extension NN Physical
technique NN Physical
for IN Physical
radiofrequency NN Physical
ablation NN Physical
( ( Physical
RFA NNP Physical
) ) Physical
therapy NN Physical
RFA NNP Physical
stepwise NN Physical
hook NN Physical
extension NN Physical
technique NN Physical
full JJ Physical
extension NN Physical
method NN Physical
10-hook JJ Other
electrode NN Other
of IN Other
LeVeen NNP Other
needle NN Other
-DOCSTART- -X- N

RelyX NNP Physical
Unicem NNP Physical
with IN Physical
or CC Physical
without IN Physical
selective JJ Physical
enamel NN Physical
etching VBG Physical
. . None
either CC None
with IN Physical
( ( Physical
RXU+E NNP Physical
) ) Physical
or CC Physical
without IN Physical
( ( Physical
RXU NNP Physical
) ) Physical
selective VBP Physical
enamel JJ Physical
etching NN Physical
. . None
PCC NNP Physical
RXU NNP Physical
PCC NNP Physical
RXU+E NNP Physical
. . None
Cerec NNP Physical
3 CD Physical
system NN Physical
. . None
RXU NN Physical
: : None
RXU+E NN Physical
: : None
( ( None
RXU NNP Physical
) ) None
( ( None
RXU+E NNP Physical
) ) None
RXU NNP Physical
and CC None
RXU+E NNP Physical
RXU NNP Physical
-DOCSTART- -X- N

We PRP Educational
identified VBD Educational
independent JJ Educational
predictors NNS Educational
of IN Educational
beta-blocker NN None
use NN None
-DOCSTART- -X- N

Endurance NNP Physical
physical JJ Physical
activity NN Physical
, , Physical
diet JJ Other
long-term JJ Physical
, , Physical
heavy JJ Physical
exercise NN Physical
14-day JJ Physical
skiing NN Physical
tour NN Physical
through IN Physical
the DT Physical
Swedish JJ Physical
mountains NNS Physical
, , Physical
carrying VBG Physical
a DT Physical
pack NN Physical
load NN Physical
of IN Physical
30 CD Physical
kg NNS Physical
, , Physical
and CC Physical
spending VBG Physical
each DT Physical
night NN Physical
in IN Physical
self-dug JJ Physical
igloos NN Physical
( ( Physical
ambient JJ Physical
temp NN Physical
-10 NN Physical
degrees NNS Physical
to TO Physical
-25 VB Physical
degrees NNS Physical
C NNP Physical
) ) Physical
, , None
and CC None
were VBD None
randomized VBN None
to TO None
2 CD Other
food NN Other
regimens NNS Other
having VBG Other
30 CD Other
or CC Other
40 CD Other
energy NN Other
percent NN Other
of IN Other
fat NN Other
. . None
Individual JJ Educational
records NNS Educational
were VBD Educational
kept VBN Educational
of IN Educational
all DT Educational
consumed VBN Educational
food NN Educational
. . None
was VBD Physical
obtained VBN Physical
before IN Physical
and CC Physical
after IN Physical
1 CD Physical
and CC Physical
2 CD Physical
weeks NNS Physical
of IN Physical
exercise NN Physical
: : Physical
was VBD Physical
assessed VBN Physical
by IN Physical
a DT Physical
10 CD Physical
min NN Physical
venous JJ Physical
occlusion NN Physical
( ( Physical
VO NNP Physical
) ) Physical
test NN Physical
. . None
endurance JJ Physical
physical JJ Physical
activity NN Physical
-DOCSTART- -X- N

behavioral JJ Educational
intervention NN Educational
receive VB Educational
the DT Educational
ESDM NNP Educational
or CC None
referral JJ Other
to TO Other
community NN Other
intervention NN Other
for IN Educational
2 CD Educational
years NNS Educational
. . None
was VBD None
measured VBN None
during IN None
the DT None
presentation NN None
of IN None
faces VBZ None
versus JJ None
objects NNS None
. . None
ESDM NNP Educational
-DOCSTART- -X- N

Stilboestrol NNP Pharmocological
Cyproterone NNP Pharmocological
acetate NN Pharmocological
Medroxyprogesterone NNP Pharmocological
acetate NN Pharmocological
Stilboestrol NNP Pharmocological
Estracyt NNP Pharmocological
Stilboestrol NNP Pharmocological
Adriamycin NNP Pharmocological
Procarbazine NNP Pharmocological
Procarbazine NNP Pharmocological
-DOCSTART- -X- N

methylphenidate NN Pharmocological
treatment NN Pharmocological
psychostimulant JJ None
medication NN None
, , None
combining VBG None
extended-release JJ Pharmocological
methylphenidate NN Pharmocological
( ( Pharmocological
MPH NNP Pharmocological
) ) Pharmocological
in IN Pharmocological
the DT Pharmocological
morning NN Pharmocological
with IN None
immediate-release JJ Pharmocological
MPH NNP Pharmocological
in IN Pharmocological
the DT Pharmocological
afternoon NN Pharmocological
. . None
MPH NNP Pharmocological
MPH NNP Pharmocological
-DOCSTART- -X- N

parent NN Educational
education NN Educational
and CC Educational
skills NNS Educational
training VBG Educational
intervention NN Educational
parent NN Educational
education NN Educational
on IN Educational
parent NN Educational
education NN Educational
and CC Educational
counselling VBG Educational
intervention NN Educational
and CC Educational
a DT Educational
parent NN Educational
education NN Educational
and CC Educational
behaviour JJ Educational
management NN Educational
intervention NN Educational
to TO Educational
control VB Educational
for IN Educational
parent NN Educational
skills NNS Educational
training NN Educational
and CC None
a DT None
control NN Educational
sample NN Educational
. . None
parent VB Educational
education NN Educational
and CC Educational
behaviour JJ Educational
management NN Educational
or CC Educational
parent JJ Educational
education NN Educational
and CC Educational
counselling NN Educational
-DOCSTART- -X- N

naltrexone NN Pharmocological
naltrexone NN Pharmocological
( ( Pharmocological
NTX NNP Pharmocological
) ) Pharmocological
daily JJ None
oral JJ None
dose NN None
of IN None
0.5 CD None
mg/kg/day NN None
was VBD None
contrasted VBN None
with IN None
placebo NN Control
( ( None
PLC NNP None
) ) None
PLC NNP Pharmocological
NTX NNP Pharmocological
NTX NNP Pharmocological
PLC NNP Pharmocological
. . Pharmocological
NTX NNP Pharmocological
-DOCSTART- -X- N

cardiovascular JJ Other
risk NN Other
assessment NN Other
-DOCSTART- -X- N

whey-predominant JJ Pharmocological
, , Pharmocological
50 CD Pharmocological
% NN Pharmocological
medium NN Pharmocological
chain NN Pharmocological
triglyceride IN Pharmocological
formula NN Pharmocological
with IN Pharmocological
relatively RB Pharmocological
high JJ Pharmocological
concentrations NNS Pharmocological
of IN Pharmocological
zinc NN Pharmocological
and CC None
copper NN Pharmocological
12.5 CD Pharmocological
mg/L NN Pharmocological
of IN Pharmocological
zinc NN Pharmocological
0.9 CD Pharmocological
mg/L NN Pharmocological
or CC Pharmocological
2.1 CD Pharmocological
mg/L NN Pharmocological
of IN Pharmocological
copper NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

bupivacaine NN Pharmocological
placebo NN Control
20cc CD None
saline NN Control
without IN Control
bupivacaine NN Control
bupivacaine NN Pharmocological
0.5 CD None
% NN None
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
-DOCSTART- -X- N

Induction NNP Pharmocological
noninduction NN Pharmocological
antithymocyte NN Pharmocological
globulins NNS Pharmocological
( ( Pharmocological
ATG NNP Pharmocological
) ) Pharmocological
tacrolimus JJ Pharmocological
tacrolimus NN Pharmocological
Steroid JJ Pharmocological
boluses NNS Pharmocological
Azathioprine NNP Pharmocological
ATG NNP Pharmocological
-DOCSTART- -X- N

web- JJ Educational
and CC Educational
a DT Educational
print-based JJ Educational
decision NN Educational
aid NN Educational
booklet NN Educational
interactive JJ Educational
website NN Educational
randomized VBN Educational
controlled JJ Educational
trials NNS Educational
( ( Educational
RCTs NNP Educational
) ) Educational
website NN Educational
-DOCSTART- -X- N

Blind NNP Surgical
versus NN Surgical
open JJ Surgical
approach NN Surgical
to TO Surgical
laparoscopic VB Surgical
cholecystectomy NN Surgical
: : Surgical
laparoscopic JJ Surgical
open JJ Surgical
laparoscopic NN Surgical
technique NN Surgical
blind JJ Physical
approach NN Physical
; : None
-DOCSTART- -X- N

pegged JJ Physical
trabecular JJ Physical
metal NN Physical
screw-fixed JJ Physical
pegged JJ Physical
porous JJ Physical
titanium NN Physical
fiber NN Physical
mesh NN Physical
: : None
high-porosity NN Surgical
trabecular JJ Surgical
metal NN Surgical
( ( Surgical
TM NNP Surgical
) ) Surgical
tibial JJ Surgical
components NNS Surgical
low-porosity JJ Surgical
titanium NN Surgical
pegged VBD Surgical
porous JJ Surgical
fiber-metal JJ Surgical
( ( Surgical
Ti NNP Surgical
) ) Surgical
polyethylene NN Surgical
metal JJ Surgical
backings NNS Surgical
. . Surgical
cementless JJ Surgical
tibial JJ Surgical
25 CD Surgical
TM NNP Surgical
tibial JJ Surgical
components NNS Surgical
were VBD Surgical
fixed VBN Surgical
press-fit JJ Surgical
by IN Surgical
2 CD None
hexagonal JJ None
pegs NN None
25 CD Surgical
Ti NNP Surgical
tibial JJ Surgical
components NNS Surgical
were VBD Surgical
fixed VBN Surgical
press-fit JJ Surgical
and CC Surgical
by IN Surgical
4 CD Surgical
supplemental JJ Surgical
screws NNS Surgical
Ti NNP Physical
components NNS None
TM NNP Physical
components NNS None
Ti NNP Physical
components NNS None
TM NNP None
tibial JJ None
components NNS None
Ti NNP Physical
tibial JJ None
components NNS None
TM NNP Physical
tibial JJ None
component NN None
. . None
-DOCSTART- -X- N

propranolol NN Pharmocological
with IN Pharmocological
placebo NN Control
propranolol NN Pharmocological
-DOCSTART- -X- N

Slotted VBN Surgical
versus IN Surgical
non-slotted JJ Surgical
locked JJ Surgical
intramedullary JJ Surgical
nailing NN Surgical
two CD Surgical
slotted VBD Surgical
nails NNS Surgical
, , None
the DT Surgical
Grosse-Kempf NNP Surgical
nail NN Surgical
and CC None
the DT None
AO/ASIF NNP Surgical
universal JJ Surgical
femoral JJ Surgical
nail NN Surgical
non-slotted JJ Physical
Grosse-Kempf NNP Physical
nail NN Physical
and CC None
control NN Physical
bone NN Physical
slotted JJ Surgical
nails NNS Surgical
-DOCSTART- -X- N

Motion NNP Physical
style NN Physical
acupuncture NN Physical
treatment NN Physical
( ( Physical
MSAT NNP Physical
) ) Physical
Motion NNP Physical
style NN Physical
acupuncture NN Physical
treatment NN Physical
( ( Physical
MSAT NNP Physical
) ) Physical
acupuncture NN Physical
group NN None
and CC None
the DT None
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
injection NN Pharmocological
group NN Pharmocological
. . None
MSAT NNP Physical
and CC None
the DT None
NSAID NNP Pharmocological
injection NN Pharmocological
group NN Pharmocological
diclofenac NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

oxandrolone NN Pharmocological
anabolic JJ None
treatment NN None
placebo NN Control
or CC None
oxandrolone NN Pharmocological
-DOCSTART- -X- N

trial-and-error JJ Educational
discrimination NN Educational
task NN Educational
two CD Educational
, , Educational
two-element JJ Educational
stimuli NNS Educational
over-selected JJ Educational
-DOCSTART- -X- N

National NNP Educational
Survey NNP Educational
for IN Educational
Children NNP Educational
's POS Educational
Health NNP Educational
2003-2004 CD Educational
telephone NN Educational
interview NN Educational
. . None
-DOCSTART- -X- N

training NN Educational
strength NN Physical
aerobic JJ Pharmocological
( ( None
serial JJ Physical
CE NNP Physical
integrated VBN Physical
CE NNP Physical
) ) None
CE NNP Educational
program NN Educational
CE NNP Educational
training NN Educational
Integrated VBN Physical
CE NNP Physical
Integrated VBN Physical
CE NNP Physical
-DOCSTART- -X- N

GnRH NNP Pharmocological
agonist NN Pharmocological
treatment NN None
gonadotropin-releasing VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GnRH NNP Pharmocological
) ) Pharmocological
agonists VBZ Pharmocological
Total NNP Surgical
laparoscopic NN Surgical
hysterectomy NN Surgical
for IN Surgical
benign JJ Surgical
pathology NN Surgical
. . None
triptorelin NN Pharmocological
depot NN Pharmocological
GnRH NNP Pharmocological
-DOCSTART- -X- N

remifentanil NN Pharmocological
lidocaine NN Pharmocological
with IN Pharmocological
esmolol NN Pharmocological
. . None
remifentanil NN Pharmocological
lidocaine-esmolol JJ Pharmocological
0.9 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
10 CD Pharmocological
ml NN Pharmocological
and CC Pharmocological
remifentanil VB Pharmocological
1 CD Pharmocological
microg/kg NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
1.5 CD Pharmocological
mg/kg NN Pharmocological
and CC Pharmocological
esmolol $ Pharmocological
1.0 CD Pharmocological
mg/kg NN Pharmocological
. . None
thiopental JJ Pharmocological
sodium NN Pharmocological
rocuronium NN Pharmocological
remifentanil VBZ Pharmocological
lidocaine JJ Pharmocological
esmolol $ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
folic JJ Pharmocological
acid-supplementation NN Pharmocological
folic JJ Pharmocological
acid DT Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
folic JJ Pharmocological
acid-supplementation NN Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
or CC None
placebo NN Control
. . None
placebo NN Control
folic JJ Pharmocological
acid JJ Pharmocological
folic JJ Pharmocological
acid DT Pharmocological
-DOCSTART- -X- N

fenretinide NN Pharmocological
synthetic JJ Pharmocological
retinoid NN Pharmocological
fenretinide NN Pharmocological
fenretinide NN Pharmocological
( ( None
200 CD None
mg NNS None
day NN None
p.o NN None
. . None
for IN None
24 CD None
months NNS None
) ) None
or CC None
no DT Control
intervention NN Control
. . None
fenretinide JJ Pharmocological
-DOCSTART- -X- N

acupuncture NN Physical
oral JJ Physical
care NN Physical
sessions NNS Physical
acupuncture NN Physical
oral JJ Educational
care NN Educational
education NN Educational
acupuncture NN Physical
using VBG Physical
standardised VBN Physical
methods NNS Physical
. . None
Acupuncture NNP Physical
acupuncture NN Other
-DOCSTART- -X- N

levocarnitine NN Pharmocological
L-carnitine NNP Pharmocological
standardized JJ Pharmocological
regimen NN Pharmocological
( ( Pharmocological
50 CD Pharmocological
mg RB Pharmocological
L-carnitine/kg NNP Pharmocological
bodyweight/day NN Pharmocological
) ) Pharmocological
of IN Pharmocological
liquid JJ Pharmocological
L-carnitine NNP Pharmocological
( ( Pharmocological
n=19 NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
( ( Control
n=11 JJ Control
) ) Control
for IN Control
3-months JJ Control
. . Pharmocological
L-carnitine JJ Pharmocological
therapy NN Pharmocological
L-carnitine JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

retention NN Physical
of IN Physical
needles NNS Physical
on IN Physical
head NN Physical
] NN Physical
behavior JJ Educational
training NN Educational
with IN Educational
head NN Educational
needling VBG Educational
retention NN Educational
and CC Educational
behavior NN Educational
training NN Educational
after IN Educational
acupuncture NN Educational
head NN Educational
needling VBG Educational
retention NN Educational
and CC Educational
behavior JJ Educational
training NN Educational
group NN Educational
behavior JJ Educational
training NN Educational
after IN Educational
acupuncture NN Educational
treatment NN Educational
group NN Educational
Retention NNP Physical
needles NNS Physical
behavior JJ Educational
training NN Educational
. . Educational
behavior JJ Educational
training NN Educational
behavior JJ Educational
training NN Educational
behavior JJ None
training NN None
after IN None
acupuncture NN None
-DOCSTART- -X- N

Angio-Seal NNP Physical
( ( Physical
AS NNP Physical
) ) Physical
and CC None
StarClose NNP Physical
( ( Physical
SC NNP Physical
) ) Physical
and CC None
manual JJ Physical
compression NN Physical
( ( Physical
MC NNP Physical
) ) Physical
In IN None
a DT None
prospective JJ None
trial NN None
were VBD None
randomized VBN None
to TO None
AS NNP Physical
, , None
SC NNP Physical
, , None
or CC None
MC NNP Physical
. . None
Patients NNS None
were VBD None
mobilized VBN None
1 CD None
to TO None
2 CD None
hr NN None
after IN None
device NN None
placement NN None
, , None
and CC None
6 CD None
hr NN None
after IN None
MC NNP Physical
. . None
-DOCSTART- -X- N

cognitive JJ Educational
behavioral JJ Educational
therapy NN Educational
CBT NNP Educational
CBT NNP Educational
randomly RB None
assigned VBN None
to TO None
an DT None
immediate JJ Educational
treatment NN Educational
( ( Educational
IT NNP Educational
; : None
n JJ None
= NNP None
17 CD None
) ) None
or CC None
3-month JJ None
waitlist NN None
( ( None
WL NNP None
; : None
n CC None
= VB None
23 CD None
) ) None
condition NN None
. . None
-DOCSTART- -X- N

A DT None
simulation NN Educational
design NN Educational
randomly RB None
assigned VBN Educational
to TO Educational
the DT Educational
simulating NN Educational
and CC None
control NN Control
groups NNS Control
. . None
The DT None
simulation NN None
group NN None
was VBD None
directed VBN Educational
to TO Educational
imitate VB Educational
a DT Educational
person NN Educational
with IN Educational
a DT Educational
memory NN Educational
impairment NN Educational
. . None
-DOCSTART- -X- N

Cyproheptadine NN Pharmocological
placebo-controlled JJ Control
cyproheptadine NN Pharmocological
, , None
a DT None
5-HT2 JJ Pharmocological
antagonist NN Pharmocological
placebo-controlled JJ Control
cyproheptadine NN Pharmocological
plus CC Pharmocological
haloperidol NN Pharmocological
cyproheptadine VB Pharmocological
+ NNP Pharmocological
haloperidol NN Pharmocological
haloperidol JJ Physical
+ JJ Control
placebo NN Control
haloperidol NN Pharmocological
and CC Pharmocological
cyproheptadine NN Pharmocological
cyproheptadine NN Pharmocological
. . None
cyproheptadine NN Pharmocological
with IN None
a DT None
conventional JJ Pharmocological
antipsychotic JJ Pharmocological
conventional JJ Control
antipsychotic JJ Control
alone NN Control
-DOCSTART- -X- N

parent NN Educational
training NN Educational
intervention NN Educational
parent NN Educational
training NN Educational
intervention NN Educational
CHAT NNP None
screen NN None
and CC None
randomised VBD None
to TO None
the DT None
parent NN Educational
training VBG Educational
group NN None
or CC None
to TO None
local JJ Control
services NNS Control
only RB Control
. . None
home-based JJ Educational
behavioural JJ Educational
intervention NN Educational
-DOCSTART- -X- N

monophasic JJ Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
containing VBG None
gestodene NN Pharmocological
or CC None
desogestrel NN Pharmocological
OC NNP Pharmocological
gestodene NN Pharmocological
( ( Pharmocological
GTD NNP Pharmocological
) ) Pharmocological
ethinyl VBP Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
EE NNP Pharmocological
) ) Pharmocological
OC NNP Pharmocological
desogestrel NN Pharmocological
( ( Pharmocological
DSG NNP Pharmocological
) ) Pharmocological
EE NNP None
. . None
OC NNP Pharmocological
-DOCSTART- -X- N

concurrent JJ Pharmocological
chemoradiotherapy NN Pharmocological
radiotherapy NN Pharmocological
concurrent JJ Pharmocological
chemoradiotherapy NN Pharmocological
( ( Pharmocological
CCRT NNP Pharmocological
) ) Pharmocological
radiotherapy NN Pharmocological
( ( Pharmocological
RT NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
cisplatin NN Pharmocological
fluorouracil JJ Pharmocological
CCRT NNP Pharmocological
RT-alone NNP Pharmocological
CCRT NNP Pharmocological
RT-only JJ Pharmocological
CCRT NNP Pharmocological
RT-only JJ Pharmocological
CCRT NNP Pharmocological
CCRT NNP Pharmocological
RT VB Pharmocological
-DOCSTART- -X- N

joint JJ Educational
attention NN Educational
or CC Educational
symbolic JJ Educational
play NN Educational
-DOCSTART- -X- N

intravenous JJ Pharmocological
yohimbine NN Pharmocological
yohimbine NN Pharmocological
or CC None
normal JJ Pharmocological
saline NN Pharmocological
yohimbine JJ Pharmocological
-DOCSTART- -X- N

telmisartan NN Pharmocological
and CC None
enalapril NN Pharmocological
telmisartan NN Pharmocological
enalapril NN Pharmocological
telmisartan NN Pharmocological
at IN Pharmocological
80 CD Pharmocological
mg NNS Pharmocological
day NN Pharmocological
( ( Pharmocological
-1 NN Pharmocological
) ) Pharmocological
enalapril VBN Pharmocological
at IN Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
day NN Pharmocological
( ( Pharmocological
-1 NN Pharmocological
) ) Pharmocological
telmisartan NN Pharmocological
enalapril NN Pharmocological
telmisartan JJ Pharmocological
enalapril VB Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

self-inflation NN Physical
of IN Physical
the DT Physical
cuff NN Physical
just RB Physical
wearing VBG Physical
the DT Physical
inflated JJ Physical
cuff NN Physical
Inflating VBG Physical
the DT Physical
cuff NN Physical
inflated JJ Physical
cuff NN Physical
cuff NN Physical
inflation NN Physical
-DOCSTART- -X- N

serial JJ Physical
CPAP NNP Physical
therapy NN Physical
or CC None
high-flow JJ Control
face NN Control
mask NN Control
oxygen NN Control
therapy NN Control
without IN Control
CPAP NNP Control
( ( Control
control NN Control
) ) Control
-DOCSTART- -X- N

budesonide NN None
( ( None
Pulmicort? NNP None
Turbuhaler NNP None
) ) None
inhaled JJ None
budesonide NN None
nebulised JJ None
budesonide NN None
or CC None
saline NN None
. . None
Budesonide NNP None
the DT None
budesonide NN None
Budesonide NNP None
budesonide NN None
may MD None
-DOCSTART- -X- N

Dexamethasone NN Pharmocological
dexamethasone NN Pharmocological
with IN Pharmocological
0.5 CD Pharmocological
mg/kg NNS Pharmocological
placebo NN Control
salbutamol NN Pharmocological
-DOCSTART- -X- N

Basics NNS None
computer-assisted JJ Educational
intervention NN Educational
Computer NNP Educational
Assisted NNP Educational
Instruction NNP Educational
( ( Educational
CAI NNP Educational
) ) Educational
CAI NNP Educational
TeachTown NN Educational
: : Educational
Basics NNS Educational
, , Educational
a DT Educational
CAI NNP Educational
program NN Educational
which WDT Educational
also RB Educational
includes VBZ Educational
supplementary JJ Educational
off-computer NN Educational
activities NNS Educational
computer NN Educational
20 CD Educational
minutes NNS Educational
per IN Educational
day NN Educational
in IN Educational
supplementary JJ Educational
TeachTown NN Educational
: : Educational
Basics JJ Educational
activities NNS Educational
. . Educational
CAI NNP Other
CAI NNP Educational
-DOCSTART- -X- N

Moisture-vapour-permeable JJ Physical
film NN Physical
moisture-vapour-permeable JJ Physical
film NN Physical
( ( Physical
MVPF NNP Physical
) ) Physical
silver NN Pharmocological
sulphadiazine NN Pharmocological
MVPF NNP Physical
silver JJ Pharmocological
sulphadiazine NN Pharmocological
MVPF NNP Physical
MVPF NNP Physical
silver VB Pharmocological
sulphadiazine NN Pharmocological
. . None
-DOCSTART- -X- N

nanocrystalline JJ Pharmocological
hydroxyapatite JJ Pharmocological
paste NN Pharmocological
nanocrystalline NN Pharmocological
hydroxyapatite NN Pharmocological
( ( Pharmocological
nano-HA JJ Pharmocological
) ) Pharmocological
bone NN Pharmocological
graft NN Pharmocological
substitute NN Pharmocological
. . None
were VBD None
randomly RB None
selected VBN None
to TO None
receive VB None
nano-HA JJ None
paste NN None
in IN None
conjunction NN None
with IN None
papilla NN None
preservation NN None
flaps NNS None
or CC None
papilla NN None
preservation NN None
flaps NNS None
a DT None
customized JJ None
acrylic JJ None
stent NN None
measured VBN None
at IN None
baseline NN None
and CC None
again RB None
6 CD None
months NNS None
following VBG None
surgery NN None
. . None
with IN None
nano-HA JJ None
paste NN None
showed VBD None
with IN None
papilla NN None
preservation NN None
flap NN None
surgery NN None
-DOCSTART- -X- N

dietary JJ Pharmocological
threonine NN Pharmocological
and CC None
purified JJ Pharmocological
fiber NN Pharmocological
supplemental JJ Pharmocological
dietary JJ Pharmocological
Thr NNP Pharmocological
and CC None
purified VBD Pharmocological
fiber NN Pharmocological
Thr-deficient JJ Pharmocological
basal NN Pharmocological
70 CD Control
g/kg NN Control
of IN Control
silica NN Control
sand NN Control
( ( Control
control NN Control
) ) Control
or CC None
high-methoxy JJ Pharmocological
pectin NN Pharmocological
and CC Pharmocological
1 CD Pharmocological
of IN Pharmocological
2 CD Pharmocological
concentrations NNS Pharmocological
of IN Pharmocological
Thr NNP Pharmocological
0.5 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
distilled JJ Pharmocological
water NN Pharmocological
or CC None
an DT None
acute JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
Eimeria NNP Pharmocological
maxima NNP Pharmocological
infection NN None
or CC None
Thr NNP None
supplementation NN None
for IN None
-DOCSTART- -X- N

-DOCSTART- -X- N

enoxaparin NN Pharmocological
warfarin NN Pharmocological
. . Pharmocological
fixed-dose JJ Pharmocological
enoxaparin NN Pharmocological
adjusted VBD Pharmocological
dose JJ Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg NN Pharmocological
subcutaneously RB Pharmocological
every DT Pharmocological
12 CD Pharmocological
hours NNS Pharmocological
) ) Pharmocological
or CC Pharmocological
adjusted-dose JJ Pharmocological
warfarin NN Pharmocological
( ( Pharmocological
international JJ Pharmocological
normalized VBN Pharmocological
ratio NN Pharmocological
, , Pharmocological
2.0 CD Pharmocological
to TO Pharmocological
3.0 CD Pharmocological
) ) Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
warfarin NN Pharmocological
-DOCSTART- -X- N

transbronchial JJ Surgical
needle JJ Surgical
aspiration NN Surgical
endobronchial JJ Surgical
ultrasonography NN Surgical
( ( Surgical
EBUS NNP Surgical
) ) Surgical
-guided VBD Surgical
transbronchial JJ Surgical
needle JJ Surgical
aspiration NN Surgical
( ( Surgical
TBNA NNP Surgical
) ) Surgical
transbronchial JJ Physical
biopsy NN Physical
-DOCSTART- -X- N

tocilizumab NN Pharmocological
tocilizumab NN Pharmocological
tocilizumab JJ Pharmocological
tocilizumab NN Pharmocological
placebo NN Control
tocilizumab-treated JJ Pharmocological
patients NNS None
infliximab JJ None
tocilizumab JJ None
treatment NN None
lower JJR None
. . None
Tocilizumab-treated JJ None
patients NNS None
reduced VBN None
by IN None
tocilizumab NN Pharmocological
treatment NN None
tocilizumab NNS None
were VBD None
-DOCSTART- -X- N

bexarotene NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
psoralen-ultraviolet NN Physical
A NNP Physical
( ( Pharmocological
PUVA NNP Pharmocological
) ) Pharmocological
compared VBN None
with IN None
PUVA NNP Physical
treatment NN Physical
alone RB Physical
Psoralen NNP Physical
plus CC Physical
ultraviolet VB Physical
A NNP Physical
( ( Physical
PUVA NNP Physical
) ) Physical
combined VBN None
bexarotene NN None
( ( None
Targretin NNP None
( ( None
? . None
) ) None
) ) None
and CC None
PUVA NNP None
vs. FW None
PUVA NNP None
alone RB None
PUVA NNP None
arm NN None
the DT None
PUVA-alone JJ None
arm NN None
. . None
for IN None
PUVA NNP None
alone RB None
for IN None
PUVA NNP None
vs. FW None
received VBD None
PUVA NNP None
alone RB None
received VBN None
fewer JJR None
PUVA NNP None
with IN None
the DT None
PUVA NNP None
arm NN None
UVA NNP None
the DT None
PUVA NNP None
( ( None
PUVA NNP None
+ NNP None
bexarotene NN None
) ) None
but CC None
-DOCSTART- -X- N

interferon-omega JJ Pharmocological
antiviral JJ Pharmocological
therapies NNS Pharmocological
recombinant JJ Pharmocological
feline NN Pharmocological
interferon NN Pharmocological
( ( Pharmocological
type JJ Pharmocological
omega NN Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
IFN NNP Pharmocological
) ) None
rFeIFN-omega JJ Pharmocological
placebo NN Control
saline NN Pharmocological
rFeIFN-omega JJ Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Rye NNP Pharmocological
bran NN Pharmocological
bread NN Pharmocological
intake VB Pharmocological
Rye NNP Pharmocological
bread NN Pharmocological
rye NN Pharmocological
bran NN Pharmocological
breads NNS Pharmocological
control NN Control
breads VBZ Control
Rye NNP Educational
bran NN Educational
intervention NN Educational
-DOCSTART- -X- N

randomized VBN None
to TO None
one CD None
of IN None
two CD None
groups NNS None
: : None
group NN None
1 CD None
, , None
forced VBN Pharmocological
diuresis NN Pharmocological
and CC None
chemotherapy NN Pharmocological
( ( None
10 CD None
patients NNS None
) ) None
, , None
and CC None
group NN None
2 CD None
, , None
forced VBN Pharmocological
diuresis NN Pharmocological
, , None
chemotherapy NN Pharmocological
, , None
and CC None
plasmapheresis NN Physical
( ( None
11 CD None
patients NNS None
) ) None
. . None
-DOCSTART- -X- N

Behavioral NNP Psychological
Family NNP Psychological
Systems NNP Psychological
Therapy NNP Psychological
Behavioral NNP Psychological
Family NNP Psychological
Systems NNP Psychological
Therapy NNP Psychological
for IN Psychological
Diabetes NNP Psychological
( ( Psychological
BFST-D NNP Psychological
) ) Psychological
intervention NN Psychological
standard VB Educational
care NN Educational
( ( Educational
SC NNP Educational
) ) Educational
or CC Educational
to TO Educational
6 CD Educational
months NNS Educational
of IN Educational
an DT Educational
educational JJ Educational
support NN Educational
group NN Educational
( ( Educational
ES NNP Educational
) ) Educational
or CC Educational
BFST-D. JJ Educational
BFST-D NNP Psychological
BFST-D NNP Educational
BFST-D NNP Educational
-DOCSTART- -X- N

thumb NN Physical
be VB Physical
immobilised VBN Physical
Immobilisation NN Physical
of IN Physical
the DT Physical
thumb NN Physical
forearm JJ Physical
gauntlet NN Physical
( ( Physical
Colles NNP Physical
' POS Physical
) ) Physical
cast NN Physical
conventional JJ Physical
'scaphoid NN Physical
' '' Physical
plaster NN Physical
incorporating VBG Physical
the DT Physical
thumb NN Physical
as RB Physical
far RB Physical
as IN Physical
its PRP$ Physical
interphalangeal NN Physical
joint NN Physical
. . None
-DOCSTART- -X- N

An DT None
rating NN Physical
method NN Physical
checklist NN Other
containing VBG Educational
-DOCSTART- -X- N

Relaxation NN Educational
and CC Educational
imagery NN Educational
and CC Educational
cognitive-behavioral JJ Educational
training NN Educational
-DOCSTART- -X- N

Qigong JJ Physical
massage NN Physical
treatment NN Physical
Qigong NNP Other
Sensory NNP Other
Training NNP Other
( ( Other
QST NNP Other
) ) Other
qigong JJ Physical
massage NN Physical
intervention NN Physical
-DOCSTART- -X- N

Amiodarone NNP Pharmocological
versus NN Pharmocological
digoxin NN Pharmocological
and CC None
metoprolol NN Pharmocological
combination NN Pharmocological
amiodarone NN Pharmocological
versus NN Pharmocological
digoxin NN Pharmocological
and CC None
metoprolol JJ Pharmocological
combination NN Pharmocological
metoprolol $ Pharmocological
100 CD Pharmocological
mg/24 NN Pharmocological
h NN Pharmocological
per IN Pharmocological
oral JJ Pharmocological
digoxin NN Pharmocological
intravenously RB Pharmocological
on IN Pharmocological
the DT Pharmocological
operating NN Pharmocological
day NN Pharmocological
and CC None
digoxin NN Pharmocological
0.25 CD Pharmocological
mg NN Pharmocological
P.O.+metoprolol NNP Pharmocological
100 CD Pharmocological
mg NN Pharmocological
P.O NNP Pharmocological
. . Pharmocological
amiodarone NN Pharmocological
amiodarone NN Pharmocological
control NN Control
group NN Control
-DOCSTART- -X- N

simvastatin NN Pharmocological
simvastatin JJ Pharmocological
simvastatin NN Pharmocological
placebo NN Control
Simvastatin NNP Pharmocological
placebo VB Control
statin NN None
-DOCSTART- -X- N

Ambulatory NNP Surgical
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
: : None
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
. . None
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
compression NN Physical
sclerotherapy NN Physical
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
therapy NN Physical
. . None
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
-DOCSTART- -X- N

delayed JJ Surgical
cord NN Surgical
clamping VBG Surgical
immediate JJ Surgical
cord NN Surgical
clamping NN Surgical
cord NN Surgical
clamping VBG Surgical
delayed VBN Surgical
till JJ Surgical
descent NN Surgical
of IN Surgical
placenta NN Surgical
into IN Surgical
vagina NN Surgical
delayed JJ Surgical
clamping NN Surgical
early JJ Surgical
clamping NN Surgical
delayed JJ Surgical
clamping NN Surgical
early JJ Surgical
clamping NN Surgical
delayed JJ Surgical
clamping NN Surgical
delaying VBG Surgical
cord NN Surgical
clamping NN Surgical
-DOCSTART- -X- N

adjuvant VB Physical
therapy NN Physical
. . None
postoperative JJ Physical
radiotherapy NN Physical
with IN Pharmocological
50 CD Pharmocological
Gy NNP Pharmocological
cytotoxic JJ Pharmocological
therapy NN Pharmocological
( ( None
cyclophosphamide NN Pharmocological
, , Pharmocological
methotrexate NN Pharmocological
, , Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
) ) None
tamoxifen NN Pharmocological
. . None
Cytotoxic NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

parent-implemented JJ Educational
imitation NN Educational
intervention NN Educational
Reciprocal JJ Educational
imitation NN Educational
training NN Educational
( ( Educational
RIT NNP Educational
) ) Educational
is VBZ None
a DT None
naturalistic JJ None
imitation NN None
intervention NN None
RIT NNP Educational
RIT NNP Educational
RIT NNP Educational
RIT NNP Educational
-DOCSTART- -X- N

laryngeal NN Physical
methylene NN Pharmocological
blue JJ Pharmocological
capsule NN Pharmocological
-DOCSTART- -X- N

Risperidone NNP Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
) ) None
Risperidone CD Pharmocological
-DOCSTART- -X- N

anthelmintic JJ Pharmocological
treatment NN Pharmocological
Enzyme-linked JJ Pharmocological
immunosorbent NN Pharmocological
assays NNS Pharmocological
-DOCSTART- -X- N

Parecoxib NNP Pharmocological
placebo-controlled JJ Control
parecoxib NN Pharmocological
40 CD Pharmocological
mg NN Pharmocological
Remifentanil NNP Pharmocological
i.v NN None
. . None
morphine NN Pharmocological
i.m NN None
. . None
morphine VB Pharmocological
5 CD Pharmocological
mg NNS Pharmocological
acetaminophen NN Pharmocological
Morphine NNP Pharmocological
-DOCSTART- -X- N

unpaced JJ Physical
finger NN Physical
tapping NN Physical
synchronization-continuation NN Psychological
task NN Psychological
with IN Psychological
intertap JJ Psychological
intervals NNS Psychological
( ( Psychological
ITI NNP Psychological
) ) Psychological
-DOCSTART- -X- N

atenolol NN Pharmocological
atenolol NN Pharmocological
placebo NN Control
. . None
Atenolol NNP Pharmocological
-DOCSTART- -X- N

choice NN Educational
assessment NN Educational
A DT Educational
choice NN Educational
assessment NN Educational
choice NN Educational
assessment NN Educational
concurrent NN Educational
operants VBZ Educational
paradigm JJ Educational
. . None
choice NN Educational
assessment NN Educational
-DOCSTART- -X- N

behavioral JJ Educational
intervention NN Educational
project NN Educational
. . None
web-based JJ Educational
communication NN Educational
and CC Educational
support NN Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

water NN Pharmocological
, , Pharmocological
lavender NN Pharmocological
, , Pharmocological
or CC Pharmocological
rosemary JJ Pharmocological
scent NN Pharmocological
-DOCSTART- -X- N

indobufen NN Pharmocological
( ( Pharmocological
K NNP Pharmocological
3920 CD Pharmocological
) ) Pharmocological
. . Pharmocological
indobufen NN Pharmocological
indobufen NN Pharmocological
Indobufen NNP Pharmocological
-DOCSTART- -X- N

terfenadine NN Pharmocological
placebo NN Control
terfenadine NN Pharmocological
placebo NN Control
reference NN Pharmocological
drug NN Pharmocological
placebo NN Control
Terfenadine NNP Pharmocological
-DOCSTART- -X- N

formoterol NN Pharmocological
, , None
salmeterol NN Pharmocological
or CC None
oxitropium NN Pharmocological
bromide NN Pharmocological
formoterol NN Pharmocological
, , None
oxitropium NN Pharmocological
bromide NN Pharmocological
, , None
or CC None
salmeterol NN Pharmocological
received VBD None
24 CD Pharmocological
microg NNS Pharmocological
formoterol NN Pharmocological
, , None
50 CD Pharmocological
microg NN Pharmocological
salmeterol NN Pharmocological
, , None
200 CD Pharmocological
microg NN Pharmocological
oxitropium NN Pharmocological
bromide NN Pharmocological
, , None
or CC None
placebo VB Control
on IN None
four CD None
non-consecutive JJ None
days NNS None
. . None
Spirometric JJ Physical
testing NN Physical
constructed VBN Pharmocological
using VBG Pharmocological
doses NNS Pharmocological
of IN Pharmocological
100 CD Pharmocological
, , Pharmocological
100 CD Pharmocological
, , Pharmocological
200 CD Pharmocological
microg NN Pharmocological
and CC Pharmocological
400 CD Pharmocological
microg NN Pharmocological
-- : Pharmocological
that WDT Pharmocological
is VBZ Pharmocological
, , Pharmocological
a DT Pharmocological
total JJ Pharmocological
cumulative JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
800 CD Pharmocological
microg NN Pharmocological
. . None
Formoterol NNP Pharmocological
, , None
salmeterol NN Pharmocological
oxitropium NN Pharmocological
bromide RB Pharmocological
placebo NN Control
placebo $ Control
formoterol NN Pharmocological
salmeterol NN Pharmocological
oxitropium NN Pharmocological
bromide IN Pharmocological
placebo NN Control
: : None
formoterol NN Pharmocological
: : None
salmeterol NN Pharmocological
: : None
oxitropium JJ Pharmocological
bromide NN Pharmocological
: : None
formoterol NN Pharmocological
, , None
salmeterol NN Pharmocological
, , None
or CC None
oxitropium NN Pharmocological
bromide NN Pharmocological
placebo NN Control
. . None
formoterol NN Pharmocological
, , None
salmeterol NN Pharmocological
, , None
or CC None
oxitropium JJ Pharmocological
bromide NN Pharmocological
salbutamol NN Pharmocological
-DOCSTART- -X- N

Ropivacaine NNP Pharmocological
lidocaine NN Pharmocological
Ropivacaine NNP Pharmocological
2.5 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
0.75 CD Pharmocological
% NN Pharmocological
ropivacaine JJ Pharmocological
solution NN Pharmocological
and CC None
2.5 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine JJ Pharmocological
solution NN Pharmocological
. . None
ropivacaine NN Pharmocological
lidocaine NN Pharmocological
Lidocaine NNP Pharmocological
Ropivacaine NNP Pharmocological
lidocaine NN Pharmocological
ropivacaine NN Pharmocological
Ropivacaine NNP Pharmocological
-DOCSTART- -X- N

zidovudine NN Pharmocological
didanosine NN Pharmocological
. . None
zidovudine NN Pharmocological
and CC None
didanosine NN Pharmocological
zidovudine NN Pharmocological
didanosine NN Pharmocological
zidovudine NN Pharmocological
didanosine JJ Pharmocological
zidovudine NN Pharmocological
didanosine JJ Pharmocological
zidovudine NN Pharmocological
didanosine JJ Pharmocological
-DOCSTART- -X- N

Antihistamines NNS Pharmocological
antihistamines NNS Pharmocological
( ( Pharmocological
AHs NNP Pharmocological
) ) Pharmocological
. . None
autologous JJ Pharmocological
serum NN Pharmocological
( ( Pharmocological
AS IN Pharmocological
) ) Pharmocological
histamine NN Pharmocological
increased VBD None
their PRP$ None
daily JJ None
dose NN None
fexofenadine NN Pharmocological
histamine-induced JJ Pharmocological
fexofenadine NN Pharmocological
fourfold JJ None
AH NNP None
0.037 CD None
) ) None
. . None
AHs NNP None
-DOCSTART- -X- N

melphalan NN Pharmocological
and CC Pharmocological
cis-platinum JJ Pharmocological
hexamethylmelamine NN Pharmocological
, , Pharmocological
adriamycin NN Pharmocological
, , Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
hexamethylmelamine NN Pharmocological
, , Pharmocological
Adriamycin NNP Pharmocological
, , Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
HAC NNP Pharmocological
) ) Pharmocological
to TO None
a DT None
combination NN Pharmocological
of IN Pharmocological
melphalan NN Pharmocological
and CC Pharmocological
cis-platinum NN Pharmocological
. . None
HAC NNP Pharmocological
melphalan-platinum JJ Pharmocological
( ( None
HAC NNP Pharmocological
melphalan-platinum JJ Pharmocological
melphalan-platinum JJ Pharmocological
-DOCSTART- -X- N

Heparin NNP Pharmocological
therapy NN Pharmocological
intermittent NN Pharmocological
or CC Pharmocological
continuous JJ Pharmocological
intravenous JJ Pharmocological
heparin NN Pharmocological
therapy NN Pharmocological
. . None
continuous JJ Pharmocological
heparin NN Pharmocological
therapy NN Pharmocological
. . None
administration NN Pharmocological
of IN Pharmocological
heparin NN Pharmocological
conventional JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
or CC None
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
risperidone NN Pharmocological
Risperidone NNP Pharmocological
-DOCSTART- -X- N

lamivudine VB Pharmocological
. . None
lamivudine NN Pharmocological
lamivudine NN Pharmocological
-DOCSTART- -X- N

active JJ None
symptom NNS None
control NN None
regular JJ None
follow-up NN None
in IN None
a DT None
specialist NN None
clinic NN None
; : None
( ( None
2 CD None
) ) None
structured VBD None
assessments NNS None
of IN None
physical JJ None
, , None
psychological JJ None
and CC None
social JJ None
problems NNS None
with IN None
appropriate JJ None
action NN None
; : None
( ( None
3 CD None
) ) None
rapid JJ None
involvement NN None
of IN None
additional JJ None
specialists NNS None
; : None
and CC None
( ( None
4 CD None
) ) None
parallel NN None
nursing VBG None
support NN None
. . None
ASC NNP Other
alone RB Other
, , None
( ( None
2 CD None
) ) None
ASC NNP Pharmocological
plus CC Pharmocological
mitomycin JJ Pharmocological
vinblastine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
MVP NNP Pharmocological
) ) Pharmocological
, , None
and CC None
( ( None
3 CD None
) ) None
ASC NNP Pharmocological
plus CC Pharmocological
vinorelbine NN Pharmocological
-DOCSTART- -X- N

anticoagulant NN None
treatment NN None
warfarin NN Pharmocological
placebo-controlled JJ Control
warfarin JJ Pharmocological
placebo NN Control
warfarin NN Pharmocological
warfarin-treated JJ Pharmocological
warfarin NN Pharmocological
placebo NN Control
warfarin NN Pharmocological
anticoagulant JJ None
therapy NN None
-DOCSTART- -X- N

Activator NNP Pharmocological
protein-1 NN Pharmocological
( ( Pharmocological
AP-1 NNP Pharmocological
) ) Pharmocological
AP-1 NNP Pharmocological
( ( Pharmocological
activator IN Pharmocological
protein-1 NN Pharmocological
) ) Pharmocological
AP-1 NNP Pharmocological
activation NN Pharmocological
AP-1 NNP Pharmocological
inhibition NN Pharmocological
AP-1 JJ Pharmocological
activation NN Pharmocological
28 CD None
days NNS None
doxycycline NN None
or CC None
placebo NN None
the DT None
doxycycline NN None
intervention NN None
characterize VB None
AP-1 NNP None
as IN None
-DOCSTART- -X- N

predictive JJ Educational
model NN Educational
-DOCSTART- -X- N

Mind NNP Educational
training NN Educational
Theory NN Educational
of IN Educational
Mind NNP Educational
( ( Educational
ToM NNP Educational
) ) Educational
treatments NNS Educational
. . None
ToM NNP Educational
treatment NN Educational
-DOCSTART- -X- N

percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
-DOCSTART- -X- N

Beliefs NNP Educational
belief JJ Educational
basis NN Educational
of IN Educational
the DT Educational
theory NN Educational
of IN Educational
planned VBN Educational
behavior NN Educational
( ( Educational
TPB NNP Educational
) ) Educational
targeting VBG Educational
different JJ Educational
beliefs NNS Educational
messages NNS Educational
-DOCSTART- -X- N

fenoterol NN Pharmocological
fenoterol NN Pharmocological
fenoterol NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
a DT None
placebo NN Pharmocological
fenoterol NN Pharmocological
fenoterol NN Pharmocological
-DOCSTART- -X- N

The DT None
interstimulus JJ Physical
interval NN Physical
( ( Physical
ISI NNP Physical
) ) Physical
, , None
or CC None
time NN Physical
interval NN Physical
between IN Physical
the DT Physical
go NN Physical
and CC Physical
stop NN Physical
signals NNS Physical
was VBD None
recorded VBN None
from IN None
biceps NNS None
brachii NNS None
and CC None
triceps NNS None
brachii NN None
. . None
-DOCSTART- -X- N

dexketoprofen NN Pharmocological
dexketoprofen NNS Pharmocological
trometamol VBP Pharmocological
ilioinguinal JJ Pharmocological
iliohypogastric JJ Pharmocological
block NN Pharmocological
saline NN Pharmocological
DB NNP Pharmocological
levobupivacaine NN Pharmocological
) ) None
dexketoprofen RB Pharmocological
. . None
morphine JJ Pharmocological
analgesia NN Pharmocological
IV NNP None
dexketoprofen NN None
increases NNS None
-DOCSTART- -X- N

ME-609 NNP Pharmocological
ME-609 NNP Pharmocological
( ( Pharmocological
Xerese JJ Pharmocological
, , Pharmocological
Xerclear NNP Pharmocological
) ) Pharmocological
acyclovir NN Pharmocological
hydrocortisone NN Pharmocological
randomized VBN Pharmocological
to TO Pharmocological
self-initiate JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
ME-609 NNP Pharmocological
, , None
5 CD Pharmocological
% NN Pharmocological
acyclovir NN Pharmocological
in IN Pharmocological
ME-609 NNP Pharmocological
vehicle NN Pharmocological
, , None
or CC None
ME-609 JJ Physical
vehicle NN Physical
( ( Physical
placebo NN Physical
) ) Physical
at IN None
the DT None
earliest JJS None
sign NN None
of IN None
a DT None
cold JJ None
sore NN None
recurrence NN None
. . None
Cream NNP Pharmocological
was VBD Pharmocological
applied VBN Pharmocological
5 CD Pharmocological
times/d NN Pharmocological
for IN Pharmocological
5 CD Pharmocological
days NNS Pharmocological
. . None
ME-609 NNP Pharmocological
acyclovir FW Pharmocological
placebo NN Control
acyclovir NN Pharmocological
in IN Pharmocological
ME-609 NNP Pharmocological
vehicle NN Pharmocological
-DOCSTART- -X- N

imiquimod NN Pharmocological
imiquimod JJ Pharmocological
8 CD Pharmocological
weeks NNS Pharmocological
of IN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
once-daily JJ Pharmocological
dosing VBG Pharmocological
for IN Pharmocological
alternate JJ Pharmocological
weeks NNS Pharmocological
( ( Pharmocological
R1 NNP Pharmocological
) ) Pharmocological
and CC None
5 CD None
weeks NNS None
of IN None
once-daily JJ None
dosing NN None
with IN None
a DT None
1-week JJ None
interval NN None
in IN None
the DT None
middle NN None
of IN None
the DT None
course NN None
imiquimod JJ Pharmocological
-DOCSTART- -X- N

cytokines NNS Pharmocological
Combined VBN Pharmocological
therapy NN Pharmocological
with IN Pharmocological
antibiotics NNS Pharmocological
and CC Pharmocological
superlimf NN Pharmocological
monotherapy NN Control
with IN Control
antibiotics NNS Control
. . None
superlimf NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
rhesus-human JJ Pharmocological
reassortant JJ Pharmocological
rotavirus NN Pharmocological
vaccine NN Pharmocological
rhesus-human JJ Pharmocological
reassortant JJ Pharmocological
rotavirus NN Pharmocological
tetravalent NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
RRV-TV NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
Placebo NNP Control
or CC None
RRV-TV NNP Pharmocological
placebo NN Control
RRV-TV JJ Pharmocological
placebo NN Control
RRV-TV NNP Pharmocological
RRV-TV NNP Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

trandolapril NN Pharmocological
verapamil NN Pharmocological
trandolapril NN Pharmocological
( ( Pharmocological
T NNP Pharmocological
) ) Pharmocological
verapamil NN Pharmocological
( ( Pharmocological
FDTV NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
FDTV NNP Pharmocological
) ) Pharmocological
T NNP Pharmocological
trandolapril-verapamil JJ Pharmocological
-DOCSTART- -X- N

Leukocyte-depleted JJ Physical
reperfusion NN Physical
leukocyte-depleted JJ Physical
reperfusion NN Physical
or CC None
warm JJ Physical
leukocyte-depleted JJ Physical
blood NN Physical
reperfusion NN Physical
Reperfusion NN Pharmocological
with IN Pharmocological
leukocyte-depleted JJ Pharmocological
blood NN Pharmocological
or CC None
whole JJ Pharmocological
blood NN Pharmocological
Leukocyte-depleted JJ Physical
reperfusion NN Physical
-DOCSTART- -X- N

central JJ Physical
venous JJ Physical
catheters NNS Physical
. . None
tunnelled JJ Physical
and CC Physical
non-tunnelled JJ Physical
central JJ Physical
venous JJ Physical
catheters NNS Physical
tunnelled JJ Physical
catheters NNS Physical
conventional JJ Physical
catheters NNS Physical
cuffed NN Physical
, , Physical
tunnelled JJ Physical
central JJ Physical
venous JJ Physical
catheters NNS Physical
traditional JJ Physical
percutaneous JJ Physical
central JJ Physical
venous JJ Physical
catheters NNS Physical
-DOCSTART- -X- N

Short-term NNP Pharmocological
intravenous JJ Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
short-term JJ Physical
long-term JJ Physical
intravenous JJ Pharmocological
antibiotics NNS Pharmocological
surgical JJ Surgical
drainage NN Surgical
. . None
antibiotic JJ Pharmocological
-DOCSTART- -X- N

dietary JJ Physical
intervention NN Physical
polyunsaturated/saturated VBN Pharmocological
( ( Pharmocological
P/S NNP Pharmocological
) ) Pharmocological
ratio NN Pharmocological
-DOCSTART- -X- N

iodine NN Pharmocological
iodine NN Pharmocological
dose NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
-DOCSTART- -X- N

nursing-led JJ Other
inpatient NN Other
unit NN Other
The DT Other
nursing-led JJ Other
inpatient NN Other
unit NN Other
nursing-led JJ Other
inpatient NN Other
unit NN Other
nursing-led JJ Other
inpatient NN Other
unit NN Other
-DOCSTART- -X- N

elvitegravir/cobicistat/emtricitabine/tenofovir NN Pharmocological
disoproxil NN Pharmocological
fumarate NN Pharmocological
efavirenz/emtricitabine/tenofovir JJ Pharmocological
disoproxil NN Pharmocological
fumarate NN Pharmocological
EVG/COBI/FTC/TDF NNP Pharmocological
EFV/FTC/TDF NNP Pharmocological
EVG/COBI/FTC/TDF NNP Pharmocological
. . None
-DOCSTART- -X- N

fenfluramine NN Pharmocological
fenfluramine NN Pharmocological
fenfluramine NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
fenfluramine NN Pharmocological
's POS Pharmocological
-DOCSTART- -X- N

sumatriptan VB Pharmocological
5-HT1d JJ Pharmocological
receptor NN Pharmocological
agonist NN Pharmocological
sumatriptan NN Pharmocological
single JJ Pharmocological
dose JJ Pharmocological
sumatriptan NN Pharmocological
( ( Pharmocological
6 CD Pharmocological
mg RB Pharmocological
SQ NNP Pharmocological
) ) Pharmocological
and CC None
placebo NN Control
challenges NNS Control
, , None
separated VBN None
by IN None
a DT None
1-week JJ None
interval NN None
, , None
and CC None
was VBD Pharmocological
measured VBN Pharmocological
before IN Pharmocological
and CC Pharmocological
during IN Pharmocological
the DT Pharmocological
challenges NNS Pharmocological
. . None
sumatriptan VB Pharmocological
-DOCSTART- -X- N

RCT NNP None
of IN None
yoga NN Physical
, , None
exercise NN Physical
, , None
and CC None
omega-3 JJ Pharmocological
supplements NNS Pharmocological
. . None
3 CD None
nonhormonal JJ None
therapies NNS None
to TO None
yoga VB Physical
exercise NN None
or CC None
usual JJ Control
activity NN Control
of IN None
omega-3 JJ Pharmocological
177 CD None
) ) None
or CC None
placebo NN Control
1 CD None
) ) None
weekly JJ None
90-minute CD None
yoga NN None
classes NNS None
with IN None
daily JJ None
at-home JJ None
practice NN None
, , None
( ( None
2 CD None
) ) None
individualized VBN None
facility-based JJ None
aerobic JJ None
exercise NN None
training NN None
3 CD None
times/week NN None
, , None
omega-3 JJ Pharmocological
supplement NN Pharmocological
, , None
For IN None
yoga NN None
underwent VBP None
exercise NN Physical
and CC None
omega-3 JJ Pharmocological
therapy NN Pharmocological
yoga NN None
-DOCSTART- -X- N

ten JJ Physical
different JJ Physical
restorative NN Physical
techniques NNS Physical
. . None
deionized JJ None
water NN None
for IN None
7d CD None
prior JJ None
to TO None
longitudinal JJ None
sectioning NN None
in IN None
a DT None
mesio-distal JJ None
plane NN None
. . None
polished VBN None
using VBG None
600-grit JJ Physical
SiC NNP Physical
abrasive JJ Physical
paper NN Physical
and CC None
etched VBD None
for IN None
10 CD None
s NN None
with IN None
50 CD None
% NN None
phosphoric JJ None
acid NN None
addition-cure JJ Physical
vinyl NN Physical
polysiloxane NN Physical
impression NN Physical
material NN Physical
and CC None
an DT None
epoxy JJ Physical
resin NN Physical
. . None
sputter-coated JJ Physical
with IN Physical
gold NN Physical
glass NN Physical
ionomer-based JJ Physical
restorations NNS Physical
resin-based JJ Physical
bonding NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

antibiotics NNS Pharmocological
prophylactic JJ Pharmocological
antibiotics NNS Pharmocological
. . None
prophylactic JJ Pharmocological
antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

capecitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
concurrent NN Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
5-flurouracil JJ Pharmocological
capecitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
concurrent JJ Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
5-flurouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
concurrent NN Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
cisplatin NN Pharmocological
capecitabine NN Pharmocological
capecitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

thrombolytic JJ Pharmocological
agents NNS Pharmocological
pre-hospital JJ Pharmocological
early JJ Pharmocological
thrombolytic JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

efavirenz JJ Pharmocological
ACTG NNP Pharmocological
368 CD Pharmocological
abacavir NN Pharmocological
( ( Pharmocological
ABC NNP Pharmocological
) ) Pharmocological
efavirenz NN None
( ( None
EFV NNP None
) ) None
indinavir NN Pharmocological
( ( Pharmocological
IDV NNP Pharmocological
) ) None
placebo-controlled JJ Control
EFV NNP Pharmocological
plus CC Pharmocological
indinavir NN Pharmocological
( ( Pharmocological
EFV+IDV NNP Pharmocological
) ) Pharmocological
vs. FW Pharmocological
EFV+IDV NNP Pharmocological
plus CC Pharmocological
abacavir NN Pharmocological
( ( Pharmocological
ABC NNP Pharmocological
) ) Pharmocological
EFV-HS NNP Pharmocological
EFV-HS NNP Pharmocological
HIV NNP Pharmocological
-DOCSTART- -X- N

antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
. . None
amoxicillin NN Pharmocological
, , Pharmocological
clarithromycin NN Pharmocological
and CC Pharmocological
rabeprazole NN Pharmocological
; : None
tinidazole NN Pharmocological
, , Pharmocological
clarithromycin NN Pharmocological
and CC Pharmocological
ranitidine NN Pharmocological
bismuth NN Pharmocological
citrate NN Pharmocological
; : None
tinidazole NN Pharmocological
, , Pharmocological
clarithromycin NN Pharmocological
and CC Pharmocological
rabeprazole JJ Pharmocological
tinidazole NN Pharmocological
, , Pharmocological
tetracycline NN Pharmocological
, , Pharmocological
bismuth NN Pharmocological
and CC Pharmocological
rabeprazole NN Pharmocological
. . None
tinidazole NN Pharmocological
, , Pharmocological
tetracycline NN Pharmocological
, , Pharmocological
bismuth NN Pharmocological
rabeprazole JJ Pharmocological
triple JJ Pharmocological
rabeprazole-based JJ Pharmocological
eradicating NN Pharmocological
regimens NNS Pharmocological
Quadruple JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Sorafenib NNP Pharmocological
vascular JJ Physical
endothelial JJ Physical
growth NN Physical
factor NN Physical
( ( Physical
VEGF NNP Physical
) ) Physical
sorafenib NN Pharmocological
sorafenib NN None
concentrations NNS None
-DOCSTART- -X- N

hypertonic JJ Pharmocological
saline NN Pharmocological
and CC Pharmocological
dextran NN Pharmocological
( ( Pharmocological
HSD NNP Pharmocological
) ) Pharmocological
with IN None
normal JJ Pharmocological
saline NN Pharmocological
( ( Pharmocological
NS NNP Pharmocological
) ) None
250 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
HSD NNP Pharmocological
vs FW None
NS NNP Pharmocological
-DOCSTART- -X- N

Calcium NNP Pharmocological
chloride NN Pharmocological
before IN Pharmocological
i.v NN Pharmocological
. . None
diltiazem NN Pharmocological
Diltiazem NNP Pharmocological
calcium JJ Pharmocological
chloride NN Pharmocological
( ( Pharmocological
CaCl NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
diltiazem NN Pharmocological
CaCl NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
placebo NN Control
. . None
diltiazem NN Pharmocological
placebo NN Pharmocological
diltiazem NN Pharmocological
placebo JJ Pharmocological
CaCl NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

Albendazole JJ Pharmocological
albendazole NN Pharmocological
dexamethasone NN Pharmocological
albendazole JJ Pharmocological
corticosteroids NNS Pharmocological
-DOCSTART- -X- N

Simvastatin NNP Pharmocological
simvastatin NN Pharmocological
simvastatin NN None
( ( None
80 CD None
mg/day NN None
) ) None
or CC None
placebo NN None
. . None
RESULTS NNP None
Simvastatin NNP None
-DOCSTART- -X- N

transdermal JJ Pharmocological
nicotine NN Pharmocological
system NN Pharmocological
( ( Pharmocological
Nicoderm NNP Pharmocological
) ) Pharmocological
Transdermal NNP Pharmocological
nicotine NN Pharmocological
therapy NN Pharmocological
active JJ Pharmocological
transdermal JJ Pharmocological
nicotine JJ Pharmocological
systems NNS Pharmocological
. . Pharmocological
active JJ Pharmocological
and CC None
placebo JJ Control
systems NNS Control
concurrently RB Control
. . None
transdermal JJ Pharmocological
nicotine NN Pharmocological
system NN Pharmocological
transdermal JJ Pharmocological
nicotine NN Pharmocological
system NN Pharmocological
-DOCSTART- -X- N

clinician-guided JJ Physical
Internet-delivered JJ Physical
clinician-guided JJ Physical
Internet-delivered JJ Physical
cognitive JJ Physical
behaviour NN Physical
therapy NN Physical
( ( Physical
iCBT JJ Physical
) ) Physical
program NN Physical
Pain NNP Educational
Course NNP Educational
Treatment NNP Control
Group NNP Control
or CC Control
waitlist VB Control
Control NNP Control
Group NNP Control
. . None
5 CD Educational
iCBT-based JJ Educational
lessons NNS Educational
, , None
homework NN Pharmocological
tasks NNS Pharmocological
, , None
additional JJ Educational
resources NNS Educational
, , None
weekly JJ None
e-mail NN Educational
or CC Educational
telephone NN Educational
contact NN Educational
from IN Educational
a DT Educational
Clinical JJ Educational
Psychologist NN Educational
, , None
and CC None
automated VBD Educational
e-mails NNS Educational
. . None
5 CD None
lessons NNS None
Treatment NNP Physical
Group NNP Physical
Control NNP Control
Group NNP Control
iCBT NN None
clinician-guided JJ Physical
iCBT NN Physical
-DOCSTART- -X- N

atorvastatin JJ Pharmocological
simvastatin NN Pharmocological
, , None
pravastatin NN Pharmocological
, , None
lovastatin NN Pharmocological
, , None
and CC None
fluvastatin NN Pharmocological
3-hydroxy-3-methylglutaryl JJ Pharmocological
coenzyme NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
HMG-CoA NNP Pharmocological
) ) Pharmocological
reductase NN Pharmocological
inhibitor NN Pharmocological
atorvastatin VBD Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
, , Pharmocological
40 CD Pharmocological
, , Pharmocological
and CC Pharmocological
80 CD Pharmocological
mg NNS Pharmocological
compared VBN None
with IN None
simvastatin NN Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
, , Pharmocological
and CC Pharmocological
40 CD Pharmocological
mg NN Pharmocological
, , None
pravastatin NN Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
, , Pharmocological
and CC Pharmocological
40 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
lovastatin VBZ Pharmocological
20 CD Pharmocological
, , Pharmocological
40 CD Pharmocological
, , Pharmocological
and CC Pharmocological
80 CD Pharmocological
mg NN Pharmocological
, , None
and CC None
fluvastatin $ Pharmocological
20 CD Pharmocological
and CC Pharmocological
40 CD Pharmocological
mg. NN Pharmocological
Atorvastatin $ Pharmocological
simvastatin NN Pharmocological
, , None
pravastatin NN Pharmocological
, , None
lovastatin NN Pharmocological
fluvastatin NN Pharmocological
. . None
Atorvastatin $ Pharmocological
simvastatin NN Pharmocological
pravastatin NN Pharmocological
lovastatin CC Pharmocological
fluvastatin $ Pharmocological
Atorvastatin NNP Pharmocological
simvastatin NN Pharmocological
, , None
pravastatin NN Pharmocological
, , None
lovastatin NN Pharmocological
fluvastatin NN Pharmocological
. . None
-DOCSTART- -X- N

diet JJ Other
and CC None
Aspergillus NNP Other
oryzae VBP Other
extract NN Other
or CC None
Saccharomyces NNS Other
cervisiae VBP Other
diet JJ Physical
and CC Physical
feed JJ Physical
additive NN Physical
Aspergillus NNP None
oryzae NNP None
extract NN None
, , None
Amaferm NNP None
( ( None
AMF NNP None
) ) None
supplementation NN None
( ( None
% NN None
concentrate NN None
diet NN None
on IN None
of IN None
Saccaromyces NNP None
cervisiae NN None
boulardii NN None
CNCM NNP None
1079-Levucell CD None
SB NNP None
( ( None
LEV NNP None
) ) None
, , None
or CC None
of IN None
AMF NNP None
sources NNS None
, , None
dry JJ None
whole-shelled JJ None
corn NN None
or CC None
high JJ None
moisture NN None
corn NN None
, , None
on IN None
of IN None
LEV NNP None
addition NN None
of IN None
AMF NNP None
AMF NNP None
-DOCSTART- -X- N

granulocyte-macrophage NN Pharmocological
colony-stimulating NN Pharmocological
factor NN Pharmocological
( ( None
GM-CSF NNP Pharmocological
) ) None
Zidovudine NNP None
was VBD None
discontinued VBN None
in IN None
group NN None
A NNP None
patients NNS None
before IN None
instituting VBG None
GM-CSF NNP Pharmocological
treatment NN Pharmocological
and CC None
was VBD None
restarted VBN None
in IN None
a DT None
graduated JJ None
fashion NN None
over IN None
4 CD None
weeks NNS None
. . None
Group NNP None
B NNP None
patients NNS None
continued VBD None
on IN None
full-dose JJ Pharmocological
( ( Pharmocological
1,200 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
zidovudine NN Pharmocological
therapy NN Pharmocological
while IN Pharmocological
beginning VBG Pharmocological
GM-CSF NNP Pharmocological
therapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

asimadoline NN Pharmocological
asimadoline NN Pharmocological
placebo-controlled JJ Control
1 CD Pharmocological
, , Pharmocological
5 CD Pharmocological
, , Pharmocological
and CC Pharmocological
10 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
asimadoline NN Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
Asimadoline NNP Pharmocological
-DOCSTART- -X- N

chemotherapy NN None
-DOCSTART- -X- N

Carbenicillin-trimethoprim/sulfamethoxazole JJ Pharmocological
versus NN Pharmocological
carbenicillin-gentamicin NN Pharmocological
carbenicillin JJ Pharmocological
plus CC Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
( ( Pharmocological
C-T/S NNP Pharmocological
) ) Pharmocological
were VBD Pharmocological
compared VBN Pharmocological
to TO Pharmocological
those DT Pharmocological
obtained VBN Pharmocological
with IN Pharmocological
carbenicillin JJ Pharmocological
plus CC Pharmocological
gentamicin JJ Pharmocological
( ( Pharmocological
C-G NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

amantadine NN Pharmocological
. . None
Amantadine-sulfate NNP Pharmocological
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
TMS NNP Physical
) ) Physical
amantadine NN Pharmocological
placebo-controlled JJ Control
oral JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
50 CD Pharmocological
and CC Pharmocological
100 CD Pharmocological
mg NNS Pharmocological
amantadine VBP Pharmocological
with IN None
single JJ Pharmocological
and CC Pharmocological
paired JJ Pharmocological
pulse NN Pharmocological
TMS NNP Pharmocological
paradigms NN Pharmocological
. . None
amantadine NN Pharmocological
amantadine JJ Pharmocological
amantadine JJ Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
-DOCSTART- -X- N

maintenance NN None
treatment NN None
regimens NNS None
either DT None
induction NN Physical
intrathecal JJ Physical
chemotherapy NN Physical
( ( Pharmocological
ITC NNP Pharmocological
) ) Pharmocological
and CC None
cranial JJ Physical
irradiation NN Physical
( ( Physical
CRT NNP Physical
) ) Physical
plus CC Pharmocological
maintenance NN Physical
ITC NNP Physical
, , None
or CC None
induction NN Physical
ITC NNP Physical
and CC Pharmocological
craniospinal JJ Pharmocological
irradiation NN Pharmocological
( ( Pharmocological
CSpRT NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
no DT Pharmocological
maintenance NN Pharmocological
ITC NNP Pharmocological
. . None
methotrexate NN Pharmocological
, , None
hydrocortisone NN Pharmocological
, , None
and CC None
arabinosylcytosine NN Pharmocological
. . None
intensification NN Physical
of IN Physical
systemic JJ Physical
induction NN Physical
and CC None
maintenance NN Physical
chemotherapy NN Physical
CRT NNP Physical
+ NNP Pharmocological
ITC NNP Physical
CRT NNP Physical
ITC NNP Physical
Craniospinal JJ Physical
irradiation NN Physical
consisted VBD Physical
of IN Physical
CRT NNP Physical
-DOCSTART- -X- N

Oxytocin NNP Pharmocological
infusion NN Pharmocological
oxytocin NN Pharmocological
oxytocin NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

shuxuening VBG Pharmocological
injection NN Pharmocological
Shuxuening VBG Pharmocological
Injection NNP Pharmocological
( ( Pharmocological
SI NNP Pharmocological
) ) Pharmocological
Routine JJ Control
therapies NNS Control
for IN Control
COPD NNP Control
while IN None
15 CD Pharmocological
mL NNS Pharmocological
SI NNP Pharmocological
was VBD None
given VBN None
to TO None
those DT None
in IN None
the DT None
treatment NN None
group NN None
by IN None
intravenous JJ None
dripping NN None
, , None
twice RB None
daily RB None
for IN None
total JJ None
14 CD None
days NNS None
. . None
and CC None
were VBD None
detected VBN None
by IN None
Spirometer NNP Physical
. . None
SI NNP Pharmocological
-DOCSTART- -X- N

short-term JJ Control
cognitive JJ Control
group NN Control
treatment NN Control
program NN Control
cognitive JJ Control
short-term JJ Control
weight NN Control
reducing VBG Control
treatment NN Control
program NN Control
control NN Control
10-week JJ Control
( ( Control
30 CD Control
hours NNS Control
) ) Control
cognitive VBP Control
group NN Control
treatment NN Control
program NN Control
. . None
post-treatment JJ None
treatment NN None
cognitive JJ None
group NN None
treatment NN None
program NN None
treatment NN Control
controls NNS None
-DOCSTART- -X- N

vitamin NN None
C NNP None
, , None
vitamin NN None
E NNP None
, , None
carotenoids NNS None
antioxidants NNS Pharmocological
measured VBN None
blood NN None
levels NNS None
8-oxodeoxyguanosine JJ Pharmocological
lymphocyte NN Pharmocological
DNA NN Pharmocological
12-wk JJ Physical
carotenoid NN Physical
supplementation NN Physical
regime NN Physical
. . Physical
liquid NN Pharmocological
chromatography NN Pharmocological
-DOCSTART- -X- N

precision NN Physical
grip NN Physical
tasks NNS Physical
while IN Physical
a DT Physical
constant JJ Physical
extension NN Physical
or CC Physical
flexion NN Physical
moment NN Physical
was VBD Physical
applied VBN Physical
to TO Physical
their PRP$ Physical
elbow NN Physical
joints NNS Physical
surface NN Physical
electromyography NN Physical
( ( Physical
EMG NNP Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

Unopposed VBN Pharmocological
estrogen NN Pharmocological
placebo-controlled JJ Control
Estrogen NNP Pharmocological
therapy NN Pharmocological
unopposed JJ Pharmocological
estrogen NN Pharmocological
placebo VB Control
oral JJ Pharmocological
17beta-estradiol JJ Pharmocological
unopposed JJ Pharmocological
estrogen NN Pharmocological
replacement NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

duloxetine NN Pharmocological
duloxetine NN Pharmocological
duloxetine NN Pharmocological
placebo NN Control
placebo NN Control
duloxetine NN Pharmocological
duloxetine NN Pharmocological
placebo NN Control
duloxetine NN Pharmocological
placebo JJ Control
duloxetine NN Pharmocological
placebo NN Control
duloxetine NN Pharmocological
placebo NN Control
duloxetine NN Pharmocological
duloxetine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Warfarin NNP Pharmocological
aspirin NN Pharmocological
Warfarin NNP Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
warfarin NN Pharmocological
aspirin $ Pharmocological
325 CD Pharmocological
mg JJ Pharmocological
daily RB Pharmocological
warfarin NNS Pharmocological
aspirin NN Pharmocological
warfarin NNS Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
warfarin NNS Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
aspirin NN None
warfarin NN None
Warfarin NNP None
aspirin NN None
warfarin NN None
aspirin NN None
. . None
-DOCSTART- -X- N

Problem-solving JJ Educational
counseling NN Educational
problem-solving JJ Educational
counseling NN Educational
individualized JJ Educational
problem-solving JJ Educational
counseling NN Educational
by IN Educational
nurses NNS Educational
nurse JJ Educational
counseling NN Educational
or CC Educational
not RB Control
. . None
nurse JJ Educational
counseling NN Educational
control NN Control
counseling VBG Educational
counseling NN Educational
control VB Control
nurse RB Educational
counseling VBG Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
aspirin NN Pharmocological
and/or NN None
resistant JJ Pharmocological
starch NN Pharmocological
aspirin NNS Pharmocological
and CC None
resistant JJ Pharmocological
starch NN Pharmocological
( ( Pharmocological
RS NNP Pharmocological
) ) Pharmocological
( ( None
aspirin NN Pharmocological
and CC None
RS NNP Pharmocological
) ) None
( ( None
aspirin NN Pharmocological
) ) None
placebo-controlled JJ Control
aspirin NN Pharmocological
RS NNP Pharmocological
arms NNS None
: : None
aspirin NN None
plus CC None
RS NNP None
placebo NN None
; : None
RS NNP None
plus CC None
aspirin JJ None
placebo NN None
; : None
aspirin CC None
plus CC None
RS NNP None
; : None
RS NNP None
placebo NN None
plus CC None
aspirin JJ None
placebo NN None
; : None
of IN None
aspirin JJ None
-DOCSTART- -X- N

Cefprozil NNP Pharmocological
versus NN None
penicillin NN Pharmocological
V NNP Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
V. NNP Pharmocological
cefprozil NNS Pharmocological
penicillin NN Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
penicillin NN Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
therapy NN Pharmocological
cefprozil JJ Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
) ) None
Cefprozil NNP Pharmocological
-DOCSTART- -X- N

ischemia NN Physical
postconditioning VBG Physical
ischemia NN Physical
postconditioning VBG Physical
without IN Control
any DT Control
intervention NN Control
after IN Control
PTCA NNP Control
with IN Physical
ischemia NN Physical
postconditioning VBG Physical
angioplasty JJ Surgical
balloon NN Surgical
. . None
CONCLUSIONS NNP None
Ischemia NNP None
postconditioning NN None
can MD None
significantly RB None
-DOCSTART- -X- N

adrenocorticotrophic JJ Pharmocological
hormone NN Pharmocological
( ( Pharmocological
4-9 JJ Pharmocological
) ) Pharmocological
analog NN Pharmocological
ORG IN Pharmocological
2766 CD Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Dark-phase NNP Physical
light JJ Physical
contamination NN Physical
photobiologic JJ Physical
light-exposure JJ Physical
chambers NNS Physical
light NN Control
: : Control
dark JJ Control
cycle NN Control
without IN Control
dark-phase JJ Control
light JJ Control
contamination NN Control
low JJ None
level NN None
of IN None
light NN None
constant JJ None
bright JJ None
light NN None
( ( None
constant VB None
bright JJ None
constant VB None
bright JJ None
light NN None
or CC None
-DOCSTART- -X- N

Esmolol NNP Pharmocological
esmolol NN Pharmocological
placebo NN Control
. . Control
Esmolol NNP Pharmocological
anesthesia NN Pharmocological
extubation NN Surgical
. . None
-DOCSTART- -X- N

endogenous JJ Pharmocological
estrogen NN Pharmocological
concentrations NNS Pharmocological
serum NN Pharmocological
cholesteryl NN Pharmocological
ester NN Pharmocological
were VBD None
determined VBN None
in IN None
-DOCSTART- -X- N

Nimodipine NNP Pharmocological
placebo-controlled JJ Control
nimodipine NN Pharmocological
nimodipine NN Pharmocological
placebo VB Control
nimodipine NN Pharmocological
nimodipine NN Pharmocological
nimodipine NN Pharmocological
nimodipine NN Pharmocological
-DOCSTART- -X- N

IMZ NNP None
or CC None
ITI NNP None
implants NNS None
: : None
IMZ NNP None
implant NN None
the DT None
Br?nemark NNP None
implant NN None
system NN None
the DT None
ITI NNP None
implant NN None
system NN None
-DOCSTART- -X- N

Rotigotine NNP Pharmocological
transdermal JJ Pharmocological
patch NN Pharmocological
Rotigotine NNP Pharmocological
( ( Pharmocological
Neupro NNP Pharmocological
) ) Pharmocological
patches NNS Pharmocological
were VBD None
applied VBN None
once RB None
daily JJ None
and CC None
uptitrated JJ None
to TO None
the DT None
individual JJ None
effective JJ None
dose NN None
in IN None
increments NNS None
of IN None
2 CD None
mg/24 NNS None
h RB None
every DT None
week NN None
. . None
rotigotine NN Pharmocological
rotigotine NN Pharmocological
rotigotine NN Pharmocological
rotigotine NN Pharmocological
rotigotine NN Pharmocological
-DOCSTART- -X- N

Fulvestrant NNP Pharmocological
anastrozole NN Pharmocological
Fulvestrant NNP Pharmocological
fulvestrant NN Pharmocological
( ( None
250 CD None
mg NN None
monthly RB None
; : None
n CC None
= VB None
428 CD None
) ) None
with IN None
anastrozole NN Pharmocological
( ( None
1 CD None
mg NNS None
daily RB None
; : None
fulvestrant JJ Pharmocological
anastrozole-treated JJ Pharmocological
fulvestrant NN Pharmocological
-DOCSTART- -X- N

Kang NNP Pharmocological
Gang NNP Pharmocological
Qian NNP Pharmocological
Granule NNP Pharmocological
( ( Pharmocological
KGQG NNP Pharmocological
) ) Pharmocological
KGQG NNP Pharmocological
KGQG NNP Pharmocological
KGQG NNP Pharmocological
and CC Pharmocological
routine JJ Pharmocological
medications NNS Pharmocological
; : None
KGQG NNP Pharmocological
KGQG NNP Pharmocological
-DOCSTART- -X- N

betamethasone NN Pharmocological
vecuronium NN Pharmocological
corticosteroid NN Pharmocological
( ( Pharmocological
betamethasone NN Pharmocological
) ) Pharmocological
and CC Pharmocological
vecuronium NN Pharmocological
nondepolarizing JJ Pharmocological
muscle NN Pharmocological
relaxant NN Pharmocological
. . None
vecuronium NN Pharmocological
vecuronium NN Pharmocological
betamethasone CD Pharmocological
Corticosteroids NNS Pharmocological
non-depolarizing JJ None
muscle NN None
relaxants NNS None
-DOCSTART- -X- N

A NNP Physical
targeted JJ Physical
, , Physical
multi-component JJ Physical
disability NN Educational
prevention NN Educational
and CC Educational
disease JJ Educational
self-management JJ Educational
program NN Educational
led VBN Physical
by IN Physical
a DT Physical
geriatric JJ Physical
nurse NN Physical
practitioner NN Physical
( ( Physical
GNP NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

oral JJ Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
LGG NNP Pharmocological
) ) Pharmocological
LGG NNP Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

desflurane NN Pharmocological
isoflurane NN Pharmocological
desflurane NN Pharmocological
desflurane NN Pharmocological
. . None
desflurane NN Pharmocological
isoflurane NN Pharmocological
propofol NN Pharmocological
. . None
desflurane NN Pharmocological
isoflurane NN Pharmocological
. . None
desflurane NN Pharmocological
isoflurane NN Pharmocological
. . None
-DOCSTART- -X- N

thrombolytic JJ Physical
coronary JJ Physical
reperfusion NN Physical
: : Physical
streptokinase NN Physical
anistreplase NN Physical
. . Physical
intravenous JJ Physical
anistreplase NN Physical
( ( Physical
Eminase NNP Physical
) ) Physical
, , Physical
also RB Physical
known VBN Physical
as IN Physical
anisoylated JJ Physical
plasminogen NN Physical
streptokinase JJ Physical
activator NN Physical
complex NN Physical
( ( Physical
APSAC NNP Physical
) ) Physical
streptokinase NN Physical
. . None
anistreplase NN Physical
streptokinase NN Physical
. . None
reperfusion NN Psychological
therapy NN Psychological
thrombolytic JJ Psychological
therapy NN Psychological
. . None
thrombolytic JJ Pharmocological
drug NN Pharmocological
-DOCSTART- -X- N

limited JJ Surgical
palmar NN Surgical
incision NN Surgical
vs IN None
traditional JJ Physical
open JJ Physical
technique NN Physical
: : None
limited JJ Surgical
palmar NN Surgical
incision NN Surgical
for IN Physical
carpal JJ Surgical
tunnel NN Surgical
release NN Surgical
( ( Surgical
CTR NNP Surgical
) ) Surgical
with IN None
a DT None
traditional JJ Physical
open JJ Physical
technique NN Physical
Limited NNP Surgical
palmar NN Surgical
incision NN Surgical
CTR NNP Surgical
traditional JJ Physical
CTR NNP Physical
technique NN Physical
-DOCSTART- -X- N

Racial JJ None
differences NNS None
in IN None
multihospital NN None
study NN None
. . None
lower JJR None
or CC None
angioplasty NN None
amputation NN Educational
revascularization NN None
amputation NN Educational
amputation NN Educational
Chronic NNP None
disease NN None
prevalence NN None
and CC None
severity NN None
, , None
preadmission NN None
functional JJ None
status NN None
, , None
clinical JJ None
presentation NN None
, , None
and CC None
vascular JJ None
history NN None
amputation NN Educational
-DOCSTART- -X- N

health NN Educational
counseling NN Educational
intervention NN Educational
group NN Educational
control NN Control
group NN Control
. . Control
counselled VBN Educational
exercise NN Educational
group NN Educational
aerobics NNS Educational
exercise VBP Educational
diet JJ Educational
group NN Educational
reduce VB Educational
the DT Educational
intake NN Educational
of IN Educational
saturated JJ Educational
fat NN Educational
and CC Educational
increase VB Educational
fish JJ Educational
products NNS Educational
stop VB Educational
smoking NN Educational
. . Educational
one CD Educational
or CC Educational
more JJR Educational
behavioural JJ Educational
changes NNS Educational
Individual NNP Educational
counselling VBG Educational
diet JJ Educational
and CC Educational
smoking VBG Educational
counselling VBG Educational
models NNS Educational
-DOCSTART- -X- N

slush NN Pharmocological
nitrogen NN Pharmocological
vitrification NN Pharmocological
vitrified VBN Physical
with IN Physical
or CC Physical
without IN Physical
cumulus JJ Physical
cells NNS Physical
slush NN Pharmocological
nitrogen NN Pharmocological
vitrification NN Pharmocological
with IN Physical
or CC Physical
without IN Physical
cumulus JJ Physical
cells NNS Physical
vitrified VBD Physical
with IN Physical
and CC Physical
without IN Physical
cumulus JJ Physical
cells NNS Physical
-DOCSTART- -X- N

Lamotrigine NNP Pharmocological
therapy NN Pharmocological
lamotrigine NN Pharmocological
lamotrigine NN Pharmocological
, , Pharmocological
the DT Pharmocological
drug NN Pharmocological
was VBD Pharmocological
titrated VBN Pharmocological
upward RB Pharmocological
over IN Pharmocological
8 CD Pharmocological
weeks NNS Pharmocological
to TO Pharmocological
reach VB Pharmocological
a DT Pharmocological
mean JJ Pharmocological
maintenance NN Pharmocological
dose NN Pharmocological
of IN Pharmocological
5.0 CD Pharmocological
mg/kg NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
. . None
This DT Pharmocological
dose NN Pharmocological
was VBD Pharmocological
then RB Pharmocological
maintained VBN Pharmocological
for IN Pharmocological
4 CD Pharmocological
weeks NNS Pharmocological
. . None
Following VBG Pharmocological
maintenance NN Pharmocological
evaluations NNS Pharmocological
, , Pharmocological
the DT Pharmocological
drug NN Pharmocological
was VBD Pharmocological
tapered VBN Pharmocological
down RB Pharmocological
over RB Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
. . None
The DT Physical
trial NN Physical
ended VBD Physical
with IN Physical
a DT Physical
4-week JJ Physical
drug-free JJ Physical
period NN Physical
. . None
lamotrigine NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

ACE NNP Pharmocological
inhibitors NNS Pharmocological
or CC None
AT-1 JJ Pharmocological
antagonists NNS Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
Type NNP Pharmocological
1 CD Pharmocological
antagonist NN Pharmocological
losartan NN Pharmocological
captonpril NN Pharmocological
losartan JJ Pharmocological
captopril NN Pharmocological
losartan NN Pharmocological
and CC None
captopril NN Pharmocological
captopril NN Pharmocological
Losartan NNP Pharmocological
captopril NN Pharmocological
losartan NN Pharmocological
captopril NN Pharmocological
captopril NN Pharmocological
-DOCSTART- -X- N

Mefloquine NNP Pharmocological
mefloquine NN Pharmocological
hydrochloride NN Pharmocological
-DOCSTART- -X- N

acellular JJ Pharmocological
diphtheria NN Pharmocological
, , Pharmocological
pertussis NN Pharmocological
and CC Pharmocological
tetanus NN Pharmocological
freeze-dried JJ Pharmocological
and CC Pharmocological
liquid JJ Pharmocological
vaccines NNS Pharmocological
whole-cell JJ Pharmocological
diphtheria-pertussis-tetanus NN Pharmocological
( ( Pharmocological
DPT NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
. . Pharmocological
acellular JJ Pharmocological
vaccine NN Pharmocological
acellular JJ Pharmocological
vaccine NN Pharmocological
whole-cell JJ Physical
DPT NNP Physical
( ( Physical
WCDPT NNP Physical
) ) Physical
ADPT NNP Pharmocological
vaccines NNS Pharmocological
WCDPT NNP Pharmocological
vaccine NN Pharmocological
ADPT NNP None
WCDPT NNP None
-DOCSTART- -X- N

Mechanical NNP Physical
autotransfusion NN Physical
systems NNS Physical
controlled VBN Other
autotransfusion NN Physical
system NN Physical
WSB NNP Physical
was VBD Physical
retransfused VBN Physical
after IN Physical
processing VBG Physical
. . None
regular JJ Physical
drain NN Physical
without IN Physical
suction NN Physical
was VBD Physical
used VBN Physical
. . None
-DOCSTART- -X- N

computer-assisted JJ Educational
practice NN Educational
computer-assisted JJ Educational
practice NN Educational
on IN Educational
reading NN Educational
and CC Educational
spelling NN Educational
in IN Educational
reading NN Educational
spelling NN Educational
computer-based JJ Educational
reading NN Educational
and CC Educational
spelling NN Educational
practice NN Educational
1 CD Educational
) ) Educational
Copy NNPS Educational
the DT Educational
target NN Educational
word NN Educational
from IN Educational
the DT Educational
computer NN Educational
screen NN Educational
( ( Educational
n=22 NN Educational
) ) Educational
, , Educational
2 CD Educational
) ) Educational
Memorize VB Educational
the DT Educational
target NN Educational
word NN Educational
and CC Educational
write VB Educational
it PRP Educational
from IN Educational
memory NN Educational
( ( Educational
n=21 JJ Educational
) ) Educational
, , Educational
3 CD Educational
) ) Educational
Word NNP Educational
reading NN Educational
( ( Educational
n=21 JJ Educational
) ) Educational
, , Educational
and CC Educational
4 CD Educational
) ) Educational
the DT Educational
untrained JJ Educational
control NN Educational
group NN Educational
-DOCSTART- -X- N

isoprenaline NN Pharmocological
isoprenaline JJ Pharmocological
sulphate NN Pharmocological
isoprenaline JJ Pharmocological
sulphate NN Pharmocological
. . None
Practolol NNP Pharmocological
Practolol CC Pharmocological
Propranolol NNP Pharmocological
Practolol NNP Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
practolol NN Pharmocological
-DOCSTART- -X- N

ofloxacin NN Pharmocological
and CC None
ciprofloxacin NN Pharmocological
topical JJ Pharmocological
ofloxacin NN Pharmocological
or CC None
topical JJ Pharmocological
ciprofloxacin NN Pharmocological
surgery NN Surgical
) ) None
( ( Pharmocological
ciprofloxacin JJ Pharmocological
hydrochloride NN Pharmocological
, , Pharmocological
four CD Pharmocological
100-mg JJ Pharmocological
tablets NNS Pharmocological
, , None
or CC None
ofloxacin RB Pharmocological
, , Pharmocological
one CD Pharmocological
400-mg JJ Pharmocological
tablet NN Pharmocological
surgery NN Surgical
) ) None
ciprofloxacin NN Pharmocological
topical JJ Pharmocological
and CC Pharmocological
oral JJ Pharmocological
therapy NN Pharmocological
with IN Pharmocological
ofloxacin NN Pharmocological
-DOCSTART- -X- N

ranitidine NN Pharmocological
and CC None
amoxicillin JJ Pharmocological
plus CC None
metronidazole JJ Pharmocological
amoxicillin NN Pharmocological
metronidazole JJ Pharmocological
identical-appearing JJ Control
placebos NN Control
ranitidine NN Pharmocological
placebo NN Control
antibiotics NNS Pharmocological
placebo NN Control
antibiotics NNS Pharmocological
. . None
antibiotics NNS Pharmocological
placebo NN Control
-DOCSTART- -X- N

faropenem JJ Pharmocological
daloxate NN Pharmocological
and CC Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
( ( Pharmocological
300 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC Pharmocological
a DT Pharmocological
twice JJ Pharmocological
daily JJ Pharmocological
oral JJ Pharmocological
regimen NNS Pharmocological
of IN Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
treatment NN Pharmocological
cefuroxime VB Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
group NN Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem NN Pharmocological
daloxate NN Pharmocological
and CC Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
groups NNS Pharmocological
faropenem JJ Pharmocological
daloxate NN Pharmocological
and CC Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
faropenem JJ Pharmocological
daloxate-treated JJ Pharmocological
cefuroxime RB Pharmocological
axetil JJ Pharmocological
. . None
faropenem JJ Pharmocological
daloxate NN Pharmocological
cefuroxime NN Pharmocological
axetil NN Pharmocological
-DOCSTART- -X- N

Selaginella NNP Pharmocological
radiotherapy NN Physical
group NN None
A NNP None
received VBD None
radiotherapy NN Physical
alone RB Physical
, , None
those DT None
in IN None
group NN None
B NNP None
were VBD None
given VBN None
daily JJ Pharmocological
Selaginella NNP Pharmocological
( ( Pharmocological
30 CD Pharmocological
g NN Pharmocological
) ) Pharmocological
prepared VBD Pharmocological
into IN Pharmocological
50 CD Pharmocological
ml JJ Pharmocological
decoction NN Pharmocological
during IN Pharmocological
the DT Pharmocological
entire JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
radiotherapy NN Pharmocological
group NN Pharmocological
C NNP Pharmocological
had VBD Pharmocological
Selaginella NNP Pharmocological
30 CD Pharmocological
g JJ Pharmocological
daily RB Pharmocological
in IN None
the DT None
late JJ None
course NN None
of IN None
radiotherapy NN Pharmocological
. . None
Selaginella NNP Pharmocological
-DOCSTART- -X- N

ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
porcine NN Pharmocological
secretin NN Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
placebo-controlled JJ Control
secretin NN Pharmocological
or CC None
placebo NN Control
infusion NN Control
placebo NN Control
secretin JJ Pharmocological
secretin NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

Ribavirin JJ Pharmocological
peginterferon VB Pharmocological
alpha-2a JJ Pharmocological
180 CD Pharmocological
-DOCSTART- -X- N

aquatic JJ Physical
exercise NN Physical
aquatic JJ Physical
exercise NN Physical
classes NNS Physical
aquatic JJ Physical
classes NNS Physical
aquatic JJ Physical
classes NNS Physical
Aquatic JJ Physical
exercisers NNS Physical
Aquatic NNP Physical
exercise NN Physical
aquatic JJ Physical
exercise NN Physical
-DOCSTART- -X- N

regional JJ Pharmocological
chemotherapy NN Pharmocological
Adjuvant JJ Surgical
portal JJ Surgical
therapy NN Surgical
of IN Surgical
the DT Surgical
liver NN Surgical
with IN Surgical
resection NN Surgical
of IN Surgical
the DT Surgical
colorectal JJ Surgical
primary JJ Surgical
malignancy NN Surgical
curative JJ Surgical
resection NN Surgical
of IN Surgical
palliative JJ Pharmocological
local JJ Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

selamectin NN Pharmocological
selamectin NN Pharmocological
Selamectin NNP Pharmocological
selamectin NN Pharmocological
-DOCSTART- -X- N

Denver NNP Physical
Model NNP Physical
and CC None
PROMPT NNP Physical
interventions NNS None
. . None
Denver NNP Physical
Model NNP Physical
( ( None
which WDT None
merges VBZ None
behavioral JJ Educational
, , None
developmental JJ Educational
, , None
and CC None
relationship-oriented JJ Psychological
intervention NN None
) ) None
, , None
and CC None
PROMPT NNP Physical
( ( None
a DT None
neuro-developmental JJ Psychological
approach NN Psychological
for IN None
speech JJ None
production NN None
disorders NNS None
) ) None
. . None
-DOCSTART- -X- N

integrated VBN Psychological
, , Psychological
community-based JJ Psychological
package NN Psychological
for IN Psychological
-DOCSTART- -X- N

Engagement NN Educational
with IN Educational
electronic JJ Educational
screen JJ Educational
media NNS Educational
electronic JJ Educational
screen JJ Educational
media NNS Educational
( ( Educational
ESM NNP Educational
) ) Educational
: : Educational
animated VBN Educational
video NN Educational
, , Educational
video NN Educational
of IN Educational
self NN Educational
, , Educational
video NN Educational
of IN Educational
a DT Educational
familiar JJ Educational
person NN Educational
engaged VBD Educational
with IN Educational
an DT Educational
immersive JJ Educational
virtual JJ Educational
reality NN Educational
( ( Educational
VR NNP Educational
) ) Educational
game NN Educational
, , Educational
and CC Educational
immersion NN Educational
of IN Educational
self NN Educational
in IN Educational
the DT Educational
VR NNP Educational
game NN Educational
. . Educational
ESM NNP Educational
-DOCSTART- -X- N

fish JJ Pharmocological
oil NN Pharmocological
supplementation NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
long-chain NN Pharmocological
polyunsaturated VBD Pharmocological
fatty JJ Pharmocological
acid/day NN Pharmocological
) ) Pharmocological
or CC None
vegetable JJ Pharmocological
oil NN Pharmocological
( ( None
control NN None
) ) None
fish JJ Pharmocological
oil NN Pharmocological
( ( Pharmocological
FO NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
control NN Control
FO NNP Pharmocological
control NN Control
group NN None
Fish NNP Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

Torasemide NN Pharmocological
torasemide NN Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
furosemide JJ Pharmocological
( ( Pharmocological
50 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
low-sodium NN Pharmocological
( ( Pharmocological
40 CD Pharmocological
mmol/day NN Pharmocological
) ) Pharmocological
diet NN Pharmocological
and CC None
the DT None
aldosterone NN Pharmocological
antagonist NN Pharmocological
, , None
potassium NN Pharmocological
canrenoate NN Pharmocological
Torasemide NNP Pharmocological
furosemide NN Pharmocological
. . None
torasemide JJ Pharmocological
torasemide JJ Pharmocological
furosemide JJ Pharmocological
torasemide NN Pharmocological
-DOCSTART- -X- N

L-carnitine NNP Pharmocological
. . None
L-carnitine JJ Pharmocological
placebo-controlled JJ Control
L-carnitine NNP Pharmocological
placebo NN Control
and CC None
L-carnitine NNP Pharmocological
. . None
L-carnitine NNP Pharmocological
placebo NN Control
L-carnitine NNP Pharmocological
L-carnitine NNP Pharmocological
L-carnitine NNP Pharmocological
-DOCSTART- -X- N

acupuncture NN Physical
early JJ Physical
acupuncture NN Physical
routine JJ None
treatment NN None
of IN None
neurosurgical JJ Control
operation NN Control
and CC Control
drug NN Control
treatment NN Control
( ( Control
Mannitol NNP Pharmocological
, , Control
Citioline NNP Pharmocological
Sodium NNP Pharmocological
, , Control
Cefeazidime NNP Pharmocological
, , Pharmocological
etc. NN Pharmocological
) ) Control
. . None
routine JJ Control
treatment NN Control
and CC None
acupuncture NN Physical
treatment NN Physical
48 CD None
h NN None
( ( None
-1 NNP None
) ) None
week NN None
selected VBN Physical
main JJ Physical
points NNS Physical
were VBD Physical
Neiguan NNP Physical
( ( Physical
PC NNP Physical
6 CD Physical
) ) Physical
, , Physical
Qu-chi NNP Physical
( ( Physical
LI NNP Physical
11 CD Physical
) ) Physical
, , Physical
Waiguan NNP Physical
( ( Physical
TE NNP Physical
5 CD Physical
) ) Physical
, , Physical
Hegu NNP Physical
( ( Physical
LI NNP Physical
4 CD Physical
) ) Physical
, , Physical
Binao NNP Physical
( ( Physical
LI NNP Physical
14 CD Physical
) ) Physical
, , Physical
Jianyu NNP Physical
( ( Physical
LI NNP Physical
15 CD Physical
) ) Physical
, , Physical
Fengshi NNP Physical
( ( Physical
GB NNP Physical
31 CD Physical
) ) Physical
, , Physical
Xuehai NNP Physical
( ( Physical
SP NNP Physical
10 CD Physical
) ) Physical
, , Physical
Yinlingquan NNP Physical
( ( Physical
SP NNP Physical
9 CD Physical
) ) Physical
, , Physical
Sanyinjiao NNP Physical
( ( Physical
SP NNP Physical
6 CD Physical
) ) Physical
, , Physical
Taichong NNP Physical
( ( Physical
LR NNP Physical
3 CD Physical
) ) Physical
, , Physical
etc.. VBZ None
acupuncture NN Physical
-DOCSTART- -X- N

Rizatriptan NNP Pharmocological
placebo-controlled JJ Control
rizatriptan JJ Pharmocological
Rizatriptan NNP Pharmocological
rizatriptan NNS Pharmocological
rizatriptan JJ Pharmocological
placebo NN Control
rizatriptan NN Pharmocological
placebo NN Control
, , None
rizatriptan VBP Pharmocological
-DOCSTART- -X- N

prednisone NN Pharmocological
prednisone NN Pharmocological
10 CD Pharmocological
or CC Pharmocological
25 CD Pharmocological
mg NNS Pharmocological
prednisone JJ Pharmocological
two-step JJ Pharmocological
hyperinsulinemic JJ Pharmocological
euglycemic JJ Pharmocological
glucose NN Pharmocological
clamp NN Pharmocological
: : None
insulin NN None
infusion NN None
= VBD None
80 CD None
mU/m?/min NN None
) ) None
in IN None
prednisone NN None
compared VBN None
placebo VB None
. . None
prednisone NN None
compared VBN None
placebo VB None
; : None
prednisone NN None
, , None
-DOCSTART- -X- N

sublingual JJ Pharmocological
and CC Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
sublingual JJ Pharmocological
or CC Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
400 CD Pharmocological
microg NN Pharmocological
misoprostol NN Pharmocological
vaginal JJ Pharmocological
misoprostol NN Pharmocological
misoprostol NN Pharmocological
Vaginal NNP Pharmocological
misoprostol NN Pharmocological
sublingual JJ Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

screening VBG Physical
screening VBG Physical
Breast NNP Physical
cancer NN Physical
screening VBG Physical
-DOCSTART- -X- N

20 CD Pharmocological
ml NNS Pharmocological
of IN Pharmocological
bupivacaine NN Pharmocological
( ( Pharmocological
100 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
, , None
ropivacaine NN Pharmocological
( ( Pharmocological
150 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
saline JJ Pharmocological
as IN Pharmocological
control NN Pharmocological
group NN Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NN Pharmocological
10 CD Pharmocological
in IN Pharmocological
each DT Pharmocological
group NN Pharmocological
) ) Pharmocological
single JJ None
administration NN None
of IN None
plain JJ None
bupivacaine NN Pharmocological
( ( None
100 CD None
mg NN None
) ) None
and CC None
bupivacaine NN Pharmocological
( ( None
500 CD None
mg NN None
) ) None
-loaded VBD None
microspheres NNS None
. . None
morphine NN Pharmocological
. . None
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
. . None
ropivacaine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
anaesthetic-loaded JJ Pharmocological
microspheres NNS Pharmocological
-DOCSTART- -X- N

bupivacaine NN Pharmocological
morphine NN Pharmocological
opioid NN None
bupivacaine NN Pharmocological
and CC None
morphine NN Pharmocological
physiological JJ Pharmocological
saline NN Pharmocological
bupivacaine VBP Pharmocological
bupivacaine VBP Pharmocological
plus CC Pharmocological
morphine JJ Pharmocological
morphine NN Pharmocological
saline NN Pharmocological
saline NN Pharmocological
bupivacaine NN Pharmocological
morphine NN Pharmocological
morphine JJ Pharmocological
bupivacaine JJ Pharmocological
bupivacaine JJ Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

Periotest NNP Physical
Osstell NNP Physical
( ( None
Osstell NNP Physical
) ) None
( ( None
Periotest NNP Physical
) ) None
; : None
-DOCSTART- -X- N

CVC NNP Educational
self-care NN Educational
professionally RB None
controlled VBN None
CVC NNP None
care NN None
. . None
CVC NNP Educational
self-care NN Educational
. . None
standard JJ Educational
CVC NNP Educational
procedure NN Educational
provided VBN Educational
by IN Educational
nurses NNS Educational
. . None
Central NNP Physical
venous JJ Physical
catheter NN Physical
Central NNP Educational
venous JJ Educational
catheter NN Educational
self-care NN Educational
CVC NNP Educational
self-management NN Educational
. . None
-DOCSTART- -X- N

vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
. . None
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
chemotherapy NN Pharmocological
without IN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
chemotherapy NN Pharmocological
. . None
vitamin NN Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
vitamin JJ Pharmocological
E NNP Pharmocological
Vitamin NNP Pharmocological
E NNP Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

aversive JJ Physical
stimulation NN Physical
and CC Physical
failure NN Physical
aversive JJ Physical
stimulus NN Physical
and CC Physical
simultaneous JJ Physical
failure NN Physical
on IN Physical
a DT Physical
bogus JJ Physical
intelligence NN Physical
test NN Physical
( ( None
aversive JJ Physical
or CC Physical
nonaversive JJ Physical
) ) None
aversive JJ Physical
or CC Physical
nonaversive JJ Physical
acoustic JJ Physical
signal NN Physical
-DOCSTART- -X- N

metronidazole JJ Pharmocological
metronidazole JJ Pharmocological
dental JJ Pharmocological
gel NN Pharmocological
scaling NN Physical
and CC Physical
root NN Physical
planing NN Physical
( ( Physical
SRP NNP Physical
) ) Physical
SRP NNP Physical
metronidazole JJ Pharmocological
gel NN Pharmocological
SRP NNP Control
only RB Control
. . None
-DOCSTART- -X- N

Salmeterol NNP Pharmocological
theophylline NN Pharmocological
ketotifen NN Pharmocological
salmeterol NN Pharmocological
theophylline NN Pharmocological
and CC Pharmocological
ketotifen NN Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN None
risperidone NN None
risperidone NN None
risperidone NN None
-DOCSTART- -X- N

multifaceted VBN Educational
, , Educational
community-wide JJ Educational
intervention NN Educational
on IN Educational
overall JJ Educational
antibiotic JJ Educational
use NN Educational
physician JJ Educational
behavior-change NN Educational
strategy NN Educational
that WDT Educational
included VBD Educational
guideline JJ Educational
dissemination NN Educational
, , Educational
small-group JJ Educational
education NN Educational
, , Educational
frequent JJ Educational
updates NNS Educational
and CC Educational
educational JJ Educational
materials NNS Educational
, , Educational
and CC Educational
prescribing VBG Educational
feedback NN Educational
. . None
Parents NNS None
received VBD None
educational JJ Educational
materials NNS Educational
by IN Educational
mail NN Educational
and CC Educational
in IN Educational
primary JJ Educational
care NN Educational
practices NNS Educational
, , Educational
pharmacies NNS Educational
, , Educational
and CC Educational
child NN Educational
care NN Educational
settings NNS Educational
. . None
health-plan JJ None
data NNS None
-DOCSTART- -X- N

melphalan/prednisone NN Pharmocological
melphalan/ VB Pharmocological
prednisone NN Pharmocological
+ NNP Pharmocological
interferon VBZ Pharmocological
alpha-2b NN Pharmocological
-DOCSTART- -X- N

lexical JJ Educational
decision NN Educational
target NN Educational
word NN Educational
visual JJ Educational
display NN Educational
on IN Educational
a DT Educational
computer NN Educational
screen NN Educational
while IN Educational
listening VBG Educational
to TO Educational
a DT Educational
concurrent JJ Educational
auditory NN Educational
input NN Educational
. . None
-DOCSTART- -X- N

ad NN Pharmocological
libitum NN Pharmocological
FMS NNP Pharmocological
. . None
groundnut NNS Pharmocological
cake VBP Pharmocological
with IN None
-DOCSTART- -X- N

individual-level JJ Educational
responses NNS Educational
-DOCSTART- -X- N

irinotecan JJ Pharmocological
irinotecan JJ Pharmocological
Irinotecan NNP Pharmocological
high-fat JJ Other
, , Other
high-calorie JJ Other
breakfast NN Other
irinotecan JJ Pharmocological
irinotecan JJ Pharmocological
irinotecan JJ Pharmocological
-DOCSTART- -X- N

intraglomerular JJ Pharmocological
metastases NNS Pharmocological
intraglomerular JJ Pharmocological
metastases NNS Pharmocological
examined VBN Educational
-DOCSTART- -X- N

topical JJ Pharmocological
agents NNS Pharmocological
topical JJ Pharmocological
agents NNS Pharmocological
topical JJ Pharmocological
agents NNS Pharmocological
) ) None
or CC None
non-treatment JJ None
( ( None
control NN Control
) ) None
topical JJ Pharmocological
agents NNS Pharmocological
-DOCSTART- -X- N

clear JJ Physical
liquid NN Physical
diet NN Physical
( ( Physical
CLD NNP Physical
) ) Physical
oral JJ Physical
nutrition NN Physical
with IN Physical
a DT Physical
low-fat JJ Physical
solid JJ Physical
diet NN Physical
( ( Physical
LFSD NNP Physical
) ) Physical
CLD NNP Physical
or CC None
LFSD NNP Physical
-DOCSTART- -X- N

cryotherapy NN Physical
Cryotherapy NNP Physical
cryotherapy NN Physical
for IN None
treatment NN None
of IN None
retinopathy NN None
of IN None
prematurity NN None
Transscleral JJ Physical
cryotherapy NN Physical
cryotherapy NN Physical
cryotherapy NN Physical
-DOCSTART- -X- N

eye-tracking JJ Educational
eye-tracking VBG Educational
Eye-tracking JJ Educational
methodology NN Educational
-DOCSTART- -X- N

Vitamin NNP Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
vitamin VB Pharmocological
D NNP Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
vitamin NN None
D NNP None
serum JJ Pharmocological
25-hydroxyvitamin JJ Pharmocological
D NNP Pharmocological
placebo-controlled JJ Control
vitamin NN Pharmocological
D NNP Pharmocological
placebo VB Control
) ) None
vitamin NN None
D? NNP None
increasing VBG None
vitamin NN None
D? NNP None
dose NN None
vitamin NN None
D? NNP None
recommendations NNS None
for IN None
vitamin NN None
D NNP None
-DOCSTART- -X- N

computerized JJ Educational
touch NN Educational
screen NN Educational
version NN Educational
. . None
The DT None
computerized JJ Educational
version NN Educational
-DOCSTART- -X- N

Nateglinide NNP Pharmocological
strict JJ Pharmocological
glycemic NNS Pharmocological
control NN Pharmocological
nateglinide NN Pharmocological
( ( None
270 CD None
mg/dL NN None
) ) None
and CC None
40 CD None
to TO None
control VB Control
group NN Control
( ( Control
no DT Control
treatment NN Control
) ) Control
. . None
untreated JJ Educational
group NN None
strict JJ Pharmocological
glycemic NNS Pharmocological
control NN Pharmocological
by IN Pharmocological
nateglinide JJ Pharmocological
-DOCSTART- -X- N

monofluorophosphate NN Pharmocological
trimetaphosphate NN Pharmocological
: : None
a DT Pharmocological
low JJ Pharmocological
abrasion NN Pharmocological
paste NN Pharmocological
containing VBG Pharmocological
0.8 CD Pharmocological
% NN Pharmocological
sodium NN Pharmocological
monofluorophosphate NN Pharmocological
( ( Pharmocological
MFP NNP Pharmocological
) ) Pharmocological
a DT Pharmocological
paste NN Pharmocological
containing VBG Pharmocological
3 CD Pharmocological
% NN Pharmocological
sodium NN Pharmocological
trimetaphosphate NN Pharmocological
( ( Pharmocological
TMP NNP Pharmocological
) ) Pharmocological
. . None
conventional JJ Pharmocological
, , Pharmocological
moderately RB Pharmocological
abrasive JJ Pharmocological
paste NN Pharmocological
containing VBG Pharmocological
0.8 CD Pharmocological
% NN Pharmocological
sodium NN Pharmocological
monofluorophosphate NN Pharmocological
. . None
MFP NNP Control
control NN Control
-DOCSTART- -X- N

hydrocodone NN Pharmocological
and CC Pharmocological
ibuprofen JJ Pharmocological
codeine NN Pharmocological
and CC Pharmocological
acetaminophen NN Pharmocological
hydrocodone NN Pharmocological
ibuprofen $ Pharmocological
codeine NN Pharmocological
acetaminophen $ Pharmocological
Hydrocodone NNP Pharmocological
ibuprofen JJ Pharmocological
combination NN Pharmocological
hydrocodone NN Pharmocological
7.5 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
ibuprofen $ Pharmocological
200 CD Pharmocological
mg NN Pharmocological
2-tablet JJ None
dose NN None
codeine NN Pharmocological
30 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
acetaminophen $ Pharmocological
300 CD Pharmocological
mg NN Pharmocological
HI1 NNP None
CA NNP None
HI1 NNP None
CA NNP None
HI2 NNP None
HI1 NNP None
hydrocodone NN Pharmocological
and CC None
ibuprofen $ Pharmocological
codeine NN Pharmocological
and CC None
acetaminophen $ Pharmocological
combination NN Pharmocological
hydrocodone NN Pharmocological
7.5 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
ibuprofen $ Pharmocological
codeine NN Pharmocological
and CC None
acetaminophen $ Pharmocological
-DOCSTART- -X- N

Hanen NNP Educational
's POS Educational
'More JJR Educational
Than NNP Educational
Words NNP Educational
' POS Educational
Hanen NNP Educational
's POS Educational
'More JJR Educational
than IN Educational
Words NNS Educational
' POS Educational
( ( Educational
HMTW NNP Educational
) ) Educational
, , Educational
a DT Educational
parent-implemented JJ Educational
intervention NN Educational
'business NN Control
as IN Control
usual JJ Control
' POS Control
control NN Control
HMTW NNP Educational
intervention NN Educational
prior RB None
to TO None
randomization NN None
( ( None
Time NNP None
1 CD None
) ) None
and CC None
at IN None
5 CD None
and CC None
9 CD None
months NNS None
post VBN None
enrollment NN None
( ( None
Times NNP None
2 CD None
and CC None
3 CD None
) ) None
. . None
were VBD None
measured VBN None
at IN None
each DT None
time NN None
point NN None
. . None
, , None
was VBD None
measured VBN None
at IN None
Time NNP None
1 CD None
. . None
HMTW NNP None
The DT None
HMTW NNP None
HMTW NNP None
the DT None
HMTW NNP None
the DT None
HMTW NNP None
-DOCSTART- -X- N

restricted VBD Other
feeding NN Other
combined VBN Other
stresses NNS Other
( ( Other
thermal JJ Physical
stress NN Physical
and CC Other
restricted VBD Other
feeding VBG Other
) ) Other
control NN Control
) ) Control
thermal JJ Physical
stress NN Physical
) ) Physical
restricted VBN Educational
feeding NN Educational
) ) Educational
combined VBN Educational
stress NN Educational
) ) Educational
with IN Other
a DT Other
diet JJ Other
consisting NN Other
of IN Other
60 CD Other
% NN Other
roughage NN Other
and CC Other
40 CD Other
% NN Other
concentrate NN Other
. . Other
-DOCSTART- -X- N

TISSEEL NNP Pharmocological
VH NNP Pharmocological
S/D NNP Pharmocological
fibrin NN Pharmocological
sealant NN Pharmocological
currently RB Pharmocological
licensed VBN Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
fibrin NN Pharmocological
sealant NN Pharmocological
( ( Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
S/D NNP Pharmocological
) ) Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
S/D NNP Pharmocological
to TO Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
-DOCSTART- -X- N

fasting VBG Physical
fasting VBG Other
ate VBP Physical
a DT Physical
standard JJ Physical
supper NN Physical
but CC Physical
fasted VBD Physical
for IN Physical
24 CD Physical
h NN Physical
thereafter RB Physical
. . None
standard JJ Physical
supper NN Physical
, , Physical
snacks NNS Physical
, , Physical
breakfast NN Physical
and CC Physical
lunch NN Physical
. . None
-DOCSTART- -X- N

A-V NNP Physical
Impulse NNP Physical
System NNP Physical
A-V NNP Physical
Impulse NNP Physical
System NNP Physical
Doppler NNP Physical
ultrasonography NN Physical
-DOCSTART- -X- N

experiments NNS Educational
standard JJ Educational
duration NN Educational
( ( None
between IN None
or CC None
within IN None
subjects NNS None
) ) None
, , None
presentations NNS Educational
of IN Educational
the DT Educational
standard NN Educational
-DOCSTART- -X- N

prophylactic JJ Educational
management NN Educational
and CC Educational
therapeutics NNS Educational
antihypertensive JJ Pharmocological
agents NNS Pharmocological
: : Pharmocological
placebo NN Pharmocological
, , Pharmocological
hydralazine NN Pharmocological
, , Pharmocological
or CC Pharmocological
methyldopa NN Pharmocological
. . None
-DOCSTART- -X- N

Chemotherapy NNP Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN None
using VBG None
5-fluorouracil JJ Pharmocological
, , Pharmocological
doxorubicin JJ Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
FAMTX NNP Pharmocological
) ) Pharmocological
prior RB Pharmocological
to TO Pharmocological
surgery NN Pharmocological
or CC None
to TO None
undergo VB None
surgery NN Surgical
only RB Surgical
. . None
The DT None
response NN None
to TO None
chemotherapy NN Pharmocological
was VBD None
evaluated VBN None
after IN None
two CD None
and CC None
four CD None
courses NNS None
. . None
FAMTX NNP Pharmocological
-DOCSTART- -X- N

angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blocker NN Pharmocological
therapy NN Pharmocological
( ( None
olmesartan JJ Pharmocological
or CC None
valsartan NN Pharmocological
) ) None
( ( None
olmesartan NN Pharmocological
or CC None
valsartan NN Pharmocological
olmesartan NN Pharmocological
valsartan NN Pharmocological
olmesartan PRP None
or CC None
valsartan VB None
for IN None
6 CD None
months NNS None
-DOCSTART- -X- N

treatment NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
a DT Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitor NN Pharmocological
azithromycin JJ Pharmocological
500 CD Pharmocological
mg JJ Pharmocological
daily JJ Pharmocological
and CC Pharmocological
tinidazole JJ Pharmocological
500 CD Pharmocological
mg NN Pharmocological
two CD Pharmocological
tablets NNS Pharmocological
daily RB Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
lansoprasole JJ Pharmocological
30 CD Pharmocological
mg JJ Pharmocological
daily RB Pharmocological
for IN Pharmocological
6 CD Pharmocological
days NNS Pharmocological
( ( Pharmocological
ATL-group NNP Pharmocological
) ) Pharmocological
or CC None
with IN None
placebo NN Pharmocological
( ( Pharmocological
ATP-group NNP Pharmocological
) ) Pharmocological
. . None
was VBD None
performed VBN None
at IN None
inclusion NN None
and CC None
after IN None
a DT None
minimum NN None
of IN None
6 CD None
weeks NNS None
after IN None
end NN None
of IN None
therapy NN None
. . None
-DOCSTART- -X- N

cyclophosphamide VB Pharmocological
plasma NN None
exchanges NNS None
prednisone NN Pharmocological
and CC Pharmocological
PE NNP Pharmocological
prednisone VB Pharmocological
steroid NN Pharmocological
and CC Pharmocological
immunosuppressive JJ Pharmocological
therapy NN Pharmocological
: : None
short-term JJ Pharmocological
steroid NN Pharmocological
therapy NN Pharmocological
and CC Pharmocological
PE NNP Pharmocological
anti-viral JJ Pharmocological
therapy NN Pharmocological
prednisone NN Pharmocological
in IN Pharmocological
association NN Pharmocological
with IN Pharmocological
CYC NNP Pharmocological
anti-viral JJ Pharmocological
agents NNS Pharmocological
and CC Pharmocological
PE NNP Pharmocological
. . None
PE NNP Pharmocological
PE NN Pharmocological
PE NNP Pharmocological
-DOCSTART- -X- N

behavioral JJ Educational
plus CC Educational
nutrition JJ Educational
education NN Educational
intervention NN Educational
with IN None
a DT None
nutrition NN Educational
education NN Educational
intervention NN Educational
alone RB Educational
. . None
-DOCSTART- -X- N

active JJ Surgical
pectoral JJ Surgical
pulse NN Surgical
generator NN Surgical
active JJ Surgical
pectoral JJ Surgical
electrode NN Surgical
( ( Surgical
active JJ Surgical
can MD Surgical
) ) Surgical
active JJ Physical
pectoral NN Physical
can MD Physical
comparison NN Educational
of IN Educational
two CD Educational
shock NN Educational
configurations NNS Educational
dual-coil JJ Surgical
transvenous JJ Surgical
defibrillation NN Surgical
lead NN None
with IN None
a DT None
left JJ Surgical
pectoral JJ Surgical
pulse NN Surgical
generator NN Surgical
emulator NN Surgical
right JJ None
ventricular NN None
coil NN None
and CC None
proximal JJ None
atrial JJ None
coil NN None
( ( None
lead JJ None
) ) None
or CC None
between IN None
the DT None
right JJ None
ventricular NN None
coil NN None
and CC None
an DT None
active JJ None
can MD None
in IN None
common JJ None
with IN None
the DT None
atrial JJ None
coil NN None
active JJ Surgical
can MD Surgical
active JJ Surgical
can MD Surgical
active JJ Surgical
can MD Surgical
active JJ Surgical
pectoral JJ Surgical
electrode NN Surgical
-DOCSTART- -X- N

transplantation NN Physical
transplantation NN Physical
marrow NN Physical
blood NN Physical
stem NN Physical
cell NN Physical
blood NN None
stem NN None
cell NN None
-DOCSTART- -X- N

fluid NN Physical
resuscitation NN Physical
Phlebotomy NNP Physical
fluid JJ Physical
resuscitation NN Physical
5 CD Pharmocological
mL/kg NN Pharmocological
intravenous JJ Pharmocological
bolus NN Pharmocological
of IN Pharmocological
crystalloids NNS Pharmocological
, , None
hetastarch NN Pharmocological
( ( Pharmocological
HES NNP Pharmocological
) ) Pharmocological
, , None
or CC None
a DT None
hemoglobin-based JJ Pharmocological
oxygen-carrying JJ Pharmocological
solution NN Pharmocological
( ( Pharmocological
HBOCS NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

propranolol NN Pharmocological
( ( Pharmocological
a DT Pharmocological
beta NN Pharmocological
adrenergic JJ Pharmocological
antagonist NN Pharmocological
) ) Pharmocological
and CC None
following VBG None
placebo NN Control
propranolol NN Pharmocological
-DOCSTART- -X- N

benzodiazepine JJ Pharmocological
Ro NNP Pharmocological
15-1788 JJ Pharmocological
. . None
Ro NNP Pharmocological
15-1788 JJ Pharmocological
Ro NNP Pharmocological
15-1788 JJ Pharmocological
-DOCSTART- -X- N

desflurane NN Pharmocological
versus IN None
isoflurane NN Pharmocological
. . None
desflurane NN Pharmocological
( ( None
D NNP None
) ) None
or CC None
isoflurane NN Pharmocological
( ( None
I PRP None
) ) None
for IN None
-DOCSTART- -X- N

acupuncture NN Physical
acupuncture NN Physical
rehabilitation NN Physical
training NN Physical
including VBG Physical
ABA NNP Physical
training NN Physical
, , Physical
the DT Physical
Conductive NNP Physical
Education NNP Physical
Approach NNP Physical
and CC Physical
the DT Physical
training NN Physical
of IN Physical
sensory JJ Physical
integration NN Physical
acupuncture JJ Physical
treatment NN Physical
after IN Physical
the DT Physical
rehabilitation NN Physical
training NN Physical
. . Educational
Acupuncture NNP Physical
scientific JJ Physical
and CC Physical
effective JJ Physical
rehabilitation NN Physical
training NN Physical
simple JJ Physical
rehabilitation NN Physical
training NN Physical
-DOCSTART- -X- N

laser NN Physical
photocoagulation NN Physical
solid-state NN Physical
green JJ Physical
laser NN Physical
( ( Physical
GLX NNP Physical
) ) Physical
multispot NN Physical
532-nm JJ Physical
pattern JJ Physical
scan JJ Physical
laser NN Physical
one CD Physical
eye NN Physical
with IN Physical
GLX NNP Physical
PASCAL NNP Physical
-DOCSTART- -X- N

Esomeprazole NNP Pharmocological
esomeprazole NN Pharmocological
esomeprazole JJ Pharmocological
esomeprazole JJ Pharmocological
placebo NN None
esomeprazole JJ Pharmocological
placebo NN None
Esomeprazole NNP Pharmocological
placebo NN None
esomeprazole NN Pharmocological
placebo NN None
. . None
Esomeprazole NNP Pharmocological
-DOCSTART- -X- N

corticosteroids NNS Pharmocological
Tocolysis NN Pharmocological
, , Pharmocological
prophylactic JJ Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

ranitidine NN Pharmocological
ranitidine NN Pharmocological
triazolam NN Pharmocological
0.25-mg JJ Pharmocological
triazolam NN Pharmocological
tablet NN Pharmocological
after IN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
ranitidine NN Pharmocological
; : None
0.25-mg JJ Pharmocological
triazolam NN Pharmocological
tablet NN Pharmocological
, , Pharmocological
with IN Pharmocological
no DT Pharmocological
ranitidine JJ Pharmocological
pretreatment NN Pharmocological
; : None
0.25-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
triazolam NN Pharmocological
after IN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
ranitidine NN Pharmocological
; : None
0.25-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
triazolam NN Pharmocological
, , Pharmocological
with IN Pharmocological
no DT Pharmocological
ranitidine NN Pharmocological
pretreatment NN Pharmocological
. . None
Ranitidine NNP Pharmocological
triazolam NN Pharmocological
ranitidine NN Pharmocological
Ranitidine NNP Pharmocological
Ranitidine JJ Pharmocological
-DOCSTART- -X- N

arginine NN Pharmocological
arginine NN Pharmocological
19.6 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
arginine/d NN Pharmocological
placebo NN Control
arginine-supplemented JJ Pharmocological
arginine NN Pharmocological
-DOCSTART- -X- N

Reduction NN None
of IN None
with IN None
nonverbal JJ Educational
differential JJ Educational
observing NN Educational
responses NNS Educational
. . None
two CD Educational
sample NN Educational
stimuli NNS Educational
differential JJ Educational
observing NN Educational
responses NNS Educational
-DOCSTART- -X- N

collaborative JJ Educational
care NN Educational
including VBG Educational
PST NNP Educational
and CC None
an DT None
antidepressant JJ Pharmocological
treatment NN Pharmocological
algorithm NN Pharmocological
collaborative JJ Educational
care NN Educational
approach NN Educational
with IN Educational
and CC None
an DT None
antidepressant JJ Pharmocological
treatment NN Pharmocological
algorithm NN Pharmocological
Problem NNP Educational
Solving VBG Educational
Treatment NNP Educational
. . None
adapted JJ None
collaborative NN None
care NN None
framework NN None
, , None
including VBG None
contracting NN None
and CC None
adherence-improving JJ None
strategies NNS None
, , None
combined VBN None
with IN None
Problem NNP None
Solving NNP None
Treatment NNP None
and CC None
antidepressant JJ None
medication NN None
according VBG None
to TO None
a DT None
treatment NN None
algorithm NN None
. . None
randomised VBN None
to TO None
either CC None
the DT None
intervention NN None
group NN None
or CC None
the DT None
control NN None
group NN None
. . None
Patients NNS None
in IN None
the DT None
intervention NN None
group NN None
will MD None
receive VB None
treatment NN None
based VBN None
on IN None
the DT None
collaborative JJ None
care NN None
approach NN None
, , None
and CC None
patients NNS None
in IN None
the DT None
control NN None
group NN None
will MD None
receive VB None
care NN None
as IN None
usual JJ None
. . None
Baseline NN None
measurements NNS None
and CC None
follow VB None
up RP None
measures NNS None
( ( None
3 CD None
, , None
6 CD None
, , None
9 CD None
and CC None
12 CD None
months NNS None
) ) None
are VBP None
assessed VBN None
using VBG None
questionnaires NNS Educational
and CC None
an DT None
interview NN Educational
. . None
collaborative JJ Educational
care NN Educational
model NN Educational
-DOCSTART- -X- N

oral JJ Pharmocological
contraceptives NNS Pharmocological
ethinyl NN Pharmocological
estradiol $ Pharmocological
drospirenone NN Pharmocological
or CC None
desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol NN Pharmocological
20 CD Pharmocological
microg/drospirenone NN Pharmocological
3 CD Pharmocological
mg NN Pharmocological
ethinyl JJ Pharmocological
estradiol NN Pharmocological
20 CD Pharmocological
microg/desogestrel NN Pharmocological
-DOCSTART- -X- N

standard JJ Control
outpatient NN Control
clinic JJ Control
treatment NN Control
-DOCSTART- -X- N

colon NN Educational
cancer NN Educational
screening VBG Educational
usual JJ Educational
care NN Educational
; : None
( ( Educational
2 CD Educational
) ) Educational
physician JJ Educational
chart NN Educational
reminder NN Educational
; : None
( ( Educational
3 CD Educational
) ) Educational
physician JJ Educational
chart NN Educational
reminder NN Educational
, , None
mailed VBN Educational
education NN Educational
, , None
CRC NNP Educational
reminder NN Educational
magnet NN Educational
, , None
and CC None
fecal JJ Educational
immunochemical JJ Educational
test NN Educational
( ( Educational
FIT NNP Educational
) ) Educational
( ( Educational
mailed JJ Educational
education/FIT NN Educational
) ) Educational
; : None
or CC None
( ( Educational
4 CD Educational
) ) Educational
all PDT Educational
the DT Educational
preceding VBG Educational
plus CC Educational
a DT Educational
structured JJ Educational
telephone NN Educational
call NN Educational
to TO Educational
the DT Educational
patient NN Educational
from IN Educational
project JJ Educational
staff NN Educational
to TO Educational
provide VB Educational
education NN Educational
, , None
assess JJ Educational
interest NN Educational
in IN Educational
screening VBG Educational
, , Educational
explain VB Educational
the DT Educational
screening NN Educational
tests NNS Educational
, , Educational
and CC Educational
address JJ Educational
barriers NNS Educational
-DOCSTART- -X- N

propranolol NN Pharmocological
or CC None
a DT None
placebo NN Control
-DOCSTART- -X- N

ozonotherapy NN Pharmocological
and CC None
klimadynon NN Pharmocological
-DOCSTART- -X- N

enoxaparin NN Pharmocological
and CC None
standard JJ Pharmocological
heparin NN Pharmocological
enoxaparin NN Pharmocological
standard NN Pharmocological
heparin NN Pharmocological
( ( Pharmocological
SH NNP Pharmocological
) ) Pharmocological
2,500 CD Pharmocological
IU NNP Pharmocological
enoxaparin NN Pharmocological
once RB None
daily JJ None
and CC None
SH NNP Pharmocological
in IN None
a DT None
dose NN None
of IN None
5,000 CD None
IU NNP None
three CD None
times NNS None
daily RB None
. . None
enoxaparin/day NN Pharmocological
-DOCSTART- -X- N

General NNP Pharmocological
anaesthesia NN Pharmocological
enflurane NN Pharmocological
halothane NN Pharmocological
. . None
enflurane NN Pharmocological
halothane NN Pharmocological
halothane NN Pharmocological
general JJ Pharmocological
anaesthesia NN Pharmocological
. . None
-DOCSTART- -X- N

iron NN Pharmocological
formula NN Control
milk NN Control
with IN Control
no DT Control
added JJ Control
iron NN Control
against IN None
the DT None
same JJ Pharmocological
formula NN Pharmocological
milk NN Pharmocological
containing VBG Pharmocological
1.2 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
iron NN Pharmocological
per IN Pharmocological
100 CD Pharmocological
ml NN Pharmocological
. . None
iron NN Pharmocological
iron NN Pharmocological
-DOCSTART- -X- N

Cardiopulmonary JJ Physical
exercise NN Physical
cardiopulmonary JJ Physical
exercise NN Physical
( ( Physical
CPX NNP Physical
) ) Physical
CPX NNP Physical
CPX NNP Physical
echocardiography NN None
standardized JJ Physical
CPX NNP Physical
test NN Physical
-DOCSTART- -X- N

high-dose JJ Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
HD-MPA NNP Pharmocological
) ) Pharmocological
placebo NN Control
Combination NNP Physical
therapy NN Physical
, , Physical
( ( Physical
CT NNP Physical
) ) Physical
MPA NNP Pharmocological
CT NNP Physical
+ NNP Physical
MPA NNP Physical
CT NNP Control
+ NNP Control
placebo NN Control
. . None
MPA NNP Physical
-DOCSTART- -X- N

Bevacizumab-augmented JJ Pharmocological
retinal JJ Physical
laser NN Physical
photocoagulation NN Physical
intravitreal NN Pharmocological
bevacizumab NN Pharmocological
injection NN Pharmocological
standard JJ Physical
laser NN Physical
treatment NN Physical
laser NN Physical
treatment NN Physical
1.25 CD Pharmocological
mg NNS Pharmocological
intravitreal JJ Pharmocological
bevacizumab NN Pharmocological
Fluorescein NNP Physical
angiography NN Physical
Avastin-treated JJ Pharmocological
bevacizumab NN Pharmocological
Avastin NNP Pharmocological
-DOCSTART- -X- N

formoterol VB Pharmocological
, , None
ipratropium NN Pharmocological
, , None
and CC None
their PRP$ None
combination NN Pharmocological
placebo-controlled JJ Control
ipratropium NN Pharmocological
bromide NN Pharmocological
( ( Pharmocological
Atrovent NNP Pharmocological
MDI NNP Pharmocological
, , Pharmocological
20 CD Pharmocological
micrograms/puff NN Pharmocological
) ) Pharmocological
plus CC None
2 CD Control
puffs NNS Control
placebo NN Control
; : None
formoterol JJ Pharmocological
fumarate NN Pharmocological
( ( Pharmocological
Foradil NNP Pharmocological
MDI NNP Pharmocological
, , Pharmocological
12 CD Pharmocological
micrograms/puff NN Pharmocological
) ) Pharmocological
plus CC None
3 CD Control
puffs NNS Control
placebo VBP Control
; : None
80 CD Pharmocological
micrograms NNS Pharmocological
ipratropium NN Pharmocological
; : None
D. NNP None
24 CD Pharmocological
micrograms NNS Pharmocological
formoterol JJ Pharmocological
plus CC Pharmocological
2 CD Pharmocological
puffs NNS Pharmocological
placebo VBP Pharmocological
; : None
E. NNP None
12 CD Pharmocological
micrograms NNS Pharmocological
formoterol JJ Pharmocological
plus CC None
40 CD Pharmocological
micrograms NNS Pharmocological
ipratropium JJ Pharmocological
plus CC None
1 CD Control
puff NN Control
placebo NN Control
; : None
4 CD Control
puffs NNS Control
placebo NN Control
. . None
ipratropium NN Pharmocological
and CC None
formoterol NN Pharmocological
ipratropium NN Pharmocological
-DOCSTART- -X- N

joint JJ Physical
attention NN Physical
play NN Physical
interventions NNS Physical
joint JJ Physical
attention NN Physical
( ( Physical
JA NNP Physical
) ) Physical
symbolic JJ Physical
play NN Physical
( ( Physical
SP NNP Physical
) ) Physical
JA NNP Educational
SP NNP Educational
JA NNP Educational
SP NNP Physical
JA NNP Educational
SP NNP Physical
-DOCSTART- -X- N

cervical JJ Physical
spine NN Physical
manipulative JJ Physical
therapy NN Physical
cervical JJ Physical
spinal JJ Physical
manipulative JJ Physical
therapy NN Physical
( ( Physical
SMT NNP Physical
) ) Physical
chiropractic JJ Physical
SMT NNP Physical
and CC None
sham NN Control
. . None
chiropractic JJ Physical
SMT NNP Physical
-DOCSTART- -X- N

Allogeneic NNP Surgical
hematopoietic JJ Surgical
stem-cell NN Surgical
transplantation NN Surgical
data NNS Educational
from IN Educational
a DT Educational
-DOCSTART- -X- N

grammatical JJ Educational
uninterpretable JJ Educational
extra JJ Educational
argument NN Educational
legitimate JJ Educational
arguments NNS Educational
. . None
grammatical JJ Educational
-DOCSTART- -X- N

CNS NNP Physical
irradiation NN Physical
. . None
-DOCSTART- -X- N

lithium NN Pharmocological
carbonate NN Pharmocological
and CC Pharmocological
haloperidol NN Pharmocological
lithium NN Pharmocological
carbonate NN Pharmocological
and CC Pharmocological
haloperidol NN Pharmocological
placebo-controlled JJ Control
Haloperidol NNP Pharmocological
Lithium JJ Pharmocological
carbonate NN Pharmocological
-DOCSTART- -X- N

Tinzaparin NNP Pharmocological
versus NN None
dalteparin NN Pharmocological
Low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
( ( Pharmocological
LMWH NNP Pharmocological
) ) Pharmocological
tinzaparin NN Pharmocological
dalteparin VB Pharmocological
warfarin JJ Pharmocological
therapy NN Pharmocological
3 CD Pharmocological
daily JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
tinzaparin NN Pharmocological
( ( Pharmocological
175 CD Pharmocological
IU/kg NNP Pharmocological
) ) Pharmocological
or CC None
dalteparin NN Pharmocological
tinzaparin JJ Pharmocological
dalteparin JJ Pharmocological
. . None
for IN None
tinzaparin NN None
for IN None
dalteparin NN Pharmocological
( ( None
the DT None
tinzaparin NN None
arm NN None
thrombosis NN None
[ NNP None
dalteparin NN None
group NN None
CONCLUSIONS NNP None
Dalteparin NNP None
and CC None
tinzaparin VB None
significantly RB None
warfarin NN None
therapy NN None
has VBZ None
intravenous JJ None
heparin NN None
, , None
-DOCSTART- -X- N

maximum JJ Physical
cycle NN Physical
ergometry NN Physical
: : Physical
maximum VB Physical
ramp-incremental JJ Physical
cycle NN Physical
ergometry NN Physical
-DOCSTART- -X- N

Unpleasant NNP Educational
, , Educational
pleasant NN Educational
, , Educational
and CC Educational
neutral JJ Educational
words NNS Educational
were VBD Educational
randomly RB Educational
presented VBN Educational
to TO Educational
one CD Educational
in IN Educational
which WDT Educational
they PRP Educational
decided VBD Educational
whether IN Educational
a DT Educational
letter NN Educational
string NN Educational
was VBD Educational
a DT Educational
word NN Educational
or CC Educational
a DT Educational
non-word JJ Educational
( ( Educational
lexical JJ Educational
decision NN Educational
) ) Educational
and CC Educational
two CD Educational
affective JJ Educational
classification NN Educational
tasks NNS Educational
neutral NN Educational
or CC Educational
unpleasant JJ Educational
neutral NN Educational
or CC Educational
pleasant NN Educational
. . None
-DOCSTART- -X- N

fluticasone NN Pharmocological
propionate/salmeterol NN Pharmocological
tiotropium VB Pharmocological
fluticasone/salmeterol NN Pharmocological
( ( Pharmocological
FSC NNP Pharmocological
) ) Pharmocological
to TO None
tiotropium VB Pharmocological
daily RB None
) ) None
( ( None
TIO NNP None
18 CD None
mcg NN None
FSC NNP None
to TO None
-DOCSTART- -X- N

telcagepant NN Pharmocological
Telcagepant NNP Pharmocological
oral JJ Physical
calcitonin NN Physical
gene-related JJ Physical
peptide NN Physical
receptor NN Physical
oral JJ Pharmocological
triptans NNS Pharmocological
. . Pharmocological
telcagepant NN Pharmocological
. . None
telcagepant NN Pharmocological
( ( Pharmocological
150 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
300 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
zolmitriptan VBZ Pharmocological
5 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
or CC Pharmocological
placebo NN Pharmocological
For IN None
zolmitriptan JJ None
, , None
for IN None
telcagepant JJ None
and CC None
placebo NN None
receiving VBG None
telcagepant JJ None
receiving VBG None
zolmitriptan NN None
for IN None
telcagepant JJ None
from IN None
zolmitriptan NN None
to TO None
triptans NNS None
or CC None
telcagepant JJ None
-DOCSTART- -X- N

values-affirmation NN Other
exercise NN Other
or CC None
a DT None
control NN Control
exercise NN Control
values-affirmation NN Other
exercise NN Other
-DOCSTART- -X- N

linezolid NNS Pharmocological
linezolid NN Pharmocological
placebo-controlled JJ Control
linezolid VBD Pharmocological
or CC None
placebo VB Control
linezolid JJ Pharmocological
. . Pharmocological
Linezolid NNP Pharmocological
linezolid JJ Pharmocological
linezolid JJ Pharmocological
-DOCSTART- -X- N

bitolterol NN Pharmocological
mesylate NN Pharmocological
and CC None
isoproterenol NN Pharmocological
. . None
Nebulized VBN Pharmocological
bitolterol NN Pharmocological
solution NN Pharmocological
and CC None
isoproterenol JJ Pharmocological
solution NN Pharmocological
Bitolterol NNP Pharmocological
-DOCSTART- -X- N

anesthetics NNS Physical
saline NN Pharmocological
, , Pharmocological
bupivacaine NN Pharmocological
lignocaine NN Pharmocological
placebo NN Control
isotonic JJ Pharmocological
saline NN Pharmocological
irrigation NN Pharmocological
bupivacaine JJ Pharmocological
irrigation NN Pharmocological
lignocaine JJ Pharmocological
irrigation NN Pharmocological
. . None
bupivacaine NN Pharmocological
Lignocaine NNP None
saline NN Pharmocological
bupivacaine NN None
. . None
saline NN None
, , None
bupivacaine NN None
lignocaine NN None
Lignocaine NNP None
-DOCSTART- -X- N

imiquimod JJ Pharmocological
reflectance-mode JJ Physical
confocal JJ Physical
microscopy NN Physical
Mohs NNP Surgical
micrographic JJ Surgical
surgery NN Surgical
Imiquimod NNP Pharmocological
imiquimod JJ Pharmocological
reflectance-mode JJ Physical
confocal JJ Physical
microscopy NN Physical
imiquimod JJ Pharmocological
Confocal NNP Physical
microscopy NN Physical
Mohs NNP Surgical
micrographic JJ Surgical
surgery NN Surgical
. . None
Mohs NNP Surgical
micrographic JJ Surgical
surgery NN Surgical
excision NN Surgical
Confocal JJ Physical
microscopy NN Physical
Imiquimod NNP Pharmocological
-DOCSTART- -X- N

conventional JJ Control
and CC None
complementary/alternative JJ Other
treatments NNS Other
conventional JJ Control
treatments NNS Control
and CC None
utilization NN None
of IN None
complementary JJ Pharmocological
and CC Pharmocological
alternative JJ Pharmocological
medicine NN Pharmocological
CAM NNP Pharmocological
conventional JJ Physical
services NNS Physical
CAM NNP Pharmocological
CAM NNP Pharmocological
. . None
CAM NNP Pharmocological
CAM NNP Pharmocological
. . None
CAM NNP Pharmocological
CAM NNP Pharmocological
-DOCSTART- -X- N

etch-and-rinse JJ Physical
adhesive JJ Physical
systems NNS Physical
and CC Physical
a DT Physical
self-etching JJ Physical
system NN Physical
posts NNS Physical
used VBD Physical
for IN Physical
luting VBG Physical
were VBD Physical
duplicated VBN Physical
with IN Physical
dual JJ Physical
resin NN Physical
cement NN Physical
( ( Physical
Duo-link NNP Physical
) ) Physical
inside IN Physical
Aestheti NNP Physical
Plus NNP Physical
# # Physical
2 CD Physical
molds NNS Physical
. . None
All-Bond JJ Other
2 CD Other
( ( Other
TE3 NNP Other
) ) Other
+ VBP Other
resin JJ Other
cement NN Other
post NN Other
( ( Other
rcp NN Other
) ) Other
+ VBZ Other
Duo-link NNP Other
( ( Other
Dl NNP Other
) ) Other
; : None
One-Step JJ Other
Plus NNP Other
( ( Other
TE2 NNP Other
) ) Other
+ VBP Other
rcp JJ Other
+ NNP Other
Dl NNP Other
; : Other
Tyrian/One-Step JJ Other
Plus NNP Other
( ( Other
SE NNP Other
) ) Other
+ VBP Other
rcp JJ Other
+ NNP Other
Dl NNP Other
. . None
-DOCSTART- -X- N

Propranolol NNP Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
propranolol- JJ Pharmocological
placebo-treated JJ Control
propranolol NN Pharmocological
-DOCSTART- -X- N

ipilimumab JJ Pharmocological
were VBD None
randomized VBN None
to TO None
receive VB None
concomitant NN None
blinded VBN None
prophylactic JJ None
oral JJ None
budesonide NN None
( ( None
9 CD None
mg/d NN None
with IN None
gradual JJ None
taper NN None
through IN None
week NN None
16 CD None
) ) None
or CC None
placebo NN None
. . None
Outcome NNP None
resulted VBD None
Prophylactic NNP None
budesonide NN None
did VBD None
-DOCSTART- -X- N

halothane NN Pharmocological
isoflurane NN Pharmocological
Halothane NNP Pharmocological
or CC None
isoflurane NN Pharmocological
halothane NN Pharmocological
group NN Pharmocological
isoflurane JJ Physical
group NN Physical
anesthesia NN None
midazolam NN Pharmocological
, , None
fentanyl NN Pharmocological
, , None
and CC None
pancuronium NN Pharmocological
. . None
Anesthesia NNP None
fentanyl NN Pharmocological
and CC None
halothane NN Pharmocological
or CC None
isoflurane NN Pharmocological
in IN Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
and CC Pharmocological
oxygen NN Pharmocological
isoflurane NN Pharmocological
isoflurane-anesthetized JJ None
halothane-anesthetized JJ Pharmocological
anesthesia NN Pharmocological
halothane NN Pharmocological
-DOCSTART- -X- N

repeated JJ Educational
high-single-dose JJ Educational
allergen NN Educational
challenge NN Educational
. . None
repetitive JJ Educational
high-dose JJ Educational
allergen NN Educational
challenges NNS Educational
with IN Educational
household NN Educational
dust NN Educational
mites NNS Educational
for IN Educational
four CD Educational
consecutive JJ Educational
days NNS Educational
. . None
requiring VBG None
prednisolone NN None
-DOCSTART- -X- N

diltiazem NN Pharmocological
sustained-release JJ Pharmocological
diltiazem NN Pharmocological
placebo NN Control
. . Control
diltiazem NN Pharmocological
. . Pharmocological
Diltiazem NNP Pharmocological
diltiazem JJ Pharmocological
Diltiazem NNP Pharmocological
-DOCSTART- -X- N

N-acetylcysteine NNP Pharmocological
N-acetylcysteine NNP Pharmocological
3 CD None
g NN None
acetaminophen NN Pharmocological
one CD None
hour NN None
later RB None
by IN None
the DT None
normal JJ None
loading VBG None
dose NN None
of IN None
N-acetylcysteine NNP Pharmocological
3 CD None
g NN None
acetaminophen NN Pharmocological
60 CD None
g NNS None
activated VBN Pharmocological
charcoal NN Pharmocological
and CC None
a DT None
supranormal JJ Pharmocological
loading NN Pharmocological
dose NN Pharmocological
of IN Pharmocological
N-acetylcysteine NNP Pharmocological
N-acetylcysteine NNP Pharmocological
N-acetylcysteine NNP Pharmocological
N-acetylcysteine JJ Pharmocological
-DOCSTART- -X- N

diazepam NN Pharmocological
and CC Pharmocological
midazolam NN Pharmocological
diazepam NN Pharmocological
and CC Pharmocological
midazolam NN Pharmocological
nitrous JJ Pharmocological
oxide/oxygen NN Pharmocological
inhalation NN Pharmocological
oral JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
either DT Pharmocological
diazepam NN Pharmocological
0.3 CD Pharmocological
mg/kg NN Pharmocological
or CC Pharmocological
midazolam VB Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
-DOCSTART- -X- N

terazosin NN Pharmocological
enalapril NN Pharmocological
antihypertensive JJ Pharmocological
drug NN Pharmocological
selective JJ Pharmocological
alpha NN Pharmocological
1-adrenergic JJ Pharmocological
blocker NN Pharmocological
terazosin NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
enalapril NN Pharmocological
placebo JJ Control
Terazosin NNP Pharmocological
and CC None
enalapril VB Pharmocological
terazosin NN Pharmocological
enalapril NN Pharmocological
placebo NN Control
terazosin NN Pharmocological
enalapril NN Pharmocological
; : None
terazosin NN Pharmocological
enalapril NN Pharmocological
; : None
placebo NN Control
-DOCSTART- -X- N

encapsulated JJ Pharmocological
juice NN Pharmocological
powder NN Pharmocological
concentrate NN Pharmocological
Phytonutrients NNS Pharmocological
from IN Pharmocological
plant NN Pharmocological
foods NNS Pharmocological
commercially RB Pharmocological
available JJ Pharmocological
encapsulated JJ Pharmocological
juice NN Pharmocological
powder NN Pharmocological
concentrate NN Pharmocological
( ( Pharmocological
JPC NNP Pharmocological
) ) Pharmocological
JPC NNP Pharmocological
or CC Control
placebo NN Control
We PRP None
collected VBD None
plasma NN None
at IN None
baseline NN None
and CC None
study NN None
wk VBP None
4 CD None
, , None
8 CD None
, , None
16 CD None
, , None
and CC None
28 CD None
for IN None
analysis NN None
of IN None
JPC NNP Pharmocological
JPC NNP Pharmocological
placebo NN Control
placebo NN Control
JPC NNP Pharmocological
JPC NNP Pharmocological
-DOCSTART- -X- N

in-person NN Educational
recall NN Educational
with IN Educational
an DT Educational
obese JJ Educational
interviewer NN Educational
in-person NN Educational
recall NN Educational
with IN Educational
a DT Educational
lean JJ Educational
interviewer NN Educational
telephone NN Educational
recall NN Educational
with IN Educational
an DT Educational
unknown JJ Educational
interviewer NN Educational
. . None
telephone-administered JJ Educational
multiple-pass JJ Educational
24-hour JJ Educational
recall NN Educational
unknown JJ None
interviewer NN None
in-person JJ Educational
MP24R NNP Educational
with IN Educational
either CC Educational
a DT Educational
lean JJ Educational
or CC Educational
obese JJ Educational
interviewer NN Educational
to TO Educational
gather VB Educational
Caltrac NNP None
accelerometer NN None
. . None
-DOCSTART- -X- N

transperitoneal JJ Surgical
versus NN None
retroperitoneal NN Surgical
laparoscopic JJ Surgical
adrenalectomy NN Surgical
. . None
transperitoneal JJ Surgical
laparoscopic JJ Surgical
adrenalectomy NN Surgical
( ( Surgical
TLA NNP Surgical
) ) Surgical
vs FW None
retroperitoneal JJ Surgical
laparoscopic NN Surgical
adrenalectomy NN Surgical
( ( Surgical
RLA NNP Surgical
) ) Surgical
prospectively RB None
randomized VBN None
to TO None
undergo VB None
TLA NNP Surgical
( ( None
25 CD None
) ) None
or CC None
RLA NNP Surgical
( ( None
32 CD None
) ) None
. . None
laparoscopic NN Surgical
adrenalectomy NN Surgical
-DOCSTART- -X- N

Topical JJ None
therapy NN None
with IN None
beta-antagonists NNS None
timolol NNS Pharmocological
carteolol NN Pharmocological
betaxolol NN Pharmocological
betaxolol VB Pharmocological
carteolol NN Pharmocological
timolol NNS Pharmocological
-DOCSTART- -X- N

ibutilide JJ Pharmocological
procainamide NN Pharmocological
ibutilide NN Pharmocological
procainamide NN Pharmocological
placebo NN Control
ibutilide NN Pharmocological
, , None
procainamide NN Pharmocological
placebo NN Control
. . Control
ibutilide JJ Pharmocological
procainamide JJ Pharmocological
placebo NN Control
. . Control
placebo NN Control
ibutilide RB Pharmocological
procainamide RB Pharmocological
Ibutilide NNP Pharmocological
procainamide RB Pharmocological
placebo NN Control
ibutilide NN Pharmocological
procainamide NN Pharmocological
. . Pharmocological
ibutilide NN Pharmocological
procainamide NN Pharmocological
-DOCSTART- -X- N

Intensive JJ Educational
case NN Educational
management NN Educational
comprehensive JJ Physical
pre-release JJ Physical
discharge NN Physical
planning NN Physical
antiretroviral JJ Physical
therapy NN Physical
motivational JJ Educational
Strengths NNP Educational
Model NNP Educational
bridging VBG Educational
case NN Educational
management NN Educational
intervention NN Educational
( ( Educational
BCM NNP Educational
) ) Educational
standard NN None
of IN None
care NN None
prison-administered JJ None
discharge NN None
planning VBG None
program NN None
( ( None
SOC NNP None
) ) None
SOC NNP None
assigned VBD None
the DT None
BCM NNP None
case NN None
management NN None
intervention NN None
bridging VBG None
incarceration NN None
and CC None
pre-release JJ None
discharge NN None
planning VBG None
program NN None
in IN None
supporting VBG None
-DOCSTART- -X- N

short JJ Educational
nurse-based JJ Educational
and CC Educational
a DT Educational
long JJ Educational
multidisciplinary JJ Educational
version NN Educational
of IN Educational
structured JJ Educational
patient JJ Educational
education NN Educational
Structured NNP Educational
multidisciplinary JJ Educational
patient NN Educational
group NN Educational
education NN Educational
long JJ Educational
multidisciplinary JJ Educational
group NN Educational
education NN Educational
short JJ Educational
nurse-based JJ Educational
group NN Educational
education NN Educational
short JJ Educational
nurse-based JJ Educational
or CC Educational
a DT Educational
long JJ Educational
multidisciplinary-based JJ Educational
education NN Educational
. . Educational
self-administered JJ Educational
questionnaires NNS Educational
short JJ Educational
, , Educational
nurse-based JJ Educational
educational JJ Educational
intervention NN Educational
longer RBR Educational
multidisciplinary JJ Educational
-DOCSTART- -X- N

Psychosocial NNP Psychological
interventions NNS Psychological
telephone-delivered JJ Psychological
psychosocial JJ Psychological
interventions NNS Psychological
three CD None
different JJ None
6-week JJ None
programs NNS None
: : None
( ( None
a DT None
) ) None
telephone NN Psychological
interpersonal JJ Psychological
counseling NN Psychological
( ( Educational
TIP-C NNP Educational
) ) Educational
; : None
( ( None
b NN None
) ) None
self-managed JJ Educational
exercise NN Educational
; : None
or CC None
( ( None
c NN None
) ) None
attention NN Educational
control NN Educational
( ( Educational
AC NNP Educational
) ) Educational
. . None
TIP-C NNP Psychological
TIP-C NNP Psychological
-DOCSTART- -X- N

[ JJ None
Rilmenidine NNP Pharmocological
rilmenidine NN Pharmocological
placebo NN Control
( ( None
rilmenidine VB Pharmocological
1 CD Pharmocological
mg JJ Pharmocological
bid NN Pharmocological
, , None
placebo NN Control
) ) None
placebo NN Control
-DOCSTART- -X- N

whey JJ Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
whey JJ Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
immunized VBN Pharmocological
against IN Pharmocological
Clostridium NNP Pharmocological
difficile NN Pharmocological
( ( None
C. NNP None
difficile NN Pharmocological
) ) Pharmocological
and CC Pharmocological
its PRP$ Pharmocological
toxins NNS Pharmocological
, , Pharmocological
toxin NN Pharmocological
A NNP Pharmocological
and CC Pharmocological
toxin NN Pharmocological
B NNP Pharmocological
anti-C. JJ None
difficile NN Pharmocological
whey NN Pharmocological
protein VBP Pharmocological
concentrate NN Pharmocological
( ( Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
) ) Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
regular JJ Pharmocological
whey NN Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
placebo NN Control
diltiazem NN Pharmocological
. . None
-DOCSTART- -X- N

Pre-operative JJ Physical
radiochemotherapy NN Physical
pre-operative JJ Physical
vs. FW None
postoperative JJ Physical
radiochemotherapy NN Physical
pre-operative JJ Physical
radiochemotherapy NN Physical
postoperative JJ Physical
radiochemotherapy NN Physical
pre-operative JJ Physical
( ( Physical
PRE NNP Physical
) ) Physical
postoperative JJ Physical
( ( Physical
POST NNP Physical
) ) Physical
radiochemotherapy NN Physical
radiotherapy NN Physical
. . None
PRE NNP Physical
POST NNP Physical
pre-operative JJ Physical
radiotherapy NN Physical
postoperative JJ Physical
radiotherapy NN Physical
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
D-cycloserine NNP Pharmocological
D-cycloserine NNP Pharmocological
D-cycloserine NNP Pharmocological
placebo NN Control
D-cycloserine NNP Pharmocological
placebo NN Control
D-cycloserine NNP Pharmocological
placebo NN Control
D-cycloserine NNP Pharmocological
-DOCSTART- -X- N

3'-azido-2',3'-dideoxythymidine JJ Pharmocological
interferon-? NN None
Human JJ None
interferon-?2a JJ None
( ( None
huIFN-?2a JJ None
) ) None
and CC None
3'-azido-2',3'-dideoxythymidine JJ None
( ( None
AZT NNP None
) ) None
have VBP None
huIFN-?2a NN None
, , None
AZT NNP None
huIFN-?2a NN None
( ( None
10 CD None
( ( None
, , None
AZT NNP None
or CC None
placebo NN None
( ( None
10 CD None
or CC None
AZT NNP None
-DOCSTART- -X- N

captopril NN Pharmocological
enalapril NN Pharmocological
Captopril NNP Pharmocological
enalapril NNS Pharmocological
captopril NN Pharmocological
enalapril $ Pharmocological
Captopril NNP Pharmocological
placebo NN Control
. . None
Enalapril NNP Pharmocological
captopril JJ Pharmocological
enalapril NNS Pharmocological
captopril NN Pharmocological
enalapril NN Pharmocological
-DOCSTART- -X- N

replicated VBN Physical
and CC Physical
gold-coated JJ Physical
. . None
-DOCSTART- -X- N

patient-controlled JJ Pharmocological
and CC None
nurse-administered JJ Pharmocological
analgesia NN Pharmocological
fentanyl NN Pharmocological
citrate NN Pharmocological
patient-controlled JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
fentanyl NN Pharmocological
administration NN Pharmocological
by IN Pharmocological
nurses NNS Pharmocological
on IN Pharmocological
request NN Pharmocological
. . Pharmocological
administration NN Pharmocological
by IN Pharmocological
the DT Pharmocological
patient NN Pharmocological
administration NN Pharmocological
by IN Pharmocological
the DT Pharmocological
nurses NNS Pharmocological
-DOCSTART- -X- N

furosemide NN Pharmocological
no DT Control
therapeutic JJ Control
intervention NN Control
mometasone NN Pharmocological
furoate NN Pharmocological
, , Pharmocological
a DT Pharmocological
corticosteroid NN Pharmocological
treatment NN None
with IN None
intranasal JJ Pharmocological
furosemide NN Pharmocological
received VBD Control
no DT Control
therapeutic JJ Control
treatment NN Control
treated VBN None
with IN None
mometasone NN Pharmocological
. . None
furosemide JJ Pharmocological
-DOCSTART- -X- N

First-intron NNP Physical
polymorphisms NN Physical
polymorphism NN Physical
evaluated VBD Physical
the DT Physical
possible JJ Physical
-DOCSTART- -X- N

Armodafinil NNP Pharmocological
and CC Pharmocological
modafinil NN Pharmocological
Armodafinil NNP Pharmocological
armodafinil NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

urea JJ Pharmocological
fertiliser NN Pharmocological
urea JJ Pharmocological
fertiliser NN Pharmocological
urea JJ Pharmocological
fertiliser NN Pharmocological
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
curative JJ Surgical
resection NN Surgical
Adjuvant NNP Pharmocological
locoregional JJ Pharmocological
chemotherapy NN Pharmocological
cisplatin/lipiodol NN Pharmocological
Adjuvant NNP Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

test VB Educational
alternative JJ Educational
explanations NNS Educational
donate VB Educational
adults NNS None
donated VBD None
significantly RB None
-DOCSTART- -X- N

Instant JJ None
Recess? NNP None
: : None
policy NN None
implementation NN None
intervention NN None
in-school JJ None
PA NNP None
Instant NNP None
Recess? NNP None
was VBD None
10-minute JJ None
PA NNP None
breaks NNS None
in IN None
classroom-based JJ None
-DOCSTART- -X- N

terbinafine NN Pharmocological
. . None
terbinafine NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
78628-80-5 NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

anti-cancer JJ Pharmocological
drugs NNS Pharmocological
Adriamycin NNP Control
Adriamycin NNP Pharmocological
Nocardia NNP Pharmocological
rubra NN Pharmocological
cell NN Pharmocological
wall NN Pharmocological
skeleton NN Pharmocological
tube NN Surgical
thoracostomy NN Surgical
N-CWS NNP Pharmocological
group NN Pharmocological
N-CWS NNP Pharmocological
group NN Pharmocological
. . None
anti-cancer JJ Pharmocological
agent NN Pharmocological
and CC Pharmocological
immunopotentiator NN Pharmocological
anti-cancer JJ Pharmocological
drugs NNS Pharmocological
Carbazilquinone NNP Pharmocological
, , Pharmocological
Mitomycin-C NNP Pharmocological
ACNU NNP Pharmocological
pericardial JJ None
drainage NN None
. . None
anti-cancer JJ Pharmocological
drug NN Pharmocological
anti-cancer JJ Pharmocological
agents NNS Pharmocological
pericardial JJ None
drainage NN None
-DOCSTART- -X- N

rheopheresis NN Pharmocological
Rheopheresis NNP Pharmocological
placebo-controlled JJ Control
rheopheresis NN Pharmocological
treatment NN None
placebo-control JJ Control
treatment NN None
. . None
rheopheresis NN Pharmocological
or CC None
sham NN Pharmocological
treatment NN Pharmocological
placebo NN Control
placebo NN Control
rheopheresis NN Pharmocological
-DOCSTART- -X- N

nifedipine NN Pharmocological
. . None
nifedipine JJ Pharmocological
real-time JJ Pharmocological
ST NNP Pharmocological
segment NN Pharmocological
depression NN Pharmocological
monitor NN Pharmocological
. . None
placebo NN Control
nifedipine NN Pharmocological
therapy NN Pharmocological
nifedipine JJ Pharmocological
Nifedipine NNP Pharmocological
therapy NN Pharmocological
( ( Pharmocological
immediate JJ Pharmocological
release NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

intensive JJ None
therapy NN None
program NN None
intensive JJ Psychological
therapy NN Psychological
program NN Psychological
-DOCSTART- -X- N

increase VB Educational
their PRP$ Educational
verbal JJ Educational
responsiveness NN Educational
short-term JJ Educational
language NN Educational
intervention NN Educational
group NN Educational
parent NN Educational
education NN Educational
sessions NNS Educational
individual JJ Educational
and CC Educational
small-group JJ Educational
coaching NN Educational
sessions NNS Educational
of IN Educational
parent-child JJ Educational
play NN Educational
interactions NNS Educational
. . None
parent-mediated JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

calcium NN Pharmocological
channel NN Pharmocological
blockers NNS Pharmocological
, , None
verapamil NN Pharmocological
and CC None
nifedipine NN Pharmocological
. . None
calcium NN Physical
channel NN Physical
blocking VBG Physical
agents NNS Physical
nifedipine NN Pharmocological
verapamil NN Pharmocological
placebos NNS Control
placebo NN Control
. . None
calcium NN Physical
channel NN Physical
blockers NNS Physical
-DOCSTART- -X- N

enrolled VBN Physical
and CC Physical
randomly RB Physical
assigned VBN Physical
to TO Physical
either VB Physical
a DT Physical
postconditioning NN Physical
group NN Physical
( ( None
three CD Surgical
cycles NNS Surgical
of IN Surgical
30 CD Surgical
seconds NNS Surgical
of IN Surgical
ischemia NN Surgical
and CC Surgical
30 CD Surgical
seconds NNS Surgical
of IN Surgical
reperfusion NN Surgical
using VBG Surgical
re-clamping JJ Surgical
and CC None
de-clamping JJ Surgical
starting VBG Surgical
30 CD Surgical
seconds NNS Surgical
after IN Surgical
the DT Surgical
initial JJ Surgical
de-clamping NN Surgical
of IN Surgical
the DT Surgical
aorta NN Surgical
, , Surgical
n JJ Surgical
= NNP Surgical
41 CD Surgical
) ) None
or CC None
a DT None
control NN Control
group NN Control
( ( None
n JJ None
= NNP None
39 CD None
) ) None
. . None
( ( None
cTnI NN None
) ) None
was VBD None
assayed VBN None
preoperatively RB None
, , None
and CC None
then RB None
4 CD None
hours NNS None
, , None
8 CD None
hours NNS None
, , None
12 CD None
hours NNS None
, , None
20 CD None
hours NNS None
, , None
and CC None
48 CD None
hours NNS None
after IN Educational
persistent JJ Educational
reperfusion NN Educational
. . None
-DOCSTART- -X- N

brisk JJ Physical
walking VBG Physical
in IN Physical
two CD Physical
different JJ Physical
environments NNS Physical
: : Physical
30 CD Physical
minute NN Physical
brisk NN Physical
walk VBP Physical
-DOCSTART- -X- N

video NN Surgical
assisted VBN Surgical
thoracic NN Surgical
surgery NN Surgical
insertion NN Surgical
of IN Surgical
a DT Surgical
chest NN Surgical
tube NN Surgical
( ( Surgical
ICT NNP Surgical
) ) Surgical
video NN Surgical
assisted VBN Surgical
thoracoscopy NN Surgical
( ( Surgical
VATS NNP Surgical
) ) Surgical
ICT NNP Surgical
or CC None
VATS NNP Surgical
. . None
ICT JJ Surgical
VATS NNP Surgical
ICT JJ Surgical
VATS NNP Surgical
ICT NNP Surgical
VATS NNP Surgical
VATS NNP Surgical
-DOCSTART- -X- N

synthetic JJ Pharmocological
appeasing VBG Pharmocological
pheromone NN Pharmocological
synthetic JJ Pharmocological
, , Pharmocological
dog-appeasing JJ Pharmocological
pheromone NN Pharmocological
( ( Pharmocological
sDAP NN Pharmocological
) ) Pharmocological
sDAP JJ Physical
solution NN Physical
or CC None
sham NN Control
treated VBN Control
with IN Control
the DT Control
carrier NN Control
used VBN None
in IN None
the DT None
solution NN None
20 CD None
minutes NNS None
prior RB None
to TO None
use VB None
. . None
sDAP NN Physical
sham JJ Control
treatment NN Control
sDAP NN Pharmocological
-DOCSTART- -X- N

by IN None
a DT None
direct JJ None
PCR NNP None
method NN None
in IN None
fecal JJ None
samples NNS None
from IN None
mothers NNS None
breast-milk JJ Physical
samples NNS Physical
1 CD None
month NN None
post-partum NN None
. . None
-DOCSTART- -X- N

EPI-NO NNP Other
EPI-NO NNP Other
EPI-NO NNP Other
EPI-NO NNP Other
EPI-NO NNP Physical
-DOCSTART- -X- N

epoetin NN Pharmocological
zeta NN Pharmocological
to TO None
epoetin VB Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
zeta NN Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
zeta NN Pharmocological
or CC None
epoetin NN Pharmocological
alfa NN Pharmocological
epoetin NN Pharmocological
epoetin NN Pharmocological
epoetin NN Pharmocological
zeta NN Pharmocological
epoetin JJ Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
zeta NN Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
Epoetin NNP Pharmocological
zeta NN Pharmocological
-DOCSTART- -X- N

emotion NN Psychological
recognition NN Psychological
emotion NN Psychological
training NN Psychological
programme NN Psychological
emotion NN Psychological
training NN Psychological
emotion NN Educational
training NN Educational
programme NN Educational
emotion NN Psychological
recognition NN Psychological
skills NNS Psychological
the DT None
Transporters NNPS Educational
Thomas NNP Control
the DT Control
Tank NNP Control
Engine NNP Control
The DT Educational
Transporters NNP Psychological
Transporters NNP Psychological
-DOCSTART- -X- N

home NN Educational
visiting NN Educational
asthma JJ Educational
education NN Educational
program NN Educational
: : None
nurse JJ Educational
home NN Educational
visiting NN Educational
asthma JJ Educational
education NN Educational
program NN Educational
home-based JJ Educational
asthma NN Educational
education NN Educational
programs NNS Educational
-DOCSTART- -X- N

perioperative JJ Pharmocological
enterococcus NN Pharmocological
and CC Pharmocological
bacteroides NNS Pharmocological
therapy NN Pharmocological
. . None
Perioperative JJ Pharmocological
antibiotics NNS Pharmocological
cefoxitin NN Pharmocological
or CC None
ampicillin/sulbactam NN Pharmocological
-DOCSTART- -X- N

Osteoporosis NN Pharmocological
timed VBN None
up RP None
and CC None
go VB None
, , None
chair NN None
stand NN None
, , None
single JJ None
leg NN None
stand NN None
step VB Other
test NN Other
. . None
-DOCSTART- -X- N

Hypericum NNP Pharmocological
treatment NN Pharmocological
placebo-controlled JJ Control
hypericum JJ Pharmocological
extract JJ Pharmocological
LI NNP Pharmocological
160 CD Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Clinical JJ Physical
massage NN Physical
and CC None
modified VBD Physical
Proprioceptive NNP Physical
Neuromuscular NNP Physical
Facilitation NNP Physical
stretching VBG Physical
modified JJ Physical
Proprioceptive NNP Physical
Neuromuscular NNP Physical
Facilitation NNP Physical
( ( Physical
PNF NNP Physical
) ) Physical
stretching NN Physical
Myofascial JJ Physical
Trigger NNP Physical
Point NNP Physical
( ( Physical
MTrP NNP Physical
) ) Physical
therapy NN Physical
plus CC Physical
modified JJ Physical
PNF NNP Physical
stretching NN Physical
no DT Other
treatment NN Other
. . None
MTrP NNP Physical
therapy NN Physical
modified JJ Physical
PNF NNP Physical
stretching NN Physical
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
low-dose JJ Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
CY NNP Pharmocological
) ) Pharmocological
conventional JJ None
chemotherapy JJ None
CY NNP Pharmocological
CY NNP Pharmocological
-DOCSTART- -X- N

polyfrequency NN Physical
oscillation NN Physical
method NN Physical
bodyplethysmograph NN Physical
transcutaneous JJ Pharmocological
oxygen NN Pharmocological
pressure NN Pharmocological
bodyplethysmography NN Physical
polyfrequent JJ Physical
oscillation NN Physical
method NN Physical
-DOCSTART- -X- N

fluticasone NN Pharmocological
placebo-controlled JJ Control
fluticasone NN Pharmocological
fluticasone NN Pharmocological
placebo NN Control
fluticasone NN Pharmocological
fluticasone NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

perindopril NN Pharmocological
and CC Pharmocological
hydrochlorothiazide VB Pharmocological
alone RB Pharmocological
and CC Pharmocological
in IN Pharmocological
combination NN Pharmocological
perindopril NN Pharmocological
hydrochlorothiazide NN Pharmocological
alone RB None
in IN None
combination NN None
perindopril NN Pharmocological
perindopril NN Pharmocological
or CC None
hydrochlorothiazide NN Pharmocological
perindopril NN Pharmocological
hydrochlorothiazide NN Pharmocological
. . None
hydrochlorothiazide NN Pharmocological
Perindopril NNP Pharmocological
hydrochlorothiazide NN Pharmocological
perindopril NN Pharmocological
and CC None
hydrochlorothiazide NN Pharmocological
-DOCSTART- -X- N

doxorubicin NN Pharmocological
epirubicin NN Pharmocological
40 CD Pharmocological
mg NNS Pharmocological
doxorubicin VBD Pharmocological
or CC None
40 CD Physical
mg NNS Physical
epirubicin VBP Physical
with IN None
no DT None
instillation NN None
after IN None
transurethral JJ None
resection NN None
of IN None
tumor NN None
( ( None
s NN None
) ) None
doxorubicin NN Pharmocological
epirubicin JJ Pharmocological
-DOCSTART- -X- N

Self-Care JJ Educational
Rehabilitation NNP Educational
Program NNP Educational
Self-Care JJ Educational
Rehabilitation NNP Educational
six CD Educational
1-hour JJ Educational
classes NNS Educational
scheduled VBN Educational
twice RB Educational
a DT Educational
week NN Educational
for IN Educational
3 CD Educational
weeks NNS Educational
. . None
eight CD Educational
90-minute JJ Educational
classes NNS Educational
for IN Educational
both DT Educational
scheduled VBN Educational
SCRPA NNP Educational
-DOCSTART- -X- N

primary JJ Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

were VBD None
divided VBN None
into IN None
4 CD None
groups NNS None
randomly RB None
, , None
and CC None
boosted VBD None
3 CD None
dose NN None
of IN None
4 CD None
different JJ None
types NNS None
of IN None
HepB NNP Pharmocological
at IN None
0 CD None
, , None
1 CD None
, , None
6 CD None
months NNS None
. . None
revaccination NN Pharmocological
HepB-Y NNP Pharmocological
HepB-Y NNP Pharmocological
HepB-CHO NNP Pharmocological
HepB-HY NNP Pharmocological
-DOCSTART- -X- N

betamethasone NN Pharmocological
valerate NN Pharmocological
active JJ Pharmocological
corticosteroid NN Pharmocological
preparation NN Pharmocological
( ( Pharmocological
Betamethasone NNP Pharmocological
valerate NN Pharmocological
) ) Pharmocological
basal NN Control
formulation NN Control
only RB Control
( ( Control
placebo NN Control
) ) Control
. . Control
-DOCSTART- -X- N

Trace NNP Pharmocological
element NN Pharmocological
supplementation NN Pharmocological
TE NNP Pharmocological
supplements NNS Pharmocological
placebo-controlled JJ Control
Intravenous JJ Pharmocological
copper NN Pharmocological
, , Pharmocological
selenium NN Pharmocological
, , Pharmocological
and CC Pharmocological
zinc NN Pharmocological
( ( Pharmocological
TE NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
or CC None
vehicle NN Pharmocological
TE NNP Pharmocological
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
thrombopoietin NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
thrombopoietin NN Pharmocological
( ( Pharmocological
rhTPO NN Pharmocological
) ) Pharmocological
placebo NN Control
, , Control
placebo NN Control
, , None
rhTPO VBZ Pharmocological
high-dose JJ Pharmocological
chemotherapy NN Pharmocological
and CC Pharmocological
PBPC NNP Pharmocological
transplantation NN Pharmocological
placebo JJ Control
rhTPO NN Pharmocological
rhTPO NN Pharmocological
rhTPO NN Pharmocological
placebo VB Control
rhTPO-treated JJ Physical
rhTPO VB Pharmocological
rhTPO NN Pharmocological
chemotherapy NN Pharmocological
PBPC NNP Pharmocological
transplantation NN Pharmocological
. . None
-DOCSTART- -X- N

melodic NNS Psychological
based VBN Psychological
communication NN Psychological
therapy NN Psychological
melodic NNS Psychological
based VBN Psychological
communication NN Psychological
therapy NN Psychological
( ( Psychological
MBCT NNP Psychological
) ) Psychological
to TO None
traditional JJ Psychological
speech NN Psychological
and CC Psychological
language NN Psychological
therapy NN Psychological
MBCT NNP Psychological
MBCT NNP Psychological
MBCT NNP Educational
-DOCSTART- -X- N

fish JJ Pharmocological
oil NN Pharmocological
corn NN Pharmocological
oil NN Pharmocological
. . None
fish JJ Pharmocological
oil NN Pharmocological
corn NN Pharmocological
oil NN Pharmocological
cyclosporin-treated JJ Pharmocological
oil NN Pharmocological
. . None
cyclosporin NN Pharmocological
oil NN Pharmocological
cyclosporin-induced JJ Pharmocological
-DOCSTART- -X- N

Lanoxin NNP Pharmocological
from IN Pharmocological
an DT Pharmocological
oral JJ Pharmocological
solution NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Anastrozole NNP Pharmocological
anastrozole NN Pharmocological
clomiphene NN Pharmocological
citrate NN Pharmocological
( ( Pharmocological
CC NNP Pharmocological
) ) Pharmocological
Single-dose JJ Pharmocological
anastrozole NN Pharmocological
5-day JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
CC NNP Pharmocological
anastrozole NN None
at IN None
the DT None
anastrozole JJ None
5 CD None
single-dose JJ None
anastrozole NN None
at IN None
-DOCSTART- -X- N

non-invasive JJ Physical
methods NNS Physical
haemodynamic JJ Physical
laser NN Physical
interferometry NN Physical
of IN Physical
ocular JJ Physical
fundus NN Physical
pulsations NNS Physical
and CC None
of IN None
non-invasive JJ Physical
methods NNS Physical
intravenous JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
phenylephrine NN Pharmocological
, , None
isoprenaline NN Pharmocological
, , None
sodium NN Pharmocological
nitroprusside NN Pharmocological
and CC None
of IN None
placebo NN Control
. . None
Laser NNP Physical
interferometry NN Physical
-DOCSTART- -X- N

intervention NN Educational
adult NN Educational
intervention NN Educational
( ( None
low JJ Educational
, , Educational
medium NN Educational
, , Educational
high JJ Educational
intervention NN Educational
, , None
or CC None
no-intervention JJ Physical
control NN None
) ) None
systematically RB None
varying VBG None
the DT None
manner NN Educational
and CC Educational
frequency NN Educational
with IN Educational
which WDT Educational
objects NNS Educational
were VBD Educational
presented VBN Educational
, , None
the DT None
extent NN Educational
to TO Educational
which WDT Educational
the DT Educational
experimenter NN Educational
talked VBD Educational
to TO Educational
the DT Educational
infant NN Educational
, , None
and CC None
physical JJ Educational
proximity NN Educational
. . None
intervention NN Educational
-DOCSTART- -X- N

Capsaicin NNP Pharmocological
jelly RB Pharmocological
Capsaicin NNP Pharmocological
Topical JJ Pharmocological
capsaicin NN Pharmocological
topical JJ Pharmocological
periarterial JJ Pharmocological
capsaicin NN Pharmocological
topical JJ Pharmocological
capsaicin NN Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
vaseline NN Pharmocological
jelly RB Pharmocological
Topical NNP Pharmocological
capsaicin NN Pharmocological
capsaicin NN Pharmocological
vaseline NN Control
. . None
topical JJ Pharmocological
capsaicin NN Pharmocological
capsacinoids NNS Pharmocological
-DOCSTART- -X- N

health NN None
care NN None
services NNS None
placebo-controlled JJ Control
sibenadet NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

progressive JJ Educational
muscle NN Educational
relaxation NN Educational
training NN Educational
progressive JJ Educational
muscle NN Educational
relaxation NN Educational
training NN Educational
( ( Educational
PMRT NNP Educational
) ) Educational
PMRT NNP Educational
-DOCSTART- -X- N

interactive JJ Educational
vs. FW Educational
lecture-based JJ Educational
programs NNS Educational
. . None
patient JJ Educational
education NN Educational
interactive JJ Educational
, , Educational
patient-oriented JJ Educational
group NN Educational
program NN Educational
to TO None
a DT None
lecture-based JJ Educational
, , Educational
information-only JJ Educational
program NN Educational
interactive JJ Educational
intervention NN Educational
or CC Educational
lectures VBZ Educational
providing VBG Educational
information NN Educational
. . Educational
interactive JJ Educational
patient NN Educational
education NN Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

Transdermal NNP None
scopolamine NN Pharmocological
patch NN None
ondansetron VB Pharmocological
transdermal JJ None
scopolamine NN Pharmocological
ondansetron VB Pharmocological
transdermal JJ None
scopolamine NN Pharmocological
( ( None
TDS NNP None
) ) None
patch NN None
a DT None
placebo JJ Control
patch NN None
scopolamine NN Pharmocological
-DOCSTART- -X- N

oral JJ Physical
hygiene NN Physical
measures NNS Physical
oral JJ Physical
hygiene NN Physical
measures NNS Physical
professional JJ Physical
mechanical JJ Physical
tooth-cleaning NN Physical
, , Educational
tongue-scraping NN Physical
, , Educational
chlorhexidine NN Control
treatment NN Control
, , Educational
and CC Educational
oral JJ Educational
hygiene NN Educational
instructions NNS Educational
oral JJ Educational
hygiene NN Educational
instructions NNS Educational
preventive JJ Educational
program NN Educational
provided VBN Educational
by IN Educational
the DT Educational
local JJ Educational
Dental NNP Educational
Health NNP Educational
Office NNP Educational
mechanical JJ Physical
plaque NN Physical
control NN Physical
topical JJ Pharmocological
use NN Pharmocological
of IN Pharmocological
fluorides NNS Pharmocological
and CC Pharmocological
chlorhexidine NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Left NNP None
ventricular JJ None
mass NN None
regression NN None
calcium NN Pharmocological
blocker NN Pharmocological
, , Pharmocological
verapamil NN Pharmocological
, , None
and CC None
the DT None
beta-blocker NN Pharmocological
, , Pharmocological
atenolol NN Pharmocological
2-D JJ Physical
echocardiographic JJ Physical
evaluation NN Physical
verapamil NN Pharmocological
atenolol NN Pharmocological
verapamil NN Pharmocological
atenolol NN Pharmocological
. . None
-DOCSTART- -X- N

Single-needle JJ Physical
acupuncture NN Physical
single-needle JJ Physical
acupuncture NN Physical
single-needle JJ Physical
acupuncture NN Physical
no DT Physical
acupuncture NN Physical
Acupuncture NNP Physical
of IN Physical
CV24 NNP Physical
-DOCSTART- -X- N

splinting VBG Physical
teeth NNS Physical
periodontal JJ Surgical
reconstructive JJ Surgical
surgery NN Surgical
splinted VBN Surgical
to TO Surgical
at IN Surgical
least JJS Surgical
two CD Surgical
rigid JJ Surgical
teeth NNS Surgical
before IN Surgical
surgery NN Surgical
splinted VBN Physical
at IN Physical
suture NN Physical
removal NN Physical
treated JJ Physical
teeth NNS Physical
were VBD Physical
not RB Physical
splinted VBN Physical
at IN Physical
all DT Physical
. . None
-DOCSTART- -X- N

radiotherapy NN Physical
vs. IN Surgical
trans-oral JJ Surgical
robotic JJ Surgical
surgery NN Surgical
( ( Surgical
ORATOR NNP Surgical
) ) Surgical
-- : Surgical
study NN Surgical
Primary JJ Physical
radiotherapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
concurrent NN Physical
chemotherapy NN Physical
Transoral NNP Surgical
robotic JJ Surgical
surgery NN Surgical
( ( Surgical
TORS NNP Surgical
) ) Surgical
TORS NNP Surgical
RT NNP Physical
primary JJ None
RT NNP None
( ( None
? . None
chemotherapy NN None
) ) None
TORS NNP None
( ( None
? . None
adjuvant NN None
[ NN None
chemo NN None
] NNP None
RT NNP None
) ) None
in IN None
1 CD None
( ( None
RT NNP None
? . None
chemotherapy NN None
) ) None
and CC None
( ( None
TORS NNP None
? . None
adjuvant JJ None
[ NN None
chemo NN None
] NNP None
RT NNP None
) ) None
. . None
In IN None
Arm NNP None
receive VB None
RT NNP None
alone RB None
, , None
receive VB None
concurrent JJ None
chemoradiation NN None
. . None
In IN None
Arm NNP None
2 CD None
undergo VB None
TORS NNP None
along IN None
with IN None
selective JJ None
neck NN None
dissections NNS None
, , None
which WDT None
may MD None
requirement NN None
for IN None
adjuvant JJ None
radiotherapy NN None
+/- JJ None
chemotherapy NN None
. . None
The DT None
primary JJ None
-DOCSTART- -X- N

HMG NNP Pharmocological
CoA NNP Pharmocological
reductase NN Pharmocological
inhibitors NNS Pharmocological
statins NNS Pharmocological
statins VBZ Pharmocological
atorvastatin NN Pharmocological
simvastatin NN Pharmocological
atorvastatin NN Pharmocological
simvastatin NN Pharmocological
statin NN Pharmocological
atorvastatin NN Pharmocological
. . None
statin NN Pharmocological
-DOCSTART- -X- N

smoking VBG Educational
cessation NN Educational
smoking VBG Educational
cessation NN Educational
programs NNS Educational
smoking NN Educational
cessation NN Educational
smoking VBG Educational
cessation NN Educational
interventions NNS Educational
-DOCSTART- -X- N

vaccination NN Pharmocological
and CC None
of IN None
DHEA NNP Pharmocological
administration NN Pharmocological
vaccination NN Pharmocological
dehydroepiandrosterone NN Pharmocological
( ( Pharmocological
DHEA NNP Pharmocological
) ) Pharmocological
influenza VB Pharmocological
vaccine NN Pharmocological
DHEA NNP Pharmocological
placebo NN Control
. . Control
DHEA NNP Pharmocological
treatment NN Pharmocological
DHEA NNP Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

transurethral JJ Surgical
resection NN Surgical
room NN Physical
temperature NN Physical
irrigation NN Physical
fluid NN Physical
( ( Physical
70 CD Physical
degrees NNS Physical
F NNP Physical
) ) Physical
throughout IN None
TURP NNP Surgical
; : None
warmed JJ Pharmocological
irrigation NN Pharmocological
fluid NN Pharmocological
warm JJ Pharmocological
-DOCSTART- -X- N

Ciprofloxacin/dexamethasone NNP Pharmocological
ciprofloxacin JJ Pharmocological
0.3 CD Pharmocological
% NN Pharmocological
/dexamethasone CD Pharmocological
Ciprodex NNP Pharmocological
or CC None
no DT Control
treatment NN Control
for IN Control
5 CD Control
days NNS Control
post-operatively RB Control
-DOCSTART- -X- N

presyncopal JJ Physical
symptom-limited JJ Physical
lower JJR Physical
body NN Physical
negative JJ Physical
pressure NN Physical
( ( Physical
PSL-LBNP NNP Physical
) ) Physical
exposure NN Physical
protocols NNS Physical
PSL-LBNP NNP Physical
PSL-LBNP NNP Physical
PSL-LBNP NNP Physical
PSL-LBNP JJ Physical
tests NNS None
PSL-LBNP JJ Physical
-DOCSTART- -X- N

combination NN Pharmocological
of IN Pharmocological
valsartan NN Pharmocological
and CC None
benazepril NN Pharmocological
Valsartan NNP Pharmocological
combination NN Pharmocological
of IN Pharmocological
valsartan NN Pharmocological
and CC None
benazepril NN Pharmocological
. . None
valsartan JJ Pharmocological
160 CD Pharmocological
mg NN Pharmocological
valsartan JJ Pharmocological
80 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
plus CC None
benazepril JJ Pharmocological
5 CD Pharmocological
or CC Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
once RB Pharmocological
daily JJ Pharmocological
valsartan JJ Pharmocological
160 CD Pharmocological
mg NN Pharmocological
plus CC None
benazepril JJ Pharmocological
5 CD Pharmocological
or CC Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
-DOCSTART- -X- N

either DT None
conventional JJ Control
chemotherapy NN Control
with IN Control
CEOP-Bleo NNP Control
( ( Control
cyclophosphamide VB Control
750 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
vincristine JJ Control
1.4 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
prednisone RB Control
40 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
epirubicin $ Control
70 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
and CC Control
bleomycin $ Control
10 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
) ) Control
or CC None
mega JJ Pharmocological
CEOP-Bleo NNP Pharmocological
( ( Pharmocological
cyclophosphamide JJ Pharmocological
1000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
, , Pharmocological
epirubicin $ Pharmocological
120 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
prednisone NN Pharmocological
, , Pharmocological
and CC Pharmocological
bleomycin NN Pharmocological
at IN Pharmocological
the DT Pharmocological
same JJ Pharmocological
doses NNS Pharmocological
) ) Pharmocological
every DT None
21 CD None
days NNS None
for IN None
six CD None
cycles NNS None
, , None
followed VBN None
by IN None
radiotherapy NN Physical
to TO Physical
the DT Physical
mediastinum NN Physical
with IN Physical
the DT Physical
mantle NN Physical
technique NN Physical
( ( Physical
35-45 JJ Physical
Gy NNP Physical
, , Physical
mean VBP Physical
38 CD Physical
Gy NNP Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

hydrotalcite JJ Pharmocological
esomeprazole NN Pharmocological
hydrotalcite NN Pharmocological
esomeprazole VB Pharmocological
hydrotalcite NN Pharmocological
or CC None
esomeprazole NN Pharmocological
hydrotalcite NN Pharmocological
esomeprazole JJ Pharmocological
of IN None
hydrotalcite NN None
to TO None
of IN None
esomeprazole NN None
( ( None
per IN None
CONCLUSION NNP None
Hydrotalcite NNP None
is VBZ None
-DOCSTART- -X- N

Combined VBN Other
delivery NN Other
approach NN Other
bone NN Physical
marrow NN Physical
mononuclear JJ Physical
stem NN Physical
cells NNS Physical
early RB Physical
bone-marrow-derived JJ Physical
stem NN Physical
cell NN Physical
therapy NN Physical
stem NN Physical
cells NNS Physical
cardiac JJ Surgical
stem NN Surgical
cell NN Surgical
delivery NN Surgical
-DOCSTART- -X- N

-DOCSTART- -X- N

mitral JJ Surgical
valve FW Surgical
replacement NN Surgical
of IN None
the DT None
chordae NN None
tendineae NN None
and CC None
papillary JJ None
muscles NNS None
during IN None
mitral JJ Surgical
valve FW Surgical
replacement NN Surgical
. . None
Rest NNP Physical
and CC Physical
exercise NN Physical
nuclear JJ Physical
ventriculograms NNS Physical
-DOCSTART- -X- N

toothpastes NNS Physical
abrasivity NN Physical
. . None
five-treatment JJ None
cross-over NN None
design NN None
Drinking NN Physical
water NN Physical
brushing NN Physical
toothpaste NN None
Drinking VBG None
orange NN Physical
juice NN Physical
. . None
orange NN Physical
juice NN Physical
and CC None
brushing VBG Physical
with IN Physical
toothpaste NN Physical
-DOCSTART- -X- N

Alvimopan NNP Pharmocological
alvimopan NN Pharmocological
Alvimopan NNP Pharmocological
alvimopan RB Pharmocological
( ( None
alvimopan NN Pharmocological
placebo NN Control
( ( None
alvimopan NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

ebrotidine NN Pharmocological
and CC None
ranitidine NN Pharmocological
combined VBN None
with IN None
amoxicillin NN Pharmocological
and CC None
metronidazole NN Pharmocological
ebrotidine NN Pharmocological
( ( Pharmocological
N- JJ Pharmocological
[ NN Pharmocological
( ( Pharmocological
E NNP Pharmocological
) ) Pharmocological
- : Pharmocological
[ JJ Pharmocological
[ JJ Pharmocological
2- JJ Pharmocological
[ NN Pharmocological
[ NNP Pharmocological
[ NNP Pharmocological
2- JJ Pharmocological
[ NNP Pharmocological
( ( Pharmocological
diaminomethylene NN Pharmocological
) ) Pharmocological
amino NN Pharmocological
] JJ Pharmocological
-4-thiazolyl NNP Pharmocological
] NNP Pharmocological
methyl NN Pharmocological
] NNP Pharmocological
thio NN Pharmocological
] NNP Pharmocological
ethyl VBZ Pharmocological
] NNP Pharmocological
amino NN Pharmocological
] NNP Pharmocological
methylene NN Pharmocological
] NNP Pharmocological
-4-bromo-benzenesulfonamide NNP Pharmocological
, , Pharmocological
CAS NNP Pharmocological
100981-43-9 CD Pharmocological
, , Pharmocological
FI-3542 NNP Pharmocological
) ) Pharmocological
400 CD Pharmocological
mg NN Pharmocological
and CC None
ranitidine VB Pharmocological
300 CD Pharmocological
mg NN Pharmocological
combined VBN None
with IN None
amoxicillin JJ Pharmocological
metronidazole $ Pharmocological
-DOCSTART- -X- N

medication NN Pharmocological
parent NN Educational
training NN Educational
risperidone NN Pharmocological
structured JJ Educational
parent NN Educational
training NN Educational
risperidone VB Pharmocological
-DOCSTART- -X- N

Codeine/acetaminophen NNP Pharmocological
hydrocodone/acetaminophen JJ Pharmocological
combination NN Pharmocological
acetaminophen VBP Pharmocological
. . None
codeine NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
in IN None
combination NN Pharmocological
with IN Pharmocological
acetaminophen NN Pharmocological
. . None
codeine NN Pharmocological
phosphate NN Pharmocological
versus IN None
hydrocodone NN Pharmocological
bitartrate NN Pharmocological
acetaminophen NN Pharmocological
of IN None
codeine/acetaminophen NN None
( ( None
C/A NNP None
) ) None
or CC None
hydrocodone/acetaminophen NN None
( ( None
H/A NNP None
) ) None
received VBD None
C/A NNP None
received VBD None
H/A NNP None
. . None
received VBD None
C/A NNP None
, , None
with IN None
H/A NNP None
, , None
the DT None
C/A NNP None
and CC None
H/A NNP None
between IN None
C/A NNP None
and CC None
H/A NNP None
-DOCSTART- -X- N

ipsilateral JJ Physical
backward NN Physical
arm NN Physical
swing NN Physical
ipsilateral JJ Physical
arm NN Physical
forward NN Physical
swing NN Physical
. . None
-DOCSTART- -X- N

extradural JJ Pharmocological
analgesia NN Pharmocological
-DOCSTART- -X- N

repetitive JJ Surgical
transcranial JJ Surgical
magnetic JJ Surgical
stimulation NN Surgical
( ( Surgical
rTMS NN Surgical
) ) Surgical
repetitive JJ Surgical
transcranial JJ Surgical
magnetic JJ Surgical
stimulation NN Surgical
( ( Surgical
rTMS NN Surgical
) ) None
10 CD Surgical
Hz NNP Surgical
rTMS NN Surgical
sham NN None
sham JJ Control
stimulation NN Control
. . None
-DOCSTART- -X- N

ketorolac NN Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
ketorolac NNS Pharmocological
-DOCSTART- -X- N

2-chlorodeoxyadenosine JJ Pharmocological
2-chlorodeoxyadenosine JJ Pharmocological
( ( Pharmocological
Cladribine NNP Pharmocological
, , Pharmocological
CDA NNP Pharmocological
) ) Pharmocological
CDA NNP Pharmocological
( ( None
CDA NNP Pharmocological
( ( None
CDA NNP Pharmocological
CDA NNP Pharmocological
-DOCSTART- -X- N

L-arginine JJ Pharmocological
S-nitrosoglutathione JJ Pharmocological
L-Arginine JJ Pharmocological
L-arginine NNP Pharmocological
S-nitrosoglutathione NNP Pharmocological
( ( Pharmocological
GSNO NNP Pharmocological
) ) Pharmocological
L-arginine NNP Pharmocological
GSNO NNP Pharmocological
placebo NN Control
placebo NN None
L-arginine JJ Pharmocological
GSNO NNP Pharmocological
L-arginine NNP Pharmocological
GSNO NNP Pharmocological
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
ciliary JJ Pharmocological
neurotrophic JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
rHCNTF NN Pharmocological
) ) Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
ciliary JJ Pharmocological
neurotrophic JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
rHCNTF NN Pharmocological
) ) Pharmocological
placebo VB Control
CNTF NNP Pharmocological
rHCNTF NN Pharmocological
rHCNTF NN Pharmocological
-DOCSTART- -X- N

parecoxib NN Pharmocological
placebo-controlled JJ Control
parecoxib NN Pharmocological
parecoxib NN Pharmocological
sodium NN Pharmocological
and CC None
placebo NN None
group NN None
receiving VBG None
normal JJ None
saline JJ None
2 CD None
in IN None
placebo NN None
group NN None
administration NN None
of IN None
parecoxib NN None
after IN None
primary JJ None
-DOCSTART- -X- N

nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
nitric-oxidegenerating JJ Pharmocological
gel NN Pharmocological
We PRP None
prepared VBD None
the DT None
nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
by IN None
mixing VBG None
a DT None
solution NN None
of IN None
KY NNP Pharmocological
jelly RB Pharmocological
and CC Pharmocological
sodium JJ Pharmocological
nitrite NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
% NN Pharmocological
weight/volume NN Pharmocological
) ) Pharmocological
, , Pharmocological
with IN Pharmocological
a DT Pharmocological
solution NN Pharmocological
of IN Pharmocological
KY NNP Pharmocological
jelly RB Pharmocological
and CC Pharmocological
ascorbic JJ Pharmocological
acid NN Pharmocological
( ( None
5 CD None
% NN None
weight/volume NN None
) ) None
About IN None
0.5 CD None
mL NNS None
of IN None
each DT None
solution NN None
was VBD None
separately RB None
applied VBN Pharmocological
to TO Pharmocological
the DT Pharmocological
skin NN Pharmocological
of IN Pharmocological
the DT Pharmocological
forearm NN Pharmocological
( ( None
3 CD None
cm2 NN None
) ) None
, , None
and CC None
then RB None
mixed JJ None
with IN None
a DT None
sterile JJ None
cotton NN None
bud NN None
. . None
A DT None
similar JJ None
procedure NN None
was VBD None
done VBN None
simultaneously RB None
on IN None
the DT None
other JJ None
arm NN None
with IN None
KY NNP Control
jelly RB Control
only RB Control
( ( Control
placebo NN Control
) ) Control
nitric-oxide-generating JJ Pharmocological
system NN Pharmocological
-DOCSTART- -X- N

postural JJ Physical
supports NNS Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
and/or VBZ None
a DT None
postural JJ Physical
support NN Physical
roll NN Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
, , None
postural JJ Physical
support NN Physical
nappy JJ Physical
and CC Physical
postural JJ Physical
support NN Physical
roll NN Physical
, , None
or CC None
disposable JJ Physical
nappy JJ Physical
and CC Physical
postural JJ Physical
support NN Physical
roll NN Physical
. . None
postural JJ Physical
support NN Physical
roll NN Physical
and CC Physical
a DT Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
postural JJ Physical
support NN Physical
roll NN Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
postural JJ Physical
support NN Physical
roll NN Physical
postural JJ Physical
support NN Physical
nappy JJ Physical
postural JJ Physical
support NN Physical
roll NN Physical
-DOCSTART- -X- N

Vitamin JJ Pharmocological
supplements NNS Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
-DOCSTART- -X- N

social JJ Educational
support NN Educational
and CC Educational
education NN Educational
A DT Educational
Roy NNP Educational
adaptation NN Educational
model-based JJ Educational
support NN Educational
and CC Educational
education NN Educational
intervention NN Educational
combined JJ Educational
individual JJ Educational
telephone NN Educational
and CC Educational
in-person NN Educational
group NN Educational
support NN Educational
and CC Educational
education NN Educational
telephone-only JJ Educational
individual JJ Educational
support NN Educational
and CC Educational
education NN Educational
one-time RB Educational
mailed JJ Educational
educational JJ Educational
information NN Educational
. . Educational
-DOCSTART- -X- N

complementary JJ Pharmocological
foods NNS Pharmocological
complementary JJ Educational
feeding NN Educational
continued VBN Other
full JJ Other
breast-feeding NN Other
until IN Other
6 CD Other
mo NNS Other
introduction NN Other
of IN Other
complementary JJ Other
foods NNS Other
at IN Other
4 CD Other
mo NN Other
with IN Other
ad NN Other
libitum NN Other
breast-feeding NN Other
from IN Other
4 CD Other
to TO Other
6 CD Other
mo NN Other
introduction NN Psychological
of IN Psychological
complementary JJ Psychological
foods NNS Psychological
at IN Psychological
4 CD Psychological
mo NN Psychological
with IN Psychological
maintenance NN Psychological
of IN Psychological
baseline JJ Psychological
breast-feeding JJ Psychological
frequency NN Psychological
from IN Psychological
4 CD Psychological
to TO Psychological
6 CD Psychological
mo NNS Psychological
complementary JJ Pharmocological
foods NNS Pharmocological
-DOCSTART- -X- N

lidocaine NN Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
placebo VB Control
lidocaine NN Pharmocological
placebo NN Pharmocological
lidocaine NN Pharmocological
Lidocaine NNP Pharmocological
-DOCSTART- -X- N

Social NNP Educational
Communication NNP Educational
Assessment NNP Educational
for IN Educational
Toddlers NNP Educational
with IN Educational
Autism NNP Educational
( ( Educational
SCATA NNP Educational
) ) Educational
: : None
Social NNP Educational
Communication NNP Educational
Assessment NNP Educational
for IN Educational
Toddlers NNP Educational
with IN Educational
Autism NNP Educational
( ( Educational
SCATA NNP Educational
) ) Educational
SCATA NNP Educational
-DOCSTART- -X- N

meal NN Educational
plan NN Educational
of IN Educational
'eating VBG Educational
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
' '' Educational
exchange-based JJ Educational
meal NN Educational
plan NN Educational
'eat VB Educational
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
' '' None
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
exchange-based JJ Educational
meal NN Educational
plan NN Educational
meal NN Educational
plan NN Educational
of IN Educational
'eating VBG Educational
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
' '' Educational
-DOCSTART- -X- N

, , None
sorbitol NN Pharmocological
and CC None
xylitol NNP Pharmocological
] NNP None
fructose VBP Pharmocological
, , None
sorbitol JJ Pharmocological
and CC None
xylitol NNS Pharmocological
25 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
each DT Pharmocological
sugar NN Pharmocological
sorbitol NN Pharmocological
fructose JJ Pharmocological
xylitol NNP Pharmocological
sorbitol NN Pharmocological
versus NN None
fructose NN Pharmocological
and CC None
xylitol NN Pharmocological
) ) None
sorbitol NN Pharmocological
fructose JJ Pharmocological
xylitol NN Pharmocological
xylitol NN Pharmocological
fructose JJ Pharmocological
sorbitol NN Pharmocological
. . None
-DOCSTART- -X- N

Transthoracic NNP Physical
contrast NN Physical
examinations NNS Physical
contrast NN Pharmocological
agent NN Pharmocological
injections NNS Pharmocological
( ( Pharmocological
10 CD Pharmocological
ml NN Pharmocological
dextrose NN Pharmocological
in IN Pharmocological
water/0.25 NN Pharmocological
ml NNP Pharmocological
air NN Pharmocological
) ) Pharmocological
Femoral NNP Physical
vein NNP Physical
contrast NN Physical
delivery NN Physical
-DOCSTART- -X- N

Tecnis NNP Physical
Z9000 NNP Physical
intraocular JJ Physical
lens NNS Physical
( ( Physical
Pharmacia NNP Physical
) ) Physical
or CC None
the DT Physical
AMO NNP Physical
AR40e NNP Physical
Opti-Edge NNP Physical
intraocular JJ Physical
lens NNS Physical
-DOCSTART- -X- N

1-week JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
omeprazole JJ Pharmocological
, , Pharmocological
amoxicillin NN Pharmocological
, , Pharmocological
and CC Pharmocological
clarithromycin NN Pharmocological
( ( Pharmocological
OAC NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
placebo NN Control
. . Pharmocological
OAC NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

Granulocyte-colony JJ Pharmocological
stimulating NN Pharmocological
factor NN Pharmocological
stem NN Physical
cell VBP Physical
Granulocyte-colony NNP Pharmocological
stimulating VBG Pharmocological
factor NN Pharmocological
( ( Pharmocological
G-CSF NNP Pharmocological
) ) Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP None
( ( None
10 CD None
?g/kg NN None
) ) None
or CC None
placebo NN None
given VBN None
SC NNP None
versus NN None
placebo NN Control
7 CD None
placebo NN None
3.0 CD None
G-CSF NNP None
is VBZ None
safe JJ None
-DOCSTART- -X- N

B-type JJ Other
natriuretic JJ Other
peptide NN Other
diagnostic JJ Other
strategy NN Other
including VBG Other
point-of-care JJ Other
measurement NN Other
of IN Other
BNP NNP Other
standard JJ Control
assessment NN Control
without IN Control
BNP NNP Control
BNP NNP Other
levels NNS Other
-DOCSTART- -X- N

sulindac-mediated JJ Pharmocological
Sulindac NNP Pharmocological
sulindac NN Pharmocological
placebo NN Control
sulindac RB Pharmocological
sulindac NN Pharmocological
sulindac NN Pharmocological
. . None
sulindac NN Pharmocological
-DOCSTART- -X- N

risedronate NN Pharmocological
risedronate NN Pharmocological
risedronate NN Pharmocological
oral JJ Pharmocological
risedronate NN Pharmocological
calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
vitamin $ Pharmocological
D NNP Pharmocological
-DOCSTART- -X- N

low-dose JJ Pharmocological
hydrocortisone NN Pharmocological
placebo-controlled JJ Control
hydrocortisone NN Pharmocological
therapy NN None
. . None
hydrocortisone NN Pharmocological
hydrocortisone NN Pharmocological
placebo NN Control
Hydrocortisone CD Pharmocological
Hydrocortisone NNP Pharmocological
hydrocortisone NN Pharmocological
therapy NN None
-DOCSTART- -X- N

fluticasone NN Pharmocological
placebo-controlled JJ Control
fluticasone NN Pharmocological
placebo NN Control
or CC None
fluticasone NN Pharmocological
-DOCSTART- -X- N

very RB Physical
low JJ Physical
level NN Physical
exercise NN Physical
. . None
supine JJ Physical
exercise NN Physical
-DOCSTART- -X- N

Cys NNP Physical
LT1 NNP Physical
receptor NN Physical
blockade NN Physical
leukotriene NN Pharmocological
receptor NN Pharmocological
antagonist NN Pharmocological
, , Pharmocological
MK-571 NNP Pharmocological
placebo-controlled JJ Control
8-hour JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
MK-571 NNP Pharmocological
or CC None
placebo NN Pharmocological
histamine NN Pharmocological
MK-571 NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

Low JJ Physical
protein NN Physical
provision NN Physical
Low JJ Physical
protein NN Physical
low JJ Physical
protein NN Physical
provision NN Physical
low JJ Physical
protein NN Physical
( ( Physical
LP NNP Physical
) ) Physical
provision NN Physical
low JJ Physical
protein NNS Physical
in IN Physical
low JJ Physical
protein NN Physical
provision NN Physical
-DOCSTART- -X- N

naloxone NN Pharmocological
placebo NN Control
. . None
naloxone JJ Pharmocological
-DOCSTART- -X- N

oxytocin NN Pharmocological
oxytocin NN Pharmocological
( ( Pharmocological
OT NNP Pharmocological
) ) Pharmocological
OT NNP Pharmocological
application NN Pharmocological
placebo-controlled JJ Control
OT NNP Pharmocological
pharmacological JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

2-min JJ Physical
iCSO NN Physical
. . Physical
at IN Physical
2 CD Physical
min NN Physical
of IN Physical
coronary JJ Physical
artery NN Physical
balloon NN Physical
occlusion NN Physical
. . Physical
-DOCSTART- -X- N

pulsed-dye JJ Surgical
laser NN Surgical
pulsed-dye JJ Surgical
laser NN Surgical
( ( Surgical
PDL NNP Surgical
) ) Surgical
PDL NNP Surgical
C/BPO NNP Surgical
alone RB Surgical
or CC Surgical
in IN Surgical
combination NN Surgical
with IN Surgical
PDL NNP Surgical
treatment NN Surgical
( ( None
C/BPO NNP Surgical
) ) None
( ( None
C/BPO NNP Surgical
+ NNP Surgical
laser NN Surgical
) ) None
PDL NNP Surgical
-DOCSTART- -X- N

potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
and CC None
bipolar JJ Surgical
radiofrequency NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
with IN None
those DT None
of IN None
bipolar JJ Surgical
radiofrequency NN Surgical
techniques NNS Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
tonsillectomy NN Surgical
and CC None
bipolar JJ Surgical
radiofrequency NN Surgical
tonsillectomy NN Surgical
. . None
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
group NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
bipolar JJ Surgical
radiofrequency NN Surgical
group NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
and CC None
the DT None
bipolar JJ Surgical
radiofrequency NN Surgical
techniques NNS Surgical
Potassium NNP Surgical
titanyl JJ Surgical
phosphate NN Surgical
laser NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
-DOCSTART- -X- N

cognitive JJ Pharmocological
rehabilitation NN Pharmocological
intervention NN Pharmocological
. . None
calendar/notebook NN Physical
rehabilitation NN Physical
intervention NN Physical
Memory NNP Educational
support NN Educational
system NN Educational
training NN Educational
-DOCSTART- -X- N

Epigastric JJ Physical
impedance NN Physical
epigastric JJ Physical
impedance NN Physical
-DOCSTART- -X- N

ketorolac NN Pharmocological
Ketorolac NNP Pharmocological
NSAIDs NNP Pharmocological
placebo-controlled JJ Control
normal JJ Pharmocological
saline NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
30 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
placebo NN Control
ketorolac NN Pharmocological
ketorolac NN Pharmocological
-DOCSTART- -X- N

Diamox NNP Pharmocological
Sustets NNP Pharmocological
( ( Pharmocological
acetazolamide RB Pharmocological
) ) Pharmocological
peroperative JJ Pharmocological
intracameral JJ Pharmocological
Miochol NNP Pharmocological
( ( Pharmocological
acetylcholine NN Pharmocological
) ) Pharmocological
treatments NNS Control
combined VBN Control
acetazolamide IN Pharmocological
acetylcholine NN Pharmocological
acetylcholine NN Pharmocological
acetazolamide NN Pharmocological
acetylcholine NN Pharmocological
acetazolamide NN Pharmocological
acetazolamide IN Pharmocological
acetylcholine NN Pharmocological
acetylcholine NN Pharmocological
acetazolamide NN Pharmocological
combined JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

Sivelestat NNP Pharmocological
sodium NN Pharmocological
hydrate NN Pharmocological
Sivelestat NNP Pharmocological
sodium NN Pharmocological
hydrate NN Pharmocological
( ( Pharmocological
sivelestat NN Pharmocological
) ) Pharmocological
sivelestat NNS Pharmocological
sivelestat NN Pharmocological
sivelestat NN Pharmocological
-DOCSTART- -X- N

facial JJ Educational
sensory JJ Educational
re-training NN Educational
standard JJ Educational
opening NN Educational
exercises VBZ Educational
re-training JJ Educational
-DOCSTART- -X- N

application NN None
of IN None
C-reactive JJ Physical
protein NN Physical
High-sensitivity NNP Pharmocological
C-reactive JJ Pharmocological
protein NN Pharmocological
( ( Pharmocological
hsCRP NN Pharmocological
) ) Pharmocological
hsCRP NN Pharmocological
hsCRP NN Pharmocological
hsCRP NN Pharmocological
hsCRP NN Pharmocological
hsCRP JJ Pharmocological
hsCRP JJ Pharmocological
-DOCSTART- -X- N

cessation NN Pharmocological
interventions NNS Pharmocological
INDEPENDENT NNP None
VARIABLE NNP None
type NN None
of IN None
intervention NN None
. . None
Minimal NNP Pharmocological
Intervention NNP Pharmocological
Advanced NNP Pharmocological
Intervention NNP Pharmocological
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
thyrotropin-stimulated JJ Pharmocological
radioiodine NN Pharmocological
therapy NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
( ( Pharmocological
rhTSH NN Pharmocological
) ) Pharmocological
radioiodine NN Physical
( ( Physical
131I CD Physical
) ) Physical
therapy NN Physical
rhTSH NN Pharmocological
0.1 CD None
mg NN None
rhTSH NN Pharmocological
thyroid JJ Physical
dose NN Physical
of IN Physical
50 CD Physical
Gy NNP Physical
or CC None
placebo NN Control
placebo NN Control
rhTSH NN Pharmocological
rhTSH NN Pharmocological
placebo NN Control
placebo NN Control
rhTSH NN Pharmocological
rhTSH NN Pharmocological
131I-therapy JJ Physical
-DOCSTART- -X- N

metronidazole JJ Pharmocological
placebo-controlled JJ Control
metronidazole NN Pharmocological
single JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
metronidazole NN Pharmocological
seven-day JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metronidazole JJ Pharmocological
metronidazole JJ Pharmocological
-DOCSTART- -X- N

amantadine NN Pharmocological
and CC None
desipramine NN Pharmocological
psychotherapy NN Psychological
placebo-controlled JJ Control
desipramine JJ Pharmocological
hydrochloride NN Pharmocological
and CC None
amantadine JJ Pharmocological
hydrochloride NN Pharmocological
desipramine NN Pharmocological
amantadine-placebo JJ Pharmocological
placebo NN Control
desipramine NN Pharmocological
desipramine NN Pharmocological
desipramine NN Pharmocological
-DOCSTART- -X- N

netilmicin-cefoxitin JJ Pharmocological
gentamicin-cefoxitin JJ Pharmocological
gentamicin NN Pharmocological
netilmicin NN Pharmocological
cefoxitin NN Pharmocological
gentamicin-cefoxitin JJ Pharmocological
netilmicin-cefoxitin JJ Pharmocological
-DOCSTART- -X- N

Confidential JJ Educational
registration NN Educational
confidential JJ Educational
registration NN Educational
. . None
Binary NNP Other
choices NNS Other
ordinal JJ Other
visual JJ Other
analogue NN Other
validated JJ Educational
questionnaire NN Educational
on IN Educational
self NN Educational
reported VBN Educational
measures NNS Educational
: : None
screened JJ Other
area NN Other
Confidential JJ Other
registration NN Other
Confidential JJ Other
registration NN Other
-DOCSTART- -X- N

lidocaine NN Pharmocological
epinephrine NN Pharmocological
mepivacaine NN Pharmocological
. . None
epinephrine NN None
mepivacaine NN None
topical JJ Pharmocological
anesthetic NN Pharmocological
P-ASA NNP Pharmocological
injections NNS Pharmocological
of IN Pharmocological
1.4 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
1:100,000 CD None
epinephrine NN Pharmocological
and CC None
1.4 CD None
mL NN None
of IN None
3 CD None
% NN None
mepivacaine NN Pharmocological
topical JJ Pharmocological
anesthetic JJ Pharmocological
gel NN Pharmocological
placebo NN Control
gel NN Control
. . None
mepivacaine JJ Pharmocological
placebo JJ Control
lidocaine JJ Pharmocological
mepivacaine JJ None
lidocaine JJ Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine JJ Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine JJ Pharmocological
lidocaine NN Pharmocological
epinephrine NN Pharmocological
mepivacaine NN Pharmocological
placebo NN Control
. . Control
lidocaine NN Pharmocological
epinephrine NN Pharmocological
mepivacaine NN Pharmocological
-DOCSTART- -X- N

mometasone NN Pharmocological
furoate NN Pharmocological
mometasone NN Pharmocological
furoate NN Pharmocological
MF-DPI NNP Pharmocological
400 CD Pharmocological
microg NN Pharmocological
once-daily RB Pharmocological
in IN Pharmocological
the DT Pharmocological
evening NN Pharmocological
or CC None
MF-DPI JJ Pharmocological
200 CD Pharmocological
microg JJ Pharmocological
twice-daily RB Pharmocological
. . None
MF-DPI NNP Pharmocological
-DOCSTART- -X- N

ziprasidone NN Pharmocological
: : None
placebo-controlled JJ Control
ziprasidone NN Pharmocological
or CC None
placebo NN Pharmocological
-DOCSTART- -X- N

DRE NNP Physical
PSA NNP Pharmocological
. . None
DRE NNP Physical
PSA NNP Pharmocological
PSA+ NNP Pharmocological
-DOCSTART- -X- N

Estrogen NNP Pharmocological
therapy NN Pharmocological
estrogen NN Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
conjugated VBN Pharmocological
estrogen NN Pharmocological
Placebos NNS Control
estrogen-treated JJ Pharmocological
placebo NN Control
estrogen NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

pre- NN Physical
and CC Physical
postoperative JJ Physical
radiation NN Physical
( ( Physical
45 CD Physical
Gy NNP Physical
) ) Physical
surgery NN Surgical
only RB Surgical
. . None
preoperative JJ Physical
irradiation NN Physical
irradiated JJ Physical
postoperative JJ Physical
preoperatively RB Physical
irradiated JJ Physical
surgery NN Surgical
postoperatively RB Physical
irradiated JJ Physical
surgery NN Surgical
preoperatively RB Physical
treated JJ Physical
postoperative JJ Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

placebo-controlled JJ Control
usual JJ Pharmocological
care NN Pharmocological
placebo NN Control
physiotherapy NN Control
exercise NN Physical
therapy NN Physical
exercise NN Physical
therapy NN Physical
Exercise NNP Physical
therapy NN Physical
exercise NN Physical
therapy NN Physical
placebo NN Control
usual JJ Pharmocological
care NN Pharmocological
exercise NN Physical
therapy NN Physical
group NN Physical
exercise NN Physical
group NN Physical
usual JJ Pharmocological
care NN Pharmocological
placebo NN Control
Exercise NNP Physical
therapy NN Physical
-DOCSTART- -X- N

Dobutamine NNP Physical
stress NN Physical
echo NN Physical
-DOCSTART- -X- N

lexical JJ Educational
information NN Educational
lexically RB Educational
induced VBN Educational
conversational JJ Educational
speech NN Educational
( ( Educational
Experiment NNP Educational
clear JJ Educational
speech NN Educational
noise NN Physical
two CD Educational
cognitive JJ Educational
loads NNS Educational
optimal JJ Educational
conditions NNS Educational
cognitive JJ Educational
load NN Educational
conditions NNS Educational
noise NN Educational
condition NN Educational
. . None
-DOCSTART- -X- N

nedocromil JJ Pharmocological
sodium NN Pharmocological
( ( Pharmocological
NS NNP Pharmocological
) ) Pharmocological
, , None
beclomethasone JJ Pharmocological
dipropionate NN Pharmocological
( ( Pharmocological
BDP NNP Pharmocological
) ) Pharmocological
and CC None
beclomethasone NN Pharmocological
dipropionate NN Pharmocological
plus CC Pharmocological
salmeterol NN Pharmocological
( ( Pharmocological
BDP NNP Pharmocological
+ NNP Pharmocological
S NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

pravastatin NN Pharmocological
pravastatin NN Pharmocological
pravastatin NN Pharmocological
40 CD Pharmocological
mg/day NN Pharmocological
placebo NN Control
Pravastatin NNP Pharmocological
Pravastatin NNP Pharmocological
-DOCSTART- -X- N

somatostatin NN Pharmocological
analogue NN Pharmocological
octreotide NN Pharmocological
. . None
octreotide NN Pharmocological
placebo NN Control
octreotide-induced JJ Pharmocological
placebo NN Control
placebo NN Control
. . None
( ( None
octreotide IN Pharmocological
: : None
placebo NN Control
: : None
octreotide IN Pharmocological
placebo NN None
Octreotide NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

serum NN Physical
vancomycin NN Physical
concentration NN None
monitoring NN None
vancomycin NN Pharmocological
serum NN None
concentration NN None
monitoring NN None
control NN Control
group NN None
patient JJ None
follow-up NN None
by IN None
a DT None
clinical JJ None
pharmacist NN None
to TO None
obtain VB None
and CC None
pharmacokinetically RB None
interpret JJ None
serum NN None
vancomycin NN Physical
concentrations NNS None
for IN None
dosage NN None
individualization NN None
. . None
vancomycin JJ Pharmocological
vancomycin NN Pharmocological
vancomycin NN Pharmocological
-DOCSTART- -X- N

intranasal NN Surgical
surgery NN Surgical
-- : None
comparison NN None
Mallinckrodt NNP Surgical
Hi-Lo-Evac NNP Surgical
tube NN Surgical
and CC None
Portex NNP Surgical
blue JJ Surgical
line NN Surgical
tube NN Surgical
-DOCSTART- -X- N

alpha JJ Pharmocological
1-blocker NN Pharmocological
, , Pharmocological
YM617 NNP Pharmocological
alpha JJ Pharmocological
1-blocker CD Pharmocological
, , Pharmocological
( ( Pharmocological
R NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
- : Pharmocological
) ) Pharmocological
-5- VBP Pharmocological
[ JJ Pharmocological
2- JJ Pharmocological
[ NN Pharmocological
[ CD Pharmocological
2- JJ Pharmocological
( ( Pharmocological
o-ethoxyphenoxy JJ Pharmocological
) ) Pharmocological
ethyl FW Pharmocological
] NNP Pharmocological
amino NN Pharmocological
] NNP Pharmocological
propyl NN Pharmocological
] NNP Pharmocological
-2- NNP Pharmocological
methoxybenzenesulfonamide NN Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
YM617 NNP Pharmocological
) ) Pharmocological
placebo IN Control
P NNP Control
-- : Control
placebo NN Control
YM617 NNP Pharmocological
. . Pharmocological
placebo NN Control
alpha JJ None
1-blocker NN None
, , None
YM617 NNP None
. . None
-DOCSTART- -X- N

treated VBN Pharmocological
topically RB Pharmocological
with IN Pharmocological
Contractubex NNP Pharmocological
gel NN Pharmocological
( ( Pharmocological
Merz NNP Pharmocological
+ NNP Pharmocological
Co. NNP Pharmocological
D-Frankfurt/Main NNP Pharmocological
) ) Pharmocological
, , Pharmocological
containing VBG Pharmocological
10 CD Pharmocological
% NN Pharmocological
onion NN Pharmocological
extract NN Pharmocological
, , Pharmocological
50/U CD Pharmocological
of IN Pharmocological
sodium NN Pharmocological
heparin NN Pharmocological
per IN Pharmocological
one CD Pharmocological
g NN Pharmocological
of IN Pharmocological
gel NN Pharmocological
and CC Pharmocological
1 CD Pharmocological
% NN Pharmocological
allantoin NN Pharmocological
, , None
or CC None
to TO None
a DT None
group NN None
receiving VBG None
no DT None
treatment NN None
. . None
average JJ None
26 CD None
days NNS None
after IN None
the DT None
operation NN None
and CC None
was VBD None
continued VBN None
for IN None
one CD None
year NN None
. . None
-DOCSTART- -X- N

Use NNP Educational
of IN Educational
an DT Educational
Internet NNP Educational
portal NN Educational
quality NN Educational
improvement NN Educational
program NN Educational
training NN Educational
, , Educational
including VBG Educational
didactic JJ Educational
lectures NNS Educational
and CC Educational
office NN Educational
flow NN Educational
modification NN Educational
workshops NNS Educational
. . Educational
ADHD NNP Educational
Internet NNP Educational
portal NN Educational
control NN Control
A DT Educational
quality NN Educational
improvement NN Educational
intervention NN Educational
Internet-based JJ Educational
information NN Educational
technology NN Educational
-DOCSTART- -X- N

randomized VBD None
controlled VBN None
trial NN None
in IN None
. . None
receive VB Physical
full-dose JJ Pharmocological
thrombolysis NN Pharmocological
, , None
preferably RB None
pre-hospital JJ None
, , None
and CC None
then RB None
be VB None
randomized VBN None
to TO None
either DT None
strategy NN None
. . None
-DOCSTART- -X- N

Beta NNP Physical
radiation NN Physical
intraoperative JJ Physical
beta NN Physical
radiation NN Physical
beta NN Physical
radiation NN Physical
. . None
-DOCSTART- -X- N

ophthalmic JJ Pharmocological
timolol NN Pharmocological
ophthalmic JJ Pharmocological
timolol NN Pharmocological
timolol NN Pharmocological
placebo NN Control
Timolol NNP Pharmocological
timolol-induced JJ Pharmocological
ophthalmic JJ Pharmocological
timolol NN Pharmocological
-DOCSTART- -X- N

Naltrexone NN Pharmocological
naltrexone NN Pharmocological
naltrexone CD Pharmocological
or CC None
placebo NN Control
and CC None
received VBD None
daily JJ None
doses NNS None
over IN None
a DT None
period NN None
of IN None
21 CD None
days NNS None
. . None
Naltrexone NN Pharmocological
placebo VB Control
naltrexone NN Pharmocological
Naltrexone NN Pharmocological
-DOCSTART- -X- N

two CD None
communication NN None
interventions NNS None
2 CD Educational
communication NN Educational
interventions NNS Educational
( ( Educational
Responsive JJ Educational
Education NN Educational
and CC Educational
Prelinguistic NNP Educational
Milieu NNP Educational
Teaching NNP Educational
[ NNP Educational
RPMT NNP Educational
] NNP Educational
and CC Educational
the DT Educational
Picture NNP Educational
Exchange NNP Educational
Communication NNP Educational
System NNP Educational
[ NNP Educational
PECS NNP Educational
] NNP Educational
) ) None
RPMT NNP Educational
PECS NNP Pharmocological
-DOCSTART- -X- N

DIR/Floortime? NNP None
parent NN None
training NN None
intervention NN None
adding VBG None
home-based JJ None
Developmental NNP None
, , None
Individual-Difference NNP None
, , None
Relationship-Based JJ None
( ( None
DIR NNP None
) ) None
/Floortime? VBZ None
intervention NN None
to TO None
added VBD None
home-based JJ None
DIR/Floortime? NNP None
intervention NN None
at IN None
an DT None
-DOCSTART- -X- N

guided JJ Physical
imagery NN Physical
. . None
guided JJ Other
imagery NN Other
modality NN Other
. . Educational
and CC None
control NN Control
groups NNS Control
a DT None
4-day JJ None
period NN None
of IN None
time NN None
. . None
Guided VBN Physical
imagery NN Physical
-DOCSTART- -X- N

laparoscopy NN Surgical
laparotomy NN Surgical
. . None
laparoscopy NN Surgical
laparotomy NN Surgical
laparoscopy NN Surgical
laparotomy NN Surgical
operative JJ Surgical
laparoscopy NN Surgical
laparotomy NN Surgical
. . None
-DOCSTART- -X- N

( ( Pharmocological
cometidine NN Pharmocological
, , Pharmocological
omeprazole NN Pharmocological
, , Pharmocological
colloidal JJ Pharmocological
bismuth NN Pharmocological
subcitrate NN Pharmocological
( ( Pharmocological
CBS NNP Pharmocological
) ) Pharmocological
, , Pharmocological
CBS NNP Pharmocological
and CC Pharmocological
metronidazole JJ Pharmocological
double JJ Pharmocological
therapy NN Pharmocological
, , Pharmocological
CBS NNP Pharmocological
, , Pharmocological
metronidazole NN Pharmocological
and CC Pharmocological
amoxicillin JJ Pharmocological
triple JJ Pharmocological
therapy NN Pharmocological
) ) Pharmocological
cimetidine NN Pharmocological
omeprazole NN Pharmocological
CBS NNP None
double JJ Pharmocological
therapy NN Pharmocological
triple JJ None
therapy NN None
-DOCSTART- -X- N

Aminocaproic NNP Pharmocological
acid VBZ Pharmocological
prednisone NN Pharmocological
aminocaproic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
Amicar NNP Pharmocological
) ) Pharmocological
systemic JJ Pharmocological
prednisone NN Pharmocological
oral JJ None
dosage NN None
of IN None
50 CD None
mg/kg NN None
of IN None
aminocaproic JJ Pharmocological
acid NN Pharmocological
oral JJ None
dosage NN None
of IN None
40 CD None
mg NN None
of IN None
prednisone JJ Pharmocological
daily JJ None
Placebo NNP Control
-DOCSTART- -X- N

-DOCSTART- -X- N

eleutherococcus JJ Educational
senticosus NN Educational
extract NN Educational
placebo-controlled JJ Control
Eleutherococcus NNP Educational
senticosus NN Educational
extract NN Educational
( ( Educational
Eleukokk NNP Educational
) ) Educational
ethanolic JJ Educational
( ( Educational
vincamine JJ Educational
free JJ Educational
) ) Educational
eleutherococcus VBP Educational
senticosus JJ Educational
preparation NN Educational
placebo NN Control
, , Control
the DT Control
eleutherococcus NN Control
extract NN Control
was VBD Control
substituted VBN Control
by IN Control
additional JJ Control
wine NN Control
, , Control
resulting VBG Control
in IN Control
identical JJ Control
final JJ Control
concentrations NNS Control
of IN Control
ethanol NN Control
in IN Control
both DT Control
preparations NNS Control
. . None
-DOCSTART- -X- N

Combined VBN Physical
chemotherapy NN Physical
and CC Physical
radiotherapy NN Physical
radiotherapy NN Physical
alone RB Physical
combined JJ Physical
chemotherapy NN Physical
and CC Physical
radiation NN Physical
therapy NN Physical
fluorouracil NN Pharmocological
( ( Pharmocological
1000 CD Pharmocological
mg NN Pharmocological
per IN Pharmocological
square JJ Pharmocological
meter NN Pharmocological
of IN Pharmocological
body-surface JJ Pharmocological
area NN Pharmocological
daily RB Pharmocological
for IN Pharmocological
four CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
75 CD Pharmocological
mg NN Pharmocological
per IN Pharmocological
square JJ Pharmocological
meter NN Pharmocological
on IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
day NN Pharmocological
) ) Pharmocological
plus CC Pharmocological
5000 CD Physical
cGy NN Physical
of IN Physical
radiation NN Physical
therapy NN Physical
6400 CD Physical
cGy NN Physical
of IN Physical
radiation NN Physical
therapy NN Physical
chemotherapy NN Physical
and CC Physical
radiation NN Physical
therapy NN Physical
. . None
combined VBN Physical
therapy NN Physical
Concurrent NNP Physical
therapy NN Physical
with IN Physical
cisplatin NN Physical
and CC Physical
fluorouracil NN Physical
and CC Physical
radiation NN Physical
radiation VB Physical
therapy NN Physical
-DOCSTART- -X- N

ropivacaine/fentanyl NN Pharmocological
Ropivacaine NNP Pharmocological
fentanyl JJ Pharmocological
ropivacaine-fentanyl NN Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
ropivacaine-4 JJ Pharmocological
microg NN Pharmocological
fentanyl VBD Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
ropivacaine-2 JJ Pharmocological
microg NN Pharmocological
fentanyl NN Pharmocological
, , None
or CC None
0.05 CD Pharmocological
% NN Pharmocological
ropivacaine-1 JJ Pharmocological
microg NN Pharmocological
fentanyl NN Pharmocological
ropivacaine-4 JJ Pharmocological
ropivacaine-2 JJ None
ropivacaine NN Pharmocological
fentanyl JJ Pharmocological
-DOCSTART- -X- N

interferon NN Pharmocological
alpha NN Pharmocological
2b CD Pharmocological
and CC None
ribavirin VB Pharmocological
combination NN Pharmocological
of IN Pharmocological
interferon NN Pharmocological
alpha NN Pharmocological
plus CC Pharmocological
ribavirin NN Pharmocological
. . None
interferon NN Pharmocological
alpha NN Pharmocological
2b CD Pharmocological
oral JJ Pharmocological
ribavirin NN Pharmocological
-DOCSTART- -X- N

epothilone NN None
B NNP None
analog NN None
ixabepilone NN None
( ( None
BMS-247550 NNP None
) ) None
with IN None
or CC None
without IN None
estramustine JJ None
phosphate NN None
epothilone NN Pharmocological
B NNP Pharmocological
analog NN Pharmocological
, , Pharmocological
ixabepilone NN Pharmocological
, , Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
estramustine JJ Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
EMP NNP Pharmocological
) ) Pharmocological
ixabepilone NN Pharmocological
intravenous JJ None
infusion NN None
every DT None
3 CD None
weeks NNS None
with IN None
or CC None
without IN None
EMP NNP Pharmocological
280 CD None
mg NN None
orally RB None
Ixabepilone NNP Pharmocological
estramustine JJ Pharmocological
phosphate NN Pharmocological
-DOCSTART- -X- N

Ultrasonographic JJ Physical
tissue NN Physical
characterisation NN Physical
three-dimensional JJ Physical
imaging NN Physical
of IN Physical
the DT Physical
Achilles NNP Physical
tendon NN Physical
by IN Physical
ultrasonographic JJ Physical
tissue NN Physical
characterisation NN Physical
( ( Physical
UTC NNP Physical
) ) Physical
Symptomatic NNP None
and CC None
asymptomatic JJ None
tendons NNS None
were VBD None
scanned VBN Physical
using VBG Physical
the DT Physical
One CD None
researcher NN None
performed VBD None
the DT None
data NNS Physical
collection NN Physical
. . None
UTC NNP Physical
UTC NNP Physical
-DOCSTART- -X- N

surgical JJ Surgical
or CC None
endovascular JJ Pharmocological
Follow-up NNP Physical
angiography NN Physical
MRI NNP Physical
-DOCSTART- -X- N

intraoperative JJ Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
placebo NN Control
intraoperative JJ Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
excision NN None
, , None
with IN None
or CC None
without IN None
a DT None
single JJ None
intraoperative JJ Pharmocological
application NN Pharmocological
of IN Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
-DOCSTART- -X- N

phenylephrine NN Pharmocological
phenylephrine JJ Pharmocological
saline NN Pharmocological
or CC Pharmocological
phenylephrine NN Pharmocological
infusion NN Pharmocological
( ( Pharmocological
PE NNP Pharmocological
) ) Pharmocological
phenylephrine NN Pharmocological
-DOCSTART- -X- N

Ropivacaine-clonidine JJ Pharmocological
combination NN Pharmocological
clonidine NN Pharmocological
weak JJ Pharmocological
ropivacaine JJ Pharmocological
solutions NNS Pharmocological
ropivacaine JJ Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
-clonidine JJ Pharmocological
mixture NN Pharmocological
plain NN Pharmocological
ropivacaine VBP Pharmocological
randomly RB None
allocated VBN None
to TO None
receive VB None
a DT None
caudal JJ None
injection NN None
of IN None
either DT None
plain NN Pharmocological
ropivacaine VBP Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
ml/kg NN Pharmocological
) ) Pharmocological
( ( None
R0.2 NNP None
) ) None
or CC None
a DT None
mixture NN None
of IN None
ropivacaine JJ Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
with IN None
clonidine JJ Pharmocological
2 CD Pharmocological
microg/kg NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
ml/kg NN Pharmocological
) ) Pharmocological
( ( None
R0.1C NNP None
) ) None
were VBD None
used VBN None
to TO None
evaluate VB None
analgesia NN None
during IN None
the DT None
first JJ None
24 CD None
h NN None
postoperatively RB None
. . None
was VBD None
also RB None
assessed VBN None
. . None
clonidine NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
microg/kg NN Pharmocological
) ) Pharmocological
and CC Pharmocological
ropivacaine VB Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
plain VB Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
ropivacaine NN Pharmocological
. . None
-DOCSTART- -X- N

enflurane NN Pharmocological
halothane NN Pharmocological
sodium NN Pharmocological
thiopentone NN Pharmocological
, , None
suxamethonium NN Pharmocological
and CC None
d-tubocurarine JJ Pharmocological
chloride NN Pharmocological
. . None
nitrous JJ Pharmocological
oxide NN Pharmocological
, , None
oxygen NN Pharmocological
and CC None
either DT None
halothane NN Pharmocological
or CC None
enflurane NN Pharmocological
. . None
-DOCSTART- -X- N

Prophylactic JJ None
cranial JJ None
irradiation NN None
Prophylactic NNP Physical
cranial JJ Physical
irradiation NN Physical
prophylactic JJ Physical
cranial JJ Physical
irradiation NN Physical
prophylactic JJ Physical
cranial JJ Physical
irradiation NN Physical
no DT Physical
prophylactic JJ Physical
cranial JJ Physical
irradiation NN Physical
( ( Physical
control VB Physical
group NN Physical
) ) Physical
. . None
Prophylactic NNP Physical
cranial JJ Physical
irradiation NN Physical
-DOCSTART- -X- N

phosphodiesterase-4 JJ Pharmocological
inhibitor NN Pharmocological
cilomilast NN Pharmocological
( ( Pharmocological
Ariflo NNP Pharmocological
) ) Pharmocological
Cilomilast NNP Pharmocological
( ( Pharmocological
Ariflo NNP Pharmocological
) ) Pharmocological
oral JJ Pharmocological
phosphodiesterase-4 JJ Pharmocological
selective JJ Pharmocological
inhibitor NN Pharmocological
cilomilast NN Pharmocological
placebo NN Control
placebo NN None
cilomilast NN Pharmocological
cilomilast NN Pharmocological
Phosphodiesterase-4 JJ Pharmocological
inhibitors NNS Pharmocological
-DOCSTART- -X- N

health NN Educational
information NN Educational
package NN Educational
experimental JJ None
validated JJ Other
planned JJ Other
educational JJ Other
programme NN Other
with IN Other
visual JJ Other
aids NNS Other
and CC Other
iron NN Other
supplementation NN Other
. . None
iron NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Chlorthalidone NN Pharmocological
nifedipine NN Pharmocological
nifedipine JJ Pharmocological
+ NNP Pharmocological
chlorthalidone NN Pharmocological
placebo NN Control
nifedipine VB Pharmocological
chlorthalidone NN Pharmocological
placebo NN Control
. . None
nifedipine NN Pharmocological
placebo NN Control
chlorthalidone NN Pharmocological
. . None
nifedipine JJ Pharmocological
+ FW Pharmocological
chlorthalidone NN Pharmocological
nifedipine JJ Pharmocological
dihydropyridine JJ Pharmocological
calcium NN Pharmocological
antagonist NN Pharmocological
+ VBD Pharmocological
a DT Pharmocological
thiazide JJ Pharmocological
diuretic NN Pharmocological
-DOCSTART- -X- N

enterostatin JJ Pharmocological
intake NN Pharmocological
Enterostatin NNP Pharmocological
( ( Pharmocological
ENT NNP Pharmocological
) ) Pharmocological
ENT NNP Pharmocological
ENT NNP Pharmocological
placebo-controlled JJ Control
( ( None
ENT NNP Pharmocological
PLA NNP Control
( ( None
ENT NNP Pharmocological
PLA NNP Control
( ( None
ENT $ Pharmocological
PLA NNP Control
( ( None
ENT NNP Pharmocological
PLA NNP Control
ENT NNP Pharmocological
-DOCSTART- -X- N

ofloxacin NN Pharmocological
amoxycillin/clavulanate NN Pharmocological
ofloxacin NN Pharmocological
amoxycillin/clavulanate NN Pharmocological
. . None
Ofloxacin NNP Pharmocological
ofloxacin NN Pharmocological
ofloxacin NN Pharmocological
ofloxacin NN Pharmocological
-DOCSTART- -X- N

pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
pyridostigmine NN Pharmocological
on IN None
the DT None
night NN None
before IN None
surgery NN None
morning NN None
dose NN None
of IN None
the DT None
drug NN None
on IN None
the DT None
day NN None
of IN None
surgery NN None
. . None
Neostigmine NNP Pharmocological
Vecuronium NNP Pharmocological
trans-sternal JJ Surgical
thymectomy NN Surgical
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
vecuronium NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Theta NNP Physical
burst JJS Physical
stimulation NN Physical
cortical JJ Physical
stimulation NN Physical
theta JJ Physical
burst JJ Physical
stimulation NN Physical
( ( Physical
TBS NNP Physical
) ) Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
TMS NNP Physical
) ) Physical
sham NN Physical
TBS NNP Physical
. . Control
TBS NNP Physical
TBS NNP Physical
. . None
-DOCSTART- -X- N

silodosin NN Pharmocological
silodosin NN Pharmocological
placebo NN Control
controlled VBD Control
silodosin NN Pharmocological
silodosin NN Pharmocological
-DOCSTART- -X- N

Acupuncture NNP Physical
with IN Physical
sham JJ Physical
device NN Physical
twice RB Physical
a DT Physical
week NN Physical
for IN Physical
six CD Physical
weeks NNS Physical
or CC Physical
placebo NN Control
pill NN Control
once RB Control
a DT Control
day NN Control
for IN Control
eight CD Control
weeks NNS Control
. . None
-DOCSTART- -X- N

Exemestane NN Pharmocological
placebo-controlled JJ Control
exemestane NN Pharmocological
exemestane NN Pharmocological
or CC None
placebo NN Control
. . None
exemestane NN Pharmocological
placebo NNS Control
placebo NN Control
Exemestane NNP Pharmocological
-DOCSTART- -X- N

cetuximab NN Pharmocological
, , None
capecitabine NN Pharmocological
radiotherapy NN Pharmocological
chemoradiotherapy NN Pharmocological
( ( Pharmocological
CRT NNP Pharmocological
) ) Pharmocological
capecitabine JJ Pharmocological
intravenous JJ Pharmocological
cetuximab NNS Pharmocological
cetuximab NN Pharmocological
plus CC Pharmocological
CRT NNP Pharmocological
capecitabine NN Pharmocological
radiotherapy NN Pharmocological
cetuximab NN Pharmocological
with IN Pharmocological
capecitabine-based JJ Pharmocological
CRT NNP Pharmocological
-DOCSTART- -X- N

selamectin NN Pharmocological
selamectin NN Pharmocological
selamectin NN Pharmocological
selamectin VBP Pharmocological
selamectin NN Pharmocological
fenthion NN Pharmocological
pyrethrins NNS Pharmocological
Selamectin NNP Pharmocological
selamectin-treated JJ Pharmocological
Selamectin NNP Pharmocological
selamectin NN None
ivermectin NN Pharmocological
Selamectin NNP None
Selamectin NNP None
selamectin NN None
Selamectin NNP None
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
formulation NN Pharmocological
( ( Pharmocological
OAD NNP Pharmocological
morphine NN Pharmocological
) ) Pharmocological
morphine NN Pharmocological
) ) None
CR NNP Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
CR NNP None
morphine NN Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

metoprolol NN Pharmocological
hydrochlorothiazide NN Pharmocological
hydralazine NN Pharmocological
200 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metoprolol JJ Pharmocological
plus CC Pharmocological
placebo NN Pharmocological
; : None
200 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metoprolol NN Pharmocological
plus CC None
25 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
hydrochlorothiazide NN Pharmocological
; : None
200 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
metoprolol NN Pharmocological
plus CC None
50 CD Pharmocological
mg NN Pharmocological
hydrochlorothiazide NN Pharmocological
, , None
or CC None
; : None
200 CD Pharmocological
mg NN Pharmocological
metoprolol NN Pharmocological
plus CC None
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
hydralazine NN Pharmocological
. . None
metoprolol NN Pharmocological
hydralazine NN Pharmocological
. . None
beta-blocker NN None
hydralazine NN Pharmocological
. . None
-DOCSTART- -X- N

to TO Educational
receive VB Educational
either CC Educational
a DT Educational
cessation NN Educational
advice NN Educational
report NN Educational
and CC Educational
progress JJ Educational
report NN Educational
that WDT Educational
were VBD Educational
tailored VBN Educational
to TO Educational
individual-level JJ Educational
characteristics NNS Educational
or CC Educational
a DT Educational
cessation NN Educational
advice NN Educational
report NN Educational
that WDT Educational
presented VBD Educational
standardized JJ Educational
( ( Educational
non-tailored JJ Educational
) ) Educational
content NN Educational
. . Educational
baseline NN Educational
assessments NNS Educational
-DOCSTART- -X- N

Netilmicin NNP Pharmocological
versus NN Pharmocological
tobramycin NN Pharmocological
netilmicin-ticarcillin NN Pharmocological
tobramycin-ticarcillin NN Pharmocological
-DOCSTART- -X- N

Memantine NNP Pharmocological
risperidone VB Pharmocological
placebo-controlled JJ Control
memantine NN Pharmocological
plus CC Pharmocological
risperidone NN Pharmocological
risperidone VB Pharmocological
plus JJ Pharmocological
memantine NN Pharmocological
placebo NN Control
plus CC Control
risperidone NN Control
risperidone NN Pharmocological
and CC None
memantine NN None
received VBD None
memantine NN None
had VBD None
that IN None
memantine NN None
may MD None
-DOCSTART- -X- N

corticosteroids NNS Pharmocological
. . Pharmocological
corticosteroid JJ Pharmocological
corticosteroid VB Pharmocological
corticosteroid JJ Pharmocological
-DOCSTART- -X- N

liquid NN Pharmocological
antacid NN Pharmocological
and CC None
placebo NN Control
antacids NNS Pharmocological
placebo-controlled JJ None
liquid JJ Pharmocological
antacid NN Pharmocological
vs NN None
placebo NN Control
antacid NN Pharmocological
( ( Pharmocological
Maalox NNP Pharmocological
Therapeutic NNP Pharmocological
Concentration NNP Pharmocological
placebo VB Control
active JJ Pharmocological
drug NN Pharmocological
placebo NN None
therapy NN None
. . None
antacid NN Pharmocological
placebo NN None
antacid NN Pharmocological
placebo NN None
. . None
antacid NN Pharmocological
placebo NN None
-DOCSTART- -X- N

stentless JJ Physical
conventional JJ Surgical
conventional JJ Surgical
biological JJ Surgical
versus NN None
stentless NN Surgical
aortic JJ Surgical
valve NN Surgical
replacement NN Surgical
. . None
stentless NN Physical
bioprostheses NNS Physical
-DOCSTART- -X- N

phenytoin NN Pharmocological
phenytoin NN Pharmocological
phenytoin NN Pharmocological
or CC None
placebo NN Control
phenytoin NNS Pharmocological
placebo NNS Control
phenytoin NN Pharmocological
phenytoin NN Pharmocological
phenytoin NN Pharmocological
) ) None
Phenytoin VB Pharmocological
-DOCSTART- -X- N

Intermittent JJ Physical
theta-burst JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
intermittent JJ Physical
theta-burst JJ Physical
stimulation NN Physical
( ( Physical
iTBS NN Physical
) ) Physical
Repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
rTMS NN Physical
) ) Physical
iTBS NN Physical
rTMS NN Physical
rTMS NN Physical
. . None
iTBS NN Physical
iTBS NN Physical
sham JJ Physical
stimulation NN Physical
. . None
iTBS NN Physical
iTBS NN Physical
iTBS NN Physical
-DOCSTART- -X- N

BRAF NNP Pharmocological
inhibition NN Pharmocological
vemurafenib NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
aripiprazole NN Pharmocological
aripiprazole NN Pharmocological
aripiprazole VB Pharmocological
( ( Pharmocological
5 CD Pharmocological
, , Pharmocological
10 CD Pharmocological
, , Pharmocological
or CC Pharmocological
15 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
aripiprazole JJ Pharmocological
aripiprazole JJ Pharmocological
placebo NN Control
aripiprazole JJ Pharmocological
placebo NN Control
. . None
Aripiprazole NNP Pharmocological
-DOCSTART- -X- N

naproxen NN Pharmocological
. . None
naproxen NNS Pharmocological
-DOCSTART- -X- N

Cognitive-behavioural JJ Educational
stress NN Educational
management NN Educational
group-based JJ Educational
cognitive-behavioural JJ Educational
stress NN Educational
management NN Educational
( ( Educational
CBSM NNP Educational
) ) Educational
intervention NN Educational
wait-list NN Control
control NN Control
condition NN Control
CBSM NNP Educational
intervention NN Educational
battery NN None
of IN None
administered VBN None
by IN None
a DT None
research NN None
assistant NN None
at IN None
baseline NN None
, , None
immediately RB None
following VBG None
the DT None
10-week JJ Educational
CBSM NNP Educational
intervention NN Educational
period NN None
, , None
and CC None
at IN None
a DT None
6-month JJ None
follow-up NN None
. . None
-DOCSTART- -X- N

resistance VB Physical
training NN Physical
resistance NN Physical
training NN Physical
11weeks CD Physical
of IN Physical
resistance NN Physical
exercise NN Physical
training NN Physical
either DT None
resistance NN None
exercise NN None
( ( None
n=19 JJ None
inactive JJ None
control NN None
group NN None
( ( None
n=18 RB None
randomised VBN None
to TO None
resistance VB None
training NN None
, , None
compared VBN None
to TO None
non-exercising JJ None
controls NNS None
-DOCSTART- -X- N

Marimastat NNP Pharmocological
matrix JJ None
metalloproteinase NN None
inhibitor NN None
, , None
marimastat NN Pharmocological
marimastat NN Pharmocological
( ( None
10 CD None
mg NN None
b.d NN None
. . None
) ) None
or CC None
placebo NN Control
. . None
marimastat NN Pharmocological
placebo NN Control
marimastat NN Pharmocological
marimastat NNS Pharmocological
placebo VB None
Marimastat NNP Pharmocological
placebo NN None
marimastat NN Pharmocological
-DOCSTART- -X- N

with IN None
controlled JJ Physical
compared VBN None
to TO None
an DT None
with IN None
with IN Physical
with IN Physical
expectant JJ None
management NN None
with IN None
expectant JJ Physical
management NN Physical
-DOCSTART- -X- N

arachidonic JJ None
acid NN None
docosahexaenoic VB None
acid NN None
placebo-controlled JJ Control
Polyunsaturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
arachidonic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ARA NNP Pharmocological
) ) Pharmocological
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
ARA NNP Pharmocological
ARA NNP Pharmocological
doses VBZ Pharmocological
added VBN Pharmocological
to TO Pharmocological
DHA NNP Pharmocological
placebo-controlled JJ Control
placebo NN Control
placebo NN Control
placebo NN Control
ARA NNP Pharmocological
doses VBZ Pharmocological
added VBN Pharmocological
to TO Pharmocological
DHA NNP Pharmocological
-DOCSTART- -X- N

conventional JJ Pharmocological
hypofractionated VBD Physical
three-dimensional JJ Physical
conformal JJ Physical
radiotherapy NN Physical
hypofractionation NN Pharmocological
vs. FW None
conventional JJ Pharmocological
fractionation NN Pharmocological
hypofractionated VBN Physical
or CC None
conventionally RB Pharmocological
fractionated VBN Pharmocological
three-dimensional JJ Pharmocological
conformal JJ Pharmocological
radiotherapy NN Pharmocological
hypofractionation NN Physical
-DOCSTART- -X- N

PSK NNP Pharmocological
oral JJ Pharmocological
adjuvant JJ Pharmocological
immunochemotherapy NN Pharmocological
with IN None
protein-bound JJ Pharmocological
polysaccharide NN Pharmocological
K NNP Pharmocological
( ( Pharmocological
PSK NNP Pharmocological
) ) Pharmocological
and CC None
tegafur/uracil NN Pharmocological
( ( Pharmocological
UFT NNP Pharmocological
) ) Pharmocological
UFT NNP Pharmocological
alone RB None
. . None
PSK NNP Pharmocological
PSK NNP Pharmocological
PSK NNP Pharmocological
plus CC Pharmocological
300 CD Pharmocological
mg NN Pharmocological
UFT NNP Pharmocological
( ( Pharmocological
PSK NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
UFT NNP Pharmocological
alone RB Pharmocological
PSK NNP Pharmocological
control NN Control
group NN None
PSK NNP Pharmocological
PSK NNP Pharmocological
+ NNP Pharmocological
UFT NNP Pharmocological
PSK NNP Pharmocological
-DOCSTART- -X- N

sound-producing JJ Other
voice NN Other
prosthesis NN Other
. . None
pneumatic JJ Other
sound NN Other
source NN Other
sound-producing JJ Other
voice NN Other
prosthesis NN Other
-DOCSTART- -X- N

given VBN None
nicotine JJ Pharmocological
or CC None
placebo JJ Control
solution NN None
on IN None
two CD None
separate JJ None
occasions NNS None
in IN None
a DT None
randomized JJ None
sequence NN None
. . None
water-perfused JJ None
manometry NN None
catheter NN None
, , None
with IN None
openings NNS None
at IN None
5 CD None
, , None
10 CD None
and CC None
15 CD None
cm NN None
from IN None
the DT None
tip NN None
, , None
was VBD None
placed VBN None
by IN None
rigid JJ None
sigmoidoscopy NN None
in IN None
the DT None
recto-sigmoid JJ None
region NN None
. . None
were VBD None
measured VBN None
for IN None
15 CD None
min NNS None
prior RB None
to TO None
instillation NN None
of IN None
20 CD None
ml NN None
of IN None
saline JJ None
alone NN None
or CC None
with IN None
nicotine JJ None
, , None
1.2 CD None
mg NN None
, , None
at IN None
pH JJ None
4.5 CD None
. . None
-DOCSTART- -X- N

omeprazole NN Pharmocological
, , None
clarithromycin NN Pharmocological
tinidazole NN Pharmocological
omeprazole JJ Pharmocological
20 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
clarithromycin VBP Pharmocological
250 CD Pharmocological
mg NN Pharmocological
b.d NN Pharmocological
. . None
and CC Pharmocological
tinidazole JJ Pharmocological
500 CD Pharmocological
mg NN Pharmocological
b.d NN Pharmocological
. . Pharmocological
placebos NN Control
. . None
-DOCSTART- -X- N

antioxidants NNS Pharmocological
, , None
zinc NN Pharmocological
, , None
and CC None
copper NN Pharmocological
antioxidants NNS Pharmocological
( ( Pharmocological
vitamin JJ Pharmocological
C NNP Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
; : Pharmocological
vitamin CC Pharmocological
E NNP Pharmocological
, , Pharmocological
400 CD Pharmocological
IU NNP Pharmocological
; : Pharmocological
beta NN Pharmocological
carotene NN Pharmocological
, , Pharmocological
15 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
, , Pharmocological
zinc NN Pharmocological
and CC Pharmocological
copper NN Pharmocological
( ( Pharmocological
zinc NN Pharmocological
, , Pharmocological
80 CD Pharmocological
mg NN Pharmocological
; : Pharmocological
cupric JJ Pharmocological
oxide NN Pharmocological
, , Pharmocological
2 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
, , Pharmocological
antioxidants NNS Pharmocological
plus CC Pharmocological
zinc NN Pharmocological
and CC Pharmocological
copper NN Pharmocological
, , None
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

Low NNP None
Energy NNP None
Safety NNP None
Study NNP None
( ( None
LESS NNP None
) ) None
: : None
Low NNP None
Energy NNP None
Safety NNP None
Study NNP None
( ( None
LESS NNP None
) ) None
initial JJ Physical
2 CD Physical
shocks NNS Physical
for IN Physical
ventricular JJ Physical
fibrillation NN Physical
conversion NN Physical
programmed VBD Physical
at IN Physical
2 CD Physical
energy NN Physical
steps NNS Physical
above IN Physical
DFT++ NNP Physical
( ( Physical
typically RB Physical
4-6 JJ Physical
J NNP Physical
, , Physical
maximum JJ Physical
10 CD Physical
J NNP Physical
) ) Physical
with IN Physical
subsequent JJ Physical
shocks NNS Physical
at IN Physical
maximum JJ Physical
energy NN Physical
all DT Physical
shocks NNS Physical
programmed VBN Physical
at IN Physical
maximum JJ Physical
energy NN Physical
. . None
DFT++ NNP Physical
LESS NNP None
-DOCSTART- -X- N

CT NNP Other
versus NNP None
digital JJ Other
subtraction NN Other
angiography NN Other
multi-detector JJ Other
row NN Other
computed VBN Other
tomographic JJ Other
( ( Other
CT NNP Other
) ) Other
angiography NN Other
and CC None
digital JJ Other
subtraction NN Other
angiography NN Other
( ( Other
DSA NNP Other
) ) Other
revascularization NN Surgical
CT NNP Other
and CC None
DSA NNP Other
CT NNP Other
DSA NNP Other
CT NNP Other
DSA NNP Other
CT NNP Other
DSA NNP Other
. . None
CT NNP Other
DSA NNP Other
CT NNP Other
angiography NN Other
CT NNP Other
DSA NNP Other
CT NNP Other
DSA NNP Other
-DOCSTART- -X- N

i.e NN None
. . None
implant JJ None
treatment NN None
and CC None
one CD None
group NN None
receiving VBG None
conventional JJ None
complete JJ None
dentures NNS None
( ( None
CD NN None
) ) None
. . None
implant-supported JJ Physical
mandibular JJ Physical
overdenture NN Physical
transmandibular JJ Physical
implant NN Physical
( ( Physical
TMI NNP Physical
) ) Physical
implant-tissue-supported JJ None
mandibular JJ None
overdenture NN None
IMZ JJ None
implants NNS None
( ( None
IMZ NNP None
) ) None
. . None
TMI NNP None
IMZ NNP None
-DOCSTART- -X- N

chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
vincristine NN Pharmocological
cyclophosphamide NN Pharmocological
5-fluoro-uracil JJ Pharmocological
doxorubicine NN Pharmocological
methotrexate NN Pharmocological
doxorubicine NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

plain NN Pharmocological
mepivacaine NN Pharmocological
subarachnoid JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine NN Pharmocological
. . None
preservative-free JJ Pharmocological
plain NN Pharmocological
mepivacaine NN Pharmocological
plain NN Pharmocological
mepivacaine NN Pharmocological
. . None
spinal-epidural JJ Physical
anesthetic JJ Physical
technique NN Physical
. . None
subarachnoid JJ Pharmocological
mepivacaine NN Pharmocological
. . None
mepivacaine NN Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
hydroxide NN Pharmocological
sealers NNS Pharmocological
. . None
apical JJ Physical
seal NN Physical
root NN Pharmocological
canal JJ Pharmocological
sealers NNS Pharmocological
. . None
gutta-percha JJ Pharmocological
sealers NNS Physical
canal NN Physical
was VBD Physical
filled VBN Physical
with IN Physical
gutta-percha JJ Physical
along IN Physical
with IN Physical
either DT Physical
Roth NNP Physical
's POS Physical
sealer NN Physical
, , Physical
AH26 NNP Physical
, , Physical
Sealapex NNP Physical
, , Physical
CRCS NNP Physical
, , Physical
or CC Physical
Nogenol NNP Physical
sealer NN Physical
, , Physical
respectively RB Physical
. . None
filled VBN Control
with IN Control
gutta-percha JJ Control
and CC Control
without IN Control
sealer NN Control
to TO None
serve VB None
as IN None
a DT None
control NN None
. . None
amalgam NN Pharmocological
. . None
-DOCSTART- -X- N

CRP NNP Pharmocological
-DOCSTART- -X- N

Polydioxanone NNP Surgical
sternal JJ Surgical
sutures NNS Surgical
polydioxanone NN Surgical
( ( Surgical
PDS NNP Surgical
) ) Surgical
suture NN Surgical
PDS NNP Surgical
stainless JJ Other
steel NN Other
PDS NNP Surgical
PDS NNP Surgical
PDS NNP Surgical
-DOCSTART- -X- N

magnesium NN Pharmocological
levobupivacaine VB Pharmocological
magnesium NN Pharmocological
0.25 CD None
% NN None
levobupivacaine NN Pharmocological
and CC None
1 CD None
ml NN None
of IN None
15 CD None
% NN None
magnesium NN Pharmocological
sulphate NN Pharmocological
Group NNP None
L NNP None
was VBD None
administered VBN None
20 CD None
ml NN None
of IN None
0.25 CD Pharmocological
% NN Pharmocological
levobupivacaine NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

theophylline NN Pharmocological
: : Pharmocological
theophylline NN Pharmocological
theophylline NN None
theophylline NN Pharmocological
theophylline NN Pharmocological
theophylline NN Pharmocological
-DOCSTART- -X- N

piroxicam NN Pharmocological
piroxicam NN Pharmocological
piroxicam NN Pharmocological
codeine NN Pharmocological
sulfate NN Pharmocological
and CC None
placebo NN Control
. . None
Piroxicam NNP Pharmocological
placebo NN Control
Codeine VB Pharmocological
placebo VB None
Piroxicam NNP Pharmocological
codeine VBP Pharmocological
piroxicam NN Pharmocological
aspirin JJ Pharmocological
placebo NN None
. . None
piroxicam NN Pharmocological
placebo NN None
Piroxicam NNP Pharmocological
aspirin RB Pharmocological
Piroxicam VB Pharmocological
aspirin NN Pharmocological
piroxicam VBD Pharmocological
aspirin NN Pharmocological
placebo NN None
piroxicam NNS Pharmocological
codeine NN Pharmocological
or CC None
aspirin NN Pharmocological
-DOCSTART- -X- N

Tongbu NNP Physical
No NNP Physical
. . Educational
1 CD None
( ( None
TB1 NNP Pharmocological
, , None
a DT None
prescription NN None
for IN None
reinforcing VBG None
Kidney NNP None
and CC None
Spleen NNP None
, , None
clearing VBG None
up RP None
the DT None
bowel NN None
viscera NN None
to TO None
send VB None
Turbid NNP None
downward NN None
and CC None
regulating NN None
Qi NNP None
and CC None
blood NN None
) ) None
-DOCSTART- -X- N

bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
randomly RB None
assigned VBN None
to TO None
receive VB None
a DT None
local JJ Pharmocological
injection NN Pharmocological
of IN Pharmocological
bupivacaine NN Pharmocological
with IN Pharmocological
1:200,000 CD Pharmocological
epinephrine NN Pharmocological
, , None
an DT None
injection NN Pharmocological
of IN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
, , None
or CC None
no DT Control
injection NN Control
, , Control
just RB Control
superior JJ None
to TO None
each DT None
band NN None
. . None
was VBD None
graded VBN None
by IN None
the DT None
patient NN None
and CC None
by IN None
the DT None
study NN None
nurse NN None
within IN None
30 CD None
minutes NNS None
, , None
and CC None
any DT None
were VBD None
recorded VBN None
. . None
At IN None
intervals NNS None
6 CD None
, , None
24 CD None
, , None
and CC None
48 CD None
hours NNS None
postbanding VBG None
, , None
the DT None
patient NN None
recorded VBD None
bupivacaine NN Pharmocological
normal JJ Control
saline JJ Control
no DT Control
injection NN Control
. . None
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
Bupivacaine NNP Pharmocological
-DOCSTART- -X- N

standard VB Control
pain NN Control
treatment NN Control
, , None
the DT Physical
SCION-PAIN JJ Physical
program NN Physical
consisting NN Physical
of IN Physical
3 CD Physical
modules NNS Physical
: : Physical
pharmacologic NN Physical
pain NN Physical
management NN Physical
, , Physical
nonpharmacologic RB Physical
pain JJ Physical
management NN Physical
and CC Physical
discharge NN Physical
management NN Physical
. . None
patient JJ Educational
education NN Educational
, , Educational
skills NNS Educational
training NN Educational
and CC Educational
counseling NN Educational
to TO Educational
improve VB Educational
self PRP Educational
care VB Educational
regarding VBG Educational
pain JJ Educational
management NN Educational
beginning VBG Educational
with IN Educational
admission NN Educational
followed VBN Educational
by IN Educational
booster NN Educational
session NN Educational
every DT Educational
3rd CD Educational
day NN Educational
and CC Educational
one CD Educational
follow VBP Educational
up RP Educational
telephone NN Educational
counseling NN Educational
within IN Educational
2 CD Educational
to TO Educational
3 CD Educational
days NNS Educational
after IN Educational
discharge NN Educational
. . None
-DOCSTART- -X- N

emergency NN Physical
coronary JJ Physical
angioplasty NN Physical
intracoronary JJ Physical
streptokinase NN Physical
. . None
emergency NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
and CC None
intracoronary JJ Physical
streptokinase NN Physical
intracoronary JJ Physical
streptokinase NN Physical
. . None
Recatheterization NN Physical
and CC Physical
submaximal JJ Physical
exercise NN Physical
thallium-201 JJ Physical
single JJ Physical
photon NN Physical
emission NN Physical
computed VBD Physical
tomography NN Physical
emergency NN Physical
angioplasty NN Physical
streptokinase NN Physical
streptokinase NN Physical
. . None
coronary JJ Physical
angioplasty NN Physical
-DOCSTART- -X- N

laparoscopy $ Surgical
laparoscopic NN Surgical
surgery NN Surgical
minimally RB Surgical
invasive JJ Surgical
techniques NNS Surgical
conventional JJ Physical
instrument NN Physical
laparoscopic JJ Physical
instrument NN Physical
laparoscopic JJ Surgical
instruments NNS Surgical
-DOCSTART- -X- N

dihydroergotamine NN Pharmocological
( ( Pharmocological
DHE NNP Pharmocological
) ) Pharmocological
heparin NN Pharmocological
DHE NNP Pharmocological
heparin JJ Pharmocological
DHE NNP Pharmocological
heparin JJ Pharmocological
heparin NN Pharmocological
DHE NNP Pharmocological
placebo NN Control
DHE/Hep NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

inspiratory JJ Physical
impedance NN Physical
threshold JJ Physical
device NN Physical
on IN Physical
a DT Physical
facemask NN Physical
and CC Physical
endotracheal VB Physical
tube NN Physical
inspiratory JJ Physical
impedance NN Physical
threshold NN Physical
device NN Physical
( ( Physical
ITD NNP Physical
) ) Physical
ITD NNP Physical
facemask NN Physical
or CC Physical
ETT NNP Physical
. . None
An DT None
active JJ Physical
and CC Physical
sham JJ Physical
ITD NNP Physical
facemask NN Physical
ETT NNP Physical
A DT None
sham NN Physical
and CC Physical
an DT Physical
active JJ Physical
ITD NNP Physical
facemask NN Physical
ETT NNP Physical
. . None
sham NN Physical
active JJ Physical
ITD NN Physical
facemask NN Physical
and CC Physical
ETT NNP Physical
active JJ Physical
ITD NNP Physical
attached VBD Physical
to TO Physical
a DT Physical
facemask NN Physical
or CC Physical
an DT Physical
ETT NNP Physical
ITD NNP Physical
a DT None
facemask NN Physical
ETT NNP Physical
ITD-facemask JJ Physical
combination NN Physical
-DOCSTART- -X- N

satraplatin NN Pharmocological
platinum NN Pharmocological
plus CC Pharmocological
prednisone NN Pharmocological
vs. FW None
prednisone NN Pharmocological
alone RB Pharmocological
Satraplatin NNP Pharmocological
platinum NN Pharmocological
cisplatin-resistant JJ Pharmocological
narcotic JJ Pharmocological
analgesics NNS Pharmocological
. . None
satraplatin NN Pharmocological
prednisone JJ Pharmocological
prednisone VB Pharmocological
satraplatin NN Pharmocological
prednisone NN Pharmocological
prednisone NN Pharmocological
satraplatin NN Pharmocological
plus CC Pharmocological
prednisone NN Pharmocological
prednisone NN Pharmocological
satraplatin NN Pharmocological
prednisone NN Pharmocological
prednisone NN Pharmocological
satraplatin NN Pharmocological
and CC None
prednisone NN Pharmocological
-DOCSTART- -X- N

tibiofibular JJ Physical
joint NN Physical
manipulation NN Physical
tibiofibular JJ Physical
joint JJ Physical
manipulation NN Physical
( ( None
proximal JJ Physical
tibiofibular NN Physical
manipulation NN Physical
, , None
distal JJ Physical
tibiofibular JJ Physical
manipulation NN Physical
, , None
or CC None
control NN Control
) ) None
tibiofibular JJ None
joint NN None
manipulation NN None
tibiofibular JJ None
joint NN None
manipulation NN None
control NN Control
-DOCSTART- -X- N

surgical JJ Surgical
staging NN Surgical
adjuvant JJ Physical
therapy NN Physical
. . None
intraperitoneal JJ Pharmocological
radioactive JJ Pharmocological
phosphorus NN Pharmocological
or CC None
oral JJ Pharmocological
melphalan NN Pharmocological
. . None
-DOCSTART- -X- N

Aortic JJ Physical
valve NN Physical
replacement NN Physical
. . None
Bj?rk-Shiley NNP None
and CC None
Lillehei-Kaster NNP None
disc NN None
valves NNS None
. . None
Cine-aortography NN None
was VBD None
small JJ None
L-K JJ None
valves NNS None
( ( None
the DT None
B-S NNP None
than IN None
the DT None
L-K NNP None
valves NNS None
the DT None
L-K NNP None
the DT None
L-K NNP None
valves NNS None
-DOCSTART- -X- N

RRR-alpha-tocopherol NNP Pharmocological
and CC Pharmocological
all-racemic JJ Pharmocological
alpha-tocopherol NN Pharmocological
alpha-tocopherol NN Pharmocological
RRR-AT NNP Pharmocological
and CC Pharmocological
all-rac-AT NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Esmolol NNP Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
verapamil NN Pharmocological
esmolol-treated JJ Pharmocological
verapamil RB Pharmocological
Esmolol NNP Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
. . None
-DOCSTART- -X- N

Wheelchair NNP Physical
skills VBZ Physical
training NN Physical
wheelchair NN Physical
skills NNS Physical
training VBG Physical
two CD Physical
1-hour JJ Physical
training NN Physical
sessions NNS Physical
that WDT Physical
followed VBD Physical
the DT Physical
Wheelchair NNP Physical
Skills NNP Physical
Training NNP Physical
Program NNP Physical
( ( Physical
WSTP NNP Physical
) ) Physical
protocol NN Physical
. . None
single JJ Educational
socialization NN Educational
contact NN Educational
. . None
-DOCSTART- -X- N

tetrabenazine NN Pharmocological
. . None
tetrabenazine JJ Pharmocological
100 CD Pharmocological
mg NN Pharmocological
in IN Pharmocological
divided JJ Pharmocological
dosage NN Pharmocological
. . None
diazepam NN Pharmocological
Tetrabenazine NNP Pharmocological
-DOCSTART- -X- N

prophylactic JJ Physical
transluminal JJ Physical
balloon NN Physical
angioplasty NN Physical
Prophylactic JJ Physical
Transluminal NNP Physical
Balloon NNP Physical
Angioplasty NNP Physical
( ( Physical
pTBA NN Physical
) ) Physical
pTBA NN Physical
pTBA NN None
angioplasty NN Physical
pTBA NN None
pTBA NN None
-DOCSTART- -X- N

Gemcitabine NNP Pharmocological
paclitaxel NN Pharmocological
docetaxel NN Pharmocological
split-dose JJ Pharmocological
paclitaxel NN Pharmocological
or CC None
docetaxel NN Pharmocological
in IN None
combination NN Pharmocological
with IN Pharmocological
gemcitabine NN Pharmocological
gemcitabine NN Pharmocological
1,250 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
Days VBZ Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
and CC Pharmocological
paclitaxel VB Pharmocological
175 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
as IN Pharmocological
a DT Pharmocological
3-h JJ Pharmocological
infusion NN Pharmocological
on IN Pharmocological
Day NNP Pharmocological
1 CD Pharmocological
( ( Pharmocological
GP1 NNP Pharmocological
) ) Pharmocological
; : None
gemcitabine $ Pharmocological
1,000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
Days VBZ Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
and CC Pharmocological
paclitaxel VB Pharmocological
100 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
as IN Pharmocological
a DT Pharmocological
1-h JJ Pharmocological
infusion NN Pharmocological
on IN Pharmocological
Days NNP Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
( ( Pharmocological
GP2 NNP Pharmocological
) ) Pharmocological
; : None
gemcitabine $ Pharmocological
1,000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
Days VBZ Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
and CC Pharmocological
docetaxel VB Pharmocological
40 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
as IN Pharmocological
a DT Pharmocological
1-h JJ Pharmocological
infusion NN Pharmocological
on IN Pharmocological
Days NNP Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
( ( Pharmocological
GD NNP Pharmocological
) ) None
gemcitabine-taxane JJ Pharmocological
combinations NNS Pharmocological
paclitaxel NN Pharmocological
docetaxel NN Pharmocological
paclitaxel NN Pharmocological
combinations NNS Pharmocological
-DOCSTART- -X- N

moxifloxacin NN Pharmocological
moxifloxacin NN Pharmocological
400-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
moxifloxacin NN Pharmocological
. . None
moxifloxacin JJ Pharmocological
-DOCSTART- -X- N

sensory JJ Psychological
integration NN Psychological
therapy NN Psychological
program NN Psychological
sensory JJ Psychological
integration NN Psychological
therapy NN Psychological
program NN Psychological
sensory JJ Psychological
integration NN Psychological
therapy NN Psychological
program NN Psychological
-DOCSTART- -X- N

ciprofloxacin NN Pharmocological
intra-peritoneal JJ Pharmocological
vancomycin NN Pharmocological
gentamicin NN Pharmocological
oral JJ Pharmocological
ciprofloxacin NN Pharmocological
and CC None
intraperitoneal JJ Pharmocological
vancomycin/gentamicin NN Pharmocological
ciprofloxacin NN Pharmocological
-DOCSTART- -X- N

Risperidone NNP Pharmocological
versus NN None
haloperidol NN Pharmocological
risperidone NN Pharmocological
with IN None
haloperidol NN Pharmocological
-DOCSTART- -X- N

condition NN Educational
involving VBG Educational
negative JJ Educational
evaluation NN Educational
based VBN Educational
on IN Educational
( ( Educational
negative JJ Educational
evaluation/academic NN Educational
) ) Educational
, , Educational
or CC Educational
a DT Educational
condition NN Educational
involving VBG Educational
negative JJ Educational
evaluation NN Educational
based VBN Educational
on IN Educational
as RB Educational
well RB Educational
as IN Educational
negative JJ Other
evaluation/social JJ Other
rejection NN Other
stressor NN Other
negative JJ Other
evaluation/academic JJ Other
( ( Other
writing VBG Other
) ) Other
stressor NN Other
. . None
negative JJ Educational
evaluation/social JJ Educational
rejection NN Educational
stressor NN Educational
negative JJ Other
evaluation/academic JJ Other
stressor NN Other
. . None
social JJ Educational
rejection NN Educational
stressor NN Educational
negative JJ Other
evaluation NN Other
stressor NN Other
-DOCSTART- -X- N

Transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
plus CC Pharmocological
conservative JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
ibuprofen JJ Pharmocological
, , None
bite JJ Pharmocological
plate NN Pharmocological
, , None
self-physiotherapy NN Physical
) ) None
TENS NNP Physical
TENS NNP Physical
. . None
Subthreshold NNP Physical
TENS NNP Physical
-DOCSTART- -X- N

Tele-Airway NNP Educational
Management NNP Educational
System NNP Educational
Tele-Airway NNP Educational
Management NNP Educational
System NNP Educational
TAMS NNP Educational
TAMS NNP Educational
. . None
( ( None
TAMS NNP Other
OSD NNP Educational
TAMS NNP Educational
OSD NNP Other
TAMS NNP Educational
. . None
OSD NNP Educational
. . None
-DOCSTART- -X- N

Defibrotide NNP Pharmocological
calcium NN Pharmocological
heparin NN Pharmocological
Defibrotide NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
b.i.d NN Pharmocological
. . None
i.v NN Pharmocological
. . None
in IN Pharmocological
50 CD Pharmocological
ml JJ Pharmocological
phleboclysis NN Pharmocological
in IN Pharmocological
5 CD Pharmocological
minutes NNS Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
108 CD Pharmocological
) ) Pharmocological
; : None
2 CD None
) ) None
calcium NN Pharmocological
heparin NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
5000 CD Pharmocological
IU NNP Pharmocological
t.i.d NN Pharmocological
. . Pharmocological
subcutaneously RB Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
103 CD Pharmocological
) ) Pharmocological
The DT Control
treatment NN Control
began VBD Control
the DT Control
day NN Control
before IN Control
operation NN Control
and CC Control
continued VBN Control
on IN Control
average NN Control
up RB Control
to TO Control
the DT Control
eighth JJ Control
day NN Control
for IN Control
the DT Control
Defibrotide NNP Control
group NN Control
. . None
Defibrotide NNP Pharmocological
Defibrotide NNP Pharmocological
Defibrotide VB Pharmocological
-DOCSTART- -X- N

sticking VBG Physical
needling NN Physical
group NN Physical
( ( None
150 CD None
cases NNS None
) ) None
and CC None
an DT Physical
acupuncture NN Physical
group NN Physical
sticking VBG Physical
needling NN Physical
the DT Physical
manual JJ Physical
sticking NN Physical
needling NN Physical
technique NN Physical
conventional JJ Physical
acupuncture NN Physical
therapy NN Physical
was VBD Physical
applied VBN Physical
acupuncture NN Physical
acupuncture NN Physical
manual JJ Physical
sticking NN Physical
needling NN Physical
technique NN Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
tamoxifen NN Pharmocological
-DOCSTART- -X- N

Fluorouracil NNP Surgical
Filtering NNP Surgical
Surgery NNP Surgical
Fluorouracil NNP Surgical
Filtering NNP Surgical
Surgery NNP Surgical
Study NNP None
subconjunctival JJ Pharmocological
5- JJ Pharmocological
fluorouracil NN Pharmocological
injections NNS Pharmocological
trabeculectomy NN Physical
alone RB Pharmocological
or CC Pharmocological
trabeculectomy VB Physical
with IN Pharmocological
postoperative JJ Pharmocological
subconjunctival JJ Pharmocological
5-fluorouracil JJ Pharmocological
injections NNS Pharmocological
. . Pharmocological
5-fluorouracil JJ Pharmocological
5-fluorouracil JJ Pharmocological
subconjunctival JJ Pharmocological
5-fluorouracil JJ Pharmocological
-DOCSTART- -X- N

Allopurinol NNP Pharmocological
allopurinol NN Pharmocological
allopurinol JJ Pharmocological
6 CD Pharmocological
weeks NNS Pharmocological
' POS Pharmocological
treatment NN Pharmocological
with IN Pharmocological
high- NN Pharmocological
( ( Pharmocological
300 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
a DT Pharmocological
day NN Pharmocological
) ) Pharmocological
or CC Pharmocological
low- JJ Pharmocological
( ( Pharmocological
100 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
a DT Pharmocological
day NN Pharmocological
) ) Pharmocological
dose NN Pharmocological
allopurinol NN Pharmocological
allopurinol NN Pharmocological
Allopurinol NNP Pharmocological
allopurinol NN Pharmocological
-DOCSTART- -X- N

ticlopidine NN Pharmocological
cyclosporin NN Pharmocological
ticlopidine NN Pharmocological
cyclosporin NN Pharmocological
cyclosporin NN Pharmocological
A NNP Pharmocological
and CC Pharmocological
ticlopidine NN Pharmocological
cyclosporin NN Pharmocological
ticlopidine JJ Pharmocological
ticlopidine NN Pharmocological
. . None
ticlopidine NN Pharmocological
placebo NN Pharmocological
placebo NN Pharmocological
ticlopidine NN Pharmocological
ticlopidine NN Pharmocological
. . None
cyclosporin NN Pharmocological
ticlopidine NN Pharmocological
. . None
-DOCSTART- -X- N

pulse JJ Physical
oximetry NN Physical
pulse JJ Physical
oximetry NN Physical
infusion NN Physical
experiments NNS Physical
Ringer NNP None
's POS None
acetate NN None
( ( None
20 CD None
ml RB None
kg NN None
) ) None
, , None
hydroxyethyl VBD None
starch NN None
130/0.4 CD None
( ( None
10 CD None
ml RB None
kg NN None
) ) None
and CC None
a DT None
combination NN None
of IN None
both DT None
infusions NNS None
of IN None
Ringer NNP None
's POS None
acetate NN None
by IN None
pulse JJ None
oximetry NN None
is VBZ None
-DOCSTART- -X- N

alcohol NN Educational
dependence NN Educational
Concurrent NNP Educational
alcohol NN Educational
dependence NN Educational
( ( Educational
AD NNP Educational
) ) Educational
contingency JJ Educational
management NN Educational
( ( Educational
CM NNP Educational
) ) Educational
AD NNP Educational
, , Educational
randomized VBN Educational
to TO Educational
standard VB Educational
care NN Educational
( ( Educational
SC NNP Educational
) ) Educational
with IN Educational
or CC Educational
without IN Educational
CM NNP Educational
. . Educational
AD NNP Educational
AD NN Educational
non-AD JJ Educational
CM NNP Educational
SC NNP Educational
AD NNP Educational
AD NNP Educational
non-AD JJ Educational
-DOCSTART- -X- N

amoxicillin NN Pharmocological
erythromycin NN Pharmocological
benzathine-penicillin NN Pharmocological
amoxicillin NN Pharmocological
erythromycin NN Pharmocological
. . Pharmocological
amoxicillin NN Pharmocological
erythromycin $ Pharmocological
; : Pharmocological
-DOCSTART- -X- N

ACLR NNP Surgical
ACLR NNP Surgical
-DOCSTART- -X- N

ibuprofen NN Pharmocological
acetaminophen NN Pharmocological
analgesics NNS Pharmocological
acetaminophen NN Pharmocological
or CC None
ibuprofen NN Pharmocological
. . None
acetaminophen NN Pharmocological
( ( Pharmocological
paracetamol NN Pharmocological
) ) None
15 CD None
mg.kg-1 JJ None
, , None
ibuprofen JJ Pharmocological
10 CD None
mg.kg-1 NN None
, , None
or CC None
placebo NN Control
. . None
ibuprofen NN Pharmocological
acetaminophen VB Pharmocological
-DOCSTART- -X- N

sedative JJ Pharmocological
drugs NNS Pharmocological
dexmedetomidine NN Pharmocological
and CC None
midazolam+fentanyl JJ Pharmocological
sedation NN Pharmocological
dexmedetomidine NN Pharmocological
and CC None
topical JJ Pharmocological
anesthesia NN Pharmocological
, , None
dexmedetomidine NN Pharmocological
and CC None
peribulbar NN Pharmocological
anesthesia NN Pharmocological
, , None
midazolam+fentanyl NN Pharmocological
and CC None
topical JJ Pharmocological
anesthesia NN Pharmocological
midazolam+fentanyl NN Pharmocological
and CC None
peribulbar NN Pharmocological
anesthesia NN Pharmocological
. . None
midazolam+fentanyl NN Pharmocological
midazolam+fentanyl NN Pharmocological
combination NN Pharmocological
-DOCSTART- -X- N

sedation NN Pharmocological
regimens NNS Pharmocological
standard JJ Pharmocological
sedation NN Pharmocological
regimens NNS Pharmocological
Mini-Mental JJ Educational
State NNP Educational
Examination NNP Educational
propofol JJ Pharmocological
plus CC Pharmocological
fentanyl JJ Pharmocological
midazolam NN Pharmocological
plus CC Pharmocological
fentanyl JJ Pharmocological
propofol-alone JJ Pharmocological
propofol NN Pharmocological
fentanyl NN Pharmocological
. . None
-DOCSTART- -X- N

3 CD Pharmocological
% NN Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
and CC None
5 CD Pharmocological
% NN Pharmocological
5-fluorouracil JJ Pharmocological
. . None
Diclofenac NNP Pharmocological
sodium NN Pharmocological
and CC None
5-Fluorouracil JJ Pharmocological
3 CD Pharmocological
% NN Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
hyaluronic JJ Pharmocological
acid NN Pharmocological
and CC None
of IN None
5 CD Pharmocological
% NN Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
or CC None
5-Fluorouracil JJ Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac NN Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac NN Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac NN Pharmocological
sodium NN Pharmocological
5-Fluorouracil JJ Pharmocological
5-Fluorouracil NN Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
. . None
-DOCSTART- -X- N

stent JJ Surgical
implantation NN Surgical
Lunar NNP Surgical
stent NN Surgical
from IN Surgical
Inflow NNP Surgical
Dynamics NNP Surgical
iridium NN Pharmocological
oxide IN Pharmocological
implantation NN Surgical
of IN Surgical
Lunar NNP Surgical
stents NNS Surgical
. . None
iridium-oxide JJ Pharmocological
coated VBN Surgical
Lunar NNP Surgical
stents NNS Surgical
. . None
Lunar NNP Surgical
stent NN Surgical
-DOCSTART- -X- N

selumetinib NN Pharmocological
chemotherapy NN Pharmocological
selumetinib NN Pharmocological
selumetinib JJ Pharmocological
chemotherapy NN Physical
selumetinib NN Pharmocological
chemotherapy NN None
( ( None
temozolomide JJ Pharmocological
, , None
150 CD None
dacarbazine NN None
, , None
1000 CD None
in IN None
the DT None
chemotherapy NN None
group NN None
could MD None
selumetinib NN None
at IN None
the DT None
randomized VBN None
to TO None
chemotherapy VB None
was VBD None
7 CD None
weeks NNS None
randomized VBN None
to TO None
selumetinib VB Pharmocological
was VBD None
15.9 CD None
selumetinib NN Pharmocological
with IN None
chemotherapy NN None
. . None
Forty-nine JJ None
with IN None
selumetinib NN Pharmocological
compared VBN None
with IN None
chemotherapy NN None
resulted VBN None
-DOCSTART- -X- N

Levosulpiride NNP Pharmocological
levosulpiride NN Pharmocological
levosulpiride NN Pharmocological
domperidone NN Pharmocological
metoclopramide RB Pharmocological
placebo NN Control
levosulpiride NN Pharmocological
domperidone VB Pharmocological
, , None
metoclopramide NN Pharmocological
placebo VB Control
Active JJ Pharmocological
treatments NNS Pharmocological
placebo NNS Control
-DOCSTART- -X- N

Low-dose JJ Pharmocological
oral JJ Pharmocological
etoposide-based JJ Pharmocological
low-dose JJ Pharmocological
etoposide NN Pharmocological
epipodophyllotoxins NNS Pharmocological
during IN Pharmocological
frontline JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
patients NNS None
received VBD None
etoposide RB Pharmocological
( ( None
50 CD None
mg/m NN None
( ( None
2 CD None
) ) None
per IN None
day NN None
) ) None
administered VBD None
orally RB None
as IN None
a DT None
single JJ None
agent NN None
once RB None
or CC None
twice RB None
daily RB None
. . None
dexamethasone NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
and CC Pharmocological
L-asparaginase NNP Pharmocological
. . None
Etoposide NNP Pharmocological
was VBD None
administered VBN None
until IN None
Day NNP None
22 CD None
. . None
Two CD None
courses NNS None
of IN None
consolidation NN None
therapy NN None
were VBD None
followed VBN None
by IN None
continuation NN Physical
therapy NN Physical
or CC Physical
hematopoietic JJ Physical
stem NN Physical
cell NN Physical
transplantation NN Physical
. . None
low-dose JJ Pharmocological
etoposide NN Pharmocological
-DOCSTART- -X- N

angiotensin-converting JJ Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
zofenopril NN Pharmocological
. . None
placebo NN Control
placebo NN None
zofenopril NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
-DOCSTART- -X- N

Yufeining VBG Pharmocological
Yufeining NNP Pharmocological
Yufeining VBG Pharmocological
pills NNS Pharmocological
control NN Control
group NN Control
was VBD Control
not RB Control
given VBN Control
any DT Control
medicine NN Control
. . Control
-DOCSTART- -X- N

Multiple NNP Other
risk NN Other
factor NN Other
intervention NN Other
multiple JJ None
risk NN None
factor NN None
intervention NN None
B-mode NNP Physical
ultrasound NN Physical
High NNP Physical
resolution NN Physical
B-mode NNP Physical
ultrasound NN Physical
intervention NN None
group NN None
usual JJ Control
care NN Control
group NN Control
intervention NN Physical
group NN Physical
. . None
multiple NN Physical
risk NN Physical
intervention NN Physical
programme NN Physical
-DOCSTART- -X- N

formoterol NN Pharmocological
salmeterol NN Pharmocological
regularly RB Pharmocological
treated VBN Pharmocological
with IN Pharmocological
salbutamol JJ Pharmocological
200 CD Pharmocological
micrograms NNS Pharmocological
twice RB Pharmocological
daily RB Pharmocological
during IN Pharmocological
the DT Pharmocological
study NN Pharmocological
period NN Pharmocological
, , Pharmocological
to TO Pharmocological
avoid VB Pharmocological
variability NN Pharmocological
in IN Pharmocological
were VBD Physical
followed VBN Physical
as IN Physical
measures NNS Physical
of IN Physical
systemic JJ Physical
effects NNS Physical
. . None
Formoterol NNP Pharmocological
methacholine NN Pharmocological
responsiveness NN Pharmocological
( ( Pharmocological
4.6 CD Pharmocological
doubling VBG Pharmocological
doses NNS Pharmocological
after IN Pharmocological
120 CD Pharmocological
micrograms NNS Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

polyvinylpyrrolidone-iodine NN Pharmocological
polyvinylpyrrolidone-iodine JJ Pharmocological
( ( Pharmocological
PVP-I NNP Pharmocological
) ) Pharmocological
procedure NN Educational
Terramycin NNP Pharmocological
cum NN Pharmocological
polymyxin NN Pharmocological
B NNP Pharmocological
cream NN Pharmocological
PVP-I NNP Pharmocological
PVP-I NNP Pharmocological
. . None
PVP-I NNP Pharmocological
PVP-I NNP Pharmocological
-DOCSTART- -X- N

placebo NN Control
citalopram NN Pharmocological
hydrobromide NN Pharmocological
citalopram VB Pharmocological
placebo NN Control
citalopram NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

Ambient JJ None
temperature NN None
and CC None
biomarkers NNS None
12 CD Educational
weeks NNS Educational
of IN Educational
tai NN Educational
chi NN Educational
classes NNS Educational
or CC Educational
to TO Educational
time-matched JJ Control
education NN Control
control NN Control
. . Educational
-DOCSTART- -X- N

Plasmakinetic JJ Surgical
prostate NN Surgical
resection NN Surgical
plasmakinetic JJ Surgical
resection NN Surgical
of IN Surgical
prostate NN Surgical
( ( Surgical
PKRP NNP Surgical
) ) Surgical
transurethral JJ Surgical
resection NN Surgical
of IN Surgical
prostate NN Surgical
TURP NNP Surgical
PKRP NNP Surgical
. . None
PKRP NNP Surgical
PKRP NNP Surgical
-DOCSTART- -X- N

diltiazem NN Pharmocological
] NN Pharmocological
diltiazem JJ Pharmocological
placebo NN Control
diltiazem JJ Pharmocological
and CC None
placebo NN Control
( ( None
diltiazem JJ Pharmocological
placebo NN Control
. . None
diltiazem NN Pharmocological
placebo NN Control
diltiazem NN Pharmocological
. . None
Diltiazem NNP Pharmocological
-DOCSTART- -X- N

intraocular JJ Surgical
lens NNS Surgical
( ( Surgical
IOL NNP Surgical
) ) Surgical
was VBD Surgical
implanted VBN Surgical
left VBN Physical
aphakic NN Physical
, , Physical
treated VBD Physical
with IN Physical
contact NN Physical
lens NNS Physical
( ( Physical
CL NNP Physical
) ) Physical
. . None
IOL NNP Surgical
CL NNP Physical
IOL NNP Surgical
CL NNP Physical
-DOCSTART- -X- N

Transdermal NNP Pharmocological
nitroglycerin NN Pharmocological
transdermal JJ Pharmocological
nitroglycerin JJ Pharmocological
transdermal JJ Pharmocological
nitroglycerin NN Pharmocological
in IN Pharmocological
placebo NN Control
transdermal JJ Pharmocological
nitroglycerin NN Pharmocological
-DOCSTART- -X- N

ketamine NN Pharmocological
ketamine NN Pharmocological
ketamine JJ Pharmocological
0.15 CD Pharmocological
mg/kg NN Pharmocological
as IN Pharmocological
a DT Pharmocological
5-mL JJ Pharmocological
i.v NN Pharmocological
. . Pharmocological
injection NN Surgical
5 CD Surgical
min NN Surgical
before IN Surgical
surgery NN Surgical
and CC None
isotonic JJ Pharmocological
saline NN Pharmocological
5 CD Pharmocological
mL NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
5 CD Pharmocological
mL NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
of IN Pharmocological
isotonic JJ Pharmocological
saline NN Pharmocological
, , Pharmocological
then RB None
0.15 CD Pharmocological
mg/kg NNS Pharmocological
i.v NN Pharmocological
. . Pharmocological
ketamine NN Pharmocological
. . None
ketamine VBP Pharmocological
ketamine NN Pharmocological
ketamine NN Pharmocological
ketamine NN Pharmocological
Ketamine VB Pharmocological
-DOCSTART- -X- N

mefloquine NN Pharmocological
chloroquine VB Pharmocological
mefloquine VB Pharmocological
-DOCSTART- -X- N

nicorandil JJ Pharmocological
nicorandil NN Pharmocological
nicorandil NN Pharmocological
or CC None
a DT None
placebo NN Pharmocological
nicorandil JJ Pharmocological
placebo NN Control
nicorandil JJ Pharmocological
placebo NN Control
nicorandil NN Pharmocological
nicorandil NN Pharmocological
placebo NN Control
nicorandil NNS Pharmocological
-DOCSTART- -X- N

[ JJ None
Intra-arterial JJ Pharmocological
chemotherapy NN Pharmocological
intra-arterially RB Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
and CC None
5-FU CD Pharmocological
systemically RB Pharmocological
with IN Pharmocological
the DT Pharmocological
CMFV-combination NNP Pharmocological
only RB Physical
systemically RB Physical
intra-arterial JJ Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

acetaminophen NN Pharmocological
, , None
diclofenac NN Pharmocological
, , None
or CC None
naproxen RB Pharmocological
on IN None
aspirin-induced JJ None
Nonsteroidal NNP Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
aspirin NN Pharmocological
( ( Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
) ) Pharmocological
aspirin NN Pharmocological
NSAID NNP Pharmocological
aspirin JJ Pharmocological
3 CD None
x VBD None
1 CD None
g NN None
acetaminophen NN Pharmocological
, , None
3 CD None
x NN None
50 CD None
mg NN None
diclofenac NN Pharmocological
, , None
3 CD None
x NN None
250 CD None
mg NN None
naproxen NN Pharmocological
, , None
or CC None
3 CD None
x JJ None
1 CD None
placebo NN Control
. . None
Naproxen NNP Pharmocological
aspirin NN Pharmocological
Diclofenac NNP Pharmocological
aspirin NN Pharmocological
Acetaminophen NNP Pharmocological
placebo NN Control
. . None
NSAID NNP Pharmocological
aspirin NN Pharmocological
naproxen JJ Pharmocological
diclofenac NN Pharmocological
. . None
NSAID NNP Pharmocological
aspirin NN Pharmocological
. . None
-DOCSTART- -X- N

high-dose JJ Pharmocological
rate NN Pharmocological
intracavitary JJ Pharmocological
therapy NN Pharmocological
High-dose JJ Pharmocological
rate NN Pharmocological
( ( Pharmocological
HDR NNP Pharmocological
) ) Pharmocological
remote VBP Pharmocological
afterloading VBG Pharmocological
intracavitary JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

20 CD Pharmocological
microg NNS Pharmocological
( ( Pharmocological
low-dose JJ Pharmocological
) ) Pharmocological
teriparatide NN Pharmocological
per IN None
day NN None
, , None
but CC None
not RB Control
with IN Control
40 CD Control
microg NNS Control
( ( Control
high-dose JJ Control
) ) Control
teriparatide RB None
-DOCSTART- -X- N

imatinib NN Pharmocological
mesylate NN Pharmocological
imatinib JJ Pharmocological
mesylate NN Pharmocological
imatinib VB Pharmocological
800 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
imatinib VB Pharmocological
imatinib NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

pegylated JJ None
interferon-?2a JJ None
and CC None
ribavirin VB None
of IN None
pegylated JJ None
interferon NN None
and CC None
ribavirin NN None
receive VB None
pegylated VBN None
interferon-?2a JJ None
270 CD None
?g/week JJ None
plus CC None
ribavirin JJ None
1,600 CD None
mg JJ None
epoetin-? JJ None
for IN None
followed VBN None
by IN None
pegylated JJ None
interferon-?2a NN None
at IN None
standard JJ None
, , None
or CC None
pegylated VBD None
interferon-?2a JJ None
plus CC None
WBR NNP None
for IN None
induction NN None
with IN None
pegylated JJ None
interferon-?2a JJ None
plus CC None
ribavirin NN None
was VBD None
associated VBN None
-DOCSTART- -X- N

abstinence-contingent JJ Educational
incentives NNS Educational
detoxification NN None
contingent-voucher JJ Educational
-DOCSTART- -X- N

EEG NNP Physical
Recording VBG Physical
blocks NNS Physical
consisted VBN Physical
of IN Physical
targets NNS Physical
preceded VBN Physical
by IN Physical
randomized JJ Physical
sequences NNS Physical
of IN Physical
standards NNS Physical
and CC Physical
by IN Physical
sequences NNS Physical
of IN Physical
standards NNS Physical
that WDT Physical
included VBD Physical
a DT Physical
predictive JJ Physical
sequence NN Physical
signaling VBG Physical
the DT Physical
occurrence NN Physical
of IN Physical
a DT Physical
subsequent JJ Physical
target NN Physical
event NN Physical
. . None
controls NNS Physical
. . None
-DOCSTART- -X- N

Transesophageal NNP Physical
echocardiography NN Physical
reamed VBN Surgical
unreamed JJ Surgical
femoral JJ Surgical
nailing NN Surgical
. . None
reamed VB Surgical
unreamed JJ Surgical
reamed VBD Surgical
unreamed JJ Surgical
nail NN Surgical
. . None
Transesophageal NNP Physical
echocardiography NN Physical
( ( Physical
TEE NNP Physical
) ) None
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
placebo-controlled JJ Control
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

socio-demographic JJ Physical
factors NNS Physical
participation NN Physical
in IN Physical
oral JJ Physical
visual JJ Physical
inspection NN Physical
intervention NN Physical
population-based JJ Physical
oral JJ Physical
screening NN Physical
patient-provider JJ Educational
communication NN Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
expressed VBN Pharmocological
breast NN Pharmocological
milk NN Pharmocological
placebo-controlled JJ Control
venepuncture NN Physical
5 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
distilled JJ Pharmocological
water NN Pharmocological
( ( Pharmocological
DW NNP Pharmocological
) ) Pharmocological
as IN Pharmocological
placebo NN Pharmocological
. . None
venepuncture NN Physical
. . None
EBM NNP Pharmocological
EBM NNP Pharmocological
EBM NNP Pharmocological
EBM NNP Pharmocological
venepuncture NN Physical
-DOCSTART- -X- N

multimodal NN Physical
exercise NN Physical
intervention NN Physical
chemotherapy NN Physical
exercise NN Physical
intervention NN Physical
supervised JJ Physical
multimodal NN Physical
exercise NN Physical
intervention NN Physical
, , None
adjunct JJ Physical
to TO Physical
chemotherapy VB Physical
and CC Physical
standard VB Physical
care NN Physical
intervention NN Educational
group NN Educational
wait-list JJ Control
control NN Control
group NN Control
. . None
Supervised VBD Physical
exercise NN Physical
, , Physical
comprising VBG Physical
high-intensity NN Physical
cardiovascular NN Physical
and CC Physical
heavy JJ Physical
resistance NN Physical
training NN Physical
, , Physical
relaxation- JJ Physical
and CC Physical
body NN Physical
awareness JJ Physical
training NN Physical
and CC Physical
massage NN Physical
supervised JJ Physical
multimodal NN Physical
exercise NN Physical
intervention NN Physical
-DOCSTART- -X- N

contrast NN Physical
echocardiography NN Physical
wall JJ Physical
motion NN Physical
and CC Physical
technetium-99m JJ Physical
sestamibi NN Physical
single-photon JJ Physical
emission NN Physical
computed VBD Physical
tomography NN Physical
. . Physical
myocardial JJ Physical
contrast NN Physical
echocardiography NN Physical
( ( Physical
MCE NNP Physical
) ) Physical
Myocardial NNP Physical
contrast NN Physical
echocardiography NN Physical
perfusion NN Physical
scintigraphy NN Physical
perfluorocarbon-filled JJ Pharmocological
contrast NN Pharmocological
agent NN Pharmocological
( ( Pharmocological
NC100100 NNP Pharmocological
) ) Pharmocological
. . Physical
single-photon JJ Physical
emission NN Physical
computed VBN Physical
tomography NN Physical
( ( Physical
SPECT NNP Physical
) ) Physical
after IN None
the DT None
injection NN None
of IN None
technetium-99m JJ None
( ( None
Tc-99m NNP None
) ) None
sestamibi NN None
at IN None
rest NN None
. . None
Quantitative NNP None
and CC None
semiquantitative JJ None
SPECT NNP Physical
MCE NNP Physical
-DOCSTART- -X- N

altered JJ Educational
pain NN Educational
processing NN Educational
pain NN Educational
modulation NN Educational
response NN Educational
cold VB Educational
pressor NN Educational
task NN Educational
altered JJ Educational
central JJ Educational
processing NN Educational
-DOCSTART- -X- N

online NN Educational
continuing VBG Educational
medical JJ Educational
education NN Educational
( ( Educational
CME NNP Educational
) ) Educational
seminars VBZ Educational
seminar NN Educational
about IN Educational
type NN Educational
2 CD Educational
diabetes NNS Educational
or CC None
a DT None
seminar NN Educational
about IN Educational
systolic JJ Educational
heart NN Educational
failure NN Educational
. . None
seminar NN Educational
online JJ Educational
CME NNP Educational
programs NNS Educational
-DOCSTART- -X- N

Pelvic NNP None
lymphadenectomy NN None
laparotomy JJ None
extraperitoneal NN None
, , None
transperitoneal NN None
or CC None
laparoscopic NN None
transperitoneal NN None
, , None
extraperitoneal NN None
and CC None
laparoscopic NN None
pelvic JJ None
lymphadenectomy NN None
transperitoneal VB Surgical
( ( Surgical
TPL NNP Surgical
) ) Surgical
, , Surgical
extraperitoneal FW Surgical
( ( Surgical
EPL NNP Surgical
) ) Surgical
or CC Surgical
laparoscopic JJ Surgical
pelvic JJ Surgical
lymphadenectomy NN Surgical
( ( Surgical
LPL NNP Surgical
) ) Surgical
. . Surgical
( ( None
TPL NNP Surgical
EPL NNP Surgical
TPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
, , None
EPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
, , None
EPL NNP Surgical
and CC None
LPL NNP Surgical
group NN None
( ( None
TPL NNP Surgical
EPL NNP Surgical
TPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
, , None
EPL NNP Surgical
LPL NNP Surgical
EPL NNP Surgical
LPL NNP Surgical
TPL NNP Surgical
LPL NNP Surgical
EPL NNP Surgical
LPL NNP Surgical
-DOCSTART- -X- N

propranolol NN Pharmocological
?-adrenergic JJ None
antagonist NN None
propranolol NN None
. . None
suggested VBD None
propranolol NN None
of IN None
propranolol NN None
mg NNS None
propranolol JJ None
after IN None
placebo NN None
, , None
Propranolol NNP None
of IN None
propranolol NN None
-DOCSTART- -X- N

5-fluorouracil JJ Pharmocological
human JJ Pharmocological
interferon-beta NN Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
monotherapy NN Pharmocological
5-FU JJ Pharmocological
combined VBN Pharmocological
with IN Pharmocological
natural JJ Pharmocological
human JJ Pharmocological
interferon-beta NN Pharmocological
( ( Pharmocological
IFN-beta NNP Pharmocological
) ) Pharmocological
IFN-beta NNP Pharmocological
IFN-3 NNP Pharmocological
to TO Pharmocological
5-FU CD Pharmocological
5-FU JJ Pharmocological
IFN-beta NNP Pharmocological
. . None
-DOCSTART- -X- N

Intervention NN Physical
for IN Physical
in IN Physical
and CC None
control NN None
) ) None
by IN None
change VB None
of IN None
positioning NN None
and CC None
stimulation NN None
of IN None
cough NN None
. . None
-DOCSTART- -X- N

cetamolol NN Pharmocological
: : None
placebo-controlled JJ Control
cetamolol JJ Pharmocological
hydrochloride NN Pharmocological
placebo JJ Control
cetamolol JJ Pharmocological
5-10-15 JJ None
mg/d NN None
cetamolol JJ Pharmocological
15-25-50 JJ Pharmocological
mg/d NN Pharmocological
placebo NN Control
low-dose JJ Pharmocological
high-dose JJ Pharmocological
placebo NN Control
cetamolol NN Pharmocological
-DOCSTART- -X- N

person-centred JJ Educational
dementia NN Educational
care NN Educational
Dementia NNP Educational
Care NNP Educational
Mapping NNP Educational
( ( Educational
DCM NNP Educational
) ) Educational
VIPS NNP Educational
practice NN Educational
model NN Educational
( ( Educational
VPM NNP Educational
) ) Educational
dementia NN None
DCM NNP Educational
VPM NNP Educational
-DOCSTART- -X- N

microcrystalline NN Pharmocological
sustained-release JJ Pharmocological
preparations NNS Pharmocological
theophylline NN Pharmocological
theophylline JJ Pharmocological
therapy NN None
. . None
Nuelin NNP Pharmocological
Retard NNP Pharmocological
-DOCSTART- -X- N

control NN Control
group NN Control
or CC None
an DT None
added JJ None
treatment NN None
group NN None
( ( None
doxazosin JJ Pharmocological
1-4 JJ Pharmocological
mg NN Pharmocological
and CC None
atenolol NN Pharmocological
when WRB None
needed VBN None
) ) None
. . None
atenolol NN Pharmocological
antiadrenergic JJ Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

coriander NN Pharmocological
oil NN Pharmocological
in IN None
coriander NN Pharmocological
oil NN Pharmocological
6 CD Pharmocological
% NN Pharmocological
coriander NN Pharmocological
oil NN Pharmocological
placebo NN Control
coriander NN Pharmocological
oil NN Pharmocological
Coriander NNP Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

patient JJ Physical
position NN Physical
patient JJ Physical
position NN Physical
supine NN Physical
45-degree JJ Physical
upright JJ Physical
position NN Physical
45-degree JJ Physical
upright JJ Physical
position NN Physical
supine NN Physical
flat JJ Physical
position NN Physical
-DOCSTART- -X- N

dietary JJ Educational
intake NN Educational
-DOCSTART- -X- N

decision NN Educational
aid NN Educational
( ( Educational
DA NNP Educational
) ) Educational
immediate JJ Educational
or CC Educational
delayed JJ Educational
access NN Educational
to TO Educational
the DT Educational
online NN Educational
DA NNP Educational
control NN Control
-DOCSTART- -X- N

hyaluronic JJ Pharmocological
acid NN Pharmocological
triamcinolone NN Pharmocological
hexacetonide NN Pharmocological
intra-articular JJ Pharmocological
( ( Pharmocological
i/a NN Pharmocological
) ) Pharmocological
triamcinolone NN Pharmocological
. . Pharmocological
hexacetonide NN Pharmocological
( ( Pharmocological
TH NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
i/a JJ Pharmocological
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
five CD None
HA NNP Pharmocological
injections NNS Pharmocological
at IN None
weekly JJ None
intervals NNS None
; : None
or CC None
20 CD Control
mg NN Control
TH NNP Pharmocological
followed VBN None
by IN None
four CD None
placebo NN Control
( ( Control
saline NN Control
) ) Control
injections NNS Control
. . None
HA NNP Pharmocological
HA NNP Pharmocological
HA NNP Pharmocological
. . None
HA NNP Pharmocological
-DOCSTART- -X- N

Bridge NNP Surgical
plate NN Surgical
osteosynthesis NN Surgical
using VBG None
dynamic JJ Surgical
condylar JJ Surgical
screw NN Surgical
( ( Surgical
DCS NNP Surgical
) ) Surgical
or CC None
retrograde VBN Surgical
intramedullary JJ Surgical
supracondylar JJ Surgical
nail NN Surgical
( ( Surgical
RIMSN NNP Surgical
) ) Surgical
-DOCSTART- -X- N

6-thioguanine JJ Pharmocological
versus NN None
6-mercaptopurine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
6-thioguanine NN Pharmocological
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
6-thioguanine JJ Pharmocological
( ( None
750 CD None
6-mercaptopurine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
, , None
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
-DOCSTART- -X- N

treatment NN None
group NN None
( ( None
pricking VBG Physical
therapy NN Physical
group NN None
) ) None
and CC None
a DT None
control NN None
group NN None
( ( None
medication NN Surgical
group NN None
) ) None
. . None
pricking VBG Physical
thyroid JJ Physical
gland NN Physical
high JJ Physical
point NN Physical
or CC Pharmocological
oral JJ Control
administration NN Control
of IN Control
tapazole NN Control
. . Pharmocological
-DOCSTART- -X- N

mechlorethamine NN Physical
, , Physical
Oncovin NNP Physical
, , Physical
procarbazine NN Physical
, , Physical
and CC Physical
prednisone NN Physical
( ( Physical
MOPP NNP Physical
) ) Physical
and CC None
supradiaphragmatic JJ Physical
radiotherapy NN Physical
( ( Physical
40 CD Physical
Gy NNP Physical
) ) Physical
, , None
and CC None
no DT Physical
laparotomy NN Physical
MOPP NNP Pharmocological
CCNU NNP Pharmocological
, , Pharmocological
vinblastine NN Pharmocological
, , Pharmocological
procarbazine NN Pharmocological
prednisone NN Pharmocological
laparotomy NN Surgical
supradiaphragmatic JJ Physical
radiotherapy NN Physical
-DOCSTART- -X- N

outside-the-boot JJ Physical
braces NNS Physical
. . None
-DOCSTART- -X- N

composite JJ Physical
cements NNS Physical
phosphoric JJ Pharmocological
acid NN Pharmocological
coating NN Physical
with IN Physical
a DT Physical
self-etching JJ Physical
adhesive NN Physical
( ( Physical
Linkmax NNP Physical
) ) Physical
and CC Physical
its PRP$ Physical
respective JJ Physical
cement NN Physical
, , None
coating VBG Physical
with IN Physical
a DT Physical
conventionally RB Physical
etched VBN Physical
adhesive NN Physical
( ( Physical
RelyX NNP Physical
ARC NNP Physical
) ) Physical
and CC Physical
its PRP$ Physical
cement NN Physical
, , None
or CC None
no DT None
treatment NN None
self-etching JJ Physical
adhesive NN Physical
and CC Physical
its PRP$ Physical
respective JJ Physical
cement NN Physical
etched VBN Physical
adhesive JJ Physical
and CC Physical
its PRP$ Physical
cement NN Physical
Linkmax NNP Physical
treatment NN None
-DOCSTART- -X- N

dose-escalated JJ Pharmocological
and CC Pharmocological
accelerated JJ Pharmocological
regimen NNS Pharmocological
COPP/ABVD NNP Pharmocological
standard JJ Pharmocological
polychemotherapy NN Pharmocological
novel JJ Pharmocological
bleomycin NN Pharmocological
, , None
etoposide RB Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
procarbazine NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( None
BEACOPP NNP None
) ) None
scheme NN None
( ( None
standard JJ None
and CC None
escalated VBD None
dose NN None
) ) None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
procarbazine NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( Pharmocological
COPP NNP Pharmocological
) ) Pharmocological
/doxorubicin NN Pharmocological
, , None
bleomycin NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
and CC None
dacarbazine NN Pharmocological
( ( Pharmocological
ABVD NNP Pharmocological
) ) Pharmocological
. . None
COPP/ABVD NNP Pharmocological
cyclophosphamide NN Pharmocological
, , None
doxorubicin NN Pharmocological
, , None
and CC None
etoposide RB Pharmocological
with IN Pharmocological
granulocyte JJ Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
G-CSF NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
COPP/ABVD NNP Pharmocological
BEACOPP NNP Pharmocological
BEACOPP NNP Pharmocological
BEACOPP NNP Pharmocological
COPP/ABVD NNP Pharmocological
; : None
BEACOPP NNP Pharmocological
BEACOPP NNP Pharmocological
COPP/ABVD NNP Pharmocological
-DOCSTART- -X- N

Simplified NNP Psychological
subjective JJ Psychological
workload NN Psychological
assessment NN Psychological
technique NN Psychological
. . Educational
( ( Educational
SWAT NNP Educational
) ) Educational
five CD Psychological
variations NNS Psychological
of IN Psychological
SWAT NNP Psychological
continuous JJ Psychological
SWAT NNP Psychological
subscales NNS Psychological
discrete JJ Psychological
SWAT NNP Psychological
subscale NN Psychological
. . Educational
SWAT NNP Educational
original JJ Educational
SWAT NNP Educational
scale NN Educational
. . Educational
conventional JJ Educational
pretask JJ Educational
procedure NN Educational
-DOCSTART- -X- N

chemotherapy NN None
radiation NN None
therapy NN None
breast-conserving JJ Pharmocological
therapy NN Pharmocological
and CC None
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
. . None
chemotherapy NN Pharmocological
and CC None
radiation NN Pharmocological
therapy NN Pharmocological
12-week JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
chemotherapy NN Pharmocological
either CC Pharmocological
before IN Pharmocological
or CC Pharmocological
after IN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
. . None
radiotherapy-first JJ Pharmocological
chemotherapy-first JJ Pharmocological
radiotherapy-first JJ Pharmocological
and CC None
chemotherapy-first JJ Pharmocological
chemotherapy NN None
radiation NN Pharmocological
therapy NN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
chemotherapy NN Pharmocological
. . None
-DOCSTART- -X- N

bibrocathol NN None
( ( None
Posiformin? NNP None
2 CD None
% NN None
) ) None
. . None
BACKGROUND NNP None
Bibrocathol NNP None
well-established JJ None
antiseptic JJ None
drug NN None
of IN None
bibrocathol $ None
2 CD None
% NN None
of IN None
bibrocathol NN None
( ( None
Posiformin? NNP None
2 CD None
double-masked JJ None
, , None
placebo-controlled JJ None
parallel-group NN None
bibrocathol JJ None
2 CD None
% NN None
eye NN None
ointment NN None
was VBD None
receiving VBG None
bibrocathol RB None
2 CD None
% NN None
the DT None
placebo NN None
bibrocathol NN None
. . None
Patients NNS None
bibrocathol NN None
over IN None
placebo NN None
the DT None
antiseptic JJ None
bibrocathol NN None
2 CD None
% NN None
in IN None
this DT None
-DOCSTART- -X- N

Sucralfate NNP Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine- NN Pharmocological
sucralfate-healed JJ Pharmocological
cimetidine NN Pharmocological
sucralfate NN Pharmocological
cimetidine NN Pharmocological
cimetidine NN Pharmocological
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
methylphenidate NN Pharmocological
methylphenidate NN Pharmocological
( ( Pharmocological
MPH NNP Pharmocological
) ) Pharmocological
MPH NNP Pharmocological
titration NN Pharmocological
placebo NN Control
optimal JJ Pharmocological
dose NN Pharmocological
MPH NNP Pharmocological
MPH NNP Pharmocological
MPH NNP Pharmocological
-DOCSTART- -X- N

horizontally RB Other
moving VBG Other
sound NN Other
500-Hz JJ Other
low-pass JJ Other
noise NN Other
or CC None
a DT None
6300-Hz JJ Other
high-pass NN Other
noise NN Other
moving NN Other
probe NN Other
-DOCSTART- -X- N

indirect JJ Physical
laser NN Physical
photocoagulation NN Physical
or CC None
cryotherapy NN Physical
. . None
-DOCSTART- -X- N

gonadotropin-releasing JJ Pharmocological
hormone-agonist JJ Pharmocological
leuprolide NN Pharmocological
acetate NN Pharmocological
. . None
leuprolide JJ Pharmocological
acetate NN Pharmocological
( ( Pharmocological
LA NNP Pharmocological
) ) Pharmocological
LA NNP Pharmocological
according VBG None
to TO None
short JJ None
or CC None
ultrashort JJ None
protocols NNS None
. . None
LA NNP Pharmocological
LA NNP Pharmocological
LA NNP Pharmocological
LA NNP Pharmocological
-DOCSTART- -X- N

[ JJ None
Pleural NNP Surgical
tent NN Surgical
creation NN Other
of IN Other
pleural JJ Surgical
tent NN Surgical
did VBD Control
not RB Control
pleural JJ Surgical
tent NN Surgical
-DOCSTART- -X- N

joint JJ Psychological
attention NN Psychological
and CC None
symbolic JJ Psychological
play NN Psychological
. . None
joint JJ Psychological
attention NN Psychological
intervention NN Psychological
, , None
a DT None
symbolic JJ Psychological
play NN Psychological
intervention NN Psychological
, , None
or CC Physical
control NN Control
group NN Control
. . Physical
-DOCSTART- -X- N

Intranasal NNP None
recombinant JJ None
alfa-2b JJ Pharmocological
interferon NN Pharmocological
recombinant JJ Pharmocological
alfa-2b JJ Pharmocological
interferon NN Pharmocological
placebo VB Control
placebo VBN Control
placebo NN Control
nasal JJ Physical
washings NNS Physical
placebo NN Control
interferon NN Pharmocological
Interferon NNP Pharmocological
placebo VB Control
placebo NN Control
recombinant JJ None
alfa-2b JJ Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

race NN Educational
-DOCSTART- -X- N

caffeine JJ Pharmocological
ingestion NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

low-dose JJ Pharmocological
bolus JJ Pharmocological
growth NN Pharmocological
hormone-releasing VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH2 NNP Pharmocological
) ) Pharmocological
supramaximal JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
GHRH NNP Pharmocological
radiotherapy NN Physical
. . None
GHRH NNP Pharmocological
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
( ( None
median JJ None
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Granulocyte-macrophage JJ Physical
colony-stimulating JJ Physical
factor NN Physical
( ( Physical
GM-CSF NNP Physical
) ) Physical
CEF NNP Pharmocological
chemotherapy NN Pharmocological
: : None
( ( None
GM-CSF NNP Physical
) ) None
standard-dose JJ Physical
CEF NNP Physical
regimen NNS Physical
chemotherapy JJ Pharmocological
CEF NNP Pharmocological
( ( None
cyclophosphamide VB Pharmocological
600 CD Pharmocological
mg JJ Pharmocological
m-2 NN Pharmocological
, , None
epidoxorubicin VBZ Pharmocological
60 CD Pharmocological
mg NN Pharmocological
m-2 NN Pharmocological
and CC None
fluorouracil NN Pharmocological
600 CD Pharmocological
mg JJ Pharmocological
m-2 NN Pharmocological
) ) None
chemotherapy NN Pharmocological
GM-CSF NNP Physical
CEF NNP Physical
+ NNP Physical
GM-CSF NNP Physical
GM-CSF NNP Physical
CEF NNP Pharmocological
CEF NNP Pharmocological
+ NNP Pharmocological
GM-CSF NNP Pharmocological
GM-CSF NNP Pharmocological
CEF NNP Pharmocological
+ NNP Pharmocological
GM-CSF NNP Pharmocological
-DOCSTART- -X- N

an DT Other
environment NN Other
of IN Other
recorded VBN Other
helicopter NN Other
noise NN Other
from IN Other
a DT Other
Speech NNP Other
audiometry NN Other
was VBD Other
performed VBN Other
under IN Other
four CD Other
different JJ Other
conditions NNS Other
: : Other
headset NN Physical
only RB Physical
, , Other
and CC Other
three CD Physical
different JJ Physical
ear NN Physical
plugs NNS Physical
worn VBN Physical
under IN Physical
the DT Physical
headset NN Physical
. . None
Fitting NN Other
of IN Other
the DT Other
ear JJ Physical
plugs NN Physical
was VBD Other
performed VBN Other
by IN Other
an DT Other
ear NN Other
, , Other
nose JJ Other
and CC Other
throat JJ Other
specialist NN Other
to TO Other
ensure VB Other
similar JJ Other
conditions NNS Other
. . None
-DOCSTART- -X- N

S-phase JJ Pharmocological
kinase-associated JJ Pharmocological
protein NN Pharmocological
S-phase JJ Pharmocological
kinase-associated JJ Pharmocological
protein NN Pharmocological
( ( None
Skp2 NNP Pharmocological
) ) None
Skp2 NNP Pharmocological
Skp2 NNP Pharmocological
immunohistochemical JJ Physical
study NN Physical
. . Educational
Skp2 NNP Pharmocological
Skp2 NNP Pharmocological
Skp2 NNP Pharmocological
-DOCSTART- -X- N

androgen NN Pharmocological
therapy NN Pharmocological
control NN Control
group NN Control
or CC Physical
to TO Physical
nandrolone CD Pharmocological
decanoate NN Pharmocological
therapy NN Physical
. . None
androgen NN Pharmocological
therapy NN Pharmocological
androgen-treated JJ Pharmocological
-DOCSTART- -X- N

first JJ None
postoperative JJ None
tacrolimus NN None
dose NN None
was VBD None
upon IN None
tacrolimus JJ None
trough IN None
pre-transplant JJ None
tacrolimus NN None
C NNP None
( ( None
2 CD None
) ) None
does VBZ None
pre-transplant JJ None
tacrolimus NN None
C NNP None
( ( None
2 CD None
) ) None
does VBZ None
-DOCSTART- -X- N

a DT Educational
nurse JJ Educational
assessment NN Educational
visit NN Educational
and CC Educational
follow-up JJ Educational
interventions NNS Educational
targeting VBG Educational
risk NN Educational
factors NNS Educational
for IN Educational
disability NN Educational
and CC Educational
falls NNS Educational
a DT None
general JJ Educational
health NN Educational
promotion NN Educational
nurse JJ Educational
visit NN Educational
usual JJ Control
care NN Control
-DOCSTART- -X- N

Sinemet NNP Pharmocological
CR NNP Pharmocological
carbidopa/levodopa NN Pharmocological
preparation NN Pharmocological
carbidopa/levodopa NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

conventional JJ Physical
outpatient NN Physical
dermatology NN Physical
care NN Physical
telemedicine JJ Educational
consultation NN Educational
conventional JJ Physical
hospital NN Physical
outpatient JJ Physical
consultation NN Physical
. . None
telemedicine NN Pharmocological
conventionally RB Physical
. . None
realtime NN Physical
teledermatology NN Physical
consultation NN Physical
conventional JJ Physical
consultation NN Physical
conventional JJ Physical
care NN Physical
telemedicine NN Pharmocological
conventional JJ Physical
consultations NNS Physical
telemedicine NN Physical
consultation NN Physical
conventional JJ Physical
consultation NN Physical
. . None
-DOCSTART- -X- N

chosen VBN None
randomly RB None
and CC None
for IN None
180 CD None
days NNS None
, , None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
propionyl-L-carnitine NN Pharmocological
was VBD None
orally RB None
administered VBN None
, , None
3 CD None
times NNS None
a DT None
day NN None
in IN None
addition NN None
to TO None
their PRP$ None
usual JJ None
treatment NN None
. . None
At IN None
basal JJ None
conditions NNS None
and CC None
after IN None
30 CD None
, , None
90 CD None
and CC None
180 CD None
days NNS None
the DT None
performed VBD None
on IN None
an DT None
ergometer NN None
bicycle NN None
and CC None
the DT None
was VBD None
tested VBN None
by IN None
means NNS None
of IN None
-DOCSTART- -X- N

were VBD None
monitored VBN None
throughout IN None
the DT None
procedure NN None
by IN None
means NNS None
of IN None
( ( Physical
SpO2 NNP Physical
) ) Physical
. . None
measured VBN None
at IN None
six CD None
points NNS None
before IN None
, , None
during IN None
and CC None
after IN None
endoscopy NN Surgical
from IN None
automated VBN None
cardiac NN None
flow NN None
measurement NN None
by IN None
color NN Physical
Doppler NNP Physical
echocardiography NN Physical
. . Physical
midazolam NN Pharmocological
-DOCSTART- -X- N

surgical JJ Surgical
technique NN Surgical
subtotal JJ Surgical
and CC Surgical
bilateral JJ Surgical
thyroidectomy NN Surgical
surgical JJ Surgical
technique NN Surgical
bilateral JJ Surgical
strumectomies NNS Surgical
surgical JJ Surgical
techniques NNS Surgical
-DOCSTART- -X- N

radiotherapy NN Physical
cisplatin JJ Pharmocological
chemo-radiotherapy NN Pharmocological
adding VBG Pharmocological
chemotherapy NN Pharmocological
to TO Pharmocological
radiotherapy VB Pharmocological
in IN None
RT NNP Physical
group NN Physical
received VBD Physical
50 CD Physical
Gy/25 NNP Physical
fx/5 JJ Physical
weeks NNS Physical
of IN Physical
teletherapy NN Physical
followed VBD Physical
1-2 JJ Physical
weeks NNS Physical
later RB Physical
with IN Physical
12 CD Physical
Gy/2 NNP Physical
fx NN Physical
of IN Physical
high-dose-rate JJ Physical
intra-lumenal JJ Physical
brachytherapy NN Physical
spaced VBD Physical
a DT Physical
week NN Physical
apart RB Physical
. . Physical
brachytherapy NN Pharmocological
received VBD Pharmocological
identical JJ Pharmocological
radiotherapy NN Pharmocological
with IN Pharmocological
concurrent JJ Pharmocological
weekly JJ Pharmocological
cisplatin NN Pharmocological
at IN Pharmocological
35 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
for IN Pharmocological
6-7 JJ Pharmocological
cycles NNS Pharmocological
. . None
cisplatin NN Pharmocological
radiotherapy VB Pharmocological
-DOCSTART- -X- N

Thoracoscopic NNP Pharmocological
talc NN Pharmocological
insufflation NN Pharmocological
talc NN Pharmocological
slurry NN Pharmocological
video-assisted JJ Pharmocological
thoracoscopic NN Pharmocological
talc NN Pharmocological
insufflation NN Pharmocological
with IN None
bedside JJ Pharmocological
talc NN Pharmocological
slurry NN Pharmocological
in IN None
video-assisted JJ Pharmocological
thoracoscopic NN Pharmocological
talc NN Pharmocological
insufflation NN Pharmocological
general JJ Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

clindamycin JJ Pharmocological
phosphate JJ Pharmocological
1.2 CD Pharmocological
% NN Pharmocological
-benzoyl NNP Pharmocological
peroxide RB Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
aqueous JJ Pharmocological
gel NN Pharmocological
clindamycin NN Pharmocological
phosphate VBP Pharmocological
1.2 CD Pharmocological
% NN Pharmocological
-benzoyl NNP Pharmocological
peroxide RB Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
( ( Pharmocological
clindamycin-BPO JJ Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
) ) Pharmocological
gel NN Pharmocological
clindamycin-BPO JJ Pharmocological
clindamycin-BPO JJ Pharmocological
-DOCSTART- -X- N

naltrexone NN Pharmocological
hydrochloride NN Pharmocological
placebo-controlled JJ Control
naltrexone JJ Pharmocological
hydrochloride NN Pharmocological
naltrexone JJ Pharmocological
hydrochloride NN Pharmocological
. . Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
Naltrexone CD Pharmocological
naltrexone RB Pharmocological
-DOCSTART- -X- N

pharmacy NN Other
discharge NN Other
plan NN Other
hospital NN Other
pharmacist NN Other
developed VBD Other
discharge NN Other
plans NNS Other
discharged VBN Other
from IN Other
hospital NN Other
following VBG Other
standard JJ Other
procedures NNS Other
community NN Other
pharmacy NN Other
care NN Other
discharge NN Other
plans NNS Other
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
enzyme JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
( ( None
P NNP None
9808 CD None
) ) None
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
enzyme JJ Pharmocological
preparation NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
-DOCSTART- -X- N

Intravenous JJ Pharmocological
regional JJ Pharmocological
anaesthesia NN Pharmocological
prilocaine NN Pharmocological
prilocaine NN Pharmocological
-DOCSTART- -X- N

Nicotinic JJ Pharmocological
acid NN Pharmocological
nicotinic JJ Pharmocological
acid NN Pharmocological
nicotinic JJ Pharmocological
acid NN Pharmocological
no DT Control
therapy NN Control
nicotinic JJ Pharmocological
acid NN Pharmocological
nicotinic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

intervention NN Educational
program NN Educational
( ( None
a DT Educational
special JJ Educational
behavior JJ Educational
therapy NN Educational
group NN Educational
behavior JJ Educational
therapy NN Educational
special JJ Psychological
behavior JJ Psychological
therapy NN Psychological
regular JJ Educational
behavior NN Educational
therapy NN Educational
psychotherapy NN Educational
-DOCSTART- -X- N

depot-pilocarpine NN Pharmocological
. . None
new JJ Pharmocological
pilocarpine NN Pharmocological
polymer NN Pharmocological
( ( Pharmocological
Polym NNP Pharmocological
) ) Pharmocological
traditional JJ Pharmocological
pilocarpine NN Pharmocological
salt NN Pharmocological
solution NN Pharmocological
( ( Pharmocological
Plc NNP Pharmocological
) ) Pharmocological
given VBN None
1 CD None
drop NN None
into IN None
each DT None
eye NN None
: : None
1 CD None
drop NN None
every DT None
12 CD None
hours NNS None
for IN None
Polym NNP None
, , None
1 CD None
drop NN None
every DT None
6 CD None
hours NNS None
for IN None
Plc NNP None
. . None
The DT None
patients NNS None
were VBD None
observed VBN None
for IN None
a DT None
period NN None
of IN None
24 CD None
hours NNS None
. . None
Polym NNP Pharmocological
Plc NNP Pharmocological
) ) None
pilocarpine JJ Pharmocological
Plc NNP Pharmocological
pilocarpine NN Pharmocological
Polym NNP Pharmocological
. . None
Polym NNP Pharmocological
Plc VB Pharmocological
pilocarpine JJ Pharmocological
pilocarpine NN Pharmocological
salt NN Pharmocological
pilocarpine JJ Pharmocological
polymer NN Pharmocological
-DOCSTART- -X- N

telephone-delivered JJ Educational
intervention NN Educational
for IN Educational
Telephone NNP Educational
Counselling NNP Educational
intervention NN Educational
to TO None
improve VB None
physical JJ None
activity NN None
and CC None
diet NN None
Telephone NNP None
Counselling NNP None
with IN None
a DT None
Usual NNP None
Care NNP None
( ( None
brief JJ None
intervention NN None
) ) None
, , Physical
Usual NNP Physical
Care NNP Physical
and CC Physical
an DT Physical
existing VBG Control
practice NN Control
( ( Control
Real NNP Control
Control NNP Control
) ) Control
Telephone CD Educational
Counselling VBG Educational
Usual NNP Physical
Care NNP Physical
Usual NNP Physical
Care NNP Physical
Telephone CD Educational
Counselling VBG Educational
existing VBG None
practice NN None
( ( None
Real NNP None
Control NNP None
) ) None
Usual JJ Other
Care NNP Other
( ( Other
brief JJ Other
intervention NN Other
) ) Other
existing VBG Control
practice NN Control
( ( Control
Real NNP Control
Control NNP Control
) ) Control
Telephone CD None
Counselling VBG None
existing VBG None
practice NN None
( ( None
Real NNP None
Control NNP None
) ) None
'Usual JJ Physical
Care NNP Physical
' POS Physical
brief NN Physical
intervention NN Physical
existing VBG None
practice NN None
( ( None
Real NNP None
Control NNP None
) ) None
-DOCSTART- -X- N

health-promotion NN Educational
programme NN Educational
health-promotion JJ Educational
programme NN Educational
individual JJ Educational
programme NN Educational
( ( Educational
individual JJ Control
intervention NN Control
health-promotion NN Educational
programme NN Educational
health-promotion NN Educational
group NN Educational
individual JJ Educational
intervention NN Educational
health-promotion NN Educational
group NN Educational
health-promotion NN Physical
health-promotion NN None
programme NN None
-DOCSTART- -X- N

placebo NN Control
oral JJ Pharmocological
vaccine NN Pharmocological
prepared VBN Pharmocological
from IN Pharmocological
insect JJ Pharmocological
saliva NN Pharmocological
placebo NN Control
( ( Control
stable JJ Control
vaccine NN Control
solvent NN Control
) ) Control
. . Control
Vaccine NNP Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

tamsulosin NN Pharmocological
and CC None
silodosin NN Pharmocological
the DT None
T-S NNP None
group NN None
( ( None
tamsulosin $ None
0.2 CD None
mg NN None
orally RB None
once RB None
daily JJ None
for IN None
4 CD None
weeks NNS None
then RB None
silodosin VBD None
4 CD None
mg NNS None
orally RB None
twice RB None
daily RB None
for IN None
4 CD None
weeks NNS None
) ) None
or CC None
the DT None
S-T JJ None
group NN None
( ( None
silodosin $ None
4 CD None
mg NN None
orally RB None
twice JJ None
daily RB None
for IN None
4 CD None
weeks NNS None
then RB None
tamsulosin VBD None
0.2 CD None
mg NNS None
orally RB None
once RB None
daily JJ None
for IN None
4 CD None
weeks NNS None
) ) None
. . None
preferred VBD None
tamsulosin NN None
preferred VBD None
silodosin NN None
with IN None
tamsulosin NN None
with IN None
silodosin NN None
that IN None
tamsulosin NN None
-DOCSTART- -X- N

aspirin-treated JJ Pharmocological
aspirin NN Pharmocological
placebo NN Pharmocological
placebo-treated JJ Control
aspirin NN Pharmocological
aspirin-treated JJ Pharmocological
aspirin-treated JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
aprindine NN Pharmocological
and CC None
digoxin NN Pharmocological
placebo-controlled JJ Control
aprindine NN Pharmocological
and CC None
digoxin NN Pharmocological
placebo NN Control
aprindine NN Pharmocological
digoxin NN Pharmocological
or CC None
placebo NN Pharmocological
aprindine NN Pharmocological
, , None
digoxin NN Pharmocological
placebo NN Control
placebo NN Control
digoxin NN Pharmocological
aprindine NN Pharmocological
placebo NN Control
digoxin NN Pharmocological
. . None
-DOCSTART- -X- N

High-dose JJ Pharmocological
pyridoxine NN Pharmocological
and CC Pharmocological
magnesium NN Pharmocological
administration NN Pharmocological
pyridoxine NN Pharmocological
and CC Pharmocological
magnesium NN Pharmocological
( ( Pharmocological
HDPM NNP Pharmocological
) ) Pharmocological
HDPM NNP Pharmocological
HDPM NNP Pharmocological
pyridoxine NN Pharmocological
magnesium NN Pharmocological
oxide NN Pharmocological
HDPM NNP Pharmocological
HDPM NNP Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
histamine-free JJ Pharmocological
diet NN Pharmocological
-DOCSTART- -X- N

macronutrient JJ Physical
fat NN Physical
in IN Physical
the DT Physical
diet JJ Physical
high-fat JJ Other
diet NN Other
( ( Other
HFD NNP Other
) ) Other
( ( Other
65 CD Other
% NN Other
of IN Other
energy NN Other
content NN Other
fat NN Other
, , Other
15 CD Other
% NN Other
protein NN Other
, , Other
20 CD Other
% NN Other
carbohydrate NN Other
) ) Other
or CC Other
a DT Other
high-carbohydrate JJ Other
diet NN Other
( ( Other
HCD NNP Other
) ) Other
( ( Other
70 CD Other
% NN Other
carbohydrate NN Other
, , Other
15 CD Other
% NN Other
protein NN Other
, , Other
15 CD Other
% NN Other
fat NN Other
) ) Other
for IN Other
5 CD Other
days NNS Other
, , Other
with IN Other
a DT Other
washout JJ Other
period NN Other
of IN Other
10 CD Other
days NNS Other
between IN Other
the DT Other
diets NNS Other
. . Other
isoprenaline NN Pharmocological
epinephrine NN Pharmocological
aerobic JJ Physical
exercise NN Physical
HFD NNP Physical
-DOCSTART- -X- N

simvastatin NN Pharmocological
and CC None
fenofibrate NN Pharmocological
simvastatin NN Pharmocological
fenofibrate NN Pharmocological
-DOCSTART- -X- N

Iron NNP Pharmocological
Iron NNP Pharmocological
Dietary NNP Pharmocological
iron NN Pharmocological
iron NN Pharmocological
iron NN Pharmocological
-DOCSTART- -X- N

tirasemtiv NN Pharmocological
Abstract NNP Pharmocological
Tirasemtiv NNP Pharmocological
tirasemtiv NN Pharmocological
Tirasemtiv NNP Pharmocological
-DOCSTART- -X- N

sirolimus NN Pharmocological
single JJ Pharmocological
subconjunctival NN Pharmocological
( ( Pharmocological
SCJ NNP Pharmocological
) ) Pharmocological
intravitreal NN Pharmocological
( ( Pharmocological
IVT NNP Pharmocological
) ) Pharmocological
injection NN Pharmocological
sirolimus NN Pharmocological
sirolimus NN None
administered VBN None
administered VBD None
sirolimus NN None
was VBD None
well-tolerated JJ None
-DOCSTART- -X- N

Ultrasonography-guided JJ Physical
bilateral JJ Physical
rectus NN Physical
sheath NN Physical
block NN Physical
vs NN None
local JJ Physical
anesthetic JJ Physical
infiltration NN Physical
Regional NNP Pharmocological
anesthetic JJ Pharmocological
techniques NNS Pharmocological
Ropivacaine NNP Pharmocological
hydrochloride NN Pharmocological
administered VBD None
at IN None
the DT None
conclusion NN None
of IN None
surgery NN Surgical
as IN None
LAI NNP None
by IN None
the DT None
surgeon NN None
as IN None
ultrasonography-guided JJ None
BRSB NNP None
by IN None
the DT None
anesthesiologist NN None
( ( None
n JJ None
-DOCSTART- -X- N

nursing NN Psychological
intervention NN Psychological
utilizing VBG Psychological
problem-solving JJ Psychological
approaches NNS Psychological
to TO Psychological
symptom VB Psychological
management NN Psychological
and CC Psychological
improving VBG Psychological
intervention NN Educational
Behavioral NNP Educational
interventions NNS Educational
nursing VBG Educational
care NN Educational
nursing NN Educational
interventions NNS Educational
-DOCSTART- -X- N

platelet-activating JJ Pharmocological
factor NN Pharmocological
intrauterine JJ Physical
insemination NN Physical
exogenous JJ Pharmocological
platelet-activating JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
PAF NNP Pharmocological
) ) Pharmocological
intrauterine JJ Physical
insemination NN Physical
( ( Physical
IUI NNP Physical
) ) Physical
IUI NNP Physical
with IN None
or CC None
without IN None
exogenous JJ Pharmocological
PAF NNP Pharmocological
treatment NN Pharmocological
IUI NNP Physical
sperm JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
PAF NNP Pharmocological
PAF NNP Pharmocological
sperm FW Pharmocological
treatment NN Pharmocological
exogenous JJ Pharmocological
PAF NNP Pharmocological
-DOCSTART- -X- N

inflation NN None
of IN None
400 CD None
ml NN None
of IN None
air NN None
. . None
-DOCSTART- -X- N

risperidone NN Pharmocological
placebo-controlled JJ Control
risperidone NN Pharmocological
placebo NN None
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Pharmocological
( ( None
placebo NN None
risperidone NN Pharmocological
risperidone NN Pharmocological
; : Pharmocological
placebo NN None
) ) None
placebo NN None
risperidone NN Pharmocological
placebo NN None
) ) None
-DOCSTART- -X- N

catheter-tip JJ Other
transducers NNS Other
catheter-tip JJ Other
transducers NNS Other
catheters NNS None
catheters NNS None
catheters NNS Physical
catheter NN None
Intrauterine NNP Other
catheter-tip JJ Other
transducers NNS Other
-DOCSTART- -X- N

canalith NN Surgical
repositioning NN Surgical
procedure NN Surgical
. . None
modified JJ Surgical
CRP NNP Surgical
technique NN Surgical
CRP NNP Surgical
CRP NNP Surgical
CRP NNP Surgical
CRP NNP Surgical
CRP NNP Surgical
-DOCSTART- -X- N

VX-770 NNP Pharmocological
oral JJ Pharmocological
VX-770 NNP Pharmocological
placebo NN None
VX-770 JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

whole JJ Pharmocological
pelvic JJ Pharmocological
conventional JJ Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
intensity NN Pharmocological
modulated VBN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
to TO None
receive VB None
50.4 CD None
Gy NNP None
in IN None
28 CD None
fractions NNS None
delivered VBN None
via IN None
either DT None
WP-CRT JJ Physical
or CC None
WP-IMRT JJ Physical
with IN None
concurrent JJ None
weekly JJ None
cisplatin NN None
40 CD None
mg/m NN None
( ( None
2 CD None
) ) None
. . None
was VBD None
graded VBN None
according VBG None
to TO None
the DT None
WP-CRT NNP Pharmocological
WP-IMRT NNP Pharmocological
. . None
WP-CRT JJ Pharmocological
IMRT NNP Pharmocological
WP-CRT NNP Pharmocological
WP-IMRT NNP Pharmocological
CONCLUSION NNP None
WP-IMRT NNP None
is VBZ None
WP-CRT NNP None
and CC None
-DOCSTART- -X- N

low-intensity NN Physical
back RB Physical
exercise NN Physical
home-based JJ Physical
, , Physical
simple JJ Physical
, , Physical
low-intensity JJ Physical
exercise NN Physical
. . None
Low-intensity JJ Physical
back-strengthening JJ Physical
exercise NN Physical
-DOCSTART- -X- N

conventional JJ Control
PCNL NNP Control
and CC None
two CD None
modifications NNS None
to TO None
standard JJ None
procedure NN None
. . None
conventional JJ Control
nephrostomy JJ Physical
tube NN Physical
( ( Physical
NT NNP Physical
) ) Physical
and CC None
temporary JJ Physical
ureteral JJ Physical
catheter NN Physical
( ( Physical
TU NNP Physical
) ) Physical
only RB Physical
TU NNP Physical
only RB Physical
indwelling VBG Physical
ureteral JJ Physical
catheter NN Physical
( ( Physical
IU NNP Physical
) ) Physical
PCNL NNP Surgical
Tubeless NNP Surgical
PCNL NNP Surgical
-DOCSTART- -X- N

antazoline NN Pharmocological
class NN Pharmocological
IA NNP Pharmocological
, , Pharmocological
IC NNP Pharmocological
and CC Pharmocological
III NNP Pharmocological
antiarrhythmic JJ Pharmocological
drugs NNS Pharmocological
or CC None
vernakalant JJ Pharmocological
hydrochloride NN Pharmocological
. . None
Antazoline NNP Pharmocological
antazoline JJ Pharmocological
placebo-controlled JJ Control
antazoline NN Pharmocological
antazoline NN Pharmocological
placebo NN Control
placebo JJ Control
antazoline JJ Pharmocological
-DOCSTART- -X- N

azithromycin NN Pharmocological
, , None
doxycycline NN Pharmocological
and CC None
phenoxymethylpenicillin NN Pharmocological
. . None
Azithromycin NNP Pharmocological
, , None
doxycycline NN Pharmocological
and CC None
phenoxymethylpenicillin NN Pharmocological
oral JJ Pharmocological
azithromycin NN Pharmocological
phenoxymethylpenicillin $ Pharmocological
doxycycline NN Pharmocological
penicillin NN Pharmocological
doxycycline NN Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
. . None
phenoxymethylpenicillin NN Pharmocological
doxycycline VBP Pharmocological
azithromycin RB Pharmocological
. . None
azithromycin NN Pharmocological
-DOCSTART- -X- N

hydrochlorothiazide NN Pharmocological
therapy NN Pharmocological
hydrochlorothiazide NN Pharmocological
therapy NN Pharmocological
patients NNS None
were VBD None
treated VBN None
with IN None
placebo NN Control
followed VBN None
by IN None
hydrochlorothiazide NN Pharmocological
. . None
hydrochlorothiazide JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
placebo NN Control
hydrochlorothiazide NN Pharmocological
. . Pharmocological
hydrochlorothiazide NN Pharmocological
-DOCSTART- -X- N

oxygen NN Other
and CC None
hypoxic NN Other
gas NN Other
arterial JJ None
oxygen NN None
saturations NNS None
( ( None
SaO2 NNP None
) ) None
100 CD Other
percent NN Other
oxygen NN Other
room NN Other
air NN Other
-DOCSTART- -X- N

social-communication-based JJ Educational
approach NN Educational
therapy NN Educational
and CC Educational
coaching VBG Educational
social-interaction NN Educational
and CC Educational
the DT Educational
parent-child JJ Educational
relationship NN Educational
. . None
community NN Control
treatment NN Control
variety NN Other
of IN Other
services NNS Other
averaging VBG Other
3.9 CD Other
hours NNS Other
per IN Other
week NN Other
. . None
-DOCSTART- -X- N

Shenyanning NNP Pharmocological
] NNP None
Shenyanning NNP Pharmocological
( ( Pharmocological
SYN NNP Pharmocological
) ) Pharmocological
SYN NNP Pharmocological
Decoction NNP Pharmocological
Losartan NNP Pharmocological
SYN NNP Pharmocological
-DOCSTART- -X- N

plastic NN Physical
cast NN Physical
fixation NN Physical
plaster NN Physical
cast NN Physical
wrist NN Physical
was VBD Physical
immobilized VBN Physical
in IN Physical
neutral JJ Physical
flexion-extension NN Physical
. . None
dorsiflexed JJ Physical
20 CD Physical
degrees NNS Physical
, , Physical
while IN Physical
the DT Physical
carpus NN Physical
was VBD Physical
pushed VBN Physical
in IN Physical
a DT Physical
volar JJ Physical
direction NN Physical
by IN Physical
an DT Physical
impression NN Physical
in IN Physical
the DT Physical
plaster NN Physical
cast NN Physical
. . None
-DOCSTART- -X- N

fentanyl NN Pharmocological
remifentanil NN Pharmocological
fentanyl NN Pharmocological
and CC None
remifentanil NN Pharmocological
isoflurane NN Pharmocological
in IN Pharmocological
oxygen NN Pharmocological
Fentanyl NNP Pharmocological
remifentanil NN Pharmocological
Fentanyl NNP Pharmocological
remifentanil NN Pharmocological
remifentanil NN Pharmocological
remifentanil NN Pharmocological
remifentanil NN Pharmocological
fentanyl VB Pharmocological
-DOCSTART- -X- N

acylaminopenicillins NNS Pharmocological
. . None
nondepolarizing VBG Pharmocological
muscle NN Pharmocological
relaxants NNS Pharmocological
and CC None
acylaminopenicillins NNS Pharmocological
apalcillin JJ Pharmocological
, , Pharmocological
azlocillin NN Pharmocological
, , Pharmocological
mezlocillin NN Pharmocological
or CC Pharmocological
piperacillin NN Pharmocological
acylaminopenicillins NNS Pharmocological
-DOCSTART- -X- N

improvisational JJ Psychological
music NN Psychological
therapy NN Psychological
's POS Psychological
music NN Psychological
therapy NN Psychological
improvisational JJ Educational
music NN Educational
therapy NN Educational
music NN Educational
therapy NN Educational
three CD Educational
sessions NNS Educational
of IN Educational
parent NN Educational
counselling NN Educational
individual JJ Psychological
, , Psychological
improvisational JJ Psychological
music NN Psychological
therapy NN Psychological
music NN Educational
therapy NN Educational
music NN Educational
therapy NN Educational
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
granulocyte NN Pharmocological
and CC Pharmocological
granulocyte-macrophage JJ Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
G-CSF NNP Pharmocological
and CC Pharmocological
GM-CSF NNP Pharmocological
) ) Pharmocological
cytotoxic NN Pharmocological
chemotherapy NNS Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
G-CSF NNP Pharmocological
GM-CSF NNP Pharmocological
post-chemotherapy NN Pharmocological
. . None
dexamethasone RB Pharmocological
24 CD Pharmocological
mg JJ Pharmocological
days NNS Pharmocological
1-7 CD Pharmocological
, , Pharmocological
melphalan FW Pharmocological
30 CD Pharmocological
mg/m2 NNS Pharmocological
day NN Pharmocological
3 CD Pharmocological
, , Pharmocological
BCNU NNP Pharmocological
60 CD Pharmocological
mg/m2 NN Pharmocological
day NN Pharmocological
3 CD Pharmocological
, , Pharmocological
etoposide RB Pharmocological
75 CD Pharmocological
mg/m2 JJ Pharmocological
days NNS Pharmocological
4-7 CD Pharmocological
, , Pharmocological
Ara-C NNP Pharmocological
100 CD Pharmocological
mg/m2 NN Pharmocological
twice RB Pharmocological
daily JJ Pharmocological
days NNS Pharmocological
4-7 JJ Pharmocological
( ( Pharmocological
Dexa-BEAM NNP Pharmocological
) ) Pharmocological
receive VB Pharmocological
5/microg/kg/day CD Pharmocological
G-CSF NNP Pharmocological
5 CD Pharmocological
microg/kg/day JJ Pharmocological
GM-CSF NNP Pharmocological
Dexa-BEAM NNP Pharmocological
. . None
cyclophosphamide NN Pharmocological
BCNU NNP Pharmocological
etoposide RB Pharmocological
-DOCSTART- -X- N

cimetidine NN Pharmocological
antacid NN Pharmocological
. . Pharmocological
cimetidine NN Pharmocological
or CC None
antacid NN Pharmocological
. . None
cimetidine NN Pharmocological
or CC None
Mylanta NNP Pharmocological
II NNP Pharmocological
antacid NN Pharmocological
cimetidine NN Pharmocological
antacid JJ Physical
therapy NN None
cimetidine JJ Pharmocological
therapy NN None
. . None
-DOCSTART- -X- N

nonhandicapped JJ Educational
peers NNS Educational
regular JJ Educational
opportunities NNS Educational
to TO Educational
interact VB Educational
with IN Educational
a DT Educational
normally RB Educational
developing VBG Educational
peer NN Educational
peer-mediated JJ Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

resting NN Physical
state NN Physical
fMRI NN Physical
study NN Physical
and CC Physical
were VBD Physical
scanned VBN Physical
during IN Physical
two CD Physical
separate JJ Physical
sessions NNS Physical
while IN Physical
receiving VBG Physical
a DT Physical
placebo NN Control
or CC Physical
nicotine JJ Pharmocological
patch NN Pharmocological
, , Pharmocological
in IN Physical
a DT Physical
randomized JJ Physical
, , Physical
cross-over JJ Physical
design NN Physical
. . None
-DOCSTART- -X- N

motor NN Other
imagery NN Other
program NN Other
imagined JJ Physical
movements NNS Physical
mirror NN Physical
movements NNS Physical
hand NN Physical
laterality NN Physical
recognition NN Physical
, , Physical
imagined VBD Physical
movements NNS Physical
, , Physical
mirror NN Physical
movements NNS Physical
( ( Physical
RecImMir NNP Physical
, , Physical
MIP NNP Physical
) ) Physical
; : Physical
imagined VBN Physical
movements NNS Physical
, , Physical
recognition NN Physical
, , Physical
imagined VBD Physical
movements NNS Physical
( ( Physical
ImRecIm NNP Physical
) ) Physical
; : Physical
recognition NN Physical
, , Physical
mirror NN Physical
movements NNS Physical
, , Physical
recognition NN Physical
( ( Physical
RecMirRec NNP Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

Ciprofloxacin NNP Pharmocological
and CC Pharmocological
rifampicin VB Pharmocological
versus NN None
doxycycline NN Pharmocological
and CC Pharmocological
rifampicin NN Pharmocological
rifampicin NN Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
and CC Pharmocological
doxycycline VB Pharmocological
200 CD Pharmocological
mg/day NN Pharmocological
rifampicin VBZ Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
and CC Pharmocological
ciprofloxacin NN Pharmocological
1 CD Pharmocological
g/day NN Pharmocological
for IN Pharmocological
30 CD Pharmocological
days NNS Pharmocological
Ciprofloxacin NNP Pharmocological
and CC Pharmocological
rifampicin VB Pharmocological
doxycycline NN Pharmocological
and CC Pharmocological
rifampicin NN Pharmocological
-DOCSTART- -X- N

EEG NNP Physical
EEGs NNP Physical
-DOCSTART- -X- N

mitral JJ Surgical
valve NN Surgical
surgery NN Surgical
Mitral JJ Surgical
surgery NN Surgical
Group NNP None
I PRP None
contained VBD None
, , None
and CC None
Group NNP None
II NNP None
contained VBD None
-DOCSTART- -X- N

Pimecrolimus NNP Pharmocological
cream VBZ Pharmocological
betamethasone CD Pharmocological
17-valerate JJ Pharmocological
Pimecrolimus NNP Pharmocological
pimecrolimus NN Pharmocological
corticosteroid NN Pharmocological
( ( Pharmocological
betamethasone CD Pharmocological
17-valerate NN Pharmocological
) ) Pharmocological
pimecrolimus FW Pharmocological
betamethasone NN Pharmocological
Betamethasone NNP Pharmocological
pimecrolimus NN Pharmocological
betamethasone NN Pharmocological
pimecrolimus NN Pharmocological
. . None
pimecrolimus NN Pharmocological
betamethasone NN Pharmocological
pimecrolimus NN Pharmocological
-DOCSTART- -X- N

high JJ Other
and CC Other
low JJ Other
fat NN Other
meals NNS Other
meals NNS Pharmocological
upright JJ Other
and CC Other
recumbent JJ Physical
position NN Physical
. . None
-DOCSTART- -X- N

graded JJ Physical
exercise NN Physical
graded JJ Physical
aerobic JJ Physical
exercise NN Physical
programme NN Physical
graded VBN Physical
aerobic NN Physical
exercise NN Physical
flexibility NN Physical
exercises NNS Physical
and CC None
relaxation NN Physical
therapy NN Physical
. . None
flexibility NN Physical
programme NN Physical
exercise NN Physical
programme NN Physical
exercise NN Physical
flexibility NN Control
treatment NN Control
exercise NN Physical
treatment NN Physical
flexibility NN Control
treatment NN Control
. . None
exercise NN Physical
flexibility NN Control
treatment NN Control
. . None
exercise VB Physical
exercise NN Physical
treatment NN Physical
supervised JJ Physical
exercise NN Physical
treatment NN Physical
. . None
graded VBN Physical
aerobic JJ Physical
exercise NN Physical
-DOCSTART- -X- N

Naftidrofuryl NNP Pharmocological
placebo-controlled JJ Control
Naftidrofuryl NNP Pharmocological
placebo NN Pharmocological
Naftidrofuryl NNP None
placebo NN None
placebo NN None
Naftidrofuryl NNP Pharmocological
-DOCSTART- -X- N

Anabolic JJ Pharmocological
steroids NNS Pharmocological
methandienone NN Pharmocological
methandienone NN Pharmocological
placebo NN Control
; : None
Methandienone NNP Pharmocological
Anabolic JJ Pharmocological
steroids NNS Pharmocological
-DOCSTART- -X- N

amiodarone VB Pharmocological
or CC None
placebo VB Control
. . None
-DOCSTART- -X- N

Treadmill NNP Physical
exercise NN Physical
testing VBG Physical
-DOCSTART- -X- N

Amiprilose NNP Pharmocological
hydrochloride NN Pharmocological
amiprilose JJ Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
HCl NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ None
amiprilose VB Pharmocological
HCl NNP Pharmocological
, , Pharmocological
6 CD Pharmocological
g/d NN Pharmocological
, , None
or CC None
placebo NN None
amiprilose JJ Pharmocological
placebo NN Control
amiprilose JJ Pharmocological
placebo NN Control
amiprilose JJ Pharmocological
placebo NN Control
amiprilose NN Pharmocological
Amiprilose NNP Pharmocological
HCl NNP Pharmocological
-DOCSTART- -X- N

FSH NNP Pharmocological
priming NN Pharmocological
FSH NNP Pharmocological
no DT Physical
stimulation NN Physical
recombinant JJ Pharmocological
FSH NNP Pharmocological
-DOCSTART- -X- N

doxorubicin NN Pharmocological
pegylated VBN Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
( ( None
DOX NNP None
) ) None
pegylated JJ Pharmocological
liposomal JJ Pharmocological
formulation NN Pharmocological
( ( Pharmocological
PLD NNP Pharmocological
) ) Pharmocological
DOX NNP Pharmocological
PLD NNP Pharmocological
DOX NNP Pharmocological
PLD NNP Pharmocological
-DOCSTART- -X- N

face NN Other
gaze NN Other
Bubbles NNP Other
method NN Other
-DOCSTART- -X- N

hormonal JJ Pharmocological
contraceptives NNS Pharmocological
Hormonal NNP Pharmocological
contraceptives NNS Pharmocological
hormonal JJ Pharmocological
contraceptive NN Pharmocological
hormonal JJ Pharmocological
contraceptive NN Pharmocological
hormonal JJ None
contraception NN None
hormonal JJ None
contraception NN None
hormonal JJ None
contraception NN None
hormonal JJ None
contraception NN None
hormonal JJ None
contraceptive NN None
-DOCSTART- -X- N

metoclopramide RB Pharmocological
either DT Pharmocological
5 CD Pharmocological
% NN Pharmocological
D-glucose NNP Pharmocological
( ( Pharmocological
placebo NN Control
) ) Pharmocological
or CC Pharmocological
ANF NNP Pharmocological
pmol JJ Pharmocological
Metoclopramide NNP Pharmocological
ANF NNP Pharmocological
3 CD Pharmocological
-DOCSTART- -X- N

pre-operative JJ Pharmocological
and CC Pharmocological
post-operative JJ Pharmocological
anastrozole NN Pharmocological
or CC Pharmocological
tamoxifen NN Pharmocological
. . None
following VBG None
pre-operative JJ Pharmocological
( ( Pharmocological
3 CD Pharmocological
months NNS Pharmocological
) ) Pharmocological
and CC Pharmocological
post-operative JJ Pharmocological
( ( Pharmocological
5 CD Pharmocological
years NNS Pharmocological
) ) Pharmocological
adjuvant VBP Pharmocological
treatment NN Pharmocological
with IN None
either DT None
anastrozole NN Pharmocological
or CC None
tamoxifen NN Pharmocological
. . None
receive VB None
anastrozole NN Pharmocological
( ( None
1 CD None
mg/day NN None
) ) None
plus CC None
tamoxifen JJ Control
placebo NN Control
or CC None
tamoxifen NN Pharmocological
( ( None
20 CD None
mg/day NN None
) ) None
plus CC None
anastrozole JJ Control
placebo NN Control
pre-operatively RB None
. . None
patients NNS None
continued VBD None
on IN None
the DT None
same JJ None
study NN None
medication NN None
as IN None
adjuvant JJ Pharmocological
therapy NN Pharmocological
for IN None
up IN None
to TO None
5 CD None
years NNS None
or CC None
until IN None
recurrence NN None
, , None
intolerable JJ None
toxicity NN None
or CC None
withdrawal NN None
of IN None
patient JJ None
consent NN None
. . None
anastrozole NN Pharmocological
tamoxifen NN Pharmocological
anastrozole NN Pharmocological
anastrozole JJ Pharmocological
and CC None
tamoxifen NN Pharmocological
anastrozole JJ Pharmocological
tamoxifen NN Pharmocological
. . None
-DOCSTART- -X- N

dorsal NN Physical
and CC Physical
volar JJ Physical
resting NN Physical
hand NN Physical
splints NNS Physical
dorsal NN Physical
and CC Physical
volar JJ Physical
resting NN Physical
hand NN Physical
splints NNS Physical
dorsal NN Physical
splints NNS Physical
volar JJ Physical
splints NNS Physical
. . None
volar NN Physical
and CC Physical
dorsal NN Physical
splints NNS Physical
-DOCSTART- -X- N

Conservative NNP Pharmocological
fluid NN Pharmocological
management NN Pharmocological
mechanical JJ Physical
ventilation NN Physical
. . None
-DOCSTART- -X- N

haloperidol NN Pharmocological
placebo-controlled JJ Control
haloperidol JJ Pharmocological
Haloperidol NNP Pharmocological
haloperidol NN Pharmocological
placebo NN None
. . None
-DOCSTART- -X- N

fluorescent JJ Pharmocological
tracers NNS Pharmocological
end-to-side JJ Physical
neurorrhaphy NN Physical
-DOCSTART- -X- N

zoledronic JJ Pharmocological
acid NNS Pharmocological
risedronate NN Pharmocological
zoledronic JJ Pharmocological
acid JJ Pharmocological
Zoledronic JJ Pharmocological
acid NN Pharmocological
risedronate NN Pharmocological
zoledronic NN Pharmocological
acid NN Pharmocological
risedronate NN Pharmocological
. . None
zoledronic JJ Pharmocological
acid NN Pharmocological
risedronate NN Pharmocological
glucocorticoids NNS Pharmocological
, , None
zoledronic JJ None
acid NN None
significantly RB None
risedronate NN None
in IN None
zoledronic JJ None
acid NN None
significantly RB None
versus NN None
risedronate NN None
in IN None
subpopulations NNS None
, , None
zoledronic JJ Pharmocological
acid NN Pharmocological
significantly RB None
versus NN None
risedronate NN Pharmocological
at IN None
zoledronic JJ None
acid NNS None
versus NN None
risedronate NN None
at IN None
zoledronic JJ None
acid NN None
is VBZ None
risedronate NN None
in IN None
-DOCSTART- -X- N

epidural JJ Pharmocological
tramadol-ropivacaine JJ Pharmocological
and CC None
fentanyl-ropivacaine JJ Pharmocological
tramadol NN Pharmocological
fentanyl NN Pharmocological
ropivacaine NN Pharmocological
tramadol VBD Pharmocological
( ( Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
ropivacaine NN Pharmocological
plus CC Pharmocological
tramadol JJ Pharmocological
5 CD Pharmocological
mg/mL NN Pharmocological
) ) Pharmocological
fentanyl NNP Pharmocological
( ( Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
ropivacaine NN Pharmocological
plus CC Pharmocological
fentanyl JJ Pharmocological
3 CD Pharmocological
ug/mL NN Pharmocological
) ) Pharmocological
fentanyl VBD Pharmocological
tramadol NN Pharmocological
tramadol NN Pharmocological
fentanyl VB Pharmocological
-DOCSTART- -X- N

phenylbutazone NN Pharmocological
Phenylbutazone NNP Pharmocological
phenylbutazone NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

serum NN Pharmocological
prostate NN Pharmocological
specific JJ Pharmocological
antigen NN Pharmocological
5alpha-reductase JJ Pharmocological
inhibitors NNS Pharmocological
dutasteride JJ Pharmocological
placebo NN Control
dutasteride RB Pharmocological
dutasteride JJ Pharmocological
dutasteride NN Pharmocological
vs NN None
placebo NN Control
dutasteride NN Pharmocological
dutasteride NN Pharmocological
. . None
dutasteride NN Pharmocological
-DOCSTART- -X- N

Three CD Pharmocological
diets NNS Pharmocological
Diet NNP Pharmocological
A NNP Pharmocological
, , Pharmocological
an DT Physical
average JJ Physical
American JJ Physical
diet NN Physical
, , Pharmocological
was VBD Pharmocological
designed VBN Pharmocological
to TO Pharmocological
provide VB Pharmocological
37 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
fat JJ Pharmocological
, , Pharmocological
16 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
saturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
SFAs NNP Pharmocological
) ) Pharmocological
; : None
diet JJ Pharmocological
B NNP Pharmocological
( ( Pharmocological
step NN Pharmocological
1 CD Pharmocological
diet NN Pharmocological
) ) Pharmocological
was VBD Pharmocological
designed VBN Pharmocological
to TO Pharmocological
provide VB Pharmocological
30 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
fat JJ Pharmocological
, , Pharmocological
9 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
SFA NNP Pharmocological
; : None
diet JJ Pharmocological
C NNP Pharmocological
( ( Pharmocological
low JJ Pharmocological
SFA NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
was VBD Pharmocological
designed VBN Pharmocological
to TO Pharmocological
provide VB Pharmocological
26 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
fat JJ Pharmocological
, , Pharmocological
5 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
-DOCSTART- -X- N

clarithromycin NN Pharmocological
clarithromycin JJ Pharmocological
caffeine NN Pharmocological
tolbutamide RB Pharmocological
dextromethorphan NN Pharmocological
clarithromycin NN Pharmocological
clarithromycin JJ Pharmocological
clarithromycin NN Pharmocological
clarithromycin NN Pharmocological
-DOCSTART- -X- N

fasting VBG Physical
and CC None
treatment NN Pharmocological
omission NN Pharmocological
omitted VBD None
normal JJ None
dose NN None
of IN None
evening VBG Pharmocological
GH NNP Pharmocological
and/or NN None
morning NN Pharmocological
hydrocortisone NN Pharmocological
. . None
omitted VBN None
. . None
-DOCSTART- -X- N

levosimendan NN Pharmocological
dobutamine NN Pharmocological
Levosimendan NNP Pharmocological
levosimendan NNS Pharmocological
dobutamine NN Pharmocological
levosimendan NN Pharmocological
or CC None
dobutamine NN Pharmocological
. . None
levosimendan NN Pharmocological
dobutamine NN Pharmocological
Levosimendan NNP Pharmocological
levosimendan JJ Pharmocological
levosimendan JJ Pharmocological
-DOCSTART- -X- N

high JJ Pharmocological
fat NN Pharmocological
diet JJ Pharmocological
rich JJ Pharmocological
in IN Pharmocological
monounsaturated JJ Pharmocological
fat NN Pharmocological
( ( Pharmocological
MUFA-diet NNP Pharmocological
) ) Pharmocological
moderate JJ Pharmocological
fat NN Pharmocological
diet JJ Pharmocological
rich JJ Pharmocological
in IN Pharmocological
polyunsaturated JJ Pharmocological
fat NN Pharmocological
( ( Pharmocological
PUFA-diet NNP Pharmocological
) ) Pharmocological
PUFA-rich JJ Pharmocological
MUFA NNP Pharmocological
. . None
-DOCSTART- -X- N

Low JJ Physical
intensity NN Physical
physical JJ Physical
training NN Physical
low JJ Physical
intensity NN Physical
general JJ Physical
training NN Physical
program NN Physical
low JJ Physical
intensity NN Physical
training NN Physical
. . None
two CD Physical
treadmill NN Physical
tests NNS Physical
-DOCSTART- -X- N

physiotherapy JJ Physical
management NN Physical
placebo NN Control
multimodal JJ Physical
physiotherapy NN Physical
programme NN Physical
including VBG None
taping VBG Physical
, , None
exercises NNS Physical
, , None
and CC None
massage NN Physical
placebo NN Control
Physiotherapy NNP Physical
and CC None
placebo JJ Control
Physiotherapy NNP Physical
included VBD Physical
exercise NN Physical
, , None
massage NN Physical
, , None
taping VBG Physical
, , None
and CC None
mobilisation NN Physical
, , None
followed VBN None
by IN None
12 CD None
weeks NNS None
of IN None
self JJ None
management NN None
. . None
Placebo NNP Control
sham VBN Control
ultrasound JJ Control
and CC Control
light JJ Control
application NN Control
of IN Control
a DT Control
non-therapeutic JJ Control
gel NN Control
, , Control
followed VBN Control
by IN Control
no DT Control
treatment NN Control
. . None
physiotherapy NN Physical
programme NN Physical
-DOCSTART- -X- N

Infrared NNP Physical
LED NNP Physical
irradiation NN Physical
LED NNP Physical
irradiation NN Physical
( ( None
1 CD None
) ) None
the DT None
LED NNP None
group NN None
( ( None
treadmill IN None
training VBG None
associated VBN None
with IN None
phototherapy NN None
, , None
n JJ None
= NNP None
10 CD None
) ) None
, , None
( ( None
2 CD None
) ) None
the DT None
exercise NN None
group NN None
( ( None
treadmill IN None
training NN None
, , None
n JJ None
= NNP None
10 CD None
) ) None
, , None
and CC None
( ( None
3 CD None
) ) None
the DT None
sedentary JJ None
group NN None
( ( None
neither DT None
physical JJ None
training NN None
nor CC None
phototherapy NN None
, , None
n JJ None
= NNP None
10 CD None
) ) None
. . None
The DT None
training NN None
the DT None
LED NNP None
exercise NN None
Therefore RB None
, , None
the DT None
infrared JJ None
LED NNP None
irradiation NN None
-DOCSTART- -X- N

( ( Physical
CAA NNP Physical
) ) Physical
colon-j-pouch JJ Physical
( ( Physical
CPA NNP Physical
) ) Physical
constructed VBD Physical
. . None
-DOCSTART- -X- N

Verapamil NNP Pharmocological
lithium NN Pharmocological
treatment NN None
lithium VB Pharmocological
( ( Pharmocological
lithium NN Pharmocological
, , Pharmocological
valproate NN Pharmocological
) ) Pharmocological
and CC None
some DT Pharmocological
novel NN Pharmocological
( ( Pharmocological
tamoxifen NN Pharmocological
) ) Pharmocological
antimanic JJ Pharmocological
agents NNS Pharmocological
. . None
Verapamil NNP Pharmocological
Verapamil NNP Pharmocological
verapamil NN Pharmocological
, , Pharmocological
used VBD Pharmocological
alone RB Pharmocological
or CC Pharmocological
as IN Pharmocological
an DT Pharmocological
adjunctive JJ Pharmocological
treatment NN Pharmocological
lithium NN Pharmocological
verapamil NN Pharmocological
continued-lithium NN Pharmocological
combined VB Pharmocological
verapamil/lithium NN Pharmocological
verapamil NNS Pharmocological
continued-lithium NN Pharmocological
. . None
verapamil JJ Pharmocological
verapamil JJ Pharmocological
plus CC Pharmocological
lithium NN Pharmocological
verapamil NN Pharmocological
lithium NN Pharmocological
. . None
-DOCSTART- -X- N

vancomycin NN Pharmocological
vancomycin NN Pharmocological
vancomycin NN Pharmocological
vancomycin NN Pharmocological
-DOCSTART- -X- N

meloxicam NN Pharmocological
and CC Pharmocological
a DT Pharmocological
glucosamine-chondroitin JJ Pharmocological
supplement NN Pharmocological
meloxicam NN Pharmocological
and CC None
a DT None
glucosamine-chondroitin JJ Pharmocological
( ( Pharmocological
Glu-Ch NNP Pharmocological
) ) Pharmocological
supplement NN Pharmocological
Glu-Ch NNP Pharmocological
or CC Pharmocological
meloxicam NN Pharmocological
placebo NN Control
meloxicam NN Pharmocological
meloxicam NN Pharmocological
meloxicam NN Pharmocological
placebo NN None
meloxicam NN Pharmocological
meloxicam NN Pharmocological
placebo NN None
meloxicam NN Pharmocological
-DOCSTART- -X- N

short JJ Educational
theory NN Educational
of IN Educational
mind NN Educational
intervention NN Educational
theory NN Educational
of IN Educational
mind NN Educational
skills NNS Educational
short JJ Educational
theory NN Educational
of IN Educational
mind NN Educational
intervention NN Educational
intervention NN None
or CC None
a DT None
waiting JJ None
list NN None
control NN Control
group NN None
. . None
intervention NN None
mind NN Educational
intervention NN Educational
-DOCSTART- -X- N

Radiotherapy NNP Pharmocological
CCNU NNP Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
1- JJ Pharmocological
( ( Pharmocological
2-chloroethyl JJ Pharmocological
) ) Pharmocological
-3-cyclohexyl-1-nitrosourea FW Pharmocological
CCNU NNP Pharmocological
) ) Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
plus CC Pharmocological
CCNU NNP Pharmocological
CCNU NNP Pharmocological
-DOCSTART- -X- N

BCAH NNP Surgical
and CC Surgical
PTFE NNP Surgical
vascular JJ Surgical
access NN Surgical
grafts NNS Surgical
PTFE NNP Surgical
grafts NNS Surgical
BCAHs NNP Surgical
BCAH NNP Surgical
PTFE NNP Surgical
grafts NNS Surgical
PTFE NNP Surgical
grafts NNS Surgical
. . Surgical
-DOCSTART- -X- N

Pre-bent JJ Physical
instruments NNS Physical
single-port JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
versus IN Surgical
conventional JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
: : Surgical
single-incision NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
SILS NNP Surgical
) ) Surgical
conventional JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
CLS NNP Surgical
) ) Surgical
single-port JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

Evidence-based JJ Educational
narratives NNS Educational
evidence-based JJ Educational
narrative JJ Educational
traditional JJ Educational
summary JJ Educational
narrative JJ Educational
summary JJ Educational
read VB Educational
either CC Educational
a DT Educational
summary NN Educational
of IN Educational
the DT Educational
guideline NN Educational
( ( Educational
control NN Educational
) ) Educational
or CC Educational
a DT Educational
narrative JJ Educational
( ( Educational
intervention NN Educational
) ) Educational
. . None
opioid JJ Educational
guidelines NNS Educational
-DOCSTART- -X- N

binary JJ Educational
logistic JJ Educational
regression NN Educational
physician JJ Educational
counseling NN Educational
and CC Educational
improvements NNS Educational
-DOCSTART- -X- N

psychotherapy NN Psychological
alone RB Psychological
, , None
drug NN Pharmocological
alone RB Pharmocological
, , None
psychotherapy JJ Psychological
plus CC Psychological
drug NN Psychological
, , None
electroconvulsive JJ Physical
therapy NN Physical
( ( Physical
ECT NNP Physical
, , Physical
and CC Physical
milieu NN Physical
. . None
-DOCSTART- -X- N

oxprenolol JJ Pharmocological
or CC Pharmocological
methyldopa NN Pharmocological
beta-adrenoreceptor NN Pharmocological
blocking VBG Pharmocological
agents NNS Pharmocological
. . None
oxprenolol NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

collaborative JJ Other
care NN Other
PD NNP Pharmocological
pharmacotherapy NN Pharmocological
embedded VBD None
in IN None
a DT None
disease NN None
management NN None
framework NN None
of IN None
collaborative JJ None
care NN None
( ( None
CC NNP None
) ) None
. . None
CC NNP Educational
usual JJ None
care NN None
( ( None
UC NNP None
) ) None
. . None
educational JJ Educational
videotapes NNS Educational
and CC Educational
pamphlets NNS Educational
; : None
pharmacotherapy NN Pharmocological
with IN Pharmocological
the DT Pharmocological
selective JJ Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
paroxetine NN Pharmocological
; : None
2 CD Educational
psychiatrist NN Educational
visits NNS Educational
and CC None
2 CD None
telephone NN None
calls NNS None
telephone NN None
calls NNS None
-DOCSTART- -X- N

self-report JJ Educational
methods NNS Educational
illicit JJ None
drug NN None
use NN None
: : None
1 CD None
) ) None
Individual NNP Educational
interview NN Educational
in IN Educational
the DT Educational
workplace NN Educational
, , None
2 CD None
) ) None
group-administered JJ Educational
questionnaire NN Educational
in IN Educational
the DT Educational
workplace NN Educational
, , None
3 CD None
) ) None
telephone NN Educational
interview NN Educational
, , None
and CC None
4 CD None
) ) None
individual JJ Educational
interview NN Educational
off IN Educational
the DT Educational
worksite NN Educational
. . None
-DOCSTART- -X- N

human JJ Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
: : Pharmocological
intravenous JJ Pharmocological
human JJ Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
( ( Pharmocological
hEGF NN Pharmocological
) ) Pharmocological
cetraxate VB Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
CH NNP Pharmocological
) ) Pharmocological
EGF NNP Pharmocological
CH NNP Pharmocological
. . Pharmocological
hEGF NN Pharmocological
hydroxypropyl NN Pharmocological
cellulose NN Pharmocological
EGF NNP Pharmocological
EGF NNP Pharmocological
-DOCSTART- -X- N

maprotiline NN Pharmocological
( ( Educational
MMS NNP Educational
) ) Educational
( ( Educational
GDS NNP Educational
) ) Educational
placebo-controlled JJ Control
maprotiline NN Pharmocological
-DOCSTART- -X- N

[ NNS None
Sublingually RB Pharmocological
administered VBN Pharmocological
captopril NN Pharmocological
versus NN None
nifedipine NN Pharmocological
sublingual JJ Pharmocological
captopril NN Pharmocological
( ( Pharmocological
SLC NNP Pharmocological
) ) Pharmocological
sublingual JJ Pharmocological
nifedipine NN Pharmocological
( ( Pharmocological
SLN NNP Pharmocological
) ) Pharmocological
SLN NNP Pharmocological
SLC NNP Pharmocological
SLN NNP Pharmocological
SLC NNP Pharmocological
SLN NNP Pharmocological
; : None
SLC NNP Pharmocological
SLN NNP Pharmocological
; : None
SLC NNP Pharmocological
SLN NNP Pharmocological
-DOCSTART- -X- N

dipeptidyl JJ Pharmocological
peptidase-4 JJ Pharmocological
inhibitor NN Pharmocological
vildagliptin NN Pharmocological
Dipeptidyl NNP Pharmocological
peptidase NN Pharmocological
4 CD Pharmocological
( ( Pharmocological
DPP-4 NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
DPP-4 NNP Pharmocological
inhibitors NNS Pharmocological
DPP-4 NNP Pharmocological
inhibitors NNS Pharmocological
placebo-controlled JJ Control
metformin NN Pharmocological
diet NN None
vildagliptin NN Pharmocological
placebo NN Control
metformin NN Pharmocological
diet JJ None
DPP-4 JJ Pharmocological
inhibitor NN Pharmocological
Vildagliptin NNP Pharmocological
-DOCSTART- -X- N

loteprednol JJ Pharmocological
etabonate JJ Pharmocological
loteprednol JJ Pharmocological
etabonate NN Pharmocological
( ( Pharmocological
LE NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
LE NNP Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

lapatinib VB Pharmocological
plus JJ Pharmocological
vinorelbine NN Pharmocological
[ NNP None
( ( None
N NNP None
= NNP None
75 CD None
) ) None
1,250 CD None
mg NN None
orally RB None
once RB None
daily JJ None
( ( None
QD NNP None
) ) None
continuously RB None
plus CC None
20 CD None
mg/m NN None
( ( None
2 CD None
) ) None
/day NN None
intravenously RB None
] VBZ None
or CC None
lapatinib JJ Pharmocological
plus CC Pharmocological
capecitabine JJ Pharmocological
[ NNP None
( ( None
N NNP None
= NNP None
37 CD None
) ) None
1,250 CD None
mg NN None
orally RB None
QD NNP None
continuously RB None
plus CC None
2,000 CD None
mg/m NN None
( ( None
2 CD None
) ) None
/day NN None
orally RB None
, , None
2 CD None
doses NNS None
] RB None
. . None
-DOCSTART- -X- N

Pre-operative JJ Physical
short-term JJ Physical
pulmonary JJ Physical
rehabilitation NN Physical
for IN Physical
pre-operative JJ Physical
short-term JJ Physical
pulmonary JJ Physical
rehabilitation NN Physical
short-term JJ Physical
pulmonary JJ Physical
rehabilitation NN Physical
or CC None
no DT Control
such JJ Control
programme NN Control
-DOCSTART- -X- N

workplace NN Educational
intervention NN Educational
solar JJ Educational
protection NN Educational
intervention NN Educational
individual JJ Educational
skin NN Educational
screening NN Educational
by IN Educational
a DT Educational
dermatologist NN Educational
and CC Educational
participated VBD Educational
in IN Educational
an DT Educational
education NN Educational
session NN Educational
. . Educational
-DOCSTART- -X- N

ethanol NN Pharmocological
diazepam NN Pharmocological
. . None
ethanol NN Pharmocological
and CC None
diazepam NN Pharmocological
vs. FW None
placebo NN Control
Ethanol NNP Pharmocological
Ethanol JJ Pharmocological
Diazepam NNP Pharmocological
Diazepam NNP Pharmocological
-DOCSTART- -X- N

versus JJ Surgical
conventional JJ Physical
hybrid JJ Surgical
prosthesis NN Surgical
. . Surgical
MOM NNP Physical
hip NN Physical
resurfacing VBG Physical
system NN Physical
( ( Physical
ReCap NNP Physical
) ) Physical
standard JJ Physical
MOP NNP Physical
total JJ Physical
hip NN Physical
arthoplasty NN Physical
( ( Physical
Mallory NNP Physical
Head/Exeter NNP Physical
) ) Physical
. . Surgical
MOM NNP Physical
MOM NNP Physical
-DOCSTART- -X- N

intraocular JJ None
pressure NN None
( ( None
IOP NNP None
) ) None
for IN None
central JJ None
corneal NN None
thickness NN None
( ( None
CCT NNP None
) ) None
. . None
baseline NN Physical
prediction NN Physical
model NN Physical
prediction NN Physical
model NN None
-DOCSTART- -X- N

addition NN Pharmocological
of IN Pharmocological
adriamycin NN Control
( ( Control
ADR NNP Control
) ) Control
or CC Control
bilateral JJ Physical
pulmonary JJ Physical
radiotherapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
to TO Control
vincristine VB Control
, , Control
dactinomycin NN Control
, , Control
and CC Control
cyclophosphamide NN Control
( ( Control
VAC NNP Control
therapy NN Control
) ) Control
RT NNP None
ADR NNP None
VAC NNP None
-DOCSTART- -X- N

psychosocial JJ Educational
intervention NN Educational
-DOCSTART- -X- N

nonpharmacologic JJ Control
treatments NNS Control
topical JJ Control
antiallergic JJ Control
medication NN Control
. . None
INTERVENTION NNP None
Controlled VBD None
exposure NN None
to TO None
grass VB None
pollen NN None
using VBG None
an DT None
environmental JJ None
chamber NN None
to TO None
stimulate VB None
an DT None
ocular JJ None
allergic NN None
reaction NN None
followed VBN None
by IN None
application NN None
of IN None
artificial JJ None
tears NNS None
( ( None
ATs NNP None
) ) None
, , None
5 CD None
minutes NNS None
of IN None
cold JJ None
compress NN None
( ( None
CC NNP None
) ) None
, , None
ATs NNP None
combined VBD None
with IN None
CC NNP None
, , None
or CC None
no DT None
treatment NN None
applied VBN None
at IN None
each DT None
separate JJ None
visit NN None
in IN None
random JJ None
order NN None
. . None
had VBD None
epinastine JJ Pharmocological
hydrochloride NN Pharmocological
( ( None
EH NNP None
) ) None
applied VBD None
alone RB None
and CC None
combined VBN None
with IN None
CC NNP None
in IN None
random JJ None
order NN None
or CC None
instillation NN None
of IN None
a DT None
volume-matched JJ None
saline NN None
control NN None
. . None
with IN None
nonpharmaceutical JJ None
treatments NNS None
with IN None
no DT None
treatment NN None
with IN None
CC NNP None
effect NN None
of IN None
EH NNP None
was VBD None
combined VBN None
with IN None
ATs NNP None
or CC None
EH NNP None
or CC None
CC NNP None
with IN None
ATs NNP None
or CC None
EH NNP None
had VBD None
of IN None
a DT None
CC NNP None
in IN None
combination NN None
with IN None
ATs NNP None
or CC None
EH NNP None
. . None
-DOCSTART- -X- N

sodium NN Pharmocological
cromoglycate NN Pharmocological
Sodium NN Pharmocological
cromoglycate NN Pharmocological
placebo NN Control
Sodium NNP Pharmocological
cromoglycate NN Pharmocological
placebo VB Control
sodium NN Pharmocological
cromoglycate NN Pharmocological
sodium NN Pharmocological
cromoglycate NN Pharmocological
placebo VB Control
sodium NN Pharmocological
cromoglycate NN Pharmocological
placebo VB Control
-DOCSTART- -X- N

7 CD Pharmocological
mg.kg-1 NN Pharmocological
identical JJ Control
placebo NN Control
. . Control
-DOCSTART- -X- N

-DOCSTART- -X- N

amoxycillin NN Pharmocological
and CC Pharmocological
omeprazole NN Pharmocological
metronidazole NN Pharmocological
of IN None
amoxycillin NN Pharmocological
and CC Pharmocological
omeprazole NN Pharmocological
metronidazole NN Pharmocological
, , Pharmocological
amoxycillin NN Pharmocological
and CC Pharmocological
omeprazole NN Pharmocological
amoxycillin NN Pharmocological
omeprazole JJ Pharmocological
metronidazole NN Pharmocological
plus CC None
amoxycillin JJ Pharmocological
and CC Pharmocological
omeprazole JJ Pharmocological
-DOCSTART- -X- N

brief NN Psychological
alcohol NN Psychological
interventions NNS Psychological
brief VB Psychological
intervention NN Psychological
or CC Pharmocological
treatment NN Control
as IN Control
usual JJ Control
. . None
-DOCSTART- -X- N

perindopril-indapamide JJ Pharmocological
or CC None
placebo NN Control
. . None
perindopril-indapamide JJ Pharmocological
-DOCSTART- -X- N

zoster NN Pharmocological
vaccine NN Pharmocological
zoster NN None
vaccine NN None
( ( None
ZV NNP None
) ) None
ZV NNP None
ZV NNP None
ZV NNP None
placebo NN None
ZV NNP None
ZV NNP None
placebo NN None
ZV NNP None
ZV NNP None
-DOCSTART- -X- N

ginseng NN Pharmocological
extract JJ Pharmocological
supplementation NN Pharmocological
ginseng NN Pharmocological
extract NN Pharmocological
streptozotocin NN Pharmocological
Standardized VBN Pharmocological
ginseng NN Pharmocological
extract NN Pharmocological
ginseng JJ Pharmocological
extract NN Pharmocological
Ginseng NNP Pharmocological
extract NN Pharmocological
-DOCSTART- -X- N

immunomodulating VBG Pharmocological
treatment NN Pharmocological
immunomodulatory NN Pharmocological
drugs NNS Pharmocological
thymostimulin NN Pharmocological
drug NN Pharmocological
therapy NN Pharmocological
thymostimulin NN Pharmocological
-DOCSTART- -X- N

Long-stay JJ Physical
short-stay JJ Physical
hospital NN Physical
treatment NN Physical
early JJ Other
discharge NN Other
attempted VBD Other
full JJ Other
nutritional JJ Other
rehabilitation NN Other
short-stay NN Physical
( ( Physical
SS NNP Physical
) ) Physical
or CC None
long-stay JJ Physical
( ( Physical
LS NNP Physical
) ) Physical
group NN None
. . None
LS NNP Physical
retained VBD None
in IN None
hospital NN None
for IN None
full JJ None
nutritional JJ None
rehabilitation NN None
SS NNP Physical
discharged VBD None
immediately RB None
for IN None
standard JJ None
Health NNP None
Service NNP None
care NN None
at IN None
home NN None
plus CC None
high-energy JJ None
supplement NN None
LS NNP Physical
-DOCSTART- -X- N

rosuvastatin NN None
fenofibrate NN None
?-3 JJ None
fatty JJ None
acids NNS None
rosuvastatin NN None
fenofibrate NN None
?-3 JJ None
fatty JJ None
acids NNS None
rosuvastatin VB None
rosuvastatin $ None
fenofibrate JJ None
?-3 JJ None
fatty JJ None
acids NNS None
RF NNP None
RF NNP None
R NNP None
R? NNP None
-DOCSTART- -X- N

timolol NN Pharmocological
latanoprost VB Pharmocological
latanoprost NN Pharmocological
timolol VB Pharmocological
timolol NN Pharmocological
timolol NN Pharmocological
timolol NN Pharmocological
latanoprost VB Pharmocological
latanoprost RB Pharmocological
timolol VB Pharmocological
-DOCSTART- -X- N

granisetron NN Pharmocological
cisplatin-based JJ Pharmocological
chemotherapy NN Pharmocological
. . None
granisetron NN Pharmocological
Granisetron NNP Pharmocological
chemotherapy NN Pharmocological
granisetron NN Pharmocological
granisetron VBZ Pharmocological
-DOCSTART- -X- N

high-dose JJ Pharmocological
cisplatin NN Pharmocological
paclitaxel NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
Paclitaxel NNP Pharmocological
cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
-DOCSTART- -X- N

artemisinin-based JJ Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
rapid JJ Physical
diagnostic JJ Physical
tests NNS Physical
( ( Physical
RDTs NNP Physical
) ) Physical
microscopy VB Other
RDTs NNP None
-DOCSTART- -X- N

GH NNP Pharmocological
GH NNP Pharmocological
treatment NN None
GH NNP None
GH NNP Pharmocological
treatment NN None
GH NNP Pharmocological
2 CD None
mg/m NN None
( ( None
2 CD None
) ) None
GnRH NNP None
analog NN None
( ( None
GnRHa NNP None
) ) None
improves VBZ None
combined JJ None
GH/GnRHa NNP None
and CC None
subsequent JJ None
GH NNP None
treatment NN None
until IN None
0.001 CD None
) ) None
. . None
Treatment NN None
with IN None
GH NNP None
2 CD None
received VBD None
GH/GnRHa NNP None
, , None
compared VBN None
received VBD None
GH NNP None
only RB None
( ( None
P NNP None
adolescence NN None
, , None
GH NNP None
treatment NN None
significantly RB None
combined JJ None
GH/GnRHa NNP None
treatment NN None
. . None
-DOCSTART- -X- N

dalcetrapib NN Pharmocological
novel JJ Surgical
non-invasive JJ Surgical
multimodality NN Surgical
imaging NN Surgical
( ( Surgical
dal-PLAQUE JJ Surgical
) ) Physical
: : None
Dalcetrapib NNP Pharmocological
dalcetrapib VB Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
or CC None
placebo NN Control
for IN None
24 CD None
months NNS None
. . None
dalcetrapib NN Pharmocological
dalcetrapib NNS Pharmocological
placebo VB Control
dalcetrapib NN None
group NN None
placebo NN None
group NN None
. . None
Dalcetrapib NNP None
did VBD None
not RB None
INTERPRETATION NNP None
Dalcetrapib NNP None
showed VBD None
of IN None
dalcetrapib NN None
, , None
including VBG None
-DOCSTART- -X- N

cytokine NN Physical
removal NN Physical
between IN Physical
online JJ Physical
hemodiafiltration NN Physical
( ( Physical
HDF NNP Physical
) ) Physical
, , Physical
which WDT Physical
combines VBZ Physical
convective NN Physical
and CC Physical
diffusive JJ Physical
solute NN Physical
removal NN Physical
, , Physical
and CC Physical
high-flux JJ Physical
hemodialysis NN Physical
( ( Physical
HD NNP Physical
) ) Physical
-DOCSTART- -X- N

cicloxilic JJ Pharmocological
acid NN Pharmocological
cicloxilic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

( ( Other
13 CD Other
) ) Other
C-octanoic NNP Other
-DOCSTART- -X- N

hydrofluoroalkane-134a NN Pharmocological
( ( Pharmocological
HFA NNP Pharmocological
) ) Pharmocological
albuterol NN Pharmocological
. . Pharmocological
Hydrofluoroalkane-134a NNP Pharmocological
( ( Pharmocological
HFA NNP Pharmocological
) ) Pharmocological
switched VBN Pharmocological
from IN Pharmocological
CFC NNP Pharmocological
albuterol NN Pharmocological
to TO Pharmocological
HFA NNP Pharmocological
albuterol NN Pharmocological
. . None
either DT Physical
continue NN Physical
receiving VBG Physical
CFC NNP Pharmocological
albuterol NN Pharmocological
or CC None
to TO Physical
be VB Physical
switched VBN Physical
to TO Physical
receive VB Physical
HFA NNP Pharmocological
albuterol NN Pharmocological
in IN Physical
a DT Physical
yearlong JJ Physical
safety NN Physical
and CC Physical
efficacy NN Physical
trial NN Physical
. . None
HFA NNP Physical
albuterol NN Physical
HFA NNP Physical
albuterol NN Physical
-DOCSTART- -X- N

fMRI NN Physical
-DOCSTART- -X- N

ondansetron NN Pharmocological
placebo-controlled JJ Control
ondansetron RB Pharmocological
1 CD Pharmocological
, , Pharmocological
8 CD Pharmocological
and CC Pharmocological
16 CD Pharmocological
mg NN Pharmocological
placebo VB Control
8 CD Pharmocological
mg JJ Pharmocological
ondansetron NN Pharmocological
to TO None
placebo VB Control
. . None
8 CD Pharmocological
and CC Pharmocological
16 CD Pharmocological
mg NN Pharmocological
ondansetron NN Pharmocological
groups NNS Pharmocological
placebo NN Control
Ondansetron NNP Pharmocological
ondansetron VBP Pharmocological
-DOCSTART- -X- N

perioperative JJ Pharmocological
blood NN Pharmocological
transfusion NN Pharmocological
Perioperative NNP Pharmocological
red VBD Pharmocological
blood NN Pharmocological
cell NN Pharmocological
( ( Pharmocological
RBC NNP Pharmocological
) ) Pharmocological
transfusion NN Pharmocological
transfusion NN Pharmocological
with IN Pharmocological
LD NNP Pharmocological
versus IN Pharmocological
non-LD JJ Physical
RBC NNP Physical
transfusions NNS Physical
. . None
-DOCSTART- -X- N

sodium JJ Pharmocological
restriction NN Pharmocological
no DT Control
dietary JJ Control
restriction NN Control
an DT None
energy NN None
reduced VBN None
diet JJ None
sodium NN Pharmocological
intake NN Pharmocological
being VBG Pharmocological
supplemented VBN Pharmocological
and CC None
hence RB None
unchanged JJ None
no DT Control
intervention NN Control
, , None
which WDT None
was VBD None
followed VBN None
by IN None
taking VBG None
a DT None
diet JJ None
restricted VBN None
in IN None
energy NN None
sodium NN Pharmocological
-DOCSTART- -X- N

droperidol NN Pharmocological
. . Pharmocological
morphine NN Pharmocological
droperidol NN Pharmocological
. . Pharmocological
droperidol NN Pharmocological
or CC None
morphine NN Pharmocological
epidural JJ Pharmocological
anesthesia NN Pharmocological
with IN None
0.5 CD None
% NN None
bupivacaine NN Pharmocological
containing VBG None
1:200,000 CD None
epinephrine NN Pharmocological
, , None
to TO None
which WDT None
2 CD None
mg NN None
morphine NN Pharmocological
sulfate NN Pharmocological
droperidol NN Pharmocological
droperidol NN Pharmocological
) ) Pharmocological
droperidol NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
. . Pharmocological
morphine NN Pharmocological
droperidol NN Pharmocological
. . Pharmocological
morphine NN None
droperidol RB Pharmocological
-DOCSTART- -X- N

Pemetrexed NNP Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
cisplatin JJ Pharmocological
versus NN Pharmocological
cisplatin NN Pharmocological
monotherapy NN Pharmocological
placebo-controlled JJ Control
Platinum-based JJ Pharmocological
chemotherapy NN Pharmocological
Pemetrexed NNP Pharmocological
pemetrexed-cisplatin NN Pharmocological
pemetrexed-cisplatin JJ Pharmocological
placebo-cisplatin JJ Control
( ( Pharmocological
pemetrexed-cisplatin NN Pharmocological
placebo-cisplatin NN None
pemetrexed-cisplatin NN Pharmocological
placebo-cisplatin NN None
pemetrexed-cisplatin NN Pharmocological
placebo-cisplatin NN None
Pemetrexed-cisplatin NNP Pharmocological
pemetrexed-cisplatin NN Pharmocological
-DOCSTART- -X- N

diltiazem NNS Pharmocological
diltiazem NNS Pharmocological
nitroglycerin NN Pharmocological
diltiazem VB Pharmocological
or CC None
nitroglycerin VB Pharmocological
diltiazem NN Pharmocological
nitroglycerin NN Pharmocological
nitroglycerin NN Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

saline JJ Educational
solution NN Educational
load NN Educational
test NN Educational
. . None
saline JJ Educational
solution NN Educational
load NN Educational
test NN Educational
saline NN Pharmocological
solution NN Pharmocological
A DT None
standard JJ None
inferolateral JJ None
arthroscopic NN None
portal NN None
was VBD None
made VBN None
with IN None
a DT None
single JJ Physical
stab NN Physical
incision NN Physical
with IN Physical
use NN Physical
of IN Physical
a DT Physical
number-11 JJ Physical
blade NN Physical
. . None
injection NN Pharmocological
of IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
at IN Pharmocological
a DT Pharmocological
rate NN Pharmocological
of IN Pharmocological
5 CD Pharmocological
mL/sec NNS Pharmocological
through IN Pharmocological
an DT Pharmocological
18-gauge JJ Pharmocological
needle NN Pharmocological
-DOCSTART- -X- N

epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
receptor NN Pharmocological
-DOCSTART- -X- N

dietary JJ Other
folate NN Other
intakes NNS Other
white JJ None
flour NN None
and CC None
select JJ None
cereal NN None
grain NN None
products NNS None
dietary JJ None
folate JJ None
intakes NNS None
folic JJ Pharmocological
acid NN Pharmocological
supplement NN Pharmocological
weighed VBN None
food NN None
records NNS None
folic JJ Pharmocological
acid JJ Pharmocological
supplement NN Pharmocological
-DOCSTART- -X- N

web-based JJ Educational
approach NN Educational
Web-based JJ Educational
health NN Educational
and CC Educational
leadership NN Educational
development NN Educational
program NN Educational
-- : Educational
designed VBN Educational
6-month JJ Educational
Internet-based JJ Educational
program NN Educational
or CC Educational
a DT Educational
control JJ Control
condition NN Control
. . None
intervention NN Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

intermittent NN Pharmocological
or CC Pharmocological
continuous JJ Pharmocological
methotrexate JJ Pharmocological
plus CC None
6-mercaptopurine JJ Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
PRD NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
vincristine JJ Pharmocological
( ( Pharmocological
VCR NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
vindesine NN Pharmocological
( ( Pharmocological
VDS NNP Pharmocological
) ) Pharmocological
. . None
18 CD Physical
Gy NNP Physical
cranial JJ Physical
irradiation NN Physical
intrathecal JJ Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
PRD NNP Pharmocological
plus CC Pharmocological
6-mercaptopurine JJ Pharmocological
( ( Pharmocological
6MP CD Pharmocological
) ) Pharmocological
plus CC Pharmocological
VCR NNP Pharmocological
( ( Pharmocological
2.0 CD Pharmocological
alternating VBG None
biweekly NN Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
6MP CD Pharmocological
plus CC Pharmocological
MTX NNP Pharmocological
combined VBN Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
-DOCSTART- -X- N

rectal JJ Physical
distension NN Physical
rectal JJ Physical
distension NN Physical
with IN Physical
and CC Physical
without IN Physical
rectal JJ Physical
balloon NN Physical
distension NN Physical
. . Physical
with IN None
rectal JJ None
distention NN None
as IN None
CONCLUSION NNP None
Rectal NNP None
distention NN None
in IN None
-DOCSTART- -X- N

eprinomectin JJ Pharmocological
versus NN None
ivermectin NN Pharmocological
eprinomectin NN Pharmocological
eprinomectin JJ Pharmocological
ivermectin NN Pharmocological
eprinomectin NN Pharmocological
eprinomectin NN Pharmocological
ivermectin NN Pharmocological
eprinomectin NN Pharmocological
-DOCSTART- -X- N

Epimedium NNP Pharmocological
brevicornum NN Pharmocological
Epimedium NNP Pharmocological
brevicornum NN Pharmocological
( ( Pharmocological
EB NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

triggered VBN None
and CC None
conventional JJ Physical
fast JJ Physical
rate NN Physical
ventilation NN Physical
conventional JJ None
or CC None
trigger JJ Pharmocological
ventilation NN Pharmocological
with IN None
the DT None
SLE NNP Pharmocological
2000 CD Pharmocological
ventilator NN Pharmocological
. . None
-DOCSTART- -X- N

diuresis NN Pharmocological
with IN Pharmocological
i.v NN Pharmocological
. . Pharmocological
crystalloid NN Pharmocological
, , Pharmocological
furosemide RB Pharmocological
, , Pharmocological
mannitol NN Pharmocological
( ( Pharmocological
if IN Pharmocological
pulmonary JJ Pharmocological
capillary JJ Pharmocological
wedge NN Pharmocological
pressure NN Pharmocological
was VBD Pharmocological
< JJ Pharmocological
20 CD Pharmocological
mmHg NN Pharmocological
) ) Pharmocological
, , Pharmocological
and CC None
low JJ Pharmocological
dose JJ Pharmocological
dopamine NN Pharmocological
versus NN Pharmocological
intravenous JJ Pharmocological
crystalloid NN Pharmocological
and CC None
matching VBG Control
placebos NNS Control
. . None
-DOCSTART- -X- N

oral JJ Pharmocological
, , Pharmocological
inactivated JJ Pharmocological
, , Pharmocological
whole-cell JJ Pharmocological
vaccine NN Pharmocological
for IN Pharmocological
vaccines NNS Pharmocological
whole-cell JJ Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
SsWC NNP Pharmocological
) ) Pharmocological
SsWC NNP Pharmocological
vaccine NN Pharmocological
placebo-controlled JJ Control
SsWC NNP Pharmocological
SsWC NNP Pharmocological
or CC None
placebo VB Control
SsWC NNP Pharmocological
SsWC NNP Pharmocological
SsWC NNP Pharmocological
-DOCSTART- -X- N

estramustine NN Pharmocological
and CC Pharmocological
vinblastine JJ Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
vs JJ None
estramustine NN Pharmocological
alone RB Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
estramustine JJ Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
EMP NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
vinblastine NN Pharmocological
( ( Pharmocological
VBL NNP Pharmocological
) ) Pharmocological
oral JJ Pharmocological
EMP NNP Pharmocological
( ( Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
kg JJ Pharmocological
day NN Pharmocological
continuously RB Pharmocological
) ) Pharmocological
or CC Pharmocological
oral JJ Pharmocological
EMP NNP Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
intravenous JJ Pharmocological
VBL NNP Pharmocological
EMP/VBL NNP Pharmocological
EMP NNP Pharmocological
VBL NNP Pharmocological
-DOCSTART- -X- N

motivational JJ Educational
music NN Educational
motivational JJ Educational
music NN Educational
( ( Educational
music NN Educational
that WDT Educational
stimulates VBZ Educational
or CC Educational
inspires VBZ Educational
physical JJ Educational
activity NN Educational
) ) Educational
6-minute JJ None
run NN None
at IN None
peak NN None
oxygen NN None
consumption NN None
speed NN None
and CC None
without IN None
music NN None
. . None
-DOCSTART- -X- N

prelinguistic JJ Educational
milieu NN Educational
teaching NN Educational
and CC Educational
parent NN Educational
responsivity NN Educational
education NN Educational
facilitating VBG Educational
prelinguistic JJ Educational
communication NN Educational
Responsivity NNP Educational
education NN Educational
for IN Educational
the DT Educational
RPMT NNP Educational
control NN Control
group NN Control
. . Control
RPMT NNP Educational
RPMT NNP Educational
RPMT NNP Educational
RPMT NNP Educational
PMT NNP Educational
-DOCSTART- -X- N

lithium JJ Pharmocological
carbonate NN Pharmocological
. . Pharmocological
lithium JJ Pharmocological
carbonate NN Pharmocological
or CC None
placebo NN Control
Lithium NNP Pharmocological
placebo NN Control
. . Control
-DOCSTART- -X- N

epanolol NN Pharmocological
Epanolol NNP Pharmocological
epanolol JJ Pharmocological
epanolol NN Pharmocological
atenolol NN Pharmocological
epanolol NN Pharmocological
-DOCSTART- -X- N

low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
, , None
enoxaparin JJ Pharmocological
sodium NN Pharmocological
enoxaparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
( ( Pharmocological
UFH NNP Pharmocological
) ) Pharmocological
enoxaparin NN Pharmocological
UFH NNP Pharmocological
. . None
UFH NNP Pharmocological
enoxaparin NN Pharmocological
Enoxaparin NNP Pharmocological
UFH NNP Pharmocological
enoxaparin NN Pharmocological
low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

rh-TGF-beta JJ Pharmocological
1 CD Pharmocological
growth NN Pharmocological
factor-beta JJ Pharmocological
1 CD Pharmocological
no DT Control
treatment NN Control
( ( None
control NN None
) ) None
, , None
carrier NN Pharmocological
( ( Pharmocological
Methyl NNP Pharmocological
Cellulose NNP Pharmocological
gel NN Pharmocological
) ) Pharmocological
, , None
50 CD Pharmocological
ng/wound IN Pharmocological
rhTGF-beta JJ Pharmocological
1 CD Pharmocological
in IN Pharmocological
carrier NN Pharmocological
, , Pharmocological
and CC None
500 CD Pharmocological
ng/wound JJ Pharmocological
rhTGF-beta JJ Pharmocological
1 CD Pharmocological
in IN Pharmocological
carrier NN Pharmocological
. . None
TGF-beta NNP Pharmocological
1 CD Pharmocological
-DOCSTART- -X- N

Positive NNP Educational
Action NNP Educational
Positive JJ Educational
Action NNP Educational
( ( Educational
PA NNP Educational
) ) Educational
school-based JJ Educational
social-emotional JJ Educational
learning NN Educational
and CC Educational
health NN Educational
promotion NN Educational
program NN Educational
PA NNP Educational
control NN None
universal JJ None
, , None
school-based JJ None
programs NNS None
can MD None
benefit VB None
-DOCSTART- -X- N

exercise NN Physical
training NN Physical
: : None
cardiorespiratory JJ Physical
exercise NN Physical
training NN Physical
exercise NN Physical
training NN Physical
. . None
exercise NN Physical
training NN Physical
exercise NN Physical
training NN Physical
exercise NN Physical
intervention NN Physical
Moderate NNP Physical
intensity NN Physical
exercise NN Physical
training NN Physical
exercise NN Physical
-DOCSTART- -X- N

premedication NN Pharmocological
. . None
diazepam NN Pharmocological
water NN Pharmocological
diazepam NN Pharmocological
with IN Pharmocological
water NN Pharmocological
premedication NN Pharmocological
-DOCSTART- -X- N

Low-dose JJ Pharmocological
growth NN Pharmocological
hormone NN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
diet JJ Pharmocological
restriction NN Pharmocological
Growth NNP Pharmocological
hormone NN Pharmocological
diet NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
GH NNP Pharmocological
placebo NN Control
GH NNP Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
injections NNS Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

blood NN Physical
purifying VBG Physical
technologies NNS Physical
polymyxin NN None
B NNP None
immobilized VBD None
fiber NN None
, , None
charcoal NN None
hemoperfusion NN None
plasma NN Physical
or CC Physical
whole JJ Physical
blood NN Physical
exchange NN Physical
. . None
polymyxin NN None
B NNP None
immobilized JJ None
fiber NN None
-DOCSTART- -X- N

indomethacin NN Pharmocological
anesthetized VBN Pharmocological
with IN Pharmocological
thiopental JJ Pharmocological
, , Pharmocological
fentanyl JJ Pharmocological
, , Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
, , Pharmocological
and CC Pharmocological
isoflurane NN Pharmocological
. . Pharmocological
intravenous JJ Pharmocological
indomethacin JJ Pharmocological
50 CD Pharmocological
mg NN Pharmocological
or CC None
placebo NN Pharmocological
administrated VBN Pharmocological
after IN Pharmocological
exposure NN Pharmocological
of IN Pharmocological
the DT Pharmocological
dura NN Pharmocological
. . None
was VBD Physical
measured VBN Physical
continuously RB Physical
subdurally RB Physical
with IN Physical
a DT Physical
22-gauge JJ Physical
canula NN Physical
connected VBN Physical
to TO Physical
a DT Physical
transducer NN Physical
. . None
indomethacin/placebo JJ None
indomethacin NN Pharmocological
-DOCSTART- -X- N

personalized JJ Educational
EHR-generated JJ Educational
informed JJ Educational
consent NN Educational
SmartConsents NNS Educational
standard JJ Educational
consent NN Educational
SmartConsent NNP Educational
. . None
-DOCSTART- -X- N

diabetes NN Physical
specific JJ Physical
formula NN Physical
diabetes NN Physical
specific JJ Physical
formula NN Physical
( ( Pharmocological
Diason NNP Physical
low JJ Physical
energy NN Physical
: : Pharmocological
313.8 CD Pharmocological
kJ/100 NNS Pharmocological
ml NN Pharmocological
) ) Pharmocological
, , Pharmocological
compared VBN None
with IN None
a DT None
standard JJ Pharmocological
formula NN Pharmocological
Enteral NNP Physical
formulas NNS Physical
were VBD None
given VBN None
orally RB None
as IN None
the DT None
sole JJ None
source NN None
of IN None
nutrition NN None
to TO None
the DT None
subjects NNS None
for IN None
6 CD None
days NNS None
. . None
diabetes VBZ Physical
specific JJ Physical
formula NN Physical
standard JJ Pharmocological
formula NN Pharmocological
. . None
diabetes NNS Pharmocological
specific JJ Pharmocological
formula NN Pharmocological
diabetes NNS Pharmocological
specific JJ Pharmocological
formula NN Pharmocological
standard JJ Pharmocological
formula NN Pharmocological
nutrition NN Physical
formulas NNS Physical
standard NN Physical
mixed JJ Physical
meal NN Physical
. . None
diabetes NNS Physical
specific JJ Physical
formula NN Physical
disease NN Physical
specific JJ Physical
formula NN Physical
-DOCSTART- -X- N

COX-2 NNP Pharmocological
selective JJ Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
versus NN None
placebo NN Control
placebo-controlled JJ Control
rofecoxib JJ Pharmocological
or CC None
placebo NN Control
. . None
hydrocodone NN Pharmocological
bitartrate NN Pharmocological
-DOCSTART- -X- N

ondansetron NN Pharmocological
droperidol NN Pharmocological
perphenazine NN Pharmocological
metoclopramide RB Pharmocological
ondansetron NN Pharmocological
droperidol NN Pharmocological
perphenazine NN Pharmocological
metoclopramide NN Pharmocological
ondansetron NN Pharmocological
droperidol VBZ Pharmocological
perphenazine VBP Pharmocological
metoclopramide RB Pharmocological
placebo RB Control
metoclopramide NN Pharmocological
-DOCSTART- -X- N

Aspirin NNP Pharmocological
aspirin NNS Pharmocological
aspirin NN Pharmocological
or CC None
placebo NN Control
and CC None
clonidine NN None
or CC None
placebo NN None
. . None
aspirin JJ Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
aspirin NN Pharmocological
placebo VB Control
aspirin JJ Pharmocological
aspirin NN Pharmocological
placebo NN Control
placebo NN Control
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

atenolol NN Pharmocological
, , None
propranolol NN Pharmocological
, , None
oxprenolol NN Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
. . None
beta-blockade JJ Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
propranolol NN Pharmocological
, , Pharmocological
atenolol NN Pharmocological
, , None
or CC None
placebo NN Control
atenolol NN Pharmocological
propranolol NN Pharmocological
oxprenolol NN Pharmocological
, , Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
, , None
or CC None
placebo NN Pharmocological
. . None
disopyramide JJ Pharmocological
phosphate NN Pharmocological
. . None
three CD Pharmocological
beta-blockers NNS Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
-DOCSTART- -X- N

Methylphenidate NNP Pharmocological
0.3 CD Pharmocological
and CC Pharmocological
0.6 CD Pharmocological
mg/kg NN Pharmocological
methylphenidate NN Pharmocological
placebo-controlled JJ Control
methylphenidate NN Pharmocological
-DOCSTART- -X- N

zoledronic JJ Pharmocological
acid NN Pharmocological
bisphosphonates NNS Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
4 CD Pharmocological
mg NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
intravenously RB Pharmocological
every DT Pharmocological
no DT Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
four CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
neoadjuvant JJ Pharmocological
epirubicin NN Pharmocological
plus CC None
docetaxel JJ Pharmocological
and CC Pharmocological
two CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
adjuvant JJ Pharmocological
epirubicin JJ Pharmocological
plus CC Pharmocological
docetaxel JJ Pharmocological
. . None
zoledronic JJ Pharmocological
acid NN Pharmocological
Zoledronic NNP Pharmocological
acid NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Left NNP Surgical
internal JJ Surgical
thoracic NN Surgical
artery-radial JJ Surgical
artery NN Surgical
composite JJ Surgical
grafts NNS Surgical
left JJ Surgical
internal JJ Surgical
thoracic NN Surgical
artery-radial JJ Surgical
artery NN Surgical
composite JJ Surgical
grafts NNS Surgical
conventional JJ Surgical
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
grafts NNS Surgical
composite JJ Surgical
Y-graft NN Surgical
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

Magnocellular JJ Other
visual JJ Other
, , None
motion NN Other
processing NN Other
and CC None
visual JJ Other
pathway NN Other
integrity NN Other
. . None
-DOCSTART- -X- N

triple JJ Pharmocological
dye NN Pharmocological
application NN Pharmocological
Povidone-iodine NN Pharmocological
-DOCSTART- -X- N

nuclear JJ Other
magnetic JJ Other
resonance NN Other
imaging NN Other
. . Other
nuclear JJ Other
magnetic JJ Other
resonance NN Other
( ( Other
NMR NNP Other
) ) Other
imaging NN Other
NMR NNP Other
images NNS Other
-DOCSTART- -X- N

Physical JJ Educational
activity NN Educational
physical JJ Educational
activity NN Educational
physical JJ Educational
activity NN Educational
physical JJ Educational
activity NN Educational
increase VB Educational
activity NN Educational
levels NNS Educational
-DOCSTART- -X- N

cardiac JJ Physical
contractility NN Physical
modulation NN Physical
electrical JJ Physical
signals NNS Physical
electrical JJ Physical
signals NNS Physical
cardiac NN Physical
contractility NN Physical
modulating NN Physical
( ( Physical
CCM NNP Physical
) ) Physical
electrical JJ Physical
signals NNS Physical
CCM NNP Physical
signals NNS Physical
CCM NNP Physical
therapy NN Physical
. . None
CCM NNP Physical
therapy NN Physical
CCM NNP Physical
therapy NN Physical
CCM NNP Physical
therapy NN Physical
CCM NNP Physical
therapy NN Physical
-DOCSTART- -X- N

spironolactone NN Pharmocological
Spironolactone NNP Pharmocological
mineral JJ Pharmocological
corticoid NN Pharmocological
antagonist NN Pharmocological
aldosterone NN Pharmocological
antagonist NN Pharmocological
placebo NN Control
150 CD Pharmocological
mg NNS Pharmocological
Spironolactone CD Pharmocological
per IN Pharmocological
day NN Pharmocological
; : Pharmocological
placebo NN Control
Spironolactone NNP Pharmocological
Spironolactone NNP Pharmocological
. . None
Spironolactone NNP Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
enalapril NN Pharmocological
enalapril NN Pharmocological
Enalapril NNP Pharmocological
placebo NN Control
enalapril NN Pharmocological
enalapril JJ Pharmocological
enalapril JJ Pharmocological
enalapril VB Pharmocological
enalapril NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

HCG NNP Pharmocological
supplementation NN Pharmocological
combined VBN Pharmocological
GnRH NNP Pharmocological
agonist/HMG JJ Pharmocological
luteal-phase JJ Pharmocological
supplementation NN Pharmocological
clomiphene NN Pharmocological
human JJ Pharmocological
menopausal NN Pharmocological
gonadotrophin NN Pharmocological
( ( Pharmocological
HMG NNP Pharmocological
) ) Pharmocological
GnRH NNP Pharmocological
agonist/HMG NN Pharmocological
human JJ Pharmocological
chorionic NN Pharmocological
gonadotrophin NN Pharmocological
( ( Pharmocological
HCG NNP Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
HCG NNP Physical
-DOCSTART- -X- N

therapeutic JJ Physical
targets NNS Physical
-DOCSTART- -X- N

OK-432 NNP Pharmocological
OK-432 NNP Pharmocological
( ( Pharmocological
receiving VBG Pharmocological
OK-432 NNP Pharmocological
) ) Pharmocological
control NN Control
OK-432 NNP Pharmocological
) ) None
OK-432 NNP Pharmocological
-DOCSTART- -X- N

MSLT NNP Physical
multiple JJ Physical
sleep JJ Physical
latency NN Physical
test NN Physical
( ( Physical
MSLT NNP Physical
) ) Physical
nocturnal JJ Physical
polysomnograms NNS Physical
( ( Physical
NPSG NNP Physical
) ) Physical
MSLT NNP Physical
zolpidem NN Pharmocological
placebo NN Control
MSLTs NNP Physical
MSLT NNP Physical
. . None
MSLT NNP Physical
MSLTs NNP Physical
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
, , Pharmocological
adriamycin NN Pharmocological
, , Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
CAF NNP Pharmocological
) ) Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
Adriamycin NNP Pharmocological
( ( Pharmocological
doxorubicin NN Pharmocological
) ) Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
CAF NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Trunk NNP Physical
exercise NN Physical
combined VBN Physical
with IN Physical
spinal JJ Physical
manipulative NN Physical
or CC None
NSAID NNP Pharmocological
therapy NN Pharmocological
Spinal NNP Physical
manipulative JJ Physical
therapy NN Physical
( ( Physical
SMT NNP Physical
) ) Physical
combined VBD Physical
with IN Physical
trunk NN Physical
strengthening VBG Physical
exercises NNS Physical
( ( Physical
TSE NNP Physical
) ) Physical
vs. FW Physical
SMT NNP Physical
combined VBD Physical
with IN Physical
trunk NN Physical
stretching VBG Physical
exercises NNS Physical
, , Physical
and CC Physical
SMT NNP Physical
combined VBN Physical
with IN Physical
TSE NNP Physical
vs. FW Physical
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
TSE NNP Pharmocological
. . None
SMT NNP Physical
or CC None
NSAID NNP Pharmocological
therapy NN Physical
in IN Physical
combination NN Physical
with IN Physical
supervised JJ Physical
trunk NN Physical
exercise NN Physical
supervised JJ Physical
exercise NN Physical
alone RB Physical
. . Physical
SMT NNP Physical
or CC None
NSAID NNP Pharmocological
therapy NN Pharmocological
( ( Control
placebo NN Control
) ) Control
-DOCSTART- -X- N

chemo NN Physical
+ NN Physical
radio NN Physical
+ NNP Physical
BCG-therapy NNP Physical
. . None
chemo NN Pharmocological
+ NNP Pharmocological
radiotherapy NN Pharmocological
and CC Pharmocological
thereafter RB Pharmocological
by IN Pharmocological
maintenance NN Pharmocological
BCG NNP Pharmocological
therapy NN Pharmocological
. . None
BCG NNP Physical
. . None
-DOCSTART- -X- N

phlebotomy NN Control
alone RB Control
myelosuppressive JJ Pharmocological
agents NNS Pharmocological
, , None
32P CD Pharmocological
or CC None
chlorambucil NN Pharmocological
supplemented VBN None
by IN None
phlebotomy NN Physical
single JJ None
optimal JJ None
therapy NN None
-DOCSTART- -X- N

Allopurinol NNP Pharmocological
blood NN Physical
samples NNS Physical
allopurinol NN Pharmocological
placebo NN None
-DOCSTART- -X- N

Different NNP Pharmocological
aprotinin NN Pharmocological
applications NNS Pharmocological
aprotinin NN Pharmocological
applications NNS Pharmocological
aprotinin RB Pharmocological
bolus NN Pharmocological
of IN Pharmocological
0.5 CD Pharmocological
Mill NNP Pharmocological
. . None
continuous JJ Pharmocological
aprotinin JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
0.1-0.4 JJ Pharmocological
Mill NNP Pharmocological
. . Pharmocological
aprotinin NN Pharmocological
-DOCSTART- -X- N

haloperidol NN Pharmocological
and CC Pharmocological
risperidone NN Pharmocological
. . None
-DOCSTART- -X- N

aromatherapy JJ Physical
massage NN Physical
aromatherapy JJ Physical
massage NN Physical
aromatherapy JJ Physical
massage NN Physical
or CC None
usual JJ Control
supportive JJ Control
care NN Control
alone RB Control
. . None
aromatherapy JJ Physical
massage NN Physical
aromatherapy JJ Physical
massage NN Physical
Aromatherapy NNP Physical
massage NN Physical
-DOCSTART- -X- N

autologous JJ Physical
transplantation NN Physical
of IN Physical
bone-marrow JJ Physical
cells NNS Physical
: : Physical
autologous JJ Physical
implantation NN Physical
of IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
in IN None
injected VBN Physical
with IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
into IN Physical
the DT Physical
gastrocnemius NN Physical
of IN Physical
the DT Physical
ischaemic JJ Physical
limb NN Physical
and CC Physical
with IN Physical
saline NN Physical
into IN Physical
the DT Physical
less JJR Physical
ischaemic JJ Physical
limb NN Physical
. . None
injected VBN Physical
with IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
in IN Physical
one CD Physical
leg NN Physical
and CC Physical
peripheral JJ Physical
blood-mononuclear JJ Physical
cells NNS Physical
in IN Physical
the DT Physical
other JJ Physical
as IN Physical
a DT Physical
control NN Physical
. . None
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
peripheral JJ Physical
blood-mononuclear JJ Physical
cells NNS Physical
Autologous NNP Physical
implantation NN Physical
of IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
-DOCSTART- -X- N

soy NN Pharmocological
isoflavones NNS Pharmocological
placebo-controlled JJ Control
isoflavones NNS Pharmocological
placebo NN Control
Isoflavone NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

interventions NNS None
intended VBN None
outreach NN Educational
interventions NNS Educational
( ( Educational
a DT Educational
mail NN Educational
reminder NN Educational
and CC Educational
a DT Educational
telephone NN Educational
reminder NN Educational
plus CC Educational
appointment JJ Educational
scheduling NN Educational
) ) Educational
routine JJ Educational
publicity NN Educational
campaign NN Educational
a DT Educational
mail NN Educational
reminder NN Educational
, , Educational
( ( Educational
2 CD Educational
) ) Educational
a DT Educational
telephone NN Educational
reminder NN Educational
, , Educational
or CC Educational
( ( Educational
3 CD Educational
) ) Educational
routine JJ Educational
publicity NN Educational
on IN Educational
mammography NN Educational
for IN Educational
all DT Educational
women NNS Educational
. . Educational
routine JJ Educational
publicity NN Educational
campaign NN Educational
. . Educational
Telephone NNP Educational
contact NN Educational
-DOCSTART- -X- N

echocardiography NN Physical
at IN None
24-48 JJ None
hours NNS None
from IN None
symptom JJ None
onset NN None
-DOCSTART- -X- N

needle-through-needle JJ Pharmocological
double JJ Physical
segment NN Physical
technique NN Physical
spinal JJ Physical
epidural JJ Physical
anaesthesia NN Physical
the DT Physical
needle-through-needle JJ Physical
technique NN Physical
and CC None
the DT Physical
double JJ Physical
segment NN Physical
technique NN Physical
27G CD Physical
pencil NN Physical
point NN Physical
needle NN Physical
, , Physical
an DT Physical
18G CD Physical
Tuohy NNP Physical
needle NN Physical
, , Physical
and CC Physical
a DT Physical
20G CD Physical
multiport NN Physical
epidural JJ Physical
catheter NN Physical
needle-through-needle JJ Pharmocological
technique NN Pharmocological
needle-through-needle JJ Physical
double JJ Physical
segment NN Physical
needle-through-needle JJ Physical
technique NN Physical
double JJ Pharmocological
segment NN Pharmocological
-DOCSTART- -X- N

Levamisole NNP Psychological
versus NN None
placebo NN Control
levamisole JJ Pharmocological
( ( None
150 CD None
mg NNS None
daily RB None
during IN None
three CD None
consecutive JJ None
days NNS None
, , None
every DT None
fortnight NN None
) ) None
or CC None
placebo NN None
-DOCSTART- -X- N

rubber NN Educational
hand NN Educational
illusion NN Educational
. . None
rubber JJ Educational
hand NN Educational
illusion NN Educational
. . None
body NN Educational
ownership NN Educational
illusions NNS Educational
rubber NN Educational
hand NN Educational
illusion NN Educational
noxious JJ Physical
heat NN Physical
stimuli NNS Physical
rubber NN None
hand NN None
illusion NN None
or CC None
during IN None
a DT None
control JJ None
condition NN None
. . None
There EX None
rubber NN None
hand NN None
illusion NN None
or CC None
rubber NN None
hand NN None
illusion NN None
does VBZ None
-DOCSTART- -X- N

Yohimbine NN Pharmocological
clonidine NN Pharmocological
( ( Pharmocological
CLO NNP Pharmocological
) ) Pharmocological
or CC None
yohimbine NN Pharmocological
CLO NNP Pharmocological
YHO NNP Pharmocological
CLO NNP Pharmocological
-DOCSTART- -X- N

Fadrozole NNP Pharmocological
HCL NNP Pharmocological
( ( Pharmocological
CGS-16949A NNP Pharmocological
) ) Pharmocological
megestrol NN Pharmocological
acetate VBP Pharmocological
fadrozole JJ Pharmocological
HCL NNP Pharmocological
randomized VBN None
to TO None
receive VB None
either DT None
fadrozole JJ Pharmocological
HCL NNP Pharmocological
, , Pharmocological
1 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , None
or CC None
megestrol NN Pharmocological
acetate NN Pharmocological
, , Pharmocological
40 CD Pharmocological
mg NN Pharmocological
4 CD Pharmocological
times NNS Pharmocological
daily RB Pharmocological
, , None
in IN None
a DT None
double JJ None
blind NN None
fashion NN None
after IN None
progression NN None
on IN None
first-line JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
. . None
Fadrozole NNP Pharmocological
HCL NNP Pharmocological
fadrozole NN Pharmocological
HCL NNP Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
placebo NN Control
risperidone NN None
placebo-controlled JJ None
risperidone NN None
. . None
placebo NN None
risperidone NN None
. . None
Risperidone NNP None
placebo VB None
risperidone NN None
-DOCSTART- -X- N

Amisulpride NNP Pharmocological
bromocriptine NN Pharmocological
DA NNP Pharmocological
antagonist NN Pharmocological
( ( Pharmocological
amisulpride IN Pharmocological
) ) Pharmocological
DA NNP Pharmocological
agonist NN Pharmocological
( ( Pharmocological
bromocriptine NN Pharmocological
) ) Pharmocological
Amisulpride NNP Pharmocological
bromocriptine JJ Pharmocological
DA NNP Pharmocological
agonists NNS Pharmocological
DA NNP Pharmocological
antagonists NNS Pharmocological
benzamides NNS Pharmocological
. . None
-DOCSTART- -X- N

youdujing VBG Pharmocological
preparation NN Pharmocological
Youdujing NNP Pharmocological
( ( Pharmocological
YDJ NNP Pharmocological
) ) Pharmocological
preparation NN Pharmocological
treatment NN Control
control NN Control
YDJ NNP Control
external JJ Control
lotion NN Control
and CC Control
YDJ NNP Control
cream NN Control
normal JJ None
saline NN None
control NN Control
YDJ NNP Pharmocological
-DOCSTART- -X- N

Paricalcitol NNP Pharmocological
capsule NN Pharmocological
paricalcitol NN Pharmocological
paricalcitol NNS Pharmocological
placebo NN Control
. . None
Paricalcitol NNP Pharmocological
-DOCSTART- -X- N

long-term JJ None
lowering NN None
of IN None
( ( Physical
HbA1 NNP Physical
% NN Physical
) ) Physical
Individual NNP None
( ( None
OP-1 NNP None
, , None
OP-2 NNP None
, , None
OP-3 NNP None
) ) None
and CC None
summed VBN None
( ( None
OP-sum NNP None
) ) None
amplitudes NNS None
of IN None
oscillatory JJ None
potentials NNS None
( ( None
OPs NNP None
) ) None
of IN None
electroretinography NN Physical
were VBD None
recorded VBN None
-DOCSTART- -X- N

early JJ Physical
developmental JJ Physical
intervention NN Physical
early JJ Physical
developmental NN Physical
intervention NN Physical
parent-implemented JJ Physical
EDI NNP Physical
health NN Educational
and CC Educational
safety NN Educational
counseling NN Educational
-DOCSTART- -X- N

carbohydrate NN Pharmocological
and CC Pharmocological
fiber NN Pharmocological
increased JJ Pharmocological
carbohydrate NN Pharmocological
and CC Pharmocological
fiber NN Pharmocological
intakes NNS Pharmocological
energy NN Pharmocological
from IN Pharmocological
low-fiber JJ Pharmocological
breakfast NN Pharmocological
cereal NN Pharmocological
( ( Pharmocological
LF NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
, , None
high-fiber JJ Pharmocological
breakfast NN Pharmocological
cereal NN Pharmocological
( ( Pharmocological
HF NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
, , None
or CC None
monounsaturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
MUFA NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

bacille JJ None
Calmette-Gu?rin NNP None
( ( None
BCG NNP None
) ) None
of IN None
BCG NNP None
when WRB None
BCG NNP None
given VBN None
BCG NNP None
-DOCSTART- -X- N

neodymium-doped JJ Surgical
yttrium NN Surgical
aluminum NN Surgical
garnet NN Surgical
laser NN Surgical
treatment NN Surgical
cold JJ Surgical
knife NN Surgical
endoscopic NN Surgical
incision NN Surgical
visual JJ Surgical
laser NN Surgical
ablation NN Surgical
treatment NN Surgical
with IN Surgical
neodymium-doped JJ Surgical
yttrium NN Surgical
aluminum NN Surgical
garnet NN Surgical
( ( Surgical
Nd NNP Surgical
: : Surgical
YAG NN Surgical
) ) Surgical
visual JJ Surgical
laser NN Surgical
ablation NN Surgical
of IN Surgical
urethral JJ Surgical
strictures NNS Surgical
( ( Surgical
VLASU NNP Surgical
) ) Surgical
with IN Surgical
Nd NNP Surgical
: : Surgical
YAGlaser NN Surgical
correction NN None
of IN None
urethral JJ None
strictures NNS None
using VBG None
Sachse NNP Surgical
's POS Surgical
optical JJ Surgical
urethrotomy NN Surgical
. . None
optical JJ Surgical
urethrotomy NN Surgical
VLASU NNP Surgical
VLASU NNP Surgical
VLASU NNP Surgical
-DOCSTART- -X- N

topical JJ Pharmocological
and CC Pharmocological
systemic JJ Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
systemic JJ Educational
and CC Educational
topical JJ Educational
folate NN Educational
placebo JJ Control
mouthwash NN Control
and CC Control
tablets NNS Control
; : Pharmocological
placebo NN Pharmocological
mouthwash NN Pharmocological
and CC Pharmocological
5 CD Pharmocological
mg NN Pharmocological
folate JJ Pharmocological
tablets NNS Pharmocological
; : Pharmocological
folate NN Pharmocological
mouthwash NN Pharmocological
and CC Pharmocological
placebo NN Pharmocological
tablets NNS Pharmocological
. . Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
etoricoxib $ Pharmocological
ibuprofen NN Pharmocological
etoricoxib $ Pharmocological
placebo VB Control
ibuprofen VB Pharmocological
placebo- JJ Control
placebo NN Control
, , None
etoricoxib VBZ Pharmocological
ibuprofen VB Pharmocological
etoricoxib NN Pharmocological
's POS Pharmocological
placebo NN Control
ibuprofen VB Pharmocological
etoricoxib JJ Pharmocological
ibuprofen NN Pharmocological
etoricoxib JJ Pharmocological
ibuprofen JJ Pharmocological
etoricoxib NN Pharmocological
ibuprofen NN Pharmocological
placebo VB Control
etoricoxib $ Pharmocological
ibuprofen VB Pharmocological
etoricoxib JJ Pharmocological
placebo NN Control
ibuprofen NN Pharmocological
-DOCSTART- -X- N

teicoplanin NN Pharmocological
prophylaxis NN Pharmocological
parenteral JJ Pharmocological
prophylaxis NN Pharmocological
with IN Pharmocological
Teicoplanin NNP Pharmocological
-DOCSTART- -X- N

JobTIPS NN None
: : None
JobTIPS NNP None
employment NN None
program NN None
-DOCSTART- -X- N

Clobazam NNP Pharmocological
benzodiazepine NN Pharmocological
, , Pharmocological
clobazam NN Pharmocological
. . Pharmocological
placebo NN Control
clobazam NN Pharmocological
placebo VB Control
Clobazam NNP Pharmocological
-DOCSTART- -X- N

placebo NN Control
clofibrate NN Pharmocological
clofibrate NN Pharmocological
clofibrate NN Pharmocological
clofibrate JJ Physical
therapy NN Physical
clofibrate NN Pharmocological
-DOCSTART- -X- N

transdermal JJ Pharmocological
glyceryl NN Pharmocological
trinitrate NN Pharmocological
glyceryl JJ Pharmocological
trinitrate NN Pharmocological
placebo NN Control
patches NNS Control
glyceryl NN Pharmocological
trinitrate NN Pharmocological
placebo JJ Control
patches NNS Control
. . None
analgesics NNS None
. . None
-DOCSTART- -X- N

rituximab NN Pharmocological
rituximab NN Pharmocological
( ( Pharmocological
RTX NNP Pharmocological
) ) Pharmocological
placebo VB Control
( ( None
PBO NNP None
) ) None
+ NN Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
; : Pharmocological
PBO-randomized NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
RTX NNP Pharmocological
+ NNP Pharmocological
MTX NNP Pharmocological
( ( Pharmocological
RTX-randomized NNP Pharmocological
) ) Pharmocological
. . None
RTX NNP Pharmocological
RTX NNP Pharmocological
RTX NNP Pharmocological
RTX-randomized JJ Pharmocological
RTX NNP Pharmocological
RTX-randomized NNP Pharmocological
both DT None
PBO-randomized NNP None
( ( None
and CC None
RTX-randomized NNP None
( ( None
PBO-randomized NNP None
versus NN None
RTX-randomized JJ None
patients NNS None
CONCLUSION NNP None
RTX NNP None
re-treatment NN None
over IN None
initiating VBG None
RTX NNP None
treatment NN None
may MD None
-DOCSTART- -X- N

controlled VBN Physical
heated VBN Physical
breathing VBG Physical
tube NN Physical
humidifier NN Physical
heated VBN Physical
humidifier NN Physical
continuous JJ Physical
positive JJ Physical
airway NN Physical
pressure NN Physical
( ( Physical
CPAP NNP Physical
) ) Physical
therapy NN Physical
conventional JJ Physical
heated JJ Physical
humidification NN Physical
added VBD Physical
to TO Physical
CPAP NNP Physical
controlled VBN Physical
heated VBN Physical
breathing VBG Physical
tube NN Physical
humidifier NN Physical
( ( Physical
ThermoSmart NNP Physical
( ( Physical
R NNP Physical
) ) Physical
; : Physical
controlled VBN Physical
heated VBD Physical
breathing VBG Physical
tube NN Physical
humidifier NN Physical
controlled VBN Physical
heated VBN Physical
breathing VBG Physical
tube JJ Physical
humidification NN Physical
technology NN Physical
-DOCSTART- -X- N

value-congruence NN None
model NN None
made-in-the-U.S. JJ Other
scenario NN Educational
made-in-Japan JJ Other
scenario NN Educational
daily RB Educational
event NN Educational
sampling VBG Educational
study NN Educational
) ) None
-DOCSTART- -X- N

Tomato NNP Pharmocological
paste NN Pharmocological
rich JJ Pharmocological
in IN Pharmocological
lycopene JJ Pharmocological
tomato NN Pharmocological
paste NN Pharmocological
-- : Pharmocological
rich JJ Pharmocological
in IN Pharmocological
lycopene NN Pharmocological
55 CD Physical
g NN Physical
tomato NN Physical
paste NN Physical
( ( Physical
16 CD Physical
mg RB Physical
lycopene NN Physical
) ) Physical
in IN Physical
olive JJ Physical
oil NN Physical
, , Physical
or CC Physical
olive JJ Physical
oil NN Physical
alone RB Physical
, , Physical
daily JJ Physical
for IN Physical
12 CD Physical
weeks NNS Physical
. . Physical
tomato JJ None
paste NN None
( ( None
P NNP None
= NNP None
0?01 CD None
CONCLUSIONS NNP None
Tomato NNP None
paste NN None
-DOCSTART- -X- N

Dairy NN Other
products NNS Other
dairy NN Pharmocological
calcium NN Pharmocological
dairy NN Pharmocological
calcium NN Pharmocological
control NN Physical
: : Physical
continue NN Physical
established VBD Physical
dietary JJ Physical
intake NN Physical
; : None
medium NN None
dairy NN None
: : None
substitute NN None
dairy NN None
products NNS None
to TO None
achieve VB None
intake NN Pharmocological
of IN Pharmocological
calcium NN Pharmocological
of IN Pharmocological
approximately RB Pharmocological
1000-1100 JJ Pharmocological
mg/d NN Pharmocological
and CC None
maintain VB None
isocaloric JJ Pharmocological
intake NN Pharmocological
; : None
high JJ None
dairy NN None
: : None
substitute NN None
dairy NN None
products NNS None
to TO None
achieve VB None
intake NN Pharmocological
of IN Pharmocological
calcium NN Pharmocological
of IN Pharmocological
1300-1400 JJ Pharmocological
mg/d NN Pharmocological
and CC None
maintain VB None
isocaloric JJ Pharmocological
intake NN Pharmocological
. . None
dairy NN Pharmocological
products NNS Pharmocological
-DOCSTART- -X- N

leukocyte JJ Pharmocological
IFN-alpha NN Pharmocological
HBV NNP Pharmocological
vaccine NN Pharmocological
IFN-alpha NNP Pharmocological
adjuvant NN Pharmocological
of IN Pharmocological
HBV NNP Pharmocological
vaccine NN Pharmocological
IFN-alpha NNP Pharmocological
-DOCSTART- -X- N

Social NNP Educational
skills NNS Educational
training VBG Educational
social JJ Educational
skills NNS Educational
interventions NNS Educational
an DT Educational
evidence-based JJ Educational
, , None
caregiver-assisted JJ Educational
social JJ Educational
skills NNS Educational
intervention NN Educational
known VBN Educational
as IN Educational
PEERS NNP Educational
for IN Educational
Young NNP Educational
Adults NNP Educational
caregiver-assisted JJ Educational
, , None
manualized VBN Educational
intervention NN Educational
-DOCSTART- -X- N

endocrine NN None
treatments NNS None
aromatase NN Pharmocological
inhibitors NNS Pharmocological
tamoxifen NN Pharmocological
exemestane VB Pharmocological
endocrine JJ Pharmocological
treatment NN Pharmocological
tamoxifen NN Pharmocological
exemestane NN Pharmocological
exemestane NN Pharmocological
-DOCSTART- -X- N

Insecticide-treated JJ Other
bednets NNS Other
free JJ Educational
Interviews NNS Educational
coverage NN Other
of IN Other
per IN Other
bednet NN Other
owned VBN Other
. . None
bednet NN Other
free JJ Other
bednet NN Other
distribution NN Other
program NN Other
-DOCSTART- -X- N

plasma NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
metabolites VBZ Pharmocological
, , None
vitamin FW None
D NNP None
receptor NN None
polymorphisms NN None
25-hydroxyvitamin JJ Pharmocological
D3 NNP None
( ( None
25 CD None
[ NNP None
OH NNP None
] NNP None
D NNP None
) ) None
25 CD Pharmocological
( ( Pharmocological
OH NNP Pharmocological
) ) Pharmocological
D NNP Pharmocological
1,25 CD Pharmocological
( ( Pharmocological
OH NNP Pharmocological
) ) Pharmocological
2D CD Pharmocological
vitamin NN None
D NNP None
status NN None
VDR NNP None
FokI NNP None
polymorphism NN None
-DOCSTART- -X- N

vaccine NN Pharmocological
vaccine NN Pharmocological
vaccine NN Pharmocological
vaccine NN Pharmocological
vaccine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

denbufylline NN Pharmocological
denbufylline JJ Pharmocological
placebo NN Control
Denbufylline NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

full JJ Physical
orthodontic JJ Physical
appliances NNS Physical
. . None
-DOCSTART- -X- N

Thai NNP Educational
Traditional NNP Educational
Massage NNP Educational
( ( Educational
TTM NNP Educational
) ) Educational
Standard NNP Educational
sensory JJ Educational
integration NN Educational
therapy NN Educational
( ( Educational
SI NNP Educational
) ) Educational
TTM NNP Educational
-DOCSTART- -X- N

Paracetamol NNP Pharmocological
paracetamol NN Pharmocological
( ( Pharmocological
acetaminophen NN Pharmocological
, , Pharmocological
APAP NNP Pharmocological
) ) Pharmocological
intravenous JJ Pharmocological
paracetamol NN Pharmocological
( ( None
APAP NNP None
1 CD None
g NN None
) ) None
or CC None
saline NN Control
( ( None
placebo NN Control
, , None
pl NN None
) ) None
IV NNP Pharmocological
naloxone NN Pharmocological
( ( None
Nal NNP None
8 CD None
mg NN None
) ) None
or CC None
saline NN Control
APAP/pl NNP Pharmocological
APAP/Nal NNP Pharmocological
. . None
APAP/Nal NNP Pharmocological
naloxone RB Pharmocological
paracetamol JJ Pharmocological
-DOCSTART- -X- N

interactive JJ Educational
expert NN Educational
system NN Educational
intervention NN Educational
the DT Educational
interactive JJ Educational
expert NN Educational
system NN Educational
intervention NN Educational
; : None
expert NN Educational
system NN Educational
intervention NN Educational
plus CC Educational
counselor NN Educational
calls VBZ Educational
; : None
the DT None
expert NN Educational
system NN Educational
intervention NN Educational
plus CC Educational
the DT Educational
stimulus NN Educational
control NN Educational
computer NN Educational
; : None
assessment NN Educational
only RB Educational
condition NN Educational
. . None
interactive JJ Educational
expert NN Educational
system NN Educational
-DOCSTART- -X- N

risedronate NN Pharmocological
alendronate NN Pharmocological
Bisphosphonates NNPS Pharmocological
risedronate NN Pharmocological
, , Pharmocological
a DT Pharmocological
pyridinyl NN Pharmocological
bisphosphonate NN Pharmocological
, , None
or CC None
alendronate NN Pharmocological
, , Pharmocological
a DT Pharmocological
primary JJ Pharmocological
amino NN Pharmocological
bisphosphonate NN Pharmocological
risedronate NN Pharmocological
alendronate $ Pharmocological
Endoscopy NNP Surgical
risedronate NN Pharmocological
risedronate NN Pharmocological
alendronate NN Pharmocological
risedronate NN Pharmocological
alendronate NN Pharmocological
risedronate NN Pharmocological
alendronate NN Pharmocological
Risedronate NNP Pharmocological
alendronate NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

P-selectin NNP Pharmocological
blocking NN Pharmocological
agent NN Pharmocological
heparin NN Pharmocological
Pentosan NNP Pharmocological
Polysulfate NNP Pharmocological
Sodium NNP Pharmocological
( ( Pharmocological
PPS NNP Pharmocological
) ) Pharmocological
PPS NNP Pharmocological
PPS NNP Pharmocological
-DOCSTART- -X- N

heparin NN Pharmocological
the DT None
low-dose JJ None
heparin NN None
group NN None
anticoagulant JJ None
heparin NN None
and CC None
the DT None
low-dose JJ None
heparin NN None
group NN None
the DT None
heparin-free JJ None
group NN None
MARS NNP None
was VBD None
the DT None
heparin-free JJ None
group NN None
the DT None
MARS NNP None
circuit NN None
before IN None
MARS NNP None
. . None
low JJ None
dose JJ None
heparin NN None
in IN None
MARS NNP None
improves VBZ None
while IN None
heparin-free JJ None
during IN None
-DOCSTART- -X- N

nifedipine NN Pharmocological
sustained VBN Pharmocological
release NN Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
nifedipine NN Pharmocological
sustained VBN Pharmocological
release NN Pharmocological
nifedipine JJ Pharmocological
SR NNP Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
nifedipine JJ Pharmocological
SR NNP Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
nifedipine JJ Pharmocological
SR NNP Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
-DOCSTART- -X- N

Pethidine NNP Pharmocological
versus NN Pharmocological
tramadol NN Pharmocological
tramadol NN Pharmocological
pethidine NN Pharmocological
pethidine VBP Pharmocological
; : Pharmocological
tramadol NN Pharmocological
pethidine NN Pharmocological
tramadol JJ Pharmocological
tramadol NN Pharmocological
Pethidine NNP Pharmocological
tramadol NN Pharmocological
-DOCSTART- -X- N

glyceryl NN Pharmocological
trinitrate NN Pharmocological
isosorbide NN Pharmocological
dinitrate NN Pharmocological
treatment NN Pharmocological
30 CD Pharmocological
mg NNS Pharmocological
isosorbide JJ Pharmocological
dinitrate NN Pharmocological
( ( Pharmocological
ISDN NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
placebo VB Control
intravenous JJ None
infusion NN None
of IN None
glyceryl NN Pharmocological
trinitrate NN Pharmocological
( ( Pharmocological
GTN NNP Pharmocological
) ) Pharmocological
ISDN NNP Pharmocological
ISDN NNP Pharmocological
treatment NN Pharmocological
, , Pharmocological
GTN NNP Pharmocological
ISDN NNP Pharmocological
ISDN NNP Pharmocological
-DOCSTART- -X- N

GH-releasing NNP Physical
hormone NN Physical
alone RB Physical
combined VBN Physical
with IN Physical
arginine NN Physical
GHRH NNP Pharmocological
injection NN Pharmocological
alone RB Pharmocological
combined VBN None
with IN None
an DT None
infusion NN None
of IN None
the DT None
functional JJ None
somatostatin NN None
antagonist NN None
, , None
arginine NN None
. . None
arginine NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
g NN Pharmocological
) ) Pharmocological
was VBD None
infused VBN None
from IN None
-30 NN None
to TO None
0 CD None
min NN None
, , None
and CC None
GHRH NNP Pharmocological
( ( Pharmocological
100 CD Pharmocological
microg NN Pharmocological
) ) Pharmocological
was VBD None
injected VBN None
as IN None
a DT None
bolus NN None
at IN None
0 CD None
min NNS None
serum NN Physical
GH NNP Physical
[ NNP Physical
immunoradiometric JJ Physical
assay NN Physical
( ( Physical
IRMA NNP Physical
) ) Physical
] VBP Physical
Plasma NNP Physical
IGF-I NNP Physical
( ( Physical
RIA NNP Physical
after IN Physical
acid-ethanol JJ Physical
extraction NN Physical
) ) Physical
GHRH NNP Pharmocological
plus CC Pharmocological
arginine NN Pharmocological
-DOCSTART- -X- N

Ketorolac NNP Pharmocological
versus NN Pharmocological
fentanyl NN Pharmocological
fentanyl NN Pharmocological
ketorolac NN Pharmocological
Fentanyl NNP Pharmocological
ketorolac NN Pharmocological
propofol NN Pharmocological
, , None
nitrous JJ Pharmocological
oxide NN Pharmocological
and CC None
enflurane NN Pharmocological
. . None
-DOCSTART- -X- N

neutral-pH JJ Pharmocological
bicarbonate JJ Pharmocological
dialysis NN Pharmocological
solution NN Pharmocological
novel JJ Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
buffered VBD Pharmocological
with IN Pharmocological
34 CD Pharmocological
mM NNS Pharmocological
pure JJ Pharmocological
bicarbonate NN Pharmocological
at IN Pharmocological
neutral JJ Pharmocological
pH NN Pharmocological
conventional JJ Pharmocological
, , Pharmocological
acidic JJ Pharmocological
, , Pharmocological
35 CD Pharmocological
mM NN Pharmocological
lactate NN Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
neutral-pH JJ Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
with IN Pharmocological
reduced VBN Pharmocological
glucose JJ Pharmocological
degradation NN Pharmocological
product NN Pharmocological
content NN Pharmocological
. . None
, , Pharmocological
neutral-pH JJ Pharmocological
, , Pharmocological
bicarbonate-buffered JJ Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
conventional JJ Pharmocological
, , Pharmocological
acidic JJ Pharmocological
, , Pharmocological
lactate-based JJ Pharmocological
fluids NNS Pharmocological
. . None
-DOCSTART- -X- N

oil NN Pharmocological
with IN Pharmocological
medium- NN Pharmocological
and CC Pharmocological
long-chain JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
oil NN Pharmocological
with IN Pharmocological
medium- NN Pharmocological
and CC Pharmocological
long-chain JJ Pharmocological
triglyceride NN Pharmocological
( ( Pharmocological
MLCT NNP Pharmocological
) ) Pharmocological
those DT None
that IN None
consumed VBD None
MLCT NNP None
oil NN None
and CC None
those DT None
that WDT None
consumed VBD None
long-chain JJ None
triglyceride NN None
( ( None
LCT NNP None
) ) None
oil NN None
LCT NNP Pharmocological
MLCT NNP Pharmocological
LCT NNP Pharmocological
-DOCSTART- -X- N

40 CD None
% NN None
maximal JJ None
voluntary JJ None
contraction NN None
handgrip NN None
for IN None
3 CD None
min NN None
of IN None
postexercise NN None
circulatory NN None
occlusion NN None
( ( None
PECO NNP None
) ) None
to TO None
breathed JJ None
room NN None
air NN None
-DOCSTART- -X- N

oral JJ Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
Fleet NNP Pharmocological
Phospho-Soda NNP Pharmocological
) ) Pharmocological
, , None
lemon-flavored JJ Pharmocological
castor NN Pharmocological
oil NN Pharmocological
( ( Pharmocological
Purge NNP Pharmocological
) ) Pharmocological
, , None
or CC None
standard JJ Pharmocological
polyethylene NN Pharmocological
glycol-based JJ Pharmocological
lavage NN Pharmocological
solution NN Pharmocological
( ( Pharmocological
GoLYTELY NNP Pharmocological
) ) Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
castor JJ Pharmocological
oil NN Pharmocological
. . None
sodium NN Pharmocological
phosphate NN Pharmocological
castor NN Pharmocological
oil NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
polyethylene JJ Pharmocological
glycol-electrolyte JJ Pharmocological
lavage NN Pharmocological
solution NN Pharmocological
or CC None
castor NN Pharmocological
oil NN Pharmocological
. . None
-DOCSTART- -X- N

Standardized JJ Psychological
Psychological JJ Psychological
tests NNS Psychological
-DOCSTART- -X- N

propofol NN Pharmocological
propofol NN Pharmocological
Propofol NNP Pharmocological
-DOCSTART- -X- N

corifollitropin NN Pharmocological
alfa NN Pharmocological
versus NN None
recombinant JJ Pharmocological
FSH NNP Pharmocological
corifollitropin NN Pharmocological
alfa NN Pharmocological
recombinant JJ Pharmocological
FSH NNP Pharmocological
( ( Pharmocological
rFSH NN Pharmocological
) ) Pharmocological
150?g CD None
corifollitropin NN None
alfa NN None
versus IN None
daily JJ None
200IU CD None
rFSH NN None
after IN None
corifollitropin NN None
alfa NN None
compared VBN None
corifollitropin NN None
alfa NN None
and CC None
rFSH NN None
are VBP None
corifollitropin NN None
alfa NN None
can MD None
recombinant JJ None
FSH NNP None
( ( None
rFSH NN None
) ) None
using VBG None
corifollitropin NN None
alfa JJ None
versus JJ None
daily JJ None
rFSH NN None
. . None
A DT None
150?g CD None
corifollitropin NN None
alfa NN None
or CC None
200IU CD None
rFSH NN None
for IN None
corifollitropin NN None
alfa NN None
compared VBN None
daily JJ None
rFSH NN None
regimen NNS None
reached VBN None
. . None
Corifollitropin NNP None
alfa JJ None
treatment NN None
pharmacokinetics NNS None
of IN None
corifollitropin NN Pharmocological
alfa NN Pharmocological
and CC None
rFSH NN Pharmocological
are VBP None
-DOCSTART- -X- N

secretin NN Pharmocological
: : Pharmocological
Secretin NNP Pharmocological
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
placebo NN Control
secretin VB Pharmocological
secretin NN Pharmocological
-DOCSTART- -X- N

Continuous NNP Pharmocological
infusion NN Pharmocological
of IN Pharmocological
ranitidine NN Pharmocological
at IN Pharmocological
6.25 CD Pharmocological
mg/hr NN Pharmocological
( ( None
n JJ None
= NNP None
9 CD None
) ) None
or CC None
placebo NN Control
( ( None
n JJ None
= NNP None
11 CD None
) ) None
for IN None
a DT None
maximum NN None
of IN None
5 CD None
days NNS None
. . None
ranitidine NN Pharmocological
placebo VB Control
ranitidine NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

of IN Physical
adjuvant JJ Physical
immunochemotherapy NN Physical
adjuvant JJ Physical
immunochemotherapy NN Physical
with IN Physical
the DT Physical
use NN Physical
of IN Physical
BCG NNP Pharmocological
( ( Pharmocological
bacille IN Pharmocological
Calmette-Guerin NNP Pharmocological
) ) Pharmocological
and CC None
FAM NNP Pharmocological
( ( None
5-fluorouracil JJ Pharmocological
, , None
adriamycin JJ Pharmocological
, , None
mitomycin JJ Pharmocological
C NNP Pharmocological
) ) None
chemotherapy NN Pharmocological
randomly RB Pharmocological
assigned VBN Pharmocological
to TO Pharmocological
three CD Pharmocological
treatment NN Pharmocological
groups NNS Pharmocological
: : Pharmocological
BCG NNP Pharmocological
+ NNP Pharmocological
FAM NNP Pharmocological
( ( None
immunochemotherapy NN Pharmocological
) ) None
, , None
FAM NNP None
( ( None
chemotherapy NN Pharmocological
) ) None
, , None
and CC None
control NN Surgical
( ( Surgical
surgery NN Surgical
only RB Surgical
) ) Surgical
. . None
Treatment NN Other
was VBD Other
continued VBN Other
for IN Other
2 CD Other
years NNS Other
or CC Other
until IN Other
death NN Other
. . None
Further NNP Other
postsurgical JJ Other
follow VBP Other
up RP Other
was VBD Other
carried VBN Other
on IN Other
for IN Other
up IN Other
to TO Other
10 CD Other
years NNS Other
. . None
FAM NNP Physical
chemotherapy NN Physical
BCG NNP Physical
+ NNP Physical
FAM NNP Physical
BCG NNP None
+ NNP None
FAM NNP None
Immunochemotherapy NNP None
FAM NNP None
adjuvant JJ None
chemotherapy NN None
. . None
-DOCSTART- -X- N

Osteocalcin NNP Pharmocological
intramuscular JJ Pharmocological
( ( Pharmocological
im NN Pharmocological
) ) Pharmocological
gold NN Pharmocological
with IN Pharmocological
im JJ Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
DMARD NNP Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

corticosteroid NN Pharmocological
methylprednisolone NN Pharmocological
( ( None
30 CD None
-DOCSTART- -X- N

prednisolone NN Pharmocological
and CC None
dexamethasone NN Pharmocological
glucocorticoid JJ Pharmocological
treatment NN None
prednisolone VB Pharmocological
or CC None
dexamethasone VB Pharmocological
prednisolone NN Pharmocological
( ( None
40 CD None
mg/m2 NN None
) ) None
or CC None
dexamethasone NN Pharmocological
( ( None
6.5 CD None
mg/m2 NN None
) ) None
as IN None
part NN None
of IN None
the DT None
MRC-ALL97/99 NNP None
induction NN Pharmocological
chemotherapy NN Pharmocological
for IN None
ALL NNP None
. . None
dexamethasone NN Pharmocological
prednisolone NN Pharmocological
glucocorticoid JJ Pharmocological
treatment NN None
regimens NNS None
-DOCSTART- -X- N

salbutamol VB Pharmocological
salbutamol VB Pharmocological
histamine NN Pharmocological
or CC None
methacholine NN Pharmocological
, , None
or CC None
a DT None
sham JJ Pharmocological
challenge NN Pharmocological
with IN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
salbutamol NN Pharmocological
-DOCSTART- -X- N

salbutamol NN Pharmocological
and CC Pharmocological
terbutaline NN Pharmocological
beta2-adrenergic JJ Pharmocological
salbutamol NN Pharmocological
inhaled VBN Pharmocological
terbutaline NN Pharmocological
. . None
salbutamol NN Pharmocological
terbutaline NN Pharmocological
salbutamol NN Pharmocological
terbutaline JJ Pharmocological
Acute NNP Pharmocological
salbutamol NN Pharmocological
and CC Pharmocological
terbutaline JJ Pharmocological
inhalation NN Pharmocological
-DOCSTART- -X- N

ORG-2766 NNP Pharmocological
adrenocorticotropin4-9 JJ Pharmocological
analogue NN Pharmocological
ORG-2766 NNP Pharmocological
-DOCSTART- -X- N

lomustine NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
control VB Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
or CC None
the DT Pharmocological
8-drugs-in-1-day JJ Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
experimental JJ Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
; : None
-DOCSTART- -X- N

Epidural JJ Pharmocological
fentanyl-bupivacaine JJ Pharmocological
clonidine-bupivacaine NN Pharmocological
clonidine NN Pharmocological
50 CD Pharmocological
microg NNS Pharmocological
fentanyl NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine-clonidine JJ Pharmocological
bupivacaine-fentanyl JJ Pharmocological
fentanyl-bupivacaine JJ Pharmocological
clonidine-bupivacaine JJ Pharmocological
bupivacaine NN Pharmocological
clonidine NN Pharmocological
bupivacaine-fentanyl NN Pharmocological
. . None
-DOCSTART- -X- N

stapled VBN Surgical
technique NN Surgical
with IN Surgical
the DT Surgical
well-accepted JJ Surgical
conventional JJ Surgical
Stapled NNP Surgical
hemorrhoidectomy NN Surgical
-DOCSTART- -X- N

Lanthanum NNP Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
Fosrenol NNP Pharmocological
) ) Pharmocological
Lanthanum NNP Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
Fosrenol NNP Pharmocological
) ) Pharmocological
lanthanum JJ Pharmocological
carbonate NN Pharmocological
treatment NN Pharmocological
placebo NN Control
lanthanum NN Pharmocological
carbonate NN Pharmocological
lanthanum NN Pharmocological
carbonate NN Pharmocological
or CC None
placebo NN Control
lanthanum JJ Pharmocological
carbonate-treated JJ Pharmocological
lanthanum JJ Pharmocological
carbonate NN Pharmocological
lanthanum NN Pharmocological
carbonate NN Pharmocological
Lanthanum NNP Pharmocological
carbonate NN Pharmocological
Lanthanum NNP Pharmocological
carbonate NN Pharmocological
lanthanum NN Pharmocological
carbonate NN Pharmocological
-DOCSTART- -X- N

Intravenous JJ Pharmocological
flecainide NN Pharmocological
versus NN None
verapamil NN Pharmocological
intravenous JJ Pharmocological
flecainide NN Pharmocological
versus VBP None
verapamil NN Pharmocological
verapamil NN Pharmocological
verapamil NNS Pharmocological
flecainide NN Pharmocological
flecainide EX Pharmocological
Verapamil NNP Pharmocological
-DOCSTART- -X- N

breast-feeding JJ Educational
promotion NN Educational
with IN Physical
duplicate JJ Physical
measurements NNS Physical
of IN Physical
height NN Physical
, , Physical
weight NN Physical
, , Physical
waist JJ Physical
circumference NN Physical
, , Physical
triceps NNS Physical
and CC Physical
subscapular JJ Physical
skinfold NN Physical
thicknesses NNS Physical
, , Physical
systolic JJ Physical
and CC Physical
diastolic JJ Physical
BP NNP Physical
. . None
breast-feeding JJ None
promotion NN None
intervention NN None
-DOCSTART- -X- N

psychotherapy VBN Psychological
increase VB Psychological
the DT Psychological
number NN Psychological
of IN Psychological
self-disclosures NNS Psychological
treatment NN Psychological
refrain NN Psychological
from IN Psychological
making VBG Psychological
self-disclosures NNS Psychological
during IN Psychological
treatment NN Psychological
psychotherapy NN Psychological
therapist NN Psychological
disclosure NN Psychological
-DOCSTART- -X- N

zengjing VBG None
no DT None
. . None
1 CD None
capsule NN None
Zengjing VBG Pharmocological
Capsule NNP Pharmocological
No NNP Pharmocological
. . Pharmocological
1 CD Pharmocological
( ( Pharmocological
ZJC1 NNP Pharmocological
) ) Pharmocological
ZJC1 NNP Pharmocological
Wuzi NNP Pharmocological
Yanzong NNP Pharmocological
Pill NNP Pharmocological
ZJC1 NNP Pharmocological
-DOCSTART- -X- N

new JJ Educational
computer NN Educational
intervention NN Educational
new JJ Educational
computer NN Educational
program NN Educational
one CD Educational
group NN Educational
used VBD Educational
the DT Educational
computer NN Educational
program NN Educational
for IN Educational
10 CD Educational
half-hour JJ Educational
sessions NNS Educational
over IN Educational
2 CD Educational
weeks NNS Educational
. . None
computer NN Educational
program NN Educational
-DOCSTART- -X- N

conventional JJ Pharmocological
therapy NN Pharmocological
with IN Pharmocological
digoxin NN Pharmocological
, , Pharmocological
diuretic JJ Pharmocological
drugs NNS Pharmocological
and CC Pharmocological
a DT Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
-DOCSTART- -X- N

Pentoxifylline NNP Pharmocological
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
800 CD Pharmocological
mg JJ Pharmocological
thrice JJ Pharmocological
daily RB Pharmocological
6 CD Pharmocological
week NN Pharmocological
treatment NN Pharmocological
period NN Pharmocological
and CC None
a DT None
6 CD Control
week NN Control
control NN Control
period NN Control
. . None
-DOCSTART- -X- N

mild JJ Physical
endurance NN Physical
exercise NN Physical
training NN Physical
pravastatin NN Pharmocological
Exercise NNP Physical
training NN Physical
mild JJ Physical
exercise NN Physical
training NN Physical
statin NN Pharmocological
therapy NN Pharmocological
statin NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
pravastatin NN Pharmocological
exercise NN Physical
training NN Physical
therapy NN Physical
( ( None
mild JJ None
endurance NN None
exercise NN None
three CD None
or CC None
more JJR None
times NNS None
a DT None
week NN None
) ) None
Cardiopulmonary NNP Physical
exercise NN Physical
pravastatin NN Pharmocological
therapy NN None
Exercise NN Physical
training NN Physical
pravastatin-treated JJ Pharmocological
pravastatin NNS Pharmocological
mild JJ Physical
endurance NN Physical
exercise NN Physical
training NN Physical
mild JJ Physical
endurance NN Physical
exercise NN Physical
training NN Physical
pravastatin NN Pharmocological
-DOCSTART- -X- N

diclofenac NN Pharmocological
diclofenac NN Pharmocological
diclofenac VB Pharmocological
control NN Control
cyclopentolate NN Pharmocological
phenylephrine JJ Pharmocological
hydrochloride NN Pharmocological
diclofenac NN Pharmocological
diclofenac NNS Pharmocological
diclofenac NN Pharmocological
diclofenac NN Pharmocological
-DOCSTART- -X- N

gabapentin NN Pharmocological
( ( Pharmocological
1200 CD Pharmocological
mg FW Pharmocological
daily RB Pharmocological
) ) Pharmocological
or CC Pharmocological
vigabatrin NN Pharmocological
( ( Pharmocological
2000 CD Pharmocological
mg FW Pharmocological
daily RB Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

two CD Pharmocological
theophylline NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
58-55-9 NNP Pharmocological
) ) Pharmocological
sustained VBD Pharmocological
release NN Pharmocological
preparations NNS Pharmocological
( ( None
T NNP Pharmocological
: : Pharmocological
Bronchoretard NNP Pharmocological
Capsules/R NNP Pharmocological
: : Pharmocological
Capsule JJ Pharmocological
formulation NN Pharmocological
from IN Pharmocological
the DT Pharmocological
US NNP Pharmocological
market NN Pharmocological
) ) None
Following VBG Pharmocological
individual JJ Pharmocological
dosing NN Pharmocological
of IN Pharmocological
100-300 JJ Pharmocological
mg NNS Pharmocological
theophylline VB Pharmocological
twice RB Pharmocological
a DT Pharmocological
day NN Pharmocological
, , None
a DT None
pharmacokinetic JJ Pharmocological
profile NN Pharmocological
for IN Pharmocological
24 CD Pharmocological
h NN Pharmocological
was VBD Pharmocological
derived VBN Pharmocological
after IN Pharmocological
seven CD Pharmocological
days NNS Pharmocological
of IN Pharmocological
multiple JJ Pharmocological
dosing NN Pharmocological
. . None
All DT None
and CC None
were VBD None
calculated VBN None
for IN None
both DT None
formulations NNS None
. . None
-DOCSTART- -X- N

diets NNS Physical
with IN Physical
low JJ Physical
and CC Physical
high JJ Physical
protein NN Physical
: : Physical
carbohydrate JJ Physical
high JJ Physical
( ( Physical
HP NNP Physical
, , Physical
30 CD Physical
% NN Physical
) ) Physical
, , Physical
low JJ Physical
( ( Physical
LP NNP Physical
, , Physical
6.5 CD Physical
% NN Physical
) ) Physical
, , Physical
or CC Physical
adequate NN Physical
( ( Physical
AP NNP Physical
, , Physical
12.1 CD Physical
% NN Physical
) ) Physical
protein NN Physical
diets NNS Physical
maternal JJ Physical
diets NNS Physical
with IN Physical
during IN Physical
gestation NN Physical
-DOCSTART- -X- N

insecticide-treated JJ Pharmocological
bed NN Pharmocological
nets NNS Pharmocological
( ( Pharmocological
ITN NNP Pharmocological
) ) Pharmocological
ITN NNP Pharmocological
ITN NNP Pharmocological
salivary JJ Surgical
glands NNS Surgical
were VBD Surgical
dissected VBN Surgical
microscopy NN Physical
. . None
ITN NNP Pharmocological
ITN NNP Pharmocological
-DOCSTART- -X- N

dexamethasone JJ Pharmocological
dexamethasone NN None
dexamethasone NN None
placebo NN None
dexamethasone NN None
placebo NN None
granisetron NN None
dexamethasone NN None
granisetron NN None
fluorouracil/epirubicin/cyclophosphamide NN None
doxorubicin/cyclophosphamide NN None
placebo NN None
dexamethasone NN None
dexamethasone NN None
dexamethasone NN None
placebo NN None
-DOCSTART- -X- N

partial JJ Physical
stepwise NN Physical
partial JJ Physical
caries NNS Physical
removal NN Physical
( ( Physical
PCR NNP Physical
) ) Physical
and CC Physical
stepwise JJ Physical
excavation NN Physical
( ( Physical
SW NNP Physical
) ) Physical
-DOCSTART- -X- N

High-dose JJ Physical
weekly JJ Physical
fractionation NN Physical
radiotherapy NN Physical
-DOCSTART- -X- N

Amonafide NN Pharmocological
Amonafide NNP Pharmocological
Amonafide NNP Pharmocological
cyclophosphamide-doxorubicin-5-fluorouracil NN Pharmocological
cyclophosphamide-doxorubicin-5-fluorouracil NN Physical
amonafide RB Pharmocological
cyclophosphamide-doxorubicin-5-fluorouracil JJ Pharmocological
Amonafide NNP Pharmocological
amonafide NN Pharmocological
-DOCSTART- -X- N

technique NN Physical
-DOCSTART- -X- N

Providing VBG Educational
Assistance NNP Educational
to TO Educational
Caregivers NNPS Educational
in IN Educational
Transition NNP Educational
( ( Educational
PACT NNP Educational
) ) Educational
program NN Educational
PACT NNP Other
program NN Other
PACT NNP Educational
case NN Educational
management NN Educational
in IN Educational
addition NN Educational
to TO Educational
their PRP$ Educational
usual JJ Educational
medical JJ Educational
and CC Educational
nursing NN Educational
home NN Educational
care NN Educational
. . None
usual JJ Educational
care NN Educational
. . None
PACT-type JJ Educational
intervention NN Educational
-DOCSTART- -X- N

m-chlorophenylpiperazine NN Pharmocological
m-chlorophenylpiperazine NN Pharmocological
( ( Pharmocological
mCPP NN Pharmocological
) ) Pharmocological
mCPP NN Pharmocological
placebo $ Control
-DOCSTART- -X- N

retroperitoneal JJ Physical
partial JJ Physical
no-closure NN Physical
retroperitoneal JJ Physical
partial JJ Physical
no-closure NN Physical
retroperitoneal JJ Physical
partial JJ Physical
no-closure JJ Physical
group NN Physical
or CC None
a DT Surgical
closure NN Physical
group NN Physical
. . None
Retroperitoneal NNP Physical
partial JJ Physical
no-closure NN Physical
retroperitoneal JJ Surgical
lymphadenectomy NN Surgical
. . None
-DOCSTART- -X- N

risperidone NN Pharmocological
Risperidone NN Pharmocological
-DOCSTART- -X- N

postoperative JJ None
rhythm NNS None
versus JJ None
rate NN None
control NN None
and CC None
anticoagulation NN None
for IN None
by IN None
and CC None
warfarin NN Pharmocological
-DOCSTART- -X- N

logMAR NN Physical
Kay NNP Physical
picture NN Physical
test NN Physical
logMAR JJ Physical
acuity NN Physical
test NN Physical
: : None
crowded JJ Physical
and CC Physical
uncrowded JJ Physical
versions NNS Physical
logMAR JJ Physical
acuity NN Physical
test NN Physical
Kay NNP Physical
picture NN Physical
test NN Physical
logMAR NN Physical
crowded VBD Physical
Kay NNP Physical
picture NN Physical
test NN Physical
crowded VBN Physical
logMAR NN Physical
acuity NN Physical
test NN Physical
uncrowded JJ Physical
test NN Physical
test NN Physical
The DT None
logMAR NN Physical
crowded VBD Physical
Kay NNP Physical
picture NN Physical
test NN Physical
crowded VBD Physical
logMAR JJ Physical
acuity NN Physical
test NN Physical
-DOCSTART- -X- N

ibuprofen NN Pharmocological
ibuprofen NN Pharmocological
ibuprofen NN Pharmocological
or CC None
ibuprofen-arginate NN Pharmocological
Endoscopies NNS Physical
ELISA NNP Physical
-DOCSTART- -X- N

immediate JJ Pharmocological
antimicrobial JJ Pharmocological
treatment NN Pharmocological
versus NN None
watchful JJ Physical
waiting VBG Physical
amoxicillin-clavulanate NN Pharmocological
or CC None
placebo NN Control
amoxicillin-clavulanate NN Pharmocological
placebo NN Control
amoxicillin-clavulanate JJ Pharmocological
placebo NN Control
amoxicillin-clavulanate JJ Pharmocological
placebo NN Control
amoxicillin-clavulanate JJ Pharmocological
placebo NN Control
: : None
placebo NN Control
. . None
amoxicillin-clavulanate NN Pharmocological
. . None
amoxicillin-clavulanate NN Pharmocological
-DOCSTART- -X- N

ad NN Physical
libitum NN Physical
access NN Physical
to TO Physical
high-concentrate JJ Physical
diets NNS Physical
( ( Pharmocological
13 CD Pharmocological
% NN Pharmocological
CP NNP Pharmocological
) ) Pharmocological
containing VBG None
71 CD None
% NN None
whole JJ None
shelled VBN None
corn NN None
, , None
10 CD None
% NN None
corn NN None
silage NN None
, , None
4 CD None
% NN None
condensed JJ None
distillers NNS None
solubles NNS None
, , None
and CC None
15 CD None
% NN None
protein NN None
supplements NNS None
( ( None
DM NNP None
basis NN None
) ) None
. . None
-DOCSTART- -X- N

Social NNP Educational
Skills NNP Educational
Training NNP Educational
Group-based JJ Educational
Program NNP Educational
( ( Educational
SST-GP NNP Educational
) ) Educational
Leisure NN Educational
Activities VBZ Educational
Group-based JJ Educational
Program NNP Educational
( ( Educational
LA-GP NNP Educational
) ) Educational
SST NNP Educational
LA NNP Educational
SST NNP Educational
LA NNP Educational
SST NNP Educational
SST NNP Educational
SST-GP NNP Educational
LA-GP NNP Educational
-DOCSTART- -X- N

Parent-mediated JJ Educational
communication-focused JJ Educational
treatment NN Educational
( ( Educational
Preschool NNP Educational
Autism NNP Educational
Communication NNP Educational
Trial NNP Educational
[ NNP Educational
PACT NNP Educational
] NNP Educational
) ) Educational
intervention NN Educational
treatment NN Control
as IN Control
usual JJ Control
PACT NNP Educational
intervention NN Educational
-DOCSTART- -X- N

Dexamethasone NNP Pharmocological
placebo-controlled JJ Pharmocological
placebo NN Control
normal JJ Control
saline JJ Control
dexamethasone RB Pharmocological
-DOCSTART- -X- N

interferon NN Pharmocological
. . None
interferon JJ Pharmocological
alpha-2a NN Pharmocological
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
cryotherapy NN Pharmocological
placebo-controlled JJ Control
cryotherapy NN Pharmocological
plus CC Pharmocological
subcutaneously RB Pharmocological
administered VBN Pharmocological
interferon NN Pharmocological
alpha-2a NN Pharmocological
cryotherapy NN Control
plus CC Control
placebo NN Control
. . None
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
placebo NN Control
interferon NN Pharmocological
placebo NN Control
interferon NN Pharmocological
therapy NN Pharmocological
interferon NN Pharmocological
placebo NN Control
Interferon NNP Pharmocological
alpha-2a NN Pharmocological
chemotherapeutic JJ Pharmocological
adjuvant NN Pharmocological
to TO Pharmocological
cryotherapy VB Pharmocological
-DOCSTART- -X- N

echis JJ Pharmocological
antivenom NN Pharmocological
made VBD Pharmocological
either CC Pharmocological
by IN Pharmocological
the DT Pharmocological
South JJ Pharmocological
African NNP Pharmocological
Institute NNP Pharmocological
for IN Pharmocological
Medical NNP Pharmocological
Research NNP Pharmocological
( ( Pharmocological
S.A.I.M.R NNP Pharmocological
. . Pharmocological
) ) Pharmocological
( ( None
North NNP None
and CC None
West NNP None
African NNP None
polyvalent NN None
antivenom NN None
) ) None
S.A.I.M.R NNP Pharmocological
. . Pharmocological
antivenom RB None
Behringwerke NNP Pharmocological
antivenom VBP Pharmocological
Behringwerke NNP Pharmocological
antivenom NN Pharmocological
-DOCSTART- -X- N

treatment NN Pharmocological
. . None
short-term JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
alprazolam NN Pharmocological
or CC None
imipramine NN Pharmocological
. . None
-DOCSTART- -X- N

Immunotherapy NNP Pharmocological
BCG NNP Pharmocological
chemotherapy NN Control
alone RB Control
chemotherapy JJ None
plus CC None
Bacille NNP None
Calmette-Gu?rin NNP None
vaccine NN None
( ( None
BCG NNP None
) ) None
of IN None
BCG NNP None
-DOCSTART- -X- N

intubation NN Physical
. . None
Tracheal NNP Physical
tube JJ Physical
placement NN Physical
gum-elastic JJ Physical
bougie NN Physical
. . None
tracheal NN Physical
tube NN Physical
rotation NN Physical
simulated VBN Other
laryngoscope NN Physical
-DOCSTART- -X- N

diltiazem NN Pharmocological
and CC None
propranolol NN Pharmocological
] NN None
diltiazem NN Pharmocological
and CC None
propranolol NN Pharmocological
diltiazem NN Pharmocological
or CC None
propranolol NN Pharmocological
coronary JJ Physical
arteriography NN Physical
propranolol NN Pharmocological
-DOCSTART- -X- N

soy NN Pharmocological
protein NN Pharmocological
containing VBG Pharmocological
isoflavones NNS Pharmocological
Dietary NNP Pharmocological
intake NN Pharmocological
of IN Pharmocological
soy JJ Pharmocological
protein NN Pharmocological
with IN Pharmocological
isoflavones NNS Pharmocological
water-washed JJ Pharmocological
soy NN Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
milk-protein JJ Pharmocological
based VBN Pharmocological
control NN Pharmocological
milk NN Pharmocological
protein-based JJ Pharmocological
supplement NN Pharmocological
( ( None
continued VBN Pharmocological
milk NN Pharmocological
protein NN Pharmocological
) ) None
( ( None
soy JJ Pharmocological
protein NN Pharmocological
) ) None
soy NN Pharmocological
protein NN Pharmocological
protein NN Pharmocological
supplement NN Pharmocological
. . None
-DOCSTART- -X- N

extended JJ Surgical
radical JJ Surgical
radical JJ Surgical
mastectomy NN Surgical
. . None
standard NN Surgical
Halsted NNP Surgical
radical NN Surgical
( ( Surgical
RDL NNP Surgical
) ) Surgical
operation NN Surgical
complete JJ Surgical
extended JJ Surgical
radical NN Surgical
( ( Surgical
EXT NNP Surgical
) ) Surgical
mastectomy NN Surgical
-DOCSTART- -X- N

Levobunolol NNP Pharmocological
timolol NN Pharmocological
levobunolol NN Pharmocological
levobunolol NN Pharmocological
timolol NN Pharmocological
Levobunolol NNP Pharmocological
timolol NN Pharmocological
levobunolol NNS Pharmocological
timolol NN Pharmocological
-DOCSTART- -X- N

haloperidol NN Pharmocological
haloperidol NN Pharmocological
placebo-controlled JJ Control
haloperidol-placebo-haloperidol JJ Pharmocological
or CC None
placebo-haloperidol-placebo JJ Pharmocological
haloperidol NN Pharmocological
placebo VB Control
haloperidol NN Pharmocological
placebo NNS Control
haloperidol NN Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

CBT NNP Educational
intervention NN Educational
brief JJ Educational
CBT NNP Educational
intervention NN Educational
for IN Educational
anxiety NN Educational
intervention NN Educational
for IN Educational
child NN Educational
only RB Educational
, , Educational
intervention NN Educational
for IN Educational
child NN Educational
and CC Educational
parent NN Educational
, , Educational
wait-list JJ Educational
control NN Educational
. . Educational
-DOCSTART- -X- N

nifedipine NN Pharmocological
nitrendipine NN Pharmocological
nitrendipine NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
b.i.d NN Pharmocological
. . Pharmocological
; : Pharmocological
nitrendipine NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
; : Pharmocological
or CC Pharmocological
placebo VB Control
-DOCSTART- -X- N

Paclitaxel NNP Pharmocological
plus CC Pharmocological
carboplatin NN Pharmocological
versus NN None
paclitaxel NN Pharmocological
plus CC Pharmocological
carboplatin NN Pharmocological
paclitaxel NN Pharmocological
and CC None
carboplatin NN Pharmocological
paclitaxel NN Pharmocological
plus CC Pharmocological
carboplatin NN Pharmocological
paclitaxel NN Pharmocological
chemotherapy NN Pharmocological
paclitaxel NN Pharmocological
paclitaxel JJ Pharmocological
paclitaxel NNS Pharmocological
-DOCSTART- -X- N

frusemide NN Pharmocological
Diuretic NNP Pharmocological
40 CD Pharmocological
mg NNS Pharmocological
frusemide JJ Pharmocological
daily RB Pharmocological
or CC Pharmocological
placebo VB Pharmocological
frusemide JJ Pharmocological
placebo NN Pharmocological
frusemide NN Pharmocological
placebo NN Pharmocological
frusemide NN Pharmocological
placebo NN Pharmocological
. . None
frusemide NN Pharmocological
frusemide NN Pharmocological
frusemide NN Pharmocological
-DOCSTART- -X- N

micronutrient JJ Pharmocological
supplementation NN Pharmocological
micronutrient NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
supplementation NN Pharmocological
with IN Pharmocological
beta-carotene NN Pharmocological
, , Pharmocological
vitamins VBZ Pharmocological
C NNP Pharmocological
and CC Pharmocological
E NNP Pharmocological
, , Pharmocological
zinc NN Pharmocological
, , Pharmocological
and CC Pharmocological
selenium NN Pharmocological
surgery NN Surgical
Perioperative NNP Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
micronutrients NNS Pharmocological
-DOCSTART- -X- N

High-pressure NN Physical
, , Physical
rapid-inflation NN Physical
pneumatic JJ Physical
compression NN Physical
duplex JJ Physical
ultrasound NN Physical
scanning NN Physical
Three CD Physical
high-pressure NN Physical
, , Physical
rapid-compression NN Physical
devices NNS Physical
and CC Physical
two CD Physical
standard NN Physical
, , Physical
low-pressure JJ Physical
, , None
slow-inflation JJ Physical
compression NN Physical
devices NNS Physical
-DOCSTART- -X- N

pantoprazole NN Pharmocological
and CC Pharmocological
digoxin NN Pharmocological
Substituted JJ Pharmocological
benzimidazole JJ Pharmocological
inhibitors NNS Pharmocological
pantoprazole JJ Pharmocological
digoxin NN Pharmocological
. . None
digoxin NN Pharmocological
pantoprazole NN Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
( ( Pharmocological
40 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
and CC None
serum JJ None
concentrations NNS None
beta-acetyldigoxin NN Pharmocological
concomitant JJ Pharmocological
oral JJ Pharmocological
pantoprazole NN Pharmocological
placebo JJ Control
pantoprazole NN Pharmocological
and CC None
digoxin NN Pharmocological
pantoprazole NN Pharmocological
) ) None
pantoprazole JJ Pharmocological
( ( None
with IN None
and CC None
without IN None
digoxin NN Pharmocological
) ) None
Pantoprazole NNP Pharmocological
pantoprazole NN Pharmocological
and CC None
digoxin NN Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
Risperidone NNP Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
-DOCSTART- -X- N

sensory JJ Surgical
integration NN Surgical
interventions NNS Surgical
sensory JJ Surgical
integration NN Surgical
( ( Surgical
SI NNP Surgical
) ) Surgical
fine JJ Surgical
motor NN Surgical
SI NNP Physical
treatment NN Physical
-DOCSTART- -X- N

anal JJ Physical
dilator NN Physical
anal JJ Physical
stretch NN Physical
with IN None
or CC None
without IN None
continued JJ Physical
dilatation NN Physical
anal JJ Physical
stretch NN Physical
-DOCSTART- -X- N

Laparoscopically RB Physical
assisted VBN Physical
vaginal JJ Physical
hysterectomy NN Physical
abdominal JJ Physical
hysterectomy NN Physical
laparoscopic JJ Physical
treatment NN Physical
traditional JJ Physical
transabdominal JJ Physical
approach NN Physical
laparoscopic JJ Physical
treatment NN Physical
laparoscopic JJ Physical
procedure NN Physical
-DOCSTART- -X- N

oral JJ Pharmocological
ketoprofen NN Pharmocological
'controlled VBD Pharmocological
release NN Pharmocological
' '' Pharmocological
indomethacin JJ Pharmocological
suppository NN Pharmocological
'controlled-release NNP Pharmocological
' POS Pharmocological
ketoprofen NN Pharmocological
tablets NNS Pharmocological
indomethacin NN Pharmocological
suppositories NNS Pharmocological
ketoprofen JJ Pharmocological
indomethacin JJ Pharmocological
suppository NN Pharmocological
ketoprofen NN Pharmocological
-DOCSTART- -X- N

dependence NN Educational
personal JJ Educational
persuasion NN Educational
abstinence NN Educational
control NN Educational
. . Educational
abstinence NN Educational
-DOCSTART- -X- N

ginger NN Pharmocological
root NN Pharmocological
extract NN Pharmocological
ginger NN Pharmocological
2.0 CD Pharmocological
g/d NN Pharmocological
ginger NN Pharmocological
or CC Pharmocological
placebo NN Control
liquid JJ Physical
chromatography NN Physical
mass NN Physical
spectrometry NN Physical
method NN Physical
Ginger NNP Pharmocological
-DOCSTART- -X- N

telephone NN Educational
videophone NN Other
telephone NN Educational
videophone VB Other
. . None
telephone NN Educational
videophone NN Other
. . None
videophone NN Other
videophone NN Other
. . None
videophone NN Other
telephone NN Educational
. . None
videophone NN Other
-DOCSTART- -X- N

purified JJ Pharmocological
chick JJ Pharmocological
embryo NN Pharmocological
cell NN Pharmocological
culture NN Pharmocological
rabies VBZ Pharmocological
vaccine NN Pharmocological
human JJ Pharmocological
diploid NN Pharmocological
cell NN Pharmocological
vaccine NN Pharmocological
: : None
purified JJ Pharmocological
chick JJ Pharmocological
embryo NN Pharmocological
cell NN Pharmocological
culture NN Pharmocological
rabies VBZ Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
PCECV NNP Pharmocological
) ) Pharmocological
human JJ Pharmocological
diploid NN Pharmocological
cell NN Pharmocological
strain NN Pharmocological
rabies NNS Pharmocological
vaccine VBP Pharmocological
( ( Pharmocological
HDCSV NNP Pharmocological
) ) Pharmocological
PCECV NNP Pharmocological
HDCSV NNP Pharmocological
. . None
PCECV NNP Pharmocological
. . None
-DOCSTART- -X- N

moderate JJ Physical
to TO Physical
aerobic JJ Physical
exercise NN Physical
Exercise NN Physical
exercise NN Physical
exercise NN Physical
randomised VBN None
to TO None
no-exercise NN None
or CC None
to TO None
a DT None
bout NN None
of IN None
treadmill NN None
exercise NN None
at IN None
Sleep VB None
on IN None
no-exercise NN None
and CC None
exercise NN None
nights NNS None
assessed VBN None
by IN None
polysomnography NN None
. . None
Participants NNS None
after IN None
exercise NN None
at IN None
no-exercise JJ None
condition NN None
vigorous JJ None
exercise NN None
did VBD None
level NN None
of IN None
exercise NN None
-DOCSTART- -X- N

Liposome-entrapped JJ Pharmocological
D. NNP Pharmocological
pteronyssinus NN Pharmocological
vaccination NN Pharmocological
placebo-controlled JJ Control
liposome-entrapped JJ Pharmocological
D. NNP Pharmocological
pteronyssinus NN Pharmocological
vaccine NN Pharmocological
methacholine NN Pharmocological
-DOCSTART- -X- N

Haloperidol NNP Pharmocological
haloperidol NN Pharmocological
( ( Pharmocological
HAL NNP Pharmocological
) ) Pharmocological
: : None
haloperidol NN Pharmocological
haloperidol NN Pharmocological
haloperidol NN Pharmocological
-DOCSTART- -X- N

all-norgestrel NN Pharmocological
dl-norgestrel NN Pharmocological
alone RB Pharmocological
estradiol-17 JJ Pharmocological
beta NN Pharmocological
alone RB Pharmocological
combined JJ Pharmocological
hormones NNS Pharmocological
placebo NN Control
control NN None
dl-norgestrel JJ Pharmocological
dl-norgestrel JJ Pharmocological
-DOCSTART- -X- N

Clozapine NNP Pharmocological
versus NN None
placebo NN Control
clozapine NN Pharmocological
clozapine NN Pharmocological
or CC None
placebo NN Control
Clozapine NNP Pharmocological
Clozapine NNP Pharmocological
Clozapine NNP Pharmocological
clozapine NN Pharmocological
-DOCSTART- -X- N

perindopril/indapamide NN Pharmocological
combination NN Pharmocological
low JJ Pharmocological
dose NN Pharmocological
combination NN Pharmocological
perindopril VBD Pharmocological
2 CD Pharmocological
mg/indapamide RB Pharmocological
atenolol $ Pharmocological
Per/Ind NNP Pharmocological
or CC None
Ate NNP Pharmocological
-DOCSTART- -X- N

cuff NN Other
pressure NN Other
release NN Other
valve NN Other
. . None
release NN Other
valve NN Other
( ( None
with IN Other
and CC None
without IN Physical
CPRV NNP Other
) ) None
-DOCSTART- -X- N

etidronate NN Pharmocological
therapy NN Pharmocological
etidronate NN Pharmocological
etidronate NN Pharmocological
placebo NN Control
etidronate NN Pharmocological
placebo NN Control
placebo NN Control
etidronate NN Pharmocological
etidronate NN Pharmocological
-DOCSTART- -X- N

amnioinfusion NN Pharmocological
amnioinfusion NN Pharmocological
with IN Pharmocological
warmed JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
, , None
room-temperature JJ Pharmocological
saline NN Pharmocological
, , None
or CC None
control NN Control
. . None
amnioinfusion NN Pharmocological
amnioinfusion NN Pharmocological
-DOCSTART- -X- N

Montelukast NNP Control
treatment NN Control
placebo-controlled JJ Control
placebo-controlled JJ Control
leukotriene JJ Physical
antagonist NN Physical
montelukast NN Physical
. . None
montelukast NN Physical
placebo NN Control
. . None
-DOCSTART- -X- N

Alcohol NNP Educational
Dependence NNP Educational
Scale NNP Educational
-DOCSTART- -X- N

peginterferon NN Pharmocological
alpha NN Pharmocological
2a CD Pharmocological
interferon NN Pharmocological
alpha NN Pharmocological
2b CD Pharmocological
plus CC Pharmocological
ribavirin VB Pharmocological
peginterferon NN Pharmocological
alpha NN Pharmocological
( ( Pharmocological
pegIFNalpha NN Pharmocological
) ) Pharmocological
2a CD None
monotherapy NN Physical
combination NN Pharmocological
of IN Pharmocological
interferon NN Pharmocological
alpha NN Pharmocological
( ( Pharmocological
IFNalpha NNP Pharmocological
) ) Pharmocological
2b CD Pharmocological
plus CC Pharmocological
ribavirin NN Pharmocological
( ( Pharmocological
RBV NNP Pharmocological
) ) Pharmocological
open-label JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
either DT Pharmocological
pegIFNalpha NN Pharmocological
2a CD Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
206 CD Pharmocological
) ) Pharmocological
or CC None
IFNalpha $ Pharmocological
2b/RBV CD Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
206 CD Pharmocological
) ) Pharmocological
. . None
PegIFNalpha $ Pharmocological
2a CD Pharmocological
IFNalpha $ Pharmocological
2b/RBV CD Pharmocological
pegIFNalpha NN Pharmocological
2a CD Pharmocological
IFNalpha NNP Pharmocological
2b/RBV CD Pharmocological
pegIFNalpha VB Pharmocological
2a CD Pharmocological
IFNalpha NNP Pharmocological
2b/RBV CD Pharmocological
. . None
pegIFNalpha JJ Pharmocological
2a CD Pharmocological
IFNalpha NNP Pharmocological
2b/RBV CD Pharmocological
pegIFNalpha VB Pharmocological
2a CD Pharmocological
-DOCSTART- -X- N

Extra JJ Educational
prompts NNS Educational
no DT Educational
extra JJ Educational
prompts NNS Educational
color-coded JJ Educational
extra JJ Educational
prompt JJ Educational
procedure NN Educational
was VBD None
compared VBN Educational
to TO Educational
a DT Educational
no DT Educational
extra JJ Educational
prompt JJ Educational
procedure NN Educational
learned VBD Educational
to TO Educational
lace VB Educational
shoes NNS Educational
whose WP$ Educational
laces NNS Educational
and CC Educational
eyelets NNS Educational
were VBD Educational
color-coded JJ Educational
red JJ Educational
and CC Educational
white JJ Educational
, , None
and CC None
then RB None
encountered VBD Educational
the DT Educational
no DT Educational
extra JJ Educational
prompt JJ Educational
condition NN Educational
in IN Educational
which WDT Educational
color NN Educational
codes NNS Educational
could MD Educational
no RB Educational
longer RB Educational
be VB Educational
depended VBN Educational
upon IN Educational
to TO Educational
solve VB Educational
the DT Educational
position NN Educational
discriminations NNS Educational
required VBN Educational
to TO Educational
lace VB Educational
properly RB Educational
. . None
-DOCSTART- -X- N

percutaneous JJ Surgical
laser NN Surgical
radiofrequency NN Surgical
ablation NN Surgical
percutaneous JJ Surgical
laser NN Surgical
ablation NN Surgical
( ( Surgical
PLA NNP Surgical
) ) Surgical
radiofrequency NN Surgical
thermoablation NN Surgical
( ( Surgical
RFA NNP Surgical
) ) Surgical
using VBG None
a DT None
multifibre NN None
system NN None
connected VBN None
to TO None
a DT None
neodymium JJ None
yttrium-aluminium-garnet NN None
laser NN None
, , None
using VBG None
an DT None
expandable JJ None
needle JJ None
compared VBN None
to TO None
PLA NNP None
-DOCSTART- -X- N

Angiotensin-converting JJ Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
inhibitor NN Pharmocological
) ) Pharmocological
captopril NN Pharmocological
ACE NNP Pharmocological
inhibitor NN Pharmocological
. . Pharmocological
captopril JJ Pharmocological
captopril NN Pharmocological
ACE NNP Pharmocological
inhibitor NN Pharmocological
ACE NNP Pharmocological
inhibitor JJ Pharmocological
administration NN Physical
ACE NNP Pharmocological
inhibitor NN Pharmocological
-DOCSTART- -X- N

dietary JJ Physical
exposure NN Physical
Dietary JJ Physical
factors NNS Physical
daidzein NN Pharmocological
genistein NN Pharmocological
. . None
soy JJ Pharmocological
foods NNS Pharmocological
and CC Pharmocological
fatty JJ Pharmocological
fish NN Pharmocological
-DOCSTART- -X- N

treadmill NN Physical
interventions NNS Physical
treadmill NN Physical
interventions NNS Physical
lower-intensity-generalized JJ Physical
( ( Physical
LG NNP Physical
) ) Physical
training VBG Physical
group NN Physical
, , None
or CC None
a DT None
higher-intensity-individualized JJ Physical
( ( Physical
HI NNP Physical
) ) Physical
training VBG Physical
group NN Physical
. . None
-DOCSTART- -X- N

Antifibrinolytic JJ Pharmocological
therapy NN Pharmocological
antifibrinolytic JJ Pharmocological
drug NN Pharmocological
tranexemic JJ Pharmocological
acid NN Pharmocological
saline NN Pharmocological
tranexemic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

mecamylamine NN Pharmocological
nicotinic JJ Pharmocological
acetylcholine NN Pharmocological
receptor NN Pharmocological
( ( Pharmocological
nAChR JJ Pharmocological
) ) Pharmocological
agent NN Pharmocological
Mecamylamine NNP None
, , None
because IN None
placebo VB None
( ( None
n=8 NN None
mecamylamine NN None
( ( None
n=12 JJ None
placebo NN None
group NN None
placebo NN None
. . None
Of IN None
continued JJ None
mecamylamine NN None
at IN None
their PRP$ None
CONCLUSION NNP None
Mecamylamine NNP None
appeared VBD None
specific JJ None
?4?2 NNP None
nAChR JJ None
agonist NN None
, , None
such JJ None
as IN None
varenicline NN None
. . None
-DOCSTART- -X- N

afferent JJ Physical
stimulation NN Physical
and CC None
mirror NN Physical
therapy NN Physical
Mirror NNP Physical
therapy NN Physical
( ( Physical
MT NNP Physical
) ) Physical
and CC None
mesh JJ Physical
glove NN Physical
( ( Physical
MG NNP Physical
) ) Physical
afferent NN Physical
stimulation NN Physical
MT NNP Physical
combined VBD Physical
with IN Physical
MG NNP Physical
( ( Physical
MT NNP Physical
+ NNP Physical
MG NNP Physical
) ) Physical
MG NNP Physical
+ NNP Physical
MT NNP Physical
, , Physical
MT NNP Physical
control NN Control
treatment NN Control
( ( Control
CT NNP Control
) ) Control
MT NNP Physical
+ NNP Physical
MG NNP Physical
, , None
MT NNP Physical
CT NNP Control
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
CT NNP Control
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
. . None
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
CT. NNP Control
MG NNP Physical
+ NNP Physical
MT NNP Physical
-DOCSTART- -X- N

ascorbic JJ Pharmocological
acid NN Pharmocological
placebo-controlled JJ Control
ascorbic JJ Pharmocological
acid NN Pharmocological
ascorbate-ascorbate-placebo JJ Pharmocological
treatment NN Pharmocological
order NN Pharmocological
group NN Pharmocological
or CC None
ascorbate-placebo-ascorbate JJ Pharmocological
treatment NN Pharmocological
order NN None
ascorbic JJ Pharmocological
acid NN Pharmocological
treatment NN Pharmocological
. . None
ascorbic JJ Pharmocological
acid NN Pharmocological
. . None
-DOCSTART- -X- N

alfentanil NN Pharmocological
, , None
fentanyl NN Pharmocological
sufentanil NN Pharmocological
propofol NN Pharmocological
alfentanil NN Pharmocological
, , None
fentanyl NN Pharmocological
sufentanil VB Pharmocological
propofol NN Pharmocological
. . None
alfentanil NN Pharmocological
, , None
fentanyl NN Pharmocological
and CC None
sufentanil NN Pharmocological
fentanyl NN Pharmocological
sufentanil NN Pharmocological
alfentanil NN Pharmocological
fentanyl NN Pharmocological
alfentanil NN Pharmocological
sufentanil NN Pharmocological
fentanyl NN Pharmocological
propofol NN Pharmocological
alfentanil NN Pharmocological
sufentanil NN Pharmocological
propofol NN Pharmocological
. . None
alfentanil NN Pharmocological
fentanyl NN Pharmocological
-DOCSTART- -X- N

buflomedil NN Pharmocological
and CC None
dihydrogenated VBD Pharmocological
ergot JJ Pharmocological
alkaloids NNS Pharmocological
. . None
-DOCSTART- -X- N

halothane NN Pharmocological
lidocaine NN Pharmocological
ornipressin NN Pharmocological
fentanyl NN Pharmocological
lidocaine NN Pharmocological
ornipressin NN Pharmocological
fentanyl NN Pharmocological
lidocaine NN Pharmocological
epinephrine NN Pharmocological
prilocaine NN Pharmocological
epinephrine NN Pharmocological
-DOCSTART- -X- N

mitomycin NN Pharmocological
C NNP Pharmocological
adjunctive JJ Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
randomly RB None
assigned VBN None
to TO None
receive VB None
either DT None
no DT Control
adjunctive JJ Control
mitomycin NN Control
C NNP Control
( ( Control
101 CD Control
eyes NNS Control
of IN Control
101 CD Control
patients NNS Control
) ) Control
or CC None
to TO None
receive VB Pharmocological
adjunctive JJ Pharmocological
subconjunctival NN Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
( ( Pharmocological
96 CD Pharmocological
eyes NNS Pharmocological
of IN Pharmocological
96 CD Pharmocological
patients NNS Pharmocological
) ) Pharmocological
during IN Pharmocological
the DT Pharmocological
primary JJ Pharmocological
glaucoma NN Pharmocological
triple JJ Pharmocological
procedure NN Pharmocological
. . None
control NN None
mitomycin NN None
C NNP None
Adjunctive NNP None
mitomycin NN None
C NNP None
adjunctive JJ None
mitomycin NN None
C NNP None
mitomycin NN None
C NNP None
-DOCSTART- -X- N

Alinidine NNP Pharmocological
alinidine NN Pharmocological
alinidine NN Pharmocological
or CC None
placebo NN Control
Alinidine NNP Pharmocological
upright JJ Physical
bicycle NN Physical
exercise NN Physical
. . None
Alinidine NN Pharmocological
alinidine NN Pharmocological
placebo NN Control
alinidine NN Pharmocological
-DOCSTART- -X- N

external JJ Physical
beam NN Physical
radiotherapy NN Physical
cryoablation NN Physical
external JJ Physical
beam NN Physical
radiation NN Physical
therapy NN Physical
( ( Physical
EBRT NNP Physical
) ) Physical
external JJ Physical
beam NN Physical
EBRT NNP Physical
cryoablation NN Physical
or CC None
EBRT NNP Physical
neoadjuvant JJ Pharmocological
antiandrogen NN Pharmocological
EBRT NNP Physical
cryoablation NN Physical
cryoablation NN Physical
cryoablation NN Physical
cryoablation NN Physical
. . None
EBRT NNP Physical
cryoablation NN Physical
. . None
-DOCSTART- -X- N

Aerobic NNP Educational
and CC Educational
strength NN Educational
training NN Educational
nutrition NN Pharmocological
combination NN Educational
of IN Educational
aerobic JJ Educational
and CC Educational
strength NN Educational
training NN Educational
( ( Educational
CAST NNP Educational
) ) Educational
nutrition NN Pharmocological
CAST NNP Educational
nutrition NN Pharmocological
only RB None
nutrition NN Pharmocological
strength NN Physical
training NN Physical
C NNP Pharmocological
N NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
ST NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
modified JJ Pharmocological
carbohydrate NN Pharmocological
nutrition NN Pharmocological
classes NNS Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
ST NNP Pharmocological
received VBD Educational
strength NN Educational
training NN Educational
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
a DT None
combination NN Educational
of IN Educational
strength NN Educational
and CC Educational
aerobic JJ Educational
training NN Educational
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
ST NNP Pharmocological
N NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
CAST NNP Pharmocological
nutrition NN Pharmocological
nutrition JJ Pharmocological
strength NN Educational
training NN Educational
-DOCSTART- -X- N

Systematic JJ Physical
approach NN Physical
canalith NN Physical
repositioning VBG Physical
maneuver NN Physical
( ( Physical
CRM NNP Physical
) ) Physical
and CC Physical
vestibular JJ Physical
rehabilitation NN Physical
( ( Physical
VR NNP Physical
) ) Physical
the DT None
CRM NNP Control
and CC Control
avoidance NN Control
( ( Control
no DT Control
treatment NN Control
) ) Control
. . None
an DT None
individualized JJ Physical
combination NN Physical
of IN Physical
CRM NNP Physical
and CC Physical
VR NNP Physical
-DOCSTART- -X- N

Direct JJ Surgical
aortic JJ Surgical
cannulation NN Surgical
minimally RB Surgical
invasive JJ Surgical
Port-Access NNP Surgical
femoral JJ Surgical
arterial JJ Surgical
cannulation NN Surgical
direct JJ Surgical
aortic JJ Surgical
cannulation NN Surgical
direct JJ Surgical
aortic JJ Surgical
cannulation NN Surgical
standard JJ Surgical
femoral JJ Surgical
artery NN Surgical
cannulation NN Surgical
. . None
-DOCSTART- -X- N

Specific JJ Physical
immunoglobulin NN Physical
Immunoglobulin NNP Physical
immunoglobulins NNS Physical
placebo-controlled JJ Control
monocomponent NN Pharmocological
pertussis NN Pharmocological
toxoid JJ Pharmocological
vaccine NN Pharmocological
; : None
( ( None
b NN None
) ) None
two-component NN Pharmocological
acellular JJ Pharmocological
vaccine NN Pharmocological
also RB Pharmocological
containing VBG Pharmocological
filamentous JJ Pharmocological
haemagglutinin NN Pharmocological
; : None
or CC None
( ( None
c NN None
) ) None
20 CD Control
% NN Control
albumin JJ Pharmocological
solution NN Pharmocological
( ( Control
placebo NN Control
) ) Control
. . None
immunoglobulins NNS Physical
immunoglobulin NN Physical
placebo NN Control
immunoglobulin NN Physical
-DOCSTART- -X- N

Cognitive JJ Educational
behavioral JJ Educational
therapy NN Educational
modular JJ None
cognitive JJ Educational
behavioral JJ Educational
therapy NN Educational
( ( Educational
CBT NNP Educational
) ) Educational
CBT NNP Educational
CBT NNP Educational
3-month JJ Educational
waitlist NN Educational
CBT NNP Educational
CBT NNP Educational
waitlist NN Educational
CBT NNP Educational
waitlist NN Educational
CBT NNP Educational
-DOCSTART- -X- N

rabeprazole NN Pharmocological
rabeprazole JJ Pharmocological
placebo-controlled JJ Control
rabeprazole JJ Pharmocological
placebo NN Control
. . None
rabeprazole JJ Pharmocological
placebo NN Control
rabeprazole NN Pharmocological
placebo NN Control
rabeprazole NN Pharmocological
Rabeprazole NNP Pharmocological
-DOCSTART- -X- N

3,4-Methylenedioxymethamphetamine CD Pharmocological
( ( Pharmocological
MDMA NNP Pharmocological
or CC Pharmocological
ecstasy NN Pharmocological
) ) Pharmocological
MDMA NNP Pharmocological
placebo-controlled JJ Control
dexfenfluramine NN Pharmocological
. . None
dexfenfluramine JJ Pharmocological
-DOCSTART- -X- N

Internet-based JJ Educational
intervention NN Educational
12-week JJ Educational
educational JJ Educational
intervention NN Educational
both DT Educational
the DT Educational
cellular JJ Educational
phone NN Educational
and CC Educational
the DT Educational
Internet NNP Educational
to TO Educational
send VB Educational
short JJ Educational
message NN Educational
service NN Educational
. . None
access NN Educational
a DT Educational
Web NNP Educational
site NN Educational
by IN Educational
using VBG Educational
a DT Educational
cellular JJ Educational
phone NN Educational
or CC Educational
wire NN Educational
Internet NNP Educational
and CC Educational
input VB Educational
their PRP$ Educational
every DT Educational
day NN Educational
. . Educational
optimal JJ Educational
recommendations NNS Educational
-DOCSTART- -X- N

Lactoferrin NNP Pharmocological
supplementation NN Pharmocological
supplemental JJ Pharmocological
lactoferrin NN Pharmocological
lactoferrin NN Pharmocological
lactoferrin JJ Pharmocological
supplements NNS Pharmocological
lactoferrin JJ Pharmocological
supplements NNS Pharmocological
Lactoferrin NNP Pharmocological
supplementation NN Pharmocological
lactoferrin JJ Pharmocological
supplementation NN Pharmocological
lactoferrin NN Pharmocological
-DOCSTART- -X- N

Topical JJ Pharmocological
PUVA NNP Pharmocological
, , Pharmocological
etretinate NN Pharmocological
combined VBN Pharmocological
PUVA NNP Pharmocological
and CC Pharmocological
etretinate VB Pharmocological
topical JJ Pharmocological
PUVA NNP Pharmocological
, , Pharmocological
oral JJ Pharmocological
etretinate NN Pharmocological
( ( Pharmocological
Re NNP Pharmocological
) ) Pharmocological
combined VBN Pharmocological
PUVA NNP Pharmocological
and CC Pharmocological
etretinate VB Pharmocological
( ( Pharmocological
Re-PUVA NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

salmeterol NN Pharmocological
, , None
salmeterol NN Pharmocological
+ NNP None
ipratropium NN Pharmocological
bromide NN Pharmocological
, , None
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

thrombosis JJ Physical
embolic JJ Physical
deterrent NN Physical
stockings NNS Physical
alone RB Physical
or CC None
thrombosis VB Physical
embolic JJ Physical
deterrent NN Physical
stockings NNS Physical
and CC None
pneumatic JJ Physical
compression NN Physical
boots NNS Physical
-DOCSTART- -X- N

idarubicin NN Pharmocological
and CC Pharmocological
daunorubicin NN Pharmocological
-DOCSTART- -X- N

appliance NN Physical
therapy NN Physical
stabilization NN Physical
appliance NN Physical
control NN Physical
appliance NN Physical
stabilization NN Physical
appliance NN Physical
stabilization NN Physical
appliance NN Physical
stabilization NN Physical
appliance NN Physical
-DOCSTART- -X- N

Nizatidine NNP Pharmocological
ranitidine NN Pharmocological
nizatidine NN Pharmocological
ranitidine NN Pharmocological
nizatidine VB Pharmocological
300 CD Pharmocological
mg NN Pharmocological
nocte NN Pharmocological
, , Pharmocological
150 CD Pharmocological
mg NN Pharmocological
b.d NN Pharmocological
. . Pharmocological
or CC Pharmocological
ranitidine VB Pharmocological
150 CD Pharmocological
mg NN Pharmocological
nizatidine VB Pharmocological
300 CD Pharmocological
mg JJ Pharmocological
nocte NN Pharmocological
or CC Pharmocological
ranitidine VB Pharmocological
300 CD Pharmocological
mg NN Pharmocological
nocte NN Pharmocological
. . Pharmocological
Nizatidine NNP Pharmocological
ranitidine NN Pharmocological
-DOCSTART- -X- N

citalopram VB Pharmocological
and CC Pharmocological
reboxetine VB Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
SSRI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
citalopram NN Pharmocological
, , Pharmocological
and CC Pharmocological
a DT Pharmocological
noradrenaline JJ Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
NARI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
reboxetine NN Pharmocological
citalopram NN Pharmocological
reboxetine NN Pharmocological
. . None
citalopram NN Pharmocological
reboxetine NN Pharmocological
reboxetine NN Pharmocological
Citalopram NNP Pharmocological
reboxetine NN Pharmocological
-DOCSTART- -X- N

prethrombolytic JJ Pharmocological
cyclosporine-A JJ Pharmocological
injection NN Pharmocological
Cyclosporine-A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
Patients NNS None
in IN None
the DT None
treatment NN None
group NN None
received VBD None
an DT None
intravenous JJ None
bolus NN None
injection NN None
of IN None
2.5 CD None
mg/kg NN None
of IN None
CsA NNP Pharmocological
immediately RB None
before IN None
TLT NNP None
. . None
The DT None
patients NNS None
in IN None
the DT None
control NN None
group NN None
received VBD None
an DT None
equivalent JJ None
volume NN None
of IN None
normal JJ Control
saline NN Control
. . None
-DOCSTART- -X- N

sensory JJ Physical
level-high JJ Physical
volt NN Physical
pulsed VBD Physical
electrical JJ Physical
current JJ Physical
( ( Physical
HVPC NNP Physical
) ) Physical
experimental JJ Physical
condition NN Physical
( ( Physical
HVPC NNP Physical
) ) Physical
placebo JJ Control
HVPC NNP Physical
placebo NN Control
( ( None
HVPC NNP Physical
or CC None
placebo NN Control
) ) None
HVPC NNP Physical
placebo NN Control
-DOCSTART- -X- N

wet JJ Other
corn NN Other
gluten NNS Other
feed VBP Other
( ( Other
WCGF NNP Other
) ) Other
control NN Physical
-- : Physical
WCGF NNP Physical
not RB Physical
fed RB Physical
( ( None
n JJ None
= NNP None
27 CD None
) ) None
; : None
2 CD None
) ) None
WCGF-L-cows NNP None
received VBD None
diets NNS Other
containing VBG Other
WCGF NNP Other
( ( None
38 CD None
% NN None
DM NNP None
basis NN None
) ) None
during IN None
lactation NN None
( ( None
n JJ None
= NNP None
23 CD None
) ) None
; : None
and CC None
3 CD None
) ) None
WCGF-DL NNP None
-- : None
cows VBZ None
received VBN None
diets NNS Other
containing VBG Other
WCGF NNP Other
( ( None
38 CD None
% NN None
DM NNP None
basis NN None
) ) None
during IN None
the DT None
dry JJ None
period NN None
and CC None
lactation NN None
( ( None
n JJ None
= NNP None
26 CD None
) ) None
. . None
-DOCSTART- -X- N

prophylactic JJ Pharmocological
chemotherapy NN Pharmocological
prophylactic JJ Pharmocological
chemotherapy NN Pharmocological
post-operative JJ Pharmocological
prophylactic JJ Pharmocological
chemotherapy NN Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
Endoxan NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
radiotherapy NN Physical
-DOCSTART- -X- N

strontium NN Pharmocological
strontium NN Pharmocological
. . None
strontium NN Pharmocological
SrRan NNP Pharmocological
placebo NN Control
SrRan NNP Pharmocological
. . None
-DOCSTART- -X- N

ultrasound IN Physical
dating VBG Physical
scan JJ Physical
ultrasound JJ Physical
dating NN Physical
scan NN Physical
between IN None
8 CD None
and CC None
12 CD None
weeks NNS None
, , None
measuring VBG None
crown-rump JJ None
length NN None
. . None
ultrasound IN Physical
dating VBG Physical
scan JJ Physical
-DOCSTART- -X- N

novel NN Physical
technique NN Physical
using VBG Physical
a DT Physical
barbed JJ Surgical
suture NN Surgical
. . None
barbed JJ Physical
suture NN Physical
barbed JJ Physical
suture NN Physical
conventional JJ Physical
closure NN Physical
3-0 JJ Pharmocological
polydioxanone NN Pharmocological
suture NN Pharmocological
. . None
conventional JJ Physical
suture NN Physical
-DOCSTART- -X- N

folic JJ Pharmocological
acid-containing JJ Pharmocological
multivitamin NN Pharmocological
supplementation NN Pharmocological
mg NN None
) ) None
-containing VBG Pharmocological
multivitamin JJ Pharmocological
supplementation NN Pharmocological
carbamazepine NN Pharmocological
and CC Pharmocological
a DT Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
mg NN None
) ) None
-containing VBG Pharmocological
multivitamin NN Pharmocological
-DOCSTART- -X- N

7-day JJ Pharmocological
and CC Pharmocological
14-day JJ Pharmocological
proton NN Pharmocological
pump IN Pharmocological
inhibitor-containing JJ Pharmocological
triple JJ Pharmocological
therapy NN Pharmocological
triple JJ Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
a DT None
proton NN Pharmocological
pump NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
PPI NNP Pharmocological
) ) Pharmocological
two CD Pharmocological
antibiotics NNS Pharmocological
7-day JJ Pharmocological
and CC Pharmocological
14-day JJ Pharmocological
PPI-containing JJ Pharmocological
triple NN Pharmocological
therapy NN Pharmocological
. . None
PAC7 NNP Pharmocological
( ( None
omeprazole JJ Pharmocological
20 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
equivalent JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
other JJ Pharmocological
PPIs NNP Pharmocological
, , Pharmocological
amoxicillin NN Pharmocological
1000 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
and CC Pharmocological
clarithromycin VBZ Pharmocological
500 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
for IN Pharmocological
7 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
PAC14 NNP Pharmocological
( ( None
the DT Pharmocological
same JJ Pharmocological
regimen NN Pharmocological
as IN Pharmocological
the DT Pharmocological
PAC7 NNP Pharmocological
group NN Pharmocological
but CC Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) None
PAC7 NNP Pharmocological
PAC14 NNP Pharmocological
PAC7 NNP Pharmocological
PAC14 NNP Pharmocological
7-day JJ None
PPI-containing JJ None
triple JJ None
anti-H. JJ None
pylori NN None
therapy NN None
14-day JJ Other
